PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Luo, ZC; Karlberg, J				Luo, ZC; Karlberg, J			Timing of birth and infant and early neonatal mortality in Sweden 1973-95: longitudinal birth register study	BRITISH MEDICAL JOURNAL			English	Article							DEATHS; ASPHYXIA	Objective To assess the impact of time of birth on infant mortality and early neonatal mortality in full term and preterm births. Design Analysis of data from the Swedish birth register, 1973-95. Participants 2 102 324 spontaneous live births of infants without congenital malformation. Outcome measurements Absolute and relative risk of infant mortality, early neonatal mortality, and early neonatal mortality related to asphyxia. Results Infant mortality, early neonatal morality, and early neonatal mortality related to asphyxia were higher in infants who were born during the night (9 pm to 9 am) compared with those born during the day for 1973-9, 1980-9, and 1990-5. The difference was more dramatic for preterm infants. The largest difference was observed during 1990-5, when there was a 30% increase in early neonatal morality (relative risk 1.31, 95% confidence interval 1.10 to 1.57) and a 70% increase in early neonatal mortality related to asphyxia (1.70, 1.22 to 2.38) in preterm infants born during the night compared with rates for preterm infants born during the day. A detailed analysis over 24 hours revealed two "high risk" periods: between 5 pm and 1 am and around 9 am. Conclusions Infants born during the night have a greater risk of infant and early neonatal mortality and early neonatal mortality related to asphyxia than those born during th day. There has been no improvement over the past two decades. The problem is more serious for preterm births and was even worse in the 1990s. Shift changes and the hours immediately after such changes are high risk periods for neonatal care.	Univ Hong Kong, Clin Trials Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Karlberg, J (corresponding author), Univ Hong Kong, Clin Trials Ctr, Hong Kong, Hong Kong, Peoples R China.		Luo, Zhong-Cheng/T-3882-2017; Karlberg, Johan Petter Einar/C-4290-2009; Karlberg, Johan/AAZ-7864-2020	Luo, Zhong-Cheng/0000-0002-1794-1312; 				Chalmers JWT, 1998, BRIT MED J, V317, P539; Cheung YB, 2000, AM J EPIDEMIOL, V152, P1107, DOI 10.1093/aje/152.12.1107; Cheung YB, 2001, STAT MED, V20, P2455, DOI 10.1002/sim.858; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Heller G, 2000, BRIT MED J, V321, P274, DOI 10.1136/bmj.321.7256.274; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; *PAN AM HLT ORG, 1998, HLTH AM; Stewart JH, 1998, BRIT MED J, V316, P657, DOI 10.1136/bmj.316.7132.657	8	54	55	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2001	323	7325					1327	1330		10.1136/bmj.323.7325.1327	http://dx.doi.org/10.1136/bmj.323.7325.1327			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501ZC	11739216	Bronze, Green Published			2022-12-01	WOS:000172716900013
J	Nash, P; Tang, XJ; Orlicky, S; Chen, QH; Gertler, FB; Mendenhall, MD; Sicheri, F; Pawson, T; Tyers, M				Nash, P; Tang, XJ; Orlicky, S; Chen, QH; Gertler, FB; Mendenhall, MD; Sicheri, F; Pawson, T; Tyers, M			Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication	NATURE			English	Article							UBIQUITIN-LIGASE COMPLEX; PROTEIN-PROTEIN INTERACTIONS; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; F-BOX; DEPENDENT DEGRADATION; S-PHASE; KAPPA-B; KINASE	SCF ubiquitin ligases target phosphorylated substrates for ubiquitin-dependent proteolysis by means of adapter subunits called F-box proteins. The F-box protein Cdc4 captures phosphorylated forms of the cyclin-dependent kinase inhibitor Sic1 for ubiquitination in late G1 phase, an event necessary for the onset of DNA replication. The WD40 repeat domain of Cdc4 binds with high affinity to a consensus phosphopeptide motif (the Cdc4 phospho-degron, CPD), yet Sic1 itself has many sub-optimal CPD motifs that act in concert to mediate Cdc4 binding. The weak CPD sites in Sic1 establish a phosphorylation threshold that delays degradation in vivo, and thereby establishes a minimal G1 phase period needed to ensure proper DNA replication. Multisite phosphorylation may be a more general mechanism to set thresholds in regulated protein-protein interactions.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Kentucky, Dept Biochem, LP Markey Canc Ctr, Lexington, KY 40536 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Kentucky; Massachusetts Institute of Technology (MIT); University of Toronto	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@mshri.on.ca; tyers@mshri.on.ca	Pawson, Tony J/E-4578-2013; Sicheri, Frank/F-8856-2013; Tyers, Michael/ABE-3194-2021	Orlicky, Stephen/0000-0002-8172-2042				Amati B, 1999, NAT CELL BIOL, V1, pE91, DOI 10.1038/12087; Annan RS, 2001, ANAL CHEM, V73, P393, DOI 10.1021/ac001130t; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cormack B, 1998, CURR OPIN MICROBIOL, V1, P406, DOI 10.1016/S1369-5274(98)80057-X; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Guthrie C, 1991, METHODS ENZYMOLOGY; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; MCKINNEY JD, 1995, MOL CELL BIOL, V15, P2509; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pawson T, 2000, GENE DEV, V14, P1027; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; Schneider BL, 1998, NATURE, V395, P86, DOI 10.1038/25774; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SPENCER F, 1990, GENETICS, V124, P237; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Winston JT, 1999, GENE DEV, V13, P2751, DOI 10.1101/gad.13.21.2751; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	48	630	638	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2001	414	6863					514	521		10.1038/35107009	http://dx.doi.org/10.1038/35107009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734846				2022-12-01	WOS:000172405900039
J	Irgens, HU; Reisaeter, L; Irgens, LM; Lie, RT				Irgens, HU; Reisaeter, L; Irgens, LM; Lie, RT			Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER RISK; REMOTE PROGNOSIS; NORWEGIAN WOMEN; PREGNANCY; PREECLAMPSIA; HYPERTENSION; SMOKING; BIRTH; NORWAY; AGE	Objective To assess whether mothers and fathers have a higher long term risk of death, particularly from cardiovascular disease and cancer, after the mother has had pre-eclampsia. Design Population based cohort study of registry data. Subjects Mothers and fathers of all 626 272 births that were the mothers' first deliveries, retarded in the Norwegian medical birth registry from 1967 to 1992. Parents were divided into two cohorts based on whether the mother had pre-eclampsia during the pregnancy. Subjects were also stratified by whether the birth was term or preterm, given that pre-eclampsia might be more severe in preterm pregnancies. Main outcome measures Total mortality and mortality from cardiovascular causes, cancer, and stroke from 1967 to 1992, from data from the Norwegian registry of causes of death. Results Women who lead pre-eclampsia had a 1.2-fold higher long term risk of death (95% confidence interval 1.02 to 1.37) than women who did not have pre-eclampsia. The risk ill women with pre-eclampsia and a preterm delivery mss 2.71-fold higher (1.99 to 3.68) than in women who did not have pre-eclampsia and whose pregnancies event to term. In particular, the risk of death from cardiovascular causes among women with pre-eclampsia and a preterm delivery was 8.12-fold higher (4.31 to 15.33). However, these women had a 0.36-fold (not significant) decreased risk of cancer. The long term risk of death was no higher among the fathers of the pre-eclamptic pregnancies than the fathers of pregnancies in which pre-eclampsia did not occur. Conclusions Genetic factors that increase the risk of cardiovascular disease may also be linked to pre-eclampsia. A possible genetic contribution from fathers to the risk of pre-eclampsia was not reflected in increased risks of death from cardiovascular causes or cancer among fathers.	Univ Bergen, Haukeland Hosp, Dept Publ Hlth & Primary Hlth Care, Med Birth Registry Norway,Locus Registry Based Ep, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital	Irgens, LM (corresponding author), Univ Bergen, Haukeland Hosp, Dept Publ Hlth & Primary Hlth Care, Med Birth Registry Norway,Locus Registry Based Ep, N-5021 Bergen, Norway.			Reisaeter, Lars/0000-0002-1242-1502				ALBREKTSEN G, 1994, EPIDEMIOLOGY, V5, P604, DOI 10.1097/00001648-199411000-00008; ALBREKTSEN G, 1995, BRIT J CANCER, V72, P480, DOI 10.1038/bjc.1995.359; ALBREKTSEN G, 1995, INT J CANCER, V60, P341, DOI 10.1002/ijc.2910600311; CHESLEY LC, 1976, AM J OBSTET GYNECOL, V124, P446, DOI 10.1016/0002-9378(76)90168-X; Cnattingius S, 1997, AM J OBSTET GYNECOL, V177, P156, DOI 10.1016/S0002-9378(97)70455-1; De Groot CJM, 1999, AM J OBSTET GYNECOL, V181, P975, DOI 10.1016/S0002-9378(99)70335-2; FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Higgins JR, 2001, LANCET, V357, P131, DOI 10.1016/S0140-6736(00)03552-2; Innes KE, 1999, EPIDEMIOLOGY, V10, P722, DOI 10.1097/00001648-199911000-00013; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Li DK, 2000, AM J EPIDEMIOL, V151, P57, DOI 10.1093/oxfordjournals.aje.a010122; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; LINDHEIMER MD, 1985, NEW ENGL J MED, V313, P675, DOI 10.1056/NEJM198509123131107; MARCOUX S, 1989, AM J EPIDEMIOL, V130, P950, DOI 10.1093/oxfordjournals.aje.a115427; *MED BIRTH REG NOR, 1997, BIRTHS NORW 30 YEARS, P1; Mogren I, 1999, EPIDEMIOLOGY, V10, P518, DOI 10.1097/00001648-199909000-00009; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Smith GD, 2000, BRIT MED J, V320, P839, DOI 10.1136/bmj.320.7238.839; Smith GD, 2000, LANCET, V356, P2066, DOI 10.1016/S0140-6736(00)03406-1	22	801	823	0	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 24	2001	323	7323					1213	1216		10.1136/bmj.323.7323.1213	http://dx.doi.org/10.1136/bmj.323.7323.1213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497HZ	11719411	Green Published, Bronze			2022-12-01	WOS:000172450500015
J	Cukierman, E; Pankov, R; Stevens, DR; Yamada, KM				Cukierman, E; Pankov, R; Stevens, DR; Yamada, KM			Taking cell-matrix adhesions to the third dimension	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; FOCAL ADHESIONS; INTEGRINS; DYNAMICS; FIBRONECTIN; MIGRATION	Adhesions between fibroblastic cells and extracellular matrix have been studied extensively in vitro, but tittle is known about their in vivo counterparts. Here, we characterized the composition and function of adhesions in three-dimensional (3D) matrices derived from tissues or cell culture. "3D-matrix adhesions" differ from focal and fibrillar adhesions characterized on 2D substrates in their content of alpha (5)beta (1) and alpha (v)beta (3) integrins, paxillin, other cytoskeletal components, and tyrosine phosphorylation of focal adhesion kinase (FAK). Relative to 2D substrates, 3D-matrix interactions also display enhanced cell biological activities and narrowed integrin usage. These distinctive in vivo 3D-matrix adhesions differ in structure, localization, and function from classically described in vitro adhesions, and as such they may be more biologically relevant to living organisms.	Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Yamada, KM (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA.		Pankov, Roumen G/B-3284-2014; Ladoux, Benoit/A-9879-2013; Pankov, Roumen/AAK-3205-2021; cukierman, edna/AAU-8932-2020; Cukierman, Edna/A-3951-2013	Pankov, Roumen G/0000-0002-3157-3659; Pankov, Roumen/0000-0002-3157-3659; cukierman, edna/0000-0002-1452-9576; 	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000525, ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524, Z01DE000525] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adams JC, 2001, CELL MOL LIFE SCI, V58, P371, DOI 10.1007/PL00000864; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Hayashi K, 1999, J CELL SCI, V112, P1149; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cb.11.110195.002115; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Roskelley CD, 1995, BIOCHEM CELL BIOL, V73, P391, DOI 10.1139/o95-046; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; TURNER DC, 1983, DEV BIOL, V95, P497, DOI 10.1016/0012-1606(83)90052-0; VLODAVSKY I, 1999, CURR PROTOCOLS CELL, V1; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Zamir E, 1999, J CELL SCI, V112, P1655	23	2308	2413	11	561	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1708	1712		10.1126/science.1064829	http://dx.doi.org/10.1126/science.1064829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721053				2022-12-01	WOS:000172307400042
J	Bartke, A; Wright, JC; Mattison, JA; Ingram, DK; Miller, RA; Roth, GS				Bartke, A; Wright, JC; Mattison, JA; Ingram, DK; Miller, RA; Roth, GS			Longevity - Extending the lifespan of long-lived mice	NATURE			English	Article							AMES DWARF MICE; CALORIC RESTRICTION; GENE		So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; NIA, NIH, Anim Ctr, Poolesville, MD 20837 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Gerontol Res Ctr, Baltimore, MD 21224 USA	Southern Illinois University System; Southern Illinois University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan	Bartke, A (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.		Bartke, Andzej/D-6640-2017	Bartke, Andzej/0000-0002-2569-557X	NATIONAL INSTITUTE ON AGING [Z01AG000304] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bartke A, 2000, RES PRO CEL, V29, P181; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; HARRIS SB, 1994, MECH AGEING DEV, V73, P209, DOI 10.1016/0047-6374(94)90053-1; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Mattison JA, 2000, J AM AGING ASSOC, V23, P9, DOI 10.1007/s11357-000-0002-0; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618	11	310	321	0	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					412	412		10.1038/35106646	http://dx.doi.org/10.1038/35106646			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719795	Green Published, Bronze			2022-12-01	WOS:000172304500033
J	Solomon, CG; Hu, FB; Dunaif, A; Rich-Edwards, J; Willett, WC; Hunter, DJ; Colditz, GA; Speizer, FE; Manson, JE				Solomon, CG; Hu, FB; Dunaif, A; Rich-Edwards, J; Willett, WC; Hunter, DJ; Colditz, GA; Speizer, FE; Manson, JE			Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYCYSTIC-OVARY-SYNDROME; IMPAIRED GLUCOSE-TOLERANCE; PIMA INDIAN WOMEN; INSULIN-RESISTANCE; ORAL-CONTRACEPTIVES; PREVALENCE; HYPERINSULINEMIA; DYSFUNCTION; ANDROGENS; DISEASE	Context Although oligomenorrhea has been associated cross-sectionally with insulin resistance and glucose intolerance, it is not known whether oligomenorrhea is a marker for increased future risk of type 2 diabetes mellitus (DM). Objective To prospectively assess risk of type 2 DM in women with a history of long or highly irregular menstrual cycles. Design and Setting The Nurses' Health Study II, a prospective observational cohort study. Participants A total of 101073 women who had no. prior history of DM and who reported their usual menstrual cycle pattern at age 18 to 22 years on the baseline (1989) questionnaire. Main Outcome Measure Incident reports of DM, with follow-up through 1997, compared among women categorized by menstrual cycle length (5 categories). Results During 564333 person-years of follow-up, there were 507 cases of type 2 DM. Compared with women with a usual cycle length of 26 to 31 days (referent category) at age 18 to 22 years, the relative risk (RR) of type 2 DM among women with a menstrual cycle length that was 40 days or more or was too irregular to estimate was 2.08 (95% confidence interval [CI], 1.62-2.66), adjusting for body mass index at age 18 years and several other potential confounding variables. The RR of type 2 DM associated with long or highly irregular menstrual cycles was greater in obese women, but was also increased in nonobese women (at body mass indexes at age 18 years of <25,25-29, and <greater than or equal to>30 kg/m(2), RRs were 1.67 [95% CI, 1.14-2.45],1.74 [95% CI, 1.07-2.82], and 3.86 [95% CI, 2.33-6.38], respectively). Conclusion Women with long or highly irregular menstrual cycles have a significantly increased risk for developing type 2 DM that is not completely explained by obesity.	Brigham & Womens Hosp, Dept Med, Div Womens Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Gen Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; Harvard Pilgrim Hlth Plan, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Solomon, CG (corresponding author), Brigham & Womens Hosp, Dept Med, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NCI NIH HHS [CA-50385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS J, 1986, BRIT MED J, V293, P355, DOI 10.1136/bmj.293.6543.355; Chang RJ, 1999, ENDOCRIN METAB CLIN, V28, P397, DOI 10.1016/S0889-8529(05)70076-1; CHANG RJ, 1983, J CLIN ENDOCR METAB, V57, P356, DOI 10.1210/jcem-57-2-356; ChasanTaber L, 1997, DIABETES CARE, V20, P330, DOI 10.2337/diacare.20.3.330; Diamanti-Kandarakis E, 1999, J CLIN ENDOCR METAB, V84, P4006, DOI 10.1210/jc.84.11.4006; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P942, DOI 10.1210/jc.81.3.942; DUNAIF A, 1987, J CLIN ENDOCR METAB, V65, P499, DOI 10.1210/jcem-65-3-499; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; GODSLAND IF, 1992, J CLIN ENDOCR METAB, V74, P64, DOI 10.1210/jc.74.1.64; HAFFNER SM, 1988, METABOLISM, V37, P683, DOI 10.1016/0026-0495(88)90091-1; HAFFNER SM, 1993, J CLIN ENDOCR METAB, V77, P56, DOI 10.1210/jc.77.1.56; HARRIS M, 1979, DIABETES, V28, P1039; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hosmer DW, 1997, STAT MED, V16, P965; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hull M G, 1987, Gynecol Endocrinol, V1, P235, DOI 10.3109/09513598709023610; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Legro RS, 1998, AM J OBSTET GYNECOL, V179, pS101, DOI 10.1016/S0002-9378(98)70240-6; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; POLDERMAN KH, 1994, J CLIN ENDOCR METAB, V79, P265, DOI 10.1210/jc.79.1.265; Roumain J, 1998, DIABETES CARE, V21, P346, DOI 10.2337/diacare.21.3.346; SINGH KB, 1981, AM J OBSTET GYNECOL, V140, P299, DOI 10.1016/0002-9378(81)90277-5; TROY LM, 1995, INT J OBESITY, V19, P570; WEISS DJ, 1994, METABOLISM, V43, P803, DOI 10.1016/0026-0495(94)90257-7; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; 2001, DIABETES CARE, V24, pS21	28	239	252	2	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2001	286	19					2421	2426		10.1001/jama.286.19.2421	http://dx.doi.org/10.1001/jama.286.19.2421			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DH	11712937	Bronze			2022-12-01	WOS:000172266100021
J	Sonnenberg, P; Murray, J; Glynn, JR; Shearer, S; Kambashi, B; Godfrey-Faussett, P				Sonnenberg, P; Murray, J; Glynn, JR; Shearer, S; Kambashi, B; Godfrey-Faussett, P			HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; 2-YEAR FOLLOW-UP; SHORT-COURSE CHEMOTHERAPY; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; EXOGENOUS REINFECTION; MOLECULAR EPIDEMIOLOGY; INFECTED PATIENTS; MORTALITY; THERAPY	Background The proportion of recurrent tuberculosis cases attributable to relapse or reinfection and the risk factors associated with these different mechanisms are poorly understood. We followed up a cohort of 326 South African mineworkers, who had successfully completed treatment for pulmonary tuberculosis in 1995, to determine the rate and mechanisms of recurrence. Methods Patients were examined 3 and 6 months after cure, and then were monitored by the routine tuberculosis surveillance system until December, 1998. IS6110 DNA fingerprints from initial and subsequent episodes of tuberculosis were compared to determine whether recurrence was due to relapse or reinfection All patients gave consent for HIV-1 testing. Findings During follow-up (median 25.1 months, IQR 13.2-33.4), 65 patients (20%) had a recurrent episode of tuberculosis, a recurrence rate of 10.3 episodes per 100 person-years at risk (PYAR)-16.0 per 100 PYAR in HIV-1-positive patients and 6.4 per 100 PYAR in HIV-1-negative patients. Paired DNA fingerprints were available in 39 of 65 recurrences: 25 pairs were identical (relapse) and 14 were different (reinfection). 93% (13/14) of recurrences within the first 6 months were attributable to relapse compared with 48% (12/25) of later recurrences. HIV-1 infection was a risk factor for recurrence (hazard ratio 2.4, 95% CI 1.5-4.0), due to its strong association with disease caused by reinfection (18.7 2.4-143), but not relapse (0.58; 0.24-1.4). Residual cavitation and increasing years of employment at the mine were risk factors for relapse. Interpretation In a setting with a high risk of tuberculous Infection, HIV-1 increases the risk of recurrent tuberculosis because of an Increased risk of reinfection. Interventions to prevent recurrent disease, such as lifelong chemoprophylaxis in HIV-1-positive tuberculosis patients, should be further assessed.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Univ Witwatersrand, Natl Ctr Occupat Hlth, Dept Hlth, Johannesburg, South Africa; Univ Witwatersrand, Natl Ctr Occupat Hlth, Dept Community Hlth, Johannesburg, South Africa; Univ Teaching Hosp, Dept Med, ZAMBART Project, Lusaka, Zambia; Univ Teaching Hosp, Dept Pathol & Microbiol, ZAMBART Project, Lusaka, Zambia	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; University of Witwatersrand; University of Zambia; University of Zambia	Sonnenberg, P (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.			Sonnenberg, Pam/0000-0002-1067-1583				ABER V R, 1978, Bulletin of the International Union Against Tuberculosis, V53, P260; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Connolly C, 1999, AIDS, V13, P1543, DOI 10.1097/00002030-199908200-00015; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; DAS S, 1993, TUBERCLE LUNG DIS, V74, P47, DOI 10.1016/0962-8479(93)90068-9; Das S, 1995, TUBERCLE LUNG DIS, V76, P550, DOI 10.1016/0962-8479(95)90533-2; De Boer AS, 2000, NEW ENGL J MED, V342, P1050; ELLIOTT AM, 1995, J TROP MED HYG, V98, P9; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6; HAWKEN M, 1993, LANCET, V342, P332, DOI 10.1016/0140-6736(93)91474-Z; Johnson JL, 1997, INT J TUBERC LUNG D, V1, P446; KASSIM S, 1995, AIDS, V9, P1185, DOI 10.1097/00002030-199510000-00011; Kelly PM, 1999, T ROY SOC TROP MED H, V93, P287, DOI 10.1016/S0035-9203(99)90025-1; Mallory KF, 2000, INT J TUBERC LUNG D, V4, P455; MEDICAL RES. COUNCIL, 1962, Tubercle, V43, P201; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; OYAMA T, 1955, AM REV TUBERC PULM, V72, P613; PERRIENS JH, 1995, NEW ENGL J MED, V332, P779, DOI 10.1056/NEJM199503233321204; PERRIENS JH, 1991, AM REV RESPIR DIS, V144, P750, DOI 10.1164/ajrccm/144.4.750; Pulido F, 1997, ARCH INTERN MED, V157, P227, DOI 10.1001/archinte.157.2.227; SAHADEVAN R, 1995, J CLIN MICROBIOL, V33, P3037, DOI 10.1128/JCM.33.11.3037-3039.1995; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Sonnenberg P, 1998, INT J TUBERC LUNG D, V2, P168; Sterling TR, 1999, AIDS, V13, P1899, DOI 10.1097/00002030-199910010-00012; Sudre P, 1999, INFECTION, V27, P323, DOI 10.1007/s150100050037; TRIPATHY S. P., 1981, Indian Journal of Tuberculosis, V28, P45; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993	30	331	337	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2001	358	9294					1687	1693		10.1016/S0140-6736(01)06712-5	http://dx.doi.org/10.1016/S0140-6736(01)06712-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495MC	11728545				2022-12-01	WOS:000172344100013
J	Sijen, T; Fleenor, J; Simmer, F; Thijssen, KL; Parrish, S; Timmons, L; Plasterk, RHA; Fire, A				Sijen, T; Fleenor, J; Simmer, F; Thijssen, KL; Parrish, S; Timmons, L; Plasterk, RHA; Fire, A			On the role of RNA amplification in dsRNA-triggered gene silencing	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; C-ELEGANS; MESSENGER-RNA; ANTISENSE RNA; VIRUS-RESISTANCE; TOMATO LEAVES; INTERFERENCE; POLYMERASE; PLANTS	We have investigated the role of trigger RNA amplification during RNA interference (RNAi) in Caenorhabditis elegans. Analysis of small interfering RNAs (siRNAs) produced during RNAi in C. elegans revealed a substantial fraction that cannot derive directly from input dsRNA. Instead, a population of siRNAs (termed secondary siRNAs) appeared to derive from the action of a cellular RNA-directed RNA polymerase (RdRP) on mRNAs. that are being targeted by the RNAi mechanism. The distribution of secondary siRNAs exhibited a distinct polarity (5'-->3' on the antisense strand), suggesting a cyclic amplification process in which RdRP is primed by existing siRNAs. This amplification mechanism substantially augments the potency of RNAi-based surveillance, while ensuring that the RNAi machinery will focus on expressed mRNAs.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; Johns Hopkins Univ, Biol Grad Program, Baltimore, MD 21218 USA; Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Johns Hopkins University; Carnegie Institution for Science	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Greiver, Michelle/N-8764-2015; Simmer, Femke/N-2150-2015	Greiver, Michelle/0000-0001-8957-0285; Fire, Andrew/0000-0001-6217-8312	NICHD NIH HHS [HD08353] Funding Source: Medline; NIGMS NIH HHS [GM07231, R01 GM037706, GM37706] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bender J, 2001, CELL, V106, P129, DOI 10.1016/S0092-8674(01)00441-X; BENIAN GM, 1993, GENETICS, V134, P1097; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bosher JM, 1999, GENETICS, V153, P1245; BRENNER S, 1974, GENETICS, V77, P71; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; DIENER TO, 1991, FASEB J, V5, P2808, DOI 10.1096/fasebj.5.13.1717335; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; FIRE A, 1991, DEVELOPMENT, V113, P503; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; HERMAN RK, 1982, GENETICS, V102, P379; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; KIFF JE, 1988, NATURE, V331, P631, DOI 10.1038/331631a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Modahl LE, 2000, MOL CELL BIOL, V20, P6030, DOI 10.1128/MCB.20.16.6030-6039.2000; MOERMAN DG, 1988, GENE DEV, V2, P93, DOI 10.1101/gad.2.1.93; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Mullen GP, 1999, MOL BIOL CELL, V10, P3205, DOI 10.1091/mbc.10.10.3205; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; PARRISH S, 2001, IN PRESS RNA; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2000, BIOESSAYS, V22, P520, DOI 10.1002/(SICI)1521-1878(200006)22:6&lt;520::AID-BIES5&gt;3.0.CO;2-W; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	50	943	1092	3	103	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 16	2001	107	4					465	476		10.1016/S0092-8674(01)00576-1	http://dx.doi.org/10.1016/S0092-8674(01)00576-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	494GG	11719187	Bronze			2022-12-01	WOS:000172272900007
J	Morrow, DA; Antman, EM; Giugliano, RP; Cairns, R; Charlesworth, A; Murphy, SA; de Lemos, JA; McCabe, CH; Braunwald, E				Morrow, DA; Antman, EM; Giugliano, RP; Cairns, R; Charlesworth, A; Murphy, SA; de Lemos, JA; McCabe, CH; Braunwald, E			A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy	LANCET			English	Article							THROMBOLYTIC THERAPY; THROMBIN INHIBITION; MORTALITY; STRATIFICATION; HIRUDIN; PREDICT; SCORE	Background Rapid, effective triage is integral to emergency cardiac care of patients with ST-elevation myocardial infarction (STEMI). Available models for predicting mortality in STEMI include up to 45 variables, but have consistently shown advanced age, Increased heart rate, and decreased blood pressure to be among the strongest predictors. Methods On the basis of observed risk relations among 13 253 patients with STEMI from the InTIME II trial, we developed and assessed a simple risk index using age, heart rate, and systolic blood pressure (SBP) for predicting mortality over 30 days: (heart rate X [age/10](2))/SBP. Findings The risk index was a strong (c statistic=0.78) and independent predictor of mortality risk (p<0.0001). When the risk index was categorised into quintiles for convenient clinical use, it revealed a more than 20-fold gradient of increasing mortality from 0.8 to 17.4%, p<0.0001. The risk Index was also a robust predictor of very early events, including death by 24 h (c statistic=0.81). External validation in patients with STEMI from the TIMI 9 trials (n=3659) showed both a high discriminatory capacity (c statistic=0.79), and excellent concordance between the observed 30-day mortality in each of the five risk groups and the predictions based on InTIME II (goodness-of-fit, p=0.7). Interpretation A simple risk index based on characteristics easily assessed by any paramedical or clinical personnel captures most of the information from more complex tools, and is likely to be useful In the rapid triage of patients with STEMI outside hospital or on first arrival in the hospital.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Trials Grp, Boston, MA 02115 USA; Nottingham Clin Res, Nottingham, England; Harvard Univ, Clin Res Inst, Boston, MA 02115 USA; Univ Texas SW, Dept Med, Dallas, TX USA	Harvard University; Brigham & Women's Hospital; Harvard University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrow, DA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Trials Grp, 75 Francis St, Boston, MA 02115 USA.		de Lemos, James/ABD-6669-2021; Giugliano, Robert/N-7233-2017	Giugliano, Robert/0000-0003-4110-7675				ANTMAN EM, 1994, CIRCULATION, V90, P1624, DOI 10.1161/01.CIR.90.4.1624; Antman EM, 1996, CIRCULATION, V94, P911, DOI 10.1161/01.CIR.94.5.911; Arntz HR, 1998, EUR HEART J, V19, P1140; Braunwald E, 2000, EUR HEART J, V21, P2005; Cannon CP, 2000, J EMERG MED, V19, p21S, DOI 10.1016/S0736-4679(00)00251-1; Canto JG, 1997, J AM COLL CARDIOL, V29, P498, DOI 10.1016/S0735-1097(96)00532-3; CRAGG DR, 1991, ANN INTERN MED, V115, P173, DOI 10.7326/0003-4819-115-3-173; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HILLIS LD, 1990, J AM COLL CARDIOL, V16, P313, DOI 10.1016/0735-1097(90)90579-E; Hutter AM, 2000, J AM COLL CARDIOL, V35, P846; Jacobs DR, 1999, CIRCULATION, V100, P599, DOI 10.1161/01.CIR.100.6.599; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4	17	216	225	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 10	2001	358	9293					1571	1575		10.1016/S0140-6736(01)06649-1	http://dx.doi.org/10.1016/S0140-6736(01)06649-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VM	11716882				2022-12-01	WOS:000172188300009
J	Smith, O				Smith, O			Microbiology - Know thine enemy	SCIENCE			English	Editorial Material																		Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998	2	0	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1298	1298		10.1126/science.294.5545.1298	http://dx.doi.org/10.1126/science.294.5545.1298			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701920				2022-12-01	WOS:000172130200037
J	Lister, AM; Sher, AV				Lister, AM; Sher, AV			The origin and evolution of the woolly mammoth	SCIENCE			English	Article								The mammoth lineage provides an example of rapid adaptive evolution in response to the changing environments of the Pleistocene. Using welt-dated samples from across the mammoth's Eurasian range, we document geographical and chronological variation in adaptive morphology. This work illustrates an incremental (if mosaic) evolutionary sequence but also reveals a complex interplay of local morphological innovation, migration, and extirpation in the origin and evolution of a mammalian species. In particular, northeastern Siberia is identified as an area of successive allopatric innovations that apparently spread to Europe, where they contributed to a complex pattern of stasis, replacement, and transformation.	UCL, Dept Biol, London WC1E 6BT, England; Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 117071, Russia	University of London; University College London; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Lister, AM (corresponding author), UCL, Dept Biol, London WC1E 6BT, England.	a.lister@ucl.ac.uk		Lister, Adrian/0000-0002-7985-138X				Azzaroli A, 1977, MEMORIE CLASSE SCI F, V14, P149; Carroll RL, 1997, PATTERNS PROCESSES V; Dietrich W.O., 1965, PALAONTOLOGISCHE A A, V2, P521; Dubrovo I. A, 1964, PAL ZH, V3, P82; Dubrovo I.A., 1966, B KOM IZUC CHETV, V32, P63; Ferretti MP, 1999, ECLOGAE GEOL HELV, V92, P503; Foronova Irina V., 1999, Deinsea, V6, P103; GARUTT VE, 1986, P ZOOL I ST PET, V149, P21; GOULD S J, 1977, Paleobiology, V3, P115; ILFORD KS, 1925, Q J GEOL SOC LOND, V81, P62; Jablonski D, 2000, PALEOBIOLOGY, V26, P15, DOI 10.1666/0094-8373(2000)26[15:MAMSAH]2.0.CO;2; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; KOTSAKIS T, 1978, Geologica Romana, V17, P411; Lister A.M., 1992, P185; Lister Adrian M., 1996, P203; Lister Adrian M., 1993, Quaternary International, V19, P77, DOI 10.1016/1040-6182(93)90026-C; Maglio V.J., 1973, Transactions Am phil Soc, V63, P1, DOI 10.2307/1006229; Roopnarine PD, 1999, PALEOBIOLOGY, V25, P41; SCHREVE D, IN PRESS FOSSIL MAMM; SHER A, UNPUB; Sher A.V., 1987, Palaeontographia Italica, V74, P97; Sher A.V., 1999, 2 INT MAMM C OFF C P, P58; Sher A.V., 1997, TERRESTRIAL PALEOENV, P3; SHER AV, 1985, DOKL AKAD NAUK SSSR+, V285, P221; STEINHEIM WO, 1912, JAHRESH VER VATERL N, V68, P42; Stuart AJ, 2001, QUATERNARY SCI REV, V20, P1677, DOI 10.1016/S0277-3791(01)00034-8	26	128	145	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1094	1097		10.1126/science.1056370	http://dx.doi.org/10.1126/science.1056370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691991				2022-12-01	WOS:000172013800048
J	Mushlin, AI; Ruchlin, HS; Callahan, MA				Mushlin, AI; Ruchlin, HS; Callahan, MA			Costeffectiveness of diagnostic tests	LANCET			English	Article								We review the principles underlying cost-effectiveness analysis of diagnostic tests and procedures. We use two clinical examples, diagnostic testing for early multiple sclerosis and for Helicobacter pylori to illustrate the methods of analysis and to show how the results can be useful for physicians or payers of health services in making decisions about provision and use of diagnostic services. Economic assessments of diagnostic tests are Inherently more difficult than assessments of therapeutic interventions, mainly because of uncertainty about the relation between diagnosis and end results (outcomes) of care. Nonetheless, because of the increasing Importance of diagnostic technology in medicine and healthcare, only with such assessments will the most value be gained from restricted medical resources.	Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA	Cornell University	Mushlin, AI (corresponding author), Cornell Univ, Weill Med Coll, Dept Publ Hlth, 411 E 69th St, New York, NY 10021 USA.	aim2001@mail.med.cornell						Anderson GF, 2000, HEALTH AFFAIR, V19, P150, DOI 10.1377/hlthaff.19.3.150; *CAN COORD OFF HLT, 1997, GUID EC EV PHARM; *COMM DEP HUM SERV, 1995, GUID PHARM IND PREP; FENDRICK AM, 1995, ANN INTERN MED, V123, P260, DOI 10.7326/0003-4819-123-4-199508150-00003; Garber AM, 2000, HANDB ECON, V17, P181; MOONEY C, 1990, MED DECIS MAKING, V10, P77, DOI 10.1177/0272989X9001000201; MUSHLIN AI, 1994, ARCH NEUROL-CHICAGO, V51, P67, DOI 10.1001/archneur.1994.00540130093017; Mushlin AI, 1997, INT J TECHNOL ASSESS, V13, P21, DOI 10.1017/S0266462300010205; *NAT I CLIN EXC, 2001, APPR NEW EX TECHN IN; Rabin M, 1998, J ECON LIT, V36, P11; 1989, FED REG         0130, V54, P4308	11	41	42	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1353	1355		10.1016/S0140-6736(01)06417-0	http://dx.doi.org/10.1016/S0140-6736(01)06417-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484RC	11684235				2022-12-01	WOS:000171702500032
J	Wang, YQ; Hu, YM; Meng, J; Li, C				Wang, YQ; Hu, YM; Meng, J; Li, C			An ossified Meckel's cartilage in two cretaceous mammals and origin of the mammalian middle ear	SCIENCE			English	Article							EVOLUTION; MORGANUCODON	An ossified Meckel's cartilage has been recovered from two early Cretaceous mammals from China. This element is similar to Meckel's cartilage in prenatal and some postnatal extant mammals and indicates the relationship of Meckel's cartilage with the middle ear in early mammals, The evidence shows that brain expansion may not be the initial factor that caused the separation of postdentary bones from the dentary as middle ear ossicles during mammalian evolution. The failure of the dentary to seize reduced postdentary elements during ontogeny of early mammals is postulated as an alternative mechanism for the separation. Modifications of both feeding and hearing apparatuses in early mammals may have led to the development of the definitive mammalian middle ear.	Chinese Acad Sci, IVPP, Beijing 100044, Peoples R China; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; CUNY City Coll, New York, NY 10016 USA; CUNY, Grad Sch, Biol Program Ecol Evolutionary Biol & Behav, New York, NY 10016 USA	Chinese Academy of Sciences; American Museum of Natural History (AMNH); City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Wang, YQ (corresponding author), Chinese Acad Sci, IVPP, POB 643, Beijing 100044, Peoples R China.	wang.yuanqing@pa.ivpp.ac.cn; jmeng@amnh.org						ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; BARGHUSEN HR, 1970, SCIENCE, V168, P573, DOI 10.1126/science.168.3931.573; CLARK CT, 1993, J MORPHOL, V215, P119, DOI 10.1002/jmor.1052150203; CROMPTON A. W., 1963, PROC ZOOL SOC LONDON, V140, P697; CROMPTON AW, 1985, ZOOL J LINN SOC-LOND, V85, P99, DOI 10.1111/j.1096-3642.1985.tb01500.x; Crompton AW, 1993, MAMMAL PHYLOGENY, V1, P30, DOI DOI 10.1007/978-1-4613-9249-1; Gambaryan Petr P., 1995, Acta Palaeontologica Polonica, V40, P45; Gaupp EWT, 1913, REICHERTSCHE THEORIE; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; HOPSON JA, 1966, AM ZOOL, V6, P437; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; Ji Q, 1999, NATURE, V398, P326; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z, 1998, ACTA PALAEONTOL POL, V43, P413; KUHN HJ, 1971, ABH SENCKENB NAT, V28, P1; KUHN HJ, 1987, MORPHOGENESIS MAMMAL, P1; Li J-L, 2000, CHINESE SCI BULL, V45, P2545; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; MAIER W, 1990, NETH J ZOOL, V40, P55, DOI 10.1163/156854289X00183; McKenna MC, 1997, CLASSIFICATION MAMMA; Owen R., 1871, MONOGRAPH FOSSIL MAM; ROUGIER GW, 1966, AM MUS NOVIT, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe Timothy, 1996, Memoirs of the California Academy of Sciences, V20, P71; Sanchez-Villagra Marcelo R., 1997, Journal of Mammalian Evolution, V4, P119, DOI 10.1023/A:1027318213347; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; Wang Xiaolin, 1998, Vertebrata Palasiatica, V36, P81; Zeller U., 1987, Mammalia Depicta, P17; ZELLER U, 1993, MAMMAL PHYLOGENY, P95	33	105	122	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					357	361		10.1126/science.1063830	http://dx.doi.org/10.1126/science.1063830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598297				2022-12-01	WOS:000171601400039
J	Mansley, EC; McKenna, MT				Mansley, EC; McKenna, MT			Importance of perspective in economic analyses of cancer screening decisions	LANCET			English	Article							RECOMMENDATIONS; KNOWLEDGE; BREAST	As the fifth, and final, report in this Lancet series on health economics, we discuss how economic analyses in public health, with cancer screening as the example, differ depending on the perspective taken. We identify nine different, but related, decision makers at various levels, from the individual patient to society as a whole, and discuss how their different viewpoints affect their ultimate decisions. Central to our discussion Is the identification of seven distinct components of perspective, each potentially important in the screening decision. In many fields of healthcare, decisions about the use of resources, such as time, wealth, or energy, are made by weighing up the positive and negative consequences of the alternatives under consideration and are thus based on an economic analysis of the situation (although sometimes this process is subconscious). For simplicity, we restrict our report to the effect of perspective on cancer screening decisions and show how the costs (negative consequences) and benefits (positive consequences) vary depending on the decision maker.	Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Canc Prevent & Control, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Mansley, EC (corresponding author), Merck & Co Inc, Outcomes Res & Management, POB 4,WP39-160, West Point, PA 19486 USA.	edward_mansley@merck.com						*AG HEALTHC RES QU, 2000, AHRQ RES ACTIVITIES, V239, P5; *AG HEALTHC RES QU, 2000, AHRQ RES ACTIVITIES, V239, P4; [Anonymous], 1996, COST EFFECTIVENESS H; Breslow RA, 1997, PREV MED, V26, P170, DOI 10.1006/pmed.1996.0136; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P162; Drummond MF, 1997, METHODS EC EVALUATIO, P52; Dugan E, 2000, J AM GERIATR SOC, V48, P413, DOI 10.1111/j.1532-5415.2000.tb04699.x; ELMORE JG, 1998, NEW ENGL J MED, V338, P1145; Farnham P. G., 1996, PREVENTION EFFECTIVE, P12; Fletcher SW, 1997, NEW ENGL J MED, V336, P1180, DOI 10.1056/NEJM199704173361612; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; Gold MR., 1996, COST EFFECTIVENESS H; Hurley J, 2000, HANDB ECON, V17, P55; Lee MR, 1999, EXPERT SYST APPL, V17, P315, DOI 10.1016/S0957-4174(99)00043-3; MANSLEY EC, 1997, NBCCEDP DIAGNOSIS TR; May DS, 1998, AM J ROENTGENOL, V170, P97, DOI 10.2214/ajr.170.1.9423608; Meltzer MI, 2001, LANCET, V358, P993, DOI 10.1016/S0140-6736(01)06107-4; *NIH, 1997, NIH CONS DEV C BREAS; O'Dell KJ, 1999, J FAM PRACTICE, V48, P682; Ries LAG EM, 2003, SEER CANC STAT REV 1; Torrance GW., 1996, COST EFFECTIVENESS H, P54; Torrance GW, 1996, COST EFFECTIVENESS H, P276; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, V2nd; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Woloshin S, 1999, NEW ENGL J MED, V340, P884, DOI 10.1056/NEJM199903183401112	25	8	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2001	358	9288					1169	1173		10.1016/S0140-6736(01)06258-4	http://dx.doi.org/10.1016/S0140-6736(01)06258-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479HM	11597692				2022-12-01	WOS:000171399000034
J	Garrus, JE; von Schwedler, UK; Pornillos, OW; Morham, SG; Zavitz, KH; Wang, HE; Wettstein, DA; Stray, KM; Cote, M; Rich, RL; Myszka, DG; Sundquist, WI				Garrus, JE; von Schwedler, UK; Pornillos, OW; Morham, SG; Zavitz, KH; Wang, HE; Wettstein, DA; Stray, KM; Cote, M; Rich, RL; Myszka, DG; Sundquist, WI			Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding	CELL			English	Article							VESICULAR STOMATITIS-VIRUS; PLASMA-MEMBRANE PROTEINS; GAG PROTEINS; UBIQUITIN LIGASE; MATRIX PROTEIN; LIFE-CYCLE; WW DOMAINS; RELEASE; YEAST; MOTIF	Like other enveloped viruses, HIV-1 uses cellular machinery to bud from infected cells. We now show that Tsg101 protein, which functions in vacuolar protein sorting (Vps), is required for HIV-1 budding. The UEV domain of Tsg101 binds to an essential tetrapeptide (PTAP) motif within the p6 domain of the structural Gag protein and also to ubiquitin. Depletion of cellular Tsg101 by small interfering RNA arrests HIV-1 budding at a late stage, and budding is rescued by reintroduction of Tsg101. Dominant negative mutant Vps4 proteins that inhibit vacuolar protein sorting also arrest HIV-1 and MLV budding. These observations suggest that retroviruses bud by appropriating cellular machinery normally used in the Vps pathway to form multivesicular bodies.	Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA; Myriad Genet, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Myriad Genetics, Inc	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA.				NIGMS NIH HHS [P32 GM07464] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; BARTEL PL, 1997, YEAST 2 HYBRID SCREE; Berthoud VM, 2000, METHODS, V20, P180, DOI 10.1006/meth.1999.0935; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Craven RC, 1999, J VIROL, V73, P3359, DOI 10.1128/JVI.73.4.3359-3365.1999; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Gamier L, 1996, NATURE, V381, P744, DOI 10.1038/381744a0; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; James P, 1996, GENETICS, V144, P1425; Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000; JENKINS Y, 2001, IN PRESS J VIROL; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Komada M, 2001, BIOCHEM BIOPH RES CO, V281, P1065, DOI 10.1006/bbrc.2001.4441; Koonin EV, 1997, NAT GENET, V16, P330, DOI 10.1038/ng0897-330; Lemmon SK, 2000, CURR OPIN CELL BIOL, V12, P457, DOI 10.1016/S0955-0674(00)00117-4; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li LM, 2001, P NATL ACAD SCI USA, V98, P1619, DOI 10.1073/pnas.98.4.1619; Li Y, 1999, MOL CELL BIOL, V19, P3588; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Ponting CP, 1997, J MOL MED-JMM, V75, P467; Puffer BA, 1998, J VIROL, V72, P10218, DOI 10.1128/JVI.72.12.10218-10221.1998; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vogt VM, 2000, P NATL ACAD SCI USA, V97, P12945, DOI 10.1073/pnas.97.24.12945; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; Yuan B, 1999, EMBO J, V18, P4700, DOI 10.1093/emboj/18.17.4700; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; Zhong Q, 1998, CANCER RES, V58, P2699	59	1102	1159	1	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					55	65		10.1016/S0092-8674(01)00506-2	http://dx.doi.org/10.1016/S0092-8674(01)00506-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595185	Bronze			2022-12-01	WOS:000171453100009
J	Smith, O				Smith, O			Biomedicine - In the nic of time	SCIENCE			English	Editorial Material																		Chung HM, 2001, NAT CELL BIOL, V3, P1129, DOI 10.1038/ncb1201-1129; HU Y, 2001, DEV CELL        1130; LOPEZSCHIER H, 2001, DEV CELL        1130	3	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2118	2118		10.1126/science.294.5549.2118	http://dx.doi.org/10.1126/science.294.5549.2118			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739946				2022-12-01	WOS:000172647700038
J	De Smaele, E; Zazzeroni, F; Papa, S; Nguyen, DU; Jin, RG; Jones, J; Cong, R; Franzoso, G				De Smaele, E; Zazzeroni, F; Papa, S; Nguyen, DU; Jin, RG; Jones, J; Cong, R; Franzoso, G			Induction of gadd45 beta by NF-kappa B downregulates pro-apoptotic JNK signalling	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED CELL-DEATH; TERMINAL KINASE; ACTIVATION; PROTEIN; FAMILY; STRESS; PATHWAY; C-IAP2; MYD118	In addition to coordinating immune and inflammatory responses, NF-kappaB/Rel transcription factors control cell survival(1). Normally, NF-kappaB dimers are sequestered in the cytoplasm by binding to inhibitory I kappaB proteins, and can be activated rapidly by signals that induce the sequential phosphorylation and proteolysis of I kappa Bs(1). Activation of NF-kappaB antagonizes apoptosis or programmed cell death by numerous triggers, including the ligand engagement of 'death receptors' such as tumour-necrosis factor (TNF) receptor(2). The anti-apoptotic activity of NF-kappaB is also crucial to oncogenesis and to chemo- and radio-resistance in cancer(2). Cytoprotection by NF-kappaB involves the activation of pro-survival genes(2); however, its basis remains poorly understood. Here we report that NF-kappaB complexes downregulate the c-Jun aminoterminal kinase (JNK) cascade(3), thus establishing a link between the NF-kappaB and the JNK pathways. This link involves the transcriptional upregulation of gadd45 beta /myd118 (ref. 4), which downregulates JNK signalling induced by the TNF receptor (TNF-R). This NF-kappaB-dependent inhibition of the JNK pathway is central to the control of cell death. Our findings define a protective mechanism that is mediated by NF-kappaB complexes and establish a role for the persistent activation of JNK in the apoptotic response to TNF-alpha.	Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Franzoso, G (corresponding author), Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, 924 E 57th St, Chicago, IL 60637 USA.		Papa, Salvatore/J-9413-2012; De Smaele, Enrico/C-1124-2013; Franzoso, Guido/GRR-8628-2022	Papa, Salvatore/0000-0002-8369-6538; De Smaele, Enrico/0000-0003-4524-4423; Zazzeroni, Francesca/0000-0002-4474-3274; Franzoso, Guido/0000-0002-0778-988X				Arlt A, 2001, ONCOGENE, V20, P69, DOI 10.1038/sj.onc.1204061; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen YR, 2000, INT J ONCOL, V16, P651; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Duriez PJ, 2000, J BIOL CHEM, V275, P18099, DOI 10.1074/jbc.M908925199; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; Shaulian E, 1999, J BIOL CHEM, V274, P29595, DOI 10.1074/jbc.274.42.29595; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vairapandi M, 1996, ONCOGENE, V12, P2579; VAN AD, 1996, SCIENCE, V274, P787; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XT, 1999, J BIOL CHEM, V274, P29599, DOI 10.1074/jbc.274.42.29599; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang W, 1999, ONCOGENE, V18, P4899, DOI 10.1038/sj.onc.1202885; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	30	615	627	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					308	313		10.1038/35104560	http://dx.doi.org/10.1038/35104560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713530				2022-12-01	WOS:000172150700044
J	Gillespie, IA; O'Brien, S; Adak, GK				Gillespie, IA; O'Brien, S; Adak, GK			General outbreaks of infectious intestinal diseases linked with private residences in England and Wales, 1992-9: questionnaire study	BRITISH MEDICAL JOURNAL			English	Article									Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Gastrointestinal Dis Div, London NW9 5EQ, England	Public Health England	O'Brien, S (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Gastrointestinal Dis Div, London NW9 5EQ, England.			O'Brien, Sarah Jane/0000-0003-2896-8999; Gillespie, Iain A/0000-0002-2265-9506				Cogan TA, 1999, LETT APPL MICROBIOL, V29, P354, DOI 10.1046/j.1472-765X.1999.00656.x; DERBYSHIRE D, 2000, DAILY TELEGRAPH 1206, P7; Evans J., 1996, SPORT EDUC SOC, V1, P165, DOI [DOI 10.1080/1357332960010203, https://doi.org/10.1080/1357332960010203]; POPPE C, 1999, SALMONELLA ENTERICA	4	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2001	323	7321					1097	1098		10.1136/bmj.323.7321.1097	http://dx.doi.org/10.1136/bmj.323.7321.1097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701574	Bronze, Green Published			2022-12-01	WOS:000172188400013
J	Davies, SJ; Grogan, JL; Blank, RB; Lim, KC; Locksley, RM; McKerrow, JH				Davies, SJ; Grogan, JL; Blank, RB; Lim, KC; Locksley, RM; McKerrow, JH			Modulation of blood fluke development in the liver by hepatic CD4(+) lymphocytes	SCIENCE			English	Article							T-CELL RECEPTOR; SCHISTOSOMA-MANSONI; DEFICIENT MICE; GENES	We have identified an alternate developmental pathway in the life cycle of the trematode pathogen Schistosoma mansoni. This pathway is used in immunodeficient hosts in which the parasite fails to receive appropriate signals from the host immune system. Helminth development is altered at an early stage during infection, resulting in the appearance of attenuated forms that prolong survival of host and parasite. Hepatic CD4(+) T lymphocyte populations are an integral component of the immune signal recognized by the parasite.	Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Pathol, Trop Dis Res Unit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Liver Ctr Microscopy Core, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McKerrow, JH (corresponding author), Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Pathol, Trop Dis Res Unit, San Francisco, CA 94143 USA.				NIAID NIH HHS [F32 AI010424, F32 AI010424-02, AI10424] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI010424] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; CLEGG JA, 1965, EXP PARASITOL, V16, P133, DOI 10.1016/0014-4894(65)90037-8; Davies SJ, UNPUB; DORSHKIND K, 1984, J IMMUNOL, V132, P1804; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HARRISON RA, 1983, PARASITOLOGY, V86, P429, DOI 10.1017/S0031182000050629; Harvey SC, 2000, P ROY SOC B-BIOL SCI, V267, P2057, DOI 10.1098/rspb.2000.1249; IACOMINI J, 1995, EUR J IMMUNOL, V25, P884, DOI 10.1002/eji.1830250404; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ravindran B, 2001, TRENDS PARASITOL, V17, P70, DOI 10.1016/S1471-4922(00)01835-3; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wolowczuk I, 1999, INFECT IMMUN, V67, P4183, DOI 10.1128/IAI.67.8.4183-4190.1999; ZIJLSTRA M, 1990, NATURE, V344, P1742	21	121	129	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1358	1361		10.1126/science.1064462	http://dx.doi.org/10.1126/science.1064462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701932				2022-12-01	WOS:000172130200054
J	Rice, WR; Chippindale, AK				Rice, WR; Chippindale, AK			Sexual recombination and the power of natural selection	SCIENCE			English	Article							DELETERIOUS MUTATIONS; DIRECTIONAL SELECTION; GENETIC-VARIABILITY; ADVANTAGE; EVOLUTION; FITNESS; ACCUMULATION; EPISTASIS; LINKAGE; LIMITS	Theory predicts that recombination will increase the effectiveness of natural selection. A Drosophila melanogaster model system was developed that increased experimental power with the use of high experimental replication, explicit tracking of individual genes, and high but natural levels of background selection. Each of 34 independent experiments traced the fate of a newly arisen mutation located within genome-wide, synthetic chromosomes that were propagated with or without recombination. An intrinsic advantage to recombination was demonstrated by the finding that the realized strength of selection on new mutations was markedly increased when recombination was present.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Rice, WR (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	rice@lifesci.ucsb.edu						BARTON NH, 1995, GENETICS, V140, P821; Birdsell J, 1996, P NATL ACAD SCI USA, V93, P908, DOI 10.1073/pnas.93.2.908; CARSON HL, 1958, COLD SPRING HARB SYM, V23, P291, DOI 10.1101/SQB.1958.023.01.030; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; deVisser JAGM, 1996, P ROY SOC B-BIOL SCI, V263, P193, DOI 10.1098/rspb.1996.0031; Endler J.A., 1986, Monographs in Population Biology, pviii; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher R. A., 1930, GENETICAL THEORY NAT, P135; FLEXON PB, 1982, NATURE, V298, P672, DOI 10.1038/298672a0; Fowler K, 1997, P ROY SOC B-BIOL SCI, V264, P191, DOI 10.1098/rspb.1997.0027; GEER BW, 1962, AM NAT, V96, P175, DOI 10.1086/282220; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; KOROL AB, 1994, HEREDITY, V72, P64, DOI 10.1038/hdy.1994.7; LI WH, 1978, GENETICS, V90, P349; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MALMBERG RL, 1977, GENETICS, V86, P607; MANNING JT, 1984, ACTA BIOTHEOR, V33, P219, DOI 10.1007/BF00048429; MARKOW TA, 1975, GENETICS, V79, P527; Maynard-Smith J., 1978, MODELS ECOLOGY; MCPHEE CP, 1970, GENET RES, V16, P1, DOI 10.1017/S0016672300002238; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; PECK JR, 1994, GENETICS, V137, P597; Rice WR, 1998, GENETICA, V102-3, P71, DOI 10.1023/A:1017055429755; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Rice WR, 1999, J EVOLUTION BIOL, V12, P1047; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; THOMPSON V, 1977, GENETICS, V85, P125; THOMPSON V, 1976, Evolutionary Theory, V1, P131; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; WOLF HG, 1987, GENETICA, V72, P151, DOI 10.1007/BF00123174; Wright S, 1931, GENETICS, V16, P0097; Zeyl C, 1997, NATURE, V388, P465, DOI 10.1038/41312	40	119	126	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					555	559		10.1126/science.1061380	http://dx.doi.org/10.1126/science.1061380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641490				2022-12-01	WOS:000171695600036
J	Schalkwijk, J; Zweers, MC; Steijlen, PM; Dean, WB; Taylor, G; van Vlijmen, IM; van Haren, B; Miller, WL; Bristow, J				Schalkwijk, J; Zweers, MC; Steijlen, PM; Dean, WB; Taylor, G; van Vlijmen, IM; van Haren, B; Miller, WL; Bristow, J			A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNDROME TYPE-I; COL5A1 GENE; COLLAGEN FIBRILS; GRAVIS FORM; EXPRESSION; PROPEPTIDE; MUTATIONS; NOSOLOGY; KNOCKOUT; DISTINCT	Background: The Ehlers-Danlos syndrome is a heritable connective-tissue disorder caused by defects in fibrillar-collagen metabolism. Mutations in the type V collagen genes account for up to 50 percent of cases of classic Ehlers-Danlos syndrome, but many other cases are unexplained. We investigated whether the deficiency of the tenascins, extracellular-matrix proteins that are highly expressed in connective tissues, was associated with the Ehlers-Danlos syndrome. Methods: We screened serum samples from 151 patients with the classic, hypermobility, or vascular types of the Ehlers-Danlos syndrome; 75 patients with psoriasis; 93 patients with rheumatoid arthritis; and 21 healthy persons for the presence of tenascin-X and tenascin-C by enzyme-linked immunosorbent assay. We examined the expression of tenascins and type V collagen in skin by immunohistochemical methods and sequenced the tenascin-X gene. Results: Tenascin-X was present in serum from all normal subjects, all patients with psoriasis, all patients with rheumatoid arthritis, and 146 of 151 patients with the Ehlers-Danlos syndrome. Tenascin-X was absent from the serum of the five remaining patients with Ehlers-Danlos syndrome, who were unrelated. Tenascin-X deficiency was confirmed in these patients by analysis of skin fibroblasts and by immunostaining of skin. The expression of tenascin-C and type V collagen was normal in these patients. All five of these patients had hypermobile joints, hyperelastic skin, and easy bruising, without atrophic scarring. Tenascin-X mutations were identified in all tenascin-X-deficient patients; one patient had a homozygous tenascin-X gene deletion, one was heterozygous for the deletion, and three others had homozygous truncating point mutations, confirming a causative role for tenascin-X and a recessive pattern of inheritance. Conclusions: Tenascin-X deficiency causes a clinically distinct, recessive form of the Ehlers-Danlos syndrome. This finding indicates that factors other than the collagens or collagen-processing enzymes can cause the syndrome and suggests a central role for tenascin-X in maintaining the integrity of collagenous matrix. (N Engl J Med 2001;345:1167-75.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calif San Francisco, Dept Pediat, Laurel Hts Campus,3333 Calif St,Box 1245, San Francisco, CA 94118 USA; Univ Med Ctr Nijmegen, Dept Dermatol, NL-6500 HB Nijmegen, Netherlands	University of California System; University of California San Francisco; Radboud University Nijmegen	Schalkwijk, J (corresponding author), Univ Calif San Francisco, Dept Pediat, Laurel Hts Campus,3333 Calif St,Box 1245, San Francisco, CA 94118 USA.	j.schalkwijk@derma.azn.nl	Steijlen, Peter/X-2729-2019; Zweers, Manon/E-5090-2016; Schalkwijk, Joost/R-7509-2019; Miller, Walter L/J-3696-2012; van Vlijmen-Willems, Ivonne MJJ/P-5336-2015; Schalkwijk, Joost/N-1774-2013	Schalkwijk, Joost/0000-0002-1308-1319; van Vlijmen-Willems, Ivonne MJJ/0000-0002-3522-2573; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042154, R01DK037922] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02695] Funding Source: Medline; NIDDK NIH HHS [DK42154, DK37922] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; BURCH GH, 1995, DEV DYNAM, V203, P491, DOI 10.1002/aja.1002030411; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; BYERS PH, 1994, J INVEST DERMATOL, V103, pS47, DOI 10.1038/jid.1994.9; DePaepe A, 1997, AM J HUM GENET, V60, P547; Elefteriou F, 1997, J BIOL CHEM, V272, P22866, DOI 10.1074/jbc.272.36.22866; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; ERICKSON HP, 1993, J CELL BIOL, V120, P1079, DOI 10.1083/jcb.120.5.1079; Erickson HP, 1997, NAT GENET, V17, P5, DOI 10.1038/ng0997-5; GEFFROTIN C, 1995, EUR J BIOCHEM, V231, P83, DOI 10.1111/j.1432-1033.1995.0083f.x; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; Giunta C, 2000, AM J MED GENET, V90, P72, DOI 10.1002/(SICI)1096-8628(20000103)90:1<72::AID-AJMG13>3.0.CO;2-C; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Latijnhouwers MAHE, 1998, ACTA DERM-VENEREOL, V78, P331; Lethias C, 1996, MATRIX BIOL, V15, P11, DOI 10.1016/S0945-053X(96)90122-5; Mackie EJ, 1999, J CELL SCI, V112, P3847; Mackie EJ, 1996, J ANAT, V188, P157; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; MATSUMOTO K, 1994, J CELL BIOL, V125, P483, DOI 10.1083/jcb.125.2.483; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; SCHALKWIJK J, 1991, AM J PATHOL, V139, P1143; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; SMITH LT, 1992, AM J HUM GENET, V51, P235; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; TEE MK, 1995, GENOMICS, V28, P171, DOI 10.1006/geno.1995.1128; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; VERSTRAETEN AA, 1992, BRIT J DERMATOL, V127, P571, DOI 10.1111/j.1365-2133.1992.tb14867.x; VOGEL A, 1979, LAB INVEST, V40, P201; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930	34	273	275	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1167	1175		10.1056/NEJMoa002939	http://dx.doi.org/10.1056/NEJMoa002939			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642233	Green Published			2022-12-01	WOS:000171605800004
J	Hyde, TB; Gay, K; Stephens, DS; Vugia, DJ; Pass, M; Johnson, S; Barrett, NL; Schaffner, W; Cieslak, PR; Maupin, PS; Zell, ER; Jorgensen, JH; Facklam, RR; Whitney, CG				Hyde, TB; Gay, K; Stephens, DS; Vugia, DJ; Pass, M; Johnson, S; Barrett, NL; Schaffner, W; Cieslak, PR; Maupin, PS; Zell, ER; Jorgensen, JH; Facklam, RR; Whitney, CG		Active Bacterial Core Surveillance	Macrolide resistance among invasive Streptococcus pneumoniae isolates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; UNITED-STATES; ANTIBIOTICS; LINCOSAMIDE; PREVALENCE; MECHANISMS; EMERGENCE; COLONIZATION; AZITHROMYCIN; SURVEILLANCE	Context Macrolide antibiotics, including erythromycin, clarithromycin, and azithromycin, are the mainstays of empirical pneumonia therapy. Macrolide resistance among Streptococcus pneumoniae, the most common cause of community-acquired pneumonia, is increasing in the United States. Whether resistance is a significant problem or whether macrolides remain useful for treatment of most resistant strains is unknown. Objective To examine the epidemiology of macrolide-resistant pneumococci in the United States. Design and Setting Analysis of 15481 invasive isolates from 1995 to 1999 collected by the Centers for Disease Control and Prevention's Active Bacterial Core surveillance system in 8 states. Main Outcome Measures Trends in macrolide use (1993-1999) and resistance and factors associated with resistance, including examination of 2 subtypes, the M phenotype, associated with moderate minimum inhibitory concentrations (MICs), and the MLS8 phenotype, associated with high MICs and clindamycin resistance. Results From 1993 to 1999, macrolide use increased 13% macrolide use increased 320% among children younger than 5 years. Macrolide resistance increased from 10.6% in 1995 to 20.4% in 1999. M phenotype isolates increased from 7.4% to 16.5% (P<.001), while the proportion with the MLSB phenotype was stable (3%-4%). The median erythromycin MIC (MIC50) of M phenotype isolates increased from 4 <mu>g/mL to 8 mug/mL. In 1999, M phenotype strains were more often from children than persons 5 years or older (25.2% vs 12.6%; P<.001) and from whites than blacks (19.3% vs 11.2%; P<.001). Conclusions In the setting of increasing macrolide use, pneumococcal resistance has become common. Most resistant strains have MICs in the range in which treatment failures have been reported. Further study and surveillance are critical to understanding the clinical implications of our findings.	CDCP, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Emory Univ, Sch Med, Dept Vet Affairs Med Ctr, Atlanta, GA USA; Calif Dept Hlth & Human Serv, Berkeley, CA USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Minnesota Dept Hlth, Sch Publ Hlth, Minneapolis, MN USA; Connecticut Dept Publ Hlth, Hartford, CT USA; Vanderbilt Univ Sch Med, Dept Prevent Med, Nashville, TN USA; Oregon Dept Human Serv, Hlth Div, Portland, OR USA; Monroe Cty Hlth Dept Human Serv, Rochester, NY USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; California Health & Human Services Agency; Johns Hopkins University; Minnesota Department of Health (MHD); Vanderbilt University; University of Texas System; University of Texas Health San Antonio	Whitney, CG (corresponding author), CDCP, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,Mailstop C-23, Atlanta, GA 30333 USA.		Stephens, David S/A-8788-2012					Amsden GW, 1999, J ANTIMICROB CHEMOTH, V44, P1, DOI 10.1093/jac/44.1.1; ARTHUR M, 1987, J ANTIMICROB CHEMOTH, V20, P783, DOI 10.1093/jac/20.6.783; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; BOKEN DJ, 1995, PEDIATR INFECT DIS J, V14, P879, DOI 10.1097/00006454-199510000-00012; BREIMAN RF, 1994, JAMA-J AM MED ASSOC, V271, P1831, DOI 10.1001/jama.271.23.1831; DOEM GV, 1996, ANTIMICROB AGENTS CH, V40, P1208; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; Gay K, 2000, J INFECT DIS, V182, P1417, DOI 10.1086/315853; GLADUE RP, 1989, ANTIMICROB AGENTS CH, V33, P277, DOI 10.1128/AAC.33.3.277; Heffelfinger JD, 2000, ARCH INTERN MED, V160, P1399, DOI 10.1001/archinte.160.10.1399; Johnston NJ, 1998, ANTIMICROB AGENTS CH, V42, P2425, DOI 10.1128/AAC.42.9.2425; Kelley MA, 2000, CLIN INFECT DIS, V31, P1008, DOI 10.1086/318157; Lagrou K, 2000, J ANTIMICROB CHEMOTH, V45, P119, DOI 10.1093/jac/45.1.119; Marchese A, 1999, J ANTIMICROB CHEMOTH, V44, P461, DOI 10.1093/jac/44.4.461; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; McCracken GH, 1997, PEDIATR INFECT DIS J, V16, P432, DOI 10.1097/00006454-199704000-00026; *NAT COMM CLIN LAB, 2001, M100S10 NCCLS; *NAT CTR HLTH STAT, 2001, NAT HOSP AMB MED CAR; *NAT CTR HLTH STAT, 2001, NAT AMB MED CAR SURV; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; Nishijima T, 1999, J ANTIMICROB CHEMOTH, V43, P637, DOI 10.1093/jac/43.5.637; Roberts MC, 1999, ANTIMICROB AGENTS CH, V43, P2823, DOI 10.1128/AAC.43.12.2823; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Shortridge VD, 1999, CLIN INFECT DIS, V29, P1186, DOI 10.1086/313452; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Tait-Kamradt A, 2000, ANTIMICROB AGENTS CH, V44, P3395, DOI 10.1128/AAC.44.12.3395-3401.2000; Waites K, 2000, J CLIN MICROBIOL, V38, P1731, DOI 10.1128/JCM.38.5.1731-1734.2000; WEISBLUM B, 1985, J ANTIMICROB CHEMOTH, V16, P63, DOI 10.1093/jac/16.suppl_A.63; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Widdowson CA, 1998, EMERG INFECT DIS, V4, P277, DOI 10.3201/eid0402.980216; ZENNI MK, 1995, J PEDIATR-US, V127, P533, DOI 10.1016/S0022-3476(95)70108-7	33	240	266	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1857	1862		10.1001/jama.286.15.1857	http://dx.doi.org/10.1001/jama.286.15.1857			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482UH	11597287				2022-12-01	WOS:000171595300026
J	Armstrong, RJE; Barker, RA				Armstrong, RJE; Barker, RA			Neurodegeneration: a failure of neuroregeneration?	LANCET			English	Article							NEURAL STEM-CELLS; DENTATE GYRUS; ADULT; NEUROGENESIS; DIFFERENTIATION; PROLIFERATION; PATHOGENESIS; INDUCTION; NEOCORTEX; NEURONS	Evidence suggests that the brain, like many other tissues, Is In a state of dynamic equilibrium. It has an endogenous population of stem cells that proliferate in response to environmental and pharmacological manipulations and that can replace cells lost In some experimental lesions. However, the fact remains that neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases are characterised by continuous loss of neurons that are not replaced. In this hypothesis, we postulate that a primary deficit In neural stem-cell proliferation; migration, or differentiation, or both, might contribute to net cell loss and neuronal circuit disruption In these disorders. Experimental validation of this hypothesis would not only substantially advance understanding of the pathogenesis of these diseases, but could also have profound implications for future treatment of these Incurable disorders.	Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England; Univ Cambridge, Dept Neurol, Cambridge, England	University of Cambridge; University of Cambridge	Barker, RA (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 2PY, England.	rab46@cus.cam.ac.uk		Barker, Roger Alistair/0000-0001-8843-7730				Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; BARKER RA, 1999, NEUROPSY REHABIL MOD, P1; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MOTT SH, 1995, ANN NEUROL, V37, P810, DOI 10.1002/ana.410370616; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Roy NS, 2000, NAT MED, V6, P271; Schulz JB, 1999, CURR OPIN NEUROL, V12, P433, DOI 10.1097/00019052-199908000-00010; Shastry BS, 1999, BRAIN RES BULL, V48, P121, DOI 10.1016/S0361-9230(98)00156-7; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sinden JD, 2000, NOVART FDN SYMP, V231, P270, DOI 10.1002/0470870834.ch16; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Temple S, 1999, CURR BIOL, V9, pR397, DOI 10.1016/S0960-9822(99)80252-8; Trojanowski JQ, 2000, ANN NY ACAD SCI, V924, P62; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; ZHAO M, 2000, SOC NEUROSCI, V26, P302; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	31	95	103	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2001	358	9288					1174	1176		10.1016/S0140-6736(01)06260-2	http://dx.doi.org/10.1016/S0140-6736(01)06260-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597694				2022-12-01	WOS:000171399000036
J	Beech, BAL				Beech, BAL			How could I breast feed with a man in the room?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Dillner L, 1996, BRIT MED J, V312, P200	1	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1996	312	7025					256	256						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TT486	11644767				2022-12-01	WOS:A1996TT48600085
J	MORRISON, R				MORRISON, R			PATIENTS SENSE OF COMPLETION	BRITISH MEDICAL JOURNAL			English	Editorial Material											MORRISON, R (corresponding author), EASTBOURNE HOSP NHS TRUST,EASTBOURNE,E SUSSEX,ENGLAND.								0	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 25	1994	308	6945					1722	1722		10.1136/bmj.308.6945.1722	http://dx.doi.org/10.1136/bmj.308.6945.1722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU483	11644549	Green Published			2022-12-01	WOS:A1994NU48300095
J	Zhen, CL; Sangl, J; Bierman, AS; Miller, MR; Friedman, B; Wickizer, SW; Meyer, GS				Zhen, CL; Sangl, J; Bierman, AS; Miller, MR; Friedman, B; Wickizer, SW; Meyer, GS			Potentially inappropriate medication use in the community-dwelling elderly - Findings from the 1996 Medical Expenditure Panel Survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Gerontological-Society-of-America	NOV, 2000	WASHINGTON, D.C.	Gerontol Soc Amer			EXPLICIT CRITERIA; NURSING-HOMES; FACILITIES; RESIDENTS	Context Inappropriate medication use is a major patient safety concerr, especially for the elderly population. Using explicit criteria, prior studies have found that 23.5% and 17.5% of the US community-dwelling elderly population used at least 1 of 20 potentially inappropriate medications in 1987 and 1992, respectively. Objectives To determine the prevalence of potentially inappropriate medication use in community-dwelling elderly persons in 1996, to assess trends over 10 years, categorize inappropriate medication use according to explicit criteria, and to examine risk factors for inappropriate medication use. Design, Setting, and Participants Respondents aged 65 years or older (n=2455) to the 1996 Medical Expenditure Panel Survey, a nationally representative survey of the US noninstitutionalized population were included. A 7-member expert panel was convened to categorize inappropriate medications. Main Outcome Measure Prevalence of use of 33 potentially inappropriate medications. Results In 1996, 21.3% (95% confidence interval [CI], 19.5%-23.1%)of community-dwelling elderly patients in the United States received at least 1 of 33 potentially inappropriate medications. Using the expert panel's classifications, about 2.6% of elderly patients (95% Cl, 2.0%-3.2%) used at least 1 of the 11 medications that should always be avoided by elderly patients; 9.1% (95% Cl, 7.9%-10.3%) used at least 1 cf the 8 that would rarely be appropriate; and 13.3% (95% Cl, 11.7%-14.9%) used at least 1 of the 14 medications that have some indications but are often misused. Use of some inappropriate medications declined between 1987 and 1996. Persons with poor health and more prescriptions had a significantly higher risk of inappropriate medication use. Conclusions Overall inappropriate medication use in elderly patients remains a serious problem. Despite challenges in using explicit criteria for assessing inappropriate medications for elderly patients, such criteria can be applied to population-based surveys to identify opportunities to improve quality of care and patient safety. Enhancements of existing data sources to include dosage, duration, and indication may augment national improvement and monitoring efforts.	Agcy Healthcare Res & Qual, Ctr Qual Improvement & Patient Safety, Rockville, MD 20852 USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; Univ Rochester, Dept Community & Prevent Med, Rochester, NY USA	Agency for Healthcare Research & Quality; Johns Hopkins University; University of Rochester	Zhen, CL (corresponding author), Agcy Healthcare Res & Qual, Ctr Qual Improvement & Patient Safety, 6011 Execut Blvd,Suite 200, Rockville, MD 20852 USA.							Anderson G M, 1997, J Eval Clin Pract, V3, P283, DOI 10.1046/j.1365-2753.1997.t01-1-00005.x; Aparasu RR, 1997, ANN PHARMACOTHER, V31, P823, DOI 10.1177/106002809703100702; Aparasu RR, 1999, AM J HEALTH-SYST PH, V56, P433, DOI 10.1093/ajhp/56.5.433; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; BEERS MH, 1992, ANN INTERN MED, V117, P684, DOI 10.7326/0003-4819-117-8-684; Blazer D, 2000, J AM GERIATR SOC, V48, P1073, DOI 10.1111/j.1532-5415.2000.tb04782.x; Cantrill J., 1996, INT J PHARM PRACTICE, V4, P67, DOI DOI 10.1111/J.2042-7174.1996.TB00844.X; COBBS E, 1999, GERIATRICS REV SYLLA, P120; COHEN SB, 1997, 2 MEPS AG HEALTHC RE; Golden AG, 1999, J AM GERIATR SOC, V47, P948, DOI 10.1111/j.1532-5415.1999.tb01289.x; GOSNEY M, 1984, LANCET, V2, P564; GURWITZ JH, 1994, JAMA-J AM MED ASSOC, V272, P316, DOI 10.1001/jama.272.4.316; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; *I MED, 1999, ERR IS HUM BUILD SAF; LEDERLE FA, 1993, ARCH INTERN MED, V153, P705, DOI 10.1001/archinte.153.6.705; LINDLEY CM, 1992, AGE AGEING, V21, P294, DOI 10.1093/ageing/21.4.294; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; MOELLER JF, 2001, HC010A AG HEALTHC RE; Monane M, 1998, JAMA-J AM MED ASSOC, V280, P1249, DOI 10.1001/jama.280.14.1249; Mort JR, 2000, ARCH INTERN MED, V160, P2825, DOI 10.1001/archinte.160.18.2825; Nash DB., 2000, WHY ELDERLY NEED IND; Newcomer LN, 2000, HEALTH AFFAIR, V19, P59, DOI 10.1377/hlthaff.19.2.59; RAY WA, 1980, AM J PUBLIC HEALTH, V70, P485, DOI 10.2105/AJPH.70.5.485; Rothschild JM, 2000, ARCH INTERN MED, V160, P2717, DOI 10.1001/archinte.160.18.2717; Spore DL, 1997, AM J PUBLIC HEALTH, V87, P404, DOI 10.2105/AJPH.87.3.404; *US GAO, 1995, PRESCR DRUGS ELD MAN; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; WILLIAMS B, 1995, J AM GERIATR SOC, V43, P513, DOI 10.1111/j.1532-5415.1995.tb06098.x	29	150	155	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2823	2829		10.1001/jama.286.22.2823	http://dx.doi.org/10.1001/jama.286.22.2823			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500YC	11735757	Bronze			2022-12-01	WOS:000172655400030
J	Groszer, M; Erickson, R; Scripture-Adams, DD; Lesche, R; Trumpp, A; Zack, JA; Kornblum, HI; Liu, X; Wu, H				Groszer, M; Erickson, R; Scripture-Adams, DD; Lesche, R; Trumpp, A; Zack, JA; Kornblum, HI; Liu, X; Wu, H			Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC-DEVELOPMENT; MICE LACKING; STEM-CELLS; ACTIVATION; GENERATION; SURVIVAL; NEURONS; PROTEIN; DIFFERENTIATION	The mechanisms controlling neural stem cell proliferation are poorly understood. Here we demonstrate that the PTEN tumor suppressor plays an important role in regulating neural stem/progenitor cells in vivo and in vitro. Mice lacking PTEN exhibited enlarged, histoarchitecturally abnormal brains, which resulted from increased cell proliferation, decreased cell death, and enlarged cell size. Neurosphere cultures revealed a greater proliferation capacity for tripotent Pten(-/-) central nervous system stem/progenitor cells, which can be attributed, at Least in part, to a shortened cell cycle. However, cell fate commitments of the progenitors were largely undisturbed. Our results suggest that PTEN negatively regulates neural stem cell proliferation.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Inst Suisse Rech Expt Canc, CH-1066 Epalinges, Switzerland	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Liu, X (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	xliu@mednet.ucla.edu; hwu@mednet.ucla.edu	Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466; Groszer, Matthias/0000-0002-6209-305X; Scripture-Adams, Deirdre/0000-0002-3676-1771	NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH062800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038489] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD087101] Funding Source: Medline; NIMH NIH HHS [MH062800-01] Funding Source: Medline; NINDS NIH HHS [NS38489] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Fazekas de St Groth B, 1999, IMMUNOL CELL BIOL, V77, P530; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Gimm O, 2000, HUM MOL GENET, V9, P1633, DOI 10.1093/hmg/9.11.1633; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Luukko K, 1999, MECH DEVELOP, V83, P187, DOI 10.1016/S0925-4773(99)00050-7; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Morrison SJ, 2000, NEURON, V28, P1, DOI 10.1016/S0896-6273(00)00075-1; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; Takahashi T, 1999, J NEUROSCI, V19, P10357; Tropepe V, 1997, J NEUROSCI, V17, P7850	24	634	673	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2186	2189		10.1126/science.1065518	http://dx.doi.org/10.1126/science.1065518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11691952				2022-12-01	WOS:000172647700057
J	Kornack, DR; Rakic, P				Kornack, DR; Rakic, P			Cell proliferation without neurogenesis in adult primate neocortex	SCIENCE			English	Article							OLIGODENDROCYTE PROGENITOR CELLS; CEREBRAL-CORTEX; VISUAL-CORTEX; DENTATE GYRUS; DNA-SYNTHESIS; STEM-CELLS; RAT; MIGRATION; NEURONS; TELENCEPHALON	A recent assertion that new neurons are continually added to the neocortex of adult macaque monkeys has profound implications for understanding the cellular mechanisms of higher cognitive functions. Here we searched for neurogenesis in adult macaques by using immunofluorescent triple labeling for the DNA-replication indicator, bromodeoxyuridine (BrdU), and neuronal and glial cell markers. Although numerous BrdU-labeled cells were distributed throughout the cerebral wall, including the neocortex, these were identified as non-neuronal cells; evidence for newly generated neurons was limited to the hippocampus and olfactory bulb. Thus, our results do not substantiate the claim of neurogenesis in normal adult primate neocortex.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Univ Rochester, Med Ctr, Ctr Aging & Dev Biol, Dept Neurobiol & Anat, Rochester, NY 14642 USA	Yale University; University of Rochester	Rakic, P (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	pasko.rakic@yale.edu			NATIONAL EYE INSTITUTE [R01EY002593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER; NEI NIH HHS [EY02593] Funding Source: Medline; NINDS NIH HHS [NS14841] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; BRUCKNER G, 1976, J COMP NEUROL, V166, P245, DOI 10.1002/cne.901660208; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Coskun V, 2001, J NEUROSCI, V21, P3092, DOI 10.1523/JNEUROSCI.21-09-03092.2001; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GAZZANIGA MS, 1999, COGNITIVE NEUROSCIEN; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gould E, 2000, SCIENCE, V288, p771a; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; JACKSON CA, 1989, J NEUROSCI, V9, P1242; Jessel T. M., 1991, PRINCIPLES NEUROSCIE; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; KIRSCHENBAUM B, 1994, CEREB CORTEX, V4, P576, DOI 10.1093/cercor/4.6.576; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; KORR H, 1973, J COMP NEUROL, V150, P169, DOI 10.1002/cne.901500205; Korr H, 1980, Adv Anat Embryol Cell Biol, V61, P1; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MARES V, 1978, J COMP NEUROL, V177, P519, DOI 10.1002/cne.901770310; Markakis EA, 1999, J COMP NEUROL, V406, P449; MCDERMOTT KWG, 1990, DEV BRAIN RES, V57, P269, DOI 10.1016/0165-3806(90)90053-2; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; Nacher J, 2000, J COMP NEUROL, V424, P628, DOI 10.1002/1096-9861(20000904)424:4<628::AID-CNE5>3.0.CO;2-4; Neve RL, 2000, BRAIN RES, V886, P54, DOI 10.1016/S0006-8993(00)02869-9; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nowakowski R, 2000, SCIENCE, V288, p771a, DOI DOI 10.1126/SCIENCE.288.5467.771A; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; PRIVAT A, 1975, INT REV CYTOL, V40, P281, DOI 10.1016/S0074-7696(08)60955-9; RAKIC P, 1985, ANN NY ACAD SCI, V457, P193, DOI 10.1111/j.1749-6632.1985.tb20806.x; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 1998, NAT NEUROSCI, V1, P645, DOI 10.1038/3643; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; RAKIC P, 1993, RESTORATIVE NEUROLOG, V6, P257; RAKIC P, IN PRESS NATURE REV; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Seress L, 2001, NEUROSCIENCE, V105, P831, DOI 10.1016/S0306-4522(01)00156-7; SMART IHM, 1982, J ANAT, V134, P273; Thomas LB, 1996, GLIA, V17, P1; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001	53	466	490	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2127	2130		10.1126/science.1065467	http://dx.doi.org/10.1126/science.1065467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739948				2022-12-01	WOS:000172647700040
J	Yang, Q; Bermingham, NA; Finegold, MJ; Zoghbi, HY				Yang, Q; Bermingham, NA; Finegold, MJ; Zoghbi, HY			Requirement of Math1 for secretory cell lineage commitment in the mouse intestine	SCIENCE			English	Article							TRANSCRIPTION FACTOR; TRANSGENIC MICE; STEM-CELLS; DIFFERENTIATION; PROGENITORS; REGULATOR; REVEALS	The mouse small intestinal epithelium consists of four principal cell types deriving from one multipotent stem cell: enterocytes, goblet, enteroendocrine, and Paneth cells. Previous studies showed that Math1, a basic helix-loop-helix (bHLH) transcription factor, is expressed in the gut. We find that toss of Math1 leads to depletion of goblet, enteroendocrine, and Paneth cells without affecting enterocytes. Colocalization of Math1 with Ki-67 in some proliferating cells suggests that secretory cells (goblet, enteroendocrine, and Paneth cells) arise from a common progenitor that expresses Math1, whereas absorptive cells (enterocytes) arise from a progenitor that is Math1-independent. The continuous rapid renewal of these cells makes the intestinal epithelium a model system for the study of stem cell regeneration and lineage commitment.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.			Zoghbi, Huda/0000-0002-0700-3349				AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Beck F, 2000, BIOESSAYS, V22, P431, DOI 10.1002/(SICI)1521-1878(200005)22:5<431::AID-BIES5>3.0.CO;2-X; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Blaugrund E, 1996, DEVELOPMENT, V122, P309; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clatworthy JP, 2001, MECH DEVELOP, V101, P3, DOI 10.1016/S0925-4773(00)00557-8; Darmoul D, 1997, AM J PHYSIOL-GASTR L, V272, pG197, DOI 10.1152/ajpgi.1997.272.1.G197; GORDON JI, 1992, FASEB J, V6, P3039, DOI 10.1096/fasebj.6.12.1521737; Ito T, 2000, DEVELOPMENT, V127, P3913; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Pabst O, 1999, DEVELOPMENT, V126, P2215; Rindi G, 1999, DEVELOPMENT, V126, P4149; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; YANG Q, UNPUB; Zheng JL, 2000, DEVELOPMENT, V127, P4551	24	673	705	5	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2155	2158		10.1126/science.1065718	http://dx.doi.org/10.1126/science.1065718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739954				2022-12-01	WOS:000172647700048
J	Dean, C; Leakey, MG; Reid, D; Schrenk, F; Schwartz, GT; Stringer, C; Walker, A				Dean, C; Leakey, MG; Reid, D; Schrenk, F; Schwartz, GT; Stringer, C; Walker, A			Growth processes in teeth distinguish modern humans from Homo erectus and earlier hominins	NATURE			English	Article							DENTAL DEVELOPMENT; ENAMEL THICKNESS; FOSSIL HOMINIDS; LIFE-HISTORY; MICROSTRUCTURE; PATTERNS; DEATH; TOOTH; TIME; AGE	A modern human-like sequence of dental development, as a proxy for the pace of life history, is regarded as one of the diagnostic hallmarks of our own genus Homo(1-3). Brain size, age at first reproduction, lifespan and other life-history traits correlate tightly with dental development(4-6). Here we report differences in enamel growth that show the earliest fossils attributed to Homo do not resemble modern humans in their development. We used daily incremental markings in enamel to calculate rates of enamel formation in 13 fossil hominins and identified differences in this key determinant of tooth formation time. Neither australopiths nor fossils currently attributed to early Homo shared the slow trajectory of enamel growth typical of modern humans; rather, both resembled modern and fossil African apes. We then reconstructed tooth formation times in australopiths, in the similar to1.5-Myr-old Homo erectus skeleton from Nariokotome, Kenya(7), and in another Homo erectus specimen, Sangiran S7-37 from Java(8). These times were shorter than those in modern humans. It therefore seems likely that truly modern dental development emerged relatively late in human evolution.	UCL, Dept Anat & Dev Biol, Evolutionary Anat Unit, London WC1E 6BT, England; Natl Museums Kenya, Dept Palaeontol, Nairobi, Kenya; Sch Dent, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; Forschungsinst Senckenberg, D-60325 Frankfurt, Germany; George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; Nat Hist Museum, London SW7 5BD, England; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	University of London; University College London; Senckenberg Gesellschaft fur Naturforschung (SGN); George Washington University; Natural History Museum London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dean, C (corresponding author), UCL, Dept Anat & Dev Biol, Evolutionary Anat Unit, Gower St, London WC1E 6BT, England.	ucgacrd@ucl.ac.uk						Allman J, 1999, NEUROBIOL AGING, V20, P447, DOI 10.1016/S0197-4580(99)00076-7; Antoine D., 1999, DENT MORPHOLOGY 1998, P48; BEYNON AD, 1987, ARCH ORAL BIOL, V32, P773, DOI 10.1016/0003-9969(87)90002-1; BEYNON AD, 1986, AM J PHYS ANTHROPOL, V70, P177, DOI 10.1002/ajpa.1330700205; BEYNON AD, 1988, NATURE, V335, P509, DOI 10.1038/335509a0; Beynon AD, 1998, J HUM EVOL, V35, P163, DOI 10.1006/jhev.1998.0230; BOYDE A, 1990, MG PRIMATOL, V14, P229; BROMAGE TG, 1985, NATURE, V317, P525, DOI 10.1038/317525a0; BROMAGE TG, 1991, AM J PHYS ANTHROPOL, V86, P205, DOI 10.1002/ajpa.1330860209; de Castro JMB, 1999, P NATL ACAD SCI USA, V96, P4210, DOI 10.1073/pnas.96.7.4210; Dean C, 2000, J ANAT, V197, P77, DOI 10.1046/j.1469-7580.2000.19710077.x; DEAN MC, 1993, AM J PHYS ANTHROPOL, V91, P401, DOI 10.1002/ajpa.1330910402; FitzGerald CM, 1998, J HUM EVOL, V35, P371, DOI 10.1006/jhev.1998.0232; Grine F.E., 1988, P3; Grine Frederick Edward, 1994, Courier Forschungsinstitut Senckenberg, V171, P75; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; KELLEY J, HUMAN EVOLUTION DEV; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; MOGGICECCHI J, 2000, ORIGIN HUMANKIND, P35; Reid DJ, 2000, AM J PHYS ANTHROPOL, V113, P135; Risnes S, 1998, J HUM EVOL, V35, P331, DOI 10.1006/jhev.1998.0229; Rozzi FR, 1998, J HUM EVOL, V35, P543, DOI 10.1006/jhev.1998.0250; Schwartz GT, 2001, INT J PRIMATOL, V22, P837, DOI 10.1023/A:1012073601808; Schwartz GT, 2000, AM J PHYS ANTHROPOL, V111, P221, DOI 10.1002/(SICI)1096-8644(200002)111:2<221::AID-AJPA8>3.0.CO;2-G; SMITH BH, 1995, ANNU REV ANTHROPOL, V24, P257, DOI 10.1146/annurev.an.24.100195.001353; SMITH BH, 1994, AM J PHYS ANTHROPOL, V94, P307, DOI 10.1002/ajpa.1330940303; SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x; WALKER A, 1993, NARIOKOTOME HORNO ER; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B. A., 1991, HOMINID CRANIAL REMA, V4	30	350	361	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					628	631		10.1038/414628a	http://dx.doi.org/10.1038/414628a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498WB	11740557				2022-12-01	WOS:000172535600045
J	Fesik, SW; Shi, YG				Fesik, SW; Shi, YG			Structural biology - Controlling the caspases	SCIENCE			English	Editorial Material							APOPTOSIS PROTEIN XIAP; NMR STRUCTURE; CELL-DEATH; BIR DOMAIN; INHIBITOR; SMAC/DIABLO; ACTIVATION; HID; MUTAGENESIS; BINDING		Abbott Labs, Global Pharmaceut Res & Dev, Canc Res, Abbott Pk, IL 60064 USA; Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA	Abbott Laboratories; Princeton University	Fesik, SW (corresponding author), Abbott Labs, Global Pharmaceut Res & Dev, Canc Res, Abbott Pk, IL 60064 USA.			Shi, Yigong/0000-0003-2030-168X				Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(01)00274-4; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Wu JW, 2001, MOL CELL, V8, P95, DOI 10.1016/S1097-2765(01)00282-9; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	27	130	147	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1477	1478		10.1126/science.1062236	http://dx.doi.org/10.1126/science.1062236			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711663				2022-12-01	WOS:000172240500035
J	Berke, JD; Eichenbaum, HB				Berke, JD; Eichenbaum, HB			Drug addiction and the hippocampus	SCIENCE			English	Editorial Material									Boston Univ, Dept Psychol, Lab Cognit Neurobiol, Boston, MA 02215 USA	Boston University	Berke, JD (corresponding author), Boston Univ, Dept Psychol, Lab Cognit Neurobiol, 64 Cummington St, Boston, MA 02215 USA.	jberke@bu.edu						DOUGLAS RJ, 1967, PSYCHOL BULL, V67, P416, DOI 10.1037/h0024599; Eichenbaum H, 2004, CONDITIONING CONSCIO; Holden C, 2001, SCIENCE, V292, P1039; PACKARD MG, 1989, J NEUROSCI, V9, P1465; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043	6	33	33	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701892				2022-12-01	WOS:000172130200001
J	Watts, C				Watts, C			Immunology - Antigen presentation-losing its shine in the absence of GILT	SCIENCE			English	Editorial Material							THIOL REDUCTASE GILT; CLASS-II MOLECULES; DISULFIDE BONDS; LYSOSOMES; COMPLEX; DETERMINANT; PROTEIN; STEP		Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Watts, C (corresponding author), Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland.			Watts, Colin/0000-0001-6183-2087				Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Arunachalam B, 1998, J IMMUNOL, V160, P5797; COLLINS DS, 1991, J IMMUNOL, V147, P4054; FEENER EP, 1990, J BIOL CHEM, V265, P18780; GAMMON G, 1991, J EXP MED, V173, P609, DOI 10.1084/jem.173.3.609; Jensen P E, 1995, Semin Immunol, V7, P347, DOI 10.1006/smim.1995.0039; JENSEN PE, 1991, J EXP MED, V174, P1121, DOI 10.1084/jem.174.5.1121; Kang HK, 2000, J IMMUNOL, V164, P1775, DOI 10.4049/jimmunol.164.4.1775; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; PAPINI E, 1993, J BIOL CHEM, V268, P1567; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; Velazquez C, 2001, J IMMUNOL, V166, P5488, DOI 10.4049/jimmunol.166.9.5488; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	14	9	9	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1294	1295		10.1126/science.1066725	http://dx.doi.org/10.1126/science.1066725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701917				2022-12-01	WOS:000172130200034
J	Schlein, Y; Jacobson, RL				Schlein, Y; Jacobson, RL			Parasitic infection - Hunger tolerance and Leishmania in sandflies	NATURE			English	Article							PHLEBOTOMUS-PAPATASI; VECTOR		Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Parasitol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Schlein, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Parasitol, POB 12272, IL-91120 Jerusalem, Israel.							Ashford R.W., 1987, P365; Harshman LG, 1999, J EVOLUTION BIOL, V12, P370, DOI 10.1046/j.1420-9101.1999.00024.x; Hopkins W.G, 1995, INTRO PLANT PHYSL; SCHAUB GA, 1994, PARASITOL TODAY, V10, P463, DOI 10.1016/0169-4758(94)90155-4; Schlein Y, 1999, MED VET ENTOMOL, V13, P65, DOI 10.1046/j.1365-2915.1999.00138.x; Schlein Y, 2000, J MED ENTOMOL, V37, P319, DOI 10.1603/0022-2585(2000)037[0319:PMTPFO]2.0.CO;2; SCHLEIN Y, 1992, P NATL ACAD SCI USA, V89, P9944, DOI 10.1073/pnas.89.20.9944; SCHLEIN Y, 1983, ACTA TROP, V40, P65; VANHANDE.E, 1967, ANAL BIOCHEM, V19, P193, DOI 10.1016/0003-2697(67)90152-2; Yan G, 1997, EVOLUTION, V51, P441, DOI [10.2307/2411116, 10.1111/j.1558-5646.1997.tb02431.x]; Zar JH., 1999, BIOSTAT ANAL	11	11	12	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					168	168		10.1038/35102679	http://dx.doi.org/10.1038/35102679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700547				2022-12-01	WOS:000172029100035
J	McMahon, BJ; Holck, P; Bulkow, L; Snowball, M				McMahon, BJ; Holck, P; Bulkow, L; Snowball, M			Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus	ANNALS OF INTERNAL MEDICINE			English	Article							SURFACE-ANTIGEN CARRIERS; HEPATOCELLULAR-CARCINOMA; POSITIVE PATIENTS; INTERFERON THERAPY; NATURAL-HISTORY; LIVER-DISEASE; FOLLOW-UP; SEROCONVERSION; CLEARANCE; ALPHA	Background: Knowledge of the outcome of chronic hepatitis B virus (HBV) infection Is limited. Objective: To determine the incidence of and risk factors for adverse events (hepatocellular carcinoma and end-stage liver disease) and clearance of hepatitis B e antigen (HBeAg) and surface antigen (HBsAg) in carriers of HBV. Design: Population-based cohort study of hepatitis B carriers who were observed for a median of 12.3 years as part of an active surveillance program to detect carriers with hepatocellular carcinoma. Setting: 126 communities in Alaska. Patients: 1536 Alaska Natives with chronic hepatitis B. Measurements: Bivariate comparisons, multivariable models, and other statistical methods were used to examine the relationships of risk factors to outcomes and clearance of HBeAg and HBsAg. Results: 1536 chronic HBV carriers were followed up for 19 430 person-years from their first HBsAg-positive test result. At the first serologic test 641 were HBeAg positive and 893 were anti-HBe positive. Older carriers were more likely than younger carriers to clear HBeAg (P < 0.001). The observed probability of clearing HBeAg within 10 years of diagnosis was 72.5%. Clearance of HBsAg occurred in 106 (7%) of all carriers and was positively associated with older age and positive result on initial anti-HBe test. The incidence of adverse events was 2.3 per 1000 carrier-years, and the incidence of hepatocellular carcinoma was 1.9 per 1000 carrier-years (2.3 in men and 1.2 In women). Risk for hepatocellular carcinoma increased with age, among those of Yupik Eskimo ethnicity, and among carriers who reverted from anti-HBe to HBeAg. Conclusion: in HBsAg-positive carriers, observed clearance of HBeAg was more than 70% during the first 10 years of follow-up.	CDCP, Arctic Invest Program, Viral Hepatitis Program, Alaska Native Med Ctr, Anchorage, AK 99508 USA; CDCP, Arctic Invest Program, Natl Ctr Infect Dis, US Publ Hlth Serv,Dept Hlth & Human Serv, Anchorage, AK 99508 USA; Alaska Native Hlth Board, Anchorage, AK 99508 USA	Alaska Native Medical Center; United States Public Health Service	McMahon, BJ (corresponding author), CDCP, Arctic Invest Program, Viral Hepatitis Program, Alaska Native Med Ctr, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.							ADACHI H, 1992, HEPATOLOGY, V16, P1334, DOI 10.1002/hep.1840160605; Baffis V, 1999, ANN INTERN MED, V131, P696, DOI 10.7326/0003-4819-131-9-199911020-00011; BARRETT DH, 1977, AM J EPIDEMIOL, V105, P118, DOI 10.1093/oxfordjournals.aje.a112362; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; CHANG MH, 1995, HEPATOLOGY, V22, P1387, DOI 10.1016/0270-9139(95)90141-8; DAVIS GL, 1984, GASTROENTEROLOGY, V86, P230; DEFRANCHIS R, 1993, ANN INTERN MED, V118, P191, DOI 10.7326/0003-4819-118-3-199302010-00006; DEJONGH FE, 1992, GASTROENTEROLOGY, V103, P1630, DOI 10.1016/0016-5085(92)91188-A; DODD RY, 1987, J VIROL METHODS, V17, P81, DOI 10.1016/0166-0934(87)90071-1; DUSHEIKO GM, 1989, AM J EPIDEMIOL, V129, P138, DOI 10.1093/oxfordjournals.aje.a115102; Evans AA, 1997, J INFECT DIS, V176, P845, DOI 10.1086/516538; FATTOVICH G, 1986, HEPATOLOGY, V6, P167, DOI 10.1002/hep.1840060203; Fattovich G, 1997, HEPATOLOGY, V26, P1338; Gandhi MJ, 2000, TRANSFUSION, V40, P910, DOI 10.1046/j.1537-2995.2000.40080910.x; HALL AJ, 1988, VIRAL HEPATITIS LIVE; HEYWARD WL, 1985, JAMA-J AM MED ASSOC, V254, P3052, DOI 10.1001/jama.254.21.3052; HOOFNAGLE JH, 1981, ANN INTERN MED, V94, P744, DOI 10.7326/0003-4819-94-6-744; Huo TI, 1998, HEPATOLOGY, V28, P231, DOI 10.1002/hep.510280130; KIM YI, 1987, CLIN INVEST MED, V10, P383; KORENMAN J, 1991, ANN INTERN MED, V114, P629, DOI 10.7326/0003-4819-114-8-629; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; LIAW YF, 1991, HEPATOLOGY, V13, P627, DOI 10.1002/hep.1840130403; LIAW YF, 1987, HEPATOLOGY, V7, P20, DOI 10.1002/hep.1840070106; LIAW YF, 1983, GASTROENTEROLOGY, V84, P216; LOK ASF, 1987, GASTROENTEROLOGY, V92, P1839, DOI 10.1016/0016-5085(87)90613-5; Mason AL, 1998, HEPATOLOGY, V27, P1736, DOI 10.1002/hep.510270638; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; MCMAHON BJ, 1993, AM J EPIDEMIOL, V138, P544; MCMAHON BJ, 1987, LANCET, V2, P1134; MCMAHON BJ, 1980, J INFECT DIS, V142, P772, DOI 10.1093/infdis/142.5.772; MCMAHON BJ, 1997, VIRAL HEPATITIS, P315; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; SCHREEDER MT, 1983, AM J EPIDEMIOL, V118, P543, DOI 10.1093/oxfordjournals.aje.a113659; SHERMAN M, 1995, HEPATOLOGY, V22, P432, DOI 10.1016/0270-9139(95)90562-6; TOKUDOME S, 1987, HEPATO-GASTROENTEROL, V34, P246; VIOLA LA, 1981, LANCET, V2, P1156; WEISSBERG JI, 1984, ANN INTERN MED, V101, P613, DOI 10.7326/0003-4819-101-5-613; WONG DKH, 1993, ANN INTERN MED, V119, P312, DOI 10.7326/0003-4819-119-4-199308150-00011	40	298	326	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2001	135	9					759	768		10.7326/0003-4819-135-9-200111060-00006	http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VT	11694101				2022-12-01	WOS:000172013700001
J	Sweere, U; Eichenberg, K; Lohrmann, J; Mira-Rodado, V; Baurle, I; Kudla, J; Nagy, F; Schafer, E; Harter, K				Sweere, U; Eichenberg, K; Lohrmann, J; Mira-Rodado, V; Baurle, I; Kudla, J; Nagy, F; Schafer, E; Harter, K			Interaction of the response regulator ARR4 with phytochrome B in modulating red light signaling	SCIENCE			English	Article							NUCLEAR IMPORT; ARABIDOPSIS; PHOTORECEPTORS; PROTEIN; GENE	The Arabidopsis thaliana response regulator 4, expressed in response to phytochrome B action, specifically interacts with the extreme amino-terminus of the photoreceptor. The response regulator 4 stabilizes the active Pfr form of phytochrome B in yeast and in planta, thus elevates the level of the active photoreceptor in vivo. Accordingly, transgenic Arabidopsis plants overexpressing the response regulator 4 display hypersensitivity to red tight but not to light of other wavelengths. We propose that the response regulator 4 acts as an output element of a two-component system that modulates red light signaling on the level of the phytochrome B photoreceptor.	Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; Univ Ulm, D-89069 Ulm, Germany; Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary	University of Freiburg; Ulm University; Hungarian Academy of Sciences; Hungarian Biological Research Center	Harter, K (corresponding author), Univ Freiburg, Inst Biol 2, Schanzlestr 1, D-79104 Freiburg, Germany.		Nagy, Ferenc/D-3532-2015; Kudla, Jörg/C-2174-2012; Bäurle, Isabel/ABD-6356-2021	Nagy, Ferenc/0000-0002-6157-9269; Kudla, Jörg/0000-0002-8238-767X; Bäurle, Isabel/0000-0001-5633-8068				Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; Eichenberg K, 2000, PLANT CELL ENVIRON, V23, P311, DOI 10.1046/j.1365-3040.2000.00550.x; EICHENBERG K, 1999, THESIS U FREIBURG; Elich TD, 1997, PLANT CELL, V9, P2271, DOI 10.1105/tpc.9.12.2271; Imamura A, 1998, P NATL ACAD SCI USA, V95, P2691, DOI 10.1073/pnas.95.5.2691; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kircher S, 1999, J CELL BIOL, V144, P201, DOI 10.1083/jcb.144.2.201; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; KUNKEL T, 1993, EUR J BIOCHEM, V215, P587, DOI 10.1111/j.1432-1033.1993.tb18069.x; Lohrmann J, 2001, MOL GENET GENOMICS, V265, P2, DOI 10.1007/s004380000400; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; MATSUMURA P, 1984, J BACTERIOL, V160, P36, DOI 10.1128/JB.160.1.36-41.1984; NAGATANI A, 1985, CELL PHYSL, V25, P1059; Nagy F, 2000, SEMIN CELL DEV BIOL, V11, P505, DOI 10.1006/scdb.2000.0202; Neff MM, 2000, GENE DEV, V14, P257; Park CM, 2000, SEMIN CELL DEV BIOL, V11, P449, DOI 10.1006/scdb.2000.0200; SCHALLER GE, IN PRESS ARABIDOPSIS; SCHNEIDERPOETSCH HAW, 1991, FEBS LETT, V281, P245, DOI 10.1016/0014-5793(91)80403-P; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; SWEERE U, 2001, UNPUB U FREIBURG; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	22	224	242	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1108	1111		10.1126/science.1065022	http://dx.doi.org/10.1126/science.1065022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691995				2022-12-01	WOS:000172013800052
J	Archibald, JD; Averianov, AO; Ekdale, EG				Archibald, JD; Averianov, AO; Ekdale, EG			Late Cretaceous relatives of rabbits, rodents, and other extant eutherian mammals	NATURE			English	Article							EVOLUTIONARY; MONGOLIA; ORIGINS	Extant eutherian mammals and their most recent common ancestor constitute the crown group Placentalia. This taxon, plus all extinct taxa that share a more recent common ancestor with placentals than they do with Metatheria (including marsupials), constitute Eutheria(1). The oldest well documented eutherian-dominated fauna in the world is Dzharakuduk, Uzbekistan(2). Among eutherians that it yields is Kulbeckia, an 85-90-Myr-old member of Zalambdalestidae (a family of Late Cretaceous Asian eutherians)(3). This extends Zalambdalestidae back by some 10 million years from sites in the Gobi Desert, Mongolia(4). A phylogenetic analysis of well described Late Cretaceous eutherians strongly supports Zalambdalestidae, less strongly supports 'Zhelestidae' (a Late Cretaceous clade related to Tertiary ungulates), but does not support Asioryctitheria (a group of Late Cretaceous Asian eutherians). A second analysis incorporating placentals from clades that include rodents (Tribosphenomys), lagomorphs (Mimotona) and archaic ungulates (Protungulatum and Oxyprimus) strongly supports Zalambdalestidae in a clade with Glires (rabbits, rodents and extinct relatives) and less strongly 'Zhelestidae' within a clade that includes archaic ungulates ('condylarths'). This argues that some Late Cretaceous eutherians belong within the crown group Placentalia. The ages of these taxa are in line with molecularly based estimates of 64-104 Myr ago (median 84 Myr ago) for the superordinal diversification of some placentals(5), but provide no support for a Late Cretaceous diversification of extant placental orders.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia	California State University System; San Diego State University; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Archibald, JD (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	darchibald@sunstroke.sdsu.edu	Averianov, Alexander/M-8490-2013	Averianov, Alexander/0000-0001-5948-0799				Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Archibald JD, 1996, SCIENCE, V272, P1150, DOI 10.1126/science.272.5265.1150; ARCHIBALD JD, 1998, NEW MEXICO MUSEUM NA, V14, P21; ARCHIBALD JD, IN PRESS J VERT PALE; ARCHIBALD JD, 1998, TERTIARY MAMMALS N A, V1, P292; Averianov AO, 2001, ACTA PALAEONTOL POL, V46, P431; Cifelli RL, 1999, NATURE, V401, P363, DOI 10.1038/43861; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Kielan-Jaworowska Z., 1968, PALAEONTOLOGIA POLON, V19, P171; Kielan-Jaworowska Zofia, 2000, P573; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LI CK, 1993, NEW CRANIAL POSTCRAN, P151; LOPATIN AV, IN PRESS NEW MEX MUS; LUCKETT WP, 1985, EVOLUTIONARY RELATIO, P227; MADDISON WP, 1997, MACCLADE 3 07; Marshall L.G., 1990, Current Mammalogy, V2, P433; Martin T, 1997, TOOTH ENAMEL MICROSTRUCTURE, P163; MCKENNA MC, 1997, CLASSIFICATION MAMMA, V284, P104; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NESOV LA, 1997, CRETACEOUS NONMARINE, P168; Nessov L.A., 1994, Trudy Zoologicheskogo Instituta, V249, P105; Nessov Lev A., 1998, Bulletin of Carnegie Museum of Natural History, V34, P40; Novacek M. J., 1998, Journal of Vertebrate Paleontology, V18, p67A; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; SZALAY FS, 1994, EVOLUTIONARY HIST MA, V362, P35; VAUGHAN TA, 2000, MAMMALOGY, P73; Wible John R., 2001, American Museum Novitates, V3322, P1, DOI 10.1206/0003-0082(2001)322<0001:EEERAP>2.0.CO;2	31	106	114	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					62	65		10.1038/35102048	http://dx.doi.org/10.1038/35102048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689942				2022-12-01	WOS:000171898900041
J	Morais-Cabral, JH; Zhou, YF; MacKinnon, R				Morais-Cabral, JH; Zhou, YF; MacKinnon, R			Energetic optimization of ion conduction rate by the K+ selectivity filter	NATURE			English	Article							ELECTRON-DENSITY MAPS; CHANNEL; SKELETAL; COMPLEX	The K+ selectivity filter catalyses the dehydration, transfer and rehydration of a K+ ion in about ten nanoseconds. This physical process is central to the production of electrical signals in biology. Here we show how nearly diffusion-limited rates are achieved, by analysing ion conduction and the corresponding crystallographic ion distribution in the selectivity filter of the KcsA K+ channel. Measurements with K+ and its slightly larger analogue, Rb+, lead us to conclude that the selectivity filter usually contains two K+ ions separated by one water molecule. The two ions move in a concerted fashion between two configurations, K+-water-K+-water (1,3 conrguration) and water-K+-water-K+ (2,4 conrguration), until a third ion enters, displacing the ion on the opposite side of the queue. For K+, the energy difference between the 1,3 and 2,4 configurations is close to zero, the condition of maximum conduction rate. The energetic balance between these configurations is a clear example of evolutionary optimization of protein function.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716				ALCAYAGA C, 1989, BIOPHYS J, V55, P367, DOI 10.1016/S0006-3495(89)82814-0; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEGENISICH T, 1980, J GEN PHYSIOL, V76, P83, DOI 10.1085/jgp.76.1.83; BESTERGAARDBOGI.B, 1985, J MEMBRANE BIOL, V88, P67; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CUELLO LG, 1988, BIOCHEMISTRY-US, V37, P3229; DOBLER M, 1969, HELV CHIM ACTA, V52, P2573, DOI 10.1002/hlca.19690520840; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNITZ JD, 1977, BIOL ASPECTS INORGAN, P113; EISENMAN G, 1986, BIOPHYS J, V50, P1025, DOI 10.1016/S0006-3495(86)83546-9; GAMBLIN SJ, 1996, P CCP4 STUD WEEK DAR, P163; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt G. J., 1994, P CCP4 STUD WEEK 1 M, P59; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; KOONIN S, 1986, COMPUTATIONAL PHYSIC; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; NEUPERTLAVES K, 1975, HELV CHIM ACTA, V58, P432, DOI 10.1002/hlca.19750580212; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	27	626	644	8	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					37	42		10.1038/35102000	http://dx.doi.org/10.1038/35102000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689935				2022-12-01	WOS:000171898900034
J	Dinner, AR; Blackburn, GM; Karplus, M				Dinner, AR; Blackburn, GM; Karplus, M			Uracil-DNA glycosylase acts by substrate autocatalysis	NATURE			English	Article							HYDROGEN-BOND; ENERGY; MECHANISM; CATALYSIS; DYNAMICS; REPAIR; NMR; SIMULATION; ENZYME	In humans, uracil appears in DNA at the rate of several hundred bases per cell each day as a result of misincorporation of deoxyuridine (dU) or deamination of cytosine. Four enzymes that catalyse the hydrolysis of the glycosylic bond of dU in DNA to yield an apyridiminic site as the first step in base excision repair have been identified in the human genome(1). The most efficient and well characterized of these uracil-DNA glycosylases is UDG (also known as UNG and present in almost all known organisms)(2), which excises U from single- or double-stranded DNA and is associated with DNA replication forks(3). We used a hybrid quantum-mechanical/molecular-mechanical (QM/MM) approach(4) to determine the mechanism of catalysis by UDG. In contrast to the concerted associative mechanism proposed initially (5-10), we show here that the reaction proceeds in a stepwise dissociative manner(11,12). Cleavage of the glycosylic bond yields an intermediate comprising an oxocarbenium cation and a uracilate anion. Subsequent attack by a water molecule and transfer of a proton to D145 result in the products. Surprisingly, the primary contribution to lowering the activation energy comes from the substrate, rather than from the enzyme. This 'autocatalysis' derives from the burial and positioning of four phosphate groups that stabilize the rate-determining transition state. The importance of these phosphates explains the residual activity observed for mutants that lack key residues(6-9). A corresponding catalytic mechanism could apply to the DNA glycosylases TDG and SMUG1, which belong to the same structural superfamily as UDG(13,14).	Univ Oxford, Cent Chem Lab, Oxford OX1 3QH, England; Univ Sheffield, Krebs Inst, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Univ Strasbourg, ISIS, Lab Chim Biophys, F-67000 Strasbourg, France	University of Oxford; University of Sheffield; Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Univ Oxford, Cent Chem Lab, S Parks Rd, Oxford OX1 3QH, England.	marci@tammy.harvard.edu						BASH PA, 1991, BIOCHEMISTRY-US, V30, P5826, DOI 10.1021/bi00238a003; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen XY, 2000, J AM CHEM SOC, V122, P6527, DOI 10.1021/ja992751a; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Drohat AC, 2000, BIOCHEMISTRY-US, V39, P11865, DOI 10.1021/bi000922e; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Drohat AC, 2000, J AM CHEM SOC, V122, P1840, DOI 10.1021/ja993254x; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Reuter N, 2000, J PHYS CHEM A, V104, P1720, DOI 10.1021/jp9924124; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Schaefer M, 1997, J PHYS CHEM B, V101, P1663, DOI 10.1021/jp962972s; SHAPIRO R, 1969, BIOCHEMISTRY-US, V8, P1806, DOI 10.1021/bi00833a004; Shroyer MJN, 1999, BIOCHEMISTRY-US, V38, P4834, DOI 10.1021/bi982986j; Simonson T, 1997, J PHYS CHEM B, V101, P8349, DOI 10.1021/jp9711499; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Weinhold F., 1998, ENCY COMPUTATIONAL C, P1792; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797	30	201	202	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					752	755		10.1038/35099587	http://dx.doi.org/10.1038/35099587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607036				2022-12-01	WOS:000171608000048
J	Ferreira, FL; Bota, DP; Bross, A; Melot, C; Vincent, JL				Ferreira, FL; Bota, DP; Bross, A; Melot, C; Vincent, JL			Serial evaluation of the SOFA score to predict outcome in critically ill patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE UNITS; MULTIPLE ORGAN FAILURE; ACUTE-PANCREATITIS; ACUTE PHYSIOLOGY; MULTICENTER; DYSFUNCTION/FAILURE; SEPSIS; MORTALITY; TRAUMA; APACHE	Context Evaluation of trends in organ dysfunction in critically ill patients may help predict outcome. Objective To determine the usefulness of repeated measurement the Sequential Organ Failure Assessment (SOFA) score for prediction of mortality in intensive care unit (ICU) patients. Design Prospective, observational cohort study conducted from April 1 to July 31, 1999. Setting A 31-bed medicosurgical ICU at a university hospital in Belgium. Patients Three hundred fifty-two consecutive patients (mean age, 59 years) admitted to the ICU for more than 24 hours for whom the SOFA score was calculated on admission and every 48 hours until discharge. Main Outcome Measures Initial SOFA score (0-24), Delta -SOFA scores (differences between subsequent scores), and the highest and mean SOFA scores obtained during the ICU stay and their correlations with mortality. Results The initial, highest, and mean SOFA scores correlated well with mortality. Initial and highest scores of more than 11 or mean scores of more than 5 corresponded to mortality of more than 80%. The predictive value of the mean score was independent of the length of ICU stay. In univariate analysis, mean and highest SOFA scores had the strongest correlation with mortality, followed by Delta-SOFA and initial SOFA scores. The area under the receiver operating characteristic curve was largest for highest scores (0.90; SE, 0.02; P<.001 vs initial score). When analyzing trends in the SOFA score during the first 96 hours, regardless of the initial score, the mortality rate was at least 50% when the score increased, 27% to 35% when it remained unchanged, and less than 27% when it decreased. Differences in mortality were better predicted in the first 48 hours than in the subsequent 48 hours. There was no significant difference in the length of stay among these groups. Except for initial scores of more than 11 (mortality rate >90%), a decreasing score during the first 48 hours was associated with a mortality rate of less than 6%, while an unchanged or increasing score was associated with a mortality rate of 37% when the initial score was 2 to 7 and 60% when the initial score was 8 to 11. Conclusions Sequential assessment of organ dysfunction during the first few days of ICU admission is a good indicator of prognosis. Both the mean and highest SOFA scores are particularly useful predictors of outcome. Independent of the initial score, an increase in SOFA score during the first 48 hours in the ICU predicts a mortality rate of at least 50%.	Free Univ Brussels, Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Vincent, JL (corresponding author), Free Univ Brussels, Erasme Univ Hosp, Dept Intens Care, Route de Lennik 808, B-1070 Brussels, Belgium.			Vincent, Jean-Louis/0000-0001-6011-6951; MELOT, Christian/0000-0002-6172-0330				Antonelli M, 1999, INTENS CARE MED, V25, P389, DOI 10.1007/s001340050863; BION JF, 1988, INTENS CARE MED, V14, P167; Cryer HG, 1999, J TRAUMA, V46, P597, DOI 10.1097/00005373-199904000-00007; CULLEN DJ, 1994, CRIT CARE MED, V22, P1345; DEITCH EA, 1992, ANN SURG, V216, P117, DOI 10.1097/00000658-199208000-00002; Di Filippo A, 1998, CHEMOTHERAPY, V44, P63, DOI 10.1159/000007092; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; Hynninen M, 1999, J CRIT CARE, V14, P63, DOI 10.1016/S0883-9441(99)90015-1; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; LARVIN M, 1989, LANCET, V2, P201; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1988, CRIT CARE MED, V16, P470, DOI 10.1097/00003246-198805000-00002; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; SAWYER RG, 1992, AM SURGEON, V58, P82; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; TRAN DD, 1990, CRIT CARE MED, V18, P474, DOI 10.1097/00003246-199005000-00002; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; WAGNER DP, 1994, CRIT CARE MED, V22, P1359, DOI 10.1097/00003246-199409000-00004; ZWEIG MH, 1993, CLIN CHEM, V39, P561	21	1540	1617	1	38	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1754	1758		10.1001/jama.286.14.1754	http://dx.doi.org/10.1001/jama.286.14.1754			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	480NC	11594901	Bronze			2022-12-01	WOS:000171466800026
J	Hines, PJ; Purnell, BA; Marx, J				Hines, PJ; Purnell, BA; Marx, J			Stem cells branch out	SCIENCE			English	Editorial Material																			0	10	12	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1417	1417		10.1126/science.287.5457.1417	http://dx.doi.org/10.1126/science.287.5457.1417			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	11645196				2022-12-01	WOS:000085531600028
J	Bourc'his, D; Xu, GL; Lin, CS; Bollman, B; Bestor, TH				Bourc'his, D; Xu, GL; Lin, CS; Bollman, B; Bestor, TH			Dnmt3L and the establishment of maternal genomic imprints	SCIENCE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; DNA METHYLTRANSFERASE GENE; EPIGENETIC MODIFICATION; METHYLATION IMPRINT; MOUSE DEVELOPMENT; LOCUS; MECHANISMS; MUTATIONS; FAMILY	Complementary sets of genes are epigenetically silenced in male and female gametes in a process termed genomic imprinting. The Dnmt3L gene is expressed during gametogenesis at stages where genomic imprints are established. Targeted disruption of Dnmt3L caused azoospermia in homozygous mates, and heterozygous progeny of homozygous, females died before midgestation. Bisulfite genomic sequencing of DNA from oocytes and embryos showed that removal of Dnmt3L prevented methylation of sequences that are normally maternally methylated. The defect was specific to imprinted regions, and global genome methylation levels were not affected. Lack of maternal methylation imprints in heterozygous embryos derived from homozygous mutant oocytes caused biallelic expression of genes that are normally expressed only from the allele of paternal origin. The key catalytic motifs characteristic of DNA cytosine methyltransferases have been lost from Dnmt3L, and the protein is more likely to act as a regulator of imprint establishment than as a DNA methyltransferase.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Transgen Anim Facil, New York, NY 10032 USA	Columbia University; Columbia University	Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.			Bourc'his, Deborah/0000-0001-9499-7291	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059377] Funding Source: NIH RePORTER; NICHD NIH HHS [HD37687] Funding Source: Medline; NIGMS NIH HHS [GM59377] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Bartolomei M., COMMUNICATION; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; HALBERT CL, 1995, J VIROL, V69, P1473, DOI 10.1128/JVI.69.3.1473-1479.1995; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; TYCKO B, 1999, PROBL CELL DIFFER, V25, P133; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	29	975	1003	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2536	2539		10.1126/science.1065848	http://dx.doi.org/10.1126/science.1065848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11719692				2022-12-01	WOS:000172927700055
J	Ahlund, M; Andersson, M				Ahlund, M; Andersson, M			Brood parasitism - Female ducks can double their reproduction	NATURE			English	Article							PATERNITY		Univ Gothenburg, Dept Zool, S-40530 Gothenburg, Sweden	University of Gothenburg	Ahlund, M (corresponding author), Univ Gothenburg, Dept Zool, Box 463, S-40530 Gothenburg, Sweden.							Andersson M, 2000, P NATL ACAD SCI USA, V97, P13188, DOI 10.1073/pnas.220137897; Andersson M, 2001, ECOLOGY, V82, P1433, DOI 10.1890/0012-9658(2001)082[1433:PFANTR]2.0.CO;2; Brown CR, 1998, BEHAV ECOL, V9, P158, DOI 10.1093/beheco/9.2.158; Eadie J.M., 1989, THESIS U BRIT COLUMB; EADIE JM, 1988, CAN J ZOOL, V66, P1709, DOI 10.1139/z88-247; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; LYON BE, 1993, ANIM BEHAV, V46, P911, DOI 10.1006/anbe.1993.1273; McRae SB, 1998, BEHAV ECOL, V9, P93, DOI 10.1093/beheco/9.1.93; Sheldon BC, 1999, ANIM BEHAV, V57, P285, DOI 10.1006/anbe.1998.0968; SORENSON MD, 1991, ANIM BEHAV, V42, P771, DOI 10.1016/S0003-3472(05)80122-8	10	75	77	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					600	601		10.1038/414600b	http://dx.doi.org/10.1038/414600b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740548				2022-12-01	WOS:000172535600036
J	Cywes, C; Wessels, MR				Cywes, C; Wessels, MR			Group A Streptococcus tissue invasion by CD44-mediated cell signalling	NATURE			English	Article							HYALURONIC-ACID CAPSULE; CD44 INTERACTION; M PROTEIN; KERATINOCYTES; RECEPTOR; BINDING; RAC1; SKIN	Streptococcus pyogenes (also known as group A Streptococcus, GAS), the agent of streptococcal sore throat and invasive soft-tissue infections, attaches to human pharyngeal or skin epithelial cells through specific recognition of its hyaluronic acid capsular polysaccharide by the hyaluronic-acid-binding protein CD44 (refs 1, 2). Because ligation of CD44 by hyaluronic acid can induce epithelial cell movement on extracellular matrix(3-5), we investigated whether molecular mimicry by the GAS hyaluronic acid capsule might induce similar cellular responses. Here we show that CD44-dependent GAS binding to polarized monolayers of human keratinocytes induced marked cytoskeletal rearrangements manifested by membrane ruffling and disruption of intercellular junctions. Transduction of the signal induced by GAS binding to CD44 on the keratinocyte surface involved Rac1 and the cytoskeleton linker protein ezrin, as well as tyrosine phosphorylation of cellular proteins. Studies of bacterial translocation in two models of human skin indicated that cell signalling triggered by interaction of the GAS capsule with CD44 opened intercellular junctions and promoted tissue penetration by GAS through a paracellular route. These results support a model of host cytoskeleton manipulation and tissue invasion by an extracellular bacterial pathogen.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Wessels, MR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA.	mwessels@channing.harvard.edu		Cywes Bentley, Colette/0000-0002-6301-0930				Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; CLINE PR, 1983, CANCER RES, V43, P3203; CROWE DL, 1991, DIFFERENTIATION, V48, P199, DOI 10.1111/j.1432-0436.1991.tb00258.x; Cywes C, 2000, J CLIN INVEST, V106, P995, DOI 10.1172/JCI10195; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; MCCALLUM SJ, 2000, CELLULAR MICROBIOLOG, P171; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Oliferenko S, 2000, J CELL BIOL, V149, P241; Oliferenko S, 2000, J CELL BIOL, V148, P1159, DOI 10.1083/jcb.148.6.1159; PARENTEAU NL, 1992, CYTOTECHNOLOGY, V9, P163, DOI 10.1007/BF02521744; Rheinwald J G, 1980, Methods Cell Biol, V21A, P229, DOI 10.1016/S0091-679X(08)60769-4; RHEINWALD JG, 1979, INT REV CYTOL      S, V10, P25; Sabolinski ML, 1996, BIOMATERIALS, V17, P311, DOI 10.1016/0142-9612(96)85569-4; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Taher TEI, 1996, J BIOL CHEM, V271, P2863, DOI 10.1074/jbc.271.5.2863; Tchao R., 1988, ALTERN METHODS TOXIC, V6, P271; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391	22	161	168	5	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					648	652		10.1038/414648a	http://dx.doi.org/10.1038/414648a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740562				2022-12-01	WOS:000172535600050
J	Colicos, MA; Collins, BE; Sailor, MJ; Goda, Y				Colicos, MA; Collins, BE; Sailor, MJ; Goda, Y			Remodeling of synaptic actin induced by photoconductive stimulation	CELL			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL AREA CA1; CULTURED NEURONS; POSTSYNAPTIC DENSITIES; PRESYNAPTIC BOUTONS; TRANSMITTER RELEASE; DENDRITIC SPINES; MEMORY STORAGE; N-CADHERIN; LATE-PHASE	Use-dependent synapse remodeling is thought to provide a cellular mechanism for encoding durable memories, yet whether activity triggers an actual structural change has remained controversial. We. use photoconductive stimulation to demonstrate activity dependent morphological synaptic plasticity by video imaging of GFP-actin at individual synapses. A single tetanus transiently moves presynaptic actin toward and postsynaptic actin away from the synaptic junction. Repetitive spaced tetani induce glutamate receptor-dependent stable restructuring of synapses. Presynaptic actin redistributes and forms new puncta that label for an active synapse marker FM5-95 within 2 hr. Postsynaptic actin sprouts projections toward the new presynaptic actin puncta, resembling the axon-dendrite interaction during synaptogenesis. Our results indicate that activity-dependent presynaptic structural plasticity facilitates the formation of new active presynaptic terminals.	Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Goda, Y (corresponding author), Univ Calif San Diego, Div Biol, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ygoda@biomail.ucsd.edu	Sailor, Michael J/H-9044-2017; Goda, Yukiko/A-6576-2016; Goda, Yukiko/AAR-5641-2020	Sailor, Michael J/0000-0002-4809-9826; Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498				Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; GROSS GW, 1993, J NEUROSCI METH, V50, P131, DOI 10.1016/0165-0270(93)90001-8; HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Hata Y, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0002.2000; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim D, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0004.2001; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maher MP, 1999, J NEUROSCI METH, V87, P45, DOI 10.1016/S0165-0270(98)00156-3; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Merzenich M M, 1993, Curr Opin Neurobiol, V3, P187, DOI 10.1016/0959-4388(93)90209-H; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Neuhoff H, 1999, EUR J NEUROSCI, V11, P4241, DOI 10.1046/j.1460-9568.1999.00856.x; Parak WJ, 1997, SENSOR ACTUAT A-PHYS, V63, P47, DOI 10.1016/S0924-4247(97)80428-1; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; PINE J, 1980, J NEUROSCI METH, V2, P19, DOI 10.1016/0165-0270(80)90042-4; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Sorra KE, 1998, J COMP NEUROL, V398, P225; Sorra KE, 1998, J NEUROSCI, V18, P658; SUDHOF T, 2000, SYNAPSES, V1, P275; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	56	230	236	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					605	616		10.1016/S0092-8674(01)00579-7	http://dx.doi.org/10.1016/S0092-8674(01)00579-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733060	Bronze			2022-12-01	WOS:000172575300008
J	Jin, RC; Cao, YW; Mirkin, CA; Kelly, KL; Schatz, GC; Zheng, JG				Jin, RC; Cao, YW; Mirkin, CA; Kelly, KL; Schatz, GC; Zheng, JG			Photoinduced conversion of silver nanospheres to nanoprisms	SCIENCE			English	Article							WET CHEMICAL SYNTHESIS; GOLD; SHAPE; SIZE; NANOCRYSTALS; PARTICLES; NANOWIRES; CHEMISTRY; NANORODS; PHYSICS	A photoinduced method for converting large quantities of silver nanospheres into triangular nanoprisms is reported. The photo-process has been characterized by time-dependent ultraviolet-visible spectroscopy and transmission electron microscopy, allowing for the observation of several key intermediates in and characteristics of the conversion process. This light-driven process results in a colloid with distinctive optical properties that directly relate to the nanoprism shape of the particles. Theoretical calculations coupled with experimental observations allow for the assignment of the nanoprism plasmon bands and for the first identification of two distinct quadrupole plasmon resonances for a nanoparticle. Unlike the spherical particles they are derived from that Rayleigh tight-scatter in the blue, these nanoprisms exhibit scattering in the red, which could be useful in developing multicolor diagnostic labels on the basis not only of nanoparticle composition and size but also of shape.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Inst Nanotechnol, Evanston, IL 60208 USA; Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	schatz@chem.nwu.edu	bee, betty/G-1104-2011; Mirkin, Chad A/E-3911-2010; Schatz, George C./ABF-1341-2020					Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Bradley JS, 2000, J AM CHEM SOC, V122, P4631, DOI 10.1021/ja992409y; Cao YW, 2001, J AM CHEM SOC, V123, P7961, DOI 10.1021/ja011342n; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; CHERNS D, 1974, PHILOS MAG, V30, P549, DOI 10.1080/14786439808206580; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; FENDLER JH, 1995, ADV MATER, V7, P607, DOI 10.1002/adma.19950070703; FOSS CA, 1994, J PHYS CHEM-US, V98, P2963, DOI 10.1021/j100062a037; Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m; Henglein A, 2001, LANGMUIR, V17, P2329, DOI 10.1021/la001081f; Hu JT, 1999, ACCOUNTS CHEM RES, V32, P435, DOI 10.1021/ar9700365; Jana NR, 2001, CHEM COMMUN, P617, DOI 10.1039/b100521i; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; Kamat PV, 1998, J PHYS CHEM B, V102, P3123, DOI 10.1021/jp980009b; Kirkland A. I., 1990, EMAG-MICRO 89. Proceedings of the Institute of Physics Electron Microscopy and Analysis Group and Royal Microscopical Society Conference, P375; KIRKLAND AI, 1993, P ROY SOC LOND A MAT, V440, P589, DOI 10.1098/rspa.1993.0035; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; Li M, 1999, NATURE, V402, P393, DOI 10.1038/46509; Lieber CM, 1998, SOLID STATE COMMUN, V107, P607, DOI 10.1016/S0038-1098(98)00209-9; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Nikoobakht B, 2000, J PHYS CHEM B, V104, P8635, DOI 10.1021/jp001287p; Palik E. D., 1985, HDB OPTICAL CONSTANT, P350; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Pinna N, 2001, ADV MATER, V13, P261, DOI 10.1002/1521-4095(200102)13:4<261::AID-ADMA261>3.3.CO;2-O; Prochazka M, 1997, ANAL CHEM, V69, P5103, DOI 10.1021/ac970683+; Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553; Schatz G.C., 2002, HDB VIBRATIONAL SPEC, P759, DOI DOI 10.1002/0470027320.S0601; Schultz S, 2000, P NATL ACAD SCI USA, V97, P996, DOI 10.1073/pnas.97.3.996; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Taton TA, 2001, J AM CHEM SOC, V123, P5164, DOI 10.1021/ja0102639; YANG WH, 1995, J CHEM PHYS, V103, P869, DOI 10.1063/1.469787; Yu YY, 1997, J PHYS CHEM B, V101, P6661	38	3061	3204	36	1654	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1901	1903		10.1126/science.1066541	http://dx.doi.org/10.1126/science.1066541			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729310				2022-12-01	WOS:000172465000051
J	Connerney, I; Shapiro, PA; McLaughlin, JS; Bagiella, E; Sloan, RP				Connerney, I; Shapiro, PA; McLaughlin, JS; Bagiella, E; Sloan, RP			Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEART-DISEASE; LONG-TERM; GRAFT-SURGERY; MORTALITY; SURVIVAL; RISK; MEN; ASSOCIATION; PROGNOSIS	Background The association of depression with cardiac events has been investigated mainly in community cohorts, in patients undergoing catheterisation, or in patients who have had myocardial infarction. We have assessed the effect of depression on outcomes after coronary artery bypass graft (CABG) surgery. Methods In a prospective study, we followed up for 1 year 207 men and 102 women, who had undergone coronary artery bypass graft surgery. We assessed depression with a structured psychiatric interview (diagnostic interview schedule) and a questionnaire (Beck depression inventory) before discharge. Cardiac events included angina or heart failure that needed admission to hospital, myocardial infarction, cardiac arrest, percutaneous transluminal coronary angioplasty, repeat CABG, and cardiac mortality. Non-cardiac events consisted of all other reasons for mortality or readmission. Findings 63 patients (20%) met modified diagnostic statistical manual IV criteria for major depressive disorder. At 12 months, 17 (27%) of these patients had a cardiac event compared with 25 of 246 (10%) who were not depressed (p<0.0008). Five variables had significant univariate associations with cardiac events: sex, living alone, low ejection fraction (<0.35), length of hospital stay, and depression. In a Cox proportional-hazard model with these five and two other variables of cardiac severity, major depressive disorder (risk ratio 2.3 [95% Cl 1.17-4.56]), low ejection fraction (2.3 [1.07-5.03]), and female sex (2.4 [1.24-4.44]) were associated with adverse outcomes. Depression did not predict deaths or admissions for noncardiac events. Interpretation Depression is an important independent risk factor for cardiac events after CABG surgery.	Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; Columbia Univ, MAilman Sch Publ Hlth, New York, NY USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Columbia University; Columbia University; University System of Maryland; University of Maryland Baltimore	Connerney, I (corresponding author), Univ Maryland, Med Ctr, 22 S Greene St,Box 316, Baltimore, MD 21201 USA.	iconnerney@umm.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001491] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH01491] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AHERN DK, 1990, AM J CARDIOL, V66, P59, DOI 10.1016/0002-9149(90)90736-K; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ANDA R, 1993, EPIDEMIOLOGY, V4, P285, DOI 10.1097/00001648-199307000-00003; AROMAA A, 1994, ACTA PSYCHIAT SCAND, V89, P77, DOI 10.1111/j.1600-0447.1994.tb05807.x; Barefoot JC, 1996, CIRCULATION, V93, P1976, DOI 10.1161/01.CIR.93.11.1976; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; BERKMAN LF, 1992, ANN INTERN MED, V117, P1003, DOI 10.7326/0003-4819-117-12-1003; CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009; CARNEY RM, 1995, AM J CARDIOL, V76, P562, DOI 10.1016/S0002-9149(99)80155-6; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0; EAKER ED, 1989, AM HEART J, V117, P71, DOI 10.1016/0002-8703(89)90658-3; FISHER LD, 1982, J THORAC CARDIOV SUR, V84, P334; Frasure-Smith N, 2000, CIRCULATION, V101, P1919, DOI 10.1161/01.CIR.101.16.1919; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; FRASURESMITH N, 1991, AM J CARDIOL, V67, P121, DOI 10.1016/0002-9149(91)90432-K; Gray RJ, 1996, ARCH INTERN MED, V156, P769, DOI 10.1001/archinte.156.7.769; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P217, DOI 10.1054/plef.1999.0037; LADWIG KH, 1994, LANCET, V343, P20, DOI 10.1016/S0140-6736(94)90877-X; LANGELUDDECKE P, 1989, J PSYCHOSOM RES, V33, P37, DOI 10.1016/0022-3999(89)90104-9; McKhann GM, 1997, LANCET, V349, P1282, DOI 10.1016/S0140-6736(96)09466-4; Musselman DL, 1996, AM J PSYCHIAT, V153, P1313; Pirraglia PA, 1999, INT J GERIATR PSYCH, V14, P668, DOI 10.1002/(SICI)1099-1166(199908)14:8<668::AID-GPS988>3.0.CO;2-9; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Scheier MF, 1999, ARCH INTERN MED, V159, P829, DOI 10.1001/archinte.159.8.829; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; SCHROLL M, 1982, DAN MED BULL, V29, P213; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	30	346	366	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2001	358	9295					1766	1771		10.1016/S0140-6736(01)06803-9	http://dx.doi.org/10.1016/S0140-6736(01)06803-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FG	11734233				2022-12-01	WOS:000172385100011
J	Beall, CM; Laskowski, D; Strohl, KP; Soria, R; Villena, M; Vargas, E; Alarcon, AM; Gonzales, C; Erzurum, SC				Beall, CM; Laskowski, D; Strohl, KP; Soria, R; Villena, M; Vargas, E; Alarcon, AM; Gonzales, C; Erzurum, SC			Pulmonary nitric oxide in mountain dwellers	NATURE			English	Article							HAN RESIDENTS; OXYGEN; SYNTHASE; EXERCISE; TIBETAN; LHASA		Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Dept Pulm, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Crit Care Med, Cleveland, OH 44195 USA; Case Western Reserve Univ, Louis Stokes VA Med Ctr, Dept Med, Cleveland, OH 44106 USA; Inst Boliviano Biol Altura, Dept Resp, La Paz, Bolivia	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Universidad Mayor de San Andres	Beall, CM (corresponding author), Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA.			Beall, Cynthia/0000-0003-1462-8299				AbuSoud HM, 1996, J BIOL CHEM, V271, P32515, DOI 10.1074/jbc.271.51.32515; Brutsaert TD, 2000, AM J PHYS ANTHROPOL, V113, P169, DOI 10.1002/1096-8644(200010)113:2<169::AID-AJPA3>3.3.CO;2-0; Dweik RA, 1998, J CLIN INVEST, V101, P660, DOI 10.1172/JCI1378; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; GUSTAFSSON LE, 1991, BIOCHEM BIOPH RES CO, V181, P852, DOI 10.1016/0006-291X(91)91268-H; HUANG SY, 1992, J APPL PHYSIOL, V73, P2638, DOI 10.1152/jappl.1992.73.6.2638; HURSHMAN AR, 1995, BIOCHEMISTRY-US, V34, P5627, DOI 10.1021/bi00016a038; Le Cras TD, 2001, AM J PHYSIOL-LUNG C, V280, pL575, DOI 10.1152/ajplung.2001.280.4.L575; Little M., 1976, MAN ANDES MULTIDISCI, P332; Moore LG, 2001, AM J PHYS ANTHROPOL, V114, P42, DOI 10.1002/1096-8644(200101)114:1<42::AID-AJPA1004>3.0.CO;2-B; SPIELVOGEL H, 1978, RESPIRATION, V35, P125, DOI 10.1159/000193869; SUN SF, 1990, RESP PHYSIOL, V79, P151, DOI 10.1016/0034-5687(90)90015-Q	12	183	197	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					411	412		10.1038/35106641	http://dx.doi.org/10.1038/35106641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719794				2022-12-01	WOS:000172304500032
J	Benenson, Y; Paz-Elizur, T; Adar, R; Keinan, E; Livneh, Z; Shapiro, E				Benenson, Y; Paz-Elizur, T; Adar, R; Keinan, E; Livneh, Z; Shapiro, E			Programmable and autonomous computing machine made of biomolecules	NATURE			English	Article							DNA SOLUTION; COMPUTATION; IMPLEMENTATION; MOLECULES; DESIGN	Devices that convert information from one form into another according to a definite procedure are known as automata. One such hypothetical device is the universal Turing machine(1), which stimulated work leading to the development of modern computers. The Turing machine and its special cases(2), including finite automata(3), operate by scanning a data tape, whose striking analogy to information-encoding biopolymers inspired several designs for molecular DNA computers(4-8). Laboratory-scale computing using DNA and human-assisted protocols has been demonstrated(9-15), but the realization of computing devices operating autonomously on the molecular scale remains rare(16-20). Here we describe a programmable finite automaton comprising DNA and DNA-manipulating enzymes that solves computational problems autonomously. The automaton's hardware consists of a restriction nuclease and ligase, the software and input are encoded by double-stranded DNA, and programming amounts to choosing appropriate software molecules. Upon mixing solutions containing these components, the automaton processes the input molecule via a cascade of restriction, hybridization and ligation cycles, producing a detectable output molecule that encodes the automaton's final state, and thus the computational result. In our implementation 10(12) automata sharing the same software run independently and in parallel on inputs (which could, in principle, be distinct) in 120 mul solution at room temperature at a combined rate of 10(9) transitions per second with a transition fidelity greater than 99.8%, consuming less than 10(-10) W.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Technion Israel Inst Technol, Dept Chem, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Inst Catalysis Sci & Technol, IL-32000 Haifa, Israel; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Weizmann Institute of Science; Weizmann Institute of Science; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Scripps Research Institute; Scripps Research Institute	Shapiro, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.		Benenson, Yaakov/B-1433-2009		European Research Council [233047] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Adelman Leonard M., 1994, Science (Washington D C), V266, P1021; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; Chandrasegaran S, 1999, BIOL CHEM, V380, P841, DOI 10.1515/BC.1999.103; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Garzon M, 1998, LECT NOTES COMPUT SC, V1436, P56, DOI 10.1007/BFb0031381; Hartemink AJ, 1999, BIOSYSTEMS, V52, P227, DOI 10.1016/S0303-2647(99)00050-7; Hopcroft J. E., 2000, INTRO AUTOMATA THEOR; Khodor J, 1999, BIOSYSTEMS, V52, P93, DOI 10.1016/S0303-2647(99)00036-2; LANDWEBER LF, 1997, DNA BASED COMPUTERS, V3, P161; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; ROTHEMUND PWK, 1996, DNA BASED COMPUTERS, P75; Ruben AJ, 2000, NAT REV MOL CELL BIO, V1, P69, DOI 10.1038/35036086; Sakamoto K, 1999, BIOSYSTEMS, V52, P81, DOI 10.1016/S0303-2647(99)00035-0; Shapiro E., 2001, Method and system of computing similar to a turing machine, Patent No. [US6266569B1, 6266569]; Smith W. D., 1996, DIMACS SERIES DISCRE, P121; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998	21	490	557	3	141	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					430	434		10.1038/35106533	http://dx.doi.org/10.1038/35106533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719800	Green Accepted			2022-12-01	WOS:000172304500038
J	Antonova, I; Arancio, O; Trillat, AC; Wang, HG; Zablow, L; Udo, H; Kandel, ER; Hawkins, RD				Antonova, I; Arancio, O; Trillat, AC; Wang, HG; Zablow, L; Udo, H; Kandel, ER; Hawkins, RD			Rapid increase in clusters of presynaptic proteins at onset of long-lasting potentiation	SCIENCE			English	Article							TERM POTENTIATION; GLUTAMATE RECEPTORS; TRANSMITTER RELEASE; REDISTRIBUTION; EXPRESSION; LTP	A change in the efficiency of synaptic communication between neurons is thought to underlie learning. Consistent with recent studies of such changes, we find that long-tasting potentiation of synaptic transmission between cultured hippocampal neurons is accompanied by an increase in the number of clusters of postsynaptic glutamate receptors containing the subunit GLuR1. In addition, potentiation is accompanied by a rapid and long-tasting increase in the number of clusters of the presynaptic protein synaptophysin and the number of sites at which synaptophysin and GLuR1 are colocalized. These results suggest that potentiation involves rapid coordinate changes in the distribution of proteins in the presynaptic neuron as well as the postsynaptic neuron.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; SUNY Hlth Sci Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Hawkins, RD (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.	rdh1@columbia.edu	arancio, ottavio/AAB-7959-2019	arancio, ottavio/0000-0001-6335-164X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH026212] Funding Source: NIH RePORTER; NIMH NIH HHS [MH26212] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BATTAGLIA F, 2000, SOC NEUR ABSTR, V26, P879; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BI QQ, 1998, J NEUROSCI, V18, P10469; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; DELSSEROTH K, 1996, NEURON, V16, P89; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; Huang Y Y, 1994, Learn Mem, V1, P74; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Lissin DV, 1999, J NEUROSCI, V19, P1263; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shen L, 2000, J NEUROSCI, V20, P7932; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	28	138	143	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1547	1550		10.1126/science.1066273	http://dx.doi.org/10.1126/science.1066273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11641465				2022-12-01	WOS:000172240500055
J	Penuelas, J; Filella, I				Penuelas, J; Filella, I			Phenology - Responses to a warming world	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; TEMPERATURE; TRENDS		Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat, CSIC, Unitat Ecofisiol,Edifici C, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC)	Penuelas, J (corresponding author), Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat, CSIC, Unitat Ecofisiol,Edifici C, E-08193 Barcelona, Spain.		Gutierrez, Emilia/O-7568-2014; Penuelas, Josep/D-9704-2011; Filella, Iolanda/A-2860-2015	Gutierrez, Emilia/0000-0002-6085-5700; Penuelas, Josep/0000-0002-7215-0150; Filella, Iolanda/0000-0001-6262-5733				Abu-Asab MS, 2001, BIODIVERS CONSERV, V10, P597, DOI 10.1023/A:1016667125469; Ahas R, 1999, INT J BIOMETEOROL, V42, P119, DOI 10.1007/s004840050094; Beaubien EG, 2000, INT J BIOMETEOROL, V44, P53, DOI 10.1007/s004840000050; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Ellis Willem N., 1997, Entomologische Berichten (Amsterdam), V57, P66; FITTER AH, 1995, FUNCT ECOL, V9, P55, DOI 10.2307/2390090; Fleming R. A., 1995, P505; Gibbs JP, 2001, CONSERV BIOL, V15, P1175, DOI 10.1046/j.1523-1739.2001.0150041175.x; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Larcher W., 1995, PHYSL PLANT ECOLOGY; MASON CF, 1995, BIRD STUDY, V42, P182, DOI 10.1080/00063659509477167; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Osborne CP, 2000, PLANT CELL ENVIRON, V23, P701, DOI 10.1046/j.1365-3040.2000.00584.x; PENUELAS J, IN PRESS GLOBAL CHAN; Price MV, 1998, ECOLOGY, V79, P1261, DOI 10.1890/0012-9658(1998)079[1261:EOEWOP]2.0.CO;2; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Spiecker H., 1996, GROWTH TRENDS EUROPE; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Walker RD, 1998, J ANTIMICROB CHEMOTH, V41, P1, DOI 10.1093/jac/41.1.1; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	29	594	675	8	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					793	+		10.1126/science.1066860	http://dx.doi.org/10.1126/science.1066860			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679652				2022-12-01	WOS:000171851800027
J	Whiteley, M; Bangera, MG; Bumgarner, RE; Parsek, MR; Teitzel, GM; Lory, S; Greenberg, EP				Whiteley, M; Bangera, MG; Bumgarner, RE; Parsek, MR; Teitzel, GM; Lory, S; Greenberg, EP			Gene expression in Pseudomonas aeruginosa biofilms	NATURE			English	Article							MICROBIAL BIOFILMS; BACTERIAL BIOFILMS; RESISTANCE; ANTIBIOTICS; GENTAMICIN; MUTATION; SEQUENCE; BINDING; SIGNALS; FLOW	Bacteria often adopt a sessile biofilm lifestyle that is resistant to antimicrobial treatment(1-5). Opportunistic pathogenic bacteria like Pseudomonas aeruginosa can develop persistent infections(1-3). To gain insights into the differences between free-living P. aeruginosa cells and those in biofilms, and into the mechanisms underlying the resistance of biofilms to antibiotics, we used DNA microarrays. Here we show that, despite the striking differences in lifestyles, only about 1% of genes showed differential expression in the two growth modes; about 0.5% of genes were activated and about 0.5% were repressed in biofilms. Some of the regulated genes are known to affect antibiotic sensitivity of free-living P. aeruginosa. Exposure of biofilms to high levels of the antibiotic tobramycin caused differential expression of 20 genes. We propose that this response is critical for the development of biofilm resistance to tobramycin. Our results show that gene expression in biofilm cells is similar to that in free-living cells but there are a small number of significant differences. Our identification of biofilm-regulated genes points to mechanisms of biofilm resistance to antibiotics.	Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; Harvard Univ, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Northwestern Univ, Dept Civil Engn, Evanston, IL 60208 USA	University of Iowa; Harvard University; University of Washington; University of Washington Seattle; Northwestern University	Greenberg, EP (corresponding author), Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.		Bumgarner, Roger/AAA-6846-2020; Bumgarner, Roger E/K-3531-2015	Bumgarner, Roger E/0000-0002-8168-6985; Greenberg, Everett/0000-0001-9474-8041				BANGERA MG, 2000, AM SOC MICR 100 GEN; BRYAN LE, 1976, J ANTIBIOT, V29, P743, DOI 10.7164/antibiotics.29.743; BRYAN LE, 1980, ANTIMICROB AGENTS CH, V17, P71, DOI 10.1128/AAC.17.1.71; BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DEBEER D, 1994, BIOTECHNOL BIOENG, V44, P636, DOI 10.1002/bit.260440510; Greenberg EP, 2000, NATURE, V406, P947, DOI 10.1038/35023203; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HILL DF, 1991, J MOL BIOL, V218, P349, DOI 10.1016/0022-2836(91)90717-K; HOIBY N, 1993, ANNU REV MED, V44, P1, DOI 10.1146/annurev.me.44.020193.000245; HOIBY N, 1998, PSEUDOMONAS CYSTIC F, P1; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; JOHNSON JA, 1993, J CLIN MICROBIOL, V31, P732, DOI 10.1128/JCM.31.3.732-733.1993; LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991; MacLeod DL, 2000, J INFECT DIS, V181, P1180, DOI 10.1086/315312; NIKAIDO H, 1985, MICROBIOL REV, V49, P872; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; RIVERA M, 1988, ANTIMICROB AGENTS CH, V32, P649, DOI 10.1128/AAC.32.5.649; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Suh SJ, 1999, J BACTERIOL, V181, P3890, DOI 10.1128/JB.181.13.3890-3897.1999; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; ZABRISKIE JB, 1966, ANNU REV MED, V17, P337, DOI 10.1146/annurev.me.17.020166.002005	30	794	849	4	151	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					860	864		10.1038/35101627	http://dx.doi.org/10.1038/35101627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677611				2022-12-01	WOS:000171750200050
J	Lawton, RO; Nair, US; Pielke, RA; Welch, RM				Lawton, RO; Nair, US; Pielke, RA; Welch, RM			Climatic impact of tropical lowland deforestation on nearby montane cloud forests	SCIENCE			English	Article							COSTA-RICA; CUMULUS; VARIABILITY; VEGETATION; PASTURES; MOISTURE; TRENDS	Tropical montane cloud forests (TMCFs) depend on predictable, frequent, and prolonged immersion in cloud. Clearing upwind lowland forest alters surface energy budgets in ways that influence dry season cloud fields and thus the TMCF environment. Landsat and Geostationary Operational Environmental Satellite imagery show that deforested areas of Costa Rica's Caribbean lowlands remain relatively cloud-free when forested regions have well-developed dry season cumulus cloud fields. Further, regional atmospheric simulations show that cloud base heights are higher over pasture than over tropical forest areas under reasonable dry season conditions. These results suggest that [and use in tropical lowlands has serious impacts on ecosystems in adjacent mountains.	Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; Univ Alabama, Nat Sci Technol Ctr, Dept Atmospher Sci, Huntsville, AL 35806 USA; Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	University of Alabama System; University of Alabama Huntsville; University of Alabama System; University of Alabama Huntsville; Colorado State University	Lawton, RO (corresponding author), Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA.	lawtonr@email.uah.edu	Pielke, Roger A/A-5015-2009					BASTABLE HG, 1993, INT J CLIMATOL, V13, P783, DOI 10.1002/joc.3370130706; BERENDES T, 1992, IEEE T GEOSCI REMOTE, V30, P430, DOI 10.1109/36.142921; BRUIJNZEEL LA, 1995, ECOL STU AN, V110, P38; CHEN F, 1994, J APPL METEOROL, V33, P1382, DOI 10.1175/1520-0450(1994)033<1382:IOLSMV>2.0.CO;2; Dietrich W.E., 1982, ECOLOGY TROPICAL FOR, P21; Haber W. A., 2000, MONTEVERDE ECOLOGY C, P39; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lawton R. O., 1980, BRENESIA, V8, P101; Longman K. A., 1987, TROPICAL FOREST ITS; MEHERHOMJI VM, 1991, CLIMATIC CHANGE, V19, P163, DOI 10.1007/BF00142223; Nadkarni N. M., 2000, MONTEVERDE ECOLOGY C, P303; Nadkarni NM., 2000, MONTEVERDE ECOLOGY C, P15; Nair US, 1999, P SOC PHOTO-OPT INS, V3750, P345, DOI 10.1117/12.363530; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; NOBRE CA, 1991, J CLIMATE, V4, P957, DOI 10.1175/1520-0442(1991)004<0957:ADARCC>2.0.CO;2; PIELKE RA, 1992, METEOROL ATMOS PHYS, V49, P69, DOI 10.1007/BF01025401; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; SADER SA, 1988, BIOTROPICA, V20, P11, DOI 10.2307/2388421; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; SUD YC, 1993, J ARID ENVIRON, V25, P5, DOI 10.1006/jare.1993.1038; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; Vaughan C., 1983, REPORT DENSE FOREST; Veldkamp E., 1992, Land Degradation & Rehabilitation, V3, P71, DOI 10.1002/ldr.3400030202; Weitz AM, 2001, SOIL BIOL BIOCHEM, V33, P1077, DOI 10.1016/S0038-0717(01)00013-X; Wheelwight Nathaniel T., 2000, P419; WRIGHT IR, 1992, Q J ROY METEOR SOC, V118, P1083, DOI 10.1002/qj.49711850804; Zeng N, 1999, SCIENCE, V286, P1537, DOI 10.1126/science.286.5444.1537	29	235	254	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					584	587						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641496				2022-12-01	WOS:000171695600044
J	Kvist, A; Lindstrom, A; Green, M; Piersma, T; Visser, GH				Kvist, A; Lindstrom, A; Green, M; Piersma, T; Visser, GH			Carrying large fuel loads during sustained bird flight is cheaper than expected	NATURE			English	Article							DISTANCE MIGRANT SHOREBIRD; BASAL METABOLIC-RATE; CALIDRIS-CANUTUS; WIND-TUNNEL; KNOT; MIGRATION	Birds on migration alternate between consuming fuel stores during flights and accumulating fuel stores during stopovers. The optimal timing and length of flights and stopovers for successful migration depend heavily on the extra metabolic power input (fuel use) required to carry the fuel stores during flight(1,2). The effect of large fuel loads on metabolic power input has never been empirically determined. We measured the total metabolic power input of a long-distance migrant, the red knot (Calidris canutus), flying for 6 to 10 h in a wind tunnel, using the doubly labelled water technique(3). Here we show that total metabolic power input increased with fuel load, but proportionally less than the predicted mechanical power output from the flight muscles. The most likely explanation is that the efficiency with which metabolic power input is converted into mechanical output by the flight muscles increases with fuel load. This will influence current models of bird flight and bird migration. It may also help to explain why some shorebirds, despite the high metabolic power input required to fly, routinely make nonstop flights of 4,000 km longer(4).	Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9750 AA Haren, Netherlands; Ctr Isotope Res, NL-9747 AG Groningen, Netherlands	Lund University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; University of Groningen	Kvist, A (corresponding author), Lund Univ, Dept Anim Ecol, Ecol Bldg, S-22362 Lund, Sweden.		Piersma, Theunis/D-1871-2012	Kvist, Anders/0000-0002-1358-0695; Piersma, Theunis/0000-0001-9668-466X				Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T., 1990, P331; Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; Duke, 1997, ANIMAL PHYSL ADAPTAT, P169, DOI DOI 10.2307/2403350; GUDMUNDSSON GA, 1994, J AVIAN BIOL, V25, P15, DOI 10.2307/3677290; HEDENSTROM A, 1995, PHILOS T ROY SOC B, V348, P471, DOI 10.1098/rstb.1995.0082; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; Lindstrom A, 2000, J EXP BIOL, V203, P913; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V261, P395, DOI 10.1098/rspb.1995.0165; NOER H, 1979, Dansk Ornitologisk Forenings Tidsskrift, V73, P215; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; PENNYCUICK CJ, 1995, ISRAEL J ZOOL, V41, P307; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; Pennycuick CJ, 1996, J EXP BIOL, V199, P2757; PIERSMA T, 1995, J COMP PHYSIOL B, V165, P37, DOI 10.1007/BF00264684; Piersma T, 1996, PHYSIOL ZOOL, V69, P191, DOI 10.1086/physzool.69.1.30164207; RAYNER JMV, 1985, J THEOR BIOL, V117, P47, DOI 10.1016/S0022-5193(85)80164-8; RAYNER JMV, 1979, J EXP BIOL, V80, P17; Rayner JMV, 1999, P 22 INT ORN C DURB, P1786; Speakman J.R., 1997, DOUBLY LABELLED WATE; TUCKER VA, 1973, J EXP BIOL, V58, P689; Visser GH, 2000, J COMP PHYSIOL B, V170, P365, DOI 10.1007/s003600000112; VISSER GH, 2000, AM J PHYSIOL, V209, pR1795; [No title captured]	25	138	140	3	52	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					730	732		10.1038/35099556	http://dx.doi.org/10.1038/35099556			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607031	Green Published			2022-12-01	WOS:000171608000043
J	Wenger, NS; Rosenfeld, K				Wenger, NS; Rosenfeld, K			Quality indicators for end-of-life care in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							NURSING-HOME RESIDENTS; ADVANCE DIRECTIVES; RESUSCITATION PREFERENCES; SUSTAINING TREATMENT; DYING PATIENTS; ILL; PHYSICIANS; DISCUSSIONS; MANAGEMENT; INSIGHTS		Univ Calif Los Angeles, Dept Med, Div Gen Internal Med, Los Angeles, CA 90095 USA; Vet Affairs Greater Los Angeles Health Care Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Wenger, NS (corresponding author), Univ Calif Los Angeles, Dept Med, Div Gen Internal Med, 911 Broxton Plaza, Los Angeles, CA 90095 USA.	nwenger@mednet.ucla.edu						ADAMOWSKI K, 1994, CAN MED ASSOC J, V150, P326; *AM MED ASS, 1991, COD MED ETH REP AMA; [Anonymous], 1992, ANN INTERN MED, V117, P947; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; *APS, 1997, APS B, V7, P1; BLACKHALL LJ, 1989, J GEN INTERN MED, V4, P399, DOI 10.1007/BF02599689; BLANCHARD CG, 1988, SOC SCI MED, V27, P1139, DOI 10.1016/0277-9536(88)90343-7; Brody H, 1997, NEW ENGL J MED, V336, P652, DOI 10.1056/NEJM199702273360910; CAMPBELL ML, 1998, AACN CRITICAL CARE P, P61; Canadian Palliative Care Association, 1995, PALL CAR CONS STAND; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; DENNIS C, 1998, VACCOS COMMISSION QU; Desbiens NA, 1998, PAIN, V75, P237, DOI 10.1016/S0304-3959(97)00225-X; DRANE JF, 1984, JAMA-J AM MED ASSOC, V252, P925, DOI 10.1001/jama.252.7.925; Ehman JW, 1999, ARCH INTERN MED, V159, P1803, DOI 10.1001/archinte.159.15.1803; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Faber-Langendoen K, 2000, ANN INTERN MED, V133, P886, DOI 10.7326/0003-4819-133-11-200012050-00013; FABERLANGENDOEN K, 1994, CHEST, V106, P880, DOI 10.1378/chest.106.3.880; Field MJ, 1997, APPROACHING DEATH IM; Fischer GS, 1998, J GEN INTERN MED, V13, P447, DOI 10.1046/j.1525-1497.1998.00133.x; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; GERETY MB, 1993, J AM GERIATR SOC, V41, P953, DOI 10.1111/j.1532-5415.1993.tb06761.x; Goodman MD, 1998, CRIT CARE MED, V26, P701, DOI 10.1097/00003246-199804000-00018; Gregory J J, 1995, N J Med, V92, P438; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Hanson LC, 1997, ANN INTERN MED, V126, P381, DOI 10.7326/0003-4819-126-5-199703010-00007; *HAST CTR, 1987, GUID TERM LIF SUST T; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; KEAY TJ, 1994, J AM GERIATR SOC, V42, P853, DOI 10.1111/j.1532-5415.1994.tb06557.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LANKEN PN, 1991, AM REV RESPIR DIS, V144, P726, DOI 10.1164/ajrccm/144.3_Pt_1.726; Levin JR, 1999, J AM GERIATR SOC, V47, P82, DOI 10.1111/j.1532-5415.1999.tb01905.x; LO B, 1986, ARCH INTERN MED, V146, P1613, DOI 10.1001/archinte.146.8.1613; LUCHINS DJ, 1993, J AM GERIATR SOC, V41, P25; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; Martin DK, 1999, ARCH INTERN MED, V159, P86, DOI 10.1001/archinte.159.1.86; MORRISON RS, 1995, JAMA-J AM MED ASSOC, V274, P478, DOI 10.1001/jama.274.6.478; MOWER WR, 1993, ARCH INTERN MED, V153, P375, DOI 10.1001/archinte.153.3.375; PEARLMAN RA, 1993, J CLIN ETHIC, V4, P33; ROBINSON L, 1994, BRIT J GEN PRACT, V44, P461; SCHNEIDERMAN L, 1995, WRONG MED; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; SECKLER AB, 1991, ANN INTERN MED, V115, P92, DOI 10.7326/0003-4819-115-2-92; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sulmasy DP, 1996, J MED ETHICS, V22, P344, DOI 10.1136/jme.22.6.344; SULMASY DP, 1992, JAMA-J AM MED ASSOC, V267, P682; SWARTZ RD, 1993, J AM SOC NEPHROL, V3, P1623; Taylor RM, 1996, NEUROLOGY, V46, P870; TENO JM, 1995, J GEN INTERN MED, V10, P179, DOI 10.1007/BF02600252; TENO JM, 1994, HASTINGS CENT REP, V24, pS32, DOI 10.2307/3563482; Tolle SW, 2000, WESTERN J MED, V172, P374, DOI 10.1136/ewjm.172.6.374; *U CAL, 1998, TERM WEAN MECH VENT; UHLMANN RF, 1989, WESTERN J MED, V150, P705; VIRMANI J, 1994, ARCH INTERN MED, V154, P909, DOI 10.1001/archinte.154.8.909; Wenger N. S., 1997, JGIM, V12, P105; Wenger N. S., 1994, Journal of the American Geriatrics Society, V42, pSA67; Wenger NS, 2000, J AM GERIATR SOC, V48, pS44, DOI 10.1111/j.1532-5415.2000.tb03140.x; Wenger NS, 1996, J CLIN ETHIC, V7, P48; Wenger NS, 2001, JAMA-J AM MED ASSOC, V285, P2880, DOI 10.1001/jama.285.22.2880; 1983, PRESIDENTS COMM STUD; 1996, JAMA, V274, P474; 1995, J AM GERIATR SOC, V43, P577	64	54	54	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				677	685		10.7326/0003-4819-135-8_Part_2-200110161-00006	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601950				2022-12-01	WOS:000171542400006
J	Nemec, P; Altmann, J; Marhold, S; Burda, H; Oelschlager, HHA				Nemec, P; Altmann, J; Marhold, S; Burda, H; Oelschlager, HHA			Neuroanatomy of magnetoreception: The superior colliculus involved in magnetic orientation in a mammal	SCIENCE			English	Article							VISUAL-SYSTEM; C-FOS; COMPASS; ARCHITECTURE; RESPONSES; BOBOLINK; CELLS	The neural substrate subserving magnetic orientation is largely unknown in vertebrates and unstudied in mammals, We combined a behavioral test for magnetic compass orientation in mole rats and immunocytochemical visualization of the transcription factor c-Fos as a marker of neuronal activity. We found that the superior colliculus of the Zambian mote rat (Cryptomys anselli) contains neurons that are responsive to magnetic stimuli. These neurons are directionally selective and organized within a discrete sublayer. Our results constitute evidence for the involvement of a specific mammalian brain structure in magnetoreception.	Charles Univ, Dept Zool, CZ-12844 Prague, Czech Republic; Univ Frankfurt, Dept Anat 3, D-60590 Frankfurt, Germany; Univ Frankfurt, Inst Zool, D-60323 Frankfurt, Germany; Univ Essen Gesamthsch, Dept Gen Zool, D-45117 Essen, Germany	Charles University Prague; Goethe University Frankfurt; Goethe University Frankfurt; University of Duisburg Essen	Nemec, P (corresponding author), Charles Univ, Dept Zool, CZ-12844 Prague, Czech Republic.		Nemec, Pavel/K-1163-2012	Nemec, Pavel/0000-0003-0277-0239				BEASON RC, 1987, NEUROSCI LETT, V80, P229, DOI 10.1016/0304-3940(87)90659-8; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/bf01954256; Chevalier G, 2000, J COMP NEUROL, V419, P137, DOI 10.1002/(SICI)1096-9861(20000403)419:2<137::AID-CNE1>3.0.CO;2-6; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; DEMAINE C, 1985, NEUROSCI LETT, V62, P119, DOI 10.1016/0304-3940(85)90294-0; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Huerta M.F., 1984, P687; HUERTA MF, 1984, TRENDS NEUROSCI, V7, P286, DOI 10.1016/S0166-2236(84)80197-6; ILLING RB, 1992, P NATL ACAD SCI USA, V89, P10900, DOI 10.1073/pnas.89.22.10900; Illing RB, 1996, PROG BRAIN RES, V112, P17; Lohmann KJ, 2000, TRENDS NEUROSCI, V23, P153, DOI 10.1016/S0166-2236(99)01542-8; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; Morgan Marcyliena., 1991, PRAGMATICS, V1, P421; Oelschlager HHA, 2000, BRAIN BEHAV EVOLUT, V55, P209, DOI 10.1159/000006653; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; SEMM P, 1986, J COMP PHYSIOL A, V159, P619, DOI 10.1007/BF00612035; SEMM P, 1984, J COMP PHYSIOL, V155, P283, DOI 10.1007/BF00610581; SEMM P, 1980, NATURE, V288, P607, DOI 10.1038/288607a0; SPARKS DL, 1988, BRAIN BEHAV EVOLUT, V31, P49, DOI 10.1159/000116575; Stein BE, 1998, EXP BRAIN RES, V123, P124, DOI 10.1007/s002210050553; Stein BE., 1993, MERGING SENSES; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wiltschko R., 1995, TIEROSYCHOL	24	93	99	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					366	368		10.1126/science.1063351	http://dx.doi.org/10.1126/science.1063351			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598299				2022-12-01	WOS:000171601400042
J	Flum, DR; Morris, A; Koepsell, T; Dellinger, EP				Flum, DR; Morris, A; Koepsell, T; Dellinger, EP			Has misdiagnosis of appendicitis decreased over time? A population-based analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPUTED-TOMOGRAPHY; NEGATIVE APPENDECTOMY; DIAGNOSIS; IMPACT; CT	Context Misdiagnosis of presumed appendicitis is an adverse outcome that leads to unnecessary surgery. Computed tomography, ultrasonography, and laparoscopy have been suggested for use in patients with equivocal signs of appendicitis to decrease unnecessary surgery. Objective To determine if frequency of misdiagnosis preceding appendectomy has decreased with increased availability of computed tomography, ultrasonography, and laparoscopy. Design, Setting, and Patients Retrospective, population-based cohort study of data from a Washington State hospital discharge database for 85790 residents assigned International Classification of Diseases, Ninth Revision procedure codes for appendectomy, and United States Census Bureau data for 1987-1998. Main Outcome Measure Population-based age- and sex-standardized incidence of appendectomy with acute appendicitis (perforated or not) or with a normal appendix. Results Among 63707 nonincidental appendectomy patients, 84.5% had appendicitis (25.8% with perforation) and 15.5% had no associated diagnosis of appendicitis. After adjusting for age and sex, the population-based incidence of unnecessary appendectomy and of appendicitis with perforation did not change significantly over time. Among women of reproductive age, the population-based incidence of misdiagnosis increased 1% per year (P =.005). The incidence of misdiagnosis increased 8% yearly in patients older than 65 years (P<.001) but did not change significantly in children younger than 5 years (P =.17). The proportion of patients undergoing laparoscopic appendectomy who were misdiagnosed was significantly higher than that of open appendectomy patients (19.6% vs 15.5%; P<.001). Conclusion Contrary to expectation, the frequency of misdiagnosis leading to unnecessary appendectomy has not changed with the introduction of computed tomography, ultrasonography, and laparoscopy, nor has the frequency of perforation decreased. These data suggest that on a population level, diagnosis of appendicitis has not improved with the availability of advanced diagnostic testing.	Univ Washington, Hlth Sci Ctr H220, Robert Wood Johnson Clin Scholars Program, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol & Hlth Serv, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Flum, DR (corresponding author), Univ Washington, Hlth Sci Ctr H220, Robert Wood Johnson Clin Scholars Program, Dept Surg, Box 357183, Seattle, WA 98195 USA.	daveflum@u.washington.edu	Flum, David/GPX-7976-2022	Morris, Arden/0000-0001-5795-2940				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Balthazar EJ, 1998, AM J GASTROENTEROL, V93, P768; Barrat C, 1999, SURG LAPAROSC ENDOSC, V9, P27, DOI 10.1097/00019509-199901000-00005; Birnbaum BA, 2000, RADIOLOGY, V215, P337, DOI 10.1148/radiology.215.2.r00ma24337; Borgstein PJ, 1997, SURG ENDOSC-ULTRAS, V11, P923, DOI 10.1007/s004649900488; DETMER DE, 1981, JAMA-J AM MED ASSOC, V246, P1318, DOI 10.1001/jama.246.12.1318; Firilas AM, 1999, AM SURGEON, V65, P769; Franke C, 1999, WORLD J SURG, V23, P141, DOI 10.1007/PL00013165; Grunewald B, 1993, J R Coll Surg Edinb, V38, P158; JADALLAH FA, 1994, EUR J SURG, V160, P41; Korner H, 1998, BRIT J SURG, V85, P341; Korner H, 1997, WORLD J SURG, V21, P313, DOI 10.1007/s002689900235; Pittman-Waller VA, 2000, AM SURGEON, V66, P548; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1997, J COMPUT ASSIST TOMO, V21, P686, DOI 10.1097/00004728-199709000-00002; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; STRINGEL G, 1987, AM J SURG, V154, P631, DOI 10.1016/0002-9610(87)90231-5; Styrud J, 1999, DIGEST SURG, V16, P39, DOI 10.1159/000018692; Velanovich V, 1998, AM SURGEON, V64, P7; Weyant MJ, 2000, SURGERY, V128, P145, DOI 10.1067/msy.2000.107422; Wong SW, 1999, AUST NZ J SURG, V69, P31, DOI 10.1046/j.1440-1622.1999.01482.x	21	326	337	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1748	1753		10.1001/jama.286.14.1748	http://dx.doi.org/10.1001/jama.286.14.1748			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	480NC	11594900	Bronze			2022-12-01	WOS:000171466800025
J	Wilcox, AJ; Baird, DD; Dunson, D; McChesney, R; Weinberg, CR				Wilcox, AJ; Baird, DD; Dunson, D; McChesney, R; Weinberg, CR			Natural limits of pregnancy testing in relation to the expected menstrual period	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN CHORIONIC-GONADOTROPIN; URINE; SERUM; CYCLE	Context Pregnancy test kits routinely recommend testing "as early as the first day of the missed period." However, a pregnancy cannot be detected before the blastocyst implants. Due to natural variability in the timing of ovulation, implantation does not necessarily occur before the expected onset of next menses. Objective To estimate the maximum screening sensitivity of pregnancy tests when used on the first day of the expected period, taking into account the natural variability of ovulation and implantation. Design and Setting Community-based prospective cohort study conducted in North Carolina between 1982 and 1986. Participants Two hundred twenty-one healthy women 21 to 42 years of age who were planning to conceive. Main Outcome Measures Day of implantation, defined by the serial assay of first morning urine samples using an extremely sensitive immunoradiometric assay for human chorionic gonadotropin (hCG), relative to the first day of the missed period, defined as the day on which women expected their next menses to begin, based on self-reported usual cycle length. Results Data were available for 136 clinical pregnancies conceived during the study, 14 (10%) of which had not yet implanted by the first day of the missed period. The highest possible screening sensitivity for an hCG-based pregnancy test therefore is estimated to be 90% (95% confidence interval [CI], 84%-94%) on the first day of the missed period. By 1 week after the first day of the missed period, the highest possible screening sensitivity is estimated to be 97% (95% Cl, 94%-99%). Conclusions In this study, using an extremely sensitive assay for hCG, 10% of clinical pregnancies were undetectable on the first day of missed menses. fn practice, an even larger percentage of clinical pregnancies may be undetected by current test kits on this day, given their reported assay properties and other practical limitations.	NIEHS, Epidemiol Branch, Durham, NC USA; NIEHS, Biostat Branch, Durham, NC USA; Columbia Univ Barnard Coll, Dept Biol Sci, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Columbia University	Wilcox, AJ (corresponding author), NIEHS, Epidemiol Branch, MD A3-05, Res Triangle Pk, NC 27709 USA.		Baird, Donna D/D-5214-2017; Wilcox, Allen J/C-7723-2019	Baird, Donna D/0000-0002-5544-2653; Wilcox, Allen J/0000-0002-3376-1311; Weinberg, Clarice/0000-0002-7713-8556	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049003, Z01ES044003, ZIAES049003, ZIAES044003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALFTHAN H, 1993, SCAND J CLIN LAB INV, V53, P105, DOI 10.3109/00365519309086911; ARMSTRONG EG, 1984, J CLIN ENDOCR METAB, V59, P867, DOI 10.1210/jcem-59-5-867; Bastian LA, 1998, ARCH FAM MED, V7, P465, DOI 10.1001/archfami.7.5.465; CHARD T, 1992, HUM REPROD, V7, P701, DOI 10.1093/oxfordjournals.humrep.a137722; COLE LA, 1993, AM J OBSTET GYNECOL, V168, P1580, DOI 10.1016/S0002-9378(11)90802-3; Harlow SD, 2000, J CLIN EPIDEMIOL, V53, P722, DOI 10.1016/S0895-4356(99)00202-4; Ikomi A, 1998, BRIT J OBSTET GYNAEC, V105, P462, DOI 10.1111/j.1471-0528.1998.tb10135.x; LENTON EA, 1984, BRIT J OBSTET GYNAEC, V91, P681, DOI 10.1111/j.1471-0528.1984.tb04830.x; LIPSITZ R, 2000, SCI AM, V283, P110; MISHALANI SH, 1994, CLIN CHEM, V40, P1944; Shew ML, 2000, AM J PUBLIC HEALTH, V90, P974, DOI 10.2105/AJPH.90.6.974; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Wilcox AJ, 2000, BRIT MED J, V321, P1259, DOI 10.1136/bmj.321.7271.1259	14	62	62	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1759	1761		10.1001/jama.286.14.1759	http://dx.doi.org/10.1001/jama.286.14.1759			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	480NC	11594902	Bronze			2022-12-01	WOS:000171466800027
J	SMITH, T				SMITH, T			CHEAP, MANAGED DEATH	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	1995	310	6981					744	744		10.1136/bmj.310.6981.744	http://dx.doi.org/10.1136/bmj.310.6981.744			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QN461	11644673	Green Published			2022-12-01	WOS:A1995QN46100079
J	PALMER, K				PALMER, K			PEACE AND PAIN	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 23	1994	309	6949					279	279		10.1136/bmj.309.6949.279	http://dx.doi.org/10.1136/bmj.309.6949.279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NZ180	11644574	Green Published			2022-12-01	WOS:A1994NZ18000070
J	Patel, SC; Levine, SR; Tilley, BC; Grotta, JC; Lu, M; Frankel, M; Haley, EC; Brott, TG; Broderick, JP; Horowitz, S; Lyden, PD; Lewandowski, CA; Marler, JR; Welch, KMA				Patel, SC; Levine, SR; Tilley, BC; Grotta, JC; Lu, M; Frankel, M; Haley, EC; Brott, TG; Broderick, JP; Horowitz, S; Lyden, PD; Lewandowski, CA; Marler, JR; Welch, KMA		Natl Inst Neurological Disorders	Lack of clinical significance of early ischemic changes on computed tomography in acute stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CT FINDINGS; PLASMINOGEN-ACTIVATOR; CEREBRAL INFARCTION; RT-PA; ALTEPLASE; VARIABILITY; RELIABILITY; AGREEMENT	Context The prevalence and clinical significance of early ischemic changes (EICs) on baseline computed tomography (CT) scan of the head obtained within 3 hours of ischemic stroke are not established. Objective To determine the frequency and significance of EIC on baseline head CT scans in the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA (recombinant tissue plasminogen activator) Stroke Trial. Design and Setting The original study, a randomized controlled trial, took place from January 1991 through October 1994 at 43 sites, during which CT images were obtained within 3 hours of symptom onset and prior to the initiation of rt-PA or placebo. For the current analysis, detailed reevaluation was undertaken after October 1994 of all baseline head CT scans with clinical data available pretreatment (blinded to treatment arm). Patients Of 624 patients enrolled in the trial, baseline CT scans were retrieved and reviewed for 616 (99%). Main Outcome Measures Frequency of EICs on baseline CT scans; association of EIC With other baseline variables; effect of EICs on deterioration at 24 hours (greater than or equal to4 points increase from the baseline National Institutes of Health Stroke Scale [NIHSS] score); clinical outcome (measured by 4 clinical scales) at 3 months, CT lesion volume at 3 months, death at 90 days; and symptomatic intracranial hemorrhage (ICH) within 36 hours of treatment. Results The prevalence of EIC on baseline CT in the combined rt-PA and placebo groups was 31% (n = 194). The EIC was significantly associated with baseline NIHSS score (p=0.23; P<.001) and time from stroke onset to baseline CT scan (p=0.11; P=.007). After adjusting for baseline variables, there was no EIC X treatment interaction detected for any clinical outcome, including deterioration at 24 hours, 4 clinical scales, lesion volume, and death at 90 days (P<greater than or equal to>.25), implying that EIC is unlikely to affect response to rt-PA treatment. After adjusting for NIHSS score (an independent predictor of ICH), no EIC association with symptomatic ICH at 36 hours was detected in the group treated with rt-PA (P greater than or equal to .22). Conclusions Our analysis suggests that EICs are prevalent within 3 hours of stroke onset and correlate with stroke severity. However, EICs are not independently associated with increased risk of adverse outcome after rt-PA treatment. Patients treated with rt-PA did better whether or not they had EICs, suggesting that EICs on CT scan are not critical to the decision to treat otherwise eligible patients with rt-PA within 3 hours of stroke onset.	Henry Ford Hosp & Hlth Sci Ctr, Div Neuroradiol, Detroit, MI 48202 USA; Mt Sinai Sch Med, New York, NY USA; Med Univ S Carolina, Charleston, SC 29425 USA; Univ Texas, Med Ctr, Houston, TX USA; Emory Univ, Sch Med, Atlanta, GA USA; Univ Virginia Hlth Syst, Charlottesville, VA USA; Mayo Clin, Jacksonville, FL 32224 USA; Univ Cincinnati, Cincinnati, OH USA; Univ Missouri, Columbia, MO USA; Univ Calif San Diego, Stroke Ctr, San Diego, CA 92103 USA; NINCDS, NIH, Bethesda, MD 20892 USA; Univ Kansas, Sch Med, Kansas City, KS USA	Henry Ford Health System; Icahn School of Medicine at Mount Sinai; Medical University of South Carolina; University of Texas System; Emory University; University of Virginia; Mayo Clinic; University System of Ohio; University of Cincinnati; University of Missouri System; University of Missouri Columbia; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Kansas; University of Kansas Medical Center	Patel, SC (corresponding author), Henry Ford Hosp & Hlth Sci Ctr, Div Neuroradiol, 2799 W Grand Blvd,K-3, Detroit, MI 48202 USA.	spatel@rad.hfh.edu	Grotta, James/AAH-7423-2021					Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bornstein N, 2000, STROKE, V31, P309; BOZZAO L, 1989, AM J NEURORADIOL, V10, P1215; BOZZAO L, 1991, AM J NEURORADIOL, V12, P1115; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Grotta JC, 1999, STROKE, V30, P1528, DOI 10.1161/01.STR.30.8.1528; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; HOROWITZ SH, 1991, STROKE, V22, P1245, DOI 10.1161/01.STR.22.10.1245; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; HSIEH FY, 1989, STAT MED, V8, P795, DOI 10.1002/sim.4780080704; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Levine SR, 2000, STROKE, V31, P2912; Luire DN, 2000, STROKE, V31, P276; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; MAHONEY F I, 1965, Md State Med J, V14, P61; Marks MP, 1999, STROKE, V30, P389, DOI 10.1161/01.STR.30.2.389; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; MOHR JP, 1995, STROKE, V26, P807, DOI 10.1161/01.STR.26.5.807; Moulin T, 1996, NEUROLOGY, V47, P366, DOI 10.1212/WNL.47.2.366; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; Schriger DL, 1998, JAMA-J AM MED ASSOC, V279, P1293, DOI 10.1001/jama.279.16.1293; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136; TOMURA N, 1988, RADIOLOGY, V168, P463, DOI 10.1148/radiology.168.2.3393665; TRUWIT CL, 1990, RADIOLOGY, V176, P801, DOI 10.1148/radiology.176.3.2389039; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; von Kummer R, 1999, STROKE, V30, P250; von Kummer R, 2001, RADIOLOGY, V219, P95, DOI 10.1148/radiology.219.1.r01ap0695; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; vonKummer R, 1996, NEURORADIOLOGY, V38, P31, DOI 10.1007/BF00593212; VONKUMMER R, 1995, EARLY CT DIAGNOSIS H, P8; WALL SD, 1982, AM J ROENTGENOL, V138, P307, DOI 10.2214/ajr.138.2.307	39	256	267	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2830	2838		10.1001/jama.286.22.2830	http://dx.doi.org/10.1001/jama.286.22.2830			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735758	Bronze			2022-12-01	WOS:000172655400031
J	Smith, DE; Zuber, MT; Neumann, GA				Smith, DE; Zuber, MT; Neumann, GA			Seasonal variations of snow depth on Mars	SCIENCE			English	Article							GENERAL-CIRCULATION MODEL; GLOBAL SURVEYOR; GRAVITY-FIELD; WATER-VAPOR; SUMMER TEMPERATURES; CARBON-DIOXIDE; POLAR; ICE; TOPOGRAPHY; EVOLUTION	Using topography collected over one martian year from the Mars Orbiter Laser Altimeter on the Mars Global Surveyor (MGS) spacecraft, we have measured temporal changes in the elevation of the martian surface that correlate with the seasonal cycle of carbon dioxide exchange between the surface and atmosphere. The greatest elevation change (1.5 to 2 meters) occurs at high latitudes ( above 80 degrees), whereas the bulk of the mass exchange occurs at tower latitudes (below 75 degrees N and below 73 degrees S). An unexpected period of sublimation was observed during northern hemisphere autumn, coincident with dust storms in the southern hemisphere. Analysis of MGS Doppler tracking residuals revealed temporal variations in the flattening of Mars that correlate with elevation changes. The combined changes in gravity and elevation constrain the average density of seasonally deposited carbon dioxide to be 910 +/- 230 kilograms per cubic meter, which is considerably denser than terrestrial snow.	NASA, Goddard Space Flight Ctr, Terr Phys Lab, Greenbelt, MD 20771 USA; MIT, Cambridge, MA 02139 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT)	Smith, DE (corresponding author), NASA, Goddard Space Flight Ctr, Terr Phys Lab, Greenbelt, MD 20771 USA.	dsmith@tharsis.gsfc.nasa.gov	Neumann, Gregory A/I-5591-2013	Neumann, Gregory A/0000-0003-0644-9944				Albee AL, 2001, J GEOPHYS RES-PLANET, V106, P23291, DOI 10.1029/2000JE001306; BARKER ES, 1970, SCIENCE, V170, P1308, DOI 10.1126/science.170.3964.1308; CHAO BF, 1990, J GEOPHYS RES-SOLID, V95, P14755, DOI 10.1029/JB095iB09p14755; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; Foster JL, 1998, J GEOPHYS RES-PLANET, V103, P25839, DOI 10.1029/98JE02493; HABERLE RM, 1993, J GEOPHYS RES-PLANET, V98, P3093, DOI 10.1029/92JE02946; HABERLE RM, UNPUB; JAKOSKY BM, 1990, J GEOPHYS RES-SOLID, V95, P1359, DOI 10.1029/JB095iB02p01359; JAKOSKY BM, 1984, ICARUS, V57, P322, DOI 10.1016/0019-1035(84)90121-0; James P.B., 1992, MARS, P934; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; KIEFFER HH, 1968, THESIS CATECH PASADE; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Lemoine FG, 2001, J GEOPHYS RES-PLANET, V106, P23359, DOI 10.1029/2000JE001426; Maass O, 1926, P R SOC LOND A-CONTA, V111, P224, DOI 10.1098/rspa.1926.0065; MCCARTHY JJ, 1994, GEODYN SYSTEMS DESCR; NAUMANN GA, UNPUB; PAIGE DA, 1992, ICARUS, V99, P15, DOI 10.1016/0019-1035(92)90167-6; PAVLIS DE, 2001, GEODYN OPERATIONS MA; Pettengill GH, 2000, GEOPHYS RES LETT, V27, P609, DOI 10.1029/1999GL010896; ROWLANDS DD, 1993, GEODYN 2 SYSTEM DESC; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; SMITH DE, 1995, GEOPHYS RES LETT, V22, P2171, DOI 10.1029/95GL01801; Smith DE, 1996, SCIENCE, V271, P184, DOI 10.1126/science.271.5246.184; Smith DE, 1999, J GEOPHYS RES-PLANET, V104, P1885, DOI 10.1029/1998JE900024; SMITH DE, 1993, J GEOPHYS RES-PLANET, V98, P20871, DOI 10.1029/93JE01839; Smith DE, 1999, SCIENCE, V286, P94, DOI 10.1126/science.286.5437.94; Smith MD, 2001, J GEOPHYS RES-PLANET, V106, P23929, DOI 10.1029/2000JE001321; SUN X, 2001, EOS, V82; Titus TN, 2001, J GEOPHYS RES-PLANET, V106, P23181, DOI 10.1029/2000JE001284; Tyler GL, 2001, J GEOPHYS RES-PLANET, V106, P23327, DOI 10.1029/2000JE001348; Wilson RJ, 1997, GEOPHYS RES LETT, V24, P123, DOI 10.1029/96GL03814; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341; Zuber MT, 1998, SCIENCE, V282, P2053, DOI 10.1126/science.282.5396.2053; Zurek R.W., 1992, MARS, P835	39	176	183	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2141	2146		10.1126/science.1066556	http://dx.doi.org/10.1126/science.1066556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739951				2022-12-01	WOS:000172647700044
J	Barker, DJP; Forsen, T; Uutela, A; Osmond, C; Eriksson, JG				Barker, DJP; Forsen, T; Uutela, A; Osmond, C; Eriksson, JG			Size at birth and resilience to effects of poor living conditions in adult life: longitudinal study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ISCHEMIC-HEART-DISEASE; DEATH; GROWTH; FETAL; INEQUALITIES; CHILDHOOD; MORTALITY; WEIGHT	Objective To determine whether men who grew slowly in utero or during infancy are more vulnerable to the later effects of poor living conditions on coronary heart disease. Design Follow up study of men for whom there were data on body size at birth and growth and social class during childhood, educational level, and social class and income in adult life. Setting Helsinki, Finland. Participants 3676 men who were born during 1934-44, attended child welfare clinics in Helsinki, were still resident in Finland in 1971, and for whom data from the 1980 census were available. Main outcome measures Hospital admission for or death from coronary heart disease. Results Men who had low social class or low household income in adult life had increased rates of coronary heart disease. The hazard ratio among men with the lowest annual income (< <pound>8400) was 1.71 (95% confidence interval 1.18 to 2.48) compared with 1.00 in men with incomes above pound 15 700. These effects were stronger in men who were thin at birth (ponderal index < 26 kg/m(3)): hazard ratio 2.58 (1.45 to 4.60) for men with lowest annual income. Among the men who were thin at birth the effects of low social class were greater in those who had accelerated weight gain between ages 1 and 12 years. Low social class in childhood further increased risk of disease, partly because it was associated with poor growth during infancy. Low educational attainment was associated with increased risk, and low income had no effect once this was taken into account. Conclusion Men who grow slowly in utero remain biologically different to other men. They are more vulnerable to the effects of low socioeconomic status and low income on coronary heart disease.	Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland	University of Southampton; Finland National Institute for Health & Welfare	Barker, DJP (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.	djpb@mrc.soton.ac.uk		Osmond, Clive/0000-0002-9054-4655				Acheson D., 1998, INDEPENDENT INQUIRY; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1992, BMJ-BRIT MED J, V304, P148, DOI 10.1136/bmj.304.6820.148; Dickens P, 2001, SOCIOLOGY, V35, P93, DOI 10.1017/S0038038501000062; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; HAVEN H, 1998, ED FINLAND; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Macintyre K, 2001, BRIT MED J, V322, P1152, DOI 10.1136/bmj.322.7295.1152; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; MARMOT MG, 1984, LANCET, V1, P1003; MARMOT MG, 1986, LANCET, V2, P274; Phillips DIW, 2000, HYPERTENSION, V35, P1301, DOI 10.1161/01.HYP.35.6.1301; WAALER HT, 1984, ACTA MED SCAND, P1; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	18	175	184	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2001	323	7324					1273	1276		10.1136/bmj.323.7324.1273	http://dx.doi.org/10.1136/bmj.323.7324.1273			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YG	11731388	Green Published, Bronze			2022-12-01	WOS:000172655800015
J	Chabas, D; Baranzini, SE; Mitchell, D; Bernard, CCA; Rittling, SR; Denhardt, DT; Sobel, RA; Lock, C; Karpuj, M; Pedotti, R; Heller, R; Oksenberg, JR; Steinman, L				Chabas, D; Baranzini, SE; Mitchell, D; Bernard, CCA; Rittling, SR; Denhardt, DT; Sobel, RA; Lock, C; Karpuj, M; Pedotti, R; Heller, R; Oksenberg, JR; Steinman, L			The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS LESIONS; CELL-MEDIATED-IMMUNITY; GENE-EXPRESSION; MESSENGER-RNA; MICE; ENCEPHALOMYELITIS; INDUCTION; PROTEIN; REVEALS	Multiple sclerosis is a demyelinating disease, characterized by inflammation in the brain and spinal cord, possibly due to autoimmunity. Large-scale sequencing of cDNA libraries, derived from plaques dissected from brains of patients with multiple sclerosis (MS), indicated an abundance of transcripts for osteopontin (OPN). Microarray analysis of spinal cords from rats paralyzed by experimental autoimmune encephalomyelitis (EAE), a model of MS, also revealed increased OPN transcripts. Osteopontin-deficient mice were resistant to progressive EAE and had frequent remissions, and myelin-reactive T cells in OPN-/- mice produced more interleukin 10 and less interferon-gamma than in OPN+/+ mice. Osteopontin thus appears to regulate T helper cell-1 (T(H)1)-mediated demyelinating disease, and it may offer a potential target in blocking development of progressive MS.	Beckman Ctr Mol Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; La Trobe Univ, Dept Biochem, Neuroimmunol Lab, Bundoora, Vic 3083, Australia; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; Stanford Univ, Dept Pathol Neuropathol, Sch Med, Stanford, CA 94305 USA; Roche Biosci, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; La Trobe University; Rutgers State University New Brunswick; Stanford University; Roche Holding	Steinman, L (corresponding author), Beckman Ctr Mol Med, Dept Neurol & Neurol Sci, B002, Stanford, CA 94305 USA.		Baranzini, Sergio/A-9422-2013; Messier, Claude/A-2322-2008	Baranzini, Sergio/0000-0003-0067-194X; Messier, Claude/0000-0002-4791-1763; Lock, Christopher/0000-0002-4087-5894; Sobel, Raymond/0000-0002-0477-9002; Steinman, Lawrence/0000-0002-2437-2250				Aquino DA, 1998, NEUROCHEM RES, V23, P413, DOI 10.1023/A:1022473904335; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Becker KG, 1997, J NEUROIMMUNOL, V77, P27, DOI 10.1016/S0165-5728(97)00045-3; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; CHOI SS, 1995, MAMM GENOME, V6, P653, DOI 10.1007/BF00352374; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; DORHEIM MA, 1993, J CELL PHYSIOL, V154, P317, DOI 10.1002/jcp.1041540215; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; GRAINGER C, 1995, NAT MED, V1, P1063; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HWANG S, 1994, J BIOL CHEM, V269, P711; Karin N, 1998, J IMMUNOL, V160, P5188; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rittling SR, 1999, EXP NEPHROL, V7, P103; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Rittling SR, 1998, BIOCHEM BIOPH RES CO, V250, P287, DOI 10.1006/bbrc.1998.9306; Ruiz PJ, 1999, J IMMUNOL, V162, P3336; Sasaki N, 1998, GENOMICS, V49, P167, DOI 10.1006/geno.1998.5209; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Shin SL, 1999, NEUROSCI LETT, V273, P73, DOI 10.1016/S0304-3940(99)00516-9; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; SOBEL RA, 1995, J NEUROPATH EXP NEUR, V54, P202, DOI 10.1097/00005072-199503000-00007; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Villarroya H, 1997, J NEUROSCI RES, V49, P592, DOI 10.1002/(SICI)1097-4547(19970901)49:5<592::AID-JNR9>3.0.CO;2-6	33	720	769	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1731	1735		10.1126/science.1062960	http://dx.doi.org/10.1126/science.1062960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721059				2022-12-01	WOS:000172307400049
J	Martin, DK; Pater, JL; Singer, PA				Martin, DK; Pater, JL; Singer, PA			Priority-setting decisions for new cancer drugs: a qualitative case study	LANCET			English	Article							COST-EFFECTIVENESS; MANAGED CARE; HEALTH; ACCOUNTABILITY; TECHNOLOGIES; OREGON	Background Frameworks for legitimate and fair priority setting emphasise the importance of the rationales for priority setting decisions. However, priority setting rationales, in particular for new cancer drugs, are not well described. We describe the rationales used by a committee making funding decisions for new cancer drugs. Methods We did a qualitative case study of a priority setting committee (Cancer Care Ontario Policy Advisory Committee for the New Drug Funding Program) by analysing documents, interviewing committee members, and observing committee meetings. Findings We identified and described decisions and rationales related to 14 drugs in eight disease conditions over 3 years. Our main findings were that: priority setting existed in relation to resource mobilisation; clinical benefit was the primary factor in decisions; in the context of an expanding budget, rationales changed; rationales could change as costs for individual treatments increased; when all options were reasonable, groups funded a range of options and let patients decide; and priority setting rationales involve clusters of factors, not simple trade-offs. Interpretation Observing priority-setting decisions and their rationales in actual practice reveals lessons not contained in theoretical accounts.	Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5G 1L4, Canada; Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Queens University - Canada	Singer, PA (corresponding author), Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada.	peter.singer@utoronto.ca	Embrett, Mark G./H-4466-2014	Embrett, Mark G./0000-0002-3969-0219				AARON HJ, 1984, PAINFUL PRESCRIPTION; BARON J, 1995, J BEHAV DECIS MAKING, V8, P71, DOI 10.1002/bdm.3960080202; BOWLING A, 1993, SOC SCI MED, V37, P851, DOI 10.1016/0277-9536(93)90138-T; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 1998, HASTINGS CENT REP, V28, P27, DOI 10.2307/3527569; Daniels N, 1998, HEALTH AFFAIR, V17, P50, DOI 10.1377/hlthaff.17.5.50; Daniels N, 2000, STATE HLTH SER, P89; EDDY DM, 1994, JAMA-J AM MED ASSOC, V271, P792; ELSTER J, 1992, LOCAL JUSTICE I ALLO, P4; EVANS WK, 1997, ANN CANC CONTROL RES, V7, P481; Foy R, 1999, BRIT MED J, V318, P456, DOI 10.1136/bmj.318.7181.456; GARLAND A, 1997, COMMUNICATION   0730; Giacomini MK, 1999, J HEALTH POLIT POLIC, V24, P715; HADORN DC, 1991, JAMA-J AM MED ASSOC, V265, P2218, DOI 10.1001/jama.265.17.2218; HAM C, 1993, BMJ-BRIT MED J, V307, P435, DOI 10.1136/bmj.307.6901.435; Holm S, 1998, BRIT MED J, V317, P1000, DOI 10.1136/bmj.317.7164.1000; Hope T, 1998, BRIT MED J, V317, P1067; Horton R, 1999, LANCET, V353, P1028, DOI 10.1016/S0140-6736(99)00098-7; Jonsen Albert., 1988, ABUSE CASUISTRY HIST; NAYLOR CD, 1996, ACP J CLUB, V124, pA12; NORD E, 1995, SOC SCI MED, V41, P1429, DOI 10.1016/0277-9536(95)00121-M; Singer PA, 2000, BMJ-BRIT MED J, V321, P1316, DOI 10.1136/bmj.321.7272.1316; UBEL PA, 1995, HEALTH POLICY, V34, P145, DOI 10.1016/0168-8510(95)00714-4; Ubel PA, 1996, MED DECIS MAKING, V16, P108, DOI 10.1177/0272989X9601600202; Ubel PA, 1996, NEW ENGL J MED, V334, P1174, DOI 10.1056/NEJM199605023341807; Zussman Robert, 1992, INTENSIVE CARE MED E; ZWEIBEL NR, 1993, GERONTOLOGIST, V33, P74, DOI 10.1093/geront/33.1.74; 2001, CANC CARE ONTARIO NE	28	83	83	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2001	358	9294					1676	1681		10.1016/S0140-6736(01)06714-9	http://dx.doi.org/10.1016/S0140-6736(01)06714-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	495MC	11728542				2022-12-01	WOS:000172344100010
J	Nykanen, A; Haley, B; Zamore, PD				Nykanen, A; Haley, B; Zamore, PD			ATP requirements and small interfering RNA structure in the RNA interference pathway	CELL			English	Article							DOUBLE-STRANDED-RNA; GERM-LINE DEVELOPMENT; MESSENGER-RNA; C-ELEGANS; GENETIC INTERFERENCE; DROSOPHILA; TRANSGENE; ARABIDOPSIS; NEUROSPORA; EXPRESSION	We examined the role of ATP in the RNA interference (RNAi) pathway. Our data reveal two ATP-dependent steps and suggest that the RNAi reaction comprises at least four sequential steps: ATP-dependent processing of double-stranded RNA into small interfering RNAs (siRNAs), incorporation of siRNAs into an inactive similar to 360 kDa protein/RNA complex, ATP-dependent unwinding of the siRNA duplex to generate an active complex, and ATP-independent recognition and cleavage of the RNA target. Furthermore, ATP is used to maintain 5' phosphates on siRNAs. A 5' phosphate on the target-complementary strand of the siRNA duplex is required for siRNA function, suggesting that cells check the authenticity of siRNAs and license only bona fide siRNAs to direct target RNA destruction.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, 55 Lake Ave N, Worcester, MA 01655 USA.	phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62862-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Baulcombe DC, 1999, CURR BIOL, V9, pR599, DOI 10.1016/S0960-9822(99)80383-2; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; COGONI C, 1994, ANTON LEEUW INT J G, V65, P205, DOI 10.1007/BF00871948; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Dernburg AF, 2000, GENE DEV, V14, P1578; Djikeng A, 2001, RNA, V7, P1522; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELBASHIR SM, 2001, IN PRESS EMBO J; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grant SR, 1999, CELL, V96, P303, DOI 10.1016/S0092-8674(00)80541-3; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hunter CP, 1999, CURR BIOL, V9, pR440, DOI 10.1016/S0960-9822(99)80276-0; Hutvagner G, 2000, RNA, V6, P1445, DOI 10.1017/S1355838200001096; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jensen S, 1999, GENETICS, V153, P1767; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Malinsky S, 2000, GENETICS, V156, P1147; Matsuda S, 2000, BBA-GENE STRUCT EXPR, V1490, P163, DOI 10.1016/S0167-4781(99)00221-3; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Worthington C.C., 1988, WORTHINGTON ENZYME M; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	52	747	1087	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2001	107	3					309	321		10.1016/S0092-8674(01)00547-5	http://dx.doi.org/10.1016/S0092-8674(01)00547-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701122	Bronze			2022-12-01	WOS:000172022800003
J	Wang, CT; Grishanin, R; Earles, CA; Chang, PY; Martin, TFJ; Chapman, ER; Jackson, MB				Wang, CT; Grishanin, R; Earles, CA; Chang, PY; Martin, TFJ; Chapman, ER; Jackson, MB			Synaptotagmin modulation of fusion pore kinetics in regulated exocytosis of dense-core vesicles	SCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; CALCIUM-CHANNEL; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; SYNAPTIC VESICLES; MEMBRANE-FUSION; PC12 CELLS; DOMAIN; CA2+; IV	In the exocytosis of neurotransmitter, fusion pore opening represents the first instant of fluid contact between the vesicle lumen and extracellular space. The existence of the fusion pore has been established by electrical measurements, but its molecular composition is unknown. The possibility that synaptotagmin regulates fusion pores was investigated with amperometry to monitor exocytosis of single dense-core vesicles. Overexpression of synaptotagmin I prolonged the time from fusion pore opening to dilation, whereas synaptotagmin IV shortened this time. Both synaptotagmin isoforms reduced norepinephrine flux through open fusion pores. Thus, synaptotagmin interacts with fusion pores, possibly by associating with a core complex of membrane proteins and/or lipid.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.	mjackson@physiology.wisc.edu	Oka, Yoshitaka/C-9670-2010; Wang, Chih-Tien/GRE-8232-2022	Oka, Yoshitaka/0000-0002-3482-3051; Wang, Chih-Tien/0000-0001-7639-7508; Chapman, Edwin/0000-0001-9787-8140				BAUERFEIND R, 1993, NEURON, V11, P105, DOI 10.1016/0896-6273(93)90275-V; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colquhoun David, 1995, P397; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; EARLES CA, IN PRESS J CELL BIOL; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; Ferguson GD, 1999, J NEUROCHEM, V72, P1821, DOI 10.1046/j.1471-4159.1999.0721821.x; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Haller M, 1998, BIOPHYS J, V74, P2100, DOI 10.1016/S0006-3495(98)77917-2; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; JACKSON MB, 1992, METHOD ENZYMOL, V207, P729; Kasai H, 1996, J PHYSIOL-LONDON, V494, P53, DOI 10.1113/jphysiol.1996.sp021475; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; Kishimoto T, 2001, J PHYSIOL-LONDON, V533, P627, DOI 10.1111/j.1469-7793.2001.t01-1-00627.x; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; LLOYD TE, 2000, NEUROTRANSMITTER REL, P352; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; Reist NE, 1998, J NEUROSCI, V18, P7662; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; Schwarz Thomas L., 1994, Current Opinion in Neurobiology, V4, P633, DOI 10.1016/0959-4388(94)90003-5; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	41	231	239	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1111	1115		10.1126/science.1064002	http://dx.doi.org/10.1126/science.1064002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691996	Green Submitted			2022-12-01	WOS:000172013800053
J	Shoham, S; Halgren, E; Maynard, EM; Normann, RA				Shoham, S; Halgren, E; Maynard, EM; Normann, RA			Motor-cortical activity in tetraplegics	NATURE			English	Article							CORTEX; REORGANIZATION		Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA	Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital	Shoham, S (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.			Shoham, Shy/0000-0003-0376-3495				Cheney PD, 2000, PROG BRAIN RES, V128, P135; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Friston KJ., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Green JB, 1999, NEUROLOGY, V53, P736, DOI 10.1212/WNL.53.4.736; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Lotze M, 1999, RESTOR NEUROL NEUROS, V14, P183; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nitschke MF, 1996, BRAIN, V119, P1023; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Turner JA, 2001, IEEE T NEUR SYS REH, V9, P154, DOI 10.1109/7333.928575; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	13	73	74	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					793	793		10.1038/35101651	http://dx.doi.org/10.1038/35101651			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677592	Bronze			2022-12-01	WOS:000171750200031
J	Moreira-Leite, FF; Sherwin, T; Kohl, L; Gull, K				Moreira-Leite, FF; Sherwin, T; Kohl, L; Gull, K			A trypanosome structure involved in transmitting cytoplasmic information during cell division	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; BRUCEI; CYCLE; INTERFERENCE; SEGREGATION; GLYCOPROTEIN; CYTOKINESIS; POLARITY; ADHESION; SYSTEM	African trypanosomes are protozoan parasites that cause sleeping sickness in humans through a tsetse fly vector. The procyclic form of Trypanosoma brucei has a single, attached flagellum that describes a helical path along the cell from posterior to anterior. During division, a specific flagellum-flagellum connection is elaborated between the new and old flagellum. This connector was present only during cell duplication and was found to be involved in the replication of the helical cell pattern and polarity. This finding implicates the concept of cytotaxis in cell morphogenesis in trypanosomes.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Gull, K (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	k.gutt@man.ac.uk	Sherwin, Trevor/A-1217-2008	Sherwin, Trevor/0000-0002-9090-1034				Bastin P, 2000, J CELL SCI, V113, P3321; BASTIN P, 1996, PARASITOL TODAY, V12, P295; BEISSON J, 1965, P NATL ACAD SCI USA, V53, P275, DOI 10.1073/pnas.53.2.275; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; COOPER R, 1993, J CELL BIOL, V122, P149, DOI 10.1083/jcb.122.1.149; DOLAN MT, 1986, J CELL SCI, V80, P123; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GRIMES GW, 1982, AM ZOOL, V22, P35; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nozaki T, 1996, MOL BIOCHEM PARASIT, V82, P245, DOI 10.1016/0166-6851(96)02741-7; Ploubidou A, 1999, J CELL SCI, V112, P4641; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; SONNEBORN TM, 1964, P NATL ACAD SCI USA, V51, P915, DOI 10.1073/pnas.51.5.915; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	20	120	120	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					610	612		10.1126/science.1063775	http://dx.doi.org/10.1126/science.1063775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641501				2022-12-01	WOS:000171695600051
J	Lohmann, KJ; Cain, SD; Dodge, SA; Lohmann, CMF				Lohmann, KJ; Cain, SD; Dodge, SA; Lohmann, CMF			Regional magnetic fields as navigational markers for sea turtles	SCIENCE			English	Article							LONG-DISTANCE NAVIGATION; MECHANISMS	Young loggerhead sea turtles (Caretta caretta) from eastern Florida undertake a transoceanic migration in which they gradually circle the north Atlantic Ocean before returning to the North American coast. Here we report that hatchling loggerheads, when exposed to magnetic fields replicating those found in three widely separated oceanic regions, responded by swimming in directions that would, in each case, help keep turtles within the currents of the North Atlantic gyre and facilitate movement along the migratory pathway. These results imply that young loggerheads have a guidance system in which regional magnetic fields function as navigational markers and elicit changes in swimming direction at crucial geographic boundaries.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lohmann, KJ (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.							Akesson S, 1996, TRENDS ECOL EVOL, V11, P398, DOI 10.1016/0169-5347(96)30040-2; BATSCHELET E, 1981, CIRCULAR STAT BIOL, P104; BEARMAN G, 1989, OCEAN CIRCULATION; BECK W, 1988, 19 C INT ORN, V2, P1955; Bolten AB, 1998, ECOL APPL, V8, P1; CARR A, 1986, BIOSCIENCE, V36, P92, DOI 10.2307/1310109; CARR A, 1987, Conservation Biology, V1, P103, DOI 10.1111/j.1523-1739.1987.tb00020.x; GOULD JL, 1982, NATURE, V296, P205, DOI 10.1038/296205a0; GOULD JL, 1985, MAGNETITE BIOMINERAL, P257; Hays GC, 1997, CAN J ZOOL, V75, P40, DOI 10.1139/z97-005; Jacobs JA, 1994, REVERSALS EARTHS MAG; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Lohmann KJ, 1999, ETHOL ECOL EVOL, V11, P1, DOI 10.1080/08927014.1999.9522838; LOHMANN KJ, 1994, J EXP BIOL, V190, P1; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; Lohmann KJ, 1998, J AVIAN BIOL, V29, P585, DOI 10.2307/3677179; LOHMANN KJ, BIOL CONSERVATION LO; MERRITT R, 1983, REV SCI INSTRUM, V54, P879, DOI 10.1063/1.1137480; Musick John A., 1997, P137; SALMON M, 1987, J EXP MAR BIOL ECOL, V109, P137, DOI 10.1016/0022-0981(87)90012-8; Schmitz W.J., 1996, WHOI9603; Skiles D.D., 1985, MAGNETITE BIOMINERAL, P43; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Wehner R, 1998, J AVIAN BIOL, V29, P370, DOI 10.2307/3677156; WILTSCHKO R, 1995, MAGNETIC ORIENTATION, P177	26	187	201	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					364	366		10.1126/science.1064557	http://dx.doi.org/10.1126/science.1064557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598298				2022-12-01	WOS:000171601400041
J	Elliott, C				Elliott, C			Philosopher assisted suicide and euthanasia	BRITISH MEDICAL JOURNAL			English	Editorial Material											Elliott, C (corresponding author), MCGILL UNIV,MONTREAL,PQ,CANADA.								0	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1996	313	7064					1088	1089						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VP742	11644845				2022-12-01	WOS:A1996VP74200083
J	Loeffler, JM; Nelson, D; Fischetti, VA				Loeffler, JM; Nelson, D; Fischetti, VA			Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase	SCIENCE			English	Article							CONJUGATE VACCINE; CARRIAGE	Nasopharyngeal carriage is the major reservoir for Streptococcus pneumoniae in the community. Although eliminating this reservoir would greatly reduce disease occurrence, no suitable intervention has been available for this purpose. We show here that seconds after contact, a purified pneumococcal bacteriophage lytic enzyme (Pal) is able to kill 15 common serotypes of pneumococci, including highly penicillin-resistant strains. In vivo, previously colonized mice revealed undetectable pneumococcal titers 5 hours after a single enzyme treatment. Pal enzyme had little or no effect on microorganisms normally found in the human oropharynx, and Pal-resistant pneumococci could not be detected after extensive exposure to the enzyme.	Rockefeller Univ, Lab Bacterial Pathogenesis, New York, NY 10021 USA	Rockefeller University	Fischetti, VA (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis, 1230 York Ave, New York, NY 10021 USA.		Loeffler, Jutta M/C-2747-2008; Nelson, Daniel C./I-2198-2012	Nelson, Daniel C./0000-0003-3248-4831				Bernhardt TG, 2001, SCIENCE, V292, P2326, DOI 10.1126/science.1058289; Garcia P, 1997, MICROB DRUG RESIST, V3, P165, DOI 10.1089/mdr.1997.3.165; GILLESPIE SH, 1993, INFECT IMMUN, V61, P3076, DOI 10.1128/IAI.61.7.3076-3077.1993; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Pelton SI, 2000, VACCINE, V19, pS96, DOI 10.1016/S0264-410X(00)00286-3; Putnam SD, 2000, CLIN MICROBIOL INFEC, V6, P2, DOI 10.1046/j.1469-0691.2000.00001.x; Roberts RB, 2001, MICROB DRUG RESIST, V7, P137, DOI 10.1089/10766290152045011; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Sa-Leao R, 2000, J INFECT DIS, V182, P1153, DOI 10.1086/315813; SANCHEZPUELLES JM, 1992, EUR J BIOCHEM, V203, P153, DOI 10.1111/j.1432-1033.1992.tb19840.x; Sheehan MM, 1997, MOL MICROBIOL, V25, P717, DOI 10.1046/j.1365-2958.1997.5101880.x; TOMASZ A, 1967, SCIENCE, V157, P694, DOI 10.1126/science.157.3789.694; TUOMANEN E, 1991, SCAND J INFECT DIS, V74, P102; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142	18	356	407	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2170	2172		10.1126/science.1066869	http://dx.doi.org/10.1126/science.1066869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739958				2022-12-01	WOS:000172647700052
J	Kobayashi, T; Saito, T; Ohtani, H				Kobayashi, T; Saito, T; Ohtani, H			Real-time spectroscopy of transition states in bacteriorhodopsin during retinal isomerization	NATURE			English	Article							OPTICAL PARAMETRIC AMPLIFICATION; RESONANCE RAMAN-SPECTROSCOPY; LIGHT-INDUCED EVENTS; PULSE GENERATION; PRIMARY STEP; DYNAMICS; PHOTOISOMERIZATION; PHOTOCYCLE; SPECTRA; MODEL	Real-time investigations of the rearrangement of bonds during chemical transformations require femtosecond temporal resolution, so that the atomic vibrations within the reacting molecules can be observed. Following the development of lasers capable of emitting ultrashort laser flashes on this timescale, chemical reactions involving relatively simple molecules have been monitored in detail, revealing the transient existence of intermediate species as reactants are transformed into products(1-3). Here we report the direct observation of nuclear motion in a complex biological system, the retinal chromophore of bacteriorhodopsin (bR(568))(4), as it undergoes the trans-cis photoisomerization that is fundamental to the vision process. By using visible-light pulses of less than 5 femtosecond in duration(5,6), we are able to monitor changes in the vibrational spectra of the transition state and thus show that despite photoexcitation of the anti-bonding molecular orbital involved, isomerization does not occur instantly, but involves transient formation of a so-called 'tumbling state'. Our observations thus agree with growing experimental(7-14) and ab initio evidence(15,16) for a three-state photoisomerization model(8-10,17) and firmly discount the initially suggested two-state model(18-20) for this process.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Yokohama, Kanagawa 2268501, Japan	University of Tokyo; Tokyo Institute of Technology	Kobayashi, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.							ATKINSON GH, 1989, CHEM PHYS, V131, P1, DOI 10.1016/0301-0104(89)87077-6; Atkinson GH, 2000, J PHYS CHEM A, V104, P4130, DOI 10.1021/jp9918306; Bardeen CJ, 1998, J PHYS CHEM A, V102, P2759, DOI 10.1021/jp980346k; DILLER R, 1995, CHEM PHYS LETT, V241, P109, DOI 10.1016/0009-2614(95)00598-X; DOIG SJ, 1991, J PHYS CHEM-US, V95, P6372, DOI 10.1021/j100169a054; DU M, 1993, BIOPHYS CHEM, V48, P101, DOI 10.1016/0301-4622(93)85002-Y; EYRING G, 1982, BIOCHEMISTRY-US, V21, P384, DOI 10.1021/bi00531a028; Gai F, 1998, SCIENCE, V279, P1886, DOI 10.1126/science.279.5358.1886; Garavelli M, 1999, J AM CHEM SOC, V121, P1023, DOI 10.1021/ja981719y; Haran G, 1996, CHEM PHYS LETT, V261, P389, DOI 10.1016/0009-2614(96)01017-2; Hasson KC, 1996, P NATL ACAD SCI USA, V93, P15124, DOI 10.1073/pnas.93.26.15124; Humphrey W, 1998, BIOPHYS J, V75, P1689, DOI 10.1016/S0006-3495(98)77611-8; Kobayashi T, 2000, APPL PHYS B-LASERS O, V70, pS239, DOI 10.1007/s003400000325; Kobayashi T, 2000, CHEM PHYS LETT, V321, P385, DOI 10.1016/S0009-2614(00)00282-7; MATHIES RA, 1988, SCIENCE, V240, P777, DOI 10.1126/science.3363359; MYERS AB, 1983, J CHEM PHYS, V79, P603, DOI 10.1063/1.445807; Oesterhelt D, 1974, Methods Enzymol, V31, P667; PETEANU LA, 1993, P NATL ACAD SCI USA, V90, P11762, DOI 10.1073/pnas.90.24.11762; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; POLLARD WT, 1992, J PHYS CHEM-US, V96, P6147, DOI 10.1021/j100194a013; ROSE TS, 1989, J CHEM PHYS, V91, P7415, DOI 10.1063/1.457266; ROSE TS, 1988, J CHEM PHYS, V88, P6672, DOI 10.1063/1.454408; Shirakawa A, 1999, APPL PHYS LETT, V74, P2268, DOI 10.1063/1.123820; Shirakawa A, 1998, OPT LETT, V23, P1292, DOI 10.1364/OL.23.001292; SHOENLEIN RW, 1993, J PHYS CHEM-US, V97, P12087; Song L, 1998, J AM CHEM SOC, V120, P8889, DOI 10.1021/ja980390d; VANDENBERG R, 1990, BIOPHYS J, V58, P135, DOI 10.1016/S0006-3495(90)82359-6; Vreven T, 1997, J AM CHEM SOC, V119, P12687, DOI 10.1021/ja9725763; Ye T, 1999, J PHYS CHEM B, V103, P5122, DOI 10.1021/jp9846227; Zhong Q, 1996, J AM CHEM SOC, V118, P12828, DOI 10.1021/ja961058+	30	348	359	0	63	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					531	534		10.1038/35107042	http://dx.doi.org/10.1038/35107042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734850				2022-12-01	WOS:000172405900043
J	Belden, WJ; Barlowe, C				Belden, WJ; Barlowe, C			Role of Erv29p in collecting soluble secretory proteins into ER-derived transport vesicles	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; COATED VESICLES; COPII; YEAST; ERGIC-53; PATHWAY; COMPLEX	Proteins are transported from the endoplasmic reticulum (ER) in vesicles formed by coat protein complex II (COPII). Soluble secretory proteins are thought to leave the ER in these vesicles by "bulk flow" or through recognition by hypothetical shuttling receptors. We found that Erv29p, a conserved transmembrane protein, was directly required for packaging glycosylated pro-alpha -factor (gp alphaf) into COPII vesicles in Saccharomyces cerevisiae. Further, an Erv29p-gp alphaf complex was isolated from ER-derived transport vesicles. In vivo, export of gpaf from the ER was saturable and depended on the expression level of Erv29p. These results indicate that membrane receptors can link soluble cargo proteins to the COPII coat.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA.							Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; BELDEN WJ, UNPUB; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; JULIUS D, 1984, CELL, V36, P309, DOI 10.1016/0092-8674(84)90224-1; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; PELHAM HRB, 1995, CURR OPIN CELL BIOL, V7, P530, DOI 10.1016/0955-0674(95)80010-7; REEVES JE, 1995, MOL MEMBR BIOL, V12, P201, DOI 10.3109/09687689509027508; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Warren G, 1999, CELL, V98, P125, DOI 10.1016/S0092-8674(00)81006-5	19	151	155	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1528	1531		10.1126/science.1065224	http://dx.doi.org/10.1126/science.1065224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711675				2022-12-01	WOS:000172240500049
J	Athan, ES; Williamson, J; Ciappa, A; Santana, V; Romas, SN; Lee, JH; Rondon, H; Lantigua, RA; Medrano, M; Torres, M; Arawaka, S; Rogaeva, E; Song, YQ; Sato, C; Kawarai, T; Fafel, KC; Boss, MA; Seltzer, WK; Stern, Y; St George-Hyslop, P; Tycko, B; Mayeux, R				Athan, ES; Williamson, J; Ciappa, A; Santana, V; Romas, SN; Lee, JH; Rondon, H; Lantigua, RA; Medrano, M; Torres, M; Arawaka, S; Rogaeva, E; Song, YQ; Sato, C; Kawarai, T; Fafel, KC; Boss, MA; Seltzer, WK; Stern, Y; St George-Hyslop, P; Tycko, B; Mayeux, R			A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARADIGM-BASED DIAGNOSIS; APOLIPOPROTEIN-E; HETEROGENEOUS POPULATION; MISSENSE MUTATIONS; LINKAGE ANALYSIS; GENE; DEMENTIA; PREVALENCE; RISKS	Context Genetic determinants of Alzheimer disease (AD) have not been comprehensively examined in Caribbean Hispanics, a population in the United States in whom the frequency of AD is higher compared with non-Hispanic whites. Objective: Ta identify variant alleles in genes related to familial early-onset AD among Caribbean Hispanics. Design and Setting Family-based case series conducted in 1998-2001 at an AD research center in New York, NY, and clinics in the Dominican Republic. Patients Among 206 Caribbean Hispanic families with 2 or more living members with AD who were identified, 19 (9.2%) had at least 1 individual with onset of AD before the age of 55 years. Main Outcome Measure The entire coding region of the presenilin 1 gene and exons 16 and 17 of the amyloid precursor protein gene were sequenced in probands from the 19 families and their living relatives. Results A G-to-C nucleotide change resulting in a glycine-alanine amino acid substitution at codon 206 (Gly206Ala) in exon 7 of presenilin 1 was observed in 23 individuals from 8 (42%) of the 19 families. A Caribbean Hispanic individual with the Gly206Ala mutation and early-onset familial disease was also found by sequencing the corresponding genes of 319 unrelated individuals in New York City. The Gly206Ala mutation was not found in public genetic databases but was reported in 5 individuals from 4 Hispanic: families, with AD referred for genetic testing. None of the members of these families were related to one another, yet all carriers of the Gly206Ala mutation tested shared a variant allele at 2 nearby microsatellite polymorphisms, indicating a common ancestor. No mutations were found in the amyloid precursor protein gene. Conclusions The Gly206Ala mutation was found in 8 of 19 unrelated Caribbean Hispanic families with early-onset familial AD. This genetic change may be a prevalent cause of early-onset familial AD in the Caribbean Hispanic population.	Columbia Univ Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Sch Publ Hlth, Div Epidemiol, New York, NY 10032 USA; Univ Tecnol Santiago, Santiago, Dominican Rep; Univ Toronto, Dept Med, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada; Athena Diagnost Inc, Worcester, MA USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Mayeux, R (corresponding author), Columbia Univ Coll Phys & Surg, Gertrude H Sergievsky Ctr, 630 W 168th St, New York, NY 10032 USA.		Kawarai, Toshitaka/C-2822-2013; medrano, martin/AAF-8221-2020; Song, You-Qiang/E-5207-2011; Song, You-qiang/C-4401-2009; Lee, Joseph H/D-2441-2012; Mayeux, Richard/E-9788-2013	Kawarai, Toshitaka/0000-0003-4547-8131; Lee, Joseph H/0000-0002-2000-4821; Mayeux, Richard/0000-0001-6519-9696; Stern, Yaakov/0000-0001-7542-3241; Arawaka, Shigeki/0000-0002-1505-3012; Song, You-Qiang/0000-0001-9407-2256	NATIONAL INSTITUTE ON AGING [P01AG007232, R01AG015473, R37AG015473, P50AG008702] Funding Source: NIH RePORTER; NIA NIH HHS [AG15473, AG08702, AG07232] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aldudo J, 1999, HUM MUTAT, V14, P433, DOI 10.1002/(SICI)1098-1004(199911)14:5<433::AID-HUMU10>3.0.CO;2-K; Aldudo J, 1998, NEUROSCI LETT, V240, P174, DOI 10.1016/S0304-3940(97)00950-6; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Crook R, 1997, ANN NEUROL, V42, P124, DOI 10.1002/ana.410420121; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; De Jonghe C, 1999, HUM MOL GENET, V8, P1529, DOI 10.1093/hmg/8.8.1529; Finckh U, 2000, AM J HUM GENET, V66, P110, DOI 10.1086/302702; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5; HIXSON JE, 1990, J LIPID RES, V31, P545; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; JACQUIER M, 2000, NEUROBIOL AGING, V21, pS176; Klein JP., 2003, SURVIVAL ANAL TECHNI, DOI 10.1007/b97377; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kwok JBJ, 1997, NEUROREPORT, V8, P1537, DOI 10.1097/00001756-199704140-00043; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lendon CL, 1997, HUM MUTAT, V10, P186; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moya Pons Frank, 1998, DOMINICAN REPUBLIC N; Perkins P, 1997, NEUROLOGY, V49, P44, DOI 10.1212/WNL.49.1.44; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; PITTMAN J, 1992, ARCH NEUROL-CHICAGO, V49, P461, DOI 10.1001/archneur.1992.00530290043010; Ramirez-Duenas MG, 1998, ANN GENET-PARIS, V41, P149; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva EA, 2001, NEUROLOGY, V57, P621, DOI 10.1212/WNL.57.4.621; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Stricks L, 1998, J INT NEUROPSYCH SOC, V4, P311, DOI 10.1017/S1355617798003117; Tanahashi H, 1996, NEUROSCI LETT, V218, P139, DOI 10.1016/S0304-3940(96)13138-4; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Tysoe C, 1998, AM J HUM GENET, V62, P70, DOI 10.1086/301672; Zhang LL, 1999, J BIOL CHEM, V274, P8966, DOI 10.1074/jbc.274.13.8966; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	45	71	73	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2257	2263		10.1001/jama.286.18.2257	http://dx.doi.org/10.1001/jama.286.18.2257			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710891	Bronze, Green Published			2022-12-01	WOS:000172129700020
J	Maric, M; Arunachalam, B; Phan, UT; Dong, C; Garrett, WS; Cannon, KS; Alfonso, C; Karlsson, L; Flavell, RA; Cresswell, P				Maric, M; Arunachalam, B; Phan, UT; Dong, C; Garrett, WS; Cannon, KS; Alfonso, C; Karlsson, L; Flavell, RA; Cresswell, P			Defective antigen processing in GILT-free mice	SCIENCE			English	Article							THIOL REDUCTASE GILT; T-CELL ACTIVATION; DISULFIDE BONDS; DENDRITIC CELLS; HEN LYSOZYME; LYSOSOMES; CONFORMATION; GENERATION; CYSTEINE; MHC	Processing of proteins for major histocompatibility complex (MHC) class II-restricted presentation to CD4-positive T lymphocytes occurs after they are internalized by antigen-presenting cells (APCs). Antigenic proteins frequently contain disulfide bonds, and their reduction in the endocytic pathway facilitates processing. In humans, a gamma interferon-inducible lysosomal thiol reductase (GILT) is constitutively present in late endocytic compartments of APCs. Here, we identified the mouse homolog of GILT and generated a GILT knockout mouse. GILT facilitated the processing and presentation to antigen-specific T cells of protein antigens containing disulfide bonds. The response to hen egg lysozyme, a model antigen with a compact Structure containing four disulfide bonds, was examined in detail.	Yale Univ, Howard Hughes Med Inst, Immunol Sect, New Haven, CT 06520 USA; RW Johnson Pharmaceut Res Inst, San Diego, CA 92121 USA	Howard Hughes Medical Institute; Yale University; Johnson & Johnson; Johnson & Johnson USA	Cresswell, P (corresponding author), Yale Univ, Howard Hughes Med Inst, Immunol Sect, New Haven, CT 06520 USA.		dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Arunachalam, Arun/0000-0001-6486-5722; Garrett, Wendy/0000-0002-5092-0150	NIAID NIH HHS [AI23081] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023081, R37AI023081] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON H, 1976, FEBS LETT, V10, P3147; ANDERSON WL, 1976, J BIOL CHEM, V251, P3147; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Castellino F, 1998, J IMMUNOL, V161, P4048; COLIGAN JE, 1992, CURRENT PROTOCOLS IM, V1; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JENSEN PE, 1991, J EXP MED, V174, P1121, DOI 10.1084/jem.174.5.1121; JENSEN PE, 1993, J IMMUNOL, V150, P3347; Kang HK, 2000, J IMMUNOL, V164, P1775, DOI 10.4049/jimmunol.164.4.1775; LEE CL, 1973, BIOCHEMISTRY-US, V12, P2690, DOI 10.1021/bi00738a022; LLOYD JB, 1986, BIOCHEM J, V237, P271, DOI 10.1042/bj2370271; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; SHASTRI N, 1984, J MOL CELL IMMUNOL, V1, P369; So T, 1997, J BIOL CHEM, V272, P32136, DOI 10.1074/jbc.272.51.32136; STREICHER HZ, 1984, P NATL ACAD SCI-BIOL, V81, P6831, DOI 10.1073/pnas.81.21.6831; Tachibana H, 2000, FEBS LETT, V480, P175, DOI 10.1016/S0014-5793(00)01904-9	20	212	216	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1361	1365		10.1126/science.1065500	http://dx.doi.org/10.1126/science.1065500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701933				2022-12-01	WOS:000172130200055
J	Petruk, S; Sedkov, Y; Smith, S; Tillib, S; Kraevski, V; Nakamura, T; Canaani, E; Croce, CM; Mazo, A				Petruk, S; Sedkov, Y; Smith, S; Tillib, S; Kraevski, V; Nakamura, T; Canaani, E; Croce, CM; Mazo, A			Trithorax and dCBP acting in a complex to maintain expression of a homeotic gene	SCIENCE			English	Article							HISTONE ACETYLTRANSFERASES; GROUP PROTEINS; DROSOPHILA; CBP; ACETYLATION; POLYCOMB; INTERACT; DOMAIN; REGION; ASH1	Trithorax (Trx) is a member of the trithorax group (trxG) of epigenetic regulators, which is required to maintain active states of Hox gene expression during development. We have purified from Drosophila embryos a trithorax acetylation complex (TAC1) that contains Trx, dCBP, and Sbf1. Like CBP, TAC1 acetylates core histories in nucleosomes, suggesting that this activity may be important for epigenetic maintenance of gene activity. dCBP and Sbf1 associate with specific sites on salivary gland polytene chromosomes, colocalizing with many Trx binding sites. One of these is the site of the Hox gene Ultrabithorax (Ubx). Mutations in either trx or the gene encoding dCBP reduce expression of the endogenous Ubx gene as well as of transgenes driven by the bxd regulatory region of Ubx. Thus Trx, dCBP, and Sbf1 are closely linked, physically and functionally, in the maintenance of Hox gene expression.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Jefferson University; Weizmann Institute of Science	Mazo, A (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.		Tillib, Sergei/AAT-2293-2020; Young, Richard A/F-6495-2012; Tillib, Sergei/I-4115-2013	Tillib, Sergei/0000-0002-7172-8731; Young, Richard A/0000-0001-8855-8647; Tillib, Sergei/0000-0002-7172-8731	NCI NIH HHS [5PO1 CA50507] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA050507] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bantignies F, 2000, MOL CELL BIOL, V20, P9317, DOI 10.1128/MCB.20.24.9317-9330.2000; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Florence B, 1998, GENETICS, V150, P1497; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; KRAJEWSKI WA, 1993, J BIOMOL STRUCT DYN, V10, P1001, DOI 10.1080/07391102.1993.10508692; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Rozovskaia T, 1999, MOL CELL BIOL, V19, P6441; SEDKOV Y, 1994, DEVELOPMENT, V120, P1907; Tie F, 2001, DEVELOPMENT, V128, P275; Tillib S, 1999, MOL CELL BIOL, V19, P5189; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785	19	163	165	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1331	1334		10.1126/science.1065683	http://dx.doi.org/10.1126/science.1065683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701926				2022-12-01	WOS:000172130200046
J	Hypponen, E; Leon, DA; Kenward, MG; Lithell, H				Hypponen, E; Leon, DA; Kenward, MG; Lithell, H			Prenatal growth and risk of occlusive and haemorrhagic stroke in Swedish men and women born 1915-29: historical cohort study	BRITISH MEDICAL JOURNAL			English	Article							SYSTOLIC BLOOD-PRESSURE		Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ Uppsala, Dept Publ Hlth & Caring Sci, SE-75125 Uppsala, Sweden	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Uppsala University	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.		Leon, David A/G-2195-2010; Hypponen, Elina/B-2596-2014	Leon, David A/0000-0001-9747-1762; Hypponen, Elina/0000-0003-3670-9399				Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Leon DA, 2000, AM J EPIDEMIOL, V152, P597, DOI 10.1093/aje/152.7.597; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; *NAT BOARD HLTH WE, HOSP DISCH REG	5	46	46	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1033	1034		10.1136/bmj.323.7320.1033	http://dx.doi.org/10.1136/bmj.323.7320.1033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691760	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000172055900016
J	Scholes, RJ; Noble, IR				Scholes, RJ; Noble, IR			Climate change - Storing carbon on land	SCIENCE			English	Editorial Material									CSIR, Div Water Environm & Forest Technol, ZA-0001 Pretoria, South Africa; Cooperat Res Ctr Greenhouse Accounting, Canberra, ACT, Australia	Council for Scientific & Industrial Research (CSIR) - South Africa	Scholes, RJ (corresponding author), CSIR, Div Water Environm & Forest Technol, Box 395, ZA-0001 Pretoria, South Africa.	bscholes@csir.co.za; ian.noble@greenhouse.crc.org.au		Scholes, Robert/0000-0001-5537-6935				Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Orr JC, 2001, GLOBAL BIOGEOCHEM CY, V15, P43, DOI 10.1029/2000GB001273; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; PRENTICE IC, 2001, IPCC 3 ASS REP, V1, P183; SCHIMEL DS, IN PRESS NATURE; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; WATSON RT, 2000, IPCC SPECIAL REPORT, P12	9	76	97	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1012	1013		10.1126/science.1065307	http://dx.doi.org/10.1126/science.1065307			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691975				2022-12-01	WOS:000172013800031
J	Billuart, P; Winter, CG; Maresh, A; Zhao, XS; Luo, LQ				Billuart, P; Winter, CG; Maresh, A; Zhao, XS; Luo, LQ			Regulating axon branch stability: The role of p190 RhoGAP in repressing a retraction signaling pathway	CELL			English	Article							LONG-TERM POTENTIATION; NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; LINKED MENTAL-RETARDATION; C-SRC; ACTIN CYTOSKELETON; NEUROBLAST PROLIFERATION; NEURONAL MORPHOGENESIS; MUSHROOM BODIES; CELL-ADHESION	Mechanisms that regulate axon branch stability are largely unknown. Genome-wide analyses of Rho GTPase activating protein (RhoGAP) function in Drosophila using RNA interference identified p190 RhoGAP as essential for axon stability in mushroom body neurons, the olfactory learning and memory center. p190 inactivation leads to axon branch retraction, a phenotype mimicked by activation of GTPase RhoA and its effector kinase Drok and modulated by the level and phosphorylation of myosin regulatory light chain. Thus, there exists a retraction pathway from RhoA to myosin in maturing neurons, which is normally repressed by p190. Local regulation of p190 could control the structural plasticity of neurons. Indeed, genetic evidence supports negative regulation of p190 by integrin and Src, both implicated in neural plasticity.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu	Zhao, Xuesong/B-2762-2012; Billuart, Pierre/K-3832-2017	Zhao, Xuesong/0000-0003-3007-7124; Billuart, Pierre/0000-0003-1913-1687; Luo, Liqun/0000-0001-5467-9264	NINDS NIH HHS [R01-NS 36632] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGNEL M, 1992, MOL CELL BIOL, V12, P5111, DOI 10.1128/MCB.12.11.5111; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bernstein M, 1999, CURR OPIN NEUROBIOL, V9, P364, DOI 10.1016/S0959-4388(99)80053-1; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bonini NM, 1997, DEVELOPMENT, V124, P4819; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; BUNCH TA, 1992, GENETICS, V132, P519; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Dodson GS, 1998, DEVELOPMENT, V125, P2883; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haskell MD, 2001, J CELL SCI, V114, P1699; Heisenberg M, 1998, LEARN MEMORY, V5, P1; HU HL, 2001, IN PRESS NEURON; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Ito K, 1997, DEVELOPMENT, V124, P761; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Roof RW, 2000, FEBS LETT, V472, P117, DOI 10.1016/S0014-5793(00)01439-3; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sagnier T, 2000, MECH DEVELOP, V94, P267, DOI 10.1016/S0925-4773(00)00291-4; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sharma SV, 1998, ONCOGENE, V17, P271, DOI 10.1038/sj.onc.1201921; Sotillos S, 2000, DEVELOPMENT, V127, P5427; Staubli U, 1998, J NEUROSCI, V18, P3460; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WILDER EL, 1995, DEVELOPMENT, V121, P477; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wong WT, 2000, J NEUROSCI, V20, P5024	73	171	174	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					195	207		10.1016/S0092-8674(01)00522-0	http://dx.doi.org/10.1016/S0092-8674(01)00522-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672527	Bronze			2022-12-01	WOS:000171694800009
J	Schaefer, M; Petronczki, M; Dorner, D; Forte, M; Knoblich, JA				Schaefer, M; Petronczki, M; Dorner, D; Forte, M; Knoblich, JA			Heterotrimeric G proteins direct two modes of asymmetric cell division in the Drosophila nervous system	CELL			English	Article							NEURAL PRECURSOR GENE; ELEGANS EMBRYOS; SUBUNIT GENE; LOCALIZATION; PROSPERO; MELANOGASTER; NEUROBLASTS; BAZOOKA; ORIENTATION; SEGREGATION	In Drosophila, distinct mechanisms orient asymmetric cell division along the apical-basal axis in neuroblasts and along the anterior-posterior axis in sensory organ precursor (SOP) cells. Here, we show that heterotrimeric G proteins are essential for asymmetric cell division in both cell types. The G protein subunit G alphai localizes apically in neuroblasts and anteriorly in SOP cells before and during mitosis. Interfering with G protein function by G alphai overexpression or depletion of heterotrimeric G protein complexes causes defects in spindle orientation and asymmetric localization of determinants. G alphai is colocalized and associated with Pins, a protein that induces the release of the beta gamma subunit and might act as a receptor-independent G protein activator. Thus, asymmetric activation of heterotrimeric G proteins by a receptor-independent mechanism may orient asymmetric cell divisions in different cell types.	Res Inst Mol Pathol, IMP, A-1030 Vienna, Austria; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97212 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Oregon Health & Science University	Knoblich, JA (corresponding author), Res Inst Mol Pathol, IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	knoblich@nt.imp.univie.ac.at	Matthias, Schaefer Ronald/E-9157-2015; Knoblich, Juergen A/C-2974-2015	Matthias, Schaefer Ronald/0000-0003-1952-8115; Knoblich, Juergen A/0000-0002-6751-3404; Petronczki, Mark/0000-0003-0139-5692				BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; CHOU TB, 1992, GENETICS, V131, P643; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Jones KH, 1996, GENETICS, V142, P205; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Newsome TP, 2000, DEVELOPMENT, V127, P851; Offermanns S, 2001, ONCOGENE, V20, P1635, DOI 10.1038/sj.onc.1204189; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; PROVOST NM, 1988, J BIOL CHEM, V263, P12070; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; SCHUPBACH T, 1989, GENETICS, V121, P101; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; THAMBI NC, 1989, J BIOL CHEM, V264, P18552; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; YARFITZ S, 1988, P NATL ACAD SCI USA, V85, P7134, DOI 10.1073/pnas.85.19.7134; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	48	258	264	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2001	107	2					183	194		10.1016/S0092-8674(01)00521-9	http://dx.doi.org/10.1016/S0092-8674(01)00521-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672526	Bronze			2022-12-01	WOS:000171694800008
J	Vaziri, H; Dessain, SK; Eagon, EN; Imai, SI; Frye, RA; Pandita, TK; Guarente, L; Weinberg, RA				Vaziri, H; Dessain, SK; Eagon, EN; Imai, SI; Frye, RA; Pandita, TK; Guarente, L; Weinberg, RA			hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase	CELL			English	Article							HUMAN-DIPLOID FIBROBLASTS; DNA-DAMAGE; IONIZING-RADIATION; SILENCING PROTEIN; STRAND BREAKS; SIR2 PROTEIN; CELL-LINES; PHOSPHORYLATION; ACTIVATION; ACETYLATION	DNA damage-induced acetylation of p53 protein leads to its activation and either growth arrest or apoptosis. We show here that the protein product of the gene hSIR2(SIRT1), the human homolog of the S. cerevisiae Sir2 protein known to be involved in cell aging and in the response to DNA damage, binds and deacetylates the p53 protein with a specificity for its C-terminal Lys382 residue, modification of which has been implicated in the activation of p53 as a transcription factor. Expression of wild-type hSir2 in human cells reduces the transcriptional activity of p53. In contrast, expression of a catalytically inactive hSir2 protein potentiates p53-dependent apoptosis and radiosensitivity. We propose that hSir2 is involved in the regulation of p53 function via deacetylation.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; Vet Adm Med Ctr, Pittsburgh, PA 15240 USA; Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Massachusetts General Hospital	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Pandita, Tej K/AAM-9188-2020		NATIONAL CANCER INSTITUTE [R01CA078461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034746] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA78461] Funding Source: Medline; NHLBI NIH HHS [K08HL04463] Funding Source: Medline; NINDS NIH HHS [NS34746] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham J, 2000, J MOL BIOL, V295, P853, DOI 10.1006/jmbi.1999.3415; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Dhar S, 2000, MOL CELL BIOL, V20, P7764, DOI 10.1128/MCB.20.20.7764-7772.2000; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shieh SY, 2000, GENE DEV, V14, P289; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; TSANG NM, 1995, ONCOGENE, V10, P2403; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Vaziri H, 1999, MOL CELL BIOL, V19, P2373; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	34	2135	2262	4	155	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					149	159		10.1016/S0092-8674(01)00527-X	http://dx.doi.org/10.1016/S0092-8674(01)00527-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672523	Bronze			2022-12-01	WOS:000171694800005
J	Stead, ML; Fallowfield, L; Brown, JM; Selby, P				Stead, ML; Fallowfield, L; Brown, JM; Selby, P			Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							OUTCOMES; WOMEN		No & Yorkshire Clin Trials & Res Unit, Leeds LS2 9NG, W Yorkshire, England; Univ Sussex, Canc Res Campaign, Psychosocial Oncol Grp, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; St James Univ Hosp, Imperial Canc Res Fund, Canc Med Res Unit, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; University of Sussex; Saint James's University Hospital	Stead, ML (corresponding author), No & Yorkshire Clin Trials & Res Unit, Leeds LS2 9NG, W Yorkshire, England.			brown, julia/0000-0002-2719-7064; Fallowfield, Lesley/0000-0003-0577-4518				ANDERSEN BL, 1989, J CONSULT CLIN PSYCH, V57, P683, DOI 10.1037/0022-006X.57.6.683; CORNEY RH, 1993, BRIT J OBSTET GYNAEC, V100, P73, DOI 10.1111/j.1471-0528.1993.tb12955.x; CULL A, 1993, BRIT J CANCER, V68, P1216, DOI 10.1038/bjc.1993.507; Lamb M A, 1994, Cancer Pract, V2, P103; Strauss A., 1998, BASICS QUALITATIVE R	5	82	84	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2001	323	7317					836	837		10.1136/bmj.323.7317.836	http://dx.doi.org/10.1136/bmj.323.7317.836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11597967	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000171650500025
J	Anand, SS; Yusuf, S; Jacobs, R; Davis, AD; Yi, QL; Gerstein, H; Montague, PA; Lonn, E				Anand, SS; Yusuf, S; Jacobs, R; Davis, AD; Yi, QL; Gerstein, H; Montague, PA; Lonn, E		SHARE-AP Investigators	Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP)	LANCET			English	Article							DENSITY LIPOPROTEIN CHOLESTEROL; ISCHEMIC-HEART-DISEASE; ETHNIC-GROUPS SHARE; MYOCARDIAL-INFARCTION; THICKNESS; MORTALITY; DESIGN; PLASMA	Background Little is known about the rates of cardiovascular disease (CVD), atherosclerosis, and their risk factors among Canada's Aboriginal people. To establish the relative prevalence of risk factors, atherosclerosis, and CVD, we undertook a population-based study among people of Aboriginal and European ancestry in Canada. Methods We randomly recruited 301 Aboriginal people from the Six Nations Reservation, and 326 people of European origin from Hamilton, Toronto, and Edmonton, Canada. Clinical CVD was defined by history or electrocardiographic findings, atherosclerosis was measured by B-mode carotid ultrasonography, and conventional and new CVD risk factors were measured using standardised methods. Findings Aboriginal people had significantly more carotid atherosclerosis (mean of the maximum intimal-medial thickness 0.82 (SD 0.20) mm vs 0.78 (0.20) mm, p = 0.027), and had a higher frequency of CVD (18.5% vs 7.6%, p = 0.00002) compared with Europeans. Aboriginal people had significantly higher rates of smoking, glucose intolerance, obesity, abdominal obesity, and substantially higher concentrations of fibrinogen, and plasminogen activator inhibitor-1. Aboriginal people had significantly higher rates of unemployment and a lower annual household income. For any given income level, Aboriginal people had higher rates of risk factors and CVD compared with the Europeans. Interpretation A significant proportion of Aboriginal people live in poverty which is associated with high rates of CVD and CVD risk factors. Improvement of the socioeconomic status of Aboriginal people might be a key to reduce CVD in this group.	McMaster Univ, Dept Med, Prevent Cardiol & Therapeut Res Program, Hamilton, ON L8L 2X2, Canada; Six Nations Hlth Serv, Ohsweken, ON, Canada	McMaster University	Anand, SS (corresponding author), McMaster Univ, Dept Med, Prevent Cardiol & Therapeut Res Program, Hamilton, ON L8L 2X2, Canada.		Gerstein, Hertzel C/B-1235-2013; Gerstein, Hertzel/ABB-8781-2020	Gerstein, Hertzel C/0000-0001-8072-2836; Gerstein, Hertzel/0000-0001-8072-2836; Yusuf, Salim/0000-0003-4776-5601				ALLAIN CC, 1974, CLIN CHEM, V20, P470; Anand S, 1999, Can J Cardiol, V15 Suppl G, p44G; Anand SS, 1998, CAN J CARDIOL, V14, P1349; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Armitage P, 1994, STAT METHODS MED RES; BLACKBURN H, 1982, MINNESOTA CODE MANUA; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; CHOCKALINGHAM A, 2000, LANCET, V356, P347; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; ERIKSSON E, 1988, THROMB RES, V50, P91, DOI 10.1016/0049-3848(88)90177-6; FORTIN LJ, 1995, CLIN BIOCHEM, V28, P155, DOI 10.1016/0009-9120(94)00073-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Harris SB, 1997, DIABETES CARE, V20, P185, DOI 10.2337/diacare.20.2.185; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Lonn EM, 1996, AM J CARDIOL, V78, P914, DOI 10.1016/S0002-9149(96)00467-5; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; MCGOWAN MW, 1983, CLIN CHEM, V29, P538; Meigs JB, 2000, JAMA-J AM MED ASSOC, V283, P221, DOI 10.1001/jama.283.2.221; NEELEY WE, 1972, CLIN CHEM, V18, P509; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; *ROYAL COMM AB PEO, 1996, REP ROYAL COMM AB PE, V3; Scarabin PY, 1998, THROMB HAEMOSTASIS, V80, P749; Shah BR, 2000, ARCH INTERN MED, V160, P1862, DOI 10.1001/archinte.160.12.1862; Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547; *STAT CAN, 1996, 1996 CENS DIR; SYME SL, 1976, AM J EPIDEMIOL, V104, P1; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; WARNICK GR, 1985, CLIN CHEM, V31, P217; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	29	225	234	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1147	1153		10.1016/S0140-6736(01)06255-9	http://dx.doi.org/10.1016/S0140-6736(01)06255-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597669				2022-12-01	WOS:000171399000012
J	Goodman, WG				Goodman, WG			Vascular calcification in chronic renal failure	LANCET			English	Editorial Material							MINERALIZATION-REGULATING PROTEINS; CALCIPHYLAXIS; ASSOCIATION; DISEASE; OSTEODYSTROPHY; DIALYSIS		Univ Calif Los Angeles, Sch Med, Dept Med, Div Nephrol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goodman, WG (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Nephrol, Los Angeles, CA 90024 USA.							Ahmed S, 2001, AM J KIDNEY DIS, V37, P1267, DOI 10.1053/ajkd.2001.24533; ANDROGUE H, 1983, J UROLOGY, V129, P362; CONN J, 1973, ANN SURG, V177, P206, DOI 10.1097/00000658-197302000-00015; FOX R, 1983, J UROLOGY, V129, P362, DOI 10.1016/S0022-5347(17)52098-4; GIPSTEIN RM, 1976, ARCH INTERN MED, V136, P1273, DOI 10.1001/archinte.136.11.1273; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; HUTCHISON AJ, 1994, AM J NEPHROL, V14, P19, DOI 10.1159/000168681; Llach F, 2001, NEPHROL DIAL TRANSPL, V16, P448, DOI 10.1093/ndt/16.3.448; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Marchais SJ, 1999, NEPHROL DIAL TRANSPL, V14, P2178, DOI 10.1093/ndt/14.9.2178; Mawad HW, 1999, CLIN NEPHROL, V52, P160; Mazhar AR, 2001, KIDNEY INT, V60, P324, DOI 10.1046/j.1523-1755.2001.00803.x; Ruggian JC, 1996, AM J KIDNEY DIS, V28, P409, DOI 10.1016/S0272-6386(96)90499-0; SALUSKY IB, 1994, KIDNEY INT, V45, P253, DOI 10.1038/ki.1994.31; SELYE H, 1962, ENDOCRINOLOGY, V71, P554, DOI 10.1210/endo-71-4-554; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shanahan CM, 1998, CRIT REV EUKAR GENE, V8, P357, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.60; Shanahan CM, 2000, Z KARDIOL, V89, P63; Sherrard DJ, 1996, NEPHROL DIAL TRANSPL, V11, P29; Zacharias JM, 1999, PERITON DIALYSIS INT, V19, P248	21	56	57	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1115	1116		10.1016/S0140-6736(01)06299-7	http://dx.doi.org/10.1016/S0140-6736(01)06299-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597661				2022-12-01	WOS:000171399000004
J	Ruegsegger, U; Leber, JH; Walter, P				Ruegsegger, U; Leber, JH; Walter, P			Block of HAC1 mRNA translation by long-range base pairing is released by cytoplasmic splicing upon induction of the unfolded protein response	CELL			English	Article							TRANSFER-RNA LIGASE; MESSENGER-RNA; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; C-ELEGANS; KINASE; YEAST; ER; INITIATION	Expression of the yeast transcription factor Hac1p, which controls the unfolded protein response, is regulated posttranscriptionally. Hac1p is only produced when an intron at the 3' end of its mRNA is removed by a nonconventional, regulated splicing reaction. We show that a previously unrecognized base-pairing interaction between the intron and the 5' untranslated region is required and sufficient to block mRNA translation. Unspliced HAC1 mRNA is stable, located in the cytosol, and is associated with polyribosomes, yet does not produce protein, indicating that the ribosomes engaged on the rnRNA are stalled. We show that the polysomal, cytoplasmic pool of HAC1 mRNA is a substrate for splicing, suggesting that the stalled ribosomes may resume translation after the intron is removed.	Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Walter, P (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	walter@cgl.ucsf.edu						Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Clark IE, 2000, CURR BIOL, V10, P1311, DOI 10.1016/S0960-9822(00)00754-5; CLARK MW, 1987, J CELL BIOL, V105, P1515, DOI 10.1083/jcb.105.4.1515; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; JOHANSSON HE, 1994, NUCLEIC ACIDS RES, V22, P4591, DOI 10.1093/nar/22.22.4591; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; MORI K, 1993, CELL, V74, P743; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SPENA A, 1985, EMBO J, V4, P2153, DOI 10.1002/j.1460-2075.1985.tb03909.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, J CELL SCI, V113, P3697; VANDENHEUVEL JJ, 1990, YEAST, V6, P473, DOI 10.1002/yea.320060604; Vega Laso Maria R., 1993, Journal of Biological Chemistry, V268, P6453; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	33	225	234	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2001	107	1					103	114		10.1016/S0092-8674(01)00505-0	http://dx.doi.org/10.1016/S0092-8674(01)00505-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595189	Bronze			2022-12-01	WOS:000171453100013
J	Heun, P; Laroche, T; Shimada, K; Furrer, P; Gasser, SM				Heun, P; Laroche, T; Shimada, K; Furrer, P; Gasser, SM			Chromosome dynamics in the yeast interphase nucleus	SCIENCE			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; LIVING CELLS; IN-VIVO; SCALE; ORC; VISUALIZATION; TERRITORIES; DROSOPHILA	Little is known about the dynamics of chromosomes in interphase nuclei. By tagging four chromosomal regions with a green fluorescent protein fusion to lac repressor, we monitored the movement and subnuclear position of specific sites in the yeast genome, sampling at short time intervals. We found that early and late origins of replication are highly mobile in G(1) phase, frequently moving at or faster than 0.5 micrometers/10 seconds, in an energy-dependent fashion. The rapid diffusive movement of chromatin detected in G(1) becomes constrained in S phase through a mechanism dependent on active DNA replication. In contrast, telomeres and centromeres provide replication-independent constraint on chromatin movement in both G(1) and S phases.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland	University of Geneva	Gasser, SM (corresponding author), Univ Geneva, Dept Mol Biol, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.		Heun, Patrick/F-3883-2011; Heun, Patrick/AAH-7390-2020	Heun, Patrick/0000-0001-8400-1892; Gasser, Susan/0000-0003-3610-9123				Belgareh N, 1997, J CELL BIOL, V136, P747, DOI 10.1083/jcb.136.4.747; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; Blaszczyk M., UNPUB; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Buchenau P, 1997, J CELL BIOL, V137, P291, DOI 10.1083/jcb.137.2.291; COVERLEY D, 1994, ANNU REV BIOCHEM, V63, P745, DOI 10.1146/annurev.bi.63.070194.003525; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085; Csink AK, 1998, J CELL BIOL, V143, P13, DOI 10.1083/jcb.143.1.13; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Hanson PK, 2001, J BIOL CHEM, V276, P9861, DOI 10.1074/jbc.M009065200; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; JAZWINSKI SM, 1984, J BIOL CHEM, V259, P6852; Kim S, 1997, YEAST, V13, P735, DOI 10.1002/(SICI)1097-0061(19970630)13:8<735::AID-YEA136>3.3.CO;2-M; LAROCHE T, UNPUB; LEVENSON V, 1993, NUCLEIC ACIDS RES, V21, P3997, DOI 10.1093/nar/21.17.3997; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; MAHY NL, 2000, CHROMATIN STRUCTURE; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Pasero P, 1997, GENE DEV, V11, P1504, DOI 10.1101/gad.11.12.1504; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Rubbi L, 1997, BIOCHEM J, V328, P401, DOI 10.1042/bj3280401; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Tham WH, 2001, MOL CELL, V8, P189, DOI 10.1016/S1097-2765(01)00287-8; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Tumbar T, 2001, NAT CELL BIOL, V3, P134, DOI 10.1038/35055033; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	34	347	349	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2181	2186		10.1126/science.1065366	http://dx.doi.org/10.1126/science.1065366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739961				2022-12-01	WOS:000172647700056
J	Masuzaki, H; Paterson, J; Shinyama, H; Morton, NM; Mullins, JJ; Seckl, JR; Flier, JS				Masuzaki, H; Paterson, J; Shinyama, H; Morton, NM; Mullins, JJ; Seckl, JR; Flier, JS			A transgenic model of visceral obesity and the metabolic syndrome	SCIENCE			English	Article							ADIPOSE-TISSUE; FAT DISTRIBUTION; MICE; EXPRESSION; LEPTIN; BODY; GLUCOCORTICOIDS; TROGLITAZONE; ADIPOCYTES; SYSTEM	The adverse metabolic consequences of obesity are best predicted by the quantity of visceral fat. Excess glucocorticoids produce visceral, obesity and diabetes, but circulating glucocorticoid levels are normal in typical obesity. Glucocorticoids can be produced locally from inactive 11-keto forms through the enzyme 11 beta hydroxysteroid dehydrogenase type 1 (11 beta HSD-1). We created transgenic mice overexpressing 11 beta HSD-1 selectively in adipose tissue to an extent similar to that found in adipose tissue from obese humans. These mice had increased adipose levels of corticosterone and developed visceral obesity that was exaggerated by a high-fat diet. The mice also exhibited pronounced insulin-resistant diabetes, hyperlipidemia, and, surprisingly, hyperphagia despite hyperleptinemia. Increased adipocyte 11 beta HSD-1 activity may be a common molecular etiology for visceral obesity and the metabolic syndrome.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Edinburgh, Mol Med Ctr, Endocrinol Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Mol Physiol Lab, Edinburgh EH8 9AG, Midlothian, Scotland	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Edinburgh; University of Edinburgh	Flier, JS (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, 330 Brookline Ave, Boston, MA 02215 USA.		Seckl, Jonathan R/C-3555-2013; Morton, NICHOLAS/ABF-3774-2020; Flier, jeffrey/AAG-6223-2019					Abbott BD, 1999, TOXICOL SCI, V47, P76, DOI 10.1093/toxsci/47.1.76; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; AGARWAL AK, 1989, J BIOL CHEM, V264, P18939; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Aubert J, 1997, BIOCHEM J, V328, P701, DOI 10.1042/bj3280701; Berger J, 2001, J BIOL CHEM, V276, P12629, DOI 10.1074/jbc.M003592200; Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Kawai T, 1999, METABOLISM, V48, P1102, DOI 10.1016/S0026-0495(99)90122-1; KISSEBAH AH, 1989, DIABETES METAB REV, V5, P83, DOI 10.1002/dmr.5610050202; Kobayashi J, 1999, BRIT J CLIN PHARMACO, V47, P433, DOI 10.1046/j.1365-2125.1999.00920.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8; RAHIMY MH, 1989, J STEROID BIOCHEM, V33, P179, DOI 10.1016/0022-4731(89)90292-6; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rooman R, 1999, J ENDOCRINOL, V163, P543, DOI 10.1677/joe.0.1630543; ROSMOND R, 1998, J CLIN ENDOCR METAB, V83, P1806; ROSS SR, 1993, GENE DEV, V7, P1318, DOI 10.1101/gad.7.7b.1318; Satoh N, 1998, NEUROSCI LETT, V249, P107, DOI 10.1016/S0304-3940(98)00401-7; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; STRACK AM, 1995, AM J PHYSIOL-REG I, V268, pR183, DOI 10.1152/ajpregu.1995.268.1.R183; Szymczak J, 1998, STEROIDS, V63, P319, DOI 10.1016/S0039-128X(98)00019-1; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	34	1420	1550	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2166	2170		10.1126/science.1066285	http://dx.doi.org/10.1126/science.1066285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739957				2022-12-01	WOS:000172647700051
J	Kamal, A; Almenar-Queralt, A; LeBlanc, JF; Roberts, EA; Goldstein, LSB				Kamal, A; Almenar-Queralt, A; LeBlanc, JF; Roberts, EA; Goldstein, LSB			Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; SUBCELLULAR-LOCALIZATION; MICE LACKING; CLEAVAGE; DEFICITS; RELEASE; POOL	Proteolytic processing of amyloid precursor protein (APP) generates amyloid-beta peptide and has been implicated in the pathogenesis of Alzheimer's disease(1). However, the normal function of APP, whether this function is related to the proteolytic processing of APP, and where this processing takes place in neurons in vivo remain unknown. We have previously shown that the axonal transport of APP in neurons is mediated by the direct binding of APP to the kinesin light chain subunit of kinesin-I, a microtubule motor protein(2). Here we identify an axonal membrane compartment that contains APP, beta -secretase and presenilin-1. The fast anterograde axonal transport of this compartment is mediated by APP and kinesin-I. Proteolytic processing of APP can occur in the compartment in vitro and in vivo in axons. This proteolysis generates amyloid-beta and a carboxy-terminal fragment of APP, and liberates kinesin-I from the membrane. These results suggest that APP functions as a kinesin-I membrane receptor, mediating the axonal transport of beta -secretase and presenilin-1, and that processing of APP to amyloid-beta by secretases can occur in an axonal membrane compartment transported by kinesin-I.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Ciphergen Biosyst Inc, Fremont, CA 94555 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu						Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; KOO EH, 1994, J BIOL CHEM, V269, P17386; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Maltese WA, 2001, J BIOL CHEM, V276, P20267, DOI 10.1074/jbc.M007238200; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; POTEMPSKA A, 1991, J BIOL CHEM, V266, P8464; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2000, P NATL ACAD SCI USA, V97, P5690, DOI 10.1073/pnas.97.11.5690; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Walter J, 1996, MOL MED, V2, P673, DOI 10.1007/BF03401652; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	30	472	498	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					643	648		10.1038/414643a	http://dx.doi.org/10.1038/414643a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740561				2022-12-01	WOS:000172535600049
J	Assefa, F; Jabarkhil, MZ; Salama, P; Spiegel, P				Assefa, F; Jabarkhil, MZ; Salama, P; Spiegel, P			Malnutrition and mortality in Kohistan dstrict, Afghanistan, April 2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context The humanitarian situation in Afghanistan has been deteriorating for more than 3 years because of civil war and severe drought. Because of recent events, the international community is predicting a severe worsening of the country's current situation. Objective To assess the magnitude and causes of mortality and prevalence of malnutrition in Kohistan district, Faryab province, Afghanistan. Design Two-stage, 30-cluster household survey conducted April 4 through 10, 2001, which included anthropometric measurements, assessment of food coping mechanisms, and retrospective mortality data collection for November 26, 2000, through April 4, 2001. Setting and Participants A total of 378 households comprising 3165 people living in Kohistan district, Faryab province, Afghanistan. Main Outcome Measures Crude mortality rate, mortality rate among children younger than 5 years, causes of death, prevalence of wasting and stunting among children aged 6 to 59 months (weight-for-height and height-for-age z scores <-2, respectively), and food coping mechanisms. Results The crude mortality rate among the 3165 persons surveyed during the period of interest was 2.6 (95% confidence interval [CI], 1.7-3.5) per 10000 per day and the mortality rate among 763 children younger than 5 years was 5.9 (95% CI, 2.0-8.8) per 10000 per day, Diarrhea (25.0%), respiratory tract infections (19.4%), measles (15.7%), and scurvy (6.5%) caused most of the 108 deaths. The prevalences of wasting and stunting among 708 children aged 6 to 59 months were 7.0% (95% CI, 5.9%-9.0%) and 63.7% (95% CI, 58.6%-68.8%), respectively. Evidence of late-stage food coping mechanisms and prefamine indicators existed among the population. Conclusions These data indicate that, by April 2001, a humanitarian crisis already existed in Kohistan. Essential humanitarian services, including food aid and public health programs, are urgently required in such regions of Afghanistan and will be crucial if a worsening humanitarian crisis is to be avoided. For these services and programs to be implemented, the international community needs to create adequate humanitarian space (ie, a secure and accessible location where humanitarian organizations can provide services to emergency-affected populations) to ensure that humanitarian organizations have access to populations within Afghanistan as well as to refugees who flee to surrounding countries.	Save Children USA, Washington, DC 20036 USA; Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA USA	Save the Children; Centers for Disease Control & Prevention - USA	Assefa, F (corresponding author), Save Children USA, 2000 M St NW,Suite 500, Washington, DC 20036 USA.	fassefa1@dc.savechildren.org						*ACT CONTR FAIM, 2000, NUTR SURV MAZ SHER A; *AFGH SAV CHILDR U, 2001, RAP ASS IMP DROUGHT; Ahmed K, 2001, LANCET, V358, P815, DOI 10.1016/S0140-6736(01)06011-1; ASSEFA F, 2001, NUTR SURVEY REPORT K; *CDCP, 1992, MMWR-MORBID MORTAL W, V41; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; LITTLE RL, 2001, LANCET, V357, P1421; Mason JB, 1984, NUTR SURVEILLANCE; *MED SANS FRONT, 2000, NUTR SURV FAR PROV A; Ronald C, 1999, BMJ, V318; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; *STEER COMM HUM RE, 1998, SPHER PROJ HUM CHART; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1988, B WORLD HEALTH ORGAN, V66, P237; *UN SUBC NUTR, 2001, REP NUTR SIT REF DIS; United Nations Children's Fund, 2001, STAT WORLDS CHILDR; United Nations High Commissioner for Refugees, 2000, STAT WORLDS REF 2000; World Health Organization, 1999, WHO REC SURV STAND, V2nd	19	50	50	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2723	2728		10.1001/jama.286.21.2723	http://dx.doi.org/10.1001/jama.286.21.2723			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730450				2022-12-01	WOS:000172488300034
J	Blackshaw, S; Fraioli, RE; Furukawa, T; Cepko, CL				Blackshaw, S; Fraioli, RE; Furukawa, T; Cepko, CL			Comprehensive analysis of photoreceptor gene expression and the identification of candidate retinal disease genes	CELL			English	Article							RETINITIS-PIGMENTOSA; NONSENSE MUTATION; DROSOPHILA EYE; HOMEOBOX GENE; CRX; DEGENERATION; PHOSPHODIESTERASE; DIFFERENTIATION; PATTERN; PROTEIN	To identify the full set of genes expressed by mammalian rods, we conducted serial analysis of gene expression (SAGE) by using libraries generated from mature and developing mouse retina. We identified 264 uncharacterized genes that were specific to or highly enriched in rods. Nearly half of all cloned human retinal disease genes are selectively expressed in rod photoreceptors. In silico mapping of the human orthologs of genes identified in our screen revealed that 86 map within intervals containing uncloned retinal disease genes, representing 37 different loci. We expect these data will allow identification of many disease genes, and that this approach may be useful for cloning genes involved in classes of disease where cell type-specific expression of disease genes is observed.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75235 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.	cepko@rascal.med.harvard.edu			NEI NIH HHS [EY0976] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/ng0501-92; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BASCOM RA, 1993, HUM MOL GENET, V2, P385, DOI 10.1093/hmg/2.4.385; Begemann G, 1997, DEVELOPMENT, V124, P4321; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Bruhn SL, 1996, J NEUROSCI, V16, P1430; Carmody RJ, 1999, EXP CELL RES, V248, P520, DOI 10.1006/excr.1998.4421; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Clarke G, 2000, CLIN GENET, V57, P313, DOI 10.1034/j.1399-0004.2000.570501.x; Dizhoor AM, 2000, CELL SIGNAL, V12, P711, DOI 10.1016/S0898-6568(00)00134-0; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Guillonneau X, 1999, HUM MOL GENET, V8, P1541, DOI 10.1093/hmg/8.8.1541; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Le Bourlais C, 1998, PROG RETIN EYE RES, V17, P33, DOI 10.1016/S1350-9462(97)00002-5; Linari M, 1999, FEBS LETT, V458, P55, DOI 10.1016/S0014-5793(99)01117-5; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Lu CW, 1999, J NEUROSCI, V19, P7317, DOI 10.1523/JNEUROSCI.19-17-07317.1999; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Reid SNM, 1999, GENE, V227, P257, DOI 10.1016/S0378-1119(98)00578-2; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Specht S, 1999, PHOTOCHEM PHOTOBIOL, V69, P91, DOI 10.1562/0031-8655(1999)069<0091:DTRRDI>2.3.CO;2; St Croix B, 2000, SCIENCE, V289, P1197; Steel KP, 2000, NAT GENET, V24, P104, DOI 10.1038/72737; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; TREISMAN JE, 1988, MOL CELL BIOL, V8, P1570, DOI 10.1128/MCB.8.4.1570; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; Zack DJ, 1999, MOL VIS, V5, pU37; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0	41	254	259	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					579	589		10.1016/S0092-8674(01)00574-8	http://dx.doi.org/10.1016/S0092-8674(01)00574-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733058	Bronze			2022-12-01	WOS:000172575300006
J	Trusolino, L; Bertotti, A; Comoglio, PM				Trusolino, L; Bertotti, A; Comoglio, PM			A signaling adapter function for alpha 6 beta 4 integrin in the control of HGF-dependent invasive growth	CELL			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; TYROSINE KINASE; C-MET; CARCINOMA-CELLS; SCATTER FACTOR; ALPHA(6)BETA(4) INTEGRIN; SOMATIC MUTATIONS; FACTOR-RECEPTOR; DOCKING SITE; MAP KINASE	alpha6 beta4 integrin and the Met receptor for HGF have been shown independently to promote invasive growth. We demonstrate here that Met selectively associates with alpha6 beta4. In carcinoma cells expressing Met alone, HGF does not exert significant biological effects. Ectopic expression of alpha6 beta4 restores HGF-regulated processes. Following Met activation, alpha6 beta4 is tyrosine phosphorylated and combines with Shc and PI3K, generating an additional signaling platform that potentiates HGF-triggered activation of Ras- and PI3K-dependent pathways. In the presence of an alpha6 beta4 mutant defective for Shc recruitment, Met cannot sustain HGF-mediated responses. Surprisingly, a truncated beta4 unable to bind laminins retains the activity of wild-type alpha6 beta4. Such findings invoke an unexpected role for alpha6 beta4 in cancer invasion as a functional amplifier of biochemical outputs rather than a mechanical adhesive device.	Univ Turin, Sch Med, Inst Canc Res & Treatment, IRCC, I-10060 Turin, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Trusolino, L (corresponding author), Univ Turin, Sch Med, Inst Canc Res & Treatment, IRCC, I-10060 Turin, Italy.	ltrusolino@ircc.unito.it	Comoglio, Paolo/G-6323-2011; Trusolino, Livio/A-3896-2011	Trusolino, Livio/0000-0002-6379-3365; Comoglio, Paolo/0000-0002-7056-5328; Bertotti, Andrea/0000-0001-8196-7608				Adelsman MA, 1999, MOL BIOL CELL, V10, P2861, DOI 10.1091/mbc.10.9.2861; Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bardelli A, 1999, ONCOGENE, V18, P1139, DOI 10.1038/sj.onc.1202607; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; CANTLEY LC, 1994, J CELL SCI, P121; Chao C, 1996, CANCER RES, V56, P4811; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Date K, 1998, ONCOGENE, V17, P3045, DOI 10.1038/sj.onc.1202231; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; LONGATI P, 1994, ONCOGENE, V9, P49; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; Meiners S, 1998, ONCOGENE, V16, P9, DOI 10.1038/sj.onc.1201486; Michieli P, 1999, ONCOGENE, V18, P5221, DOI 10.1038/sj.onc.1202899; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1991, ONCOGENE, V6, P501; Nievers MG, 1998, J CELL SCI, V111, P1659; PELLEGRINI G, 1992, J CLIN INVEST, V89, P1783, DOI 10.1172/JCI115782; PONZETTO C, 1991, ONCOGENE, V6, P553; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Prat M, 1998, J CELL SCI, V111, P237; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rabinovitz I, 1996, BIOCHEM CELL BIOL, V74, P811, DOI 10.1139/o96-087; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; SONNENBERG A, 1993, J CELL SCI, V106, P1083; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tulasne D, 1999, MOL BIOL CELL, V10, P551, DOI 10.1091/mbc.10.3.551; Vigna E, 1999, ONCOGENE, V18, P4275, DOI 10.1038/sj.onc.1202791; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; WEIDNER KM, 1995, P NATL ACAD SCI USA, V92, P2597, DOI 10.1073/pnas.92.7.2597; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620	49	350	379	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					643	654		10.1016/S0092-8674(01)00567-0	http://dx.doi.org/10.1016/S0092-8674(01)00567-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733063	Bronze			2022-12-01	WOS:000172575300011
J	Voznesenskaya, EV; Franceschi, VR; Kiirats, O; Freitag, H; Edwards, GE				Voznesenskaya, EV; Franceschi, VR; Kiirats, O; Freitag, H; Edwards, GE			Kranz anatomy is not essential for terrestrial C-4 plant photosynthesis	NATURE			English	Article							MALIC ENZYME; CHENOPODIACEAE; COTYLEDONS; EXPANSION; LEAVES; GENUS; CO2	An important adaptation to CO2-limited photosynthesis in cyanobacteria, algae and some plants was development of CO2-concentrating mechanisms (CCM)(1). Evolution of a CCM occurred many times in flowering plants, beginning at least 15-20 million years ago, in response to atmospheric CO2 reduction, climate change, geological trends, and evolutionary diversification of species(2). In plants, this is achieved through a biochemical inorganic carbon pump called C-4 photosynthesis, discovered 35 years ago(3). C4 photosynthesis is advantageous when limitations on carbon acquisition are imposed by high temperature, drought and saline conditions. It has been thought that a specialized leaf anatomy, composed of two, distinctive photosynthetic cell types (Kranz anatomy), is required for C-4 photosynthesis(4). We provide evidence that C-4 photosynthesis can function within a single photosynthetic cell in terrestrial plants. Borszczowia aralocaspica (Chenopodiaceae) has the photosynthetic features of C-4 plants, yet lacks Kranz anatomy. This species accomplishes C-4 photosynthesis through spatial compartmentation of photosynthetic enzymes, and by separation of two types of chloroplasts and other organelles in distinct positions within the chlorenchyma cell cytoplasm.	Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; Russian Acad Sci, VL Komarov Bot Inst, Lab Anat & Morphol, St Petersburg 197376, Russia; Univ Gesamthsch Kassel, D-34109 Kassel, Germany	Washington State University; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences	Edwards, GE (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	edwardsg@wsu.edu	Voznesenskaya, Elena/H-9098-2013	Voznesenskaya, Elena/0000-0002-5919-3340				Akhani H, 1997, PLANT SYST EVOL, V206, P187, DOI 10.1007/BF00987948; Badger Murray R., 2000, Advances in Photosynthesis, V9, P369; CAROLIN RC, 1973, BOT J LINN SOC, V66, P259, DOI 10.1111/j.1095-8339.1973.tb02174.x; CERLING TE, 1994, NATURE, V371, P112, DOI 10.1038/371112a0; Dai ZY, 1996, PLANTA, V198, P563, DOI 10.1007/BF00262643; Edwards G., 1983, C3 C4 MECH CELLULAR; Edwards GE, 2001, PLANT PHYSIOL, V125, P46, DOI 10.1104/pp.125.1.46; FARQUHAR GD, 1983, AUST J PLANT PHYSIOL, V10, P205, DOI 10.1071/PP9830205; Freitag H, 2000, PLANT BIOLOGY, V2, P154, DOI 10.1055/s-2000-9462; HATCH M. D., 1971, Photosynthesis and photorespiration, P139; Kanai R., 1999, C4 PLANT BIOL, P49, DOI [DOI 10.1016/B978-012614440-6/50004-5, 10.5860/choice.36-6275, DOI 10.5860/CHOICE.36-6275]; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; LONG JJ, 1994, J BIOL CHEM, V269, P2827; Maroco JP, 2000, PLANT CELL ENVIRON, V23, P115, DOI 10.1046/j.1365-3040.2000.00531.x; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; Maurino VG, 1996, BIOCHEM MOL BIOL INT, V38, P239; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Pyankov VI, 1999, PLANT CELL PHYSIOL, V40, P125, DOI 10.1093/oxfordjournals.pcp.a029519; Pyankov VI, 2000, PHOTOSYNTH RES, V63, P69, DOI 10.1023/A:1006377708156; Sage RF, 2001, PLANT BIOLOGY, V3, P202, DOI 10.1055/s-2001-15206; Sage RF, 1999, C4 PLANT BIOL; Sheehy J.E., 2002, CROP SCI, V42, P2227, DOI [10.2135/cropsci2002.2227, DOI 10.2135/CROPSCI2002.2227]; VOZNESENSKAYA E V, 1986, Botanicheskii Zhurnal (St. Petersburg), V71, P1291; Voznesenskaya EV, 1999, J EXP BOT, V50, P1779, DOI 10.1093/jexbot/50.341.1779; Voznesenskaya EV, 2001, ANN BOT-LONDON, V88, P337, DOI 10.1006/anbo.2001.1457; Winter K, 1996, CRASSULACEAN ACID ME	26	216	248	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2001	414	6863					543	546		10.1038/35107073	http://dx.doi.org/10.1038/35107073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734854				2022-12-01	WOS:000172405900047
J	d'Aignaux, JNH; Cousens, SN; Smith, PG				d'Aignaux, JNH; Cousens, SN; Smith, PG			Predictability of the UK variant Creutzfeldt-Jakob disease epidemic	SCIENCE			English	Article							VCJD MORTALITY; AIDS EPIDEMIC; UNITED-STATES; GREAT-BRITAIN; SCRAPIE; GENOTYPE	Back-calculation analysis of the variant Creutzfeldt-Jakob disease epidemic in the United Kingdom is used to estimate the number of infected individuals and future disease incidence. The model assumes a hazard of infection proportional to the incidence of bovine spongiform encephalopathy in the United Kingdom and accounts for precautionary control measures and very wide ranges of incubation periods. The model indicates that current case data are compatible with numbers of infections ranging from a few hundred to several millions. In the tatter case, the model suggests that the mean incubation period must be well beyond the human life-span, resulting in disease epidemics of at most several thousand cases.	Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	d'Aignaux, JNH (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.		smith, peter/ABH-9627-2020	smith, peter/0000-0003-0080-7560				ANDERSON RM, 1996, NATURE, V382, P943; Balter M, 2000, SCIENCE, V289, P1663; Bonn D, 2000, LANCET, V356, P570; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; BROOKMEYER R, 1986, LANCET, V2, P1320; CARP RI, 1987, J GEN VIROL, V68, P401, DOI 10.1099/0022-1317-68-2-401; Cervenakova L, 1998, P NATL ACAD SCI USA, V95, P13239, DOI 10.1073/pnas.95.22.13239; Cooper J D, 2000, J Epidemiol Biostat, V5, P209; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; Frosh A, 2001, BRIT MED J, V322, P1558, DOI 10.1136/bmj.322.7302.1558; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Ghani AC, 1998, P ROY SOC B-BIOL SCI, V265, P2443, DOI 10.1098/rspb.1998.0596; JONES J, 2000, BRIT MED J, V321, pB469; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641	18	72	74	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1729	1731		10.1126/science.1064748	http://dx.doi.org/10.1126/science.1064748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11679631				2022-12-01	WOS:000172307400048
J	Stoll, M; Cowley, AW; Tonellato, PJ; Greene, AS; Kaldunski, ML; Roman, RJ; Dumas, P; Schork, NJ; Wang, ZT; Jacob, HJ				Stoll, M; Cowley, AW; Tonellato, PJ; Greene, AS; Kaldunski, ML; Roman, RJ; Dumas, P; Schork, NJ; Wang, ZT; Jacob, HJ			A genomic-systems biology map for cardiovascular function	SCIENCE			English	Article							GENETIC SUSCEPTIBILITY; ESSENTIAL-HYPERTENSION; LINKAGE; LOCI; SENSITIVITY	With the draft sequence of the human genome available, there is a need to better define gene function in the context of systems biology. We studied 239 cardiovascular and renal phenotypes in 113 mate rats derived from an F-2 intercross and mapped 81 of these traits onto the genome. Aggregates of traits were identified on chromosomes 1, 2, 7, and 18. Systems biology was assessed by examining patterns of correlations ("physiological profiles") that can be used for gene hunting, mechanism-based physiological studies, and, with comparative genomics, translating these data to the human genome.	Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Med Coll Wisconsin, Bioinformat Res Ctr, Milwaukee, WI 53226 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Medical College of Wisconsin; Medical College of Wisconsin; Case Western Reserve University; Medical College of Wisconsin; Jackson Laboratory; Harvard University; Harvard T.H. Chan School of Public Health	Jacob, HJ (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.		Greene, Andrew S/B-9696-2015	Schork, Nicholas/0000-0003-0920-5013; Greene, Andrew/0000-0002-3191-2112	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064541, R37HL036279, P50HL054998] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL036279, R01 HL064541, 1P50-HL-54998] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Bleecker ER, 1997, AM J RESP CRIT CARE, V156, pS113, DOI 10.1164/ajrccm.156.4.12tac7; Cowley AW, 2000, PHYSIOL GENOMICS, V2, P107, DOI 10.1152/physiolgenomics.2000.2.3.107; GUYTON AC, 1972, ANNU REV PHYSIOL, V34, P13, DOI 10.1146/annurev.ph.34.030172.000305; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HOLLENBERG NK, 1978, MEDICINE, V57, P167, DOI 10.1097/00005792-197803000-00004; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; MINER LL, 1995, PSYCHOPHARMACOLOGY, V117, P62, DOI 10.1007/BF02245099; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; Thumma BR, 2001, J EXP BOT, V52, P203, DOI 10.1093/jexbot/52.355.203; TODD JA, 1995, P NATL ACAD SCI USA, V92, P8560, DOI 10.1073/pnas.92.19.8560	16	141	150	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1723	1726		10.1126/science.1062117	http://dx.doi.org/10.1126/science.1062117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721057				2022-12-01	WOS:000172307400046
J	Bruick, RK; McKnight, SL				Bruick, RK; McKnight, SL			A conserved family of prolyl-4-hydroxylases that modify HIF	SCIENCE			English	Article							INDUCIBLE FACTOR 1-ALPHA; TUMOR-SUPPRESSOR PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; DROSOPHILA-MELANOGASTER; TRANSGENIC MICE; O-2 HOMEOSTASIS; HYPOXIA; HIF-1-ALPHA; EXPRESSION; BINDING	Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF). The alpha subunit of HIF is targeted for degradation under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF. We identified a conserved family of HIF prolyl hydoxylase (HPH) enzymes that appear to be responsible for this posttranslational modification. In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1 alpha subunit under normoxic conditions was attenuated by coexpression of HPH. Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene (LDH, encoding lactate dehydrogenase) under normoxic conditions. These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd L3-124, Dallas, TX 75390 USA.							Adryan B, 2000, ONCOGENE, V19, P2803, DOI 10.1038/sj.onc.1203611; Bacon NCM, 1998, BIOCHEM BIOPH RES CO, V249, P811, DOI 10.1006/bbrc.1998.9234; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Bruick RK, 2001, GENE DEV, V15, P2497, DOI 10.1101/gad.931601; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Lipscomb EA, 2001, J BIOL CHEM, V276, P5085, DOI 10.1074/jbc.M008407200; Ma E, 1999, MOL BRAIN RES, V73, P11, DOI 10.1016/S0169-328X(99)00224-7; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nambu JR, 1996, GENE, V172, P249, DOI 10.1016/0378-1119(96)00060-1; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	29	2014	2110	4	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1337	1340		10.1126/science.1066373	http://dx.doi.org/10.1126/science.1066373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11598268				2022-12-01	WOS:000172130200048
J	Zhou, XZ; Lu, KP				Zhou, XZ; Lu, KP			The Pin2/TRF1-interacting: Protein PinX1 is a potent telomerase inhibitor	CELL			English	Article							PUTATIVE TUMOR-SUPPRESSOR; IMMORTAL HUMAN-CELLS; CATALYTIC SUBUNIT; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; FISSION YEAST; LIFE-SPAN; GENE; LENGTH; RNA	Telomerase activity is critical for normal and transformed human cells to escape from crisis and is implicated in oncogenesis. Here we describe a novel Pin2/TRF1 binding protein, PinX1 that inhibits telomerase activity and affects tumorigenicity. PinX1 and its small TID domain bind the telomerase catalytic subunit hTERT and potently inhibit its activity. Overexpression of PinX1 or its TID domain inhibits telomerase activity, shortens telomeres, and induces crisis:, whereas depletion of endogenous PinX1 increases telomerase activity and elongates telomeres. Depletion of PinX1 also increases tumorigenicity in nude mice, consistent with its chromosome localization at 8p23, a region with frequent loss of heterozygosity in a number of human cancers. Thus, PinX1 is a potent telomerase inhibitor and a putative tumor suppressor.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lu, KP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, 330 Brookline Ave,HIM 1047, Boston, MA 02215 USA.				NIA NIH HHS [AG17870] Funding Source: Medline; NIGMS NIH HHS [GM58556, GM56230] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058556, R01GM056230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017870] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Baffa R, 2000, CLIN CANCER RES, V6, P1372; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bockmuhl U, 2001, OTOLARYNG HEAD NECK, V124, P451, DOI 10.1067/mhn.2001.114794; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; EMI M, 1992, CANCER RES, V52, P5368; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GIRARDI AJ, 1965, J CELL COMPAR PHYSL, V65, P69, DOI 10.1002/jcp.1030650110; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gustafson CE, 1996, CANCER RES, V56, P5238; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Ishwad CS, 1999, INT J CANCER, V80, P25, DOI 10.1002/(SICI)1097-0215(19990105)80:1<25::AID-IJC6>3.3.CO;2-7; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kishi S, 2001, ONCOGENE, V20, P1497, DOI 10.1038/sj.onc.1204229; Kishi S, 2001, J BIOL CHEM, V276, P29282, DOI 10.1074/jbc.M011534200; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liao C, 2000, HEPATOLOGY, V32, P721, DOI 10.1053/jhep.2000.17967; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lu KP, 1996, NATURE, V380, P544; LU KP, 1995, CELL, V81, P413, DOI 10.1016/0092-8674(95)90394-1; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Muscheck M, 2000, LAB INVEST, V80, P1089, DOI 10.1038/labinvest.3780114; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nosaka K, 1998, BIOCHEM BIOPH RES CO, V243, P342, DOI 10.1006/bbrc.1997.8097; Perinchery G, 1999, INT J ONCOL, V14, P495; Perrem K, 1999, ONCOGENE, V18, P3383, DOI 10.1038/sj.onc.1202752; Shay JW, 2001, RADIAT RES, V155, P188, DOI 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Sun PC, 1999, GENOMICS, V62, P184, DOI 10.1006/geno.1999.6020; Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Young AC, 1997, SOMAT CELL MOLEC GEN, V23, P275, DOI 10.1007/BF02674418; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(05)00083-3	71	253	282	1	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					347	359		10.1016/S0092-8674(01)00538-4	http://dx.doi.org/10.1016/S0092-8674(01)00538-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701125	Bronze			2022-12-01	WOS:000172022800006
J	Berneche, S; Roux, B				Berneche, S; Roux, B			Energetics of ion conduction through the K+ channel	NATURE			English	Article							FREE-ENERGY CALCULATIONS; MOLECULAR-DYNAMICS; POTASSIUM CHANNEL; SIMULATIONS; PERMEATION; KCSA; SELECTIVITY; MECHANISM; BILAYER; WATER	K+ channels are transmembrane proteins that are essential for the transmission of nerve impulses. The ability of these proteins to conduct K+ ions at levels near the limit of diffusion is traditionally described in terms of concerted mechanisms in which ion-channel attraction and ion-ion repulsion have compensating effects, as several ions are moving simultaneously in single file through the narrow pore(1-4). The efficiency of such a mechanism, however, relies on a delicate energy balance-the strong ion-channel attraction must be perfectly counterbalanced by the electrostatic ion-ion repulsion. To elucidate the mechanism of ion conduction at the atomic level, we performed molecular dynamics free energy simulations on the basis of the X-ray structure of the KcsA K+ channel(4). Here we rnd that ion conduction involves transitions between two main states, with two and three K+ ions occupying the selectivity filter, respectively; this process is reminiscent of the 'knock-on' mechanism proposed by Hodgkin and Keynes in 1955(1). The largest free energy barrier is on the order of 2-3 kcal mol(-1), implying that the process of ion conduction is limited by diffusion. Ion-ion repulsion, although essential for rapid conduction, is shown to act only at very short distances. The calculations show also that the rapidly conducting pore is selective.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada	Cornell University; Universite de Montreal	Roux, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	benoit.roux@med.cornell.edu	Bernèche, Simon/L-6389-2013	Bernèche, Simon/0000-0002-6274-4094				ALCAYAGA C, 1989, BIOPHYS J, V55, P367, DOI 10.1016/S0006-3495(89)82814-0; Allen TW, 2000, J CHEM PHYS, V112, P8191, DOI 10.1063/1.481420; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; ARMSTRON.CM, 1968, NATURE, V219, P1262, DOI 10.1038/2191262a0; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Crouzy S, 2001, J GEN PHYSIOL, V118, P207, DOI 10.1085/jgp.118.2.207; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1962, Biophys J, V2, P259; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LAUGER P, 1979, BIOCHIM BIOPHYS ACTA, V552, P143, DOI 10.1016/0005-2736(79)90253-0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Roux B, 1999, BIOPHYS J, V77, P139, DOI 10.1016/S0006-3495(99)76878-5; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Schlenkrich Michael, 1996, P31; SCHUMAKER MF, 1990, BIOPHYS J, V58, P975, DOI 10.1016/S0006-3495(90)82442-5; Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8	30	623	634	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					73	77		10.1038/35102067	http://dx.doi.org/10.1038/35102067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689945				2022-12-01	WOS:000171898900044
J	Salehi-Ashtiani, K; Szostak, JW				Salehi-Ashtiani, K; Szostak, JW			In vitro evolution suggests multiple origins for the hammerhead ribozyme	NATURE			English	Article							HEPATITIS-DELTA-VIRUS; RNA; TRANSCRIPTS	The hammerhead ribozyme was originally discovered in a group of RNAs associated with plant viruses, and has subsequently been identified in the genome of the newt (Notophthalamus viridescens)(1,2), in schistosomes(3) and in cave crickets (Dolichopoda species)(4). The sporadic occurrence of this self-cleaving RNA motif in highly divergent organisms could be a consequence of the very early evolution of the hammerhead ribozyme(4,5), with all extant examples being descended from a single ancestral progenitor. Alternatively, the hammerhead ribozyme may have evolved independently many times. To better understand the observed distribution of hammerhead ribozymes, we used in vitro selection to search an unbiased sample of random sequences for comparably active self-cleaving motifs. Here we show that, under near-physiological conditions, the hammerhead ribozyme motif is the most common (and thus the simplest) RNA structure capable of self-cleavage at biologically observed rates. Our results suggest that the evolutionary process may have been channelled, in nature as in the laboratory, towards repeated selection of the simplest solution to a biochemical problem.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.			Salehi-Ashtiani, Kourosh/0000-0002-6521-5243				BEATTIE TL, 1995, P NATL ACAD SCI USA, V92, P4686, DOI 10.1073/pnas.92.10.4686; BEEN MD, 1994, TRENDS BIOCHEM SCI, V19, P251, DOI 10.1016/0968-0004(94)90151-1; Conaty J, 1999, NUCLEIC ACIDS RES, V27, P2400, DOI 10.1093/nar/27.11.2400; DIENER TO, 1989, P NATL ACAD SCI USA, V86, P9370, DOI 10.1073/pnas.86.23.9370; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; GOULD SJ, 1989, WONDERFUL LIFE BURGE, P292; HAMPEL N, 1998, PROGR NUCL ACIDS RES, P1; LONG DM, 1993, FASEB J, V7, P25, DOI 10.1096/fasebj.7.1.8422971; PABONPENA LM, 1991, MOL CELL BIOL, V11, P6109, DOI 10.1128/MCB.11.12.6109; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; THILL G, 1993, BIOCHEMISTRY-US, V32, P4254, DOI 10.1021/bi00067a013; THOMSON JB, 1997, CATALYTIC RNA, P173; WILLS G, 1995, LEARNING ORG, V2, P14; Zhang Y, 1996, GENE, V172, P183, DOI 10.1016/0378-1119(96)00126-6	16	129	143	2	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					82	84		10.1038/35102081	http://dx.doi.org/10.1038/35102081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689947				2022-12-01	WOS:000171898900046
J	Ala'Aldeen, D				Ala'Aldeen, D			Risk of deliberately induced anthrax outbreak	LANCET			English	Editorial Material									Univ Nottingham Hosp, Queens Med Ctr, Div Microbiol, Mol Bacteriol & Immunol Grp, Nottingham NG7 2UH, England	University of Nottingham	Ala'Aldeen, D (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Microbiol, Mol Bacteriol & Immunol Grp, Nottingham NG7 2UH, England.							BERKELY RCW, 1997, PRINCIPLES PRACTICE, P184; Dalton R, 2001, NATURE, V413, P657, DOI 10.1038/35099687; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; *US C, 1993, PROL WEAP MASS DESTR, P53; WHO Group of Consultants, 1970, HLTH ASP CHEM BIOL W, P98	5	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1386	1388		10.1016/S0140-6736(01)06492-3	http://dx.doi.org/10.1016/S0140-6736(01)06492-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705480				2022-12-01	WOS:000171940100006
J	Schlunzen, F; Zarivach, R; Harms, J; Bashan, A; Tocilj, A; Albrecht, R; Yonath, A; Franceschi, F				Schlunzen, F; Zarivach, R; Harms, J; Bashan, A; Tocilj, A; Albrecht, R; Yonath, A; Franceschi, F			Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria	NATURE			English	Article							23S RIBOSOMAL-RNA; ESCHERICHIA-COLI; BINDING-SITE; ERYTHROMYCIN RESISTANCE; CRYSTAL-STRUCTURES; CHLORAMPHENICOL; MUTATIONS; SUBUNIT; CONFORMATION; RECOGNITION	Ribosomes, the site of protein synthesis, are a major target for natural and synthetic antibiotics. Detailed knowledge of antibiotic binding sites is central to understanding the mechanisms of drug action. Conversely, drugs are excellent tools for studying the ribosome function. To elucidate the structural basis of ribosome-antibiotic interactions, we determined the high-resolution X-ray structures of the 50S ribosomal subunit of the eubacterium Deinococcus radiodurans, complexed with the clinically relevant antibiotics chloramphenicol, clindamycin and the three macrolides erythromycin, clarithromycin and roxithromycin. We found that antibiotic binding sites are composed exclusively of segments of 23S ribosomal RNA at the peptidyl transferase cavity and do not involve any interaction of the drugs with ribosomal proteins. Here we report the details fo antibiotic interactions with the components of their binding sites. Our results also show the importance of putative Mg+2 ions for the binding of some drugs. This structural analysis should facilitate rational drug design.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Max Planck Res, Unit Ribosomal Struct, D-22603 Hamburg, Germany; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Max Planck Society; Max Planck Society; Weizmann Institute of Science	Franceschi, F (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	Franceschi@molgen.mpg.de	Schluenzen, Frank/H-6274-2014; ZARIVACH, RAZ/F-1671-2012; Schluenzen, Frank/P-9177-2019; Franceschi, Francois/AAF-5860-2021; Harms, Joerg/K-8786-2012	Schluenzen, Frank/0000-0003-2849-0542; ZARIVACH, RAZ/0000-0001-6543-0296; Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; Franceschi, Francois/0000-0002-1554-7944				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barta A., 2001, SCIENCE, V291, p203a, DOI [10.1126/science.291.5502.203a, DOI 10.1126/SCIENCE.291.5502.203A]; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CUNDLIFFE E, 1990, RIBOSOME, P479; DOUTHWAITE S, 1992, NUCLEIC ACIDS RES, V20, P4717, DOI 10.1093/nar/20.18.4717; GASC JC, 1991, J ANTIBIOT, V44, P313, DOI 10.7164/antibiotics.44.313; GOLDMAN RC, 1990, ANTIMICROB AGENTS CH, V34, P426, DOI 10.1128/AAC.34.3.426; Gregory ST, 1999, J MOL BIOL, V289, P827, DOI 10.1006/jmbi.1999.2839; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; HARMS J, IN PRESS CELL; Izard T, 2000, EMBO J, V19, P2690, DOI 10.1093/emboj/19.11.2690; KALLIARAFTOPOULOS S, 1994, MOL PHARMACOL, V46, P1009; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MANKIN AS, 1991, J BACTERIOL, V173, P3559, DOI 10.1128/jb.173.11.3559-3563.1991; MAO JCH, 1969, J MOL BIOL, V44, P347, DOI 10.1016/0022-2836(69)90180-6; MILLER KD, 1993, J AM HIST, V80, P319, DOI 10.2307/2079816; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLL M, 1973, J MOL BIOL, V75, P281, DOI 10.1016/0022-2836(73)90021-1; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; POLACEK N, 2000, RNA BINDING ANTIBIOT, P1; Poulsen SM, 2000, J MOL BIOL, V304, P471, DOI 10.1006/jmbi.2000.4229; RODRIGUEZFONSECA C, 1995, J MOL BIOL, V247, P224, DOI 10.1006/jmbi.1994.0135; Ross JI, 1997, ANTIMICROB AGENTS CH, V41, P1162, DOI 10.1128/AAC.41.5.1162; Saarma U, 1998, RNA, V4, P189; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SHAW WV, 1991, ANNU REV BIOPHYS BIO, V20, P363, DOI 10.1146/annurev.bb.20.060191.002051; SIGMUND CD, 1984, NUCLEIC ACIDS RES, V12, P4653, DOI 10.1093/nar/12.11.4653; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/BF00217518; STEINER G, 1988, EMBO J, V7, P3949, DOI 10.1002/j.1460-2075.1988.tb03281.x; STEINMETZ WE, 1992, J MED CHEM, V35, P4842, DOI 10.1021/jm00104a009; Tenson T, 1996, P NATL ACAD SCI USA, V93, P5641, DOI 10.1073/pnas.93.11.5641; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; VAZQUEZ D, 1975, INHIBITORS PROTEIN S; VESTER B, 1988, EMBO J, V7, P3577, DOI 10.1002/j.1460-2075.1988.tb03235.x; VESTER B, 1995, RNA, V1, P501; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; VINCE R, 1975, ANTIMICROB AGENTS CH, V8, P439, DOI 10.1128/AAC.8.4.439; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WITTMANN HG, 1973, MOL GEN GENET, V127, P175, DOI 10.1007/BF00333665; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	51	806	873	6	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					814	821		10.1038/35101544	http://dx.doi.org/10.1038/35101544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677599				2022-12-01	WOS:000171750200038
J	Luo, JY; Nikolaev, AY; Imai, S; Chen, DL; Su, F; Shiloh, A; Guarente, L; Gu, W				Luo, JY; Nikolaev, AY; Imai, S; Chen, DL; Su, F; Shiloh, A; Guarente, L; Gu, W			Negative control of p53 by Sir2 alpha promotes cell survival under stress	CELL			English	Article							DNA-DAMAGE; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; P53-DEPENDENT APOPTOSIS; PREMATURE SENESCENCE; OXIDATIVE STRESS; ONCOGENIC RAS; LIFE-SPAN; SIR2; ACETYLATION	The NAD-dependent histone deacetylation of Sir2 connects cellular metabolism with gene silencing as well as aging in yeast. Here, we show that mammalian Sir2 alpha physically interacts with p53 and attenuates p53-mediated functions. Nicotinamide (Vitamin B3) inhibits an NAD-dependent p53 deacetylation induced by Sir2 alpha, and also enhances the p53 acetylation levels in vivo. Furthermore, Sir2 alpha represses p53-dependent apoptosis in response to DNA damage and oxidative stress, whereas expression of a Sir2 alpha point mutant increases the sensitivity of cells in the stress response. Thus, our findings implicate a p53 regulatory pathway mediated by mammalian Sir2 alpha. These results have significant implications regarding an important role for Sir2 alpha in modulating the sensitivity of cells in p53-dependent apoptotic response and the possible effect in cancer therapy.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Columbia University; Columbia University; Massachusetts Institute of Technology (MIT)	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.		Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Nikolaev, Anatoly/0000-0003-2818-5839	NATIONAL CANCER INSTITUTE [R01CA085533] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA85533] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Appella E, 2000, PATHOL BIOL, V48, P227; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Butler LM, 2000, CANCER RES, V60, P5165; Campisi J, 2000, SCIENCE, V289, P2062, DOI 10.1126/science.289.5487.2062; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Chresta CM, 1996, NAT MED, V2, P745, DOI 10.1038/nm0796-745; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Ferbeyre G, 2000, GENE DEV, V14, P2015; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2000, GENE DEV, V14, P1021; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Marks PA, 2001, CLIN CANCER RES, V7, P759; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Prives C, 1999, J PATHOL, V187, P112; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shore D, 2000, P NATL ACAD SCI USA, V97, P14030, DOI 10.1073/pnas.011506198; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	50	1770	1884	3	124	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					137	148		10.1016/S0092-8674(01)00524-4	http://dx.doi.org/10.1016/S0092-8674(01)00524-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672522	Bronze			2022-12-01	WOS:000171694800004
J	Simonsen, L; Morens, DM; Elixhauser, A; Gerber, M; Van Raden, M; Blackwelder, WC				Simonsen, L; Morens, DM; Elixhauser, A; Gerber, M; Van Raden, M; Blackwelder, WC			Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception	LANCET			English	Article							DEVELOPING-COUNTRIES; UNITED-STATES; IMMUNIZATION; INFECTION; CHILDREN; FUTURE	Background Studies have reported a temporal association between a first dose of rotavirus vaccine (Rotashield) and infant intussusception. We investigated the effect of Rotashield vaccination use on intussusception admissions in ten US states. Methods We analysed electronic databases containing 100% hospital discharge records for 1993-99 from ten US states, where an estimated 28% of the birth cohort had received Rotashield (based on manufacturer's net sales data). We examined records of infants admitted to hospital (<365 days old) with any mention of intussusception (international Classification of Diseases, ninth revision. clinical modification code 560.0). Excess admissions for intussusception during the period of Rotashield availability (October 1998 to June 1999) were estimated by direct comparison with the corresponding period of October 1997 to June 1998 (before Rotashield was available) and with adjustment for secular trends during 1993-98 by Poisson regression. Findings Hospital admission for intussusception among infants younger than 365 days of age during the Rotashield period compared with previously was 4% lower (10 cases) by direct comparison and 10% lower (27 cases) by trend comparison, corresponding to a negative population attributable risk. Among infants aged 45-210 days (target age range for a first Rotashield dose), we estimated an increase in intussusception admissions of 1% (one excess admission) by direct comparison and 4% (4.6 excess admissions) by trend comparison, corresponding to a population attributable risk range of one excess admission in 66 000-302 000. Interpretation We found no evidence of increased infant intussusception admissions during the period of Rotashield availability. The total intussusception admission risk attributable to Rotashield was substantially lower than previous estimates based on studies focusing on the immediate postvaccination weeks.	NIAID, NIH, Bethesda, MD 20892 USA; Agcy Healthcare Res & Qual, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Agency for Healthcare Research & Quality	Simonsen, L (corresponding author), 6700-B Rockledge Dr,Room 3153, Bethesda, MD 20892 USA.		Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526				*ADV COMM IMM PRAC, 1999, ACIP C ATL OCT 22 19, P1; [Anonymous], M FUT DIR ROT VACC R; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; *CDCP, 1999, MMWR MORB MORTAL WKL, V48; CHANG HGH, IN PRESS PEDIATRICS; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; Ehresman K., 1999, Morbidity and Mortality Weekly Report, V48, P577; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Gay N, 1999, LANCET, V354, P956, DOI 10.1016/S0140-6736(05)75710-X; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; *I MED, 1986, NEW VACC DEV DIS IMP, V2; Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; Levin A, 2000, ANN INTERN MED, V133, P661, DOI 10.7326/0003-4819-133-8-200010170-00102; Melton L, 2000, LANCET, V356, P318, DOI 10.1016/S0140-6736(05)73604-7; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Nakagomi T, 2000, MICROBIOL IMMUNOL, V44, P619, DOI 10.1111/j.1348-0421.2000.tb02542.x; Parashar UD, 2000, PEDIATRICS, V106, P1413, DOI 10.1542/peds.106.6.1413; Rennels MB, 1998, PEDIATR INFECT DIS J, V17, P924, DOI 10.1097/00006454-199810000-00018; Tucker AW, 1998, JAMA-J AM MED ASSOC, V279, P1371, DOI 10.1001/jama.279.17.1371; Weijer C, 2000, BRIT MED J, V321, P525, DOI 10.1136/bmj.321.7260.525	20	92	94	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1224	1229		10.1016/S0140-6736(01)06346-2	http://dx.doi.org/10.1016/S0140-6736(01)06346-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675060				2022-12-01	WOS:000171527000012
J	Ren, DJ; Navarro, B; Perez, G; Jackson, AC; Hsu, SF; Shi, Q; Tilly, JL; Clapham, DE				Ren, DJ; Navarro, B; Perez, G; Jackson, AC; Hsu, SF; Shi, Q; Tilly, JL; Clapham, DE			A sperm ion channel required for sperm motility and male fertility	NATURE			English	Article							MOUSE SPERM; ACROSOME REACTION; CALCIUM CHANNELS; ZONA-PELLUCIDA; CA2+ CHANNELS; ENTRY; SPERMATOZOA; EXPRESSION; INCREASE	Calcium and cyclic nucleotides have crucial roles in mammalian fertilization, but the molecules comprising the Ca2+-permeation pathway in sperm motility are poorly understood. Here we describe a putative sperm cation channel, CatSper, whose amino-acid sequence most closely resembles a single, six-transmembrane-spanning repeat of the voltage-dependent Ca2+-channel four-repeat structure. CatSper is located specifically in the principal piece of the sperm tail. Targeted disruption of the gene results in male sterility in otherwise normal mice. Sperm motility is decreased markedly in CatSper(-/-) mice, and CatSper(-/-) sperm are unable to fertilize intact eggs. In addition, the cyclic-AMP-induced Ca2+ influx is abolished in the sperm of mutant mice. CatSper is thus vital to cAMP-mediated Ca2+ influx in sperm, sperm motility and fertilization. CatSper represents an excellent target for non-hormonal contraceptives for both men and women.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@rascal.med.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019; Oka, Yoshitaka/C-9670-2010	Clapham, David/0000-0002-4459-9428; Oka, Yoshitaka/0000-0002-3482-3051	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [R01 HD045339] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aoki F, 1999, MOL REPROD DEV, V53, P77, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;77::AID-MRD9&gt;3.0.CO;2-C; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Arnoult C, 1997, EMBO J, V16, P1593, DOI 10.1093/emboj/16.7.1593; Bedford JM, 1998, BIOL REPROD, V59, P1275, DOI 10.1095/biolreprod59.6.1275; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Espinosa F, 1998, FEBS LETT, V426, P47, DOI 10.1016/S0014-5793(98)00305-6; HYNE RV, 1979, P NATL ACAD SCI USA, V76, P5699, DOI 10.1073/pnas.76.11.5699; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kobori H, 2000, BIOL REPROD, V63, P113, DOI 10.1095/biolreprod63.1.113; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Santi CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1583, DOI 10.1152/ajpcell.1996.271.5.C1583; Serrano CJ, 1999, FEBS LETT, V462, P171, DOI 10.1016/S0014-5793(99)01518-5; Tash J.S., 1990, P229; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Yanagimachi R., 1994, P189	21	664	695	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					603	609		10.1038/35098027	http://dx.doi.org/10.1038/35098027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11595941	Green Accepted			2022-12-01	WOS:000171485700041
J	Cattaneo, A; Buzzetti, R				Cattaneo, A; Buzzetti, R		Breastfeeding Res Training Working	Quality improvement report - Effect on rates of breast feeding of training for the Baby Friendly Hospital Initiative	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PEER COUNSELORS; KNOWLEDGE; ATTITUDES; PROMOTION; DURATION; INTERVENTION; PREVALENCE; INCREASE	Problem Breastfeeding rates and related hospital practices need improvement in Italy and elsewhere. Training of staff is necessary, but its effectiveness needs assessment. Context Eight hospitals in different regions of Italy. Design Controlled, non-randomised study. Data collected in three phases. Training after the first phase ill group 1 hospitals and after the second phase in group 2. Strategies for change Training of trainers and Subsequent training Of health workers with a slightly adapted version of the 18 hour Unicef Course Oil breastfeeding management and promotion. Key measures for improvement Hospital practices, knowledge of 571 health workers, and breastfeeding rates at discharge, three, and six months in 2669 mother and baby pairs. Effects of change After training hospitals improved their compliance with the "ten steps to successful breast feeding," from an average of 2.4 steps at phase one to 7.7 at phase three. Knowledge scores of health professionals increased from 0.41 to 0.72 in group 1 (training after phase one) and from 0.53 to 0.75 in group 2 (after phase two). The rate of exclusive breast feeding at discharge increased significantly after training: 41% to 77% in group 1 mid 23% to 73% in group 2, as did the rates of full (exclusive plus predominant) breast feeding at three months (37% to 50% in group 1 v 40% to 59% in group 2) and any breast feeding at six months (43% to 62% in group 1 v 41% to 64% in group 2 ). Lessons learnt Training for at least three days with a course including practical sessions and counselling skills is effective in changing hospital practices, knowledge of health workers, and breastfeeding rates.	Ist Infanzia, Unit Hlth Serv Res & Int Cooperat, I-34137 Trieste, Italy; CEVEAS, Modena, Italy		Cattaneo, A (corresponding author), Ist Infanzia, Unit Hlth Serv Res & Int Cooperat, Via Istria 65-1, I-34137 Trieste, Italy.	cattanco@burlo.trieste.it	Cattaneo, Adriano/G-6685-2011; Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X				Aarts C, 2000, INT J EPIDEMIOL, V29, P1041, DOI 10.1093/ije/29.6.1041; Armitage P, 1994, STAT METHODS MED RES; Becker G E, 1992, J Hum Lact, V8, P137, DOI 10.1177/089033449200800318; BRADLEY JE, 1992, J TROP PEDIATRICS, V38, P228, DOI 10.1093/tropej/38.5.228; Cattaneo A, 2000, ACTA PAEDIATR, V89, P88, DOI 10.1080/080352500750029130; DELSANTO M, 1998, QUADERNI ASS CULTURA, V4, P10; Division of Diarrhoeal and Acute Respiratory Disease Control, 1991, IND ASS BREASTF PRAC; FREED GL, 1995, JAMA-J AM MED ASSOC, V273, P472, DOI 10.1001/jama.273.6.472; FREED GL, 1995, PEDIATRICS, V96, P490; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Henderson L, 2000, BRIT MED J, V321, P1196, DOI 10.1136/bmj.321.7270.1196; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; NHS Center for Reviews and Dissemination, 2000, EFFECTIVE HLTH CARE, V6, P1; PRASAD B, 1995, BRIT MED J, V310, P621, DOI 10.1136/bmj.310.6980.621; Radford A, 2001, BRIT MED J, V322, P555, DOI 10.1136/bmj.322.7285.555; Rea MF, 1999, B WORLD HEALTH ORGAN, V77, P492; Schafer E, 1998, BIRTH-ISS PERINAT C, V25, P101, DOI 10.1046/j.1523-536x.1998.00101.x; Schanler RJ, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e35; SIKORSKI J, 2000, COCHRANE DATABASE SY; Taylor A, 1998, BMJ-BRIT MED J, V316, P1117, DOI 10.1136/bmj.316.7138.1117; *UNICEF, 1999, BAB FRIENDL HOSP INT; UNICEF, 1993, BREASTF MAN PROM BAB; Valdes V, 1995, J Hum Lact, V11, P185, DOI 10.1177/089033449501100318; WESTPHAL MF, 1995, B WORLD HEALTH ORGAN, V73, P461; [WHO UNICEF], 1998, COMPL FEED YOUNG CHI; WHO: Global Data Bank on Breastfeeding, 1996, GLOB DAT BANK BREAST; *WHO UNICEF, 1993, IND ASS HLTH FAC PRA; WILLIAMS EL, 1995, AM J PREV MED, V11, P26, DOI 10.1016/S0749-3797(18)30497-5; World Health Organization (WHO), 1993, BREASTFEEDING COUNSE; Wright A, 1996, PEDIATRICS, V97, P669	32	135	141	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2001	323	7325					1358	1362		10.1136/bmj.323.7325.1358	http://dx.doi.org/10.1136/bmj.323.7325.1358			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501ZC	11739226	Green Published			2022-12-01	WOS:000172716900022
J	Lee, R; Kermani, P; Teng, KK; Hempstead, BL				Lee, R; Kermani, P; Teng, KK; Hempstead, BL			Regulation of cell survival by secreted proneurotrophins	SCIENCE			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIN; BRAIN; BIOSYNTHESIS; PRECURSOR; COEXPRESSION; EXPRESSION; APOPTOSIS; RECEPTORS; BINDING	Neurotrophins are growth factors that promote cell, survival, differentiation, and cell death. They are synthesized as proforms that can be cleaved intracellularly to release mature, secreted Ligands. Although proneurotrophins have been considered inactive precursors, we show here that the proforms of nerve growth factor (NGF) and the proforms of brain derived neurotrophic factor (BDNF) are secreted and cleaved extracellularly by the serine protease plasmin and by selective matrix metalloproteinases (MMPs). ProNGF is a high-affinity ligand for p75(NTR) with high affinity and induced p75(NTR)-dependent apoptosis in cultured neurons with minimal activation of TrkA-mediated differentiation or survival. The biological action of neurotrophins is thus regulated by proteolytic cleavage, with proforms preferentially activating p75(NTR) to mediate apoptosis and mature forms activating Trk receptors to promote survival.	Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, New York, NY 10021 USA	Cornell University	Hempstead, BL (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, 1300 York Ave, New York, NY 10021 USA.	blhempst@med.cornell.edu			NEI NIH HHS [T32 EY07138] Funding Source: Medline; NINDS NIH HHS [NS30687] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; EDWARDS RH, 1988, J BIOL CHEM, V263, P6810; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Frade JM, 1996, NATURE, V383, P166; Heinrich G, 2000, INT J DEV NEUROSCI, V18, P1, DOI 10.1016/S0736-5748(99)00071-4; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEYMACH JV, 1995, J BIOL CHEM, V270, P12297, DOI 10.1074/jbc.270.20.12297; KOLBECK R, 1994, EUR J BIOCHEM, V225, P995, DOI 10.1111/j.1432-1033.1994.0995b.x; Lee FS, 2001, CURR OPIN NEUROBIOL, V11, P281, DOI 10.1016/S0959-4388(00)00209-9; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; Schropel A, 1995, MOL CELL NEUROSCI, V6, P544, DOI 10.1006/mcne.1995.0006; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; Wang SY, 2000, AM J PATHOL, V157, P1247, DOI 10.1016/S0002-9440(10)64640-8	24	1269	1334	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1945	1948		10.1126/science.1065057	http://dx.doi.org/10.1126/science.1065057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729324				2022-12-01	WOS:000172465000065
J	Tynan, CT; DeMaster, DP; Peterson, WT				Tynan, CT; DeMaster, DP; Peterson, WT			Endangered right whales an the southeastern Bering Sea shelf	SCIENCE			English	Article									NOAA, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; NOAA, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; NOAA, NWFSC, Newport, OR 97365 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Tynan, CT (corresponding author), NOAA, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.							BOND NA, IN PRESS DEEP SEA 2; Clapham PJ, 1999, MAMMAL REV, V29, P35; FROST BW, 1974, MAR BIOL, V26, P77, DOI 10.1007/BF00389089; Goddard PD, 1998, MAR MAMMAL SCI, V14, P344, DOI 10.1111/j.1748-7692.1998.tb00725.x; KENNEY RD, 1995, CONT SHELF RES, V15, P373, DOI 10.1016/0278-4343(94)00070-4; Omura H., 1969, Scientific Reports of the Whales Research Institute Tokyo, VNo. 21, P1; SMITH SL, 1986, CONT SHELF RES, V5, P215, DOI 10.1016/0278-4343(86)90016-6	7	25	25	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1894	1894		10.1126/science.1065682	http://dx.doi.org/10.1126/science.1065682			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729308				2022-12-01	WOS:000172465000049
J	Wright, DE; Wagers, AJ; Gulati, AP; Johnson, FL; Weissman, IL				Wright, DE; Wagers, AJ; Gulati, AP; Johnson, FL; Weissman, IL			Physiological migration of hematopoietic stem and progenitor Celts	SCIENCE			English	Article							IN-VIVO; CELLS; TRANSPLANTATION; MOBILIZATION	Hematopoietic stem cells (HSCs) reside predominantly in bone marrow, but low numbers of HSCs are also found in peripheral blood. We examined the fate of blood-borne HSCs using genetically marked parabiotic mice, which are surgically conjoined and share a common circulation. Parabionts rapidly established stable, functional cross engraftment of partner-derived HSCs and maintained partner-derived hematopoiesis after surgical separation. Determination of the residence time of injected blood-borne progenitor cells suggests that circulating HSCs/progenitors: are cleared quickly from the blood, These data demonstrate that HSCs rapidly and constitutively migrate through the blood and play a physiological role in, at least, the functional reengraftment of unconditioned bone marrow.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Palo Alto Vet Affairs Hlth Care Syst, Sch Med, Dept Med,Cardiovasc Med Div,Cardiol Sect 111C, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NHLBI NIH HHS [5R01 HL-58770] Funding Source: Medline; NIAID NIH HHS [5T32 AI-07290] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; DORIE MJ, 1979, EXP HEMATOL, V7, P483; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; LEY K, 2000, PHYSL INFLAMMATION; LORD BI, 1995, BLOOD, V85, P3412, DOI 10.1182/blood.V85.12.3412.bloodjournal85123412; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; NANAKORN TN, UNPUB; Ramshaw H S, 1995, Biol Blood Marrow Transplant, V1, P74; Rao SS, 1997, EXP HEMATOL, V25, P114; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPENCER R P, 1975, Seminars in Nuclear Medicine, V5, P95, DOI 10.1016/S0001-2998(75)80007-9; Thomas ED, 1999, SEMIN HEMATOL, V36, P95; VANDERLOO JCM, 1994, BLOOD, V83, P1769; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	23	695	742	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1933	1936		10.1126/science.1064081	http://dx.doi.org/10.1126/science.1064081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729320				2022-12-01	WOS:000172465000061
J	Cantalupo, C; Hopkins, WD				Cantalupo, C; Hopkins, WD			Asymmetric Broca's area in great apes - A region of the ape brain is uncannily similar to one linked with speech in humans.	NATURE			English	Article							PLANUM TEMPORALE; LANGUAGE; MRI		Emory Univ, Yerkes Reg Primate Res Ctr, Div Psychobiol, Atlanta, GA 30322 USA; Emory Univ, Yerkes Reg Primate Res Ctr, Living Links Ctr, Atlanta, GA 30322 USA; Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; Berry Coll, Dept Psychol, Mt Berry, GA 30149 USA	Emory University; Emory University; University System of Georgia; Georgia State University	Cantalupo, C (corresponding author), Emory Univ, Yerkes Reg Primate Res Ctr, Div Psychobiol, Atlanta, GA 30322 USA.				NICHD NIH HHS [P01 HD038051, P01 HD038051-050005] Funding Source: Medline; NINDS NIH HHS [R01 NS036605, R01 NS036605-08, R01 NS042867-05, R01 NS042867] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036605, R01NS042867] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Bailey P, 1950, ISOCORTEX CHIMPANZEE; BROCA P, 1861, B SOC ANAT, V2, P330; CORBALLIS MC, 1992, COGNITION, V44, P197, DOI 10.1016/0010-0277(92)90001-X; Foundas AL, 1998, BRAIN LANG, V64, P282, DOI 10.1006/brln.1998.1974; GALABURDA AM, 1984, CEREBRAL DOMINANCE B, P11; Gannon PJ, 1998, SCIENCE, V279, P220, DOI 10.1126/science.279.5348.220; Hopkins WD, 1998, J COMP PSYCHOL, V112, P95, DOI 10.1037/0735-7036.112.1.95; Hopkins WD, 1998, NEUROREPORT, V9, P2913, DOI 10.1097/00001756-199808240-00043; HOSTETTER AB, IN PRESS J COMP PSYC; Luria A.R., 1970, TRAUMATIC APHASIA; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; von Bonin G, 1949, PRECENTRAL MOTOR COR, P7	13	243	243	2	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					505	505		10.1038/35107134	http://dx.doi.org/10.1038/35107134			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734839	Green Accepted			2022-12-01	WOS:000172405900032
J	Joffe, S; Cook, EF; Cleary, PD; Clark, JW; Weeks, JC				Joffe, S; Cook, EF; Cleary, PD; Clark, JW; Weeks, JC			Quality of informed consent in cancer clinical trials: a cross-sectional survey	LANCET			English	Article							INFORMATION; PERCEPTIONS	Background Investigators have to obtain informed consent before enrolling participants in clinical trials. We wanted to measure the quality of understanding among participants in clinical trials of cancer therapies, to identify correlates of increased understanding, and to assess providers' beliefs about clinical research. We also sought evidence of therapeutic misconceptions in participants and providers. Methods We sent a standard questionnaire to 287 adult patients with cancer who had recently enrolled in a clinical trial at one of three affiliated institutions, and surveyed the provider who obtained each patient's consent. Findings 207 of 287 (72%) patients responded. 90% (186) of these respondents were satisfied with the informed consent process and most considered themselves to be well informed. Nevertheless, many did not recognise nonstandard treatment (74%), the potential for incremental risk from participation (63%), the unproven nature of the treatment (70%), the uncertainty of benefits to self (29%), or that trials are done mainly to benefit future patients (25%). In multivariate analysis, increased knowledge was associated with college education, speaking only English at home, use of the US National Cancer Institute consent form template, not signing the consent form at initial discussion, presence of a nurse, and careful reading of the consent form. Only 28 of 61 providers (46%) recognised that the main reason for clinical trials is benefit to future patients. Interpretation Misconceptions about cancer clinical trials are frequent among trial participants, and physician/investigators might share some of these misconceptions. Efforts to educate providers and participants about the underlying goals of clinical trials are needed.	Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Dept Paediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA USA; Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Weeks, JC (corresponding author), Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Dept Paediat Oncol, 454 BRK Suite 21,44 Binney St, Boston, MA 02115 USA.		Joffe, Steven/H-3941-2019; Cleary, Paul/AAF-7048-2019	Joffe, Steven/0000-0002-0667-7384; 	AHRQ HHS [T32 HS00063] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000063] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Aaronson NK, 1996, J CLIN ONCOL, V14, P984, DOI 10.1200/JCO.1996.14.3.984; Advisory Committee on Human Radiation Experiments, 1996, FIN REP; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA, V7; Bjorn E, 1999, J MED ETHICS, V25, P263, DOI 10.1136/jme.25.3.263; *COMPR WORK GROUP, 2001, REC DEV INF CONS DOC; DAUGHERTY C, 1995, J CLIN ONCOL, V13, P1062, DOI 10.1200/JCO.1995.13.5.1062; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; FREEDMAN B, 1992, CLIN RES, V40, P653; HOWARD JM, 1981, CONTROL CLIN TRIALS, V2, P287, DOI 10.1016/0197-2456(81)90019-2; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; LEVINE RJ, 1986, ETHICS REGULATION CL; McCarthy CR, 1998, CONSENT SEEKING JUST, P11; MEISEL A, 1977, AM J PSYCHIAT, V134, P285; Miller CK, 1996, PHARMACOTHERAPY, V16, P872; Miller FG, 1998, JAMA-J AM MED ASSOC, V280, P1449, DOI 10.1001/jama.280.16.1449; Moreno J, 1998, JAMA-J AM MED ASSOC, V280, P1951, DOI 10.1001/jama.280.22.1951; MORROW G, 1978, CANCER, V42, P793, DOI 10.1002/1097-0142(197808)42:2<793::AID-CNCR2820420252>3.0.CO;2-C; *NAT COMM PROT HUM, 1998, ETH RES HUM SUBJ SEL, P19; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; PENMAN DT, 1984, J CLIN ONCOL, V2, P849, DOI 10.1200/JCO.1984.2.7.849; RIECKEN HW, 1982, JAMA-J AM MED ASSOC, V248, P344, DOI 10.1001/jama.248.3.344; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; SIMES RJ, 1986, BRIT MED J, V293, P1065, DOI 10.1136/bmj.293.6554.1065; SKRUTKOWSKI M, 1998, IRB, P1; SUGARMAN J, 1998, ETHICS RES HUMAN SUB, P12; TAUB HA, 1986, J AM GERIATR SOC, V34, P601, DOI 10.1111/j.1532-5415.1986.tb05766.x; United States Department of Health and Human Services, 1991, FED REGISTER, V56, P28012; *WORLD MED ASS DEC, 1998, ETH RES HUM SUBJ SEL, P14	31	445	461	1	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2001	358	9295					1772	1777		10.1016/S0140-6736(01)06805-2	http://dx.doi.org/10.1016/S0140-6736(01)06805-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496FG	11734235				2022-12-01	WOS:000172385100013
J	Riolo, RL; Cohen, MD; Axelrod, R				Riolo, RL; Cohen, MD; Axelrod, R			Evolution of cooperation without reciprocity	NATURE			English	Article							SOCIAL-STRUCTURE; GREEN BEARD; GAMES	A long-standing problem in biological and social sciences is to understand the conditions required for the emergence and maintenance of cooperation in evolving populations. For many situations, kin selection(1) is an adequate explanation, although kin-recognition may still be a problem. Explanations of cooperation between non-kin include continuing interactions that provide a shadow of the future (that is, the expectation of an ongoing relationship) that can sustain reciprocity(2-4), possibly supported by mechanisms to bias interactions such as embedding the agents in a two-dimensional space(4-6) or other context-preserving networks(7). Another explanation, indirect reciprocity(8), applies when benevolence to one agent increases the chance of receiving help from others. Here we use computer simulations to show that cooperation can arise when agents donate to others who are sufficiently similar to themselves in some arbitrary characteristic. Such a characteristic, or 'tag', can be a marking, display, or other observable trait. Tag-based donation can lead to the emergence of cooperation among agents who have only rudimentary ability to detect environmental signals and, unlike models of direct(3,4) or indirect reciprocity(9,10), no memory of past encounters is required.	Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA; Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Riolo, RL (corresponding author), Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA.	rlriolo@umich.edu	Pepper, John W/O-1662-2013	Pepper, John W/0000-0001-9888-0437				Alexander RD, 1987, BIOL MORAL SYSTEMS; ALLISON PD, 1992, SOC FORCES, V71, P279, DOI 10.2307/2580012; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1984, EVOLUTION COOPERATIO, P146; BOYD R, 1989, SOC NETWORKS, V11, P213, DOI 10.1016/0378-8733(89)90003-8; COHEN M, 1999, 9901002 SANT FE I; Cohen MD, 2001, RATION SOC, V13, P5, DOI 10.1177/104346301013001001; Dawkins R., 1982, pi; DAWKINS R, 1976, SELFISH GENE 96; Grafen A, 1998, NATURE, V394, P521, DOI 10.1038/28948; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauber Mark E., 2000, Animal Cognition, V3, P113, DOI 10.1007/s100710000071; Hauber ME, 2000, TRENDS ECOL EVOL, V15, P349, DOI 10.1016/S0169-5347(00)01923-6; Holland J.H., 1995, HIDDEN ORDER ADAPTAT; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Lindgren K., 1991, ARTIF LIFE, VX, P295; LINSTER BG, 1992, SOUTH ECON J, V58, P880, DOI 10.2307/1060227; Lomborg B, 1996, AM SOCIOL REV, V61, P278, DOI 10.2307/2096335; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; NOWAK M, 1989, J THEOR BIOL, V137, P21, DOI 10.1016/S0022-5193(89)80146-8; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Riolo R, 1997, P 7 INT C GEN ALG IC, P378; ROBSON AJ, 1990, J THEOR BIOL, V144, P379, DOI 10.1016/S0022-5193(05)80082-7; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	27	425	437	0	139	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					441	443		10.1038/35106555	http://dx.doi.org/10.1038/35106555			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	494UP	11719803	Green Published			2022-12-01	WOS:000172304500041
J	Bird, SM; Brown, AJL				Bird, SM; Brown, AJL			Criminalisation of HIV transmission: implications for public health in Scotland	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HETEROSEXUAL TRANSMISSION; OUTBREAK; INFECTION; ESCAPE		MRC, Biostat Unit, Cambridge CB2 2SR, England; Univ Calif San Diego, Dept Pathol, Treatment Ctr, San Diego, CA 92103 USA	MRC Biostatistics Unit; University of California System; University of California San Diego	Bird, SM (corresponding author), MRC, Biostat Unit, Robinson Way, Cambridge CB2 2SR, England.	sheila.bird@mrc-bsu.cam.ac.uk	Leigh Brown, Andrew/F-3802-2010; Brown, Andrew Leigh/ABF-8269-2020	Leigh Brown, Andrew/0000-0002-5700-3128; Brown, Andrew Leigh/0000-0002-5700-3128				ALLARDICE G, 1992, AIDS, V6, P213, DOI 10.1097/00002030-199202000-00013; BIRD AG, 1991, BRIT MED J, V303, P351, DOI 10.1136/bmj.303.6798.351; BIRD AG, 1993, BRIT MED J, V306, P1013, DOI 10.1136/bmj.306.6884.1013; Dyer C, 2001, BRIT MED J, V322, P633, DOI 10.1136/bmj.322.7287.633; ELLIOTT R, 1999, CANADIAN HIV AIDS PO, V4, P16; *EUR PARTN NOT STU, IN PRESS QJ MED; FIELDING KL, 1995, STAT MED, V14, P1365, DOI 10.1002/sim.4780141209; Goldberg D, 1998, INT J STD AIDS, V9, P25, DOI 10.1258/0956462981920991; GORE SM, 1993, BRIT MED J, V307, P147, DOI 10.1136/bmj.307.6897.147; GORE SM, 1995, BRIT MED J, V310, P293, DOI 10.1136/bmj.310.6975.293; Hutchinson SJ, 1999, EPIDEMIOL INFECT, V123, P271, DOI 10.1017/S0950268899002836; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; MACLAREN L, 2001, HERALD          0317, P10; *MED RES COUNC, 2000, MRC EX SUMM PERS INF; MIR N, IN PRESS SEXUALLY TR; Misegades L, 2001, AIDS, V15, P534, DOI 10.1097/00002030-200103090-00017; PATTMAN RS, 1993, GENITOURIN MED, V69, P94; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; WELLINGS K, 1994, SEXUAL BEHAV BRITAIN, P155; Yirrell DI, 1997, BRIT MED J, V314, P1446, DOI 10.1136/bmj.314.7092.1446; Yirrell DL, 1999, EPIDEMIOL INFECT, V123, P277, DOI 10.1017/S0950268899002848; 2001, SCOTTISH CTR INFECT, V35, P24; 2001, SCOTTISH CTR INFECT, V35, P100; 2000, SCOTTISH CTR INFECT, V34, pS1; 2000, SCOTTISH CTR INFECT, V34, P264; 2000, SCOTTISH CTR INFECT, V34, P92	27	31	32	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2001	323	7322					1174	1177		10.1136/bmj.323.7322.1174	http://dx.doi.org/10.1136/bmj.323.7322.1174			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	495NG	11711413	Green Published, Green Submitted			2022-12-01	WOS:000172346800022
J	Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Masterman, D; Mastaglia, F; Laing, NG; Stajich, JM; Slotterbeck, B; Booze, MW; Ribble, RC; Rampersaud, E; West, SG; Gibson, RA; Middleton, LT; Roses, AD; Haines, JL; Scott, BL; Vance, JM; Pericak-Vance, MA				Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Masterman, D; Mastaglia, F; Laing, NG; Stajich, JM; Slotterbeck, B; Booze, MW; Ribble, RC; Rampersaud, E; West, SG; Gibson, RA; Middleton, LT; Roses, AD; Haines, JL; Scott, BL; Vance, JM; Pericak-Vance, MA			Complete genomic screen in parkinson disease - Evidence for multiple genes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-DIAGNOSIS; LINKAGE; MUTATIONS; TAU; EPIDEMIOLOGY; ASSOCIATION; FEATURES; ACCURACY; DEMENTIA; MODELS	Context The relative contribution of genes vs environment in idiopathic Parkinson disease (PD) is controversial. Although genetic studies have identified 2 genes in which mutations cause rare single-gene variants of PD and observational studies have suggested a genetic component, twin studies have suggested that little genetic contribution exists in the common forms of PD. Objective To identify genetic risk factors for idiopathic PD. Design, Setting, and Participants Genetic linkage study conducted 1995-2000 in which a complete genomic screen (n=344 markers) was performed in 174 families with multiple individuals diagnosed as having idiopathic PD, identified through probands in 13 clinic populations in the continental United States and Australia. A total of 870 family members were studied: 378 diagnosed as having PD, 379 unaffected by PD, and 113 with unclear status. Main Outcome Measures Logarithm of odds (lod) scores generated from parametric and nonparametric genetic linkage analysis. Results Two-point parametric maximum parametric lod score (MLOD) and multipoint nonparametric lod score (LOD) linkage analysis detected significant evidence for linkage to 5 distinct chromosomal regions: chromosome 6 in the parkin gene (MLOD = 5.07; LOD, = 5.47) in families with at least 1 individual with PD onset at younger than 40 years, chromosomes 17q (MLOD = 2.28; LOD = 2.62), 8p (MLOD = 2.01; LOD = 2.22), and 5q (MLOD = 2.39; LOD = 1.50) overall and in families with late-onset PD, and chromosome 9q (MLOD = 1.52; LOD = 2.59) in families with both levodopa-responsive and levodopa-non responsive patients. Conclusions Our data suggest that the parkin gene is important in early-onset PD and that multiple genetic factors may be important in the development of idiopathic late-onset PD.	Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Struthers Parkinson Ctr, Golden Valley, MN USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; Marshfield Clin Fdn Med Res & Educ, Dept Neurol, Marshfield, WI USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Carolina Neurol Clin, Charlotte, NC USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; GlaxoSmithKline Res & Dev, Greenford, Middx, England; GlaxoSmithKline Res & Dev, Res Triangle Pk, NC USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA	Duke University; Duke University; Emory University; University System of Ohio; Ohio State University; University of Miami; University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Marshfield Clinic; Baylor College of Medicine; Rush University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Western Australia; GlaxoSmithKline; GlaxoSmithKline; Vanderbilt University	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Box 3445, Durham, NC 27710 USA.		Scott, William/A-7593-2009; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Vance, Jeffery/0000-0003-3815-8199; Gibson, Rachel/0000-0002-1338-1290; Laing, Nigel/0000-0001-5111-3732; Scott, William/0000-0001-9336-6404	NINDS NIH HHS [P01 NS26630, P50 NS39764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, P50NS039764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Allan W, 1937, ARCH INTERN MED, V60, P424, DOI 10.1001/archinte.1937.00180030041003; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; GOLBE LI, 1991, NEUROLOGY, V41, P168, DOI 10.1212/WNL.41.2_Part_1.168; Hubble JP, 1999, NEUROLOGY, V52, pA13; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; JOHNSON WG, 1990, MOVEMENT DISORD, V5, P187, DOI 10.1002/mds.870050302; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Langston JW, 1998, ANN NEUROL, V44, pS45, DOI 10.1002/ana.410440707; Martin ER, 2001, JAMA-J AM MED ASSOC, V286, P2245, DOI 10.1001/jama.286.18.2245; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1999, ANAL HUMAN GENETIC L; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; RISCH N, 1990, AM J HUM GENET, V46, P222; Scott WK, 2000, AM J HUM GENET, V67, P19; Sveinbjornsdottir S, 2000, NEW ENGL J MED, V343, P1765, DOI 10.1056/NEJM200012143432404; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Vance Jeffery M., 1998, P213; VIEREGGE P, 1992, NEUROLOGY, V42, P1453, DOI 10.1212/WNL.42.8.1453; WARD CD, 1990, ADV NEUROL, V53, P245; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5	31	223	234	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2239	2244		10.1001/jama.286.18.2239	http://dx.doi.org/10.1001/jama.286.18.2239			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710888	Bronze			2022-12-01	WOS:000172129700017
J	Chan, CLH; Meyer, FJ; Hay, RJ; Burnand, KG				Chan, CLH; Meyer, FJ; Hay, RJ; Burnand, KG			Toe ulceration associated with compression bandaging: observational study	BRITISH MEDICAL JOURNAL			English	Article							ULCERS	Foot ulcers can be caused by arterial insufficiency, diabetes mellitus, neuropathy, musculoskeletal. disorders, or injury.(1) The clinical features of an ulcer-such as site, shape, edge, base, and state of the surrounding tissues-often give some indication of its aetiology and aid in further management and treatment. Ulceration of the foot is seen in some patients with venous disease but has not been observed in association with any particular treatment regimen.(2) We describe a previously unreported finding of ulceration of the toe and cleft, for which there was no demonstrable ischaemic or vasculitic cause, developing in patients treated with compression bandaging for venous ulcers.	Guys Kings & St Thomas Sch Med, St Johns Inst Dermatol, London SE1 7EH, England; Guys & St Thomass NHS Trust, Dept Surg, London SE1 7EH, England	University of London; King's College London	Burnand, KG (corresponding author), Guys Kings & St Thomas Sch Med, St Johns Inst Dermatol, London SE1 7EH, England.							Dale J, 1983, Nurs Times, V79, P49; HANSSON C, 1987, ACTA DERM-VENEREOL, V67, P341; NELZEN O, 1994, BRIT J SURG, V81, P182, DOI 10.1002/bjs.1800810206; PARTSCH H, 1997, FRONTIERS COMPUTER A, P145; Sumpio BE, 2000, NEW ENGL J MED, V343, P787, DOI 10.1056/NEJM200009143431107	5	15	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2001	323	7321					1099	1099		10.1136/bmj.323.7321.1099	http://dx.doi.org/10.1136/bmj.323.7321.1099			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701575	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000172188400014
J	Bradley, KA; Mogridge, J; Mourez, M; Collier, RJ; Young, JAT				Bradley, KA; Mogridge, J; Mourez, M; Collier, RJ; Young, JAT			Identification of the cellular receptor for anthrax toxin	NATURE			English	Article							PROTECTIVE ANTIGEN; LETHAL FACTOR; CRYSTAL-STRUCTURE; ADENYLATE-CYCLASE; MAMMALIAN-CELLS; EDEMA FACTOR; HIGH-TITER; I-DOMAIN; MACROPHAGES; LIBRARIES	The tripartite toxin secreted by Bacillus anthracis, the causative agent of anthrax, helps the bacterium evade the immune system and can kill the host during a systemic infection. Two components of the toxin enzymatically modify substrates within the cytosol of mammalian cells: oedema factor (OF) is an adenylate cyclase that impairs host defences through a variety of mechanisms including inhibiting phagocytosis(1,2); lethal factor (LF) is a zinc-dependent protease that cleaves mitogen-activated protein kinase kinase and causes lysis of macrophages(3-5). Protective antigen (PA), the third component, binds to a cellular receptor and mediates delivery of the enzymatic components to the cytosol. Here we describe the cloning of the human PA receptor using a genetic complementation approach. The receptor, termed ATR (anthrax toxin receptor), is a type I membrane protein with an extracellular von Willebrand factor A domain that binds directly to PA. In addition, a soluble version of this domain can protect cells from the action of the toxin.	Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; Harvard Univ, Sch Med, Biol & Biomed Sci Grad Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Young, JAT (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.			Collier, R John/0000-0002-2427-4239				Beauregard KE, 1999, INFECT IMMUN, V67, P3026, DOI 10.1128/IAI.67.6.3026-3030.1999; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Dickeson SK, 1998, CELL MOL LIFE SCI, V54, P556, DOI 10.1007/s000180050184; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; ESCUYER V, 1991, INFECT IMMUN, V59, P3381, DOI 10.1128/IAI.59.10.3381-3386.1991; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; FRIEDLANDER AM, 1993, INFECT IMMUN, V61, P245, DOI 10.1128/IAI.61.1.245-252.1993; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; KOEHLER TM, 1991, MOL MICROBIOL, V5, P1501, DOI 10.1111/j.1365-2958.1991.tb00796.x; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MILNE JC, 1993, MOL MICROBIOL, V10, P647, DOI 10.1111/j.1365-2958.1993.tb00936.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mogridge J, 2001, J BACTERIOL, V183, P2111, DOI 10.1128/JB.183.6.2111-2116.2001; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Snitkovsky S, 2000, J VIROL, V74, P9540, DOI 10.1128/JVI.74.20.9540-9545.2000; St Croix B, 2000, SCIENCE, V289, P1197; TAFT SA, 1994, ENVIRON MOL MUTAGEN, V23, P96, DOI 10.1002/em.2850230204; Varughese M, 1999, INFECT IMMUN, V67, P1860; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704	31	714	791	2	62	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					225	229		10.1038/n35101999	http://dx.doi.org/10.1038/n35101999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700562				2022-12-01	WOS:000172029100052
J	Chai, JJ; Wu, Q; Shiozaki, E; Srinivasula, SM; Alnemri, ES; Shi, YG				Chai, JJ; Wu, Q; Shiozaki, E; Srinivasula, SM; Alnemri, ES; Shi, YG			Crystal structure of a procaspase-7 zymogen: Mechanisms of activation and substrate binding	CELL			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; 3-DIMENSIONAL STRUCTURE; BRAIN INJURY; APOPTOSIS; CASPASE-8; COMPLEX; SYSTEM; DEATH	Apoptosis is primarily executed by active caspases, which are derived from the inactive procaspase zymogens through proteolytic cleavage. Here we report the crystal structures of a caspase zymogen, procaspase-7, and an active caspase-7 without any bound inhibitors. Compared to the inhibitor-bound caspase-7, procaspase-7 zymogen exhibits significant structural differences surrounding the catalytic cleft, which precludes the formation of a productive conformation. Proteolytic cleavage between the large and small subunits allows rearrangement of essential loops in the active site, priming active caspase-7 for inhibitor/substrate binding. Strikingly, binding by inhibitors causes a 180 degrees flipping of the N terminus in the small subunit, which interacts with and stabilizes the catalytic cleft. These analyses reveal the structural mechanisms of caspase activation and demonstrate that the inhibitor/substrate binding is a process of induced fit.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Princeton University; Jefferson University	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu	Alnemri, Emad S/B-4526-2010	Shi, Yigong/0000-0003-2030-168X; Chai, Jijie/0000-0001-7591-3873	NATIONAL CANCER INSTITUTE [R01CA090269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER; NCI NIH HHS [CA90269] Funding Source: Medline; NIA NIH HHS [AG14357] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045; Horvitz HR, 1999, CANCER RES, V59, p1701S; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(01)00274-4; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Shi YG, 2001, NAT STRUCT BIOL, V8, P394, DOI 10.1038/87548; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Srinivasula SM, 1998, J BIOL CHEM, V273, P10107, DOI 10.1074/jbc.273.17.10107; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; THOMBERRY NA, 1992, NATURE, V356, P768; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	39	194	198	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2001	107	3					399	407		10.1016/S0092-8674(01)00544-X	http://dx.doi.org/10.1016/S0092-8674(01)00544-X			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701129	Bronze			2022-12-01	WOS:000172022800010
J	Begbie, J; Graham, A				Begbie, J; Graham, A			Integration between the epibranchial placodes and the hindbrain	SCIENCE			English	Article							NEURAL CREST CELLS; CHICK HINDBRAIN; MIGRATION; GANGLIA; EMBRYO; INDUCTION; ENDODERM; MESODERM; ABSENCE; REGION	Developmental integration results from coordination among components of different embryonic fields to realize the later anatomical and functional relationships. We demonstrate that in the chick head, integration between the epibranchial placodes and the hindbrain is achieved as the neuroglial hindbrain crest cells guide the epibranchial neuronal. cells inward to establish their central connections. This work defines a role for the neuroglial hindbrain crest in organizing the afferent innervation of the hindbrain.	UCL, MRC, Ctr Dev Neurobiol, London SE1 9RT, England	University of London; University College London	Graham, A (corresponding author), UCL, MRC, Ctr Dev Neurobiol, 4th Floor,New Hunts House,Guys Campus, London SE1 9RT, England.	anthony.graham@kcl.ac.uk	graham, anthony/B-1864-2008	graham, anthony/0000-0003-2011-7188				Ariens Kappers C. N., 1960, COMP ANATOMY NERVOUS; AYERLELIEVRE CS, 1982, DEV BIOL, V94, P291, DOI 10.1016/0012-1606(82)90349-9; Baker CVH, 1997, DEVELOPMENT, V124, P3077; Barlow LA, 1997, DEVELOPMENT, V124, P949; Begbie J, 1999, DEVELOPMENT, V126, P895; BIRTSCH S, 2001, GENE DEV, V15, P66; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; GRAHAM A, 1993, DEVELOPMENT, V119, P233; Graham A, 2001, BIOESSAYS, V23, P54, DOI 10.1002/1521-1878(200101)23:1<54::AID-BIES1007>3.0.CO;2-5; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; SIMON H, 1994, J NEUROBIOL, V25, P1129, DOI 10.1002/neu.480250908; TOSNEY KW, 1982, DEV BIOL, V89, P13, DOI 10.1016/0012-1606(82)90289-5; Trainor P, 2000, NAT CELL BIOL, V2, P96, DOI 10.1038/35000051; Veitch E, 1999, CURR BIOL, V9, P1481, DOI 10.1016/S0960-9822(00)80118-9	20	77	78	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					595	598		10.1126/science.1062028	http://dx.doi.org/10.1126/science.1062028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641498				2022-12-01	WOS:000171695600047
J	Urban, S; Lee, JR; Freeman, M				Urban, S; Lee, JR; Freeman, M			Drosophila Rhomboid-1 defines a family of putative intramembrane serine proteases	CELL			English	Article							EGF RECEPTOR; SIGNALING PATHWAY; ALZHEIMERS-DISEASE; GXXXG MOTIF; GENE; STAR; PROTEINS; SPITZ; PROVIDENCIA; ASSOCIATION	The polytopic membrane protein Rhomboid-1 promotes the cleavage of the membrane-anchored TGF alpha -like growth factor Spitz, allowing it to activate the Drosophila EGF receptor. Until now, the mechanism of this key signaling regulator has been obscure, but our analysis suggests that Rhomboid-1 is a novel intramembrane serine protease that directly cleaves Spitz. In accordance with the putative Rhomboid active site being in the membrane bilayer, Spitz is cleaved within its transmembrane domain, and thus is, to our knowledge, the first example of a growth factor activated by regulated intramembrane proteolysis. Rhomboid-1 is conserved throughout evolution from archaea to humans, and our results show that a human Rhomboid promotes Spitz cleavage by a similar mechanism. This growth factor activation mechanism may therefore be widespread.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Freeman, Matthew/0000-0003-0410-5451				Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Bang AG, 2000, GENE DEV, V14, P177; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; BOEL E, 1988, LIPIDS, V23, P701, DOI 10.1007/BF02535672; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DATTA S, 1988, J BIOL CHEM, V263, P1107; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fersht A, 1999, STRUCTURE MECH PROTE; FERSHT AR, 1973, BIOCHEMISTRY-US, V12, P2035, DOI 10.1021/bi00735a002; FREEMAN M, 1992, DEVELOPMENT, V116, P335; Gallio M, 2000, CURR BIOL, V10, pR693, DOI 10.1016/S0960-9822(00)00722-3; GOLEMBO M, 1996, DEVELOPMENT, V122, P3360; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Guichard A, 2000, DEV BIOL, V226, P255, DOI 10.1006/dbio.2000.9851; Guichard A, 1999, DEVELOPMENT, V126, P2663; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Rather PN, 1999, J BACTERIOL, V181, P7185, DOI 10.1128/JB.181.23.7185-7191.1999; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Salvesen G.S., 2001, PROTEOLYTIC ENZYMES; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; VERNET T, 1995, J BIOL CHEM, V270, P16645, DOI 10.1074/jbc.270.28.16645; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3	46	461	483	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					173	182		10.1016/S0092-8674(01)00525-6	http://dx.doi.org/10.1016/S0092-8674(01)00525-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672525	Bronze			2022-12-01	WOS:000171694800007
J	Pradillon, F; Shillito, B; Young, CM; Gaill, F				Pradillon, F; Shillito, B; Young, CM; Gaill, F			Deep-seaecology - Developmental arrest in vent worm embryos	NATURE			English	Article							LARVAL DISPERSAL; HOT		Univ Paris 06, Unite Mixte Rech, F-75252 Paris 05, France; Harbor Branch Oceanog Inst Inc, Div Marine Sci, Ft Pierce, FL 34946 USA	UDICE-French Research Universities; Sorbonne Universite; Harbor Branch Oceanographic Institute Foundation	Pradillon, F (corresponding author), Univ Paris 06, Unite Mixte Rech, 7 Quai St Bernard, F-75252 Paris 05, France.	francoise.gaill@snv.jussieu.fr	Pradillon, Florence/AAM-2992-2020	Pradillon, Florence/0000-0002-6473-6290				Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; CHEVALDONNE P, 1992, NATURE, V359, P593, DOI 10.1038/359593b0; EDMOND JM, 1982, NATURE, V297, P187, DOI 10.1038/297187a0; LUTZ RA, 1980, MAR BIOL, V57, P127, DOI 10.1007/BF00387378; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; MULLINEAUX LS, 1995, SEAFLOOR HYDROTHERMA, P408; YOUNG CM, 1989, OLSEN INT S, P225; YOUNG CM, 1993, LIMNOL OCEANOGR, V38, P178; ZOTTOLI R, 1983, Proceedings of the Biological Society of Washington, V96, P379	9	80	88	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					698	699		10.1038/35099674	http://dx.doi.org/10.1038/35099674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607020				2022-12-01	WOS:000171608000032
J	Heller, D				Heller, D			Validity of the evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MMR VACCINATION; AUTISM 1998; CAUSAL		Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Evidence Populat Hlth Unit, Manchester M13 9PT, Lancs, England	University of Manchester	Heller, D (corresponding author), Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Evidence Populat Hlth Unit, Manchester M13 9PT, Lancs, England.	Dick.Heller@man.ac.uk						Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; Gellin BG, 2001, NEW ENGL J MED, V344, P372, DOI 10.1056/NEJM200102013440509; HELLER RC, IN PRESS J EPIDEMIOL; *I MED, 2001, IMM SAF REV MEASL MU; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Nicoll A, 1998, BMJ-BRIT MED J, V316, P715, DOI 10.1136/bmj.316.7133.715; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Roberts R, 1998, BRIT MED J, V316, P1824, DOI 10.1136/bmj.316.7147.1824; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P1356, DOI 10.1016/S0140-6736(05)79083-8; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Wise Jacqui, 2001, BMJ-BRIT MED J, V322, P130	12	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2001	323	7317					839	840						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11683152				2022-12-01	WOS:000171650500027
J	West, GB; Brown, JH; Enquist, BJ				West, GB; Brown, JH; Enquist, BJ			A general model for ontogenetic growth	NATURE			English	Article							BODY-SIZE; LIFE; LAWS	Several equations have been proposed to describe ontogenetic growth trajectories for organisms justified primarily on the goodness of rt rather than on any biological mechanism(1-6). Here, we derive a general quantitative model based on fundamental principles(7-9) for the allocation of metabolic energy between maintenance of existing tissue and the production of new biomass. We thus predict the parameters governing growth curves from basic cellular properties(10) and derive a single parameterless universal curve that describes the growth of many diverse species. The model provides the basis for deriving allometric relationships for growth rates and the timing of life history events(2,11,12).	Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; University of New Mexico; University of Arizona	West, GB (corresponding author), Los Alamos Natl Lab, Div Theoret, MS B285, Los Alamos, NM 87545 USA.	gbw@lanl.gov	Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096				ALBERTS M, 1994, MOL BIOL CELL; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; BRETT JR, 1989, J FISH RES BOARD CAN, V22, P1491; Brody S, 1964, BIOENERGETICS GROWTH; Brown J., 2000, SCALING BIOL; Calder W. A, 1984, SIZE FUNCTION LIFE H; Charnov Eric L., 1993, P1; Cummins K. W, 1971, Mitt int Verein theor angew Limnol, VNo. 18, P1; Day T, 1997, AM NAT, V149, P381, DOI 10.1086/285995; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; HAMBURGER K, 1983, MAR BIOL, V75, P303, DOI 10.1007/BF00406016; KOHLER AC, 1964, J FISH RES BOARD CAN, V21, P57, DOI 10.1139/f64-007; Kozlowski J, 1996, P ROY SOC B-BIOL SCI, V263, P559, DOI 10.1098/rspb.1996.0084; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reiss M. J., 1989, ALLOMETRY GROWTH REP; Ricker WE., 1979, FISH PHYSIOL, P677, DOI [DOI 10.1016/S1546-5098(08)60034-5, 10.1016/S1546-5098(08)60034-5]; ROGERS DM, 1995, J APPL PHYSIOL, V79, P958, DOI 10.1152/jappl.1995.79.3.958; Stearns S.C., 1992, pi; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; WEATHERS WW, 1995, IBIS, V137, P532, DOI 10.1111/j.1474-919X.1995.tb03263.x; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; XIAOJUN X, 1990, Physiological Zoology, V63, P1181	24	769	806	10	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					628	631		10.1038/35098076	http://dx.doi.org/10.1038/35098076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675785				2022-12-01	WOS:000171485700048
J	[Anonymous]				[Anonymous]			THE RIGHT-TO-DIE	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 1	1994	308	6920					66	66						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ096	11644505				2022-12-01	WOS:A1994MQ09600081
J	BURKHART, J				BURKHART, J			AMA POLICY FOR TESTING HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											BURKHART, J (corresponding author), AMER MED ASSOC,DEPT RESIDENT PHYSICIAN SERV,515 N STATE ST,CHICAGO,IL 60610, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	1992	267	6					792	792						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC484	11642977				2022-12-01	WOS:A1992HC48400008
J	Xu, W; Chen, HW; Du, KY; Asahara, H; Tini, M; Emerson, BM; Montminy, M; Evans, RM				Xu, W; Chen, HW; Du, KY; Asahara, H; Tini, M; Emerson, BM; Montminy, M; Evans, RM			A transcriptional switch mediated by cofactor methylation	SCIENCE			English	Article							NUCLEAR-RECEPTOR FUNCTION; SOMATOSTATIN GENE; COACTIVATOR; PROTEIN; CBP/P300; CREB; PHOSPHORYLATION; BINDING; CBP; IDENTIFICATION	We describe a molecular switch based on the controlled methylation of nucleosome and the transcriptional cofactors, the CREB-binding proteins (CBP)/ p300. The CBP/p300 methylation site is localized to an arginine residue that is essential for stabilizing the structure of the KIX domain, which mediates CREB recruitment. Methylation of KIX by coactivator-associated arginine methyl-transferase 1 (CARM1) blocks CREB activation by disabling the interaction between KIX and the kinase inducible domain (KID) of CREB. Thus, CARM1 functions as a corepressor in cyclic adenosine monophosphate signaling pathway via its methyltransferase activity while acting as a coactivator for nuclear hormones. These results provide strong in vivo and in vitro evidence that histone methylation plays a key role in hormone-induced gene activation and define cofactor methylation as a new regulatory mechanism in hormone signaling.	Univ Calif Davis, Canc Ctr Basic Sci, Gene Express Lab, Sacramento, CA 95817 USA; Univ Calif Davis, Canc Ctr Basic Sci, Dept Biol Chem, Sacramento, CA 95817 USA; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of California System; University of California Davis; University of California System; University of California Davis; Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Univ Calif Davis, Canc Ctr Basic Sci, Gene Express Lab, Sacramento, CA 95817 USA.		, MT/AAU-2370-2020; zhang, shijun/K-3688-2013	Evans, Ronald/0000-0002-9986-5965	NIDDK NIH HHS [9R01DK57978] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Aleta JM, 1998, TRENDS BIOCHEM SCI, V23, P89, DOI 10.1016/S0968-0004(98)01185-2; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodman RH, 2000, GENE DEV, V14, P1553; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Lemon BD, 1999, CURR OPIN GENET DEV, V9, P499, DOI 10.1016/S0959-437X(99)00010-6; McEwan IJ, 2000, BIOCHEM SOC T, V28, P369, DOI 10.1042/0300-5127:0280369; McKenna NJ, 2000, J STEROID BIOCHEM, V74, P351, DOI 10.1016/S0960-0760(00)00112-6; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MONTMINY MR, 1986, J NEUROSCI, V6, P1171; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; ONATE SA, 1995, SCIENCE, V270, P1354; Parker D, 1999, MOL CELL BIOL, V19, P5601; Parker D, 1996, MOL CELL BIOL, V16, P694; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5	34	315	328	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2507	2511		10.1126/science.1065961	http://dx.doi.org/10.1126/science.1065961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11701890				2022-12-01	WOS:000172927700046
J	Petersen, S; Casellas, R; Reina-San-Martin, B; Chen, HT; Difilippantonio, MJ; Wilson, PC; Hanitsch, L; Celeste, A; Muramatsu, M; Pilch, DR; Redon, C; Ried, T; Bonner, WM; Honjo, T; Nussenzweig, MC; Nussenzweig, A				Petersen, S; Casellas, R; Reina-San-Martin, B; Chen, HT; Difilippantonio, MJ; Wilson, PC; Hanitsch, L; Celeste, A; Muramatsu, M; Pilch, DR; Redon, C; Ried, T; Bonner, WM; Honjo, T; Nussenzweig, MC; Nussenzweig, A			AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching	NATURE			English	Article							DOUBLE-STRAND BREAKS; CYTIDINE DEAMINASE AID; HEAVY-CHAIN SWITCH; SOMATIC HYPERMUTATION; B-CELLS; IMMUNOGLOBULIN GENES; DNA-DAMAGE; RECOMBINATION; REPAIR; SEQUENCES	Class switch recombination (CSR) is a region-specific DNA recombination reaction that replaces one immunoglobulin heavy-chain constant region (CH) gene with another. This enables a single variable (V) region gene to be used in conjunction with different downstream CH genes, each having a unique biological activity. The molecular mechanisms that mediate CSR have not been defined, but activation-induced cytidine deaminase (AID), a putative RNA-editing enzyme, is required for this reaction(1). Here we report that the Nijmegen breakage syndrome protein (Nbs1) and phosphorylated H2A histone family member X (gamma -H2AX, also known as gamma -H2afx), which facilitate DNA double-strand break (DSB) repair(2-4), form nuclear foci at the CH region in the G1 phase of the cell cycle in cells undergoing CSR, and that switching is impaired in H2AX(-/-) mice. Localization of Nbs1 and gamma -H2AX to the IgH locus during CSR is dependent on AID. In addition, AID is required for induction of switch region (S mu)-specific DNA lesions that precede CSR. These results place AID function upstream of the DNA modifications that initiate CSR.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Kyoto University	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.		Muramatsu, Masamichi/C-4339-2015; Reina-San-Martin, Bernardo/I-9484-2016; Nussenzweig, Michel/AAE-7292-2019; Honjo, Tasuku/N-4470-2016; Difilippantonio, Michael/AAF-2839-2021	Muramatsu, Masamichi/0000-0002-0153-3533; Reina-San-Martin, Bernardo/0000-0003-2083-6166; Difilippantonio, Michael/0000-0002-4676-7034; Hanitsch, Leif G./0000-0002-8181-0093	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; DIVISION OF CLINICAL SCIENCES - NCI [Z01SC010298] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; DUNNICK W, 1989, MOL CELL BIOL, V9, P1850, DOI 10.1128/MCB.9.5.1850; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Li MJ, 1996, P NATL ACAD SCI USA, V93, P10222, DOI 10.1073/pnas.93.19.10222; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; WINTER E, 1987, EMBO J, V6, P1663, DOI 10.1002/j.1460-2075.1987.tb02415.x; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	30	407	418	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					660	665		10.1038/414660a	http://dx.doi.org/10.1038/414660a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740565	Green Accepted			2022-12-01	WOS:000172535600053
J	Ye, YH; Meyer, HH; Rapoport, TA				Ye, YH; Meyer, HH; Rapoport, TA			The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE-FUSION; ENDOPLASMIC-RETICULUM; MEDIATED PROTEOLYSIS; UBIQUITIN; DEGRADATION; PROTEASOME; PATHWAY; P97; MECHANISM	In eukaryotic cells, incorrectly folded proteins in the endoplasmic reticulum (ER) are exported into the cytosol and degraded by the proteasome(1). This pathway is co-opted by some viruses. For example, the US11 protein of the human cytomegalovirus targets the major histocompatibility complex class I heavy chain for cytosolic degradation(2). How proteins are extracted from the ER membrane is unknown. In bacteria and mitochondria, members of the AAA ATPase family are involved in extracting and degrading membrane proteins(3,4). Here we demonstrate that another member of this family, Cdc48 in yeast and p97 in mammals, is required for the export of ER proteins into the cytosol. Whereas Cdc48/p97 was previously known to function in a complex with the cofactor p47 (ref. 5) in membrane fusion(6-8), we demonstrate that its role in ER protein export requires the interacting partners Ufd1 and Npl4. The AAA ATPase interacts with substrates at the ER membrane and is needed to release them as polyubiquitinated species into the cytosol. We propose that the Cdc48/p97-Ufd1-Npl4 complex extracts proteins from the ER membrane for cytosolic degradation.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Yale University	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.		Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796				ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DeHoratius C, 1996, MOL BIOL CELL, V7, P1835, DOI 10.1091/mbc.7.11.1835; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Schmidt M, 1999, CURR OPIN CHEM BIOL, V3, P584, DOI 10.1016/S1367-5931(99)00013-7; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Thuret JY, 1996, CELL, V86, P565, DOI 10.1016/S0092-8674(00)80130-0; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	30	859	878	2	60	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					652	656		10.1038/414652a	http://dx.doi.org/10.1038/414652a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740563				2022-12-01	WOS:000172535600051
J	Liou, TG; Adler, FR; Cahill, BC; FitzSimmons, SC; Huang, D; Hibbs, JR; Marshall, BC				Liou, TG; Adler, FR; Cahill, BC; FitzSimmons, SC; Huang, D; Hibbs, JR; Marshall, BC			Survival effect of lung transplantation among patients with cystic fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH; PREDICTION; MODEL; FEV1	Context Patients with cystic fibrosis (CF) are the second largest group of lung transplant recipients in the United States. The survival effect of transplantation on a general CF population has not previously been measured. Objective To determine the impact of bilateral lung transplantation on survival in patients with CF. Design, Setting, and Patients Retrospective observational cohort study of 11630 CF patients who did not undergo lung transplantation (controls) and 468 transplant recipients with CF from 115 CF centers in the United States, 1992-1998. Patients were stratified into 5 groups based on a 5-year survival prediction model (survival group 1: <30%; survival group 2:30 to <50%; survival groups 3-5: 50 to <100%.) Main Outcome Measure Five-year survival from date of transplantation in 1992-1997 in the transplant group and from January 1, 1993, in the control group. Results Lung transplantation increased 5-year survival of CF patients in survival group 1. Survival group 2 had equivocal survival effects, and groups 3-5 had negative survival effects from transplantation. From 1994-1997, there was a mean annual prevalence of 238 patients in survival group 1 and mean annual incidence of 154 patients entering the group, approximately 1.5 times the number of lung transplantations performed each year in CF patients (mean, 104). Use of the criterion of forced expiratory volume in 1 second of less than 30% resulted in an equivocal survival benefit and identified 1458 potential candidates for transplantation in 1993. Conclusions Cystic fibrosis patients in group 1 have improved 5-year survival after lung transplantation. The majority of patients with CF have equivocal or negative Survival effects from the procedure. Selection of patients with CF for transplantation based on group 1 survival predictions maximizes survival benefits to individuals and may reduce the demand for scarce donor organs.	Univ Utah, Div Resp Crit Care & Occupat Pulm Med, Salt Lake City, UT 84132 USA; Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Lung Transplantat Program, Salt Lake City, UT USA; Univ Utah, Intermt Cyst Fibrosis Program, Salt Lake City, UT USA; Cyst Fibrosis Fdn, Dept Med, Bethesda, MD USA; Salt Lake Vet Affairs Med Ctr, Salt Lake City, UT USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; New York State Dept Hlth, Albany, NY USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Cystic Fibrosis Foundation; US Department of Veterans Affairs; University of California System; University of California Los Angeles; State University of New York (SUNY) System	Liou, TG (corresponding author), Univ Utah, Div Resp Crit Care & Occupat Pulm Med, 50 N Med Dr, Salt Lake City, UT 84132 USA.	ted.liou@m.cc.utah.edu	Liou, Theodore/AAI-3667-2021	Liou, Theodore/0000-0003-0121-4847	NHLBI NIH HHS [K08 HL003656-04, K08 HL003656-03, HL-03656, K08 HL003656-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003656] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1998, Am J Respir Crit Care Med, V158, P335; [Anonymous], 1999, CYST FIBR FDN PAT RE; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Doershuk CF, 1999, CHEST, V115, P782, DOI 10.1378/chest.115.3.782; EGAN TM, 1995, J THORAC CARDIOV SUR, V109, P224, DOI 10.1016/S0022-5223(95)70383-7; Evans R W, 1990, Clin Transpl, P329; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hayllar KM, 1997, THORAX, V52, P313, DOI 10.1136/thx.52.4.313; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; HUANG NN, 1987, AM J MED, V82, P871, DOI 10.1016/0002-9343(87)90147-1; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kurland G, 2001, PEDIATRICS, V107, P1419, DOI 10.1542/peds.107.6.1419; Lai HC, 1998, J PEDIATR-US, V132, P478, DOI 10.1016/S0022-3476(98)70024-1; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1973, BIOMETRICS, V29, P479, DOI 10.2307/2529171; Mantel N, 1985, Natl Cancer Inst Monogr, V67, P169; Milla CE, 1998, CHEST, V113, P1230, DOI 10.1378/chest.113.5.1230; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Quittner AL, 2000, J PEDIATR PSYCHOL, V25, P403, DOI 10.1093/jpepsy/25.6.403; RAMIREZ JC, 1992, J THORAC CARDIOV SUR, V103, P287; Robinson W, 2000, PEDIATR PULM, V30, P198, DOI 10.1002/1099-0496(200009)30:3<198::AID-PPUL3>3.0.CO;2-E; SHARPLES L, 1993, J HEART LUNG TRANSPL, V12, P669; Starnes VA, 1996, J THORAC CARDIOV SUR, V112, P1284, DOI 10.1016/S0022-5223(96)70142-3; TAUSSIG LM, 1973, J PEDIATR-US, V82, P380, DOI 10.1016/S0022-3476(73)80110-6; *US DEP HHS, 1999, 1999 ANN REP US SCI; VENABLES WN, 1997, MODERN APPL STAT S P; Yankaskas JR, 1998, CHEST, V113, P217, DOI 10.1378/chest.113.1.217; Zar, 2011, BIOSTAT ANAL	30	133	135	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2683	2689		10.1001/jama.286.21.2683	http://dx.doi.org/10.1001/jama.286.21.2683			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730443	Bronze, Green Accepted			2022-12-01	WOS:000172488300027
J	Poser, CM; Brinar, VV				Poser, CM; Brinar, VV			Problems with diagnostic criteria for multiple sclerosis	LANCET			English	Editorial Material							PREDICT CONVERSION; MRI		Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Zagreb, Fac Med, Dept Neurol, Zagreb 41000, Croatia	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Zagreb; University of Zagreb, School of Dental Medicine	Poser, CM (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA.	oposer@caregroup.harvard.edu						Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; FAZEKAS F, 1988, NEUROLOGY, V38, P1822, DOI 10.1212/WNL.38.12.1822; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; Tintore M, 2000, AM J NEURORADIOL, V21, P702; VINUELA FV, 1982, AM J NEURORADIOL, V3, P277	8	17	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2001	358	9295					1746	1747		10.1016/S0140-6736(01)06842-8	http://dx.doi.org/10.1016/S0140-6736(01)06842-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FG	11734228				2022-12-01	WOS:000172385100006
J	Vajda, V; Raine, JI; Hollis, CJ				Vajda, V; Raine, JI; Hollis, CJ			Indication of global deforestation at the Creataceous-Tertiary boundary by New Zealand fern spike	SCIENCE			English	Article							K-T-BOUNDARY; CONTIGUOUS STRATA; WESTERN CANADA; IMPACT; EXTINCTIONS; WILDFIRES	The devastating effect on terrestrial plant communities of a bolide impact at the Cretaceous-Tertiary boundary is shown in fossil pollen and spore assemblages by a diverse flora being abruptly replaced by one dominated by a few species of fern. Well documented in North America, this fern spike signals widespread deforestation due to an impact winter or massive wildfires. A Southern Hemisphere record of a fern spike, together with a large iridium anomaly, indicates that the devastation was truly global. Recovery of New Zealand plant communities followed a pattern consistent with major climatic perturbations occurring after an impact winter that was possibly preceded by global wildfires.	Lund Univ, Dept Geol, SE-22363 Lund, Sweden; Inst Geol & Nucl Sci, Lower Hutt, New Zealand	Lund University; GNS Science - New Zealand	Vajda, V (corresponding author), Lund Univ, Dept Geol, Tomavagen 13, SE-22363 Lund, Sweden.		Vajda, Vivi/N-7693-2018; Hollis, Christopher/D-3560-2011; Raine, James I/D-5124-2009	Vajda, Vivi/0000-0003-2987-5559; Hollis, Christopher/0000-0001-8840-9852; Raine, James I/0000-0001-5294-2102				BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; DHondt S, 1996, GEOLOGY, V24, P611, DOI 10.1130/0091-7613(1996)024<0611:OMRTTC>2.3.CO;2; HEYMANN D, 1996, GEOL SOC AM SPEC PAP, V307, P453; HOLLIS CJ, 1995, GEOLOGY, V23, P835, DOI 10.1130/0091-7613(1995)023<0835:SPBITE>2.3.CO;2; HOLLIS CJ, 2000, GEOL SOC NZ MISC P A, V108, P78; JOHNSON KR, 1989, NATURE, V340, P708, DOI 10.1038/340708a0; JOHNSON KR, 1993, NATURE, V366, P511, DOI 10.1038/366511a0; Jones TP, 2000, PALAEOGEOGR PALAEOCL, V164, P57, DOI 10.1016/S0031-0182(00)00175-9; MELOSH HJ, 1990, NATURE, V343, P251, DOI 10.1038/343251a0; NICHOLS DJ, 1990, GEOLOGICAL SOC AM SP, V247, P445; NICHOLS DJ, 1990, EXTINCTION EVENTS EA, P351; PLAYFORD G, 1978, Pollen et Spores, V20, P513; Pope KO, 1997, J GEOPHYS RES-PLANET, V102, P21645, DOI 10.1029/97JE01743; SAITO T, 1986, NATURE, V323, P253, DOI 10.1038/323253a0; Scott AC, 2000, PALAEOGEOGR PALAEOCL, V164, P381, DOI 10.1016/S0031-0182(00)00182-6; SHARPTON VL, 1996, GEOL SOC AM SPEC PAP, V307, P55, DOI DOI 10.1130/0-8137-2307-8.55; STRONG CP, 1984, NEW ZEAL J GEOL GEOP, V27, P231, DOI 10.1080/00288306.1984.10422531; Sweet AR, 1999, CAN J EARTH SCI, V36, P743, DOI 10.1139/e98-061; SWEET AR, 1992, CRETACEOUS RES, V13, P31, DOI 10.1016/0195-6671(92)90027-N; TSCHUDY RH, 1984, SCIENCE, V225, P1030, DOI 10.1126/science.225.4666.1030; Vickers-Rich P, 1991, VERTEBRATE PALAEONTO; Wardle P., 1991, VEGETATION NZ; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; WOLBACH WS, 1988, NATURE, V334, P665, DOI 10.1038/334665a0; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; WOLFE JA, 1991, NATURE, V352, P420, DOI 10.1038/352420a0	26	170	185	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1700	1702		10.1126/science.1064706	http://dx.doi.org/10.1126/science.1064706			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721051				2022-12-01	WOS:000172307400039
J	Ajaj, A; Singh, MP; Abdulla, AJJ				Ajaj, A; Singh, MP; Abdulla, AJJ			Should elderly patients be told they have cancer? Questionnaire survey of older people	BRITISH MEDICAL JOURNAL			English	Article									Mid Staffordshire Gen Hosp, Dept Care Elderly, Stafford ST18 3SA, England		Abdulla, AJJ (corresponding author), Orpington Hosp, Dept Elderly Med, Orpington BR6 9JU, Kent, England.							Meredith C, 1996, BMJ-BRIT MED J, V313, P724; MOSCONI P, 1991, ANN ONCOL, V2, P273, DOI 10.1093/oxfordjournals.annonc.a057936; THOMSEN OO, 1993, LANCET, V341, P473, DOI 10.1016/0140-6736(93)90218-6; Wilkes E, 1984, PALLIATIVE CARE MANA	4	41	42	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 17	2001	323	7322					1160	1160		10.1136/bmj.323.7322.1160	http://dx.doi.org/10.1136/bmj.323.7322.1160			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495NG	11711408	Green Published, Bronze			2022-12-01	WOS:000172346800017
J	Gong, YQ; Slee, RB; Fukai, N; Rawadi, G; Roman-Roman, S; Reginato, AM; Wang, HW; Cundy, T; Glorieux, FH; Lev, D; Zacharin, M; Oexle, K; Marcelino, J; Suwairi, W; Heeger, S; Sabatakos, G; Apte, S; Adkins, WN; Allgrove, J; Arslan-Kirchner, M; Batch, JA; Beighton, P; Black, GCM; Boles, RG; Boon, LM; Borrone, C; Brunner, HG; Carle, GF; Dallapiccola, B; De Paepe, A; Floege, B; Halfhide, ML; Hall, B; Hennekam, RC; Hirose, T; Jans, A; Juppner, H; Kim, CA; Keppler-Noreuil, K; Kohlschuetter, A; LaCombe, D; Lambert, M; Lemyre, E; Letteboer, T; Peltonen, L; Ramesar, RS; Romanengo, M; Somer, H; Steichen-Gersdorf, E; Steinmann, B; Sullivan, B; Superti-Furga, A; Swoboda, W; van den Boogaard, MJ; Van Hul, W; Vikkula, M; Votruba, M; Zabel, B; Garcia, T; Baron, R; Olsen, BR; Warman, ML				Gong, YQ; Slee, RB; Fukai, N; Rawadi, G; Roman-Roman, S; Reginato, AM; Wang, HW; Cundy, T; Glorieux, FH; Lev, D; Zacharin, M; Oexle, K; Marcelino, J; Suwairi, W; Heeger, S; Sabatakos, G; Apte, S; Adkins, WN; Allgrove, J; Arslan-Kirchner, M; Batch, JA; Beighton, P; Black, GCM; Boles, RG; Boon, LM; Borrone, C; Brunner, HG; Carle, GF; Dallapiccola, B; De Paepe, A; Floege, B; Halfhide, ML; Hall, B; Hennekam, RC; Hirose, T; Jans, A; Juppner, H; Kim, CA; Keppler-Noreuil, K; Kohlschuetter, A; LaCombe, D; Lambert, M; Lemyre, E; Letteboer, T; Peltonen, L; Ramesar, RS; Romanengo, M; Somer, H; Steichen-Gersdorf, E; Steinmann, B; Sullivan, B; Superti-Furga, A; Swoboda, W; van den Boogaard, MJ; Van Hul, W; Vikkula, M; Votruba, M; Zabel, B; Garcia, T; Baron, R; Olsen, BR; Warman, ML		Osteoporosis Pseudoglioma Syndrome	LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development	CELL			English	Article							BETA-CATENIN; OSTEOBLAST LINEAGE; MOLECULAR-CLONING; MINERAL DENSITY; CELL-DEATH; MOUSE; FAMILY; MICE; DIFFERENTIATION; OSTEOPOROSIS	In humans, low peak bone mass is a significant risk factor for osteoporosis. We report that LRP5, encoding the low-density lipoprotein receptor-related protein 5, affects bone mass accrual during growth. Mutations in LRP5 cause the autosomal recessive disorder osteoporosis-pseudoglioma syndrome (OPPG). We find that OPPG carriers have reduced bone mass when compared to age- and gender-matched controls. We demonstrate LRP5 expression by osteoblasts in situ and show that LRP5 can transduce Writ signaling in vitro via the canonical pathway. We further show that a mutant-secreted form of LRP5 can reduce bone thickness in mouse calvarial explant cultures. These data indicate that Wnt-mediated signaling via LRP5 affects bone accrual during growth and is important for the establishment of peak bone mass.				mlw14@po.cwru.edu	Romanengo, Marta/AAB-5053-2021; superti-furga, andrea/E-9162-2015; Batch, Jennifer/A-6094-2011; Roman-Roman, Sergio/K-9993-2014; Votruba, Marcela/B-7306-2015; Kohlschütter, Alfried/ABH-5710-2020; Boon, Laurence/HCI-3629-2022; Ramesar, Raj S/I-6941-2015; Carle, Georges/GWC-5240-2022; Votruba, Marcela/A-6182-2011; Kohlschütter, Alfried/ABE-3495-2021; Vikkula, Miikka/Q-1038-2018; Dallapiccola, Bruno/K-8692-2016; Black, Graeme/K-7374-2015	Romanengo, Marta/0000-0002-1833-037X; superti-furga, andrea/0000-0002-3543-7531; Roman-Roman, Sergio/0000-0001-6459-2613; Votruba, Marcela/0000-0002-7680-9135; Ramesar, Raj S/0000-0001-5688-1634; Votruba, Marcela/0000-0002-7680-9135; Kohlschütter, Alfried/0000-0002-2700-0401; Vikkula, Miikka/0000-0002-6236-338X; Oexle, Konrad/0000-0001-7447-2252; Dallapiccola, Bruno/0000-0002-5031-1013; Lacombe, Didier/0000-0002-8956-2207; Kim, Chong/0000-0002-1754-1300; Van Hul, Wim/0000-0002-5065-7858; Black, Graeme/0000-0001-8727-6592; Cundy, Timothy/0000-0003-4890-9400; Rawadi, Georges/0000-0003-4735-2188				Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; BOHME K, 1995, DEV DYNAM, V204, P432; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chen D, 1999, GENOMICS, V55, P314, DOI 10.1006/geno.1998.5688; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Figueroa DJ, 2000, J HISTOCHEM CYTOCHEM, V48, P1357, DOI 10.1177/002215540004801006; Gliemann J, 1998, BIOL CHEM, V379, P951; Globus RK, 1998, J CELL SCI, V111, P1385; Glorieux FH, 2000, BONE, V26, P103, DOI 10.1016/S8756-3282(99)00257-4; Gong YQ, 1996, AM J HUM GENET, V59, P146; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Haertel-Wiesmann M, 2000, J BIOL CHEM, V275, P32046, DOI 10.1074/jbc.M000074200; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; KO M-K, 1985, Journal of Pediatric Ophthalmology and Strabismus, V22, P188; Koller DL, 1998, J BONE MINER RES, V13, P1903, DOI 10.1359/jbmr.1998.13.12.1903; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; LI Y, 1992, AM J HUM GENET, V51, P749; Lu PW, 1996, J CLIN ENDOCR METAB, V81, P1586, DOI 10.1210/jc.81.4.1586; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mornet E, 2000, HUM MUTAT, V15, P309, DOI 10.1002/(SICI)1098-1004(200004)15:4<309::AID-HUMU2>3.0.CO;2-C; Moursi AM, 1996, J CELL SCI, V109, P1369; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; SEEMAN E, 1994, J BONE MINER RES, V9, P739; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shibamoto S, 1998, GENES CELLS, V3, P659; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Stone Edwin M., 1992, Human Molecular Genetics, V1, P685, DOI 10.1093/hmg/1.9.685; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Uusitalo M, 1999, EXP CELL RES, V253, P336, DOI 10.1006/excr.1999.4710; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wennberg C, 2000, J BONE MINER RES, V15, P1879, DOI 10.1359/jbmr.2000.15.10.1879; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Zhu MD, 2000, EXP EYE RES, V70, P767, DOI 10.1006/exer.2000.0844	53	1673	1819	2	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2001	107	4					513	523		10.1016/S0092-8674(01)00571-2	http://dx.doi.org/10.1016/S0092-8674(01)00571-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	494GG	11719191	Bronze			2022-12-01	WOS:000172272900011
J	Mauch, DH; Nagler, K; Schumacher, S; Goritz, C; Muller, EC; Otto, A; Pfrieger, FW				Mauch, DH; Nagler, K; Schumacher, S; Goritz, C; Muller, EC; Otto, A; Pfrieger, FW			CNS synaptogenesis promoted by glia-derived cholesterol	SCIENCE			English	Article							RETINAL GANGLION-CELLS; APOLIPOPROTEIN-E; PROTEINS; LIPOPROTEINS; METABOLISM	The molecular mechanisms controlling synaptogenesis in the central nervous system (CNS) are poorly understood. Previous reports showed that a glia-derived factor strongly promotes synapse development in cultures of purified CNS neurons. Here, we identify this factor as cholesterol complexed to apolipoprotein E-containing lipoproteins. CNS neurons produce enough cholesterol to survive and grow, but the formation of numerous mature synapses demands additional amounts that must be provided by glia. Thus, the availability of cholesterol appears to limit synapse development. This may explain the delayed onset of CNS synaptogenesis after glia differentiation and neurobehavioral manifestations of defects in cholesterol or lipoprotein homeostasis.	Max Delbruck Ctr Mol Med, Synapse Grp, D-13092 Berlin, Germany; Max Delbruck Ctr Mol Med, Prot Chem Grp, D-13092 Berlin, Germany; Ctr Neurochim, Max Planck CNRS Grp, UPR 2396, F-67084 Strasbourg, France; Univ Hamburg, Inst Cell Biochem & Clin Neurobiol, D-20246 Hamburg, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centre National de la Recherche Scientifique (CNRS); University of Hamburg	Pfrieger, FW (corresponding author), Max Delbruck Ctr Mol Med, Synapse Grp, D-13092 Berlin, Germany.	fw-pfrieger@gmx.de	Göritz, Christian/AAK-5348-2021; Pfrieger, Frank/AAX-3208-2020	Göritz, Christian/0000-0003-0799-766X; Pfrieger, Frank/0000-0001-7085-1431				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Beffert U, 1998, BRAIN RES REV, V27, P119, DOI 10.1016/S0165-0173(98)00008-3; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Danik M, 1999, CRIT REV NEUROBIOL, V13, P357, DOI 10.1615/CritRevNeurobiol.v13.i4.20; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; ENDO A, 1977, EUR J BIOCHEM, V77, P31, DOI 10.1111/j.1432-1033.1977.tb11637.x; Farese RV, 1998, TRENDS GENET, V14, P115, DOI 10.1016/S0168-9525(97)01377-2; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Ito J, 1999, J NEUROCHEM, V72, P2362, DOI 10.1046/j.1471-4159.1999.0722362.x; Kabara J J, 1973, Prog Brain Res, V40, P363; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; LaDu MJ, 1998, J NEUROCHEM, V70, P2070; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; MAHLEY RW, 1979, BIOCHIM BIOPHYS ACTA, V575, P81, DOI 10.1016/0005-2760(79)90133-4; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAUCH DH, UNPUB; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; NORMAN AW, 1972, J BIOL CHEM, V247, P1918; Pfrieger FW, 1996, CURR OPIN NEUROBIOL, V6, P615, DOI 10.1016/S0959-4388(96)80093-6; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; STOLL G, 1989, GLIA, V2, P170, DOI 10.1002/glia.440020306; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Willnow TE, 1998, BIOL CHEM, V379, P1025; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	30	1186	1241	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545					1354	1357		10.1126/science.294.5545.1354	http://dx.doi.org/10.1126/science.294.5545.1354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701931	Green Submitted			2022-12-01	WOS:000172130200053
J	Turtle, EP; Pierazzo, E				Turtle, EP; Pierazzo, E			Thickness of a European ice shell from impact crater simulations	SCIENCE			English	Article							SUBSURFACE OCEAN; NONSYNCHRONOUS ROTATION; GEOLOGICAL EVIDENCE; LIQUID WATER; CONSTRAINTS; FEATURES; MODEL; STATE	Several impact craters on Jupiter's satellite Europa exhibit central peaks. On the terrestrial planets, central peaks consist of fractured but competent rock uplifted during cratering. Therefore, the observation of central peaks on Europa indicates that an ice layer must be sufficiently thick that the impact events did not completely penetrate it. We conducted numerical simulations of vapor and melt production during cratering of water ice layers overlying liquid water to estimate the thickness of Europa's icy crust. Because impacts disrupt material well beyond the zone of partial melting, our simulations put a lower limit on ice thickness at the locations and times of impact. We conclude that the ice must be more than 3 to 4 kilometers thick.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Turtle, EP (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		Turtle, Elizabeth/K-8673-2012	Turtle, Elizabeth/0000-0003-1423-5751				Anderson JD, 1998, SCIENCE, V281, P2019, DOI 10.1126/science.281.5385.2019; Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; Brookshaw L., 1998, TECHNICAL REPORT WOR; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; CASSEN PM, 1982, SATELLITES JUPITER, P93; Durham WB, 1997, J GEOPHYS RES-PLANET, V102, P16293, DOI 10.1029/97JE00916; Geissler P.E., 2001, LUNAR PLANETARY SCI, V32, P2068, DOI [10.1029/2021GL096939, DOI 10.1029/2021GL096939]; Geissler PE, 1998, NATURE, V391, P368, DOI 10.1038/34869; Greenberg R, 2000, J GEOPHYS RES-PLANET, V105, P17551, DOI 10.1029/1999JE001147; Grieve R. B., 1981, Proceedings of the Heartworm Symposium '80, Dallas, Texas, 23-24 February 1980., P37; HELFENSTEIN P, 1985, ICARUS, V61, P175, DOI 10.1016/0019-1035(85)90099-5; Hoppa G, 1999, ICARUS, V137, P341, DOI 10.1006/icar.1998.6065; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; MCEWEN AS, 1986, NATURE, V321, P49, DOI 10.1038/321049a0; McKinnon WB, 1999, GEOPHYS RES LETT, V26, P951, DOI 10.1029/1999GL900125; Melosh H.J., 1989, IMPACT CRATERING GEO; MELOSH HJ, 1982, J GEOPHYS RES, V87, P371, DOI 10.1029/JB087iB01p00371; Moore JM, 1998, ICARUS, V135, P127, DOI 10.1006/icar.1998.5973; Moore JM, 2001, ICARUS, V151, P93, DOI 10.1006/icar.2000.6558; OBRIEN DP, IN PRESS ICARUS; OJAKANGAS GW, 1989, ICARUS, V81, P220, DOI 10.1016/0019-1035(89)90052-3; Pappalardo RT, 1999, J GEOPHYS RES-PLANET, V104, P24015, DOI 10.1029/1998JE000628; Pappalardo RT, 1998, NATURE, V391, P365, DOI 10.1038/34862; PIETERS CM, 1982, SCIENCE, V215, P59, DOI 10.1126/science.215.4528.59; Prockter LM, 2000, SCIENCE, V289, P941, DOI 10.1126/science.289.5481.941; Rathbun JA, 1998, GEOPHYS RES LETT, V25, P4157, DOI 10.1029/1998GL900135; ROSS MN, 1987, NATURE, V325, P133, DOI 10.1038/325133a0; SCHENK PM, 1989, ICARUS, V79, P75, DOI 10.1016/0019-1035(89)90109-7; Schmidt R. M., 1987, INT J IMPACT ENG, V5, P543, DOI [10.1016/0734-743X(87)90069-8, DOI 10.1016/0734-743X(87)90069-8]; SQUYRES SW, 1983, NATURE, V301, P225, DOI 10.1038/301225a0; THOMPSON SL, 1979, SAND771339; THOMPSON SL, 1972, SAND892951; Zahnle K, 1998, ICARUS, V136, P202, DOI 10.1006/icar.1998.6015; Zimmer C, 2000, ICARUS, V147, P329, DOI 10.1006/icar.2000.6456	35	106	110	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1326	1328		10.1126/science.1062492	http://dx.doi.org/10.1126/science.1062492			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701924				2022-12-01	WOS:000172130200044
J	Parker, AR; Lawrence, CR				Parker, AR; Lawrence, CR			Water capture by a desert beetle	NATURE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; QinetiQ, Mech Sci Sector, Farnborough GU14 0LX, Hants, England	University of Oxford; Qinetiq Group Plc	Parker, AR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.							Crawford C.S., 1981, BIOL DESERT INVERTEB; HAMILTON WJ, 1976, NATURE, V262, P284, DOI 10.1038/262284a0; KOCH C., 1962, ANN TRANSVAAL MUS, V24, P61; Louw G.N., 1972, Symposia Zool Soc Lond, VNo. 31, P297; MACHIN J, 1970, J EXP BIOL, V53, P753; MCGILL DJ, 1989, STAT INTRO DYNAMICS; ROBERTS CS, 1991, PHYSIOL ENTOMOL, V16, P463, DOI 10.1111/j.1365-3032.1991.tb00586.x; Watanabe K, 2000, J JPN SOC TRIBOLOGIS, V45, P354; 01098144	9	1411	1485	92	1101	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					33	34		10.1038/35102108	http://dx.doi.org/10.1038/35102108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689930				2022-12-01	WOS:000171898900029
J	Alavi, A; Zhuang, HM				Alavi, A; Zhuang, HM			Finding infection - help from PET	LANCET			English	Editorial Material							POSITRON-EMISSION-TOMOGRAPHY; GLUCOSE		Hosp Univ Penn, Dept Radiol, Div Nucl Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Alavi, A (corresponding author), Hosp Univ Penn, Dept Radiol, Div Nucl Med, Philadelphia, PA 19104 USA.							CHAKRABARTI R, 1994, J IMMUNOL, V152, P2660; De Winter F, 2001, J BONE JOINT SURG AM, V83A, P651, DOI 10.2106/00004623-200105000-00002; Gamelli RL, 1996, J LEUKOCYTE BIOL, V59, P639, DOI 10.1002/jlb.59.5.639; Guhlmann A, 1998, RADIOLOGY, V206, P749, DOI 10.1148/radiology.206.3.9494496; Ichiya Y, 1996, Ann Nucl Med, V10, P185; MANTHEY P, 1999, J NUCL MED, V40; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Sorbara LR, 1996, J VIROL, V70, P7275, DOI 10.1128/JVI.70.10.7275-7279.1996; Sugawara Y, 1998, EUR J NUCL MED, V25, P1238, DOI 10.1007/s002590050290; WARBURG O, 1930, METABOLISM TUMORS, P75; Zhuang HM, 2000, CLIN NUCL MED, V25, P281, DOI 10.1097/00003072-200004000-00009; Zhuang HM, 2001, J NUCL MED, V42, P44	12	34	35	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1386	1386		10.1016/S0140-6736(01)06491-1	http://dx.doi.org/10.1016/S0140-6736(01)06491-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705481				2022-12-01	WOS:000171940100005
J	Weiss, HB; Songer, TJ; Fabio, A				Weiss, HB; Songer, TJ; Fabio, A			Fetal deaths related to maternal injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMA; PREGNANCY; MORTALITY; HOMICIDE; ACCIDENTS; WOMEN	Context Maternal and fetal trauma is an important cause of adverse fetal outcomes. However, systematic exclusion from US injury surveillance programs of even the most severe outcome, fetal/neonatal death, has led to a lack of understanding about frequency, causes, and prevention. Objective To determine the rate of traumatic fetal deaths reported instate fetal death registries and the types of trauma and physiologic diagnoses associated with these deaths. Design and Setting Retrospective descriptive study of fetal death certificates from 1995 through 1997 obtained from 16 states, which accounted for 55% of US live births and approximately 15000 fetal death registrations per year. Main Outcome Measure Rate of fetal injury deaths, based on fetal death certificates coded with an underlying cause of death due to maternal injury at 20 weeks' gestation or later, by cause. Results During the 3-year study period, 240 traumatic fetal injury deaths were identified (3.7 fetal deaths per 100000 live births). Motor vehicle crashes were the leading trauma mechanism (82% of cases; 2.3 fetal deaths per 100000 live births), followed by firearm injuries (6% of cases) and falls (3% of cases). In 3 states, reported crash-related fetal deaths exceeded that of crash-related infant deaths. Placental injury was mentioned in 100 cases (42%) and maternal death was noted in 27 cases (11%). A peak rate of 9.3 fetal deaths per 100000 live births was observed among 15- to 19-year-old women. Conclusions Motor vehicle crashes are the leading cause of fetal deaths related to maternal trauma. improved tracking of traumatic fetal injury deaths is important to stimulate and guide research and efforts to reduce the risks to women and fetuses from injury during pregnancy.	Univ Pittsburgh, Ctr Injury Res & Control, Dept Neurosurg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weiss, HB (corresponding author), Univ Pittsburgh, Ctr Injury Res & Control, Dept Neurosurg, 200 Lothrop St,Suite B400, Pittsburgh, PA 15213 USA.		Weiss, Hank/D-1052-2010	Fabio, Anthony/0000-0002-6808-4939; Songer, Thomas/0000-0002-5253-2514				AGRAN PF, 1987, ANN EMERG MED, V16, P1355, DOI 10.1016/S0196-0644(87)80418-3; *AM AC PED AM COLL, 1988, STAND TERM REP REPR, P308; Bausch L C, 1996, Nebr Med J, V81, P120; Brinton JH, 1884, T AM SURG ASS, V2, P425; Buchsbaum H J, 1976, Med Times, V104, P134; BUCHSBAUM HJ, 1968, AM J OBSTET GYNECOL, V102, P752, DOI 10.1016/0002-9378(68)90390-6; CROSBY WM, 1971, NEW ENGL J MED, V284, P632, DOI 10.1056/NEJM197103252841203; DANNENBERG AL, 1995, AM J OBSTET GYNECOL, V172, P1557, DOI 10.1016/0002-9378(95)90496-4; Dietz PM, 1998, AM J PUBLIC HEALTH, V88, P641, DOI 10.2105/AJPH.88.4.641; Elliott M, 1966, Aust N Z J Obstet Gynaecol, V6, P279, DOI 10.1111/j.1479-828X.1966.tb00389.x; ESPOSITO TJ, 1989, J TRAUMA, V29, P1628, DOI 10.1097/00005373-198912000-00006; FILDES J, 1992, J TRAUMA, V32, P643, DOI 10.1097/00005373-199205000-00017; Gaudino JA, 1997, AM J PUBLIC HEALTH, V87, P1323, DOI 10.2105/AJPH.87.8.1323; GREB AE, 1987, AM J PUBLIC HEALTH, V77, P1202, DOI 10.2105/AJPH.77.9.1202; HANSEN G, 1990, J MED SOC N J, V87, P995; Harper M, 1997, OBSTET GYNECOL, V90, P920, DOI 10.1016/S0029-7844(97)00485-7; HERSCHEL M, 1995, AM J PREV MED, V11, P185, DOI 10.1016/S0749-3797(18)30471-9; Horon IL, 2001, JAMA-J AM MED ASSOC, V285, P1455, DOI 10.1001/jama.285.11.1455; Jacob S, 1998, OBSTET GYNECOL, V91, P187, DOI 10.1016/S0029-7844(97)00664-9; KAUNITZ AM, 1985, OBSTET GYNECOL, V65, P605; KIRBY RS, 1993, AM J PUBLIC HEALTH, V83, P1088, DOI 10.2105/AJPH.83.8.1088; KISSINGER DP, 1991, ARCH SURG-CHICAGO, V126, P1079; KLINICH KD, 1998, ANN C ASS ADV AUT ME; KOWALSKI J, 1997, STATE DEFINITIONS RE, P3; Krulewitch CJ, 2001, J MIDWIFERY WOM HEAL, V46, P4, DOI 10.1016/S1526-9523(00)00096-9; LANE P L, 1989, Journal of Emergency Medicine, V7, P433, DOI 10.1016/0736-4679(89)90135-2; *MOD STAT VIT STAT, 1992, DHHS PUBL; *NAT CTR HLTH STAT, 1998, 1995 PER MORT DAT FI; *NAT CTR INF PREV, 2001, LEAD CAUS DEATH REP; ONI OOA, 1984, INJURY, V15, P376, DOI 10.1016/0020-1383(84)90199-2; PEARLMAN MD, 1990, AM J OBSTET GYNECOL, V162, P1502, DOI 10.1016/0002-9378(90)90913-R; PEARLMAN MD, 1990, NEW ENGL J MED, V323, P1609; PEPPERELL RJ, 1977, MED J AUSTRALIA, V1, P203, DOI 10.5694/j.1326-5377.1977.tb130630.x; Rasmussen S, 1996, ACTA OBSTET GYN SCAN, V75, P229, DOI 10.3109/00016349609047092; ROSE PG, 1985, AM J OBSTET GYNECOL, V153, P844, DOI 10.1016/0002-9378(85)90687-8; Rosner B, 1994, FUNDAMENTALS BIOSTAT, V4th; ROTHENBERGER D, 1978, J TRAUMA, V18, P173, DOI 10.1097/00005373-197803000-00004; Rumbolz W L, 1991, Nebr Med J, V76, P31; Schiff M, 1997, WESTERN J MED, V167, P19; SEEAR T, 1953, AM J OBSTET GYNECOL, V65, P450, DOI 10.1016/0002-9378(53)90459-1; Theodorou DA, 2000, AM SURGEON, V66, P809; TIMBERLAKE GA, 1989, AM SURGEON, V55, P151; VENTURA S, 1998, REPORT FINAL NATALIT, P32; VFAMER MW, 1987, SURG GYNECOL OBSTET, V168, P555; Weiss H, 2001, JAMA-J AM MED ASSOC, V285, P2854, DOI 10.1001/jama.285.22.2854; WEISS H, 1999, EPIDEMIOLOGY PERINAT, P32; Weiss HB, 2001, ACCIDENT ANAL PREV, V33, P449, DOI 10.1016/S0001-4575(00)00058-0; Woodhull RB, 1942, SURGERY, V12, P615	48	135	137	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1863	1868		10.1001/jama.286.15.1863	http://dx.doi.org/10.1001/jama.286.15.1863			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482UH	11597288				2022-12-01	WOS:000171595300027
J	Luo, MJ; Zhou, ZL; Magni, K; Christoforides, C; Rappsilber, J; Mann, M; Reed, R				Luo, MJ; Zhou, ZL; Magni, K; Christoforides, C; Rappsilber, J; Mann, M; Reed, R			Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly	NATURE			English	Article							MESSENGER-RNA EXPORT; BINDING PROTEIN; U2 SNRNP; NUCLEUS; METAZOANS; COMPLEX	Recent studies indicate that splicing of pre-messenger RNA and export of mRNA are normally coupled in vivo(1-6). During splicing, the conserved mRNA export factor Aly is recruited to the spliced mRNA-protein complex (mRNP), which targets the mRNA for export. At present, it is not known how Aly is recruited to the spliced mRNP. Here we show that the conserved DEAD-box helicase UAP56, which functions during spliceosome assembly(7-10), interacts directly and highly specifically with Aly. Moreover, UAP56 is present together with Aly in the spliced mRNP. Significantly, excess UAP56 is a potent dominant negative inhibitor of mRNA export. Excess UAP56 also inhibits the recruitment of Aly to the spliced mRNP. Furthermore, a mutation in Aly that blocks its interaction with UAP56 prevents recruitment of Aly to the spliced mRNP. These data suggest that the splicing factor UAP56 functions in coupling the splicing and export machineries by recruiting Aly to the spliced mRNP.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ So Denmark, Prot Interact Lab, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Harvard University; Harvard Medical School; University of Southern Denmark	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	rreed@hms.harvard.edu	Rappsilber, Juri/B-7265-2015; Mann, Matthias/A-3454-2013; Rappsilber, Juri/ABF-3328-2020	Rappsilber, Juri/0000-0001-5999-1310; Mann, Matthias/0000-0003-1292-4799; 				Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Virbasius CMA, 1999, MOL CELL, V4, P219, DOI 10.1016/S1097-2765(00)80369-X; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; Wichmann I, 1999, HUM IMMUNOL, V60, P57, DOI 10.1016/S0198-8859(98)00085-8; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	23	298	304	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					644	647		10.1038/35098106	http://dx.doi.org/10.1038/35098106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675789				2022-12-01	WOS:000171485700052
J	Luo, YQ; Wan, SQ; Hui, DF; Wallace, LL				Luo, YQ; Wan, SQ; Hui, DF; Wallace, LL			Acclimatization of soil respiration to warming in a tall grass prairie	NATURE			English	Article							TRACE GAS FLUXES; TEMPERATURE-DEPENDENCE; ORGANIC-CARBON; CO2 EMISSIONS; DECOMPOSITION; CLIMATE; FEEDBACKS; FOREST; MATTER; CH4	The latest report by the Intergovernmental Panel on Climate Change (IPCC) predicts a 1.4-5.8 degreesC average increase in the global surface temperature over the period 1990 to 2100 (ref. 1). These estimates of future warming are greater than earlier projections, which is partly due to incorporation of a positive feedback. This feedback results from further release of greenhouse gases from terrestrial ecosystems in response to climatic warming(2-4). The feedback mechanism is usually based on the assumption that observed sensitivity of soil respiration to temperature under current climate conditions would hold in a warmer climate(5). However, this assumption has not been carefully examined. We have therefore conducted an experiment in a tall grass prairie ecosystem in the US Great Plains to study the response of soil respiration (the sum of root and heterotrophic respiration) to artificial warming of about 2 degreesC. Our observations indicate that the temperature sensitivity of soil respiration decreases-or acclimatizes-under warming and that the acclimatization is greater at high temperatures. This acclimatization of soil respiration to warming may therefore weaken the positive feedback between the terrestrial carbon cycle and climate.	Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Luo, YQ (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.	yluo@ou.edu	Wan, Shiqiang/L-9166-2019; Wan, Shiqiang/B-5799-2009	Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; Hui, Dafeng/0000-0002-5284-2897				Atkin OK, 2000, NEW PHYTOL, V147, P141, DOI 10.1046/j.1469-8137.2000.00683.x; Cheng WX, 1996, SOIL BIOL BIOCHEM, V28, P1283, DOI 10.1016/S0038-0717(96)00138-1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; *IPCC, 2001, CLIM CHANG 2001 SYNT; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Lenton TM, 2000, TELLUS B, V52, P1159, DOI 10.1034/j.1600-0889.2000.01104.x; Lin GH, 1999, GLOB CHANGE BIOL, V5, P157, DOI 10.1046/j.1365-2486.1999.00211.x; Liski J, 1999, AMBIO, V28, P171; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; McHale PJ, 1998, CAN J FOREST RES, V28, P1365, DOI 10.1139/cjfr-28-9-1365; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; PETERJOHN WT, 1994, ECOL APPL, V4, P617, DOI 10.2307/1941962; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Rustad LE, 1998, GLOB CHANGE BIOL, V4, P597, DOI 10.1046/j.1365-2486.1998.00169.x; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Sarmiento J, 2000, NATURE, V408, P155, DOI 10.1038/35041676; Schimel DS, 1996, GLOBAL BIOGEOCHEM CY, V10, P677, DOI 10.1029/96GB01524; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Striegl RG, 1998, CAN J FOREST RES, V28, P534, DOI 10.1139/cjfr-28-4-534; TARR J, 1980, Proceedings of the Oklahoma Academy of Science, V60, P39; *USDA, 1963, NAT COOP SOIL SURV, P1; Verville JH, 1998, BIOGEOCHEMISTRY, V41, P215, DOI 10.1023/A:1005984701775; Woodwell GM, 1998, CLIMATIC CHANGE, V40, P495, DOI 10.1023/A:1005345429236; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	28	887	1213	22	638	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					622	625		10.1038/35098065	http://dx.doi.org/10.1038/35098065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675783				2022-12-01	WOS:000171485700046
J	Scheffer, M; Carpenter, S; Foley, JA; Folke, C; Walker, B				Scheffer, M; Carpenter, S; Foley, JA; Folke, C; Walker, B			Catastrophic shifts in ecosystems	NATURE			English	Review							MULTIPLE STABLE STATES; ARABIAN PENINSULA; GRAZING SYSTEMS; SHALLOW LAKES; PHASE-SHIFTS; VEGETATION; DYNAMICS; CLIMATE; SAHEL; MANAGEMENT	All ecosystems are exposed to gradual changes in climate, nutrient loading, habitat fragmentation or biotic exploitation. Nature is usually assumed to respond to gradual change in a smooth way. However, studies on lakes, coral reefs, oceans, forests and arid lands have shown that smooth change can be interrupted by sudden drastic switches to a contrasting state. Although diverse events can trigger such shifts, recent studies show that a loss of resilience usually paves the way for a switch to an alternative state. This suggests that strategies for sustainable management of such ecosystems should focus on maintaining resilience.	Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 DD Wageningen, Netherlands; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Univ Wisconsin, Ctr Sustainabil & Global Environm, Inst Environm Studies, Madison, WI 53706 USA; Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; Stockholm Univ, Ctr Res Nat Resources & Environm CNM, S-10691 Stockholm, Sweden; CSIRO Sustainable Ecosyst, Canberra, ACT 2601, Australia	Wageningen University & Research; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Stockholm University; Stockholm University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Scheffer, M (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, POB 8080, NL-6700 DD Wageningen, Netherlands.	marten.scheffer@aqec.wkao.wau.nl	Walker, Brian H/F-2386-2011; Foley, Jonathan A/GRS-5522-2022; Folke, Carl/Z-1545-2019; Carpenter, Stephen/AAQ-6404-2020; Scheffer, Marten/C-1852-2012	Folke, Carl/0000-0002-4050-3281; Carpenter, Stephen/0000-0001-8097-8700				[Anonymous], LANDSCAPE ECOLOGY FU; Brovkin V, 1998, J GEOPHYS RES-ATMOS, V103, P31613, DOI 10.1029/1998JD200006; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Carpenter SR, 1997, OIKOS, V78, P3, DOI 10.2307/3545794; CARPENTER SR, 2001, ECOLOGY ACHIEVEMENT; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; HALL CAS, 1992, OIKOS, V65, P377, DOI 10.2307/3545553; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hoelzmann P, 1998, GLOBAL BIOGEOCHEM CY, V12, P35, DOI 10.1029/97GB02733; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Ives AR, 1998, ECOLOGY, V79, P1039, DOI 10.1890/0012-9658(1998)079[1039:CDISTM]2.0.CO;2; Jeppesen E, 1999, HYDROBIOLOGIA, V395, P419, DOI 10.1023/A:1017071602549; Jolly D, 1998, J BIOGEOGR, V25, P1007, DOI 10.1046/j.1365-2699.1998.00238.x; KASSAS M, 1995, J ARID ENVIRON, V30, P115, DOI 10.1016/S0140-1963(05)80063-1; KNOWLTON N, 1992, AM ZOOL, V32, P674; Kuznetsov YA, 1995, ELEMENTS APPL BIFURC, V112; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LUDWIG D, 1997, CONSERV ECOL    0801; Maler KG, 2000, EUR ECON REV, V44, P645, DOI 10.1016/S0014-2921(00)00043-X; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Meijer M.-L., 2000, BIOMANIPULATION NETH, P1, DOI [10.1109/48.820749, DOI 10.1109/48.820749]; MEIJER ML, 1994, HYDROBIOLOGIA, V276, P457; Nicholson S, 2000, REV GEOPHYS, V38, P117, DOI 10.1029/1999RG900014; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Reid PC, 2000, ICES J MAR SCI, V57, P495, DOI 10.1006/jmsc.2000.0740; Rietkerk M, 1997, OIKOS, V80, P241, DOI 10.2307/3546592; Rinaldi S, 2000, ECOSYSTEMS, V3, P507, DOI 10.1007/s100210000045; SCHEFFER M, 1990, HYDROBIOLOGIA, V200, P475, DOI 10.1007/BF02530365; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M, 1997, ECOLOGY, V78, P272; Scheffer M, 2000, ECOSYSTEMS, V3, P451, DOI 10.1007/s100210000040; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Schelske Claire L., 1999, P367; Schelske Claire L., 1992, P393; Shiomoto A, 1997, MAR ECOL PROG SER, V150, P75, DOI 10.3354/meps150075; Taylor K, 1999, AM SCI, V87, P320, DOI 10.1511/1999.4.320; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tucker CJ, 1999, AMBIO, V28, P587; vandeKoppel J, 1997, TRENDS ECOL EVOL, V12, P352, DOI 10.1016/S0169-5347(97)01133-6; Vandermeer J, 1999, ECOLOGY, V80, P1817, DOI 10.1890/0012-9658(1999)080[1817:BBCAAM]2.0.CO;2; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walker B., 1989, P121; WALKER BH, 1993, AMBIO, V22, P2; Wang GL, 2000, GEOPHYS RES LETT, V27, P795, DOI 10.1029/1999GL011089; Wang GL, 2000, WATER RESOUR RES, V36, P1013, DOI 10.1029/1999WR900361; WILSON JB, 1992, ADV ECOL RES, V23, P263, DOI 10.1016/S0065-2504(08)60149-X; Zeng N, 1999, SCIENCE, V286, P1537, DOI 10.1126/science.286.5444.1537	61	4447	4683	110	3055	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					591	596		10.1038/35098000	http://dx.doi.org/10.1038/35098000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11595939				2022-12-01	WOS:000171485700039
J	TONKS, A				TONKS, A			INTUBATION PRACTICE ON CADAVERS SHOULD STOP	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	15	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 8	1992	305	6849					332	332						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ032	11643027				2022-12-01	WOS:A1992JJ03200014
J	LEWIS, J				LEWIS, J			A COMMONS SUBCOMMITTEE ON MEDICAL-ETHICS	LANCET			English	Editorial Material																			0	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 30	1988	1	8592					1005	1005						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	N1366	11644348				2022-12-01	WOS:A1988N136600056
J	Ni, CY; Murphy, MP; Golde, TE; Carpenter, G				Ni, CY; Murphy, MP; Golde, TE; Carpenter, G			gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase	SCIENCE			English	Article							INTRAMEMBRANE PROTEOLYSIS; MECHANISM	ErbB-4 is a transmembrane receptor tyrosine kinase that regulates cell proliferation and differentiation. After binding of its ligand heregulin (HRG) or activation of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA), the ErbB-4 ectodomain is cleaved by a metalloprotease. We now report a subsequent cleavage by gamma -secretase that releases the ErbB-4 intracellular domain from the membrane and facilitates its translocation to the nucleus. gamma -Secretase cleavage was prevented by chemical inhibitors or a dominant negative presenilin. Inhibition of gamma -secretase also prevented growth inhibition by HRG. gamma -Secretase cleavage of ErbB-4 may represent another mechanism for receptor tyrosine kinase-mediated signaling.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Mayo Clin Jacksonville, Dept Neurosci & Pharmacol, Jacksonville, FL 32224 USA	Vanderbilt University; Vanderbilt University; Mayo Clinic	Carpenter, G (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.				NCI NIH HHS [CA24071, CA68485] Funding Source: Medline; NIDDK NIH HHS [DK20593] Funding Source: Medline; NINDS NIH HHS [NS39072] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA024071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039072] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bae SS, 2001, FEBS LETT, V491, P16, DOI 10.1016/S0014-5793(01)02167-6; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; McLendon C, 2000, FASEB J, V14, P2383; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; NI CB, UNPUB; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Srinivasan R, 2000, CANCER RES, V60, P1483; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou WL, 2000, J BIOL CHEM, V275, P34737, DOI 10.1074/jbc.M003756200	18	710	728	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2179	2181		10.1126/science.1065412	http://dx.doi.org/10.1126/science.1065412			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11679632				2022-12-01	WOS:000172647700055
J	Fujiwara, M; Caswell, H				Fujiwara, M; Caswell, H			Demography of the endangered North Atlantic right whale	NATURE			English	Article							EUBALAENA-GLACIALIS; SURVIVAL	Northern right whales (Eubalaena glacialis) were formerly abundant in the northwestern Atlantic, but by 1900 they had been hunted to near extinction. After the end of commercial whaling the population was thought to be recovering slowly; however, evidence indicates that it has been declining since about 1990 (ref. 1). There are now fewer than 300 individuals, and the species may already be functionally extinct(2,3) owing to demographic stochasticity or the difficulty of females locating mates in the vast Atlantic Ocean (Allee effect(4)). Using a data set containing over 10,000 sightings of photographically identified individuals we estimated trends in right whale demographic parameters since 1980. Here we construct, using these estimates, matrix population models allowing us to analyse the causes of right whale imperilment. Mortality has increased, especially among mother whales, causing declines in population growth rate, life expectancy and the mean lifetime number of reproductive events between the period 1980-1995. Increased mortality of mother whales can explain the declining population size, suggesting that the population is not doomed to extinction as a result of the Allee effect. An analysis of extinction time shows that demographic stochasticity has only a small effect, but preventing the deaths of only two female right whales per year would increase the population growth rate to replacement level.	Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Fujiwara, M (corresponding author), Woods Hole Oceanog Inst, Dept Biol, MS34, Woods Hole, MA 02543 USA.	mfujiwara@whoi.edu	Fujiwara, Masami/C-3115-2012	Fujiwara, Masami/0000-0002-9255-6043; Caswell, Hal/0000-0003-4394-6894				Akaike H, 1973, INT S INFORMATION TH, P267; Allee WC, 1931, ANIMAL AGGREGATION S; BRAULT S, 1993, ECOLOGY, V74, P1444, DOI 10.2307/1940073; Burnham K.P., 2002, MODEL SELECTION INFE, DOI DOI 10.1007/B97636; Caswell H, 1999, P NATL ACAD SCI USA, V96, P3308, DOI 10.1073/pnas.96.6.3308; Caswell H., 2001, MATRIX POPULATION MO, V2nd; Caswell H., 1989, MATRIX POPULATION MO; CRONE MJ, 1990, RIGHT WHALE EUBALAEN; FUJIWARA M, IN PRESS ECOLOGY; Gerber LR, 2000, AM SCI, V88, P316, DOI 10.1511/2000.4.316; HOLDEN C, 2001, SCIENCE, V291, P429; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; KNOWLTON AR, 1994, CAN J ZOOL, V72, P1297, DOI 10.1139/z94-173; KNOWLTON AR, 1997, NEW ENGLAND AQUARIUM, V973, P31; KRAUS SD, 1990, MAR MAMMAL SCI, V6, P278, DOI 10.1111/j.1748-7692.1990.tb00358.x; Krause S. J., 1986, Rapid Thermal Processing, P145; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; NICHOLS JD, 1992, ECOLOGY, V73, P306, DOI 10.2307/1938741; OLESIUK PF, 1990, INDIVIDUAL RECOGNITI, P209; Planque B, 1998, J MAR BIOL ASSOC UK, V78, P1015, DOI 10.1017/S0025315400044969; Tuljapurkar S., 1997, STRUCTURED POPULATIO; WARING GT, 1999, NMFSNE153 NOAA	22	219	240	1	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2001	414	6863					537	541		10.1038/35107054	http://dx.doi.org/10.1038/35107054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734852				2022-12-01	WOS:000172405900045
J	Robinson, RC; Turbedsky, K; Kaiser, DA; Marchand, JB; Higgs, HN; Choe, S; Pollard, TD				Robinson, RC; Turbedsky, K; Kaiser, DA; Marchand, JB; Higgs, HN; Choe, S; Pollard, TD			Crystal structure of Arp2/3 complex	SCIENCE			English	Article							ALDRICH-SYNDROME PROTEIN; ACTIN NUCLEATION; N-WASP; BINDING-ACTIVITY; ACTIVATION; MECHANISM; NETWORKS; SUBUNITS; GELSOLIN; BRANCHES	We determined a crystal structure of bovine Arp2/3 complex, an assembly of seven proteins that initiates actin polymerization in eukaryotic cells, at 2.0 angstrom resolution. Actin-related protein 2 (Arp2) and Arp3 are folded like actin, with distinctive surface features. Subunits ARPC2 p34 and ARPC4 p20 in the core of the complex associate through long carboxyl-terminal a helices and have similarly folded amino-terminal alpha/beta domains. ARPC1 p40 is a seven-blade beta propeller with an insertion that may associate with the side of an actin filament. ARPC3 p21 and ARPC5 p16 are globular alpha -helical subunits. We predict that WASp/Scar proteins activate Arp2/3 complex by bringing Arp2 into proximity with Arp3 for nucleation of a branch on the side of a preexisting actin filament.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026132, R37GM026132, R01GM026338, R01GM056653] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-56653, GM-26338, GM-26132] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; DAYEL MJ, IN PRESS P NATL ACAD; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Machesky LM, 1997, BIOCHEM J, V328, P105; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Mullins RD, 1999, CURR OPIN STRUC BIOL, V9, P244; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	37	404	426	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1679	1684		10.1126/science.1066333	http://dx.doi.org/10.1126/science.1066333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721045				2022-12-01	WOS:000172307400033
J	Lake, MW; Wuebbens, MM; Rajagopalan, KV; Schindelin, H				Lake, MW; Wuebbens, MM; Rajagopalan, KV; Schindelin, H			Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD complex	NATURE			English	Article							PROTEIN STRUCTURES; BIOSYNTHESIS; ENZYME; MOLYBDOPTERIN; 4-THIOURIDINE; MUTAGENESIS; REFINEMENT; THIAMIN	The activation of ubiquitin and related protein modifiers(1,2) is catalysed by members of the E1 enzyme family that use ATP for the covalent self-attachment of the modifiers to a conserved cysteine. The Escherichia coli proteins MoeB and MoaD are involved in molybdenum cofactor (Moco) biosynthesis, an evolutionarily conserved pathway(3,4). The MoeB- and E1-catalysed reactions are mechanistically similar, and despite a lack of sequence similarity, MoaD and ubiquitin display the same fold including a conserved carboxy-terminal Gly-Gly motif(5). Similar to the E1 enzymes, MoeB activates the C terminus of MoaD to form an acyl-adenylate. Subsequently, a sulphurtransferase converts the MoaD acyl-adenylate to a thiocarboxylate that acts as the sulphur donor during Moco biosynthesis(6,7). These findings suggest that ubiquitin and E1 are derived from two ancestral genes closely related to moaD and moeB(3,5). Here we present the crystal structures of the MoeB-MoaD complex in its apo, ATP-bound, and MoaD-adenylate forms, and highlight the functional similarities between the MoeB- and E1-substrate complexes. These structures provide a molecular framework for understanding the activation of ubiquitin, Rub, SUMO and the sulphur incorporation step during Moco and thiamine biosynthesis.	SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Struct Biol, Stony Brook, NY 11794 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Duke University	Schindelin, H (corresponding author), SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA.		Schindelin, Hermann/Q-2697-2019					Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arnez JG, 1999, J MOL BIOL, V286, P1449, DOI 10.1006/jmbi.1999.2562; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; HATFIELD PM, 1992, J BIOL CHEM, V267, P14799; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; JOHNSON ME, 1987, J BACTERIOL, V169, P110, DOI 10.1128/jb.169.1.110-116.1987; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; Rajagopalan KV, 1997, BIOCHEM SOC T, V25, P757, DOI 10.1042/bst0250757; RAJAGOPALAN KV, 1996, ESCHERICHIA COLI SAL, P674; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xi J, 2001, P NATL ACAD SCI USA, V98, P8513, DOI 10.1073/pnas.141226698	28	192	198	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					325	329		10.1038/35104586	http://dx.doi.org/10.1038/35104586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713534	Green Submitted			2022-12-01	WOS:000172150700048
J	Burke, RE				Burke, RE			alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease	LANCET			English	Editorial Material							JUVENILE PARKINSONISM; ENDOPLASMIC-RETICULUM; GENE; MUTATIONS; BETA; FAMILIES; NAC		Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Burke, RE (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.		Burke, Robert/B-7226-2011	Burke, Robert/0000-0002-4760-8553				Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437	17	8	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 10	2001	358	9293					1567	1568		10.1016/S0140-6736(01)06668-5	http://dx.doi.org/10.1016/S0140-6736(01)06668-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VM	11716878				2022-12-01	WOS:000172188300005
J	Walkowiak, J; Wiener, JA; Fastabend, A; Heinzow, B; Kramer, U; Schmidt, E; Steingruber, HJ; Wundram, S; Winneke, G				Walkowiak, J; Wiener, JA; Fastabend, A; Heinzow, B; Kramer, U; Schmidt, E; Steingruber, HJ; Wundram, S; Winneke, G			Environmental exposure to polychlorinated biphenyls and quality of the home environment: effects on psychodevelopment in early childhood	LANCET			English	Article							HUMAN-MILK; PCBS; CHILDREN; INFANTS; DIOXINS; NEUROTOXICITY; SYSTEM	Background There is uncertainty whether environmental levels of exposure to polychlorinated biphenyls (PCBs) adversely affect mental and motor development in early childhood. We aimed to establish whether such an effect is of only prenatal or additional postnatal origin, and if a favourable home environment can counteract this effect. Methods Between 1993 and 1995 we recruited 171 healthy mother-infant pairs and prospectively measured psychodevelopment in newborn infants aged 7, 18, 30, and 42 months. We estimated prenatal and perinatal PCB exposure of newborn babies in cord blood and maternal milk. At 42 months we measured postnatal PCB concentrations in serum. At 18 months the quality of the home environment was assessed using the Home Observation for Measurement of the Environment scale. Mental and psychomotor development of the children were assessed using the Bayley Scales of Infant Development until 30 months and the Kaufman Assessment Battery for Children at 42 months. Findings Negative associations between milk PCB and mental/motor development were reported at all ages, becoming significant from 30 months onwards. Over 30 months, for a PCB increase from 173 (5th percentile) to 679 ng/g lipids in milk (95th percentile) there was a decrease of 8.3 points (95% CI -16.5 to 0.0) in the Bayley Scales of Infant Development mental scores, and a 9.1 point decrease (95% CI -17.2 to -1.02) in the Bayley Scales of Infant Development motor scores. There was also a negative effect of postnatal PCB exposure via breastfeeding at 42 months. Home environment had a positive effect from 30 months onwards (Bayley Scales of Infant Development mental score increase of 9.4 points [95% CI 2.2-.16.7]). Interpretation Prenatal PCB exposure at current European background levels inhibits, and a favourable home environment supports, mental and motor development until 42 months of age. PCB exposure also has an effect postnatally.	Univ Dusseldorf, Med Inst Environm Hyg, Div Analyt Chem, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Med Inst Environm Hyg, Div Epidemiol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Med Inst Environm Hyg, Div Neurobehav Toxicol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Inst Med Psychol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Fac Med, Univ Child Clin, D-40225 Dusseldorf, Germany; State Agcy Nat & Environm Schleswig Holstein, Lab Environm Toxicol, Flintbeck, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Winneke, G (corresponding author), Univ Dusseldorf, Med Inst Environm Hyg, Div Analyt Chem, Hennekamp 50, D-40225 Dusseldorf, Germany.	gerhard.winneke@uni-duesseldorf.de						Bayley N., 1993, BAYLEY SCALES INFANT; BELLINGER DC, 1995, NEUROTOXICOL TERATOL, V17, P201, DOI 10.1016/0892-0362(94)00081-N; BRADLEY R, 1984, HOME OBSERVATION MEA; BRADLEY RH, 1993, GENET SOC GEN PSYCH, V119, P439; Brouwer A, 1999, ENVIRON HEALTH PERSP, V107, P639, DOI 10.2307/3434557; ELARDO R, 1975, CHILD DEV, V46, P71; FASTEBEND A, 2000, THESIS U CLAUSTHAL; Ganzeboom HBG, 1996, SOC SCI RES, V25, P201, DOI 10.1006/ssre.1996.0010; GLADEN BC, 1988, J PEDIATR-US, V113, P991, DOI 10.1016/S0022-3476(88)80569-9; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; HUISMAN M, 1995, EARLY HUM DEV, V41, P111, DOI 10.1016/0378-3782(94)01611-R; JACOBSON JL, 1990, J PEDIATR-US, V116, P38, DOI 10.1016/S0022-3476(05)81642-7; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; JACOBSON SW, 1985, CHILD DEV, V56, P853, DOI 10.2307/1130097; KOOPMANESSEBOOM C, 1994, CHEMOSPHERE, V28, P1721, DOI 10.1016/0045-6535(94)90428-6; KoopmanEsseboom C, 1996, PEDIATRICS, V97, P700; LILIENTHAL H, 1991, FUND APPL TOXICOL, V17, P368, DOI 10.1016/0272-0590(91)90226-T; MELCHERS P, 1994, KAUFMAN ASSESSMENT B; Patandin S, 1999, J PEDIATR-US, V134, P33, DOI 10.1016/S0022-3476(99)70369-0; PORTERFIELD SP, 1994, ENVIRON HEALTH PERSP, V102, P125, DOI 10.2307/3431829; Riley EP, 1986, HDB BEHAV TERATOLOGY; ROGAN WJ, 1986, J PEDIATR-US, V109, P335, DOI 10.1016/S0022-3476(86)80397-3; Schade G, 1998, SCI TOTAL ENVIRON, V215, P31, DOI 10.1016/S0048-9697(98)00008-4; Schantz SL, 1996, NEUROTOXICOL TERATOL, V18, P217, DOI 10.1016/S0892-0362(96)90001-X; Seegal RF, 1996, CRIT REV TOXICOL, V26, P709, DOI 10.3109/10408449609037481; Tewes U, 1991, HAMBURG WECHSLER INT; *UMW KOMM HUM BIOM, 1999, BUNDESGESUNDHEITSBLA, V42, P511; WALKOWIAK J, 2000, THESIS U DUSSELDORF; Winneke G, 1998, TOXICOL LETT, V103, P423, DOI 10.1016/S0378-4274(98)00334-8	29	254	262	1	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2001	358	9293					1602	1607		10.1016/S0140-6736(01)06654-5	http://dx.doi.org/10.1016/S0140-6736(01)06654-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VM	11716887				2022-12-01	WOS:000172188300014
J	Lee, RC; Ambros, V				Lee, RC; Ambros, V			An extensive class of small RNAs in Caenorhabditis elegans	SCIENCE			English	Article							INTERFERENCE; CONSERVATION; EXPRESSION; SEQUENCE; GENES	The lin-4 and let-7 antisense RNAs are temporal regulators that control the timing of developmental events in Caenorhabditis elegans by inhibiting translation of target mRNAs. let-7 RNA is conserved among bilaterian animals, suggesting that this class of small RNAs [microRNAs (miRNAs)] is evolutionarily ancient. Using bioinformatics and cDNA cloning, we found 15 new miRNA genes in C. elegans. Several of these genes express small transcripts that vary In abundance during C. elegans larval development, and three of them have apparent homologs in mammals and/or insects. Small noncoding RNAs of the miRNA class appear to be numerous and diverse.	Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Ambros, V (corresponding author), Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA.	vambros@dartmouth.edu			NIGMS NIH HHS [R01 GM-34028] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034028] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ERDMANN VA, 1908, NUCLEIC ACIDS RES, V29, P189; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	13	2160	2520	10	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					862	864		10.1126/science.1065329	http://dx.doi.org/10.1126/science.1065329			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679672				2022-12-01	WOS:000171851800049
J	Lee, JR; Urban, S; Garvey, CF; Freeman, M				Lee, JR; Urban, S; Garvey, CF; Freeman, M			Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila	CELL			English	Article							ALPHA HOMOLOG SPITZ; DORSAL-VENTRAL AXIS; GROWTH-FACTOR-ALPHA; CELL-SURFACE; EYE DEVELOPMENT; PROTGF-ALPHA; RECEPTOR; PROTEIN; PATHWAY; GENE	The membrane proteins Star and Rhomboid-1 have been genetically defined as the primary regulators of EGF receptor activation in Drosophila, but their molecular mechanisms have been elusive. Both Star and Rhomboid-1 have been assumed to work at the cell surface to control ligand activation. Here, we demonstrate that they control receptor signaling by regulating intracellular trafficking and proteolysis of the ligand Spitz. Star is present throughout the secretory pathway and is required to export Spitz from the endoplasmic reticulum to the Golgi apparatus. Rhomboid-1 is localized in the Golgi, where it promotes the cleavage of Spitz. This defines a novel growth factor release mechanism that is distinct from metalloprotease-dependent shedding from the cell surface.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Freeman, Matthew/0000-0003-0410-5451				Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Bang AG, 2000, GENE DEV, V14, P177; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; FREEMAN M, 1992, DEVELOPMENT, V116, P335; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Golembo M, 1996, DEVELOPMENT, V122, P3363; Guichard A, 1999, DEVELOPMENT, V126, P2663; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Klambt C, 2000, CURR BIOL, V10, pR388, DOI 10.1016/S0960-9822(00)00485-1; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; PANDIELLA A, 1992, J BIOL CHEM, V267, P24028; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; RUOHOLABAKER H, 1993, CELL, V73, P953, DOI 10.1016/0092-8674(93)90273-S; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; SEELIG HP, 1994, J AUTOIMMUN, V7, P67, DOI 10.1006/jaut.1994.1006; Sturtevant MA, 1996, DEV BIOL, V174, P298, DOI 10.1006/dbio.1996.0075; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; TEIXIDO J, 1990, J BIOL CHEM, V265, P6410; Tio M, 1997, DEVELOPMENT, V124, P343; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urena JM, 1999, J CELL SCI, V112, P773; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3	40	309	319	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					161	171		10.1016/S0092-8674(01)00526-8	http://dx.doi.org/10.1016/S0092-8674(01)00526-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672524	Bronze			2022-12-01	WOS:000171694800006
J	Smith, DE; Tans, SJ; Smith, SB; Grimes, S; Anderson, DL; Bustamante, C				Smith, DE; Tans, SJ; Smith, SB; Grimes, S; Anderson, DL; Bustamante, C			The bacteriophage phi 29 portal motor can package DNA against a large internal force	NATURE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; MOLECULES; PROTEIN-GP3; PROHEAD	As part of the viral infection cycle, viruses must package their newly replicated genomes for delivery to other host cells. Bacteriophage phi 29 packages its 6.6-mum long, double-stranded DNA into a 42x54 nm capsid(1) by means of a portal complex that hydrolyses ATP(2). This process is remarkable because entropic, electrostatic and bending energies of the DNA must be overcome to package the DNA to near-crystalline density. Here we use optical tweezers to pull on single DNA molecules as they are packaged, thus demonstrating that the portal complex is a force-generating motor. This motor can work against loads of up to 57 pN on average, making it one of the strongest molecular motors reported to date. Movements of over 5 mum are observed, indicating high processivity. Pauses and slips also occur, particularly at higher forces. We establish the force-velocity relationship of the motor and find that the rate-limiting step of the motor's cycle is force dependent even at low loads. Notably, the packaging rate decreases as the prohead is filled, indicating that an internal force builds up to similar to 50 pN owing to DNA confinement. Our data suggest that this force may be available for initiating the ejection of the DNA from the capsid during infection.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Oral Sci, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.		Smith, Douglas E/A-3131-2017; Tans, Sander/AAS-2901-2020	Smith, Douglas E/0000-0002-8206-3632; Bustamante, Carlos/0000-0002-2970-0073				Anderson Dwight, 1993, P859; BARLOW R, 1989, STAT GUIDE USE STAT, P15; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BERG HC, 1993, BIOPHYS J, V65, P2201, DOI 10.1016/S0006-3495(93)81278-5; BJORNSTI MA, 1983, J VIROL, V45, P383, DOI 10.1128/JVI.45.1.383-396.1983; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Garcia LR, 1996, J BACTERIOL, V178, P6921, DOI 10.1128/jb.178.23.6921-6929.1996; GRIMES S, 1989, J MOL BIOL, V209, P91, DOI 10.1016/0022-2836(89)90172-1; Grimes S, 1997, J MOL BIOL, V266, P901, DOI 10.1006/jmbi.1996.0843; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; Ibarra B, 2000, J MOL BIOL, V298, P807, DOI 10.1006/jmbi.2000.3712; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; LEHNINGER AL, 1993, PRINCIPLES BIOCH, P375; NOVICK SL, 1988, BIOCHEMISTRY-US, V27, P7919, DOI 10.1021/bi00420a050; Odijk T, 1998, BIOPHYS J, V75, P1223, DOI 10.1016/S0006-3495(98)74041-X; RAU DC, 1984, P NATL ACAD SCI-BIOL, V81, P2621, DOI 10.1073/pnas.81.9.2621; RIEMER SC, 1978, BIOPOLYMERS, V17, P785, DOI 10.1002/bip.1978.360170317; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902	25	826	848	1	118	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					748	752		10.1038/35099581	http://dx.doi.org/10.1038/35099581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607035				2022-12-01	WOS:000171608000047
J	Breedveld, FC				Breedveld, FC			Is there a place for leflunomide in the treatment of rheumatoid arthritis?	LANCET			English	Editorial Material							METHOTREXATE; SAFETY; EFFICACY; SULFASALAZINE		Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Breedveld, FC (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands.							Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F; Emery P, 2000, RHEUMATOLOGY, V39, P655, DOI 10.1093/rheumatology/39.6.655; FRIES JF, 1993, ARTHRITIS RHEUM, V36, P297, DOI 10.1002/art.1780360303; Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0; MLADENOVIC V, 1995, ARTHRITIS RHEUM-US, V38, P1595, DOI 10.1002/art.1780381111; Smolen JS, 1999, LANCET, V353, P259, DOI 10.1016/S0140-6736(98)09403-3; Strand V, 1999, ARCH INTERN MED, V159, P2542, DOI 10.1001/archinte.159.21.2542; Weinblatt ME, 1999, ARTHRITIS RHEUM-US, V42, P1322, DOI 10.1002/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P	9	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1198	1200		10.1016/S0140-6736(01)06338-3	http://dx.doi.org/10.1016/S0140-6736(01)06338-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675052				2022-12-01	WOS:000171527000004
J	DeWildt, G; Sweeney, H				DeWildt, G; Sweeney, H			Moving away from rational medicine?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1367	1367		10.1136/bmj.312.7042.1367	http://dx.doi.org/10.1136/bmj.312.7042.1367			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	11644783	Green Published			2022-12-01	WOS:A1996UN47600079
J	CARVEL, J				CARVEL, J			EMBRYO RESEARCH	LANCET			English	Editorial Material																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 13	1988	1	8581					368	369						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	M0211	11644347				2022-12-01	WOS:A1988M021100063
J	Cho, JY; Tse, MK; Holmes, D; Maleczka, RE; Smith, MR				Cho, JY; Tse, MK; Holmes, D; Maleczka, RE; Smith, MR			Remarkably selective iridium catalysts for the elaboration of aromatic C-H bonds	SCIENCE			English	Article							FUNCTIONALIZATION; ALKANES; COMPLEXES; BORYLATION; BORANES; ROUTE	Arylboron compounds have intriguing properties and are important building blocks for chemical synthesis. A family of Ir catalysts now enables the direct synthesis of arylboron compounds from aromatic hydrocarbons and boranes under "solventless" conditions. The Ir catalysts are highly selective for C-H activation and do not interfere with subsequent in situ transformations, including Pd-mediated cross-couplings with aryl halides. By virtue of their favorable activities and exceptional selectivities, these Ir catalysts impart the synthetic versatility of arylboron reagents to C-H bonds in aromatic and heteroaromatic hydrocarbons.	Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	Smith, MR (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.		Smith, Milton/M-3511-2016	Smith, Milton/0000-0002-8036-4503	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063188] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM63188-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGMAN RG, 1984, SCIENCE, V223, P902, DOI 10.1126/science.223.4639.902; Chemler SR, 2000, ORG LETT, V2, P2695, DOI 10.1021/ol0062547; Chen HY, 1999, ANGEW CHEM INT EDIT, V38, P3391, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3391::AID-ANIE3391>3.0.CO;2-N; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Cho JY, 2000, J AM CHEM SOC, V122, P12868, DOI 10.1021/ja0013069; Diederich F., 1998, METAL CATALYZED CROS; Ezbiansky K, 1998, ORGANOMETALLICS, V17, P1455, DOI 10.1021/om980037g; Frid M, 1999, J AM CHEM SOC, V121, P9469, DOI 10.1021/ja992345r; Iverson CN, 1999, J AM CHEM SOC, V121, P7696, DOI 10.1021/ja991258w; JONES WD, 1989, ACCOUNTS CHEM RES, V22, P91, DOI 10.1021/ar00159a002; Kawamura K, 2001, J AM CHEM SOC, V123, P8422, DOI 10.1021/ja015975d; KIM YH, 1992, MACROMOLECULES, V25, P5561, DOI 10.1021/ma00047a001; MEROLA JS, 1989, ORGANOMETALLICS, V8, P778, DOI 10.1021/om00105a031; MIYAURA N, 1981, SYNTHETIC COMMUN, V11, P513, DOI 10.1080/00397918108063618; Murata M, 2000, J ORG CHEM, V65, P164, DOI 10.1021/jo991337q; NGUYEN P, 1993, J AM CHEM SOC, V115, P9329, DOI 10.1021/ja00073a075; RABLEN PR, 1994, J AM CHEM SOC, V116, P4121, DOI 10.1021/ja00088a075; Sammelson RE, 2001, CHEM REV, V101, P137, DOI 10.1021/cr000086e; Schluter AD, 2001, J POLYM SCI POL CHEM, V39, P1533, DOI 10.1002/pola.1130.abs; Shimada S, 2001, ANGEW CHEM INT EDIT, V40, P2168, DOI 10.1002/1521-3773(20010601)40:11<2168::AID-ANIE2168>3.0.CO;2-0; Suzuki A, 1999, J ORGANOMET CHEM, V576, P147, DOI 10.1016/S0022-328X(98)01055-9; Tse MK, 2001, ORG LETT, V3, P2831, DOI 10.1021/ol0162668; WALTZ KM, 1995, J AM CHEM SOC, V117, P11357, DOI 10.1021/ja00150a041; Waltz KM, 1997, SCIENCE, V277, P211, DOI 10.1126/science.277.5323.211	24	918	924	10	263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					305	308		10.1126/science.1067074	http://dx.doi.org/10.1126/science.1067074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11719693				2022-12-01	WOS:000173278600042
J	Broecker, WS; Clark, E				Broecker, WS; Clark, E			Glacial-to-Holocene redistribution of carbonate ion in the deep sea	SCIENCE			English	Article							IN-SITU MEASUREMENTS; ONTONG-JAVA PLATEAU; EQUATORIAL PACIFIC; CALCITE DISSOLUTION; CACO3 PRESERVATION; NORTH-ATLANTIC; CEARA RISE; SEDIMENTS; OCEAN; O-2	We have reconstructed the glacial-age distribution of carbonate ion concentration in the deep waters of the equatorial ocean on the basis of differences in weight between glacial and Holocene foraminifera shells picked from a series of cores spanning a range of water depth on the western Atlantic's Ceara Rise and the western Pacific's Ontong Java Plateau. The results suggest that unlike today's ocean, sizable vertical gradients in the carbonate ion concentration existed in the glacial-age deep ocean. In the equatorial Pacific, the concentration increased with depth, and in the Atlantic, it decreased with depth. In addition, the contrast between the carbonate ion concentration in deep waters produced in the northern Atlantic and deep water in the Pacific appears to have been larger than in today's ocean.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Broecker, WS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	broecker@ldeo.columbia.edu						ARCHER D, 1989, GEOCHIM COSMOCHIM AC, V53, P2831, DOI 10.1016/0016-7037(89)90161-0; Boyle EA, 1988, PALEOCEANOGRAPHY, V3, P471, DOI 10.1029/PA003i004p00471; Broecker W, 2001, PALEOCEANOGRAPHY, V16, P531, DOI 10.1029/2000PA000600; BROECKER W S, 1971, Quaternary Research (Orlando), V1, P188, DOI 10.1016/0033-5894(71)90041-X; Broecker WS, 1990, GLOBAL BIOGEOCHEM CY, V4, P103, DOI 10.1029/GB004i001p00103; BROECKER WS, 1992, NATURE, V356, P587, DOI 10.1038/356587a0; BROECKER WS, 2001, G3 GC000177; BROECKER WS, 2001, G3 GC000151; BROECKER WS, 2000, G3 1 GC000039; BROECKER WS, 1971, LATE CENOZOIC GLACIA; CROWLEY TJ, 1983, MAR GEOL, V51, P1, DOI 10.1016/0025-3227(83)90085-3; Curry WB, 1988, PALEOCEANOGRAPHY, V3, P317, DOI 10.1029/PA003i003p00317; CURRY WB, 1985, AM GEOPHYS UNION MON, V32, P285; EMERSON SR, 1990, PHILOS T R SOC A, V331, P29, DOI 10.1098/rsta.1990.0054; Farrell JW, 1991, PALEOCEANOGRAPHY, V6, P485, DOI 10.1029/91PA00877; Farrell JW, 1989, PALEOCEANOGRAPHY, V4, P447, DOI 10.1029/PA004i004p00447; Hales B, 1996, GLOBAL BIOGEOCHEM CY, V10, P527, DOI 10.1029/96GB01522; HALES B, 1994, DEEP-SEA RES PT I, V41, P695, DOI 10.1016/0967-0637(94)90050-7; Hales B, 1997, GEOCHIM COSMOCHIM AC, V61, P501, DOI 10.1016/S0016-7037(96)00366-3; HEATH GR, 1970, GEOL SOC AM BULL, V81, P3157, DOI 10.1130/0016-7606(1970)81[3157:CDOSRO]2.0.CO;2; HOWARD WR, 1994, PALEOCEANOGRAPHY, V9, P453, DOI 10.1029/93PA03524; Karlin R, 1992, PALEOCEANOGRAPHY, V7, P43, DOI 10.1029/91PA03077; Le JN, 1992, PALEOCEANOGRAPHY, V7, P21, DOI 10.1029/91PA02854; Lea DW, 1990, PALEOCEANOGRAPHY, V5, P719, DOI 10.1029/PA005i005p00719; LEA DW, 1990, NATURE, V347, P269, DOI 10.1038/347269a0; LOHMANN GP, 1995, PALEOCEANOGRAPHY, V10, P445, DOI 10.1029/95PA00059; Martin WR, 1996, GEOCHIM COSMOCHIM AC, V60, P243, DOI 10.1016/0016-7037(95)00383-5; Matsumoto K, 2001, EARTH PLANET SC LETT, V192, P319, DOI 10.1016/S0012-821X(01)00412-5; MILLERO FJ, 1972, GEOCHIM COSMOCHIM AC, V36, P92, DOI 10.1016/0016-7037(72)90123-8; Peng TH, 1987, GLOBAL BIOGEOCHEM CY, V1, P155, DOI 10.1029/GB001i002p00155; Peterson LC., 1985, GEOPHYS MONOGR SER, P251; PYTKOWICZ RM, 1967, GEOCHEM J, V6, P169; SAYLES FL, 1980, MAR CHEM, V9, P223, DOI 10.1016/0304-4203(80)90026-2; Stephens MP, 1997, PALEOCEANOGRAPHY, V12, P797, DOI 10.1029/97PA02271; WU GP, 1991, MAR GEOL, V99, P135, DOI 10.1016/0025-3227(91)90087-K	35	96	99	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2152	2155		10.1126/science.1064171	http://dx.doi.org/10.1126/science.1064171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739953				2022-12-01	WOS:000172647700047
J	Bliwise, DL; Kutner, NG; Zhang, R; Parker, KP				Bliwise, DL; Kutner, NG; Zhang, R; Parker, KP			Survival by time of day of hemodialysis in an elderly cohort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SLEEP-DEPRIVATION; MORTALITY; NONCOMPLIANCE; CHEMOTHERAPY; DURATION; RAT	Context Patients with end-stage renal disease (ESRD) typically undergo hemodialysis (HD) during the morning or afternoon, with time of treatment generally based on space availability or patient preference. No studies have investigated variation in patient survival as a function of the time of day when they receive dialysis. Objective To investigate the association of elderly patients' HD treatment shift with their continued survival, controlling for well-established HD-related mortality risk factors. Design, Setting, and Participants An 11-year follow-up cohort study conducted among 242 ESRD patients aged 60 years or older who underwent HD at 58 dialysis facilities in Georgia either during a morning shift (n=167) or an afternoon shift (n=75) and who completed baseline (1998) and follow-up (1991) interviews. Main Outcome Measure Mortality from all causes occurring through July 7, 1999, as verified by death-certificate reviews, and compared by morning- vs afternoon-shift HD. Results Morning-shift HD patients survived significantly longer than afternoon-shift patients (median survival, 941 days vs 470 days; P<.001), A Cox proportional hazards model indicated that the morning shift was protective (relative risk, 0.71; 95% confidence interval, 0.53-0.95) independent of age, race, sex, body mass index, functional status, diabetic ESRD, cardiovascular comorbidity, weekly hours of dialysis, and months of dialysis. Conclusions Possible explanations for differential survival in association with morning vs afternoon dialysis include salutary effects of sleep in the morning or less efficient biochemical exchange during afternoon dialysis. Results from this cohort study may warrant prospective observational studies and randomized clinical trials that systematically alter the time of day at which HD is administered.	Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Rehabil Med, Atlanta, GA 30322 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA; Emory Univ, Nell Hodgson Woodruff Sch Nursing, Dept Adult & Elder Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Rollins School Public Health; Emory University	Bliwise, DL (corresponding author), Emory Univ, Sch Med, Dept Neurol, WMRB 6000,1639 Pierce Dr, Atlanta, GA 30322 USA.	dbliwis@emory.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG010643, R01AG006066] Funding Source: NIH RePORTER; NIA NIH HHS [AG06066, AG10643, AG05909] Funding Source: Medline; NIDDK NIH HHS [DK42949] Funding Source: Medline; NINDS NIH HHS [NS35343] Funding Source: Medline; NINR NIH HHS [NR04340] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Baines LS, 2000, NEPHRON, V85, P1, DOI 10.1159/000045622; Bliwise D. L, 2000, PRINCIPLES PRACTICE, P26; Bliwise DL, 1999, LUNG BIOL HEALTH DIS, V133, P487; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; GARFEIN AJ, 1995, J GERONTOL B-PSYCHOL, V50, pS77, DOI 10.1093/geronb/50B.2.S77; Hanly PJ, 2001, NEW ENGL J MED, V344, P102, DOI 10.1056/NEJM200101113440204; HELD PJ, 1991, JAMA-J AM MED ASSOC, V265, P871, DOI 10.1001/jama.265.7.871; HRUSHESKY WJM, 1988, SEMIN SURG ONCOL, V4, P110; Kimmel PL, 2000, KIDNEY INT, V57, P1141, DOI 10.1046/j.1523-1755.2000.00941.x; KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103; KUSHIDA CA, 1989, SLEEP, V12, P22, DOI 10.1093/sleep/12.1.22; Kutner N G, 1997, Geriatr Nephrol Urol, V7, P23, DOI 10.1023/A:1008204311582; Kutner Nancy G., 2001, International Urology and Nephrology, V32, P441, DOI 10.1023/A:1017581726362; KUTNER NG, 1991, DIALYSIS TRANSPLANT, V20, P171; KUTNER NG, 1994, AM J KIDNEY DIS, V24, P42, DOI 10.1016/S0272-6386(12)80158-2; KUTNER NG, 1994, RES SOCIOLOGY HLTH C, V11, P127; Kutner NG, 1993, GERIATR NEPHROL UROL, V3, P145; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; Levi F, 1999, J PHARM PHARMACOL, V51, P891, DOI 10.1211/0022357991773302; Levi F, 1999, CANCER-AM CANCER SOC, V85, P2532, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2532::AID-CNCR7>3.0.CO;2-1; MATTANA J, 1995, AM J NEPHROL, V15, P208, DOI 10.1159/000168834; *NIH, 2000, US REN DAT SYST USRD; Parker KP, 2000, SLEEP, V23, P887; SCHAEFER K, 1992, AM J KIDNEY DIS, V19, P460, DOI 10.1016/S0272-6386(12)80955-3; WINGARD DL, 1982, AM J EPIDEMIOL, V116, P765, DOI 10.1093/oxfordjournals.aje.a113466; Wood PA, 1996, CRIT REV EUKAR GENE, V6, P299, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.10	26	35	35	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2690	2694		10.1001/jama.286.21.2690	http://dx.doi.org/10.1001/jama.286.21.2690			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730444	Bronze			2022-12-01	WOS:000172488300028
J	Wellings, F; Nanchahal, K; Macdowall, W; McManus, S; Erens, B; Mercer, CH; Johnson, AM; Copas, AJ; Korovessis, C; Fenton, FA; Field, J				Wellings, F; Nanchahal, K; Macdowall, W; McManus, S; Erens, B; Mercer, CH; Johnson, AM; Copas, AJ; Korovessis, C; Fenton, FA; Field, J			Sexual behaviour in Britain: early heterosexual experience	LANCET			English	Article							INTERCOURSE; AGE	Background Relatively high rates of teenage conception and sexually transmitted infection among young people in Britain have focused attention on early sexual behaviour and its determinants. We report the results of the second National Survey of Sexual Attitudes and Lifestyles (Natsal 2000). Methods We did a probability sample survey between 1999 and 2001, of men and women aged 16-44 years in Britain. Participants were interviewed using a combination of computer-assisted face-to-face and self-completion questionnaires, and asked questions regarding first heterosexual intercourse, communication about sex, pregnancy, and sexually transmitted infections (STIs). Findings We recruited 11 161 men and women to the survey (4762 men, 6399 women). The proportion of those aged 16-19 years at interview reporting first heterosexual intercourse at younger than 16 years was 30% for men and 26% for women; median age was 16 years. The proportion of women reporting first intercourse before 16 years increased up to, but not after, the mid-1990s. There has been a sustained increase in condom use and a decline in the proportion of men and women reporting no contraceptive use at first intercourse with decreasing age at interview. Among 16-24 year olds, non-use of contraception increased with declining age at first intercourse; reported by 18% of men and 22% of women aged 13-14 years at occurrence. Early age at first intercourse was significantly associated with pregnancy under 18 years, but not with occurrence of STIs. Low educational attainment was associated with motherhood before 18 years, but not abortion. Interpretation The increase in the proportion of women reporting first intercourse before age 16 years does not appear to have continued throughout the past decade. Only a small minority of teenagers have unprotected first intercourse, and early motherhood is more strongly associated with educational level than with family background. Factors mast strongly associated with risk behaviour and adverse outcomes have considerable potential for preventive intervention.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Ctr Sexual Hlth Res, London WC1E 7HT, England; Natl Ctr Social Res, London, England; UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London, England; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat SCi, Ctr Infect Dis Epidemiol, London, England; Publ Hlth Lab Serv, HIV STI Div, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; Public Health England	Wellings, F (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Ctr Sexual Hlth Res, Keppel St, London WC1E 7HT, England.	kaye.wellings@lshtm.ac.uk	McManus, Sally/S-4697-2019	McManus, Sally/0000-0003-2711-0819; Copas, Andrew/0000-0001-8968-5963; Erens, Robert/0000-0002-3054-504X; Macdowall, Wendy/0000-0001-5868-8336; Mercer, Catherine/0000-0002-4220-5034; Erens, Bob/0000-0002-4430-954X; Nanchahal, Kiran/0000-0001-8812-7628; Johnson, Anne/0000-0003-1330-7100				Bozon M, 1998, SOC AS AIDS, P37; COPAS AJ, 1990, IN PRESS ACCURACY RE; Department of Health, 2001, NAT STRAT SEX HLTH H; Dickson N, 1998, BRIT MED J, V316, P29, DOI 10.1136/bmj.316.7124.29; Edgardh K, 2000, SEX TRANSM INFECT, V76, P98, DOI 10.1136/sti.76.2.98; GIESECKE J, 1992, INT J STD AIDS, V3, P255, DOI 10.1177/095646249200300405; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Johnson AM, 1994, SEXUAL ATTITUDES LIF; KANE R, 1999, REDUCING RATE TEENAG; MICHAEL RT, 2001, SEX LOVE HLTH AM; NICOLL A, 1999, BRIT MED J, V38, P1322; Paul C, 2000, J ADOLESCENT HEALTH, V27, P136, DOI 10.1016/S1054-139X(99)00095-6; Singh S, 1999, FAM PLANN PERSPECT, V31, P212, DOI 10.2307/2991568; *SOC EXCL UN, 1999, TEEN PREGN; StuartSmith S, 1996, BRIT MED J, V312, P390; WELLINGS K, 1994, SEXUAL BEHAV BRIT; WEST P, 1993, J ADOLESCENCE, V16, P367, DOI 10.1006/jado.1993.1031; Wight D, 2000, BRIT MED J, V320, P1243, DOI 10.1136/bmj.320.7244.1243	18	426	431	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2001	358	9296					1843	1850		10.1016/S0140-6736(01)06885-4	http://dx.doi.org/10.1016/S0140-6736(01)06885-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497NU	11741623				2022-12-01	WOS:000172463000009
J	Quist, D; Chapela, IH				Quist, D; Chapela, IH			Transgenic DNA introgressed into traditional maize landraces in Oaxaca, Mexico	NATURE			English	Article							GENE FLOW; PLANTS	Concerns have been raised about the potential effects of transgenic introductions on the genetic diversity of crop landraces and wild relatives in areas of crop origin and diversification, as this diversity is considered essential for global food security. Direct effects on non-target species(1,2), and the possibility of unintentionally transferring traits of ecological relevance onto landraces and wild relatives have also been sources of concern(3,4). The degree of genetic connectivity between industrial crops and their progenitors in landraces and wild relatives is a principal determinant of the evolutionary history of crops and agroecosystems throughout the world(5,6). Recent introductions of transgenic DNA constructs into agricultural fields provide unique markers to measure such connectivity. For these reasons, the detection of transgenic DNA in crop landraces is of critical importance. Here we report the presence of introgressed transgenic DNA constructs in native maize landraces grown in remote mountains in Oaxaca, Mexico, part of the Mesoamerican centre of origin and diversification of this crop(7-9).	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Chapela, IH (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	ichapela@nature.berkeley.edu						DOEBLEY J, 1990, BIOSCIENCE, V40, P443, DOI 10.2307/1311391; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2001, PLANT PHYSIOL, V125, P1543, DOI 10.1104/pp.125.4.1543; Gachet E, 1998, TRENDS FOOD SCI TECH, V9, P380, DOI 10.1016/S0924-2244(99)00002-3; Hartl Daniel L., 1996, V58, P293; ILTIS HH, 1983, SCIENCE, V222, P886, DOI 10.1126/science.222.4626.886; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Matsuoka T, 2000, J FOOD HYG SOC JPN, V41, P137, DOI 10.3358/shokueishi.41.137; Pawlowski WP, 1998, P NATL ACAD SCI USA, V95, P12106, DOI 10.1073/pnas.95.21.12106; Piperno DR, 2001, P NATL ACAD SCI USA, V98, P2101, DOI 10.1073/pnas.98.4.2101; Saxena D, 1999, NATURE, V402, P480, DOI 10.1038/44997; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; White S, 1998, TRENDS GENET, V14, P327, DOI 10.1016/S0168-9525(98)01524-8; Zimmermann A, 2000, LEBENSM-WISS TECHNOL, V33, P210, DOI 10.1006/fstl.2000.0637; 1999, SMT4CT962072 EU BUND	15	357	433	0	138	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 29	2001	414	6863					541	543		10.1038/35107068	http://dx.doi.org/10.1038/35107068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734853				2022-12-01	WOS:000172405900046
J	Brandstetter, H; Kim, JS; Groll, M; Huber, R				Brandstetter, H; Kim, JS; Groll, M; Huber, R			Crystal structure of the tricorn protease reveals a protein disassembly line	NATURE			English	Article							INHIBITOR	The degradation of cytosolic proteins is carried out predominantly by the proteasome, which generates peptides of 7-9 amino acids long(1). These products need further processing. Recently, a proteolytic system was identified in the model organism Thermoplasma acidophilum that performs this processing(2,3). The hexameric core protein of this modular system, referred to as tricorn protease, is a 720K protease that is able to assemble further into a giant icosahedral capsid, as determined by electron microscopy(4). Here, we present the crystal structure of the tricorn protease at 2.0 Angstrom resolution. The structure reveals a complex mosaic protein whereby five domains combine to form one of six subunits, which further assemble to form the 3-2-symmetric core protein. The structure shows how the individual domains coordinate the specific steps of substrate processing, including channelling of the substrate to, and the product from, the catalytic site. Moreover, the structure shows how accessory protein components might contribute to an even more complex protein machinery that efficiently collects the tricorn-released products.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany	Max Planck Society	Brandstetter, H (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany.	hbs@biochem.mpg.de	Brandstetter, Hans/E-6754-2011; Groll, Michael/C-1174-2010; Groll, Michael/F-5572-2015	Brandstetter, Hans/0000-0002-6089-3045; 				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dryjanski M, 1998, BIOCHEMISTRY-US, V37, P14151, DOI 10.1021/bi981278v; Fulop V, 2000, EMBO REP, V1, P277, DOI 10.1093/embo-reports/kvd048; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; HUANG K, 1995, PROTEIN SCI, V4, P1985, DOI 10.1002/pro.5560041004; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Tamura T, 1996, FEBS LETT, V398, P101, DOI 10.1016/S0014-5793(96)01163-5; Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385; TURK D, 1992, CHEMISTRY; Walz J, 1997, MOL CELL, V1, P59, DOI 10.1016/S1097-2765(00)80007-6; Walz J, 1999, J STRUCT BIOL, V128, P65, DOI 10.1006/jsbi.1999.4169; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2	20	78	82	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					466	470		10.1038/35106609	http://dx.doi.org/10.1038/35106609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719810				2022-12-01	WOS:000172304500048
J	Tang, SM; Guo, A				Tang, SM; Guo, A			Choice behavior of Drosophila facing contradictory visual cues	SCIENCE			English	Article							MUSHROOM BODIES; FLIGHT ORIENTATION; DISCOVERY	We studied the underlying neural mechanism of a simple choice behavior between competing alternatives in Drosophila. In a flight simulator, individual flies were conditioned to choose one of two flight paths in response to color and shape cues; after the training, they were tested with Contradictory cues. Wild-type flies made a discrete choice that switched from one alternative to the other as the relative salience of color and shape cues gradually changed, but this ability was greatly diminished in mutant (mbm(1)) flies with miniature mushroom bodies or with hydroxyurea ablation of mushroom bodies. Thus, Drosophila genetics may be useful for elucidating the neural basis of choice behavior.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Inst Biophys, Lab Visual Informat Processing, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Guo, A (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.							Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Dujardin F., 1850, ANN SCI NAT ZOOL, V14, P195; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; HEISENBERG M, 1984, VISION DROSOPHILA; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; WOLF R, 1997, LEARN MEMORY, V4, P319	14	147	162	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1543	1547		10.1126/science.1058237	http://dx.doi.org/10.1126/science.1058237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711680				2022-12-01	WOS:000172240500054
J	Kendrick, KM; da Costa, AP; Leigh, AE; Hinton, MR; Peirce, JW				Kendrick, KM; da Costa, AP; Leigh, AE; Hinton, MR; Peirce, JW			Sheep don't forget a face	NATURE			English	Article							TEMPORAL CORTEX; DISCRIMINATION; FAMILIARITY; CELLS		Babraham Inst, Lab Cognit & Dev Neurosci, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Kendrick, KM (corresponding author), Babraham Inst, Lab Cognit & Dev Neurosci, Cambridge CB2 4AT, England.		Peirce, Jonathan Westley/AAA-8603-2020; Peirce, Jonathan/B-1807-2008	Peirce, Jonathan Westley/0000-0002-9504-4342; Peirce, Jonathan/0000-0002-9504-4342; Kendrick, Keith/0000-0002-0371-5904				Broad KD, 2000, EUR J NEUROSCI, V12, P731, DOI 10.1046/j.1460-9568.2000.00934.x; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; KENDRICK KM, 1995, ANIM BEHAV, V49, P1665, DOI 10.1016/0003-3472(95)90088-8; KENDRICK KM, 1987, SCIENCE, V236, P448, DOI 10.1126/science.3563521; Kendrick KM, 1998, NATURE, V395, P229, DOI 10.1038/26129; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Peirce JW, 2001, BEHAV PROCESS, V55, P13, DOI 10.1016/S0376-6357(01)00158-9; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003	9	206	208	0	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					165	166		10.1038/35102669	http://dx.doi.org/10.1038/35102669			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700543				2022-12-01	WOS:000172029100032
J	Dworkin, J; Losick, R				Dworkin, J; Losick, R			Differential gene expression governed by chromosomal spatial asymmetry	CELL			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTOR; CELL-SPECIFIC TRANSCRIPTION; ANTI-SIGMA FACTOR; FORESPORE-SPECIFIC TRANSCRIPTION; BACILLUS-SUBTILIS SPORULATION; ESCHERICHIA-COLI; FACTOR SPOIIAB; DIVISION; PROTEIN; ACTIVATION	The activity of the transcription factor sigma (F) is confined to one (the forespore) of two cells created by asymmetric division during sporulation in B. subtilis. We show that sigma (F) activation is partly governed by the position of the gene for the unstable anti-sigma (F) factor SpoIIAB. Because cytokinesis precedes chromosome segregation, most of the chromosome is translocated into the forespore after division. We hypothesize that because spoIIAB; enters the forespore late, SpoIIAB lost to proteolysis is temporarily not replenished. Thus, chromosome asymmetry would be translated into the asymmetric distribution of SpoIIAB. Supporting this idea, transposition of spoIIAB to sites present in the forespore at the time of division impaired sporulation when a second pathway that participates in sigma (F) activation was disabled.	Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Biol Labs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.				NIGMS NIH HHS [5F32-GM19729, GM18568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019729, R37GM018568, R01GM018568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Arigoni F, 1999, MOL MICROBIOL, V31, P1407, DOI 10.1046/j.1365-2958.1999.01282.x; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; CUTTING S, 1990, CELL, V62, P239, DOI 10.1016/0092-8674(90)90362-I; DUNCAN L, 1993, P NATL ACAD SCI USA, V90, P2325, DOI 10.1073/pnas.90.6.2325; Duncan L, 1996, J MOL BIOL, V260, P147, DOI 10.1006/jmbi.1996.0389; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Errington J, 1996, TRENDS GENET, V12, P31, DOI 10.1016/0168-9525(96)81386-2; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Feucht A, 1999, MOL MICROBIOL, V33, P1015, DOI 10.1046/j.1365-2958.1999.01543.x; Frandsen N, 1999, GENE DEV, V13, P394, DOI 10.1101/gad.13.4.394; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Harwood C.R., 1990, MOL BIOL METHODS BAC; HOFMEISTER AEM, 1995, CELL, V83, P219, DOI 10.1016/0092-8674(95)90163-9; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; KAROW ML, 1995, P NATL ACAD SCI USA, V92, P2012, DOI 10.1073/pnas.92.6.2012; Khvorova A, 2000, J BACTERIOL, V182, P4425, DOI 10.1128/JB.182.16.4425-4429.2000; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; LEVIN PA, 1994, J BACTERIOL, V176, P1451, DOI 10.1128/jb.176.5.1451-1459.1994; LEWIS PJ, 1994, P NATL ACAD SCI USA, V91, P3849, DOI 10.1073/pnas.91.9.3849; LONDONOVALLEJO JA, 1995, GENE DEV, V9, P503, DOI 10.1101/gad.9.4.503; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; LOSICK R, 1992, NATURE, V355, P601, DOI 10.1038/355601a0; LOSICK R, 1996, HARVEY LECT, V90, P1; LYNCH AS, 1993, J BACTERIOL, V175, P1645, DOI 10.1128/JB.175.6.1645-1655.1993; MARGOLIS P, 1991, SCIENCE, V254, P562, DOI 10.1126/science.1948031; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; MIN KT, 1993, CELL, V74, P735, DOI 10.1016/0092-8674(93)90520-Z; Niki H, 2000, GENE DEV, V14, P212; Pan Q, 2001, MOL CELL, V8, P873, DOI 10.1016/S1097-2765(01)00362-8; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Pogliano K, 1997, J BACTERIOL, V179, P3331, DOI 10.1128/jb.179.10.3331-3341.1997; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; SCHMIDT R, 1990, P NATL ACAD SCI USA, V87, P9221, DOI 10.1073/pnas.87.23.9221; SCHUCH R, 1994, J BACTERIOL, V176, P4104, DOI 10.1128/JB.176.13.4104-4110.1994; SUN DX, 1991, J BACTERIOL, V173, P2977, DOI 10.1128/JB.173.9.2977-2984.1991; SUN DX, 1991, J BACTERIOL, V173, P7867, DOI 10.1128/jb.173.24.7867-7874.1991; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; Zupancic ML, 2001, MOL MICROBIOL, V39, P1471, DOI 10.1046/j.1365-2958.2001.02331.x	48	65	71	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					339	346		10.1016/S0092-8674(01)00528-1	http://dx.doi.org/10.1016/S0092-8674(01)00528-1			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701124	Bronze			2022-12-01	WOS:000172022800005
J	Pascual, A; Preat, T				Pascual, A; Preat, T			Localization of long-term memory within the Drosophila mushroom body	SCIENCE			English	Article							EXTRINSIC NEURONS; BODIES; BRAIN; MELANOGASTER; GENE	The mushroom bodies, substructures of the Drosophila brain, are involved in olfactory learning and short-term memory, but their rote in long-term memory is unknown. Here we show that the alpha-lobes-absent (ala) mutant lacks either the two vertical lobes of the mushroom body or two of the three median lobes which contain branches of vertical lobe neurons. This unique phenotype allows analysis of mushroom body function. Long-term memory required the presence of the vertical lobes but not the median lobes. Short-term memory was normal in flies without either vertical lobes or the two median lobes studied.	CNRS, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Preat, T (corresponding author), CNRS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	preat@iaf.cnrs-gif.fr	Pascual, Alberto/L-2014-2019; Pascual, Alberto P/E-9609-2015; IBIS, NEURONAL/O-9910-2015	Pascual, Alberto/0000-0001-5459-6207; Pascual, Alberto P/0000-0001-5459-6207; Preat, Thomas/0000-0001-9976-1763				Armstrong JD, 1998, LEARN MEMORY, V5, P102; Boquet I, 2000, J NEUROBIOL, V42, P33; BOYNTON S, 1992, GENETICS, V131, P655; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Ito K, 1998, LEARN MEMORY, V5, P52; Lee T, 1999, DEVELOPMENT, V126, P4065; Li YS, 1997, J COMP NEUROL, V387, P631; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Nassif C, 1998, J COMP NEUROL, V402, P10; PASCUAL A, UNPUB; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	19	272	276	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1115	1117		10.1126/science.1064200	http://dx.doi.org/10.1126/science.1064200			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	489VU	11691997				2022-12-01	WOS:000172013800054
J	O'Neill, MA; Eberhard, S; Albersheim, P; Darvill, AG				O'Neill, MA; Eberhard, S; Albersheim, P; Darvill, AG			Requirement of borate cross-linking of cell wall rhamnogalacturonan II for Arabidopsis growth	SCIENCE			English	Article							FUCOSE-DEFICIENT MUTANT; PLANT-CELL; PECTIC POLYSACCHARIDE; BORON; THALIANA; ESTER; TRANSFERASE; GLYCANS; DIMER; MUR1	Turgor-driven plant cell growth depends on watt structure. Two allelic L-fucose-deficient Arabidopsis thaliana mutants (mur1-1 and 1-2) are dwarfed and their rosette leaves do not grow normally. mur1 leaf cell watts contain normal amounts of the cell watt pectic polysaccharide rhamnogalacturonan II (RG-II), but only half exists as a borate cross-linked dimer. The altered structure of mur1 RG-II reduces the rate of formation and stability of this cross-link. Exogenous aqueous borate rescues the defect. The reduced cross-linking of RG-II in dwarf mur1 plants indicates that plant growth depends on watt pectic polysaccharide organization.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	O'Neill, MA (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.							Blevins DG, 1998, ANNU REV PLANT PHYS, V49, P481, DOI 10.1146/annurev.arplant.49.1.481; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Brown PH, 1997, PLANT SOIL, V196, P211, DOI 10.1023/A:1004245823080; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Duffels A, 2000, BIOORGAN MED CHEM, V8, P2519, DOI 10.1016/S0968-0896(00)00187-5; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; Ishii T, 1999, J BIOL CHEM, V274, P13098, DOI 10.1074/jbc.274.19.13098; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; LOOMIS WD, 1992, BIOFACTORS, V3, P229; Matoh T, 1998, J PLANT RES, V111, P179, DOI 10.1007/BF02507164; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Perrin RM, 1999, SCIENCE, V284, P1976, DOI 10.1126/science.284.5422.1976; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Reiter WD, 1998, PLANT PHYSIOL BIOCH, V36, P167, DOI 10.1016/S0981-9428(98)80101-0; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; RUEHS B, UNPUB; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; VANZIN GF, COMMUNICATION; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; YORK WS, UNPUB; Zablackis E, 1996, SCIENCE, V272, P1808, DOI 10.1126/science.272.5269.1808	23	459	487	8	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					846	849		10.1126/science.1062319	http://dx.doi.org/10.1126/science.1062319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679668				2022-12-01	WOS:000171851800045
J	Wootton, JT				Wootton, JT			Local interactions predict large-scale pattern in empirically derived cellular automata	NATURE			English	Article							FOREST-FIRES; DISTURBANCE; COMPETITION; SUCCESSION; COMMUNITY; DYNAMICS; ECOLOGY; MODELS; SIZE	An important unanswered question in ecology is whether processes such as species interactions that occur at a local scale can generate large-scale patterns seen in nature(1,2). Because of the complexity of natural ecosystems, developing an adequate theoretical framework to scale up local processes has been challenging. Models of complex systems can produce a wide array of outcomes; therefore, model parameter values must be constrained by empirical information to usefully narrow the range of predicted behaviour. Under some conditions, spatially explicit models of locally interacting objects (for example, cells, sand grains, car drivers, or organisms), variously termed cellular automata(3,4) or interacting particle models(5), can self-organize to develop complex spatial and temporal patterning at larger scales in the absence of any externally imposed pattern(1,6-8). When these models are based on transition probabilities of moving between ecological states at a local level, relatively complex versions of these models can be linked readily to empirical information on ecosystem dynamics. Here, I show that an empirically derived cellular automaton model of a rocky intertidal mussel bed based on local interactions correctly predicts large-scale spatial patterns observed in nature.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.		Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344				Bak P., 2013, NATURE WORKS SCI SEL, P33, DOI 10.1007/978-1-4757-5426-1_2; Clar S, 1996, J PHYS-CONDENS MAT, V8, P6803, DOI 10.1088/0953-8984/8/37/004; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DENNY MW, 1987, J EXP MAR BIOL ECOL, V113, P231, DOI 10.1016/0022-0981(87)90103-1; DURRETT R, 1994, PHILOS T ROY SOC B, V343, P329, DOI 10.1098/rstb.1994.0028; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Jensen J. H., 1998, SELF ORG CRITICALITY; JOHNSON LE, 1992, J EXP MAR BIOL ECOL, V160, P251, DOI 10.1016/0022-0981(92)90241-2; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; Paine R. T., 1994, MARINE ROCKY SHORES; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Sokal R., 2000, BIOMETRY, V3rd ed., P451; SOLE RV, 1995, J THEOR BIOL, V173, P31, DOI 10.1006/jtbi.1995.0040; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; Stephenson T.A., 1972, LIFE TIDEMARKS ROCKY; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; WOLFRAM S, 1984, NATURE, V311, P419, DOI 10.1038/311419a0; WOOTTON JT, 1993, ECOLOGY, V74, P195, DOI 10.2307/1939514; WOOTTON JT, 1992, ECOLOGY, V73, P981, DOI 10.2307/1940174; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881	23	137	144	1	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					841	844		10.1038/35101595	http://dx.doi.org/10.1038/35101595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677606				2022-12-01	WOS:000171750200045
J	Wu, WC; Rathore, SS; Wang, Y; Radford, MJ; Krumholz, HM				Wu, WC; Rathore, SS; Wang, Y; Radford, MJ; Krumholz, HM			Blood transfusion in elderly patients with acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC COMPENSATION; MEDICARE PATIENTS; OXYGEN DELIVERY; ANEMIA; HEMATOCRIT; MORTALITY; DISEASE; STRATEGIES; TRIAL; RISK	Background: Anemia may have adverse effects in patients with coronary artery disease. However, the benefit of blood transfusion in elderly patients with acute myocardial infarction and various degrees of anemia is uncertain. Methods: We conducted a retrospective study of data on 78,974 Medicare beneficiaries 65 years old or older who were hospitalized with acute myocardial infarction. Patients were categorized according to the hematocrit on admission (5.0 to 24.0 percent, 24.1 to 27.0 percent, 27.1 to 30.0 percent, 30.1 to 33.0 percent, 33.1 to 36.0 percent, 36.1 to 39.0 percent, or 39.1 to 48.0 percent), and data were evaluated to determine whether there was an association between the use of transfusion and 30-day mortality. Results: Patients with lower hematocrit values on admission had higher 30-day mortality rates. Blood transfusion was associated with a reduction in 30-day mortality among patients whose hematocrit on admission fell into the categories ranging from 5.0 to 24.0 percent (adjusted odds ratio, 0.22; 95 percent confidence interval, 0.11 to 0.45) to 30.1 to 33.0 percent (adjusted odds ratio, 0.69; 95 percent confidence interval, 0.53 to 0.89). It was not associated with a reduction in 30-day mortality among those whose hematocrit values fell in the higher ranges. In one of seven subgroup analyses (among patients who survived at least two days), transfusion was not associated with a reduction in mortality for patients with hematocrit values of 30.1 percent or higher. Conclusions: Blood transfusion is associated with a lower short-term mortality rate among elderly patients with acute myocardial infarction if the hematocrit on admission is 30.0 percent or lower and may be effective in patients with a hematocrit as high as 33.0 percent on admission.	Brown Univ, Sch Med, Div Cardiovasc Dis, Providence, RI 02912 USA; Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Qualidigm, Middletown, CT USA	Brown University; Yale University; Yale University; Yale University	Wu, WC (corresponding author), Brown Univ, Sch Med, Div Cardiovasc Dis, Providence, RI 02912 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557				[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; BLAIR SD, 1986, BRIT J SURG, V73, P783, DOI 10.1002/bjs.1800731007; BOTTIGER LE, 1980, ATHEROSCLEROSIS, V36, P389, DOI 10.1016/0021-9150(80)90219-1; BRAZIER J, 1974, SURGERY, V75, P508; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Chiavetta JA, 1996, TRANSFUSION, V36, P699, DOI 10.1046/j.1537-2995.1996.36896374373.x; CZER LSC, 1978, SURG GYNECOL OBSTET, V147, P363; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; *DEP HLTH HUM SERV, 1989, DHHS PUBL; Ely EW, 1999, NEW ENGL J MED, V340, P467, DOI 10.1056/NEJM199902113400610; Eschbach J, 1997, AM J KIDNEY DIS, V30, pS192; FAUCI AS, 1998, HARRISONS PRINCIPLES, V1; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; Friedman BA, 1982, CLIN LABORATORY ANN, V1, P147; Geha A S, 1978, World J Surg, V2, P645; GRINDON AJ, 1985, JAMA-J AM MED ASSOC, V253, P540, DOI 10.1001/jama.253.4.540; HASLEY PB, 1994, TRANSFUSION, V34, P110, DOI 10.1046/j.1537-2995.1994.34294143936.x; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618, DOI 10.1164/ajrccm.155.5.9154866; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; HEBERT PC, 1995, JAMA-J AM MED ASSOC, V274, P944; Innes G, 1998, J Emerg Med, V16, P129; JAN KM, 1977, AM J PHYSIOL, V233, pH106, DOI 10.1152/ajpheart.1977.233.1.H106; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; JOOSTEN E, 1992, GERONTOLOGY, V38, P111, DOI 10.1159/000213315; KALCHTHALER T, 1980, J AM GERIATR SOC, V28, P108, DOI 10.1111/j.1532-5415.1980.tb00242.x; LEVY PS, 1993, AM J PHYSIOL, V265, pH340, DOI 10.1152/ajpheart.1993.265.1.H340; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MOST AS, 1986, CIRCULATION, V74, P1085, DOI 10.1161/01.CIR.74.5.1085; *ROYAL COLL PHYS E, 1994, BRIT J ANAESTH, V73, P857; Silverberg DS, 2000, J AM COLL CARDIOL, V35, P1737, DOI 10.1016/S0735-1097(00)00613-6; Smieja MJ, 1996, CAN MED ASSOC J, V155, P691; SORLIE PD, 1981, AM HEART J, V101, P456, DOI 10.1016/0002-8703(81)90136-8; VAMVAKAS EC, 1994, TRANSFUSION, V34, P464, DOI 10.1046/j.1537-2995.1994.34694295059.x; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V280, P1404; WELCH HG, 1992, ANN INTERN MED, V116, P393, DOI 10.7326/0003-4819-116-5-393; WILKERSON DK, 1988, SURGERY, V103, P665; World Health Organization, 1968, NUTR AN REP WHO SCI; Zimmermann R, 1997, TRANSFUSION, V37, P1075, DOI 10.1046/j.1537-2995.1997.371098016449.x	44	644	674	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2001	345	17					1230	1236		10.1056/NEJMoa010615	http://dx.doi.org/10.1056/NEJMoa010615			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485RU	11680442				2022-12-01	WOS:000171773100002
J	Edmunds, L; Waters, E; Elliott, EJ				Edmunds, L; Waters, E; Elliott, EJ			Evidence based paediatrics - Evidence based management of childhood obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OVERWEIGHT; CHILDREN; ADOLESCENTS; RISK		Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; Univ Melbourne, Royal Childrens Hosp, Ctr Community Child Hlth, Parkville, Vic 3052, Australia; Univ Sydney, Sydney, NSW 2145, Australia; New Childrens Hosp, Sydney, NSW 2145, Australia	University of Oxford; Royal Children's Hospital Melbourne; University of Melbourne; University of Sydney; University of Sydney	Edmunds, L (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	laurel.edmunds@dphpc.ox.ac.uk		Elliott, Elizabeth/0000-0002-6501-5487; Edmunds, Laurel/0000-0001-9677-3742				[Anonymous], 1983, J ROY COLL PHYS LOND, V17, P5; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; BIDDLE SJH, 1994, PHYSICAL ACTIVITY PR; CAMPBELL K, 2001, COCHRANE DATABASE SY, V1; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Epstein LH, 1998, PEDIATRICS, V101, P554; Flegal KM, 1999, MED SCI SPORT EXER, V31, pS509, DOI 10.1097/00005768-199911001-00004; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; FRENCH SA, 1995, OBES RES, V3, P479, DOI 10.1002/j.1550-8528.1995.tb00179.x; Gill TP, 1997, BRIT MED BULL, V53, P359, DOI 10.1093/oxfordjournals.bmb.a011618; GLENNY AM, 1997, SYSTEMATIC REV INTER; Golan M, 1998, INT J OBESITY, V22, P1217, DOI 10.1038/sj.ijo.0800749; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Haddock C. Keith, 1994, Annals of Behavioral Medicine, V16, P235; Hughes JM, 1997, ARCH DIS CHILD, V76, P182, DOI 10.1136/adc.76.3.182; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Owens S, 1999, MED SCI SPORT EXER, V31, P143, DOI 10.1097/00005768-199901000-00022; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; SUMMERBELL C, 2001, COCHRANE LIB; Wake M, 2000, PEDIATR RES, V47, p160A; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; WHO, 1998, OB PREV MAN GLOB EP	25	77	81	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2001	323	7318					916	919		10.1136/bmj.323.7318.916	http://dx.doi.org/10.1136/bmj.323.7318.916			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668139	Green Published			2022-12-01	WOS:000171798200025
J	Fonarow, GC				Fonarow, GC			Quality indicators for the management of heart failure in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING ENZYME-INHIBITORS; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; CALCIUM-CHANNEL BLOCKER; RANDOMIZED-TRIAL; DOUBLE-BLIND; MORTALITY; MORBIDITY; THERAPY; CAPTOPRIL		Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Fonarow, GC (corresponding author), Univ Calif Los Angeles, Div Cardiol, 47-123 CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				*AM HEART ASS, 1997, HEART STROK STAT UPD; Blackshear JL, 1996, LANCET, V348, P633; CAS LD, 1995, CLIN CARDIOL, V18, P370, DOI 10.1002/clc.4960180704; Cohn JN, 1997, CIRCULATION, V96, P856, DOI 10.1161/01.cir.96.3.856; Doughty RN, 1997, EUR HEART J, V18, P560; ELKAYAM U, 1985, AM J CARDIOL, V56, P560, DOI 10.1016/0002-9149(85)91185-3; ELKAYAM U, 1990, CIRCULATION, V82, P1954, DOI 10.1161/01.CIR.82.6.1954; Gambassi G, 2000, ARCH INTERN MED, V160, P53, DOI 10.1001/archinte.160.1.53; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; GOLDSTEIN RE, 1991, CIRCULATION, V83, P52, DOI 10.1161/01.CIR.83.1.52; Grossman E, 1996, ANN INTERN MED, V125, P304, DOI 10.7326/0003-4819-125-4-199608150-00009; Heidenreich PA, 1997, J AM COLL CARDIOL, V30, P27, DOI 10.1016/S0735-1097(97)00104-6; Hjalmarson A, 1999, LANCET, V353, P2001; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1969, DOI 10.1001/jama.264.15.1969; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; KONSTAM MA, 1994, AHCPR PUBL; Kostis JB, 1997, AM HEART J, V133, P550, DOI 10.1016/S0002-8703(97)70150-9; Lechat P, 1999, LANCET, V353, P9; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; Levine TB, 2000, CIRCULATION, V101, P758, DOI 10.1161/01.CIR.101.7.758; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; PARKER M, 1996, NEW ENGL J MED, V334, P1349; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Philbin EF, 1998, ARCH INTERN MED, V158, P501, DOI 10.1001/archinte.158.5.501; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; RYMAN KS, 1986, AM J CARDIOL, V58, P583, DOI 10.1016/0002-9149(86)90280-8; Senni M, 1999, J AM COLL CARDIOL, V33, P164, DOI 10.1016/S0735-1097(98)00523-3; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; TEO KK, 1993, JAMA-J AM MED ASSOC, V270, P1589, DOI 10.1001/jama.270.13.1589; Thackray S, 2000, EUR J HEART FAIL, V2, P209, DOI 10.1016/S1388-9842(00)00080-5; Yusuf S, 2000, NEW ENGL J MED, V342, P145	40	15	15	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				694	702		10.7326/0003-4819-135-8_Part_2-200110161-00008	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481WA	11601952				2022-12-01	WOS:000171542400008
J	Mutabingwa, T; Nzila, A; Mberu, E; Nduati, E; Winstanley, P; Hills, E; Watkins, W				Mutabingwa, T; Nzila, A; Mberu, E; Nduati, E; Winstanley, P; Hills, E; Watkins, W			Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania	LANCET			English	Article							PLASMODIUM-FALCIPARUM; DIHYDROPTEROATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; SULFADOXINE-PYRIMETHAMINE; SELECTIVE PRESSURE; SYNTHETASE GENE; PARASITES; FANSIDAR; CHILDREN; AFRICA	Background Resistance to the affordable malaria treatments chloroquine and pyrimethamine-sulfadoxine is seriously impeding malaria control through treatment in east Africa. We did an open, alternate drug allocation study to assess the efficacy of chlorproguanil-dapsone in the treatment of falciparum malaria clinically resistant to pyrimethamine-sulfadoxine. Methods Children younger than 5 years with non-severe falciparum malaria, attending Muheza district hospital in Tanzania, were treated with the standard regimen of pyrimethamine-sulfadoxine. Patients whose clinical symptoms resolved but who remained parasitaemic 7 days after pyrimethamine-sulfadoxine were followed up for 1 month. Clinical malaria episodes were retreated with either single dose pyrimethamine-sulfadoxine or a 3-day regimen of chlorproguanil-dapsone. Those with parasitaemia after 7 days were treated with chlorproguanil-dapsone. Parasite DNA was collected on day 7 after first treatment with pyrimethamine-sulfadoxine and we looked for point mutations in the genes encoding dihydrofolate reductase (dhfr) and dyhydropteroate synthetase (dhps). Findings 360 children were enrolled and treated with pyrimethamine-sulfadoxine. On day 7, 192 (55%) of 348 had cleared parasitaemia. Of the remaining 156 parasitaemic children, 140 (90%) were followed up to day 28, and 92 (66%) of 140 developed clinical malaria. These 92 patients were alternately retreated with either pyrimethamine-sulfadoxine (46) or chlorproguanil-dapsone (46). 28 (61%) of 46 children retreated with pyrimethamine-sulfadoxine were still parasitaemic at day 7, compared with three (15%) of 46 children retreated with chlorproguanil-dapsone. Resistance to pyrimethamine-sulfadoxine increased from 45% (156/348) at the first treatment to 61% (28/46) after retreatment. 83 of 85 parasite isolates collected after the first pyrimethamine-sulfadoxine treatment, and before and after the second treatments with pyrimethamine-sulfadoxine and chlorproguanil-dapsone showed triple-mutant dhfr alleles, associated with a variety of dhps mutations. Interpretation Most patients treated with pyrimethamine-sulfadoxine, who remain parasitaemic at day 7, develop new malaria symptoms within 1 month. Chlorproguanil-dapsone was a practicable therapy under these circumstances. Analysis of parasite dhfr and dhps before and after treatment supports the view that pyrimethamine-sulfadoxine resistance in this part of Africa is primarily due to parasites with three mutations in the dhfr domain.	Amani Med Res Ctr, Natl Inst Med Res, Amani Tanga, Tanzania; Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, Nairobi, Kenya; Muheza Designated Dist Hosp, Muheza Tanga, Tanzania	University of Liverpool; Kenya Medical Research Institute	Mutabingwa, T (corresponding author), Amani Med Res Ctr, Natl Inst Med Res, POB 4, Amani Tanga, Tanzania.							Amukoye E, 1997, ANTIMICROB AGENTS CH, V41, P2261, DOI 10.1128/AAC.41.10.2261; Basco LK, 2000, J INFECT DIS, V182, P624, DOI 10.1086/315731; BRANDLINGBENNETT AD, 1988, T ROY SOC TROP MED H, V82, P833, DOI 10.1016/0035-9203(88)90009-0; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; BZIK DJ, 1987, P NATL ACAD SCI USA, V84, P8360, DOI 10.1073/pnas.84.23.8360; Clyde David F, 1967, MALARIA TANZANIA; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; HYDE JE, 1990, PHARMACOL THERAPEUT, V48, P45, DOI 10.1016/0163-7258(90)90017-V; KILIMALI VAEB, 1985, T ROY SOC TROP MED H, V79, P482, DOI 10.1016/0035-9203(85)90071-9; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; MSUYA FHM, 1991, ACTA TROP, V49, P165, DOI 10.1016/0001-706X(91)90035-I; MUTABINGWA TK, 1999, MAL OTHER INFECT DIS, V10, P28; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Ronn AM, 1996, T ROY SOC TROP MED H, V90, P179, DOI 10.1016/S0035-9203(96)90129-7; STICH AHR, 1994, T ROY SOC TROP MED H, V88, P150, DOI 10.1016/0035-9203(94)90271-2; Trigg JK, 1997, ACTA TROP, V63, P185, DOI 10.1016/S0001-706X(96)00617-1; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Wang P, 1997, PARASITOLOGY, V115, P223, DOI 10.1017/S0031182097001431; WATKINS WM, 1993, T ROY SOC TROP MED H, V87, P75, DOI 10.1016/0035-9203(93)90431-O; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 1996, WHOMAL961077; Winstanley P, 1997, T ROY SOC TROP MED H, V91, P322, DOI 10.1016/S0035-9203(97)90093-6	26	148	149	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1218	1223		10.1016/S0140-6736(01)06344-9	http://dx.doi.org/10.1016/S0140-6736(01)06344-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675058				2022-12-01	WOS:000171527000010
J	Christian, CE				Christian, CE			Consequences of a biological invasion reveal the importance of mutualism for plant communities	NATURE			English	Article							ANT IRIDOMYRMEX-HUMILIS; ARGENTINE ANT; SEEDLING RECRUITMENT; ECOLOGY; MAYR	Seed-dispersal mutualisms have a fundamental role in regenerating natural communities(1,2). Interest in the importance of seed dispersal to plant communities has been heightened by worldwide declines in animal dispersers(3-5). One view, the 'keystone mutualist hypothesis', predicts that these human-caused losses will trigger a cascade of linked extinctions throughout the community(6). Implicitly, this view holds that mutualisms, such as seed dispersal, are crucial ecological interactions that maintain the structure and diversity of natural communities. Although many studies suggest the importance of mutualism(3,7), empirical evidence for community-level impacts of mutualists has remained anecdotal(8,9), and the central role of mutualism, relative to other species interactions, has long been debated in the theoretical literature(10,11). Here I report the community-level consequences of a biological invasion that disrupts important seed-dispersal mutualisms. I show that invasion of South African shrublands by the Argentine ant (Linepithema humile) leads to a shift in composition of the plant community, owing to a disproportionate reduction in the densities of large-seeded plants. This study suggests that the preservation of mutualistic interactions may be essential for maintaining natural communities.	Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Christian, CE (corresponding author), Univ Calif Davis, Ctr Populat Biol, 1 Shields Ave, Davis, CA 95616 USA.	cechristian@ucdavis.edu						Addicott J.F., 1984, P437; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; BOND WJ, 1985, S AFR J ZOOL, V20, P150; BOND WJ, 1991, ANT - PLANT INTERACTIONS, P448; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; CHAPMAN CA, 1995, CONSERV BIOL, V9, P675, DOI 10.1046/j.1523-1739.1995.09030675.x; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; COLE FR, 1992, ECOLOGY, V73, P1313, DOI 10.2307/1940678; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; CUSHMAN JH, 1995, ISLANDS BIOL DIVERSI, P135; DEKOCK AE, 1989, J ENTOMOL SOC S AFR, V52, P157; DEKOCK AE, 1992, FIRE S AFRICAN MOUNT, P201; Gilbert L. E., 1980, Conservation biology. An evolutionary-ecological perspective., P11; Holldobler B., 1990, pi; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HOWE HF, 1993, VEGETATIO, V108, P3; HUGHES L, 1994, J ECOL, V82, P933, DOI 10.2307/2261456; LAWTON JH, 1993, ECOL STU AN, V99, P255; Lopes MA, 2000, CONSERV BIOL, V14, P1658, DOI 10.1046/j.1523-1739.2000.98402.x; May R.M., 1976, P49; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; PASSERA L, 1994, WESTV STUD, P23; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; SLINGSBY P, 1985, S AFR J BOT, V51, P30, DOI 10.1016/S0254-6299(16)31698-2; Slingsby P., 1981, VELD FLORA, V67, P39, DOI [10.10520/AJA00423203\_1083, DOI 10.10520/AJA00423203]; Visser D, 1996, AFR ENTOMOL, V4, P285; WARD PS, 1987, HILGARDIA, V55, P1; Way MJ, 1997, INSECT SOC, V44, P415, DOI 10.1007/s000400050062; WITT ABR, 1993, FACTORS AFFECTING MY	30	278	315	4	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					635	639		10.1038/35098093	http://dx.doi.org/10.1038/35098093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675787				2022-12-01	WOS:000171485700050
J	Rogers, A				Rogers, A			Europe join debate on care for the terminally ill	LANCET			English	News Item																		1999, LANCET, V353, P2220	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 3	1999	354	9172					55	55		10.1016/S0140-6736(05)75326-5	http://dx.doi.org/10.1016/S0140-6736(05)75326-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	212XP	11657547				2022-12-01	WOS:000081243200035
J	Baron, CL; Malhotra, V				Baron, CL; Malhotra, V			Role of diacylglycerol in PKD recruitment to the TGN and protein transport to the plasma membrane	SCIENCE			English	Article							KINASE-C; PHOSPHATIDATE PHOSPHOHYDROLASE; SPHINGOLIPID BIOSYNTHESIS; GOLGI-COMPLEX; DOMAIN; INHIBITION; ACTIVATION	Protein kinase D (PKD) is a cytosolic serine-threonine kinase that binds to the trans-Golgi network (TGN) and regulates the fission of transport carriers specifically destined to the cell surface. PKD was found to bind diacylglycerol (DAG), and this binding was necessary for its recruitment to the TGN. Reducing cellular levels of DAG inhibited PKD recruitment and blocked protein transport from the TGN to the cell surface. Thus, a DAG-dependent, PKD-mediated signaling regulates the formation of transport carriers from the TGN in mammalian cells.	Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Malhotra, V (corresponding author), Univ Calif San Diego, Div Biol, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.		Malhotra, Vivek/O-9811-2014	Malhotra, Vivek/0000-0001-6198-7943	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053747] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46224, GM53747] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARON C, UNPUB; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHENG CHK, 1978, FEBS LETT, V93, P120, DOI 10.1016/0014-5793(78)80818-7; CONN PM, 1985, BIOCHEM BIOPH RES CO, V126, P532, DOI 10.1016/0006-291X(85)90638-2; DAVIS RJ, 1985, J BIOL CHEM, V260, P1562; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; FLORINCHRISTENSEN J, 1992, J BIOL CHEM, V267, P14783; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Huijbregts RPH, 2000, BBA-REV BIOMEMBRANES, V1469, P43, DOI 10.1016/S0304-4157(99)00014-3; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; LAPETINA EG, 1985, J BIOL CHEM, V260, P1358; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; PAPPU AS, 1983, NEUROCHEM RES, V8, P1565, DOI 10.1007/BF00964158; Phillips SE, 1999, MOL CELL, V4, P187, DOI 10.1016/S1097-2765(00)80366-4; Sanchez-Pinera P, 1999, BIOCHEM J, V337, P387, DOI 10.1042/0264-6021:3370387; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; WANG E, 1991, J BIOL CHEM, V266, P14486; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	23	322	329	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					325	328		10.1126/science.1066759	http://dx.doi.org/10.1126/science.1066759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11729268				2022-12-01	WOS:000173278600049
J	Bernard, P; Maure, JF; Partridge, JF; Genier, S; Javerzat, JP; Allshire, RC				Bernard, P; Maure, JF; Partridge, JF; Genier, S; Javerzat, JP; Allshire, RC			Requirement of heterochromatin for cohesion at centromeres	SCIENCE			English	Article							FISSION YEAST CENTROMERES; MITOTIC SPINDLES; CHROMOSOME ARMS; ANAPHASE; SEPARATION; COMPONENT; DOMAINS	Centromeres are heterochromatic in many organisms, but the mitotic function of this silent chromatin remains unknown. During cell division, newly replicated sister chromatids must cohere until anaphase when Scc1/Rad21-mediated cohesion is destroyed. In metazoans, chromosome arm cohesins dissociate during prophase, leaving centromeres as the only linkage before anaphase. it is not known what distinguishes centromere cohesion from arm cohesion. Fission yeast Swi6 (a Heterochromatin protein 1 counterpart) is a component of si[ent heterochromatin. Here we show that this heterochromatin is specifically required for cohesion between sister centromeres. Swi6 is required for association of Rad21-cohesin with centromeres but not along chromosome arms and, thus, acts to distinguish centromere from arm cohesion. Therefore, one function of centromeric heterochromatin is to attract cohesin, thereby ensuring sister centromere cohesion and proper chromosome segregation.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Inst Biochim & Genet Cellulaires, CNRS, Unite Mixte Rech 5095, F-33077 Bordeaux, France	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS)	Allshire, RC (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.		Partridge, Janet/M-9352-2018; Bernard, Pascal/I-1859-2015	Partridge, Janet/0000-0003-1102-6305; Bernard, Pascal/0000-0003-2732-9685; Allshire, Robin/0000-0002-8005-3625				ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Dej KJ, 2000, TRENDS CELL BIOL, V10, P392, DOI 10.1016/S0962-8924(00)01821-3; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Partridge JF, 2000, GENE DEV, V14, P783; Pidoux AL, 2000, J CELL SCI, V113, P4177; PIDOUX AL, UNPUB; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; WINES DR, 1992, GENETICS, V131, P683; Yamada H, 1997, J CELL SCI, V110, P1793	27	484	499	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2539	2542		10.1126/science.1064027	http://dx.doi.org/10.1126/science.1064027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11598266				2022-12-01	WOS:000172927700056
J	Jackson, GS; Beck, JA; Navarrete, C; Brown, J; Sutton, PM; Contreras, M; Collinge, J				Jackson, GS; Beck, JA; Navarrete, C; Brown, J; Sutton, PM; Contreras, M; Collinge, J			Pathogenesis - HLA-DQ7 antigen and resistance to variant CJD	NATURE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; BSE		UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; N London Ctr, Natl Blood Serv, London NW9 5BG, England; Royal Free & Univ Coll Med Sch, Dept Immunol, London NW3 2PF, England; Royal Free & Univ Coll Med Sch, Dept Haematol, London NW3 2PF, England; Oxford Radcliffe Hosp, Nuffield Dept Surg, Oxford Transplant Ctr, Oxford OX3 7LJ, England	University of London; University College London; University of London; University College London; University of London; University College London; University of Oxford	Jackson, GS (corresponding author), UCL, Inst Neurol, MRC, Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@ic.ac.uk		Jackson, Graham/0000-0002-3125-2011				Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	10	43	45	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					269	270		10.1038/35104694	http://dx.doi.org/10.1038/35104694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713518				2022-12-01	WOS:000172150700032
J	Ladabaum, U; Chopra, CL; Huang, G; Scheiman, JM; Chernew, ME; Fendrick, AM				Ladabaum, U; Chopra, CL; Huang, G; Scheiman, JM; Chernew, ME; Fendrick, AM			Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer - A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							GASTROINTESTINAL BLOOD-LOSS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LARGE-BOWEL; COLON-CANCER; REDUCED RISK; POLYPS; HEALTH; COLONOSCOPY; PREVALENCE; GUIDELINES	Background: Aspirin may decrease colorectal cancer incidence, but its role as an adjunct to or substitute for screening has not been evaluated. Objective: To examine the potential cost-effectiveness of aspirin chemoprophylaxis in relation to screening. Design: Markov model. Data Sources: Literature on colorectal cancer epidemiology, screening, costs, and aspirin chemoprevention (1980-1999). Target Population: General U.S. population. Time Horizon: 50 to 80 years of age. Perspective: Third-party payer. Intervention: Aspirin therapy in patients screened with sigmoidoscopy every 5 years and fecal occult blood testing every year (FS/FOBT) or colonoscopy every 10 years (COLO). Outcome Measures: Discounted cost per life-year gained. Results of Base-Case Analysis: When a 30% reduction in colorectal cancer risk was assumed, aspirin increased costs and decreased life-years because of related complications as an adjunct to FS/FOBT and cost $149 161 per life-year gained as an adjunct to COLO. In patients already taking aspirin, screening with FS/FOBT or COLO cost less than $31 000 per life-year gained. Results of Sensitivity Analysis: cost-effectiveness estimates depended highly on the magnitude of colorectal cancer risk reduction with aspirin, aspirin-related complication rates, and the screening adherence rate in the population. However, when the model's inputs were varied over wide ranges, aspirin chemoprophylaxis remained generally non-cost-effective for patients who adhere to screening. Conclusions: in patients undergoing colorectal cancer screening, aspirin use should not be based on potential chemoprevention. Aspirin chemoprophylaxis alone cannot be considered a substitute for colorectal cancer screening. Public policy should focus on improving screening adherence, even in patients who are already taking aspirin.	Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA; Univ Michigan, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Ladabaum, U (corresponding author), Univ Calif San Francisco, Div Gastroenterol, S-357,Box 0538,513 Parnassus Ave, San Francisco, CA 94143 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042, M01RR000079] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AHLQUIST DA, 1985, NEW ENGL J MED, V312, P1422, DOI 10.1056/NEJM198505303122204; ANDERSON LM, 1995, AM J PUBLIC HEALTH, V85, P840, DOI 10.2105/AJPH.85.6.840; ARNOLD JD, 1983, PHARMACOLOGY, V27, P14, DOI 10.1159/000137895; Augustovski FA, 1998, J GEN INTERN MED, V13, P824, DOI 10.1046/j.1525-1497.1998.00246.x; BROWN ML, 1990, PREV MED, V19, P562, DOI 10.1016/0091-7435(90)90054-N; Burt RW, 2000, GASTROENTEROLOGY, V119, P837, DOI 10.1053/gast.2000.16508; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; Cohen A, 1995, CLIN THER, V17, P1110, DOI 10.1016/0149-2918(95)80089-1; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; ELTA GH, 1995, TXB GASTROENTEROLOGY, P671; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FLEMING JL, 1987, MAYO CLIN PROC, V62, P159, DOI 10.1016/S0025-6196(12)62437-9; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; Greenberg PD, 1996, AM J MED, V100, P598, DOI 10.1016/S0002-9343(96)00009-5; Greenberg PD, 1999, GASTROINTEST ENDOSC, V50, P618, DOI 10.1016/S0016-5107(99)80008-X; Griffin M, 1998, AM J MED, V104, p41S; *HCIA, 1997, DRG HDB COMP CLIN FI; Hennekens CH, 1999, AM HEART J, V137, pS9, DOI 10.1016/S0002-8703(99)70391-1; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Kune GA, 2007, INT J EPIDEMIOL, V36, P951, DOI 10.1093/ije/dym193; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lewis JD, 2000, ANN INTERN MED, V133, P647, DOI 10.7326/0003-4819-133-8-200010170-00017; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LIEBERMAN DA, 1995, GASTROENTEROLOGY, V109, P1781, DOI 10.1016/0016-5085(95)90744-0; Lipscomb J, 1996, COST EFFECTIVENESS H, P214; LOEBL DH, 1977, JAMA-J AM MED ASSOC, V237, P976, DOI 10.1001/jama.237.10.976; LOGAN RFA, 1993, BRIT MED J, V307, P285, DOI 10.1136/bmj.307.6899.285; LONGSTRETH GF, 1995, AM J GASTROENTEROL, V90, P206; LYNCH NM, 1989, AUST NZ J MED, V19, P89, DOI 10.1111/j.1445-5994.1989.tb00210.x; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MIELANTS H, 1984, CLIN RHEUMATOL, V3, P47, DOI 10.1007/BF02715695; MULLER AD, 1994, DIGEST DIS SCI, V39, P2480, DOI 10.1007/BF02087670; MUSCAT JE, 1994, CANCER-AM CANCER SOC, V74, P1847, DOI 10.1002/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#; *NAT CTR HLTH STAT, 1998, LIF TABL VIT STAT A, V2; NORFLEET RG, 1983, J CLIN GASTROENTEROL, V5, P123, DOI 10.1097/00004836-198304000-00006; NORRVING B, 1991, LANCET, V338, P1345; PELEG II, 1994, ARCH INTERN MED, V154, P394, DOI 10.1001/archinte.154.4.394; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; Ries LAG, 1997, NIH PUB, V97-2789; ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355; Sandler RS, 1998, GASTROENTEROLOGY, V114, P441, DOI 10.1016/S0016-5085(98)70526-8; SLATTERY J, 1995, GUT, V37, P509, DOI 10.1136/gut.37.4.509; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; SUH O, 1993, CANCER-AM CANCER SOC, V72, P1171, DOI 10.1002/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; THUN MJ, 1993, CANCER RES, V53, P1322; Thun MJ, 1996, GASTROENTEROL CLIN N, V25, P333, DOI 10.1016/S0889-8553(05)70250-8; TORIBARA NW, 1995, NEW ENGL J MED, V332, P861, DOI 10.1056/NEJM199503303321306; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Wagner JL, 1996, PREVENTION EARLY DET, P321; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; 1999, MMWR MORB MORTAL WKL, V48, P116	62	97	97	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2001	135	9					769	781		10.7326/0003-4819-135-9-200111060-00007	http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VT	11694102				2022-12-01	WOS:000172013700002
J	Zambon, MC; Stockton, JD; Clewley, JP; Fleming, DM				Zambon, MC; Stockton, JD; Clewley, JP; Fleming, DM			Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study	LANCET			English	Article							VIROLOGICAL SURVEILLANCE; MONOCLONAL-ANTIBODIES; VIRAL-INFECTIONS; EPIDEMICS; DIAGNOSIS; DURATION; EFFICACY; STRAINS; ENGLAND; ADULTS	Background Respiratory syncytial virus (RSV) is an important cause of lower-respiratory-tract infection in children and elderly people, but its effect in other age-groups is uncertain. We did a community-based observational study of RSV infection in community-dwelling individuals of all ages who presented to general practices in the UK with influenza-like illnesses during three successive winters (1995-96,1996-97, and 1997-98). Methods Nasopharyngeal swabs routinely submitted for virological surveillance were examined by multiplex reverse transcription PCR for influenza A and B viruses and, RSV A and B, and findings were related to the clinical incidence of influenza-like illness and acute bronchitis at that time. RSV strains identified were compared with those obtained from hospital admissions. Findings 480 RSV and 709 influenza viruses were identified from a total of 2226 swabs submitted. Both types of virus were found in all age-groups for between 12 and 20 weeks In each winter. RSV A accounted for 60% of RSV detections. Similar strains of RSV were present in hospital and community patients within the same year, but there were different lineages each year. Interpretation In individuals diagnosed with Influenza-like illness, there is a substantial potential for confusion between illnesses caused by influenza and those caused by RSV. The burden of illness attributable to each needs to be clarified to define optimum management routines.	Cent Publ Hlth Lab, PHLS, Div Virus Reference, London NW9 5HT, England; Royal Coll Gen Practitioners Res Unit, Birmingham, W Midlands, England	Public Health England	Zambon, MC (corresponding author), Cent Publ Hlth Lab, PHLS, Div Virus Reference, 61 Colindale Ave, London NW9 5HT, England.							ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; ANDRADE HR, 2000, EPIDEMIOL INFECT, V124, P515; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Carman WF, 2000, BRIT MED J, V321, P736, DOI 10.1136/bmj.321.7263.736; Chonmaitree T, 2000, PEDIATR INFECT DIS J, V19, P258, DOI 10.1097/00006454-200003000-00020; Clewley J P, 1998, Commun Dis Public Health, V1, P132; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137; Ellis JS, 1997, J CLIN MICROBIOL, V35, P2076, DOI 10.1128/JCM.35.8.2076-2082.1997; Englund JA, 1999, J PEDIATR-US, V135, pS38; Falsey AR, 1996, J AM GERIATR SOC, V44, P71, DOI 10.1111/j.1532-5415.1996.tb05641.x; FALSEY AR, 1995, J AM GERIATR SOC, V43, P30, DOI 10.1111/j.1532-5415.1995.tb06238.x; FALSEY AR, 1992, J AM GERIATR SOC, V40, P115, DOI 10.1111/j.1532-5415.1992.tb01929.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fleming D M, 2000, Commun Dis Public Health, V3, P32; FLEMING DM, 1995, BRIT MED J, V311, P290, DOI 10.1136/bmj.311.7000.290; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; Fleming DM, 1999, EUR J EPIDEMIOL, V15, P467, DOI 10.1023/A:1007525402861; GARCIA O, 1994, J VIROL, V68, P5448; HALL CB, 1976, J PEDIATR-US, V89, P11, DOI 10.1016/S0022-3476(76)80918-3; Hutchinson E J, 1996, Commun Dis Rep CDR Rev, V6, pR163; Irmen KE, 2000, CLIN DIAGN LAB IMMUN, V7, P396, DOI 10.1128/CDLI.7.3.396-403.2000; Lina B, 1996, J CLIN MICROBIOL, V34, P3007, DOI 10.1128/JCM.34.12.3007-3011.1996; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Ross A M, 2000, Commun Dis Public Health, V3, P256; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Treanor J, 1999, ANTIVIR RES, V44, P79, DOI 10.1016/S0166-3542(99)00062-5; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Zambon M, 1998, Euro Surveill, V3, P29	32	281	294	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1410	1416		10.1016/S0140-6736(01)06528-X	http://dx.doi.org/10.1016/S0140-6736(01)06528-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705487				2022-12-01	WOS:000171940100012
J	Porse, BT; Pedersen, TA; Xu, XF; Lindberg, B; Wewer, UM; Friis-Hansen, L; Nerlov, C				Porse, BT; Pedersen, TA; Xu, XF; Lindberg, B; Wewer, UM; Friis-Hansen, L; Nerlov, C			E2F repression by C/EBP alpha is required for adipogenesis and granulopoiesis in vivo	CELL			English	Article							BINDING-PROTEIN-ALPHA; CELL-PROLIFERATION; S-PHASE; RETINOBLASTOMA PROTEIN; LINEAGE COMMITMENT; ADIPOSE CONVERSION; PROGENITOR CELLS; GENE-EXPRESSION; NEWBORN MICE; DIFFERENTIATION	The C/EBP alpha transcription factor is required for differentiation of adipocytes and neutrophil granulocytes, and controls cellular proliferation in vivo. To address the molecular mechanisms of C/EBP alpha action, we have identified C/EBP alpha mutants defective in repression of E2F-dependent transcription and found them to be impaired in their ability to suppress cellular proliferation, and to induce adipocyte differentiation in vitro. Using targeted mutagenesis of the mouse germline, we show that E2F repression-deficient C/EBP alpha alleles failed to support adipocyte and granulocyte differentiation in vivo. These results indicate that E2F repression by C/EBP alpha is critical for its ability to induce terminal differentiation, and thus provide genetic evidence that direct cell cycle control by a mammalian lineageinstructive transcription factor couples cellular growth arrest and differentiation.	Univ Copenhagen Hosp, Lab Gene Therapy Res, DK-2100 Copenhagen O, Denmark; Univ Copenhagen Hosp, Inst Pathol, DK-2100 Copenhagen, Denmark; Univ Copenhagen Hosp, Dept Clin Biochem, DK-2100 Copenhagen O, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Nerlov, C (corresponding author), Univ Copenhagen Hosp, Lab Gene Therapy Res, DK-2100 Copenhagen O, Denmark.		Porse, Bo/B-1332-2012	Porse, Bo/0000-0001-6043-0844; Friis-Hansen, Lennart/0000-0002-7222-0163				Bergh G, 1999, BLOOD, V94, P1971; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Crosson SM, 2000, J BIOL CHEM, V275, P5804, DOI 10.1074/jbc.275.8.5804; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dicker AJ, 2000, ONCOGENE, V19, P2887, DOI 10.1038/sj.onc.1203610; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mori A, 1999, ONCOGENE, V18, P6209, DOI 10.1038/sj.onc.1203044; Muller C, 1999, P NATL ACAD SCI USA, V96, P7276, DOI 10.1073/pnas.96.13.7276; NERLOV C, 1994, GENE DEV, V8, P350, DOI 10.1101/gad.8.3.350; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Strominger A, 1998, J HIGH ENERGY PHYS; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P3621, DOI 10.1093/nar/27.17.3621; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Vigo E, 1999, MOL CELL BIOL, V19, P6379; WANG J, 1995, CELL GROWTH DIFFER, V6, P1299; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	40	275	281	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					247	258		10.1016/S0092-8674(01)00516-5	http://dx.doi.org/10.1016/S0092-8674(01)00516-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672531	Bronze			2022-12-01	WOS:000171694800013
J	Rhew, DC				Rhew, DC			Quality indicators for the management of pneumonia in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; PROSPECTIVE PAYMENT SYSTEM; INFLUENZA VACCINATION; HOSPITALIZED-PATIENTS; PRACTICE GUIDELINE; EARLY SWITCH; LOW-RISK; IMMUNIZATION; EFFICACY		Zynx Hlth Inc, Beverly Hills, CA 90212 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Rhew, DC (corresponding author), Zynx Hlth Inc, 9100 Wilshire Blvd,Suite 655 E Tower, Beverly Hills, CA 90212 USA.	rhew@zynx.com						*ACP TASK FORC AD, 1994, GUID AD IMM, P107; ARNSTEN JH, 1995, J GEN INTERN MED S, V10, pA97; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; BLOOM HG, 1988, J AM GERIATR SOC, V36, P897, DOI 10.1111/j.1532-5415.1988.tb05782.x; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; BUFFINGTON J, 1991, J GEN INTERN MED, V6, P204, DOI 10.1007/BF02598961; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; *CDCP NAT CTR HLTH, 1998, NAT VIT STAT REP; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; CROUSE BJ, 1994, J FAM PRACTICE, V38, P258; *CTR DIS CONTR PRE, 1998, JAMA-J AM MED ASSOC, V280, P1818; DUNN WF, 1991, AM REV RESPIR DIS, V144, P526, DOI 10.1164/ajrccm/144.3_Pt_1.526; FARR BM, 1995, ARCH INTERN MED, V155, P2336, DOI 10.1001/archinte.155.21.2336; FEDSON DS, 1983, AM J PUBLIC HEALTH, V73, P442, DOI 10.2105/AJPH.73.4.442; FEDSON DS, 1990, JAMA-J AM MED ASSOC, V264, P1117; FEDSON DS, 1985, J AM GERIATR SOC, V33, P142, DOI 10.1111/j.1532-5415.1985.tb02281.x; FEDSON KS, 1994, VACCINES, P517; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; FINE MJ, 1994, ARCH INTERN MED, V154, P2666, DOI 10.1001/archinte.1994.00420230051007; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; GAILLAT J, 1985, REV EPIDEMIOL SANTE, V33, P437; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; GYORKOS TW, 1994, CAN J PUBLIC HEALTH, V85, pS14; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; HERMAN CJ, 1994, J AM GERIATR SOC, V42, P1154, DOI 10.1111/j.1532-5415.1994.tb06981.x; Honkanen PO, 1997, VACCINE, V15, P317, DOI 10.1016/S0264-410X(96)00171-5; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1969, DOI 10.1001/jama.264.15.1969; KOSECOFF J, 1990, JAMA-J AM MED ASSOC, V264, P1980, DOI 10.1001/jama.264.15.1980; Lave JR, 1999, SEM RESP CRIT CARE M, V20, P189, DOI 10.1055/s-2007-1021315; LAW M, 1995, ARCH INTERN MED, V155, P1933, DOI 10.1001/archinte.155.18.1933; MAGNUSSEN CR, 1984, ARCH INTERN MED, V144, P1755, DOI 10.1001/archinte.144.9.1755; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; McGarvey R N, 1993, QRB Qual Rev Bull, V19, P124; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; MUSHER DM, 1990, J INFECT DIS, V161, P728, DOI 10.1093/infdis/161.4.728; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; Plans Rubio P, 1995, Rev Esp Salud Publica, V69, P409; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; *PREV PNEUM DIS, 1997, MMWR-MORBID MORTAL W, V46, P1; Ramirez JA, 1999, ARCH INTERN MED, V159, P2449, DOI 10.1001/archinte.159.20.2449; RAMIREZ JA, 1995, ARCH INTERN MED, V155, P1273, DOI 10.1001/archinte.155.12.1273; Rhew DC, 1998, CHEST, V114, P115, DOI 10.1378/chest.114.1.115; SAHN SA, 1993, AM REV RESPIR DIS, V148, P813, DOI 10.1164/ajrccm/148.3.813; SETIA U, 1985, J AM GERIATR SOC, V33, P856, DOI 10.1111/j.1532-5415.1985.tb05440.x; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; *US PUBL HLTH SERV, 2001, HEALTH PEOPL, V1; Wait MA, 1997, CHEST, V111, P1548, DOI 10.1378/chest.111.6.1548; WEINGARTEN SR, 1994, CHEST, V105, P1109, DOI 10.1378/chest.105.4.1109; Weingarten SR, 1996, AM J RESP CRIT CARE, V153, P1110, DOI 10.1164/ajrccm.153.3.8630553	53	18	20	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				736	743		10.7326/0003-4819-135-8_Part_2-200110161-00013	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00013			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601957				2022-12-01	WOS:000171542400013
J	Taylor, CM				Taylor, CM			Complement factor H and the haemolytic uraemic syndrome	LANCET			English	Editorial Material							MUTATIONS; PROTECTS; CELLS		Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England	University of Birmingham	Taylor, CM (corresponding author), Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England.	cm.taylor@bhamchildrens.wmids.nhs.uk						Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069; Buddles MRH, 2000, AM J HUM GENET, V66, P1721, DOI 10.1086/302877; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Fitzpatrick MM, 1992, HEMOLYTIC UREMIC SYN, P163; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Hindmarsh EJ, 1998, J IMMUNOL, V160, P6128; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Landau D, 2001, J PEDIATR-US, V138, P412, DOI 10.1067/mpd.2001.112649; Nangaku M, 1998, J AM SOC NEPHROL, V9, P590; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Taylor CM, 2001, SEMIN THROMB HEMOST, V27, P185, DOI 10.1055/s-2001-15247; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1046/j.1523-1755.1998.00824.x; Ying LH, 1999, AM J HUM GENET, V65, P1538, DOI 10.1086/302673; Zipfel PF, 2001, SEMIN THROMB HEMOST, V27, P191, DOI 10.1055/s-2001-15248	18	48	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2001	358	9289					1200	1202		10.1016/S0140-6736(01)06339-5	http://dx.doi.org/10.1016/S0140-6736(01)06339-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675053				2022-12-01	WOS:000171527000005
J	Dolmetsch, RE; Pajvani, U; Fife, K; Spotts, JM; Greenberg, ME				Dolmetsch, RE; Pajvani, U; Fife, K; Spotts, JM; Greenberg, ME			Signaling to the nucleus by an L-type calcium channel - Calmodulin complex through the MAP kinase pathway	SCIENCE			English	Article							GENE-EXPRESSION; CREB PHOSPHORYLATION; CA2+-DEPENDENT INACTIVATION; HIPPOCAMPAL-NEURONS; CA2+ CHANNELS; TRANSCRIPTION; MECHANISM; MOTIF; FACILITATION; SUPPORTS	Increases in the intracellutar concentration of calcium ([Ca2+](i)) activate various signaling pathways that lead to the expression of genes that are essential for dendritic development, neuronal. survival, and synaptic plasticity. The mode of Ca2+ entry into a neuron plays a key rote in determining which signaling pathways are activated and thus specifies the cellular response to Ca2+. Ca2+ influx through L-type voltage-activated channels (LTCs) is particularly effective at activating transcription factors such as CREB and MEF-2. We developed a functional knock-in technique to investigate the features of LTCs that specifically couple them to the signaling pathways that regulate gene expression. We found that an isoleucine-glutamine ("IQ") motif in the carboxyl terminus of the LTC that binds Ca2+-calmodutin (CaM) is critical for conveying the Ca2+ signal to the nucleus. Ca2+-CaM binding to the LTC was necessary for activation of the Ras/mitogen-activated protein kinase (MAPK) pathway, which conveys local Ca2+ signals from the mouth of the LTC to the nucleus. CaM functions as a local Ca2+ sensor at the mouth of the LTC that activates the MAPK pathway and leads to the stimulation of genes that are essential for neuronal survival and plasticity.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Enders Pediat Res Labs, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, Boston, MA 02115 USA.		soler, martha maricel m gomez/L-6025-2014; Oka, Yoshitaka/C-9670-2010	soler, martha maricel m gomez/0000-0002-4412-8108; Oka, Yoshitaka/0000-0002-3482-3051	NICHD NIH HHS [P30-HD18655] Funding Source: Medline; NINDS NIH HHS [NS28829] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028829, R37NS028829] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COWAN CE, UNPUB; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DOLMETSCH RE, UNPUB; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; RANDALL A, 1995, J NEUROSCI, V15, P2995; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	31	682	705	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					333	339		10.1126/science.1063395	http://dx.doi.org/10.1126/science.1063395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598293				2022-12-01	WOS:000171601400033
J	Mann, K; Fox, SP; Abbs, SJ; Yau, SC; Scriven, PN; Docherty, Z; Ogilvie, CM				Mann, K; Fox, SP; Abbs, SJ; Yau, SC; Scriven, PN; Docherty, Z; Ogilvie, CM			Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosis	LANCET			English	Article							POLYMERASE CHAIN-REACTION; IN-SITU HYBRIDIZATION; CHROMOSOME ANEUPLOIDIES; DOWNS-SYNDROME; PCR; POLYMORPHISMS; INTEGRATION; GENE; SEX	Background Prenatal diagnosis for chromosome abnormality is routinely undertaken by full karyotype analysis of chromosomes from cultured cells; pregnant women must wait on average 13-14 days for their results. Autosomal trisomies, which account for around 80% of significant abnormalities, can be detected by quantitative fluorescence (QF) PCR. We report on the development and implementation of this technique as the first such routine service within a diagnostic department of the UK National Health Service (NHS). Methods We designed a "one-tube test" comprising four primer pairs for polymorphic tetranucleotide repeat sequences on chromosome 21, four primer pairs for sequences on chromosome 18, three primer pairs for sequences on chromosome 13, and one primer pair to identify the sex chromosomes. All prenatal samples received by our NHS diagnostic department between April, 2000, and April, 2001, were tested. After DNA extraction, PCR amplification was done and the products separated on a capillary-based genetic analyser; the results were interpreted with dedicated software. Follow-up karyotype analysis was done on all samples. Findings 1148 amniotic fluid samples, 188 chorionic villus samples, and 37 fetal tissue samples were tested; the amplification failure rate was zero with our current protocol. QF-PCR results were obtained and reported on 1314 (98%) of the prenatal samples; the remaining 22 (2%) were uninformative because of maternal-cell contamination. One case of mosaicism in a chorionic villus sample, and two cases indicating somatic expansion of a tetranucleotide repeat were found. No false positive or false negative results were obtained. The mean reporting time for the last 4 months of data collection was 1.25 working days. Interpretation QF-PCR aneuploidy testing is an efficient and accurate technique for the detection of autosomal trisomies in prenatal samples. Implementation of this service has led to the rapid diagnosis of abnormalities and early reassurance for women with normal results.	Guys & St Thomas Hosp Trust, Genet Ctr, London, England	Guy's & St Thomas' NHS Foundation Trust	Ogilvie, CM (corresponding author), Dept Cytogenet, 5th Floor,Guys Tower,St Thomas St, London SE1 9RT, England.		Ogilve, Caroline/AAW-3793-2021	Scriven, Paul/0000-0002-0036-984X				Bosch A, 1996, EUR J HUM GENET, V4, P135; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; Cirigliano V, 1999, PRENATAL DIAG, V19, P1099, DOI 10.1002/(SICI)1097-0223(199912)19:12<1099::AID-PD709>3.0.CO;2-2; GERKEN S, 1994, GENOMICS, V24, P612, DOI 10.1006/geno.1994.1679; KLINGER K, 1992, AM J HUM GENET, V51, P55; Levett LJ, 2001, ULTRASOUND OBST GYN, V17, P115, DOI 10.1046/j.1469-0705.2001.00340.x; MANSFIELD ES, 1993, HUM MOL GENET, V2, P43, DOI 10.1093/hmg/2.1.43; MCINNIS MG, 1991, GENOMICS, V11, P573, DOI 10.1016/0888-7543(91)90064-L; Morris A, 1999, PRENATAL DIAG, V19, P546, DOI 10.1002/(SICI)1097-0223(199906)19:6<546::AID-PD589>3.0.CO;2-8; *NEQAS, 2000, NAT EXT QUAL ASS SCH; Pertl B, 1996, HUM GENET, V98, P55, DOI 10.1007/s004390050159; Pertl B, 1997, AM J OBSTET GYNECOL, V177, P899, DOI 10.1016/S0002-9378(97)70292-8; Pertl B, 1999, J MED GENET, V36, P300; PERTL B, 1994, LANCET, V343, P1197, DOI 10.1016/S0140-6736(94)92404-X; Schmidt W, 2000, MOL HUM REPROD, V6, P855, DOI 10.1093/molehr/6.9.855; SPATHAS DH, 1994, PRENATAL DIAG, V14, P1049, DOI 10.1002/pd.1970141107; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Thilaganathan B, 2000, BRIT J OBSTET GYNAEC, V107, P262, DOI 10.1111/j.1471-0528.2000.tb11698.x; Verma L, 1998, LANCET, V352, P9, DOI 10.1016/S0140-6736(97)11090-X	19	165	206	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 29	2001	358	9287					1057	1061		10.1016/S0140-6736(01)06183-9	http://dx.doi.org/10.1016/S0140-6736(01)06183-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479EY	11589937				2022-12-01	WOS:000171393100012
J	HOWARD, R				HOWARD, R			MEMORABLE PATIENTS - INSIGHT AND HONESTY	BRITISH MEDICAL JOURNAL			English	Editorial Material														Howard, Robert/0000-0002-3071-2338					0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1993	306	6880					764	764		10.1136/bmj.306.6880.764	http://dx.doi.org/10.1136/bmj.306.6880.764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU173	11643118	Bronze, Green Published			2022-12-01	WOS:A1993KU17300027
J	Rathore, SS; Chen, J; Wang, YF; Radford, MJ; Voccarino, V; Krumholz, HM				Rathore, SS; Chen, J; Wang, YF; Radford, MJ; Voccarino, V; Krumholz, HM			Sex differences in cardiac catheterization - The role of physician gender	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE; HEART-DISEASE; CHEST PAIN; WOMEN; CARE; RACE; MANAGEMENT; BIAS; MEN	Context Many studies indicate that women are less likely than men to undergo cardiac procedures after an acute myocardial infarction (AMI), raising concerns of sexual bias in clinical care. However, no data exist regarding the relationship between patient sex, physician sex, and use of cardiac procedures. Objective To determine whether sex differences in cardiac catheterization after AM] were greater when patients were treated by male attending physicians compared with female attending physicians. Design, Setting, and Patients Analysis of data from the Cooperative Cardiovascular Project, a retrospective medical record-review. A total of 104231 Medicare fee-for-service beneficiaries who were hospitalized In US acute care hospitals for an AM] between January 1994 and February 1995. Main Outcome Measure Use of cardiac catheterization within 60 days of admission, compared between the 4 groups of patient sex-physician sex combinations. Results Women underwent fewer cardiac catheterizations than men when treated by either male physicians (38.6% vs 50.8%; P=.001) or female physicians (34.8% vs 45.8%; P=.001). Sex differences in procedure use were not greater when a patient and physician were of different sexes (P for interaction =.85). After potential confounders in multivariable analysis were accounted for, women were less likely to undergo cardiac catheterization (risk ratio, 0.90 [95% confidence interval {CI}, 0.88-0.92]), regardless of the treating physician's sex. Patients treated by male physicians were more likely to undergo cardiac catheterization (risk ratio, 1.06 [95% CI, 1.02-1.10]) than those treated by female physicians, regardless of patient sex. Conclusions Women who have had an AMI undergo a cardiac catheterization less often than men, whether treated by a male or female physician. These results suggest that factors other than sexual bias by male physicians toward women account for sex differences in cardiac procedure use.	Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; Qualidigm, Middletown, CT USA	Yale University; Yale University; Yale University; University of Pennsylvania; Pennsylvania Medicine; Emory University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557	CIT NIH HHS [500-99-CT01] Funding Source: Medline	CIT NIH HHS		Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; *AM HOSP ASS, 1994, ANN SURV HOSP DAT DO; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; BIRDWELL BG, 1993, ARCH INTERN MED, V153, P1991, DOI 10.1001/archinte.153.17.1991; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; CHERKIN D, 1977, MED CARE, V15, P767; CHIRIBOGA DE, 1993, AM J CARDIOL, V71, P268, DOI 10.1016/0002-9149(93)90789-F; COMSTOCK LM, 1982, J MED EDUC, V57, P105; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Dartmouth Medical School Center for the Evaluation of Clinical Sciences Maine Medical Center, 1999, DARTM ATL CARD HLTH; DHOORE W, 1994, AM J PUBLIC HEALTH, V84, P1013, DOI 10.2105/AJPH.84.6.1013; Douglas PS, 1996, NEW ENGL J MED, V334, P1311, DOI 10.1056/NEJM199605163342007; FENNEMA K, 1990, J FAM PRACTICE, V30, P441; FRANKS P, 1993, MED CARE, V31, P213, DOI 10.1097/00005650-199303000-00003; GILES WH, 1995, ARCH INTERN MED, V155, P318, DOI 10.1001/archinte.155.3.318; Goldberg RJ, 1998, AM HEART J, V136, P189, DOI 10.1053/hj.1998.v136.88874; HALL JA, 1990, MED CARE, V28, P489, DOI 10.1097/00005650-199006000-00002; HARRIS RB, 1991, J CLIN EPIDEMIOL, V44, P1071, DOI 10.1016/0895-4356(91)90009-X; JEZZONI LI, 1994, RISK ADJ MEAS HLTH C; Kenward K, 1996, AM J PUBLIC HEALTH, V86, P1481, DOI 10.2105/AJPH.86.10.1481; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; Lauer MS, 1996, AM J CARDIOL, V78, P278, DOI 10.1016/S0002-9149(96)00277-9; Levy S, 1992, Fam Med, V24, P58; LINK RN, 1991, J GEN INTERN MED, V6, P466; Lurie N, 1997, J GEN INTERN MED, V12, P34; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; MAHEUX B, 1990, MED CARE, V28, P87, DOI 10.1097/00005650-199001000-00009; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1994, NEW ENGL J MED, V330, P1101, DOI 10.1056/NEJM199404213301601; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Maynard C, 1996, CIRCULATION, V94, P93; Milner KA, 1999, AM J CARDIOL, V84, P396, DOI 10.1016/S0002-9149(99)00322-7; ORENTLICHER D, 1991, JAMA-J AM MED ASSOC, V266, P559; PEARSON ML, 1992, JAMA-J AM MED ASSOC, V268, P1883, DOI 10.1001/jama.268.14.1883; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Schwartz LM, 1997, ARCH INTERN MED, V157, P1545, DOI 10.1001/archinte.157.14.1545; Schwartz LM, 1999, NEW ENGL J MED, V341, P279, DOI 10.1056/NEJM199907223410411; SOFAER S, 1990, WOMEN HEALTH, V16, P47, DOI 10.1300/J013v16n03_04; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; *US BUR CENS, 1991, STAT METR AR DAT BOO; *US DEP HHS, 1988, INT CLASS DIS 9 REV; van Lennep JER, 2000, EUR HEART J, V21, P911, DOI 10.1053/euhj.1999.1941; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wong CC, 1998, AM HEART J, V135, P435, DOI 10.1016/S0002-8703(98)70319-9; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zucker DR, 1997, J GEN INTERN MED, V12, P79, DOI 10.1046/j.1525-1497.1997.00011.x	49	90	91	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2849	2856		10.1001/jama.286.22.2849	http://dx.doi.org/10.1001/jama.286.22.2849			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735761	Bronze			2022-12-01	WOS:000172655400034
J	Westbrook, JI; Duggan, AE; McIntosh, JH				Westbrook, JI; Duggan, AE; McIntosh, JH			Prescriptions for antiulcer drugs in Australia: volume, trends, and costs	BRITISH MEDICAL JOURNAL			English	Article									Univ New S Wales, Ctr Hlth Informat, Kensington, NSW 2052, Australia; John Hunter Hosp, Dept Gastroenterol, New Lambton Hts, NSW 2305, Australia; Univ Sydney, Sch Hlth Informat Management, Lidcombe, NSW 1825, Australia	University of New South Wales Sydney; John Hunter Hospital; University of Sydney	Westbrook, JI (corresponding author), Univ New S Wales, Ctr Hlth Informat, Kensington, NSW 2052, Australia.		Westbrook, Johanna/J-9045-2018	Westbrook, Johanna/0000-0003-1083-8192				BRITT H, 1999, GEN PRACTICIE ACTIVI; LATNER A, 2000, PHARM TIMES; McManus P, 1998, BRIT J CLIN PHARMACO, V46, P409, DOI 10.1046/j.1365-2125.1998.00791.x; *NAT I CLIN EXC, 2000, GUID US PROT PUMP IN; Westbrook JI, 2000, ALIMENT PHARM THER, V14, P1581, DOI 10.1046/j.1365-2036.2000.00878.x	5	23	23	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2001	323	7325					1338	1339		10.1136/bmj.323.7325.1338	http://dx.doi.org/10.1136/bmj.323.7325.1338			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501ZC	11739219	Bronze, Green Published			2022-12-01	WOS:000172716900016
J	Schwetz, BA				Schwetz, BA			Oral sodium phosphate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	10	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2660	2660		10.1001/jama.286.21.2660-b	http://dx.doi.org/10.1001/jama.286.21.2660-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730423				2022-12-01	WOS:000172488300005
J	Fang, YM; Vilella-Bach, M; Bachmann, R; Flanigan, A; Chen, J				Fang, YM; Vilella-Bach, M; Bachmann, R; Flanigan, A; Chen, J			Phosphatidic acid-mediated mitogenic activation of mTOR signaling	SCIENCE			English	Article							PIK-RELATED KINASES; P70 S6 KINASE; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; MAMMALIAN PROTEIN; PHOSPHORYLATION; BINDING; DOMAIN; TARGET; STIMULATION; REGULATORS	The mammalian target of rapamycin (mTOR) governs cell growth and proliferation by mediating the mitogen- and nutrient-dependent signal transduction that regulates messenger RNA translation. We identified phosphatidic acid (PA) as a critical component of mTOR signaling. In our study, mitogenic stimulation of mammalian cells led to a phospholipase D-dependent accumulation of cellular PA, which was required for activation of mTOR downstream effectors. PA directly interacted with the domain in mTOR that is targeted by rapamycin, and this interaction was positively correlated with mTOR's ability to activate downstream effectors. The involvement of PA in mTOR signaling reveals an important function of this lipid in signal transduction and protein synthesis, as well as a direct link between mTOR and mitogens. Furthermore, these studies suggest a potential mechanism for the in vivo actions of the immunosuppressant rapamycin.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), Univ Illinois, Dept Cell & Struct Biol, 601 S Goodwin Ave,B107, Urbana, IL 61801 USA.	jiechen@uiuc.edu		Chen, Jie/0000-0002-7887-3747	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM058064, R01GM058064] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58064] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1483, P199, DOI 10.1016/S1388-1981(99)00188-2; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; Fang Y., UNPUB; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kuruvilla FG, 1999, CHEM BIOL, V6, pR129, DOI 10.1016/S1074-5521(99)80070-2; Reeves HL, 2000, HEPATOLOGY, V31, P95, DOI 10.1002/hep.510310116; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; SEGREST JP, 1992, J LIPID RES, V33, P141; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; WENG QP, 1995, MOL CELL BIOL, V15, P2333; YANG SF, 1967, J BIOL CHEM, V242, P477	28	819	845	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1942	1945		10.1126/science.1066015	http://dx.doi.org/10.1126/science.1066015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729323				2022-12-01	WOS:000172465000064
J	Lanza, RP; Cibelli, JB; Faber, D; Sweeney, RW; Henderson, B; Nevala, W; West, MD; Wettstein, PJ				Lanza, RP; Cibelli, JB; Faber, D; Sweeney, RW; Henderson, B; Nevala, W; West, MD; Wettstein, PJ			Cloned cattle can be healthy and normal	SCIENCE			English	Article							TRANSGENIC CALVES; CELLS		Adv Cell Technol, Worcester, MA 01605 USA; Trans Ova Genet, Genet Advancement Ctr, Sioux Ctr, IA 51250 USA; Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA; Mayo Clin, Dept Surg, Rochester, MN 55905 USA; Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; Em Tran, Elizabethtown, PA 17022 USA	University of Pennsylvania; Mayo Clinic; Mayo Clinic	Lanza, RP (corresponding author), Adv Cell Technol, Worcester, MA 01605 USA.			Cibelli, Jose/0000-0002-2176-3854; West, Michael/0000-0002-4842-5468				BOYCE N, 2001, US NEWS WORLD R 0319; Campbell JDM, 1998, J LEUKOCYTE BIOL, V63, P567, DOI 10.1002/jlb.63.5.567; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Jaenisch R, 2001, SCIENCE, V291, P2552, DOI 10.1126/science.1060463; KOLATA G, 2001, NY TIMES        0325; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; *SUBC BEEF CATTL N, 2000, NUTR REQ BEEF CATTL, P40; *USDA NAT AN HLTH, 1996, PART 1 REF 1996 DAIR; VANHORN HH, 1992, LARGE DAIRY HARD MAN, P434; WEISS R, 2001, WASHINGTON POST 0329	13	110	121	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1893	1894		10.1126/science.1063440	http://dx.doi.org/10.1126/science.1063440			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729307				2022-12-01	WOS:000172465000048
J	Zeng, HK; Chattarji, S; Barbarosie, M; Rondi-Reig, L; Philpot, BD; Miyakawa, T; Bear, MF; Tonegawa, S				Zeng, HK; Chattarji, S; Barbarosie, M; Rondi-Reig, L; Philpot, BD; Miyakawa, T; Bear, MF; Tonegawa, S			Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory	CELL			English	Article							LONG-TERM DEPRESSION; GLUTAMATE RECEPTORS; PROTEIN PHOSPHATASE; GENE-EXPRESSION; SPATIAL MEMORY; RAT-BRAIN; CALMODULIN; SUBUNIT; PHOSPHORYLATION; POTENTIATION	Calcineurin is a calcium-dependent protein phosphatase that has been implicated in various aspects of synaptic plasticity. By using conditional gene-targeting techniques, we created mice in which calcineurin activity is disrupted specifically in the adult forebrain. At hippocampal Schaffer collateral-CA1 synapses, LTD was significantly diminished, and there was a significant shift in the LTD/LTP modification threshold in mutant mice. Strikingly, although performance was normal in hippocampus-dependent reference memory tasks, including contextual fear conditioning and the Morris water maze, the mutant mice were impaired in hippocampus-dependent working and episodic-like memory tasks, including the delayed matching-to-place task and the radial maze, task. Our results define a critical role for calcineurin in bidirectional synaptic plasticity and suggest a novel mechanistic distinction between working/episodic-like memory and reference memory.	MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Ctr Learning & Memory,Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Ctr Learning & Memory,Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; Brown Univ, Howard Hughes Med Inst, Dept Neurosci, Providence, RI 02912 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Brown University; Howard Hughes Medical Institute	Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, RIKEN MIT Neurosci Res Ctr, Ctr Learning & Memory,Dept Biol, Cambridge, MA 02139 USA.		Rondi-Reig, Laure/M-6141-2016; Miyakawa, Tsuyoshi/A-7741-2008; Rondi-Reig, Laure/G-2816-2011	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Bear, Mark/0000-0002-9903-2541; Rondi-Reig, Laure/0000-0003-1006-0501	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58880-03] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1983, CANADIAN PSYCHOL; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BECKER JT, 1980, BRAIN RES, V200, P307, DOI 10.1016/0006-8993(80)90922-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Halpain S, 1998, J NEUROSCI, V18, P9835; Jones MV, 1997, J NEUROSCI, V17, P7626; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KUNO T, 1992, J NEUROCHEM, V58, P1643, DOI 10.1111/j.1471-4159.1992.tb10036.x; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MERAT DL, 1985, J BIOL CHEM, V260, P1053; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olton D.S., 1983, NEUROBIOLOGY HIPPOCA, P335; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; PERRINO BA, 1992, J BIOL CHEM, V267, P15965; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; SIKKINK R, 1995, BIOCHEMISTRY-US, V34, P8348, DOI 10.1021/bi00026a016; Squire Larry R., 1994, P203; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; TAKAISHI T, 1991, BIOCHEM BIOPH RES CO, V174, P393, DOI 10.1016/0006-291X(91)90533-D; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; Willshaw D, 1990, NEURAL COMPUT, V2, P85, DOI 10.1162/neco.1990.2.1.85; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; ZHANG W, 1995, GENERATION ANAL CALC	57	382	397	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					617	629		10.1016/S0092-8674(01)00585-2	http://dx.doi.org/10.1016/S0092-8674(01)00585-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733061	Bronze			2022-12-01	WOS:000172575300009
J	Krinos, CM; Coyne, MJ; Weinacht, KG; Tzianabos, AO; Kasper, DL; Comstock, LE				Krinos, CM; Coyne, MJ; Weinacht, KG; Tzianabos, AO; Kasper, DL; Comstock, LE			Extensive surface diversity of a commensal microorganism by multiple DNA inversions	NATURE			English	Article							BACTEROIDES-FRAGILIS; REVEALS; GENE	The dynamic interactions between a host and its intestinal microflora that lead to commensalism are unclear. Bacteria that colonize the intestinal tract do so despite the development of a specific immune response by the host(1). The mechanisms used by commensal organisms to circumvent this immune response have yet to be established. Here we demonstrate that the human colonic microorganism, Bacteroides fragilis, is able to modulate its surface antigenicity by producing at least eight distinct capsular polysaccharides-a number greater than any previously reported for a bacterium-and is able to regulate their expression in an on-off manner by the reversible inversion of DNA segments containing the promoters for their expression. This means of generating surface diversity allows the organism to exhibit a wide array of distinct surface polysaccharide combinations, and may have broad implications for how the predominant human colonic microorganisms, the Bacteroides species, maintain an ecological niche in the intestinal tract.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Comstock, LE (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044193] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI044193-04, R01 AI044193] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1016/S0378-1097(00)00472-9; Comstock LE, 1999, INFECT IMMUN, V67, P3525, DOI 10.1128/IAI.67.7.3525-3532.1999; Coyne MJ, 2000, INFECT IMMUN, V68, P6176, DOI 10.1128/IAI.68.11.6176-6181.2000; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; KIM J, 1998, INFECT IMMUN, V66, P3303; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; OLSEN PB, 1994, FEMS MICROBIOL LETT, V116, P95; THOMPSON JS, 1990, J BACTERIOL, V172, P2584, DOI 10.1128/jb.172.5.2584-2593.1990	9	218	229	0	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					555	558		10.1038/35107092	http://dx.doi.org/10.1038/35107092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734857				2022-12-01	WOS:000172405900050
J	Becher, MW; Morrison, L; Davis, LE; Maki, WC; King, MK; Bicknell, JM; Reinert, BL; Bartolo, C; Bear, DG				Becher, MW; Morrison, L; Davis, LE; Maki, WC; King, MK; Bicknell, JM; Reinert, BL; Bartolo, C; Bear, DG			Oculopharyngeal muscular dystrophy in Hispanic new Mexicans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; NUCLEAR INCLUSIONS; POLY(A) BINDING-PROTEIN-2; REPEAT DISORDERS; PABP2; EXPANSIONS; DISEASE; FAMILIES; PROTEIN; LENGTH	Context Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathy caused by polyalanine triplet repeat expansion in the gene for poly(A) binding protein 2 (PABP2) and is found in isolated cohorts throughout the world. We have observed numerous cases of OPMD in New Mexico. Objective To characterize the clinical, genetic, and demographic features of the OPMD population in New Mexico. Design, Setting, and Participants Cohort study with analysis of outpatient clinic medical records from 1965 to 2001 at the University of New Mexico Hospital and the New Mexico VA Health Care System in Albuquerque, which serve the entire state. Main Outcome Measures Clinical phenotype, supplemented with genetic confirmation (n=10 patients) and in-depth clinical evaluations (n=49 patients). Results We identified 216 cases of OPMD (99 women and 117 men) from 39 kindreds of New Mexicans spanning up to 4 generations. All patients were Hispanic, and the majority of probands came from northern New Mexico. In patients who had both ocular and pharyngeal muscle weakness, ptosis was just as likely to occur before or concurrent with dysphagia. Proximal limb muscle weakness and gait abnormalities were common and occurred later than ocular or pharyngeal weakness. The clinical expression of OPMD caused marked debility, although life-table analysis showed no decrease in life expectancy compared with unaffected family members (P=.81). Ten individuals from different kindreds were found to have an identical polyalanine triplet repeat expansion ([GCG](9)) in the PABP2 gene. Conclusions Individuals in this cohort had clinical and genetic characteristics of classic OPMD. Longevity was not affected, but patients experienced considerable morbidity. The origin of the PABP2 mutation in New Mexican OPMD patients is unclear, although the geographic and genetic isolation of northern New Mexicans with a long ancestry in this region may have contributed to the development of this cohort. This disease cohort represents a large and previously unrecognized health care issue in the state of New Mexico and should serve to raise the awareness of this disorder among clinicians who treat Hispanics in the Southwest and throughout the United States.	Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Ctr Canc, Albuquerque, NM 87131 USA; New Mexico VA Hlth Care Syst, Albuquerque, NM USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Bear, DG (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, BMSB 149,915 Camino de Salud NE, Albuquerque, NM 87131 USA.			Morrison, Leslie/0000-0002-0092-193X				Andrew SE, 1997, HUM MOL GENET, V6, P2005, DOI 10.1093/hmg/6.12.2005; BARBEAU A, 1968, PROGR NEUROOPHTHALMO, V2, P3; BARBEAU A, 1966, S PROGR MUSKELDYSTRO, P102; Becher MW, 2000, ANN NEUROL, V48, P812, DOI 10.1002/1531-8249(200011)48:5<812::AID-ANA20>3.3.CO;2-U; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Blumen SC, 1996, NEUROLOGY, V46, P1324, DOI 10.1212/WNL.46.5.1324; Blumen SC, 1999, ANN NEUROL, V46, P115, DOI 10.1002/1531-8249(199907)46:1<115::AID-ANA17>3.3.CO;2-F; Bouchard J-P., 1997, NEUROMUSCULAR DISORD, V7, pS1; BOUCHARD JP, 1989, CAN J NEUROL SCI, V16, P446, DOI 10.1017/S0317167100029565; Brais B, 1999, SEMIN NEUROL, V19, P59, DOI 10.1055/s-2008-1040826; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; BROOK EMH, 1986, CLIN VIEW NEUROMUSCU, P185; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Davies SW, 1998, LANCET, V351, P131, DOI 10.1016/S0140-6736(97)08360-8; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUBOWITZ V, 1973, MUSCLE BIOPSY MODERN, P231; Fardeau M, 1997, NEUROMUSCULAR DISORD, V7, pS30, DOI 10.1016/S0960-8966(97)00078-3; Grewal RP, 1998, NEUROREPORT, V9, P961, DOI 10.1097/00001756-199804200-00002; Grewal RP, 1999, ARCH NEUROL-CHICAGO, V56, P1378, DOI 10.1001/archneur.56.11.1378; Hill ME, 2001, BRAIN, V124, P522, DOI 10.1093/brain/124.3.522; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mirabella M, 2000, NEUROLOGY, V54, P608, DOI 10.1212/WNL.54.3.608; Perie S, 1997, NEUROMUSCULAR DISORD, V7, pS96, DOI 10.1016/S0960-8966(97)00091-6; Porschke H, 1997, NEUROMUSCULAR DISORD, V7, pS57, DOI 10.1016/S0960-8966(97)00084-9; Scacheri PC, 1999, AM J MED GENET, V86, P477, DOI 10.1002/(SICI)1096-8628(19991029)86:5<477::AID-AJMG14>3.0.CO;2-A; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Stajich JM, 1996, ANN NEUROL, V40, P801, DOI 10.1002/ana.410400519; Stajich JM, 1997, NEUROMUSCULAR DISORD, V7, pS75, DOI 10.1016/S0960-8966(97)00087-4; Tome F, 1994, MYOLOGY, P1233; TOME FMS, 1980, ACTA NEUROPATHOL, V49, P85, DOI 10.1007/BF00692226; Uyama E, 2000, MUSCLE NERVE, V23, P1549, DOI 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0; Uyama E, 1996, NEUROLOGY, V46, P773, DOI 10.1212/WNL.46.3.773; VICTOR M, 1962, NEW ENGL J MED, V267, P1267, DOI 10.1056/NEJM196212202672501; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; WEBER DJ, 1982, TAOS TRAPPERS FUR TR; WEITZNER S, 1969, ORAL SURG ORAL MED O, V28, P613, DOI 10.1016/0030-4220(69)90272-2; WEITZNER S, 1971, AM J GASTROENTEROL, V56, P378; WEITZNER S, 1969, AM J DIG DIS, V14, P805, DOI 10.1007/BF02235971	40	59	65	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2001	286	19					2437	2440		10.1001/jama.286.19.2437	http://dx.doi.org/10.1001/jama.286.19.2437			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DH	11712939	Bronze			2022-12-01	WOS:000172266100023
J	Mehr, DR; Binder, EF; Kruse, RL; Zweig, SC; Madsen, R; Popejoy, L; D'Agostino, RB				Mehr, DR; Binder, EF; Kruse, RL; Zweig, SC; Madsen, R; Popejoy, L; D'Agostino, RB			Predicting mortality in nursing home residents with lower respiratory tract infection - The Missouri LRI study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERM CARE FACILITIES; ACQUIRED PNEUMONIA; RISK-FACTORS; HOSPITALIZATION; DEPRESSION; MDS; SURVEILLANCE; DECISION; 3-YEAR; ISSUES	Context Lower respiratory tract infection (LRI) is a leading cause of mortality and hospitalization in nursing home residents. Treatment decisions may be aided by a clinical prediction rule that identifies residents at low and high risk of mortality. Objective To identify patient characteristics predictive of 30-day mortality in nursing home residents with an LRI. Design, Setting, and Patients Prospective cohort study of 1406 episodes of LRI in 1044 residents of 36 nursing homes in central Missouri and the St Louis, Mo, area between August 15, 1995, and September 30, 1998. Main Outcome Measure Thirty-day all-cause mortality. Results Thirty-day mortality was 14.7% (n=207). In a logistic analysis, using generalized estimating equations to adjust for clustering, we developed an 8-variable model to predict 30-day mortality, including serum urea nitrogen, white blood cell count, body mass index, pulse rate, activities of daily living status, absolute lymphocyte count of less than 800/muL (0.8 x 10(9)/L), male sex, and deterioration in mood over 90 days. In validation testing, the model exhibited reasonable discrimination (c=.76) and calibration (nonsignificant Hosmer-Lemeshow goodness-of-fit statistic, P=.54). A point score based on this model's variables fit to the entire data set closely matched observed mortality. Fifty-two percent of residents had low (score of 0-4) or relatively low (score of 5-6) predicted 30-day mortality, with 2.2% and 6.2% actual mortality, respectively. Conclusions Our model distinguishes nursing home residents at relatively low risk for mortality due to LRI. If independently validated, our findings could help physicians identify nursing home residents in need of different therapeutic approaches for LRI.	Univ Missouri, Dept Family & Community Med, Ctr Family Med Sci, Sch Med, Columbia, MO 65212 USA; Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65212 USA; Washington Univ, Sch Med, Dept Internal Med, Div Geriatr & Gerontol, St Louis, MO 63110 USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Washington University (WUSTL); Boston University	Mehr, DR (corresponding author), Univ Missouri, Dept Family & Community Med, Ctr Family Med Sci, Sch Med, MA306 Med Sci Bldg, Columbia, MO 65212 USA.			Kruse, Robin/0000-0001-9759-7218; Mehr, David/0000-0002-5194-1383	AHRQ HHS [HS08551] Funding Source: Medline; BHP HRSA HHS [PE10038] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008551] Funding Source: NIH RePORTER; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [D15PE010038] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); BHP HRSA HHS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))		ANDREWS BE, 1987, Q J MED, V62, P195; Arfken CL, 1999, J GERONTOL A-BIOL, V54, pM152, DOI 10.1093/gerona/54.3.M152; BROOKS S, 1994, ARCH INTERN MED, V154, P902, DOI 10.1001/archinte.154.8.902; Cole MG, 1997, CAN MED ASSOC J, V157, P1055; Covinsky KE, 1999, ANN INTERN MED, V130, P563, DOI 10.7326/0003-4819-130-7-199904060-00004; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; D'Agostino RB, 1997, P BIOM, P253; DAGOSTINO RB, 1995, STAT MED, V14, P1757, DOI 10.1002/sim.4780141605; DEGELAU J, 1995, J AM GERIATR SOC, V43, P245, DOI 10.1111/j.1532-5415.1995.tb07330.x; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; FRIED TR, 1995, J GEN INTERN MED, V10, P246, DOI 10.1007/BF02599879; Gabrel C, 2000, Vital Health Stat 13, P1; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; *HLTH CAR FIN ADM, 1995, LONG TERM CAR FAC RE; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; Houston MS, 1997, ARCH INTERN MED, V157, P2190, DOI 10.1001/archinte.157.19.2190; IRVINE PW, 1984, J AM GERIATR SOC, V32, P103, DOI 10.1111/j.1532-5415.1984.tb05848.x; JACKSON MM, 1992, AM J EPIDEMIOL, V135, P685, DOI 10.1093/oxfordjournals.aje.a116348; KAYSERJONES JS, 1989, GERONTOLOGIST, V29, P502, DOI 10.1093/geront/29.4.502; *MATHS INC DAT AN, 1999, S PLUS 2000; MCGEER A, 1991, AM J INFECT CONTROL, V19, P1, DOI 10.1016/0196-6553(91)90154-5; Medina-Walpole AM, 1998, J AM GERIATR SOC, V46, P187, DOI 10.1111/j.1532-5415.1998.tb02537.x; Mehr DR, 1998, J FAM PRACTICE, V47, P298; MEHR DR, 1992, J FAM PRACTICE, V34, P585; Mehr DR, 2001, J FAM PRACTICE, V50, P931; MORLEY JE, 1995, ANN INTERN MED, V123, P850, DOI 10.7326/0003-4819-123-11-199512010-00008; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Muder RR, 1996, ARCH INTERN MED, V156, P2365, DOI 10.1001/archinte.156.20.2365; MURTAUGH CM, 1995, GERONTOLOGIST, V35, P35, DOI 10.1093/geront/35.1.35; Mylotte JM, 1998, J AM GERIATR SOC, V46, P1538, DOI 10.1111/j.1532-5415.1998.tb01539.x; Preisser JS, 1997, ANNU REV PUBL HEALTH, V18, P51, DOI 10.1146/annurev.publhealth.18.1.51; ROVNER BW, 1991, JAMA-J AM MED ASSOC, V265, P993, DOI 10.1001/jama.265.8.993; Rubenstein L Z, 1988, Clin Geriatr Med, V4, P471; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x; *SAS I INC, 1996, SAS SYST WIND VERS 6; Scott H D, 1988, R I Med J, V71, P69; SINGH MF, 1999, PRINCIPLES GERIATRIC, P81; SMITH WR, 1995, J AM GERIATR SOC, V43, P1052, DOI 10.1111/j.1532-5415.1995.tb05573.x; TERESI JA, 1991, GERONTOLOGIST, V31, P795, DOI 10.1093/geront/31.6.795; ZWEIG S, 1990, J FAM PRACTICE, V30, P153	43	87	87	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2001	286	19					2427	2436		10.1001/jama.286.19.2427	http://dx.doi.org/10.1001/jama.286.19.2427			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DH	11712938	Bronze			2022-12-01	WOS:000172266100022
J	Kovacs, A; Wasserman, SS; Burns, D; Wright, DJ; Cohn, J; Landay, A; Weber, K; Cohen, M; Levine, A; Minkoff, H; Miotti, P; Palefsky, J; Young, M; Reichelderfer, P				Kovacs, A; Wasserman, SS; Burns, D; Wright, DJ; Cohn, J; Landay, A; Weber, K; Cohen, M; Levine, A; Minkoff, H; Miotti, P; Palefsky, J; Young, M; Reichelderfer, P		DATRI; WIHS Study Grp	Determinants of HIV-1 shedding in the genital tract of women	LANCET			English	Article; Proceedings Paper	6th Conference on Retroviruses and Opportunistic Infections	JAN 31-FEB 04, 1999	CHICAGO, IL				HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 RNA LEVELS; VIRAL LOAD; HETEROSEXUAL TRANSMISSION; CERVICOVAGINAL SECRETIONS; PERINATAL TRANSMISSION; RISK-FACTORS; BLOOD; ZIDOVUDINE; PLASMA	Background Plasma HIV-1 RNA concentration has been the best predictor for risk of heterosexual and perinatal transmission. However, direct contact with HIV-1 present locally in the genital tract might be necessary for transmission. We aimed to assess the relation between HIV-1 shedding (RNA or culturable virus) in female genital secretions and other factors that might affect HIV-1 shedding. Methods This was a cross-sectional study within the Women's Interagency HIV Study (WIHS), a prospective longitudinal cohort study of HIV-Infected women. We enrolled 311 HIV positive women from Jan 30, 1997 to July 1, 1998. We did clinical assessments, cultured HIV-1, and measured RNA in peripheral blood mononuclear cells (PBMC) and genital secretions. We compared the results with univariate and multivariate analyses. Presence of HIV-1 RNA or culturable virus in genital secretions was defined as HIV-1 shedding. Findings HIV-1 RNA was present in genital secretions of 57% (152/268) of women whereas infectious virus was detected only in 6% (17/271). Genital tract HIV-1 shedding was found in 80% (130/163) of women with detectable plasma RNA and 78% (116/148) of women with positive PBMC cultures. 33% (27/83) of women with less than 500 copies/mL plasma RNA and 39% (35/90) of those with negative PBMC cultures also had genital tract shedding. Interpretation Plasma RNA concentration, both qualitatively and quantitatively, was the most important factor in predicting genital HIV-1 shedding, even among women receiving potent antiretroviral therapy. However, HIV-1 shedding did occur in women with less than 500 copies/mL plasma HIV-1 RNA. This finding suggests that a separate reservoir of HIV-1 replication may exist in some women.	Univ So Calif, Sch Med, Comprehens Maternal Child & Adolescent HIV Manage, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Norris Canc Hosp, Los Angeles, CA 90033 USA; Univ Maryland, Dept Med, Baltimore, MD 21201 USA; NICHHD, Bethesda, MD 20892 USA; Westat Corp, Rockville, MD USA; Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA; Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA; Cook Cty Hosp, Chicago, IL 60612 USA; Maimonides Hosp, Brooklyn, NY 11219 USA; NIAID, Bethesda, MD 20892 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA	University of Southern California; University of Southern California; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Westat; Wayne State University; Rush University; John H Stroger Junior Hospital Cook County; Maimonides Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; Georgetown University	Kovacs, A (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles Cty Med Ctr, Comprehens Maternal Child & Adolescent HIV Manage, 1640 Marengo St,HRA Bldg, Los Angeles, CA 90033 USA.	akovacs@hsc.usc.edu			NIAID NIH HHS [U01-AI-34994, U01-AI-34993, N01-AI-15123, U01-AI-31834, U01-AI-35004, AI-34989, U01-AI-42590] Funding Source: Medline; NICHD NIH HHS [U01-HD-32632] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034989, U01AI042590, U01AI031834, U01AI034994, U01AI035004, U01AI034993, N01AI015123] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bremer J, 2000, J CLIN MICROBIOL, V38, P2665, DOI 10.1128/JCM.38.7.2665-2669.2000; Chuachoowong R, 2000, J INFECT DIS, V181, P99, DOI 10.1086/315179; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; *DIV AIDS, 1997, VIR MAN HIV LAB; Fiore JR, 1997, AIDS, V11, P1089, DOI 10.1097/00002030-199709000-00002; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Goulston C, 1998, J INFECT DIS, V177, P1100, DOI 10.1086/517404; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hart CE, 1999, J INFECT DIS, V179, P871, DOI 10.1086/314656; HENIN Y, 1993, J ACQ IMMUN DEF SYND, V6, P72; HILL JA, 1992, AM J OBSTET GYNECOL, V166, P720, DOI 10.1016/0002-9378(92)91703-D; Howell AL, 1997, J VIROL, V71, P3498, DOI 10.1128/JVI.71.5.3498-3506.1997; Ioannidis JPA, 2001, J INFECT DIS, V183, P539, DOI 10.1086/318530; Iversen AKN, 1998, J INFECT DIS, V177, P1214, DOI 10.1086/515266; Kovacs A, 1999, J ACQ IMMUN DEF SYND, V22, P124; KREISS JK, 1989, J INFECT DIS, V160, P380, DOI 10.1093/infdis/160.3.380; Landesman SH, 1996, NEW ENGL J MED, V334, P1617, DOI 10.1056/NEJM199606203342501; Long EM, 2000, NAT MED, V6, P71; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mostad SB, 1998, AIDS RES HUM RETROV, V14, pS11; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; MYERS LE, 1994, J CLIN MICROBIOL, V32, P732, DOI 10.1128/JCM.32.3.732-739.1994; Nicholson J, 1996, CYTOMETRY, V26, P227, DOI 10.1002/(SICI)1097-0320(19960915)26:3<227::AID-CYTO8>3.0.CO;2-B; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Operskalski EA, 1997, AM J EPIDEMIOL, V146, P655, DOI 10.1093/oxfordjournals.aje.a009331; Overbaugh J, 1996, AIDS RES HUM RETROV, V12, P107, DOI 10.1089/aid.1996.12.107; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Pedraza MA, 1999, J ACQ IMMUN DEF SYND, V21, P120; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rasheed S, 1996, AM J OBSTET GYNECOL, V175, P122, DOI 10.1016/S0002-9378(96)70261-2; Reichelderfer PS, 2000, AIDS, V14, P2101, DOI 10.1097/00002030-200009290-00005; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; Uvin SC, 1997, OBSTET GYNECOL, V90, P739, DOI 10.1016/S0029-7844(97)00411-0; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	40	195	201	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2001	358	9293					1593	1601		10.1016/S0140-6736(01)06653-3	http://dx.doi.org/10.1016/S0140-6736(01)06653-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	492VM	11716886				2022-12-01	WOS:000172188300013
J	Hummer, G; Rasaiah, JC; Noworyta, JP				Hummer, G; Rasaiah, JC; Noworyta, JP			Water conduction through the hydrophobic channel of a carbon nanotube	NATURE			English	Article							MOLECULAR-DYNAMICS; SIMULATION; TRANSITION; KINETICS; IONS	Confinement of matter on the nanometre scale can induce phase transitions not seen in bulk systems(1). In the case of water, so-called drying transitions occur on this scale(2-5) as a result of strong hydrogen-bonding between water molecules, which can cause the liquid to recede from nonpolar surfaces to form a vapour layer separating the bulk phase from the surface(6). Here we report molecular dynamics simulations showing spontaneous and continuous filling of a nonpolar carbon nanotube with a one-dimensionally ordered chain of water molecules. Although the molecules forming the chain are in chemical and thermal equilibrium with the surrounding bath, we observe pulse-like transmission of water through the nanotube. These transmission bursts result from the tight hydrogen-bonding network inside the tube, which ensures that density fluctuations in the surrounding bath lead to concerted and rapid motion along the tube axis(7-9). We also rnd that a minute reduction in the attraction between the tube wall and water dramatically affects pore hydration, leading to sharp, two-state transitions between empty and filled states on a nanosecond timescale. These observations suggest that carbon nanotubes, with their rigid nonpolar structures(10,11), might be exploited as unique molecular channels for water and protons, with the channel occupancy and conductivity tunable by changes in the local channel polarity and solvent conditions.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; Univ Maine, Dept Chem, Orono, ME 04469 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Maine System; University of Maine Orono	Hummer, G (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	hummer@helix.nih.gov	Rasaiah, Jayendran C./AAD-3900-2021; Hummer, Gerhard/A-2546-2013	Hummer, Gerhard/0000-0001-7768-746X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029034, Z01DK029033, ZIADK029033] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AJAYAN PM, 1992, NATURE, V358, P23, DOI 10.1038/358023a0; BECKSTEIN O, IN PRESS J PHYS CH B; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bolhuis PG, 2000, J CHEM PHYS, V113, P8154, DOI 10.1063/1.1315997; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Gelb LD, 1999, REP PROG PHYS, V62, P1573, DOI 10.1088/0034-4885/62/12/201; Hummer G, 1996, P NATL ACAD SCI USA, V93, P8951, DOI 10.1073/pnas.93.17.8951; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Lum K, 1997, PHYS REV E, V56, pR6283, DOI 10.1103/PhysRevE.56.R6283; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Luzar A, 1996, NATURE, V379, P55, DOI 10.1038/379055a0; LyndenBell RM, 1996, J CHEM PHYS, V105, P9266, DOI 10.1063/1.472757; MACKAY DHJ, 1986, J BIOMOL STRUCT DYN, V4, P491, DOI 10.1080/07391102.1986.10506364; Pomes R, 1998, BIOPHYS J, V75, P33, DOI 10.1016/S0006-3495(98)77492-2; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Sansom MSP, 2000, TRENDS BIOCHEM SCI, V25, P368, DOI 10.1016/S0968-0004(00)01613-3; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2893, DOI 10.1021/j100009a053; Wallqvist A, 2001, J PHYS CHEM B, V105, P6745, DOI 10.1021/jp010945i; Wikstrom M, 1998, CURR OPIN STRUC BIOL, V8, P480, DOI 10.1016/S0959-440X(98)80127-9; Wilson M, 2001, J AM CHEM SOC, V123, P2101, DOI 10.1021/ja003737x; Zahab A, 2000, PHYS REV B, V62, P10000, DOI 10.1103/PhysRevB.62.10000; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhong QF, 1998, BIOPHYS J, V74, P3, DOI 10.1016/S0006-3495(98)77761-6	28	2822	2898	49	1303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2001	414	6860					188	190		10.1038/35102535	http://dx.doi.org/10.1038/35102535			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700553				2022-12-01	WOS:000172029100042
J	Zhong, TP; Childs, S; Leu, JP; Fishman, MC				Zhong, TP; Childs, S; Leu, JP; Fishman, MC			Gridlock signalling pathway fashions the first embryonic artery	NATURE			English	Article							EARLY EMBRYOGENESIS; REPRESSOR PROTEINS; NOTCH; ZEBRAFISH; TRANSCRIPTION; HAIRY; ENHANCER; HOMOLOG; SPLIT; GENES	Arteries and veins are morphologically, functionally and molecularly very different, but how this distinction is established during vasculogenesis is unknown(1,2). Here we show, by lineage tracking in zebrafish embryos, that angioblast precursors for the trunk artery and vein are spatially mixed in the lateral posterior mesoderm. Progeny of each angioblast, however, are restricted to one of the vessels. This arterial-venous decision is guided by gridlock (grl), an artery-restricted gene that is expressed in the lateral posterior mesoderm(3). Graded reduction of grl expression, by mutation or morpholino antisense, progressively ablates regions of the artery, and expands contiguous regions of the vein, preceded by an increase in expression of the venous marker EphB4 receptor (ephb4)(2) and diminution of expression of the arterial marker ephrin-B2 (efnb2)(2). grl is downstream of notch(4), and interference with notch signalling, by blocking Su(H)(4), similarly reduces the artery and increases the vein. Thus, a notch-grl pathway controls assembly of the first embryonic artery, apparently by adjudicating an arterial versus venous cell fate decision.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Fishman, MC (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, 149 13th St, Charlestown, MA 02129 USA.		Childs, Sarah/AAG-5111-2021	Childs, Sarah/0000-0003-2261-580X				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Holder N, 1999, DEVELOPMENT, V126, P2033; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Krebs LT, 2000, GENE DEV, V14, P1343; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NODEN DM, 1989, AM REV RESPIR DIS, V140, P1097, DOI 10.1164/ajrccm/140.4.1097; Pardanaud L, 1999, DEVELOPMENT, V126, P617; Serbedzija GN, 1998, DEVELOPMENT, V125, P1095; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shirayoshi Y, 1997, GENES CELLS, V2, P213, DOI 10.1046/j.1365-2443.1997.d01-310.x; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	30	404	423	1	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					216	220		10.1038/35102599	http://dx.doi.org/10.1038/35102599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700560				2022-12-01	WOS:000172029100050
J	Ford, N; Davis, A				Ford, N; Davis, A			Chaos in Afghanistan: famine, aide and bombs	LANCET			English	Editorial Material									Med Sans Frontieres, London EC1R 5DJ, England	Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, 124-32 Clerkenwell Rd, London EC1R 5DJ, England.							AHMAD K, 2001, LANCET, V358, P1248; *MSF, 2001, MSF REP NEW AFGH REF; Terry F, 2001, LANCET, V357, P1431, DOI 10.1016/S0140-6736(00)04571-2; 2001, NUTR SURVEILLANCE AF	4	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 3	2001	358	9292					1543	1544		10.1016/S0140-6736(01)06588-6	http://dx.doi.org/10.1016/S0140-6736(01)06588-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MN	11705586				2022-12-01	WOS:000172055800036
J	Fransson, T; Jakobsson, S; Johansson, P; Kullberg, C; Lind, J; Vallin, A				Fransson, T; Jakobsson, S; Johansson, P; Kullberg, C; Lind, J; Vallin, A			Bird migration - Magnetic cues trigger extensive refuelling	NATURE			English	Article							SEA-TURTLES		Swedish Museum Nat Hist, Bird Ringing Ctr, SE-10405 Stockholm, Sweden; Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden; Geol Survey Sweden, SE-75128 Uppsala, Sweden	Swedish Museum of Natural History; Stockholm University	Fransson, T (corresponding author), Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden.							ABLE KP, 1993, TRENDS ECOL EVOL, V8, P367, DOI 10.1016/0169-5347(93)90221-A; Alerstam T., 1990, P331; Alerstam T., 1990, BIRD MIGRATION, DOI 10.1046/j.1420-9101.1992.5030529.x; BERTHOLD P, 1991, TRENDS ECOL EVOL, V6, P254, DOI 10.1016/0169-5347(91)90072-6; Berthold P., 1996, CONTROL BIRD MIGRATI; FRY CH, 1970, IBIS, V112, P58, DOI 10.1111/j.1474-919X.1970.tb00076.x; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; KULLBERG C, 1996, P R SOC LOND B, V263, P619; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; Mandea M, 2000, GEOPHYS J INT, V141, P259; *SWED MUS NAT HIST, ANN REP SWED BIRD RI; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x	13	125	133	1	45	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 01	2001	414	6859					35	36		10.1038/35102115	http://dx.doi.org/10.1038/35102115			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689932				2022-12-01	WOS:000171898900031
J	Marivaux, L; Welcomme, JL; Antoine, PO; Metais, G; Baloch, IM; Benammi, M; Chaimanee, Y; Ducrocq, S; Jaeger, JJ				Marivaux, L; Welcomme, JL; Antoine, PO; Metais, G; Baloch, IM; Benammi, M; Chaimanee, Y; Ducrocq, S; Jaeger, JJ			A fossil lemur from the Oligocene of Pakistan	SCIENCE			English	Article							MOLECULAR PHYLOGENY; SINGLE-ORIGIN; PRIMATE; CHEIROGALEIDAE; MADAGASCAR	In the absence of a comprehensive fossil record, the origin and early evolution of Malagasy lemurs have been subject to much uncertainty. We report here the discovery of a strepsirrhine fossil with strong cheirogaleid lemur affinities, Bugtilemur mathesoni gen. et sp. nov., from early Oligocene deposits of the Bugti Hills (Balochistan, Pakistan). Bugtilemur represents the earliest record of Lemuriformes, which hence appear to. have already diversified outside of Madagascar at least 30 million years ago. This fossil clearly enhances the critical role of the Indian subcontinent in the early diversification of lemurs and constrains paleobiogeographic models of strepsirrhine lemur evolution.	Univ Montpellier 2, CNRS, Inst Sci Evolut, Lab Paleontol,UMR 5554, F-34095 Montpellier 5, France; Univ Balochistan, Dept Geol, Quetta, Pakistan; Museum Natl Hist Nat, CNRS, Lab Paleontol, UMR 8569, F-75231 Paris 5, France; Univ Nacl Autonoma Mexico, Inst Geofis, Lab Paleomagnetismo, Mexico City 04510, DF, Mexico; Dept Mineral Resources, Geol Survey Div, Paleontol Sect, Bangkok 10400, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Balochistan; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Universidad Nacional Autonoma de Mexico; Department of Mineral Resources - Thailand	Marivaux, L (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, Lab Paleontol,UMR 5554, CC064,Pl E Bataillon, F-34095 Montpellier 5, France.	marivaux@isem.univ-montp2.fr; jaeger@isem.univ-montp2.fr	Métais, Grégoire/F-6916-2010	Benammi, Mouloud/0000-0003-4707-7518; chaimanee, yaowalak/0000-0002-8432-3880				BEARD KC, 1988, NATURE, V331, P712, DOI 10.1038/331712a0; Cartmill M., 1975, P313; CHARLESD.P, 1970, NATURE, V227, P257, DOI 10.1038/227257a0; CIOCHON RL, 1994, INTEGRATIVE PATHS PA, P37; DAGOSTO M, 1988, J HUM EVOL, V17, P35, DOI 10.1016/0047-2484(88)90048-6; Gheerbrant Emmanuel, 1993, Palaeovertebrata (Montpellier), V22, P141; Gingerich P.D., 1975, P65; Gingerich P. D., 1977, Geobios Lyon Memoire Special, VNo. 1, P165; GOODMAN M, 1994, AM J PHYS ANTHROPOL, V94, P3, DOI 10.1002/ajpa.1330940103; Gregory WK, 1915, BULL GEOL SOC AM, V26, P419; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; JODOT P, 1952, MEM I SCI MADAGASC D, V4, P131; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; MACPHEE RDE, 1986, VERTEBRATES PHYLOGEN, V3, P131; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Martin RD, 2000, INT J PRIMATOL, V21, P1021, DOI 10.1023/A:1005563113546; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Pastorini J, 2001, MOL PHYLOGENET EVOL, V19, P45, DOI 10.1006/mpev.2000.0904; Rage JC, 1996, COLLOQ SEMI, P27; Rasmussen DT, 1998, FOLIA PRIMATOL, V69, P250; ROSENBERGER AL, 1985, FOLIA PRIMATOL, V44, P15, DOI 10.1159/000156195; Ross C, 1998, J HUM EVOL, V35, P221, DOI 10.1006/jhev.1998.0254; SCHWARTZ J H, 1985, Anthropological Papers of the American Museum of Natural History, V60, P1; Simons EL, 1997, P NATL ACAD SCI USA, V94, P180, DOI 10.1073/pnas.94.1.180; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; SZALAY FS, 1973, FOLIA PRIMATOL, V19, P88, DOI 10.1159/000155535; TATTERSALL I, 1974, ANTHROPOL PAP AM MUS, V52, P137; Welcomme JL, 2001, GEOL MAG, V138, P397, DOI 10.1017/S0016756801005428; Yoder AD, 1997, EVOL ANTHROPOL, V6, P11, DOI 10.1002/(SICI)1520-6505(1997)6:1<11::AID-EVAN6>3.0.CO;2-Z; YODER AD, 1994, AM J PHYS ANTHROPOL, V94, P25, DOI 10.1002/ajpa.1330940104; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122	33	61	65	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					587	591		10.1126/science.1065257	http://dx.doi.org/10.1126/science.1065257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641497				2022-12-01	WOS:000171695600045
J	Weimerskirch, H; Martin, J; Clerquin, Y; Alexandre, P; Jiraskova, S				Weimerskirch, H; Martin, J; Clerquin, Y; Alexandre, P; Jiraskova, S			Energy saving in flight formation - Pelicans flying in a 'V' can glide for extended periods using the other birds' air streams.	NATURE			English	Article							INDUCED DRAG		CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; Galatee Films, Peuple Migrateur Jacques Perrin, F-75017 Paris, France	Centre National de la Recherche Scientifique (CNRS)	Weimerskirch, H (corresponding author), CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France.	henriw@cebc.cnrs.fr	Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013	Weimerskirch, Henri/0000-0002-0457-586X; Martin, Julien/0000-0002-7375-129X				BADGEROW JP, 1981, J THEOR BIOL, V93, P41, DOI 10.1016/0022-5193(81)90055-2; BADGEROW JP, 1988, AUK, V105, P749, DOI 10.1093/auk/105.4.749; CUTTS CJ, 1994, J EXP BIOL, V189, P251; GOULD LL, 1974, AUK, V91, P494; HAINSWORTH FR, 1988, J EXP BIOL, V135, P431; Hamilton WJ, 1967, ANIMAL ORIENTATION N, P57; HIGDON JJL, 1978, AM NAT, V112, P727, DOI 10.1086/283314; HUMMEL D, 1983, J THEOR BIOL, V104, P321, DOI 10.1016/0022-5193(83)90110-8; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; OMALLEY JBE, 1982, CAN J ZOOL, V60, P1388, DOI 10.1139/z82-187; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223	11	296	311	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					697	698		10.1038/35099670	http://dx.doi.org/10.1038/35099670			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607019				2022-12-01	WOS:000171608000031
J	Grossman, JM; MacLean, CH				Grossman, JM; MacLean, CH			Quality indicators for the management of osteoporosis in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Review							BONE-MINERAL DENSITY; HORMONE REPLACEMENT THERAPY; RANDOMIZED CONTROLLED TRIAL; FRACTURE INTERVENTION TRIAL; EARLY POSTMENOPAUSAL WOMEN; VITAMIN-D SUPPLEMENTATION; ESTROGEN PLUS PROGESTIN; POST-MENOPAUSAL WOMEN; BREAST-CANCER RISK; HIP FRACTURE		Univ Calif Los Angeles, Los Angeles, CA 90095 USA; RAND Corp, RAND Hlth, Santa Monica, CA 90406 USA	University of California System; University of California Los Angeles; RAND Corporation	Grossman, JM (corresponding author), Univ Calif Los Angeles, 1000 Vet Ave,Room 32-59, Los Angeles, CA 90095 USA.	jgrossman@mednet.ucla.edu						*AM ASS CLIN END, 2001, AM ASS CLIN END 2001; *AM ASS CLIN END, 1998, AM ASS CLIN END CLIN; Anderson FH, 1996, BONE, V18, P171, DOI 10.1016/8756-3282(95)00441-6; Bagur A, 1996, MEDICINA-BUENOS AIRE, V56, P247; BAUER DC, 1993, ANN INTERN MED, V118, P657, DOI 10.7326/0003-4819-118-9-199305010-00001; Behre HM, 1997, J CLIN ENDOCR METAB, V82, P2386, DOI 10.1210/jc.82.8.2386; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BODY JJ, 1995, CLIN RHEUMATOL, V14, P18, DOI 10.1007/BF02210683; *CAN TASK FORC PRE, 1999, PHYS ACT COUNS; CANIGGIA A, 1984, Acta Vitaminologica et Enzymologica, V6, P117; Cardona JM, 1997, OSTEOPOROSIS INT, V7, P165, DOI 10.1007/BF01622285; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chen JT, 1997, BONE, V20, P557, DOI 10.1016/S8756-3282(97)00054-9; CHESTNUT CH, 2001, AM J MED, V109, P267; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; CHRISTIANSEN C, 1981, LANCET, V1, P459; CUMMING RG, 1990, CALCIFIED TISSUE INT, V47, P194; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Davies KM, 1996, OSTEOPOROSIS INT, V6, P160, DOI 10.1007/BF01623941; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Eiken P, 1996, BONE, V19, pS191, DOI 10.1016/S8756-3282(96)00266-9; Ensrud KE, 1997, ARCH INTERN MED, V157, P2617, DOI 10.1001/archinte.157.22.2617; ETTINGER B, 1985, ANN INTERN MED, V102, P319, DOI 10.7326/0003-4819-102-3-319; ETTINGER B, 1987, ANN INTERN MED, V106, P40, DOI 10.7326/0003-4819-106-1-40; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; GALLAGHER JC, 1990, ANN INTERN MED, V113, P649, DOI 10.7326/0003-4819-113-9-649; GALLAGHER JC, 1989, P SOC EXP BIOL MED, V191, P287; Gillespie WJ, 2000, COCHRANE DATABASE SY; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; HARRIS ST, 1993, AM J MED, V95, P557, DOI 10.1016/0002-9343(93)90350-X; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HARRISON JE, 1993, OSTEOPOROSIS INT, V3, P13, DOI 10.1007/BF01623171; Herd RJM, 1997, AM J MED, V103, P92, DOI 10.1016/S0002-9343(97)00019-3; Hochberg MC, 1996, ARTHRITIS RHEUM-US, V39, P1791; HOMIK J, 1998, COCHRANE LIB; HORSMAN A, 1983, NEW ENGL J MED, V309, P1405, DOI 10.1056/NEJM198312083092301; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; HUTCHINSON TA, 1979, LANCET, V2, P705; JACKSON JA, 1987, J CLIN ENDOCR METAB, V65, P53, DOI 10.1210/jcem-65-1-53; JAGLAL SB, 1993, AM J EPIDEMIOL, V138, P107, DOI 10.1093/oxfordjournals.aje.a116833; JOHNSON RE, 1981, AM J PUBLIC HEALTH, V71, P138, DOI 10.2105/AJPH.71.2.138; Jones G, 1996, OSTEOPOROSIS INT, V6, P233, DOI 10.1007/BF01622740; Josse R, 1996, CAN MED ASSOC J, V155, P1113; Kanis JA, 1997, OSTEOPOROSIS INT, V7, P390, DOI 10.1007/BF01623782; Karpf DB, 1997, JAMA-J AM MED ASSOC, V277, P1159; Kaufman JM, 1997, CLIN RHEUMATOL, V16, P343, DOI 10.1007/BF02242449; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; KOHRT WM, 1995, J BONE MINER RES, V10, P1303, DOI 10.1002/jbmr.5650100906; Komulainen M, 1997, OSTEOPOROSIS INT, V7, P126, DOI 10.1007/BF01623687; KREIGER N, 1982, AM J EPIDEMIOL, V116, P141, DOI 10.1093/oxfordjournals.aje.a113388; LINDSAY R, 1980, LANCET, V2, P1151; LINDSAY R, 1976, LANCET, V1, P1038; LINDSAY R, 1984, OBSTET GYNECOL, V63, P759; LINDSAY R, 1992, OSTEOPOROSIS GUIDE D; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; Lyritis GP, 1997, CLIN RHEUMATOL, V16, P354, DOI 10.1007/BF02242451; MAXIM P, 1995, OSTEOPOROSIS INT, V5, P23, DOI 10.1007/BF01623654; MENCZEL J, 1994, CLIN ORTHOP RELAT R, P241; Montessori MLM, 1997, OSTEOPOROSIS INT, V7, P52, DOI 10.1007/BF01623461; MUNKJENSEN N, 1988, BRIT MED J, V296, P1150, DOI 10.1136/bmj.296.6630.1150; Murray TM, 1996, CAN MED ASSOC J, V155, P935; NAESSEN T, 1990, ANN INTERN MED, V113, P95, DOI 10.7326/0003-4819-113-2-95; *NAT OST FDN, 1998, PHYS GUID PREV TREAT; *NAT OST FDN, 2001, PHYS GUID PREV TREAT; NIELSEN SP, 1994, BRIT J OBSTET GYNAEC, V101, P319, DOI 10.1111/j.1471-0528.1994.tb13618.x; ORIMO H, 1994, CALCIFIED TISSUE INT, V54, P370, DOI 10.1007/BF00305521; Orwoll ES, 1996, ANN INTERN MED, V124, P187, DOI 10.7326/0003-4819-124-2-199601150-00001; OTT SM, 1989, ANN INTERN MED, V110, P267, DOI 10.7326/0003-4819-110-4-267; Paganini-Hill A, 1991, Epidemiology, V2, P16; PAGANINIHILL A, 1981, ANN INTERN MED, V95, P28, DOI 10.7326/0003-4819-95-1-28; PECK WA, 1993, AM J MED, V94, P646; PERIS P, 1995, BRIT J RHEUMATOL, V34, P936; PERIS P, 1996, CURR OPIN RHEUMATOL, P357; Preisinger E, 1996, BRIT J SPORT MED, V30, P209, DOI 10.1136/bjsm.30.3.209; PREISINGER E, 1995, AM J PHYS MED REHAB, V74, P120; Prior JC, 1996, CAN MED ASSOC J, V155, P940; QUIGLEY MET, 1987, AM J OBSTET GYNECOL, V156, P1516; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Reid IR, 1996, ARCH INTERN MED, V156, P1173, DOI 10.1001/archinte.156.11.1173; REID IR, 1995, AM J MED, V98, P331, DOI 10.1016/S0002-9343(99)80310-6; REID IR, 1993, NEW ENGL J MED, V328, P460, DOI 10.1056/NEJM199302183280702; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Schneider DL, 1997, JAMA-J AM MED ASSOC, V277, P543, DOI 10.1001/jama.277.7.543; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Shiraki M, 1996, ENDOCR J, V43, P211, DOI 10.1507/endocrj.43.211; Siminoski K, 1996, CAN MED ASSOC J, V155, P962; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P1966, DOI 10.1210/jc.84.6.1966; Storm T, 1996, J RHEUMATOL, V23, P1560; TILYARD MW, 1992, NEW ENGL J MED, V326, P357, DOI 10.1056/NEJM199202063260601; Tucci JR, 1996, AM J MED, V101, P488, DOI 10.1016/S0002-9343(96)00282-3; *US CONGR OFF TECH, 1994, OTABPH120 US CONGR O; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, V2nd; WEISS NS, 1980, NEW ENGL J MED, V303, P1195, DOI 10.1056/NEJM198011203032102; 1984, NIH CONS STAT 2 4 AP, V5, P1; 1998, OSTEOPOROOS INT S4, V8, pS7; 1989, J R COLL PHYSICIANS, V23, P8	103	10	10	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				722	730		10.7326/0003-4819-135-8_Part_2-200110161-00011	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481WA	11601955				2022-12-01	WOS:000171542400011
J	Maira, SM; Galetic, I; Brazil, DP; Kaech, S; Ingley, E; Thelen, M; Hemmings, BA				Maira, SM; Galetic, I; Brazil, DP; Kaech, S; Ingley, E; Thelen, M; Hemmings, BA			Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane	SCIENCE			English	Article							KINASE-B; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATASE INHIBITORS; MOLECULAR-CLONING; ACTIVATION; MECHANISM; INSULIN; TRANSLOCATION; LYMPHOMA	The PKB (protein kinase B, also called Akt) family of protein kinases plays a key role in insulin signaling, cellular survival, and transformation. PKB is activated by phosphorylation on residues threonine 308, by the protein kinase PDK1, and Serine 473, by a putative serine 473 kinase. Several protein binding partners for PKB have been identified. Here, we describe a protein partner for PKB alpha termed CTMP, or carboxyl-terminal modulator protein, that binds specifically to the carboxyl-terminal regulatory domain of PKB alpha at the plasma membrane. Binding of CTMP reduces the activity of PKB alpha by inhibiting phosphorylation on serine 473 and threonine 308. Moreover, CTMP expression reverts the phenotype of v-Akt-transformed cells examined under a number of criteria including cell morphology, growth rate, and in vivo tumorigenesis. These findings identify CTMP as a negative regulatory component of the pathway controlling PKB activity.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland; Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Friedrich Miescher Institute for Biomedical Research; Universita della Svizzera Italiana	Hemmings, BA (corresponding author), Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.		Ingley, Evan/C-2401-2013	Ingley, Evan/0000-0002-8112-9134; Kaech Petrie, Stefanie/0000-0002-6246-6434; Brazil, Derek/0000-0003-1375-1076				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Andjelkovic M, 1999, MOL CELL BIOL, V19, P5061; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; CHATTON B, 1995, BIOTECHNIQUES, V18, P142; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0; GALETIC I, UNPUB; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; JONES PF, 1991, CELL REGUL, V2, P1001, DOI 10.1091/mbc.2.12.1001; Koh H, 2000, J BIOL CHEM, V275, P34451, DOI 10.1074/jbc.M001753200; MAIRA SM, UNPUB; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; POSNER BI, 1994, J BIOL CHEM, V269, P4596; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; STAAL SP, 1988, J EXP MED, V167, P1259, DOI 10.1084/jem.167.3.1259; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3	26	202	222	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					374	380		10.1126/science.1062030	http://dx.doi.org/10.1126/science.1062030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598301				2022-12-01	WOS:000171601400044
J	Federman, AD; Adams, AS; Ross-Degnan, D; Soumerai, SB; Ayanian, JZ				Federman, AD; Adams, AS; Ross-Degnan, D; Soumerai, SB; Ayanian, JZ			Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BETA-BLOCKER USE; MYOCARDIAL-INFARCTION; PRESCRIPTION DRUGS; COST-EFFECTIVENESS; ADVERSE SELECTION; MEDIGAP INSURANCE; UNITED-STATES; COVERAGE; HEALTH; CHOLESTEROL	Context Cost-sharing in US prescription drug coverage plans for elderly persons varies widely. Evaluation of prescription drug use among elderly persons by type of health insurance could provide useful information for designing a Medicare drug program.. Objective To determine use of effective cardiovascular drugs among elderly per sons with coronary heart disease (CHD) by type of health insurance. Design, Setting, and Patients Cross-sectional evaluation of 1908 community-dwelling adults, aged 66 years or older, with a history of CHD or myocardial infarction from the 1997 Medicare Current Beneficiary Survey, a nationally representative sample of Medicare beneficiaries. Main Outcome Measures Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins), beta -blockers, and nitrates, and out-of-pocket expenditures for prescription drugs, stratified by type of health insurance: Medicare without drug coverage (Medicare only or self-purchased supplemental insurance) or with drug coverage (Medicaid, other public program, Medigap, health maintenance organization, or employer-sponsored plan). Results Statin use ranged from 4.1% in Medicare patients with no drug coverage to 27.4% in patients with employer-sponsored drug coverage (P<.001). Less variation between these 2 types occurred for <beta>-blockers (20.7% vs 36.1%; P=.003) and nitrates (20.4% vs 38.0%; P=.005). In multivariate analyses, statin use remained significantly lower for patients with Medicare only (odds ratio [OR], 0.16; 95% confidence interval [CI], 0.05-0.49) and beta -blocker use was lower for Medicaid patients (OR, 0.55; 95% Cl, 0.34-0.88) vs those with employer-sponsored coverage. Nitrate use occurred less frequently in persons lacking drug coverage (patients with Medicare only, P=.049; patients with supplemental insurance without drug coverage, P=.03). Patients with Medicare only spent a much larger fraction of income on prescription compared with those with employer-sponsored drug coverage (7.9% vs; 1.7%; adjusted P<.001). Conclusion Elderly Medicare beneficiaries with CHD who lack drug coverage have disproportionately large drug expenditures and lower use rates of statins, a class of relatively expensive drugs that improve survival.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu			DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; BHP HRSA HHS [5T32PE11001-13] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); BHP HRSA HHS		Adams AS, 2001, HEALTH AFFAIR, V20, P276, DOI 10.1377/hlthaff.20.1.276; Adams AS, 2001, ANNU REV PUBL HEALTH, V22, P49, DOI 10.1146/annurev.publhealth.22.1.49; Adler G S, 1994, Health Care Financ Rev, V15, P153; Alecxih L, 2001, HEALTH SERV RES, V35, P1365; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; BERK ML, 1990, HEALTH AFFAIR, V9, P146, DOI 10.1377/hlthaff.9.3.146; Blustein J, 2000, HEALTH AFFAIR, V19, P219, DOI 10.1377/hlthaff.19.2.219; BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; CASSIDY A, 2000, MEDICARE PLUS CHOICE; DAVIDSON BN, 1992, SOC SCI MED, V34, P1023, DOI 10.1016/0277-9536(92)90133-B; Davis M, 1999, HEALTH AFFAIR, V18, P231, DOI 10.1377/hlthaff.18.1.231; Ettner SL, 1997, J HEALTH ECON, V16, P543, DOI 10.1016/S0167-6296(97)00011-8; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; Ganz DA, 2000, ANN INTERN MED, V132, P780, DOI 10.7326/0003-4819-132-10-200005160-00003; GOLDMAN L, 1988, NEW ENGL J MED, V319, P152, DOI 10.1056/NEJM198807213190306; GROSS D, 1999, STATE PHARM ASSISTAN; Harnick DJ, 1998, AM J CARDIOL, V81, P1416, DOI 10.1016/S0002-9149(98)00209-4; *HJ KAIS FAM FDN, 2000, HLTH POL ALT, V1; HJALMARSON A, 1988, AM J CARDIOL, V61, pB26; Hodgson TA, 1999, MED CARE, V37, P994, DOI 10.1097/00005650-199910000-00004; Hosmer D., 1989, APPL LOGISTIC REGRES, P82; Jackevicius CA, 2000, J AM COLL CARDIOL, V35, p314A; JENSEN GA, 1992, GERONTOLOGIST, V32, P693, DOI 10.1093/geront/32.5.693; Johnson RE, 1997, HEALTH SERV RES, V32, P103; LONG SH, 1994, HEALTH AFFAIR, V13, P157, DOI 10.1377/hlthaff.13.2.157; Majumdar SR, 1999, J GEN INTERN MED, V14, P711, DOI 10.1046/j.1525-1497.1999.02229.x; McClellan M, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.2.26; *MED EC CO INC, 1997, DRUG TOP RED BOOK; Miller M, 2000, ARCH INTERN MED, V160, P343, DOI 10.1001/archinte.160.3.343; MOELLER JF, 1991, HEALTH AFFAIR, V10, P210, DOI 10.1377/hlthaff.10.1.210; Pear R., 2001, NY TIMES B      1025, P1; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2000, AM J CARDIOL, V86, P257, DOI 10.1016/S0002-9149(00)00910-3; Phillips KA, 2000, JAMA-J AM MED ASSOC, V284, P2748, DOI 10.1001/jama.284.21.2748; Poisal JA, 2000, HEALTH AFFAIR, V19, P248, DOI 10.1377/hlthaff.19.2.248; Poisal JA, 2001, HEALTH AFFAIR, V20, P74, DOI 10.1377/hlthaff.20.2.74; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; *RES TRIANGL I, 1997, PROF SOFTW SURV DAT; RICE T, 1991, HEALTH SERV RES, V26, P223; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schrott HG, 1997, JAMA-J AM MED ASSOC, V277, P1281, DOI 10.1001/jama.277.16.1281; Seddon ME, 2001, AM J MED, V111, P24, DOI 10.1016/S0002-9343(01)00741-0; SEMPOS CT, 1993, JAMA-J AM MED ASSOC, V269, P3009, DOI 10.1001/jama.269.23.3009; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; SOUMERAI SB, 1994, NEW ENGL J MED, V331, P650, DOI 10.1056/NEJM199409083311006; Soumerai SB, 1999, NEW ENGL J MED, V340, P722, DOI 10.1056/NEJM199903043400909; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; Stuart B, 1998, MED CARE, V36, P202, DOI 10.1097/00005650-199802000-00009; Stuart B, 1999, HEALTH AFFAIR, V18, P201, DOI 10.1377/hlthaff.18.2.201; STUART B, 2001, DESIGNING MED DRUG B; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; VISCOLI CM, 1993, ANN INTERN MED, V118, P99, DOI 10.7326/0003-4819-118-2-199301150-00004; Vistnes JP, 1997, INQUIRY-J HEALTH CAR, V34, P311; Wang TJ, 1998, ARCH INTERN MED, V158, P1901, DOI 10.1001/archinte.158.17.1901; WOLFE JR, 1991, J HEALTH ECON, V10, P433, DOI 10.1016/0167-6296(91)90024-H	57	134	136	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1732	1739		10.1001/jama.286.14.1732	http://dx.doi.org/10.1001/jama.286.14.1732			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	480NC	11594898	Green Published, Bronze			2022-12-01	WOS:000171466800023
J	Kawabata, H; Ueno, T				Kawabata, H; Ueno, T			Screening recommendation for women taking tamoxifen	LANCET			English	Letter							BREAST-CANCER; ADJUVANT TAMOXIFEN; ENDOMETRIUM		JR Tokyo Gen Hosp, Dept Surg, Tokyo 1510053, Japan		Kawabata, H (corresponding author), JR Tokyo Gen Hosp, Dept Surg, Tokyo 1510053, Japan.							Barakat RR, 2000, J CLIN ONCOL, V18, P3459, DOI 10.1200/JCO.2000.18.20.3459; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gerber B, 2000, J CLIN ONCOL, V18, P3464, DOI 10.1200/JCO.2000.18.20.3464; Katase K, 1998, CANCER, V82, P1698, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1698::AID-CNCR16>3.3.CO;2-K; *ONC COMM, 2001, NIPPON SANFUJINNKA G, V53, P788	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 22	2001	358	9286					1018	1018		10.1016/S0140-6736(01)06150-5	http://dx.doi.org/10.1016/S0140-6736(01)06150-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474YR	11593503				2022-12-01	WOS:000171135300059
J	Bulford, R				Bulford, R			Personal view - Children have rights too	BRITISH MEDICAL JOURNAL			English	Editorial Material											Bulford, R (corresponding author), ARTICLE 12,8 WAKLEY ST,LONDON EC1V 7QE,ENGLAND.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 10	1997	314	7091					1421	1422						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WZ169	11644928				2022-12-01	WOS:A1997WZ16900077
J	Bullock, SL; Ish-Horowicz, D				Bullock, SL; Ish-Horowicz, D			Conserved signals and machinery for RNA transport in Drosophila oogenesis and embryogenesis	NATURE			English	Article							POSTERIOR DETERMINANT NANOS; PAIR-RULE TRANSCRIPTS; OSKAR MESSENGER-RNA; BICAUDAL-D PROTEIN; BICOID RNA; ANTERIOR POLE; EGG CHAMBER; LOCALIZATION; OOCYTE; GENE	Localization of cytoplasmic messenger RNA transcripts is widely used to target proteins within cells. For many transcripts, localization depends on cis-acting elements within the transcripts and on microtubule-based motors; however, little is known about other components of the transport machinery or how these components recognize specific RNA cargoes. Here, we show that in Drosophila the same machinery and RNA signals drive specific accumulation of maternal RNAs in the early oocyte and apical transcript localization in blastoderm embryos. We demonstrate in vivo that Egalitarian (Egl) and Bicaudal D (BicD), maternal proteins required for oocyte determination, are selectively recruited by, and co-transported with, localizing transcripts in blastoderm embryos, and that interfering with the activities of Egl and BicD blocks apical localization. We propose that Egl and BicD are core components of a selective dynein motor complex that drives transcript localization in a variety of tissues.	Imperial Canc Res Fund, Dev Genet Lab, London WC2A 3PX, England	Cancer Research UK	Ish-Horowicz, D (corresponding author), Imperial Canc Res Fund, Dev Genet Lab, POB 123,44 Lincolns Inn Fields, London WC2A 3PX, England.		Bullock, Simon/K-6885-2012	Ish-Horowicz, David/0000-0001-5684-7129; Bullock, Simon/0000-0001-9491-4548				Baens M, 1997, GENOMICS, V45, P601, DOI 10.1006/geno.1997.4971; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; ISHHOROWICZ D, 1987, CELL, V51, P405, DOI 10.1016/0092-8674(87)90636-2; KarlinMcginness M, 1996, DEV GENET, V19, P238, DOI 10.1002/(SICI)1520-6408(1996)19:3<238::AID-DVG7>3.0.CO;2-A; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Lall S, 1999, CELL, V98, P171, DOI 10.1016/S0092-8674(00)81012-0; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LANTZ V, 1994, MOL CELL BIOL, V14, P2235, DOI 10.1128/MCB.14.4.2235; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; MACDONALD PM, 1991, GENE DEV, V5, P2455, DOI 10.1101/gad.5.12b.2455; Macdonald PM, 1997, RNA, V3, P1413; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; MARCEY D, 1991, EMBO J, V10, P4259, DOI 10.1002/j.1460-2075.1991.tb05004.x; MOHLER J, 1986, GENETICS, V112, P803; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Oh J, 2000, GENETICS, V154, P713; Oh J, 2001, DEV BIOL, V232, P91, DOI 10.1006/dbio.2001.0170; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; RAN B, 1994, DEVELOPMENT, V120, P1233; Riedl A, 1996, MOL CELL BIOL, V16, P3047; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; SCHUPBACH T, 1991, GENETICS, V129, P1119; SERANO T, 1995, DEVELOPMENT, V121, P3809; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Swan A, 1996, DEVELOPMENT, V122, P3577; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; THEURKAUF WE, 1994, DEV BIOL, V165, P352, DOI 10.1006/dbio.1994.1258; Thio GL, 2000, DEV BIOL, V221, P435, DOI 10.1006/dbio.2000.9690; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9	45	199	206	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					611	616		10.1038/414611a	http://dx.doi.org/10.1038/414611a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740552				2022-12-01	WOS:000172535600040
J	Valencia, M; Bentele, M; Vaze, MB; Herrmann, G; Kraus, E; Lee, SE; Schar, P; Haber, JE				Valencia, M; Bentele, M; Vaze, MB; Herrmann, G; Kraus, E; Lee, SE; Schar, P; Haber, JE			NEJ1 controls non-homologous end joining in Saccharomyces cerevisiae	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-LIGASE; MATING-TYPE; ILLEGITIMATE RECOMBINATION; GENE-EXPRESSION; REPAIR; YEAST; KU70; IDENTIFICATION; MUTATIONS	Broken DNA ends are rejoined by non-homologous end-joining (NHEJ) pathways requiring the Ku proteins (Ku70, Ku80), DNA ligase IV and its associated protein Lif1/Xrcc4 (ref. 1). In mammalian meiotic cells, Ku protein levels are much lower than in somatic cells, apparently reducing the capacity of meiotic cells to carry out NHEJ and thereby promoting homologous recombination(2). In Saccharomyces cerevisiae, NHEJ is also downregulated in meiosis-competent MATa/MAT alpha diploid cells in comparison with diploids or haploids expressing only MATa or MAT alpha (3,4). Diploids expressing both MATa and MAT alpha show enhanced mitotic homologous recombination(4). Here we report that mating-type-dependent regulation of NHEJ in budding yeast is caused in part by transcriptional repression of both LIF1 and the gene NEJ1 (YLR265C)-identified from microarray screening of messenger RNAs. Deleting NEJ1 reduces NHEJ 100-fold in MATa or MAT alpha haploids. Constitutive expression of NEJ1, but not expression of LIF1, restores NHEJ in MATa/MAT alpha cells. Nej1 regulates the subcellular distribution of Lif1. A green fluorescent protein (GFP)-Lif1 fusion protein accumulates in the nucleus in cells expressing NEJ1 but is largely cytoplasmic when NEJ1 is repressed.	Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Univ Zurich, Inst Med Radiobiol, CH-8008 Zurich, Switzerland	Brandeis University; Brandeis University; University of Zurich	Haber, JE (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.		Schär, Primo/G-5967-2012	Schär, Primo/0000-0003-1843-6147; Haber, James/0000-0002-1878-0610				Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Goedecke W, 1999, NAT GENET, V23, P194, DOI 10.1038/13821; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; OOI SL, 2001, SCIENCE         1108; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Teo SH, 2000, CURR BIOL, V10, P165, DOI 10.1016/S0960-9822(00)00317-1; Tsukamoto Y, 1996, GENETICS, V142, P383; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Tsukamoto Y, 1996, NUCLEIC ACIDS RES, V24, P2067, DOI 10.1093/nar/24.11.2067; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wu XH, 1996, CELL, V87, P277, DOI 10.1016/S0092-8674(00)81345-8; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	29	174	178	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					666	669		10.1038/414666a	http://dx.doi.org/10.1038/414666a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740566				2022-12-01	WOS:000172535600054
J	Long, J; Allwright, S; Barry, J; Reynolds, SR; Thornton, L; Bradley, F; Parry, JV				Long, J; Allwright, S; Barry, J; Reynolds, SR; Thornton, L; Bradley, F; Parry, JV			Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							FACTOR ELICITATION; SURVEILLANCE; SCOTLAND	Objectives To determine the prevalence of antibodies to hepatitis B core antigen, hepatitis C virus, and HIV in enu-ants to Ir ish prisons and to examine risk factors for infection. Design Cross sectional, anonymous survey, with self completed risk factor questionnaire and oral fluid specimen for antibody testing. Setting Five of seven committal prisons in the Republic of Ireland. Participants 607 of the 718 consecutive prison entrants from 6 April to 1 May 1999. Main outcome measures Prevalence of antibodies to hepatitis B core antigen, hepatitis C virus, and HIV in prison entrants, and self reported risk factor status. Results Prevalence of antibodies to hepatitis B core antigen was 37/596 (6%; 95% confidence interval 4% to 9%), to hepatitis C virus was 130/596 (22%; 19% to 25%), and to HIV was 12/596 (2%; 1% to 4%). A third of the respondents had never previously been in prison; these had the lowest prevalence of antibodies to hepatitis B core antigen (4/197, 2%), to hepatitis C (6/197, 3%), and to HIV (0/197). In rata 29% of respondents (173/593) reported ever injecting drugs, but only 7% (14/197) of those entering prison for the first tune reported doing so compared with 40% (157/394) of those previously in prison. Use of injected drugs was the most important predictor of antibodies to hepatitis B core antigen acid hepatitis C virus. Conclusions Use of injected drugs and infection with hepatitis C virus are endemic in Irish prisons. A third of prison enu-ants were committed to prison for the first time. Oily a small number of first time entrants were affected with one or more of die viruses. These findings confirm the need for increased infection control and harm reduction measures in Irish prisons.	Adelaide & Meath Hosp, Natl Childrens Hosp, Trinity Coll, Ctr Hlth Sci,Dept Community Hlth & Gen Practice, Dublin 24, Ireland; No Area Hlth Board, Drugs AIDS Serv, Dublin 7, Ireland; Dr Steevens Hosp, Eastern Reg Hlth Author, Dept Publ Hlth, Dublin 8, Ireland; Cent Publ Hlth Lab, PHLS, Sexually Transmitted & Bloodborne Virus Lab, London NW9 5HT, England	Trinity College Dublin; Public Health England	Allwright, S (corresponding author), Adelaide & Meath Hosp, Natl Childrens Hosp, Trinity Coll, Ctr Hlth Sci,Dept Community Hlth & Gen Practice, Dublin 24, Ireland.		Allwright, Shane/A-1537-2012	Allwright, Shane/0000-0003-1841-4781				ABILDGAARD N, 1991, LANCET, V338, P460, DOI 10.1016/0140-6736(91)91095-C; Allwright S, 2000, BRIT MED J, V321, P78, DOI 10.1136/bmj.321.7253.78; BIRD AG, 1993, BRIT MED J, V307, P228, DOI 10.1136/bmj.307.6898.228; BIRD AG, 1992, AIDS, V6, P725, DOI 10.1097/00002030-199207000-00017; BIRD AG, 1995, AIDS, V9, P801, DOI 10.1097/00002030-199507000-00019; Bird AG, 1997, BRIT MED J, V315, P21, DOI 10.1136/bmj.315.7099.21; Butler TG, 1997, MED J AUSTRALIA, V166, P127, DOI 10.5694/j.1326-5377.1997.tb140041.x; CROFTS N, 1995, BRIT MED J, V310, P285, DOI 10.1136/bmj.310.6975.285; Gore SM, 1997, INT J STD AIDS, V8, P166, DOI 10.1258/0956462971919831; GORE SM, 1995, BRIT MED J, V310, P293, DOI 10.1136/bmj.310.6975.293; ROTILY M, 1997, INT J STD AIDS, V8, P735; TURNBULL PJ, 1991, PRISONS HIV AIDS RIS; Weild A R, 2000, Commun Dis Public Health, V3, P121	13	57	63	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 24	2001	323	7323					1209	1212		10.1136/bmj.323.7323.1209	http://dx.doi.org/10.1136/bmj.323.7323.1209			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497HZ	11719410	Green Published, Bronze			2022-12-01	WOS:000172450500013
J	Bodine, SC; Latres, E; Baumhueter, S; Lai, VKM; Nunez, L; Clarke, BA; Poueymirou, WT; Panaro, FJ; Na, EQ; Dharmarajan, K; Pan, ZQ; Valenzuela, DM; DeChiara, TM; Stitt, TN; Yancopoulos, GD; Glass, DJ				Bodine, SC; Latres, E; Baumhueter, S; Lai, VKM; Nunez, L; Clarke, BA; Poueymirou, WT; Panaro, FJ; Na, EQ; Dharmarajan, K; Pan, ZQ; Valenzuela, DM; DeChiara, TM; Stitt, TN; Yancopoulos, GD; Glass, DJ			Identification of ubiquitin ligases required for skeletal muscle atrophy	SCIENCE			English	Article							PROTEIN-TURNOVER; FINGER; FAMILY; RING	Skeletal muscle adapts to decreases in activity and load by undergoing atrophy. To identify candidate molecular mediators of muscle atrophy, we performed transcript profiling. Although many genes were up-regulated in a single rat model of atrophy, only a small subset was universal in all atrophy models. Two of these genes encode ubiquitin ligases: Muscle RING Finger 1 (MuRF1), and a gene we designate Muscle Atrophy F-box (MAFbx), the latter being a member of the SCF family of E3 ubiquitin ligases. Overexpression of MAFbx in myotubes produced atrophy, whereas mice deficient in either MAFbx or MuRF1 were found to be resistant to atrophy. These proteins are potential drug targets for the treatment of muscle atrophy.	Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Appl Biosyst Inc, Foster City, CA 94404 USA; Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA	Regeneron; Thermo Fisher Scientific; Applied Biosystems; Icahn School of Medicine at Mount Sinai	Glass, DJ (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	david.glass@regeneron.com	Panaro, Fabrizio/Q-1355-2017; Glass, David/AAI-3910-2021; Xia, Xianfeng/F-9169-2011	Bodine, Sue/0000-0002-5742-9145				BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Cooney RN, 1997, SHOCK, V7, P1, DOI 10.1097/00024382-199701000-00001; DECHIARA TM, UNPUB; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GOLDBERG AL, 1969, J BIOL CHEM, V244, P3223; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; JOAEIRO CA, 2000, CELL, V102, P549; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; NUNEZ L, UNPUB; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; THOMASON DB, 1987, J APPL PHYSIOL, V63, P130, DOI 10.1152/jappl.1987.63.1.130; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	19	2460	2588	12	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1704	1708		10.1126/science.1065874	http://dx.doi.org/10.1126/science.1065874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11679633				2022-12-01	WOS:000172307400041
J	Cortez, D; Guntuku, S; Qin, J; Elledge, SJ				Cortez, D; Guntuku, S; Qin, J; Elledge, SJ			ATR and ATRIP: Partners in checkpoint signaling	SCIENCE			English	Article							EARLY EMBRYONIC LETHALITY; IONIZING-RADIATION; PROTEIN; KINASE; GENE; PHOSPHORYLATION; SENSITIVITY; DISRUPTION; PATHWAY; COMPLEX	The checkpoint kinases ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3 related) transduce genomic stress signals to halt cell cycle progression and promote DNA repair. We report the identification of an ATR-interacting protein (ATRIP) that is phosphorylated by ATR, regulates ATR expression, and is an essential component of the DNA damage checkpoint pathway. ATR and ATRIP both localize to intranuclear foci after DNA damage or inhibition of replication. Deletion of ATR mediated by the Cre recombinase caused the loss of ATR and ATRIP expression, loss of DNA damage checkpoint responses, and cell death. Therefore, ATR is essential for the viability of human somatic cells. Small interfering RNA directed against ATRIP caused the loss of both ATRIP and ATR expression and the toss of checkpoint responses to DNA damage. Thus, ATRIP and ATR are mutually dependent partners in cell cycle checkpoint signaling pathways.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.							Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Brodsky MH, 2000, GENE DEV, V14, P666; Brown EJ, 2000, GENE DEV, V14, P397; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; CORTEZ D, UNPUB; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Paciotti V, 2000, GENE DEV, V14, P2046; Rouse J, 2000, EMBO J, V19, P5801, DOI 10.1093/emboj/19.21.5801; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wang Y, 2000, GENE DEV, V14, P927; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	22	732	769	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1713	1716		10.1126/science.1065521	http://dx.doi.org/10.1126/science.1065521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721054				2022-12-01	WOS:000172307400043
J	Nguyen, VT; Kiss, TS; Michels, AA; Bensaude, O				Nguyen, VT; Kiss, TS; Michels, AA; Bensaude, O			7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; POLYMERASE-II; P-TEFB; TERMINAL DOMAIN; MESSENGER-RNA; TRANSCRIPTION; ELONGATION; PHOSPHORYLATION; INITIATION; PATHWAY	The transcription of eukaryotic protein-coding genes involves complex regulation of RNA polymerase (Pol) II activity in response to physiological conditions and developmental cues. One element of this regulation involves phosphorylation of the carboxy-terminal domain (CTD) of the largest polymerase subunit by a transcription elongation factor, P-TEFb, which comprises the kinase CDK9 and cyclin T1 or T2 (ref. 1). Here we report that in human HeLa cells more than half of the P-TEFb is sequestered in larger complexes that also contain 7SK RNA, an abundant, small nuclear RNA (snRNA) of hitherto unknown function(2,3). P-TEFb and 7SK associate in a specific and reversible manner. In contrast to the smaller P-TEFb complexes, which have a high kinase activity, the larger 7SK/P-TEFb complexes show very weak kinase activity. Inhibition of cellular transcription by chemical agents or ultraviolet irradiation trigger the complete disruption of the P-TEFb/7SK complex, and enhance CDK9 activity. The transcription-dependent interaction of P-TEFb with 7SK may therefore contribute to an important feedback loop modulating the activity of RNA Pol II.	Ecole Normale Super, CNRS, UMR 8541, F-75230 Paris 05, France; Univ Toulouse 3, CNRS, Lab Biol Mol Eucaryote, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Bensaude, O (corresponding author), Ecole Normale Super, CNRS, UMR 8541, 46 Rue Ulm, F-75230 Paris 05, France.			Michels, Annemieke/0000-0002-1735-1697; Kiss, Tamas/0000-0003-0293-3093; Bensaude, Olivier/0000-0002-0259-6608				Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; EGYHAZI E, 1976, NATURE, V262, P319, DOI 10.1038/262319a0; Garber ME, 1999, CURR OPIN IMMUNOL, V11, P460, DOI 10.1016/S0952-7915(99)80077-6; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; GOODALL GJ, 1990, METHOD ENZYMOL, V181, P148; Hirose Y, 2000, GENE DEV, V14, P1415; IGNOTZ GG, 1981, BIOCHEMISTRY-US, V20, P2550, DOI 10.1021/bi00512a029; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Ramanathan Y, 1999, J VIROL, V73, P5448, DOI 10.1128/JVI.73.7.5448-5458.1999; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; VALERIE K, 1988, NATURE, V333, P78, DOI 10.1038/333078a0; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1	25	530	552	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					322	325		10.1038/35104581	http://dx.doi.org/10.1038/35104581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713533				2022-12-01	WOS:000172150700047
J	Ni, YH; Chang, MH; Huang, LM; Chen, HL; Hsu, HY; Chiu, TY; Tsai, KS; Chen, DS				Ni, YH; Chang, MH; Huang, LM; Chen, HL; Hsu, HY; Chiu, TY; Tsai, KS; Chen, DS			Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATOCELLULAR-CARCINOMA; ANTIGEN; TAIWAN; SEROEPIDEMIOLOGY; PROGRAM; VACCINE; INFANTS; TAIPEI	Background: Hepatitis B virus (HBV) infection is hyperendemic in Taiwan. Before universal HBV immunization was started in Taiwan in 1984, the carrier rate for hepatitis B surface antigen (HBsAg) was 15% to 20% in the general population. Objective: To quantify the population impact of a mass vaccination program for HBV 15 years after its implementation. Design: Descriptive analysis of serologic markers of HBV in healthy children and adolescents. Setting: Chung-Cheng District, Taipei City, Taiwan, in 1999. Participants: 1357 persons younger than 15 years of age, who were born after the implementation of universal HBV vaccination, and 559 persons 15 to 20 years of age, who were borin before the program began. Measurements: Repeated serologic surveys similar to those done before and 5 and 10 years after the national vaccination program was implemented. All participants were tested for serum HBsAg, its antibody (anti-HBs), and hepatitis B core antibody (anti-HBc). Results: During the 15 years since the vaccination program was implemented, the prevalence of HBsAg among persons younger than 15 years of age decreased from 9.8% in 1984 to 0.7% in 1999; among persons 15 to 20 years of age, the 1999 prevalence of HBsAg was 7% (P < 0.001). Hepatitis B core antibody seropositivity, which represents HBV infection, was found in 2.9% of persons younger than 15 years of age and in 20.6% of persons 15 to 20 years of age (P < 0.001); in the same age groups, the rate of anti-HBs seropositivity was 75.8% and 70.7%, respectively (P = 0.02). Conclusions: universal vaccination significantly decreased the HBV carrier rate and infection rate among children and adolescents born since the program began. By decreasing the carrier pool, continuation of the national HBV immunization program should prevent HBV infection in the children of Taiwan, and, subsequently, adults as well.	Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Taipei 10018, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, MH (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 7 Chung Shan S Rd, Taipei 100, Taiwan.	mhchang@ha.mc.ntu.edu.tw		CHEN, DING-SHINN/0000-0001-7791-6154; CHIU, TAI-YUAN/0000-0002-8528-7981; HUANG, LI-MIN/0000-0002-9291-260X; Hsu, Hong-Yuan/0000-0002-5720-4835; TSAI, KEH-SUNG/0000-0001-8528-1566; Ni, Yen-Hsuan/0000-0002-1158-5249; Chang, Mei Hwei/0000-0002-3648-9261				BEASLEY RP, 1982, HEPATOLOGY, V2, pS21; BEASLEY RP, 1981, LANCET, V2, P1129; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chang MH, 2000, J GASTROEN HEPATOL, V15, pE16, DOI 10.1046/j.1440-1746.2000.02096.x; CHEN DS, 1977, NEW ENGL J MED, V297, P668; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; Hsu HM, 1999, J INFECT DIS, V179, P367, DOI 10.1086/314585; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; Hsu HY, 1999, HEPATOLOGY, V30, P1312, DOI 10.1002/hep.510300511; LEE PI, 1995, J PEDIATR-US, V126, P716, DOI 10.1016/S0022-3476(95)70398-5; Lin H H, 1994, Asia Oceania J Obstet Gynaecol, V20, P141; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; SUNG JL, 1984, CHINESE J GASTROENTE, V1, P1; Tang JR, 1998, J PEDIATR-US, V133, P374, DOI 10.1016/S0022-3476(98)70272-0; TSEN YJ, 1991, J MED VIROL, V34, P96, DOI 10.1002/jmv.1890340205	17	265	281	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2001	135	9					796	800		10.7326/0003-4819-135-9-200111060-00009	http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VT	11694104	Green Published			2022-12-01	WOS:000172013700004
J	Warren, MS; Hill, JK; Thomas, JA; Asher, J; Fox, R; Huntley, B; Roy, DB; Telfer, MG; Jeffcoate, S; Harding, P; Jeffcoate, G; Willis, SG; Greatorex-Davies, JN; Moss, D; Thomas, CD				Warren, MS; Hill, JK; Thomas, JA; Asher, J; Fox, R; Huntley, B; Roy, DB; Telfer, MG; Jeffcoate, S; Harding, P; Jeffcoate, G; Willis, SG; Greatorex-Davies, JN; Moss, D; Thomas, CD			Rapid responses of British butterflies to opposing forces of climate and habitat change	NATURE			English	Article							AVAILABILITY; DIVERSITY; ABUNDANCE; RANGES	Habitat degradation and climate change are thought to be altering the distributions and abundances of animals and plants throughout the world, but their combined impacts have not been assessed for any species assemblage(1-4). Here we evaluated changes in the distribution sizes and abundances of 46 species of butterflies that approach their northern climatic range margins in Britain-where changes in climate and habitat are opposing forces. These insects might be expected to have responded positively to climate warming over the past 30 years, yet three-quarters of them declined: negative responses to habitat loss have outweighed positive responses to climate warming. Half of the species that were mobile and habitat generalists increased their distribution sites over this period (consistent with a climate explanation), whereas the other generalists and 89% of the habitat specialists declined in distribution size (consistent with habitat limitation). Changes in population abundances closely matched changes in distributions. The dual forces of habitat modification and climate change are likely to cause specialists to decline, leaving biological communities with reduced numbers of species and dominated by mobile and widespread habitat generalists.	Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England; Ctr Ecol & Hydrol, Huntingdon PE28 2LS, Cambs, England; Winfrith Technol Ctr, Dorset Lab, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, England; Univ Durham, Dept Biol Sci, Environm Res Ctr, Durham DH1 3LE, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Butterfly Conservat, Wareham BH20 5QP, Dorset, England	University of Leeds; UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); Durham University; University of York - UK	Thomas, CD (corresponding author), Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England.	c.d.thomas@leeds.ac.uk	Thomas, Chris D/A-1460-2014; Thomas, Chris D/A-1894-2012; Fox, Richard/G-3873-2011; Hill, Jane K./AAJ-3374-2021; Roy, David/A-6619-2009; Willis, Stephen G/F-8503-2015; Hill, Jane K/G-5151-2011	Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; Hill, Jane K./0000-0003-1871-7715; Roy, David/0000-0002-5147-0331; Willis, Stephen G/0000-0002-8656-5808; Fox, Richard/0000-0001-6992-3522				Asher J., 2001, MILLENNIUM ATLAS BUT; Coope G. R., 1995, P29; Cowley MJR, 1999, P ROY SOC B-BIOL SCI, V266, P1587, DOI 10.1098/rspb.1999.0819; Cowley MJR, 2001, J ANIM ECOL, V70, P410, DOI 10.1046/j.1365-2656.2001.00508.x; Dennis RLH, 1997, BIOL J LINN SOC, V60, P257, DOI 10.1006/bijl.1996.0099; Groombridge B, 1992, GLOBAL BIODIVERSITY; Heath J., 1984, ATLAS BUTTERFLIES BR; Hill Jane K., 2001, Symposia of the Royal Entomological Society of London, V20, P415, DOI 10.1079/9780851994567.0415; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; Hill JK, 1999, P ROY SOC B-BIOL SCI, V266, P1197, DOI 10.1098/rspb.1999.0763; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huntley B, 1995, J BIOGEOGR, V22, P967, DOI 10.2307/2845830; JONES PD, 1997, CLIMATES BRIT ISLES, P173; Leemans R., 1991, RR9118 IIASA; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; MOSS D, 1993, ECOL ENTOMOL, V18, P77, DOI 10.1111/j.1365-2311.1993.tb01083.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pollard E, 1993, MONITORING BUTTERFLI; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Roy DB, 2001, J ANIM ECOL, V70, P201, DOI 10.1046/j.1365-2656.2001.00480.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; THOMAS JA, 1994, ECOGRAPHY, V17, P215, DOI 10.1111/j.1600-0587.1994.tb00096.x; THOMAS JA, 1993, ECOGRAPHY, V16, P278, DOI 10.1111/j.1600-0587.1993.tb00217.x; Thomas JA, 1999, FUNCT ECOL, V13, P55, DOI 10.1046/j.1365-2435.1999.00008.x; Tolman T, 1997, BUTTERFLIES BRITAIN; Van Swaay C.A.M., 1999, NATURE ENV SERIES, V99	29	924	979	12	589	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					65	69		10.1038/35102054	http://dx.doi.org/10.1038/35102054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689943	Green Accepted			2022-12-01	WOS:000171898900042
J	Lau, NC; Lim, LP; Weinstein, EG; Bartel, DP				Lau, NC; Lim, LP; Weinstein, EG; Bartel, DP			An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans	SCIENCE			English	Article							C-ELEGANS; MESSENGER-RNA; GENE; INTERFERENCE; IDENTIFICATION; EXPRESSION; SEQUENCE	Two small temporal RNAs (stRNAs), lin-4 and let-7, control developmental timing in Caenorhabditis elegans. We find that these two regulatory RNAs are members of a large class of 21- to 24-nucleotide noncoding RNAs, called microRNAs (miRNAs). We report on 55 previously unknown miRNAs in C. elegans. The miRNAs have diverse expression patterns during development: a let-7 paralog is temporally coexpressed with let-7; miRNAs encoded in a single genomic cluster are coexpressed during embryogenesis; and still other miRNAs are expressed constitutively throughout development. Potential orthologs of several of these miRNA genes were identified in Drosophila and human genomes. The abundance of these tiny RNAs, their expression patterns, and their evolutionary conservation imply that, as a class, miRNAs have broad regulatory functions in animals.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartet@wi.mit.edu		Lau, Nelson/0000-0001-9907-1404				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Malinsky S, 2000, GENETICS, V156, P1147; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	29	2485	2852	5	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					858	862		10.1126/science.1065062	http://dx.doi.org/10.1126/science.1065062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679671				2022-12-01	WOS:000171851800048
J	Fellay, J; Boubaker, K; Ledergerber, B; Bernasconi, E; Furrer, H; Battegay, M; Hirschel, B; Vernazza, P; Francioli, P; Greub, G; Flepp, M; Telenti, A				Fellay, J; Boubaker, K; Ledergerber, B; Bernasconi, E; Furrer, H; Battegay, M; Hirschel, B; Vernazza, P; Francioli, P; Greub, G; Flepp, M; Telenti, A		Swiss HIV Cohort Study	Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study	LANCET			English	Article							PROTEASE INHIBITORS; THERAPY; LIPODYSTROPHY	Background Data on adverse events to antiretroviral treatment have been recorded in clinical trials, postmarketing analyses, and anecdotal reports. Such data might not be an up-to-date or comprehensive assessment of all possible treatment combinations defined as potent antiretroviral treatment. Methods Using a standard clinical and laboratory method, we assessed prevalence of adverse events in 1160 patients who were receiving antiretroviral treatment. We measured the toxic effects associated with the drug regimen (protease inhibitor [PI], non-nucleoside and nucleoside analogue reverse transcriptase inhibitor) and specific compounds using multivariate analyses. Findings 47% (545 of 1160) of patients presented with clinical and 27% (194 of 712) with laboratory adverse events probably or definitely attributed to antiretroviral treatment. Among these, 9% (47 of 545) and 16% (30 of 194), respectively, were graded as serious or severe. Single-PI and PI-sparing-antiretroviral treatment were associated with a comparable prevalence of adverse events. Compared with single-PI treatment, use of dual-PI-antiretroviral treatment and three-class-antiretroviral treatment was associated with higher prevalence of adverse events (odds ratio [OR] 2.0 [95% CI 1.0-4.0], and 3.9 [1.2-12.9], respectively). Compound specific associations were identified for zidovudine, lamivudine, stavudine, didanosine, abacavir, ritonavir, saquinavir, indinavir, nelfinavir, efavirenz, and nevirapine. Interpretation We recorded a high prevalence of toxic effects attributed to antiretroviral treatment for HIV-1. Such data provides a reference for regimen-specific and compound-specific adverse events and could be useful in postmarketing analyses of toxic effects.	Univ Lausanne Hosp, Lausanne, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Hosp Bern, CH-3010 Bern, Switzerland; Univ Basel Hosp, CH-4031 Basel, Switzerland; Univ Hosp Geneva, Geneva, Switzerland; Hosp Lugano, Lugano, Switzerland; Hosp St Gallen, St Gallen, Switzerland; Swiss HIV Cohort Study Data Ctr, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; University of Basel; University of Geneva; Kantonsspital St. Gallen	Telenti, A (corresponding author), Univ Lausanne, CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland.	amalio.telenti@chuv.hospvd.ch	Fellay, Jacques/A-6681-2009; Telenti, Amalio/AAY-1674-2021; Greub, Gilbert GG/K-5804-2017; Ledergerber, Bruno/B-5656-2009; Furrer, Hansjakob/G-6768-2013; VALLET, Yannick/F-9979-2011	Fellay, Jacques/0000-0002-8240-939X; Greub, Gilbert GG/0000-0001-9529-3317; Ledergerber, Bruno/0000-0002-6881-4401; Furrer, Hansjakob/0000-0002-1375-3146; 				BERGMANN JF, 1993, BRIT MED J, V307, P1397, DOI 10.1136/bmj.307.6916.1397; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; BOUBAKER K, IN PRESS CLIN INFECT; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Clarke S, 2000, INT J STD AIDS, V11, P336, DOI 10.1258/0956462001915831; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Hansel A, 2001, J ACQ IMMUN DEF SYND, V26, P191, DOI 10.1097/00126334-200102010-00016; Henry K, 2000, ANN INTERN MED, V132, P306, DOI 10.7326/0003-4819-132-4-200002150-00009; Hurst M, 1999, DRUGS, V58, P919, DOI 10.2165/00003495-199958050-00012; LAMBERT JS, 1990, NEW ENGL J MED, V322, P1333, DOI 10.1056/NEJM199005103221901; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; MCLEOD GX, 1992, ANN INTERN MED, V117, P487, DOI 10.7326/0003-4819-117-6-487; PIKE IM, 1993, CLIN INFECT DIS, V16, pS63, DOI 10.1093/clinids/16.Supplement_1.S63; Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009; Struble Kimberly A., 1997, American Journal of Medicine, V102, P65, DOI 10.1016/S0002-9343(97)00065-X; SUDRE P, 2001, SCHWEIZ MED WOCHENSC, V130, P500	17	240	251	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1322	1327		10.1016/S0140-6736(01)06413-3	http://dx.doi.org/10.1016/S0140-6736(01)06413-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684213				2022-12-01	WOS:000171702500012
J	Woloshin, S; Schwartz, LM; Tremmel, J; Welch, HG				Woloshin, S; Schwartz, LM; Tremmel, J; Welch, HG			Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?	LANCET			English	Article							JOURNALS; BENEFITS	Background Pharmaceutical companies spent US$1.8 billion on direct-to-consumer advertisements for prescription drugs in 1999. Our aim was to establish what messages are being communicated to the public by these advertisements. Methods We investigated the content of advertisements, which appeared in ten magazines in the USA. We examined seven issues of each of these published between July, 1998, and July, 1999. Findings 67 advertisements appeared a total of 211 times during our study. Of these, 133 (63%) were for drugs to ameliorate symptoms, 54 (26%) to treat disease, and 23 (11%) to prevent illness. In the 67 unique advertisements, promotional techniques used included emotional appeals (45, 67%) and encouragement of consumers to consider medical causes for their experiences (26, 39%). More advertisements described the benefit of medication with vague, qualitative terms (58, 87%), than with data (9, 13%). However, half the advertisements used data to describe side-effects, typically with lists of side-effects that generally occurred infrequently. None mentioned cost. Interpretation Provision of complete information about the benefit of prescription drugs in advertisements would serve the interests of physicians and the public.	Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Norris Cotton Canc Ctr, Lebanon, NH USA; Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA	VA Outcomes Group; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Schwartz, LM (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA.				NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER; NCI NIH HHS [CA9 1052-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM PHARM ASS, 1997, AM PHARM ASS PREV MA; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; Bell RA, 1999, J FAM PRACTICE, V48, P446; Bell RA, 2000, J FAM PRACTICE, V49, P1092; Charatan F, 2000, BRIT MED J, V321, P783, DOI 10.1136/bmj.321.7264.783; COHEN EP, 1988, NEW ENGL J MED, V318, P373, DOI 10.1056/NEJM198802113180608; Ferriman, 1999, BMJ, V319, P1208; *FOOD DRUGS ADM, 1985, FED REGISTER, V50, P36677; HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403; HERXHEIMER A, 1993, INT J HEALTH SERV, V23, P161, DOI 10.2190/1AK2-X8CX-QQ9E-F6ED; Hoffman JR, 1999, BRIT MED J, V318, P1301, DOI 10.1136/bmj.318.7194.1301; Hollon MF, 1999, JAMA-J AM MED ASSOC, V281, P382, DOI 10.1001/jama.281.4.382; HOMER A, 1999, JAMA-J AM MED ASSOC, V281, P380; Hueston WJ, 1997, ACAD MED, V72, P804, DOI 10.1097/00001888-199709000-00018; HUX JE, 1995, MED DECIS MAKING, V15, P152, DOI 10.1177/0272989X9501500208; Jones M, 1999, J CLIN PHARM THER, V24, P451, DOI 10.1046/j.1365-2710.1999.00255.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEXCHIN J, 1994, CAN MED ASSOC J, V151, P47; Lipsky MS, 1997, J FAM PRACTICE, V45, P495; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; *OFF MED POL, 2000, ATT BEH ASS DIR CONS; Pines WL, 1999, FOOD DRUG LAW J, V54, P489; Stryer D, 1996, J GEN INTERN MED, V11, P575, DOI 10.1007/BF02599024; TIMMINS N, FINANCIAL TIMES 0720, P200; *US C, 1984, STAFF REP PRESCR DRU; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; 1998, LANCET, V351, P921; 2001, NUTR FACTS BOX; 2001, DIRECT CONSUMER ADVE; 1998, MEDIAMARK RES MAGAZI; 1996, CONSUMER REPORTS, V61, P62	31	131	132	1	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1141	1146		10.1016/S0140-6736(01)06254-7	http://dx.doi.org/10.1016/S0140-6736(01)06254-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597668				2022-12-01	WOS:000171399000011
J	Wong, TY; Klein, R; Couper, DJ; Cooper, LS; Shahar, E; Hubbard, LD; Wofford, MR; Sharrett, AR				Wong, TY; Klein, R; Couper, DJ; Cooper, LS; Shahar, E; Hubbard, LD; Wofford, MR; Sharrett, AR			Retinal microvascular abnormalities and incident stroke: the atherosclerosis risk in communities study	LANCET			English	Article							JAPANESE PROVINCIAL CITY; BLOOD-PRESSURE; FOLLOW-UP; HYPERTENSION; RETINOPATHY; POPULATION; DISEASE; SHIBATA; COHORT	Background Retinal microvascular abnormalities reflect damage from hypertension and other vascular processes. We examined the relation of such abnormalities to incident stroke. Methods A cohort of 10 358 men and women (aged 51 to 72 years) living in four US communities underwent retinal photography and standard grading for retinal microvascular abnormalities. The calibres of all retinal arterioles and venules were measured after digital conversion of the photographs, and a summary arteriole-to-venule ratio (AVR) was calculated as an index of arteriolar narrowing (smaller AVR indicates greater narrowing). Cases of incident stroke admitted to hospital were identified and validated by case record reviews. Findings Over an average of 3.5 years, 110 participants had incident strokes. After adjustment for age, sex, race, 6-year mean arterial blood pressure, diabetes, and other stroke risk factors, most retinal microvascular characteristics were predictive of incident stroke, with adjusted relative risks of 2.58 (1.59-4.20) for any retinopathy, 3.11 (1.71-5.65) for microaneurysms, 3.08 (1.42-6.68) for soft exudates, 2.55 (1.27-5.14) for blot haemorrhages, 2.26 (1.00-5.12) for flame-shaped haemorrhages, and 1.60 (1.03-2.47) for arteriovenous nicking. The relative risk of stroke increased with decreasing AVR (p = 0.03). The associations were similar for ischaemic strokes specifically, and for strokes in individuals with hypertension, either with or without diabetes. Interpretation Retinal microvascular abnormalities are related to incident stroke. The findings support a microvascular role in the pathogenesis of stroke. They suggest that retinal photography may be useful for cerebrovascular-risk stratification in appropriate populations.	Univ Wisconsin, Dept Ophthalmol, Madison, WI 53705 USA; Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore 117548, Singapore; Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; NHLBI, Bethesda, MD 20892 USA; Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA; Univ Mississippi, Med Ctr, Div Hypertens, Jackson, MS 39216 USA	University of Wisconsin System; University of Wisconsin Madison; National University of Singapore; Singapore National Eye Center; National University of Singapore; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center	Wong, TY (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, 610 N Walnut St,460 WARF, Madison, WI 53705 USA.	wong@epi.ophth.wisc.edu	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Couper, David/0000-0002-4313-9235	NHLBI NIH HHS [N01-HC-55016, N01-HC-55015, N01-HC-35126, N01-HC-35125, N01-HC-55018, N01-HC-55020, N01-HC-55022, N01-HC-55021] Funding Source: Medline; PHS HHS [N01-C-55019] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055021, N01HC035126, N01HC055018, N01HC055022, N01HC055015, N01HC035125, N01HC055020] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AOKI N, 1975, JPN CIRC J, V39, P271, DOI 10.1253/jcj.39.271; DIMMITT SB, 1989, LANCET, V1, P1103; FUCHS FD, 1995, J HUM HYPERTENS, V9, P547; GARNER A, 1975, BRIT J OPHTHALMOL, V59, P3, DOI 10.1136/bjo.59.1.3; GOTO I, 1975, STROKE, V6, P263, DOI 10.1161/01.STR.6.3.263; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; *JOINT NAT COMM PR, 1997, NIH PUBL; KAGAN A, 1966, B WORLD HEALTH ORGAN, V34, P955; Kahn HA., 1989, STAT METHODS EPIDEMI; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P92, DOI 10.1001/archopht.1994.01090130102026; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; KORBER N, 1986, J NEUROL, V233, P30, DOI 10.1007/BF00313988; Lammie GA, 1997, STROKE, V28, P2222, DOI 10.1161/01.STR.28.11.2222; Leppala JM, 1999, STROKE, V30, P2535, DOI 10.1161/01.STR.30.12.2535; Nakayama T, 1997, STROKE, V28, P45, DOI 10.1161/01.STR.28.1.45; OKADA H, 1976, STROKE, V7, P599, DOI 10.1161/01.STR.7.6.599; PARR JC, 1974, AM J OPHTHALMOL, V77, P472, DOI 10.1016/0002-9394(74)90457-7; PARR JC, 1974, AM J OPHTHALMOL, V77, P478, DOI 10.1016/0002-9394(74)90458-9; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; SCHNEIDER R, 1993, STROKE, V24, P1874, DOI 10.1161/01.STR.24.12.1874; Shahar E, 1996, ANN EPIDEMIOL, V6, P498, DOI 10.1016/S1047-2797(96)00104-4; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; SVARDSUDD K, 1978, ACTA MED SCAND, V204, P159; TANAKA H, 1985, STROKE, V16, P773, DOI 10.1161/01.STR.16.5.773; TSO MOM, 1982, OPHTHALMOLOGY, V89, P1132; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X	28	618	644	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1134	1140		10.1016/S0140-6736(01)06253-5	http://dx.doi.org/10.1016/S0140-6736(01)06253-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597667				2022-12-01	WOS:000171399000010
J	Bird, A				Bird, A			Molecular biology - Methylation talk between histones and DNA	SCIENCE			English	Editorial Material							NEUROSPORA-CRASSA; DEACETYLASE; REPRESSION; CHROMATIN; MECP2		Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.			Bird, Adrian/0000-0002-8600-0372				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Irelan JT, 1997, GENETICS, V146, P509; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SELKER EU, 1987, SCIENCE, V238, P48, DOI 10.1126/science.2958937; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508	12	130	159	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2113	2115		10.1126/science.1066726	http://dx.doi.org/10.1126/science.1066726			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739943				2022-12-01	WOS:000172647700035
J	Fenton, KA; Korovessis, C; Johnson, AM; McCadden, A; McManus, S; Wellings, K; Mercer, CH; Carder, C; Copas, AJ; Nanchahal, K; Macdowall, W; Ridgway, G; Field, J; Erens, B				Fenton, KA; Korovessis, C; Johnson, AM; McCadden, A; McManus, S; Wellings, K; Mercer, CH; Carder, C; Copas, AJ; Nanchahal, K; Macdowall, W; Ridgway, G; Field, J; Erens, B			Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection	LANCET			English	Article								Background Studies of the epidemiology of sexually transmitted infections (STI) are largely based on surveillance data. As part of a national survey of sexual attitudes and lifestyles (Natsal 2000) in Britain, we estimated the frequency of self-reported STIs, and the prevalence of urinary Chlamydia trachomatis infection. Methods We did a stratified probability sample survey of 11 161 men and women aged 16-44 years in Britain. Computer assisted self-interviews contained items on the nature and timing of previously diagnosed STIs. Half of all sexually experienced respondents aged 18-44 years were invited to provide a urine sample for ligase chain reaction testing for C trachomatis infection. Findings 10.8% of men and 12.6% of women reported ever having an STI, 3.6% of men and 4.1% of women reported ever being diagnosed with genital warts, and 1.4% of men and 3.1% of women reported previous infection with C trachomatis. 76% of men and 57% of women ever diagnosed with an STI had been to a GUM clinic. C trachomatis was found in 2.2% (95% CI 1.5-3.2) of men and 1.5% (95% CI 1.11-2.14) of women with age-specific prevalence being highest among men aged 25-34 (3.1%) and women aged 16-24 years (3.0%). Non-married status, age, and reporting partner concurrency or two or more sexual partners in the past year were independently associated with infection with C trachomatis. Interpretation We show substantial heterogeneity in distribution of reported STIs, and the demographic and behavioural determinants of prevalent genital chlamydial infection. The results have potentially wide application for proposed chlamydia screening programmes which, given the demonstrated prevalence, must now proactively seek to involve men.	Royal Free & UCL, Ctr Infect Dis Epidemiol, Dept Primary Care, London, England; Royal Free & UCL, Ctr Infect Dis Epidemiol, Dept Populat Sci, London, England; Royal Free & UCL, Dept Sexually Transmitted Dis, London, England; PHLS Communicable Dis Surveillance Ctr, HIV STI Div, London, England; Natl Ctr Social Res, London, England; UCL Hosp NHS Trust, Dept Microbiol, London, England; London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Ctr Sexual Hlth Res, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Fenton, KA (corresponding author), Royal Free & UCL, Ctr Infect Dis Epidemiol, Dept Primary Care, London, England.	kfenton@gum.ucl.ac.uk	McManus, Sally/S-4697-2019	McManus, Sally/0000-0003-2711-0819; Erens, Robert/0000-0002-3054-504X; Nanchahal, Kiran/0000-0001-8812-7628; Mercer, Catherine/0000-0002-4220-5034; Copas, Andrew/0000-0001-8968-5963; Macdowall, Wendy/0000-0001-5868-8336; Erens, Bob/0000-0002-4430-954X; Johnson, Anne/0000-0003-1330-7100				BRUNHAM RC, 1990, MED CLIN N AM, V74, P1339, DOI 10.1016/S0025-7125(16)30484-9; Carder C, 1999, INT J STD AIDS, V10, P776, DOI 10.1258/0956462991913538; *CHIEF MED OFF MED, 1998, MAIN REP CMOS EXP AD; Department of Health, 2001, NAT STRAT SEX HLTH H, P1; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0	5	311	311	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1851	1854		10.1016/S0140-6736(01)06886-6	http://dx.doi.org/10.1016/S0140-6736(01)06886-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741624				2022-12-01	WOS:000172463000010
J	Rausch, C; Daram, P; Brunner, S; Jansa, J; Laloi, M; Leggewie, G; Amrhein, N; Bucher, M				Rausch, C; Daram, P; Brunner, S; Jansa, J; Laloi, M; Leggewie, G; Amrhein, N; Bucher, M			A phosphate transporter expressed in arbuscule-containing cells in potato	NATURE			English	Article							MYCORRHIZAL FUNGUS; GENE; IDENTIFICATION; ARABIDOPSIS; DIVERSITY; VECTORS; CLONING; PLANTS	Arbuscular mycorrhizas are the most common non-pathogenic symbioses in the roots of plants. It is generally assumed that this symbiosis facilitated the colonization of land by plants(1). In arbuscular mycorrhizas, fungal hyphae often extend between the root cells and tuft-like branched structures (arbuscules) form within the cell lumina that act as the functional interface for nutrient exchange. In the mutualistic arbuscular-mycorrhizal symbiosis the host plant derives mainly phosphorus from the fungus, which in turn benefits from plant-based glucose(2). The molecular basis of the establishment and functioning of the arbuscular-mycorrhizal symbiosis is largely not understood. Here we identify the phosphate transporter gene StPT3 in potato (Solanum tuberosum). Functionality of the encoded protein was confirmed by yeast complementation. RNA localization and reporter gene expression indicated expression of StPT3 in root sectors where mycorrhizal structures are formed. A sequence motif in the StPT3 promoter is similar to transposon-like elements, suggesting that the mutualistic symbiosis evolved by genetic rearrangements in the StPT3 promoter.	ETH Zurich, Fed Inst Technol, Inst Plant Sci, Expt Stn Eschikon 33, CH-8315 Lindau, Switzerland; Max Planck Inst Plant Mol Physiol, D-14424 Potsdam, Germany; ETH Zurich, Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bucher, M (corresponding author), ETH Zurich, Fed Inst Technol, Inst Plant Sci, Expt Stn Eschikon 33, CH-8315 Lindau, Switzerland.		Bucher, Marcel/D-4596-2013; Jansa, Jan/H-3161-2014	Bucher, Marcel/0000-0003-1680-9413; Jansa, Jan/0000-0002-0331-1774				BARIOLA PA, 1994, PLANT J, V6, P673, DOI 10.1046/j.1365-313X.1994.6050673.x; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BRUNDRETT MC, 1984, CAN J BOT, V62, P2128, DOI 10.1139/b84-290; Bucher M, 2001, J PLANT NUTR SOIL SC, V164, P209, DOI 10.1002/1522-2624(200104)164:2<209::AID-JPLN209>3.0.CO;2-F; Chiou TJ, 2001, PLANT J, V25, P281, DOI 10.1046/j.1365-313x.2001.00963.x; Daram P, 1999, PLANT CELL, V11, P2153, DOI 10.1105/tpc.11.11.2153; Daram P, 1998, PLANTA, V206, P225, DOI 10.1007/s004250050394; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; DEPICKER A, 1982, Journal of Molecular and Applied Genetics, V1, P561; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Gianinazzi-Pearson V, 2000, PLANTA, V211, P609, DOI 10.1007/s004250000323; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; HARRISON MJ, 1995, NATURE, V378, P626, DOI 10.1038/378626a0; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; Hoagland DR, 1936, PLANT PHYSIOL, V11, P471, DOI 10.1104/pp.11.3.471; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Leggewie G, 1997, PLANT CELL, V9, P381, DOI 10.1105/tpc.9.3.381; Liu H, 1998, MOL PLANT MICROBE IN, V11, P14, DOI 10.1094/MPMI.1998.11.1.14; LOCKETT TJ, 1990, ANAL BIOCHEM, V185, P230, DOI 10.1016/0003-2697(90)90284-G; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; MERRYWEATHER JW, 1991, MYCOL RES, V95, P1435, DOI 10.1016/S0953-7562(09)80399-7; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; ROCHASOSA M, 1989, EMBO J, V8, P23, DOI 10.1002/j.1460-2075.1989.tb03344.x; Rosewarne GM, 1999, NEW PHYTOL, V144, P507, DOI 10.1046/j.1469-8137.1999.00536.x; Selinger DA, 1999, P NATL ACAD SCI USA, V96, P15007, DOI 10.1073/pnas.96.26.15007; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; VARMA A, 1999, ENDOMYCORRHIZA, P521; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X	30	304	348	3	106	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					462	466		10.1038/35106601	http://dx.doi.org/10.1038/35106601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719809				2022-12-01	WOS:000172304500047
J	Reusch, TBH; Haberli, MA; Aeschlimann, PB; Milinski, M				Reusch, TBH; Haberli, MA; Aeschlimann, PB; Milinski, M			Female sticklebacks count alleles in a strategy of sexual selection explaining MHC polymorphism	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MATE CHOICE; MATING PREFERENCES; GENES; MOLECULES; EVOLUTION; ODOR; MICE	The origin and maintenance of polymorphism in major histocompatibility complex (MHC) genes in natural populations is still unresolved(1). Sexual selection, frequency-dependent selection by parasites and pathogens, and heterozygote advantage have been suggested to explain the maintenance of high allele diversity at MHC genes(2-4). Here we argue that there are two (non-exclusive) strategies for MHC-related sexual selection, representing solutions to two different problems: inbreeding avoidance and parasite resistance. In species prone to inadvertent inbreeding, partners should prefer dissimilar MHC genotypes to similar ones. But if the goal is to maximize the resistance of offspring towards potential infections, the choosing sex should prefer mates with a higher diversity of MHC alleles. This latter strategy should apply when there are several MHC loci, as is the case in most vertebrates(2,5). We tested the relative importance of an 'allele counting' strategy compared to a disassortative mating strategy using wild-caught three-spined sticklebacks (Gasterosteus aculeatus) from an interconnected system of lakes. Here we show that gravid female fish preferred the odour of males with a large number of MHC class-IIB alleles to that of males with fewer alleles. Females did not prefer male genotypes dissimilar to their own.	Max Planck Inst Limnol, Dept Evolutionary Ecol, D-24306 Plon, Germany	Max Planck Society	Reusch, TBH (corresponding author), Max Planck Inst Limnol, Dept Evolutionary Ecol, Postfach 165, D-24306 Plon, Germany.	reusch@mpil-ploen.mpg.de	Reusch, Thorsten B. H./B-9311-2019; Reusch, Thorsten B.H./G-4141-2011	Reusch, Thorsten B. H./0000-0002-8961-4337				Andersson Malte, 1994; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Binz T, 2001, J FISH BIOL, V58, P887, DOI 10.1006/jfbi.2000.1485; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; BROWN RE, 1989, BEHAV GENET, V19, P658, DOI 10.1007/BF01066029; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Darwin Charles, 1859, ORIGIN SPECIES MEANS, P88; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Kasahara M, 1999, IMMUNOL REV, V167, P17, DOI 10.1111/j.1600-065X.1999.tb01379.x; KLEIN J, 1986, NATURAL HIST MAJOR H, P615; Landry C, 2001, P ROY SOC B-BIOL SCI, V268, P1279, DOI 10.1098/rspb.2001.1659; Largiader CR, 1999, MOL ECOL, V8, P342; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; POTTS WK, 1995, IMMUNOL REV, V143, P181, DOI 10.1111/j.1600-065X.1995.tb00675.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Sato A, 1998, MOL MAR BIOL BIOTECH, V7, P221; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; Steck N, 1999, BEHAV ECOL, V10, P493, DOI 10.1093/beheco/10.5.493; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; WOOTTEN RJ, 1976, BIOL STICKLEBACK, P75; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818	28	362	371	0	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2001	414	6861					300	302		10.1038/35104547	http://dx.doi.org/10.1038/35104547			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713527				2022-12-01	WOS:000172150700041
J	Farmer, JA				Farmer, JA			Learning from the cerivastatin experience	LANCET			English	Editorial Material							SIMVASTATIN; LOVASTATIN; PRAVASTATIN; ACID		Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Farmer, JA (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	jfarmer@bcm.tmc.edu						Backman JT, 2000, CLIN PHARMACOL THER, V68, P122, DOI 10.1067/mcp.2000.108507; Davidson M H, 2000, Curr Atheroscler Rep, V2, P14, DOI 10.1007/s11883-000-0090-4; Downs JR, 2001, AM J CARDIOL, V87, P1074, DOI 10.1016/S0002-9149(01)01464-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Flint OP, 1997, TOXICOL APPL PHARM, V145, P99, DOI 10.1006/taap.1997.8174; GADBUT AP, 1995, J MOL CELL CARDIOL, V27, P2397, DOI 10.1016/S0022-2828(95)92163-X; Graham DJ, 2001, JAMA-J AM MED ASSOC, V286, P831, DOI 10.1001/jama.286.7.831; Gruer PJK, 1999, AM J CARDIOL, V84, P811, DOI 10.1016/S0002-9149(99)00442-7; Lofberg M, 1998, ACTA NEUROL SCAND, V98, P268, DOI 10.1111/j.1600-0404.1998.tb07307.x; Miller DB, 1998, CLIN PHARMACOKINET, V34, P155, DOI 10.2165/00003088-199834020-00003; PEDERSEN TR, 1994, LANCET, V344, P1383; Pfeffer MA, 2001, EUR HEART J, V22, P271; Stein E, 1998, AM J CARDIOL, V82, p40J, DOI 10.1016/S0002-9149(98)00436-6; WATTS GF, 1993, J CLIN PATHOL, V46, P1055, DOI 10.1136/jcp.46.11.1055	14	88	92	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2001	358	9291					1383	1385		10.1016/S0140-6736(01)06489-3	http://dx.doi.org/10.1016/S0140-6736(01)06489-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705478				2022-12-01	WOS:000171940100003
J	Wolpert, HA; Anderson, BJ				Wolpert, HA; Anderson, BJ			Management of diabetes: are doctors framing the benefits from the wrong perspective?	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Joslin Diabet Ctr, Sect Adult Diabet, Boston, MA 02215 USA; Joslin Diabet Ctr, Behav & Mental Hlth Res Unit, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Joslin Diabetes Center, Inc.	Wolpert, HA (corresponding author), Joslin Diabet Ctr, Sect Adult Diabet, 1 Joslin Pl, Boston, MA 02215 USA.	howard.wolpert@joslin.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046887] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK046887, DK-46887] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS33; *AM DIAB ASS, 1999, AM DIAB ASS COMPL GU; ANDERSON BJ, 1995, DIABETES SPECTRUM, V8, P69; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; Bott S, 1997, DIABETOLOGIA, V40, P926, DOI 10.1007/s001250050769; CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204; COYNE JC, 1988, MARSHALLING SOCIAL S, P309; *DAFNE STUD GROUP, 2001, DIABETIC MED S2, V18, P325; *DIAB UK, 2000, REC MAN DIAB PRIM CA; GALAZKA SS, 1984, FAMILY SYSTEMS MED, V2, P28; Gray A, 2000, BMJ-BRIT MED J, V320, P1373, DOI 10.1136/bmj.320.7246.1373; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Howorka K, 2000, J PSYCHOSOM RES, V48, P37, DOI 10.1016/S0022-3999(99)00074-4; Miller WR., 2012, MOTIVATIONAL INTERVI; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; ROLLNICK S, 1993, BRIT MED J, V307, P188, DOI 10.1136/bmj.307.6897.188; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; Wolpert HA, 2001, DIABETES CARE, V24, P1301, DOI 10.2337/diacare.24.7.1301-a	23	76	76	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2001	323	7319					994	996		10.1136/bmj.323.7319.994	http://dx.doi.org/10.1136/bmj.323.7319.994			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679393	Green Published			2022-12-01	WOS:000171918500027
J	Luna, B; Feinglos, MN				Luna, B; Feinglos, MN			Drug-induced hyperglycemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ONSET DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; BETA-BLOCKING-AGENTS; INSULIN SENSITIVITY; PROTEASE INHIBITORS; THIAZIDE DIURETICS; INDUCED DISORDERS; CLOZAPINE; KETOACIDOSIS; HYPERTENSION		Duke Univ, Med Ctr, Div Metab Endocrinol & Nutr, Dept Internal Med, Durham, NC 27710 USA; Campbell Univ, Sch Pharm, Dept Internal Med, Buies Creek, NC 27506 USA; Duke Univ Hlth Syst, Durham, NC USA	Duke University; Campbell University; Duke University	Feinglos, MN (corresponding author), Duke Univ, Med Ctr, Div Metab Endocrinol & Nutr, Dept Internal Med, Box 3921, Durham, NC 27710 USA.	feing002@mc.duke.edu						*AM DIAB ASS, 2001, DIABETES CARE, V24, pS 21; BAGDADE JD, 1978, DIABETES, V27, P677, DOI 10.2337/diabetes.27.6.677; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Bettinger TL, 2000, ANN PHARMACOTHER, V34, P865, DOI 10.1345/aph.19327; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; Chan JCN, 1996, DRUG SAFETY, V15, P135, DOI 10.2165/00002018-199615020-00005; COARKIN PE, 2000, PSYCHOSOMATICS, V41, P369; Conley RR, 2000, J CLIN PSYCHIAT, V61, P26; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Curran P, 2000, SIGHT SOUND, V10, P62; Fertig MK, 1998, J CLIN PSYCHIAT, V59, P687, DOI 10.4088/JCP.v59n1208c; Gatta B, 1999, DIABETES CARE, V22, P1002, DOI 10.2337/diacare.22.6.1002; Giugliano D, 1997, ANN INTERN MED, V126, P955, DOI 10.7326/0003-4819-126-12-199706150-00004; GOLDSTEIN L, 2000, PRIMARY PSYCHIAT, V7, P65; Goldstein LE, 1999, PSYCHOSOMATICS, V40, P438, DOI 10.1016/S0033-3182(99)71210-7; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; GRINSPOON SK, 1992, NEW ENGL J MED, V327, P1360, DOI 10.1056/NEJM199211053271906; GURWITZ JH, 1993, ANN INTERN MED, V118, P273, DOI 10.7326/0003-4819-118-4-199302150-00005; Hadigan C, 2000, JAMA-J AM MED ASSOC, V284, P472, DOI 10.1001/jama.284.4.472; Hagg S, 1998, J CLIN PSYCHIAT, V59, P294, DOI 10.4088/JCP.v59n0604; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; Henderson DC, 2000, AM J PSYCHIAT, V157, P975, DOI 10.1176/appi.ajp.157.6.975; Isakov I, 2000, PSYCHOSOMATICS, V41, P373, DOI 10.1176/appi.psy.41.4.373; Jacob S, 1996, J HYPERTENS, V14, P489; KAMRAN A, 1994, AM J PSYCHIAT, V151, P1395; Kilby JM, 1998, J ACQ IMMUN DEF SYND, V17, P46, DOI 10.1097/00042560-199801010-00007; Kingsbury SJ, 2001, J CLIN PSYCHIAT, V62, P347, DOI 10.4088/JCP.v62n0507; Kostakoglu AE, 1996, ACTA PSYCHIAT SCAND, V93, P217, DOI 10.1111/j.1600-0447.1996.tb10635.x; KOVAL MS, 1994, AM J PSYCHIAT, V151, P1520; Lindenmayer JP, 1999, AM J PSYCHIAT, V156, P1471; MCMURRY JF, 1984, SURG CLIN N AM, V64, P769; Mukherjee S, 1996, COMPR PSYCHIAT, V37, P68, DOI 10.1016/S0010-440X(96)90054-1; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Ober SK, 1999, AM J PSYCHIAT, V156, P970, DOI 10.1176/ajp.156.6.970; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; PETERS A, 1995, EXP CLIN ENDOCR DIAB, V103, P213, DOI 10.1055/s-0029-1211353; Peterson GA, 1996, AM J PSYCHIAT, V153, P737; Popli AP, 1997, J CLIN PSYCHIAT, V58, P108, DOI 10.4088/JCP.v58n0304; Procyshyn RM, 2000, CAN J PSYCHIAT, V45, P668; RAMIREZ EA, 1985, HYPERTENSION, V7, P1008; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; Rigalleau V, 2000, DIABETIC MED, V17, P484, DOI 10.1046/j.1464-5491.2000.00296.x; Saint-Marc T, 1999, AIDS, V13, P1000, DOI 10.1097/00002030-199905280-00023; SAMUELSSON O, 1994, J HUM HYPERTENS, V8, P257; Sobel M, 1999, J CLIN PSYCHIAT, V60, P556, DOI 10.4088/JCP.v60n0809f; Tsiodras S, 2000, ARCH INTERN MED, V160, P2050, DOI 10.1001/archinte.160.13.2050; US Department of Health and Human Services, 2001, GUID US ANT AG HIV I; Walli R, 2000, RES EXP MED, V199, P253, DOI 10.1007/s004330050123; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; White WB, 2000, AM J MED, V108, P238, DOI 10.1016/S0002-9343(99)00444-1; WICKLMAYR M, 1990, HORM METAB RES, V22, P29; WILSON PWF, 1991, AM HEART J, V121, P586, DOI 10.1016/0002-8703(91)90729-2; Wirshing DA, 1998, BIOL PSYCHIAT, V44, P778, DOI 10.1016/S0006-3223(98)00100-0; Yazici KM, 1998, EXP CLIN ENDOCR DIAB, V106, P475, DOI 10.1055/s-0029-1212019	55	109	112	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					1945	1948		10.1001/jama.286.16.1945	http://dx.doi.org/10.1001/jama.286.16.1945			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667913				2022-12-01	WOS:000171750500001
J	Lumaret, R; Ouazzani, N				Lumaret, R; Ouazzani, N			Plant genetics - Ancient wild olives in Mediterranean forests	NATURE			English	Article							OLEA-EUROPAEA L		CNRS, Ctr Ecol Fonct & Evolut, F-34293 Montpellier 5, France; Ecole Natl Agr, Meknes, Morocco	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Moulay Ismail University of Meknes	Lumaret, R (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, 1919 Route de Mende, F-34293 Montpellier 5, France.							LUMARET R, 1997, BOCCONEA, V7, P39; Ouazzani N, 1996, EUPHYTICA, V91, P9, DOI 10.1007/BF00035271; OUAZZANI N, 1993, J HERED, V84, P34, DOI 10.1093/oxfordjournals.jhered.a111274; OUAZZANI N, 1995, AGRONOMIE, V15, P31, DOI 10.1051/agro:19950104; Terral JF, 1999, PALAEOGEOGR PALAEOCL, V153, P71, DOI 10.1016/S0031-0182(99)00079-6; TRUJILLO T, 1995, J AM SOC HORTIC SCI, V120, P318; TURRILL WB, 1951, KEW B, V3, P439; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	8	76	77	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					700	700		10.1038/35099680	http://dx.doi.org/10.1038/35099680			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607022				2022-12-01	WOS:000171608000034
J	McDonald, LC; Rossiter, S; Mackinson, C; Wang, YY; Johnson, S; Sullivan, M; Sokolow, R; DeBess, E; Gilbert, L; Benson, JA; Hill, B; Angulo, FJ				McDonald, LC; Rossiter, S; Mackinson, C; Wang, YY; Johnson, S; Sullivan, M; Sokolow, R; DeBess, E; Gilbert, L; Benson, JA; Hill, B; Angulo, FJ			Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTROINTESTINAL-TRACT COLONIZATION; GLYCOPEPTIDE RESISTANCE; ANTIMICROBIAL RESISTANCE; HIGH PREVALENCE; FECAL CARRIAGE; UNITED-STATES; POULTRY MEAT; SATA GENE; VANCOMYCIN; ANIMALS	Background: The combination of the streptogramins quinupristin and dalfopristin was approved in the United States in late 1999 for the treatment of vancomycin-resistant Enterococcus faecium infections. Since 1974, another streptogramin, virginiamycin, has been used at subtherapeutic concentrations to promote the growth of farm animals, including chickens. Methods: To determine the frequency of quinupristin-dalfopristin-resistant E. faecium, we used selective medium to culture samples from chickens purchased in supermarkets in Georgia, Maryland, Minnesota, and Oregon and stool samples from outpatients. Results: Between July 1998 and June 1999, samples from 407 chickens from 26 stores in four states were cultured, as were 334 stool samples from outpatients. Quinupristin-dalfopristin-resistant E. faecium was isolated from 237 chicken carcasses and 3 stool specimens. The resistant isolates from stool had low-level resistance (minimal inhibitory concentration [MIC], 4 mug per milliliter; resistance was defined as a MIC of at least 4 mug per milliliter). The resistant isolates from chickens in general had higher levels of resistance (MICs ranging from 4 to 32 microg per milliliter; MIC required to inhibit 50 percent of isolates, 8 mug per milliliter). Conclusions: Quinupristin-dalfopristin - resistant E. faecium contaminates a large proportion of chickens sold in U.S. supermarkets. However, the low prevalence and low level of resistance of these strains in human stool specimens suggest that the use of virginiamycin in animals has not yet had a substantial influence. Foodborne dissemination of resistance may increase, however, as the clinical use of quinupristin-dalfopristin increases. (N Engl J Med 2001;345:1155-60.) Copyright (C) 2001 Massachusetts Medical Society.	CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Hosp Infect Program, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Univ Maryland, Baltimore, MD 21201 USA; Minnesota Dept Hlth, Minneapolis, MN USA; Oregon Hlth Div, Portland, OR USA; Georgia Div Publ Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland Baltimore; Minnesota Department of Health (MHD); Oregon Health & Science University	Angulo, FJ (corresponding author), CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A38, Atlanta, GA 30333 USA.	fangulo@cdc.gov						Aarestrup FM, 1995, MICROB DRUG RESIST, V1, P255, DOI 10.1089/mdr.1995.1.255; [Anonymous], 1997, M7A4 NCCLS; BATES J, 1994, J ANTIMICROB CHEMOTH, V34, P507, DOI 10.1093/jac/34.4.507; Bergeron M, 1997, J ANTIMICROB CHEMOTH, V39, P129, DOI 10.1093/jac/39.suppl_1.129; Borgen K, 2000, J APPL MICROBIOL, V89, P478, DOI 10.1046/j.1365-2672.2000.01137.x; *CDCP, 1999, MMWR-MORBID MORTAL W, V47, P1; *COMM DRUG US FOOD, 1999, US DRUG FOOD AN BEN; Dever LL, 1996, MICROB DRUG RESIST, V2, P415, DOI 10.1089/mdr.1996.2.415; Donskey CJ, 1999, J INFECT DIS, V180, P384, DOI 10.1086/314874; Eliopoulos GM, 1998, ANTIMICROB AGENTS CH, V42, P1088, DOI 10.1128/AAC.42.5.1088; Endtz HP, 1997, J CLIN MICROBIOL, V35, P3026, DOI 10.1128/JCM.35.12.3026-3031.1997; FORD M, 1994, J CLIN MICROBIOL, V32, P2999, DOI 10.1128/JCM.32.12.2999-3001.1994; GORDTS B, 1995, J CLIN MICROBIOL, V33, P2842, DOI 10.1128/JCM.33.11.2842-2846.1995; Hammerum AM, 1998, FEMS MICROBIOL LETT, V168, P145, DOI 10.1016/S0378-1097(98)00433-9; Jacobsen B. L., 1999, Microbial Ecology in Health and Disease, V11, P241, DOI 10.1080/08910609908540834; Jensen LB, 1998, ANTIMICROB AGENTS CH, V42, P3330, DOI 10.1128/AAC.42.12.3330; JONES RN, 1995, DIAGN MICR INFEC DIS, V21, P85, DOI 10.1016/0732-8893(94)00147-O; Jones RN, 1998, DIAGN MICR INFEC DIS, V31, P437, DOI 10.1016/S0732-8893(98)80002-3; JORDENS JZ, 1994, J ANTIMICROB CHEMOTH, V34, P515, DOI 10.1093/jac/34.4.515; Klare I, 1999, MICROB DRUG RESIST, V5, P45, DOI 10.1089/mdr.1999.5.45; KLARE I, 1995, FEMS MICROBIOL LETT, V125, P165, DOI 10.1111/j.1574-6968.1995.tb07353.x; Mellon M., 2001, HOGGING IT ESTIMATES; Moller FM, 1998, APMIS, V106, P606, DOI 10.1111/j.1699-0463.1998.tb01391.x; National Committee for Clinical Laboratory Standards, 1999, PERF STAND ANT SUSC; Pantosti A, 1999, LANCET, V354, P741, DOI 10.1016/S0140-6736(99)02395-8; RENDEFOURNIER R, 1993, ANTIMICROB AGENTS CH, V37, P2119, DOI 10.1128/AAC.37.10.2119; Sahm DF, 1999, CLIN INFECT DIS, V29, P259, DOI 10.1086/520195; Schouten MA, 1999, ANTIMICROB AGENTS CH, V43, P2542, DOI 10.1128/AAC.43.10.2542; Schouten MA, 1997, LANCET, V349, P1258, DOI 10.1016/S0140-6736(05)62461-0; Soltani M, 2000, ANTIMICROB AGENTS CH, V44, P433, DOI 10.1128/AAC.44.2.433-436.2000; Stobberingh E, 1999, ANTIMICROB AGENTS CH, V43, P2215, DOI 10.1128/AAC.43.9.2215; Teixeira, 1999, MANUAL CLIN MICROBIO, P297; vandenBogaard AE, 1997, J ANTIMICROB CHEMOTH, V40, P454, DOI 10.1093/jac/40.3.454; VanderAuwera P, 1996, J INFECT DIS, V173, P1129, DOI 10.1093/infdis/173.5.1129; Wegener HC, 1999, EMERG INFECT DIS, V5, P329, DOI 10.3201/eid0503.990303; Welton LA, 1998, ANTIMICROB AGENTS CH, V42, P705, DOI 10.1128/AAC.42.3.705; Whitman MS, 1996, ANTIMICROB AGENTS CH, V40, P1526, DOI 10.1128/AAC.40.6.1526; 2000, FED REG, V65, P20992	38	72	78	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1155	1160		10.1056/NEJMoa010805	http://dx.doi.org/10.1056/NEJMoa010805			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642231				2022-12-01	WOS:000171605800002
J	MacLehose, L; Brand, H; Camaroni, I; Fulop, N; Gill, ON; Reintjes, R; Schaefer, O; McKee, M; Weinberg, J				MacLehose, L; Brand, H; Camaroni, I; Fulop, N; Gill, ON; Reintjes, R; Schaefer, O; McKee, M; Weinberg, J			Communicable disease outbreaks involving more than one country: systems approach to evaluating the response	BRITISH MEDICAL JOURNAL			English	Article							SURVEILLANCE; ENGLAND		Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; PHLS, Ctr Communicable Dis Surveillance, Cardiff CF4 3QX, S Glam, Wales; Inst Publ Hlth N Rhine Westfalia, Munster, Germany; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Public Health England; University of London; London School of Hygiene & Tropical Medicine	Weinberg, J (corresponding author), City Univ London, London EC1 0HV, England.		McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Brand, Helmut/F-6368-2013	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Fulop, Naomi/0000-0001-5306-6140; Weinberg, Julius/0000-0001-5973-359X; Brand, Helmut/0000-0002-2755-0673				[Anonymous], 1997, Commun Dis Rep CDR Wkly, V7, P36; Burgess R., 1982, FIELD RES SOURCEBOOK; CHECKLAND P, 1994, AM BEHAV SCI, V38, P75, DOI 10.1177/0002764294038001007; DESENCLOS JC, 1993, LANCET, V341, P1003, DOI 10.1016/0140-6736(93)91084-Y; FISHER I, 1994, PHLS MICROBIOL DIGES, V9, P107; Giesecke J, 1998, LANCET, V352, P1308, DOI 10.1016/S0140-6736(98)00042-7; Joseph C, 1996, EUR J EPIDEMIOL, V12, P215, DOI 10.1007/BF00145408; Killalea D, 1996, BMJ-BRIT MED J, V313, P1105, DOI 10.1136/bmj.313.7065.1105; Lavanchy D, 1998, Euro Surveill, V3, P23; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; *NAT ADV COMM MICR, 1998, J FOOD PROTECT, V61, P1246; SAMUELSSON S, 1999, THESIS U SO DENMARK; Sorensen H T, 1995, Int J Risk Saf Med, V7, P179, DOI 10.3233/JRS-1995-7303; Van Steenbergen J.E., 1999, Euro Surveill, V4, P18; VANLOOCK F, 1997, EUROSURVEILLANCE JUN; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Yin R, 1994, CASE STUDY RES DESIG; 1996, COMMUN DIS REP CDR W, V6, P355	19	19	19	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2001	323	7317					861	863		10.1136/bmj.323.7317.861	http://dx.doi.org/10.1136/bmj.323.7317.861			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11597974	Green Accepted, Green Published			2022-12-01	WOS:000171650500036
J	Siegert, F; Ruecker, G; Hinrichs, A; Hoffmann, AA				Siegert, F; Ruecker, G; Hinrichs, A; Hoffmann, AA			Increased damage from fires in logged forests during droughts caused by El Nino	NATURE			English	Article							ERS-2 SAR IMAGES; TROPICAL FORESTS; EASTERN AMAZON; RAIN-FOREST; KALIMANTAN; BIOMASS	In 1997-98, fires associated with an exceptional drought caused by the El Nino/Southern Oscillation (ENSO) devastated large areas of tropical rain forests worldwide. Evidence suggests that in tropical rainforest environments selective logging may lead to an increased susceptibility of forests to fire(1-4). We investigated whether this was true in the Indonesian fires, the largest fire disaster ever observed(5,6). We performed a multiscale analysis using coarse- and high-resolution optical and radar satellite imagery assisted by ground and aerial surveys to assess the extent of the fire-damaged area and the effect on vegetation in East Kalimantan on the island of Borneo. A total of 5.2 +/-0.3 million hectares including 2.6 million hectares of forest was burned with varying degrees of damage. Forest fires primarily affected recently logged forests; primary forests or those logged long ago were less affected. These results support the hypothesis of positive feedback between logging and fire occurrence(4). The fires severely damaged the remaining forests and significantly increased the risk of recurrent fire disasters by leaving huge amounts of dead flammable wood.	Univ Munich, Dept Biol, D-80333 Munich, Germany; Remote Sensing Solut GmbH, D-81667 Munich, Germany; ZEBRIS GIS & Consulting, D-81373 Munich, Germany; GTZ, IFFM, Samarinda 75001, Kalimantan Timu, Indonesia; GTZ, MoFEC, SFMP, Samarinda 75123, Kalimantan Timu, Indonesia	University of Munich	Siegert, F (corresponding author), Univ Munich, Dept Biol, Luisenstr 14, D-80333 Munich, Germany.		Hoffmann, Ary/R-2972-2019; Nahas, Alberth/C-8379-2013	Hoffmann, Ary/0000-0001-9497-7645; Ruecker, Gernot/0000-0001-5995-8895				*ADB, 1999, CAUS EXT IMP COSTS 1; BARBER CV, 2000, TRIAL FIRE, P5; BROOKFIELD H, 1995, PLACE FOREST ENV SOC, P158; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; COLFER C, 2000, 8 E KAL PROV CTR INT, P1; GOLDAMMER JG, 1990, ECOL STU AN, V84, P11; Goldammer JG, 1999, SCIENCE, V284, P1782; Goldammer JG, 1996, DIPTEROCARP FOREST E, P155; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; KAUFFMAN JB, 1988, OIKOS, V53, P167, DOI 10.2307/3566059; Kuntz S, 1999, INT J REMOTE SENS, V20, P2835, DOI 10.1080/014311699211822; LEIGHTON M, 1986, TROPICAL RAIN FOREST, P75; MALINGREAU JP, 1985, AMBIO, V14, P314; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; *PROV FOR DEP E KA, 1999, FOR STAT 1998 98, P27; Siegert F, 2000, INT J REMOTE SENS, V21, P831, DOI 10.1080/014311600210632; Siegert F, 2000, REMOTE SENS ENVIRON, V72, P64, DOI 10.1016/S0034-4257(99)00092-9; SOLICHIN SH, 1999, 7B SFMP GES TECHN ZU, P8; UHL C, 1985, BIOTROPICA, V17, P265, DOI 10.2307/2388588; ULABY FT, 1986, MICROWAVE REMOTE SEN, V3, P1811	22	429	456	6	159	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					437	440		10.1038/35106547	http://dx.doi.org/10.1038/35106547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719802				2022-12-01	WOS:000172304500040
J	Jungkind, D				Jungkind, D			Molecular testing for infectious disease	SCIENCE			English	Article							POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; CHLAMYDIA-TRACHOMATIS; COBAS AMPLICOR; REACTION ASSAY; LCX; DNA; AMPLIFICATION; SPECIMENS; SYSTEM		Thomas Jefferson Univ, Sch Med, Clin Microbiol Labs, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Sch Med, Dept Pathol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Sch Med, Dept Microbiol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Jungkind, D (corresponding author), Thomas Jefferson Univ, Sch Med, Clin Microbiol Labs, Philadelphia, PA 19107 USA.							BASS CJ, 1993, J OFFSHORE TECHNOL, V1, P31; BEAVIS KG, 1995, J CLIN MICROBIOL, V33, P2582, DOI 10.1128/JCM.33.10.2582-2586.1995; BERMANN JS, 1999, J CLIN MICROBIOL, V37, P1419; Brambilla DJ, 2001, J CLIN MICROBIOL, V39, P1121, DOI 10.1128/JCM.39.3.1121-1123.2001; Carroll KC, 1998, J CLIN MICROBIOL, V36, P1630, DOI 10.1128/JCM.36.6.1630-1633.1998; Foubister V, 2000, CAP TODAY        SEP, P84; Goessens WHF, 1997, J CLIN MICROBIOL, V35, P2628, DOI 10.1128/JCM.35.10.2628-2633.1997; Jungkind D, 1996, J CLIN MICROBIOL, V34, P2778, DOI 10.1128/JCM.34.11.2778-2783.1996; Jungkind D, 2001, J CLIN VIROL, V20, P1, DOI 10.1016/S1386-6532(00)00148-7; Klapper PE, 1998, CLIN CHEM, V44, P1737; Kulkarni A, 2001, CLIN MICROBIOL INFEC, V7, P179, DOI 10.1046/j.1198-743x.2001.00227.x; Little MC, 1999, CLIN CHEM, V45, P777; Lumb R, 1999, J CLIN MICROBIOL, V37, P3102, DOI 10.1128/JCM.37.10.3102-3107.1999; Murphy DG, 2000, J CLIN MICROBIOL, V38, P4034, DOI 10.1128/JCM.38.11.4034-4041.2000; Pawlotsky JM, 2000, J VIROL METHODS, V85, P11, DOI 10.1016/S0166-0934(99)00149-4; Roth WK, 2001, TRANSFUS CLIN BIOL, V8, P282, DOI 10.1016/S1246-7820(01)00115-X; Wattanamano P, 2000, J CLIN MICROBIOL, V38, P727, DOI 10.1128/JCM.38.2.727-732.2000; WHITE TJ, 1992, ADV CLIN CHEM, V29, P161, DOI 10.1016/S0065-2423(08)60224-3; ZAAIJER HL, 1994, VOX SANG, V66, P78, DOI 10.1111/j.1423-0410.1994.tb00282.x; Zanchetta N, 2000, J CLIN MICROBIOL, V38, P3882, DOI 10.1128/JCM.38.10.3882-3886.2000	20	21	24	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1553	+		10.1126/science.294.5546.1553	http://dx.doi.org/10.1126/science.294.5546.1553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711681				2022-12-01	WOS:000172240500056
J	Sereno, PC; Larsson, HCE; Sidor, CA; Gado, B				Sereno, PC; Larsson, HCE; Sidor, CA; Gado, B			The giant crocodyliform Sarcosuchus from the Cretaceous of Africa	SCIENCE			English	Article								New fossils of the giant African crocodyliform Sarcosuchus imperator clarify its skeletal anatomy, growth patterns, size, longevity, and phylogenetic position. The skull has an expansive narial bulla and elongate jaws studded with stout, smooth crowns that do not interlock. The jaw form suggests a generalized diet of large vertebrates, including fish and dinosaurs. S. imperator is estimated to have grown to a maximum body length of at least 11 to 12 meters and body weight of about 8 metric tons over a life-span of 50 to 60 years. Unlike its closest relatives, which lived as specialized piscivores in marginal marine habitats, S. imperator thrived in fluvial environments.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA; New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; Inst Rech Sci Humaines, Niamey, Niger	University of Chicago; Yale University; New York Institute Technology	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.		Larsson, Hans/AAD-4579-2019	Larsson, Hans/0000-0002-6377-4770				Andrews C. W., 1913, Annals & Magazine of Natural History, V11; Buffetau E., 1981, MEMOIRES SOC GEOLOGI, V60, P1; BUFFETAUT E, 1977, Palaeontology (Oxford), V20, P203; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Greer A.E., 1974, Journal Herpet, V8, P381, DOI 10.2307/1562913; Grenard S., 1991, HDB ALLIGATORS CROCO; Headden Jaime A., 2001, Journal of Vertebrate Paleontology, V21, p59A; HOOLEY RW, 1907, J GEOL SOC LONDON, V63, P50; LARSSON HC, 2000, THESIS U CHICAGO; Maisey J.G., 1991, SANTANA FOSSILS ILLU, P342; Pooley A.C., 1989, P76; Ross F.D., 1983, P305; Schwimmer David R., 1999, Journal of Vertebrate Paleontology, V19, p74A; Sereno PC, 1999, SYST BIOL, V48, P329, DOI 10.1080/106351599260328; Singh L.A.K., 1982, British Journal of Herpetology, V6, P253; Smith A. G., 1994, ATLAS MESOZOIC CENOZ; SWOFFORD DL, 1993, PAUP 3 1; TAQUET P, 1975, CAH PALEONTOL, V1, P1; Taquet P., 1966, CR HEBD ACAD SCI, V262, P2326; WEBB GJW, 1983, AUST WILDLIFE RES, V10, P383, DOI 10.1071/WR9830383; WEBB GJW, 1978, AUST J ZOOL, V26, P1; WERMUTH HEINZ, 1964, SENCKENBERG BIOL, V45, P369; Woodward AR, 1995, J HERPETOL, V29, P507, DOI 10.2307/1564733; Wu XC, 2001, J VERTEBR PALEONTOL, V21, P492, DOI 10.1671/0272-4634(2001)021[0492:TACNMF]2.0.CO;2; Wu XC, 1996, CAN J EARTH SCI, V33, P606, DOI 10.1139/e96-045	25	214	224	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1516	1519		10.1126/science.1066521	http://dx.doi.org/10.1126/science.1066521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11679634				2022-12-01	WOS:000172240500045
J	Martin, ER; Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Masterman, D; Mastaglia, F; Laing, NG; Stajich, JM; Ribble, RC; Booze, MW; Rogala, A; Hauser, MA; Zhang, FY; Gibson, RA; Middleton, LT; Roses, AD; Haines, JL; Scott, BL; Pericak-Vance, MA; Vance, JM				Martin, ER; Scott, WK; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Lyons, K; Pahwa, R; Stern, MB; Colcher, A; Hiner, BC; Jankovic, J; Ondo, WG; Allen, FH; Goetz, CG; Small, GW; Masterman, D; Mastaglia, F; Laing, NG; Stajich, JM; Ribble, RC; Booze, MW; Rogala, A; Hauser, MA; Zhang, FY; Gibson, RA; Middleton, LT; Roses, AD; Haines, JL; Scott, BL; Pericak-Vance, MA; Vance, JM			Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CLINICAL-DIAGNOSIS; LINKAGE; MUTATIONS; DISEQUILIBRIUM; TRANSMISSION; HAPLOTYPE; ACCURACY; DEMENTIA	Context The human tau gene, which promotes assembly of neuronal microtubules, has been associated with several rare neurologic diseases that clinically include parkinsonian features. We recently observed linkage in idiopathic Parkinson disease (PD) to a region on chromosome 17q21 that contains the tau gene. These factors make tau a good candidate for investigation as a susceptibility gene for idiopathic PD, the most common form of the disease. Objective To: investigate whether the tau gene is involved in idiopathic PD. Design, Setting, and Participants Among a sample of 1056 individuals from 235 families selected from 13 clinical centers in the United States and Australia and from a family ascertainment core center, we tested 5 single-nucleotide polymorphisms (SNPs) within the tau gene for association with PD, using family-based tests of association. Both affected (n=426) and unaffected (n=579) family members were included; 51 individuals had unclear PD status. Analyses were conducted to test individual SNPs and SNP haplotypes within the tau gene. Main Outcome Measure Family-based tests of association, calculated using asymptotic distributions. Results Analysis of association between the SNPs and PD yielded significant evidence of association for 3 of the 5 SNPs tested: SNP 3, P=.03; SNP 9i, P=.04; and SNP 11, P=.04. The 2 other SNPs did not show evidence of significant association (SNP 9ii, P=.11, and SNP 9iii, P=.87). Strong evidence of association was found with haplotype analysis, with a positive association with one haplotype (P=.009) and a negative association with another haplotype (P=.007). Substantial linkage disequilibrium (P<.001) was detected between 4 of the 5 SNPs (SN Ps 3, 9i, 9ii, and 11). Conclusions This integrated approach of genetic linkage and positional association analyses implicates tau as a susceptibility gene for idiopathic PD.	Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Struthers Parkinson Ctr, Golden Valley, MN USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA; Marshfield Clin Fdn Med Res & Educ, Dept Neurol, Marshfield, WI USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Carolina Neurol Clin, Charlotte, NC USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; GlaxoSmithKline Res & Dev, Greenford, Middx, England; GlaxoSmithKline Res & Dev, Res Triangle Pk, NC USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA	Duke University; Duke University; Emory University; University System of Ohio; Ohio State University; University of Miami; University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Marshfield Clinic; Baylor College of Medicine; Rush University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Western Australia; GlaxoSmithKline; GlaxoSmithKline; Vanderbilt University	Vance, JM (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Inst Genome Sci & Policy, Box 2903, Durham, NC 27710 USA.		Scott, William/A-7593-2009; Scott, Burton/L-3951-2019; Zhang, Fengyu/M-1396-2019; Haines, Jonathan/C-3374-2012	Zhang, Fengyu/0000-0001-8504-0770; Haines, Jonathan/0000-0002-4351-4728; Laing, Nigel/0000-0001-5111-3732; Gibson, Rachel/0000-0002-1338-1290; Scott, William/0000-0001-9336-6404; Vance, Jeffery/0000-0003-3815-8199	NINDS NIH HHS [2 P50 NS39764-02, P50 NS039764, P01 NS26630, P01 NS026630, P50 NS039764-07] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, P50NS039764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allan W, 1937, ARCH INTERN MED, V60, P424, DOI 10.1001/archinte.1937.00180030041003; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; EGGERDING FA, 1995, HUM MUTAT, V5, P153, DOI 10.1002/humu.1380050209; Golbe LI, 2001, MOVEMENT DISORD, V16, P442, DOI 10.1002/mds.1087; Higgins JJ, 1999, NEUROLOGY, V53, P1421, DOI 10.1212/WNL.53.7.1421; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lewis P.O., 2000, GENETIC DATA ANAL CO; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; MARTIN ER, 2001, AM J HUM GENET, V69, pA511; Pastor P, 2000, ANN NEUROL, V47, P242; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sveinbjornsdottir S, 2000, NEW ENGL J MED, V343, P1765, DOI 10.1056/NEJM200012143432404; Tan EK, 2000, NEUROLOGY, V55, P533, DOI 10.1212/WNL.55.4.533; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Vance Jeffery M., 1998, P213; WARD CD, 1990, ADV NEUROL, V53, P245	29	148	155	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2245	2250		10.1001/jama.286.18.2245	http://dx.doi.org/10.1001/jama.286.18.2245			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710889	Green Accepted			2022-12-01	WOS:000172129700018
J	Fishman, MC				Fishman, MC			Genomics - Zebrafish - The canonical vertebrate	SCIENCE			English	Editorial Material							GENETIC-ANALYSIS		Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Div Cardiovasc, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Fishman, MC (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	mcfishman@partners.org						Baier H, 2000, CURR OPIN NEUROBIOL, V10, P451, DOI 10.1016/S0959-4388(00)00116-1; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Holley SA, 2000, GENE DEV, V14, P1678; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Rottbauer W, 2001, DEV CELL, V1, P265, DOI 10.1016/S1534-5807(01)00023-5; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	11	168	183	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545					1290	1291		10.1126/science.1066652	http://dx.doi.org/10.1126/science.1066652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701913				2022-12-01	WOS:000172130200030
J	Tomita, K; Weiner, AM				Tomita, K; Weiner, AM			Collaboration between CC- and A-adding enzymes to build and repair the 3 '-terminal CCA of tRNA in Aquifex aeolicus	SCIENCE			English	Article							TRANSFER-RNA NUCLEOTIDYLTRANSFERASE; SULFOLOBUS-SHIBATAE; 3' TERMINUS; ACTIVE-SITE; SUPERFAMILY; SPECIFICITY; POLYMERASES; BINDING	The universal 3'-terminal CCA sequence of all transfer RNAs (tRNAs) is repaired, and sometimes constructed de novo, by the CCA-adding enzyme [ATP(CTP):tRNA nucleotidyltransferase]. This RNA polymerase has no nucleic acid template, yet faithfully builds the CCA sequence one nucleotide at a time using cytidine triphosphate (CTP) and adenosine triphosphate (ATP) as substrates. AU previously characterized CCA-adding enzymes from all three kingdoms are single polypeptides with CCA-adding activity. Here, we demonstrate through biochemical and genetic approaches that CCA addition in Aquifex aeolicus requires collaboration between two related polypeptides, one that adds CC and another that adds A.	Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Weiner, AM (corresponding author), Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA.		Tomita, Kozo/J-5746-2013; Tomita, Kozo/E-9390-2017	Tomita, Kozo/0000-0002-7374-3898	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059804] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEI M, 1990, J BIOL CHEM, V265, P16216; Deutscher M. P., 1983, ENZYMES NUCLEIC ACID, V2, P159; DEUTSCHER MP, 1972, J BIOL CHEM, V247, P459; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Gupta RS, 1998, J MOL EVOL, V46, P716, DOI 10.1007/PL00006352; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; MASIAKOWSKI P, 1980, J BIOL CHEM, V255, P1240; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; OH BK, 1994, NUCLEIC ACIDS RES, V22, P4087, DOI 10.1093/nar/22.20.4087; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Reuven NB, 1997, J BIOL CHEM, V272, P33255, DOI 10.1074/jbc.272.52.33255; REUVEN NB, 1993, P NATL ACAD SCI USA, V90, P4350, DOI 10.1073/pnas.90.10.4350; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; Tomari Y, 2000, GENES CELLS, V5, P689, DOI 10.1046/j.1365-2443.2000.00360.x; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Yue DX, 1996, RNA, V2, P895	22	62	64	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1334	1336		10.1126/science.1063816	http://dx.doi.org/10.1126/science.1063816			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701927				2022-12-01	WOS:000172130200047
J	Attaran, A; Gillespie-White, L				Attaran, A; Gillespie-White, L			Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMBINATION THERAPY; LAMIVUDINE; STAVUDINE; ZIDOVUDINE; NEVIRAPINE; EFFICACY; REGIMEN; SAFETY; INDIVIDUALS; DIDANOSINE	Public attention and debate recently have focused on access to treatment of acquired immunodeficiency syndrome (AIDS) in poor, severely affected countries, such as those in Africa. Whether patents on antiretroviral drugs In Africa are impeding access to lifesaving treatment for the 25 million Africans with human immunodeficiency virus infection is unknown. We studied the patent statuses of 15 antiretroviral drugs in 53 African countries. Using a survey method, we found that these antiretroviral drugs are patented in few African countries (median, 3; mode, 0) and that in countries where antiretroviral drug patents exist, generally only a small subset of antiretroviral drugs are patented (median and mode, 4). The observed scarcity of patents cannot be simply explained by a lack of patent laws because most African countries have offered patent protection for pharmaceuticals for many years. Furthermore, in this particular case, geographic patent coverage does not appear to correlate with antiretroviral treatment access in Africa, suggesting that patents and patent law are not a major barrier to treatment access in and of themselves. We conclude that a variety of de facto barriers are more responsible for impeding access to antiretroviral treatment, including but not limited to the poverty of African countries, the high cost of antiretroviral treatment, national regulatory requirements for medicines, tariffs and sales taxes, and, above all, a lack of sufficient international financial aid to fund anti-retroviral treatment. We consider these findings in light of policies for enhancing antiretroviral treatment access in poor countries.	Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Int Intellectual Property Inst, Washington, DC USA	Harvard University; Harvard University	Attaran, A (corresponding author), Harvard Univ, Ctr Int Dev, 79 JFK St, Cambridge, MA 02138 USA.	amir_attaran@harvard.edu						[Anonymous], PATENT POLICY PROPOS; Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; ATTARAN A, 1999, MED SANS FRONT WHO W; ATTARAN A, 1999, HLTH HUM RIGHTS, V4, P28; BALA K, 2001, HLTH ACTION INT  APR; Bale H., 1998, J INT ECON LAW, V1, P637, DOI DOI 10.1093/JIEL/1.4.637; BALE HE, 2001, CONSUMPTION TRADE OF; BOULET P, 2000, DRUG PATENTS FRENCHS; BOULET P, 2000, PATENT PROTECTION ME; *CA DEP TRANSP, 1999, EST COST VFAR FREEW; CORREA C, 2001, INTELLECTUAL PROPERT; CORREA C, 2001, INTEGRATING PUBLIC H; *DEP HLTH HUM SERV, 2001, GUID US ANT AG HIV I; Eron JJ, 2000, AIDS, V14, P1601, DOI 10.1097/00002030-200007280-00016; Ford S., 2000, AM U INT L REV, V15, P941; Gartland M, 2001, ANTIVIR THER, V6, P127; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; JOHNSON V, 2001, 8 C RETR OPP INF FEB; *JOINT UN PROGR HI, 2000, PAT SIT HIV AIDS REL; Laing RO, 2000, INT J TUBERC LUNG D, V4, pS194; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; McKee RL, 2001, PEOPLE EYE STORIES D, V1st; *PAN I, 2001, OUR MEANS COST TREAT; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Raffi F, 2000, ANTIVIR THER, V5, P267; Rockstroh JK, 2000, AIDS, V14, P1181, DOI 10.1097/00002030-200006160-00015; Shalit P, 2001, AIDS, V15, P804, DOI 10.1097/00002030-200104130-00020; Squires KE, 2000, AIDS, V14, P1591, DOI 10.1097/00002030-200007280-00015; Stephenson J, 2001, JAMA-J AM MED ASSOC, V286, P405, DOI 10.1001/jama.286.4.405; SWAMS RL, 2001, NY TIMES        0308, pA1; *WHO, 2001, WHO INT CONS M HIV A; 1883, PAR CONVENTION PROTE; 2000, MANUAL HANDLING APPL; 2000, FED REG, V65, P30521; 2001, TOP HIV MED, V9, P14; 2001, AGREEMENT TRADE RELA	36	105	106	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1886	1892		10.1001/jama.286.15.1886	http://dx.doi.org/10.1001/jama.286.15.1886			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482UH	11597292				2022-12-01	WOS:000171595300031
J	Domning, DP				Domning, DP			The earliest known fully quadrupedal sirenian	NATURE			English	Article							EOCENE; JAMAICA; ORIGIN	Modern seacows (manatees and dugongs; Mammalia, Sirenia) are completely aquatic, with flipperlike forelimbs and no hindlimbs(1,2). Here I describe Eocene fossils from Jamaica that represent nearly the entire skeleton of a new genus and species of sirenian-the most primitive for which extensive postcranial remains are known. This animal was fully capable of locomotion on land, with four well-developed legs, a multivertebral sacrum, and a strong sacroiliac articulation that could support the weight of the body out of water as in land mammals. Aquatic adaptations show, however, that it probably spent most of its time in the water. Its intermediate form thus illustrates the evolutionary transition between terrestrial and aquatic life. Similar to contemporary primitive cetaceans(3), it probably swam by spinal extension with simultaneous pelvic paddling, unlike later sirenians and cetaceans, which lost the hindlimbs and enlarged the tail to serve as the main propulsive organ. Together with fossils of later sirenians elsewhere in the world(1,4-7), these new specimens document one of the most marked examples of morphological evolution in the vertebrate fossil record.	Howard Univ, Dept Anat, Washington, DC 20059 USA	Howard University	Domning, DP (corresponding author), Howard Univ, Dept Anat, Washington, DC 20059 USA.	ddomning@fac.howard.edu						Abel O, 1904, ABHANDLUNGEN KAISERL, V19, P1; Domning Daryl P., 2000, Historical Biology, V14, P115; Domning Daryl P., 2001, P151; Domning Daryl P., 1994, Contributions from the Museum of Paleontology University of Michigan, V29, P69; Domning Daryl P., 1994, Proceedings of the San Diego Society of Natural History, V29, P177; DOMNING DP, 1991, MAR MAMMAL SCI, V7, P331, DOI 10.1111/j.1748-7692.1991.tb00111.x; Domning DP, 1997, J VERTEBR PALEONTOL, V17, P638, DOI 10.1080/02724634.1997.10011013; DOMNING DP, 1982, SMITHSONIAN CONTRIBU, V52, P1; DOMNING DP, 2001, B ASHORO MUS PALEONT, V2, P39; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Lepsius G.R., 1882, ABHANDLUNGEN MITTELR, V1, P1; Liu FGR, 1999, SYST BIOL, V48, P54, DOI 10.1080/106351599260436; MacPhee R. D. E., 1999, Journal of Vertebrate Paleontology, V19, p61A; Matthew W. D., 1937, Transactions of the American Philosophical Society Philadelphia NS, V30, P1; Pregill GK, 1999, HERPETOLOGICA, V55, P157; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; Siegfried P., 1967, Palaeontologische Zeitschrift, V41, P165; Taylor Michael A., 2000, Historical Biology, V14, P15; Thewissen J.G.M., 1996, Courier Forschungsinstitut Senckenberg, V191, P1; Thewissen J.G.M., 1992, Journal of Vertebrate Paleontology, V12, P494; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210	22	114	121	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					625	627		10.1038/35098072	http://dx.doi.org/10.1038/35098072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675784				2022-12-01	WOS:000171485700047
J	Krieger, MJB; Ross, KG				Krieger, MJB; Ross, KG			Identification of a major gene regulating complex social behavior	SCIENCE			English	Article							ANT SOLENOPSIS-INVICTA; FIRE ANT; EVOLUTION; ORGANIZATION; POPULATIONS; SELECTION	Colony queen number, a major feature of social organization in fire ants, is associated with worker genotypes at the gene Gp-9. We sequenced Gp-9 and found that it encodes a pheromone-binding protein, a crucial molecular component in chemical recognition of conspecifics, This suggests that differences in worker Gp-9 genotypes between social forms may cause differences in workers' abilities to recognize queens and regulate their numbers. Analyses of sequence evolution indicate that regulation of social organization by Gp-9 is conserved in South American fire ant species exhibiting social polymorphism and suggest that positive selection has driven the divergence between the alleles associated with alternate social organizations. This study demonstrates that single genes of major effect can underlie the expression of complex behaviors important in social evolution.	Univ Georgia, Dept Entomol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Krieger, MJB (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.							DeHeer CJ, 1999, AM NAT, V153, P660, DOI 10.1086/303205; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Keller L, 1999, J EVOLUTION BIOL, V12, P672, DOI 10.1046/j.1420-9101.1999.00064.x; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Nei M., 2000, MOL EVOLUTION PHYLOG; PATIL RV, 1990, NUCLEIC ACIDS RES, V18, P3080, DOI 10.1093/nar/18.10.3080; Robinson GE, 1997, BIOESSAYS, V19, P1099, DOI 10.1002/bies.950191209; Robinson GE, 1999, TRENDS ECOL EVOL, V14, P202, DOI 10.1016/S0169-5347(98)01536-5; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; Ross KG, 1997, GENETICS, V147, P643; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Ross KG, 1997, GENETICS, V145, P961; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; ROSS KG, IN PRESS BEHAV ECOL; SHOEMAKER D, UNPUB; SWOFFORD DL, 1998, PAUP STAR PHYLOGENET; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Willett CS, 2000, J MOL EVOL, V50, P175, DOI 10.1007/s002399910019; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743	20	256	291	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					328	332		10.1126/science.1065247	http://dx.doi.org/10.1126/science.1065247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11711637				2022-12-01	WOS:000173278600050
J	Shi, SH				Shi, SH			Amersham Biosciences & Science Prize: AMPA receptor dynamics and synaptic plasticity	SCIENCE			English	Article							LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; CHANNELS		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Shi, SH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hebb D.O., 2002, CLIN PSYCHOL; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1999, IMAGING LIVING CELLS; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	14	9	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1851	1852		10.1126/science.1067844	http://dx.doi.org/10.1126/science.1067844			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729297				2022-12-01	WOS:000172465000039
J	Naylor, RL; Williams, SL; Strong, DR				Naylor, RL; Williams, SL; Strong, DR			Ecology - Aquaculture - A gateway for exotic species	SCIENCE			English	Editorial Material							SALMON SALMO-SALAR; ATLANTIC SALMON; PACIFIC; WILD		Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA; Univ Calif Davis, Bodega Bay, CA 94923 USA; Bodega Bay Marine Lab, Bodega Bay, CA 94923 USA; Univ Calif Davis, Davis, CA 95616 USA; Bodega Bay Marine Lab, Davis, CA 95616 USA	Stanford University; University of California System; University of California Davis; University of California System; University of California Davis	Naylor, RL (corresponding author), Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA.							[Anonymous], 1993, OTAF565; Chick JH, 2001, SCIENCE, V292, P2250, DOI 10.1126/science.292.5525.2250; Dextrase AJ, 2000, NONINDIGENOUS FRESHWATER ORGANISMS, P61; *FAO, 2000, FISH STAT 1998, V86; Ferber D, 2001, SCIENCE, V292, P203, DOI 10.1126/science.292.5515.203; Goldburg R.J., 2001, MARINE AQUACULTURE U; Gross MR, 1998, CAN J FISH AQUAT SCI, V55, P131, DOI 10.1139/cjfas-55-S1-131; Hansen LP, 1997, ICES J MAR SCI, V54, P963, DOI 10.1016/S1054-3139(97)80000-8; Kuris AM, 1999, INVERTEBR BIOL, V118, P391, DOI 10.2307/3227008; McCoy H.D., 2000, AM INT AQUACULTURE L; McKinnell S, 1997, ICES J MAR SCI, V54, P1221, DOI 10.1016/S1054-3139(97)80029-X; *NAT RES COUNC, 1985, UND MAR BIOD REV AG; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; NICOL LG, 2001, RISK ASSESSMENT BLAC; Shatkin G, 1997, J SHELLFISH RES, V16, P463; SHINE C, 2000, ENV POLICY LAW PAPER, V40; Stucky N. P., 2000, 5 YEAR PLAN ELIMINAT; THOM RM, 1990, BOT MAR, V33, P497, DOI 10.1515/botm.1990.33.6.497; Trowbridge C.D, 1999, CRIMP CONSULTANCY RE, P43; Venable DL, 2000, J WORLD AQUACULT SOC, V31, P158, DOI 10.1111/j.1749-7345.2000.tb00349.x; Verspoor E, 1997, ICES J MAR SCI, V54, P965, DOI 10.1006/jmsc.1997.0297; Volpe JP, 2000, CONSERV BIOL, V14, P899, DOI 10.1046/j.1523-1739.2000.99194.x; WELCOMME RL, 1992, ICES MAR SC, V194, P3; [No title captured]; [No title captured]	25	353	374	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1655	1656		10.1126/science.1064875	http://dx.doi.org/10.1126/science.1064875			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721035				2022-12-01	WOS:000172307400020
J	Patil, N; Berno, AJ; Hinds, DA; Barrett, WA; Doshi, JM; Hacker, CR; Kautzer, CR; Lee, DH; Marjoribanks, C; McDonough, DP; Nguyen, BTN; Norris, MC; Sheehan, JB; Shen, NP; Stern, D; Stokowski, RP; Thomas, DJ; Trulson, MO; Vyas, KR; Frazer, KA; Fodor, SPA; Cox, DR				Patil, N; Berno, AJ; Hinds, DA; Barrett, WA; Doshi, JM; Hacker, CR; Kautzer, CR; Lee, DH; Marjoribanks, C; McDonough, DP; Nguyen, BTN; Norris, MC; Sheehan, JB; Shen, NP; Stern, D; Stokowski, RP; Thomas, DJ; Trulson, MO; Vyas, KR; Frazer, KA; Fodor, SPA; Cox, DR			Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21	SCIENCE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; INFORMATION	Global patterns of human DNA sequence variation (haplotypes) defined by common single nucleotide polymorphisms (SNPs) have important implications for identifying disease associations and human traits. We have used high-density oligonucleotide arrays, in combination with somatic cell genetics, to identify a large fraction of all common human chromosome 21 SNPs and to directly observe the haplotype structure defined by these SNPs. This structure reveals blocks of limited haplotype diversity in which more than 80% of a global human sample can typically be characterized by only three common haplotypes.	Perlegen Sci Inc, Mountain View, CA 94043 USA		Cox, DR (corresponding author), Perlegen Sci Inc, 2021 Stierlin Court, Mountain View, CA 94043 USA.	david_cox@perlegen.com		Frazer, Kelly/0000-0002-6060-8902; Hinds, David/0000-0002-4911-803X				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; FU YX, 1993, GENETICS, V133, P693; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HARTL DL, 1997, PRINCIPLES POPULATIO, P57; Hodge SE, 1999, NAT GENET, V21, P360, DOI 10.1038/7687; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Marth G, 2001, NAT GENET, V27, P371, DOI 10.1038/86864; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Yang ZY, 2000, NAT GENET, V26, P13, DOI 10.1038/79113	24	803	895	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1719	1723		10.1126/science.1065573	http://dx.doi.org/10.1126/science.1065573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721056				2022-12-01	WOS:000172307400045
J	McDevitt, MR; Ma, DS; Lai, LT; Simon, J; Borchardt, P; Frank, RK; Wu, K; Pellegrini, V; Curcio, MJ; Miederer, M; Bander, NH; Scheinberg, DA				McDevitt, MR; Ma, DS; Lai, LT; Simon, J; Borchardt, P; Frank, RK; Wu, K; Pellegrini, V; Curcio, MJ; Miederer, M; Bander, NH; Scheinberg, DA			Tumor therapy with targeted atomic nanogenerators	SCIENCE			English	Article							IN-VITRO; RADIOIMMUNOTHERAPY; ANTIBODY; AC-225; CONSTRUCTS; GROWTH; MICE	A single, high linear energy transfer alpha particle can kill a target cell. We have developed methods to target molecular-sized generators of alpha-emitting isotope cascades to the inside of cancer cells using actinium-225 coupled to internalizing monoclonal antibodies. In vitro, these constructs specifically killed leukemia, lymphoma, breast, ovarian, neuroblastoma, and prostate cancer cells at becquerel (picocurie) levels. Injection of single doses of the constructs at kilobecquerel (nanocurie) levels into mice bearing solid prostate carcinoma or disseminated human lymphoma induced tumor regression and prolonged survival, without toxicity, in a substantial fraction of animals. Nanogenerators targeting a wide variety of cancers may be possible.	Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Therapeut Program, New York, NY 10021 USA; Dow Chem Co USA, Freeport, TX 77541 USA; Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Urol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Dow Chemical Company; Cornell University; NewYork-Presbyterian Hospital	Scheinberg, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Therapeut Program, 1275 York Ave, New York, NY 10021 USA.	d-scheinberg@ski.mskcc.org	Miederer, Matthias/ABA-5988-2020; Miederer, Matthias/C-4405-2014	Miederer, Matthias/0000-0001-5075-5995; 	NATIONAL CANCER INSTITUTE [R01CA055349] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA55349] Funding Source: Medline; PHS HHS [P01 33049] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ballangrud AM, 2001, CANCER RES, V61, P2008; Bidart JM, 1999, CLIN CHEM, V45, P1695; Chappell LL, 2000, BIOCONJUGATE CHEM, V11, P510, DOI 10.1021/bc990153f; Davis IA, 1999, NUCL MED BIOL, V26, P581, DOI 10.1016/S0969-8051(99)00024-4; Deal KA, 1999, J MED CHEM, V42, P2988, DOI 10.1021/jm990141f; GEERLINGS MW, 1993, NUCL MED COMMUN, V14, P121, DOI 10.1097/00006231-199302000-00009; GHETIE MA, 1994, BLOOD, V83, P1329; GLEAVE ME, 1992, CANCER RES, V52, P1598; HUMM JL, 1993, RADIAT RES, V134, P143, DOI 10.2307/3578453; Jurcic JG, 1997, BLOOD, V90, P1850; Kennel SJ, 2000, CANCER BIOTHER RADIO, V15, P235, DOI 10.1089/108497800414329; Liu H, 1998, CANCER RES, V58, P4055; Ma D, 2000, J NUCL MED, V41, p268P; MA D, IN PRESS LEUKEMIA; McDevitt MR, 1998, EUR J NUCL MED, V25, P1341, DOI 10.1007/s002590050306; McDevitt MR, 2000, CANCER RES, V60, P6095; McDevitt MR, 1999, APPL RADIAT ISOTOPES, V50, P895, DOI 10.1016/S0969-8043(98)00151-1; McDevitt MR, 1999, J NUCL MED, V40, P1722; Nikula TK, 1999, J NUCL MED, V40, P166; Smith-Jones PM, 2000, CANCER RES, V60, P5237; Zalutsky MR, 2000, CURR PHARM DESIGN, V6, P1433, DOI 10.2174/1381612003399275	21	346	399	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1537	1540		10.1126/science.1064126	http://dx.doi.org/10.1126/science.1064126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711678				2022-12-01	WOS:000172240500052
J	Mostoslavsky, R; Singh, N; Tenzen, T; Goldmit, M; Gabay, C; Elizur, S; Qi, PM; Reubinoff, BE; Chess, A; Cedar, H; Bergman, Y				Mostoslavsky, R; Singh, N; Tenzen, T; Goldmit, M; Gabay, C; Elizur, S; Qi, PM; Reubinoff, BE; Chess, A; Cedar, H; Bergman, Y			Asynchronous replication and allelic exclusion in the immune system	NATURE			English	Article							IMMUNOGLOBULIN-KAPPA; X-CHROMOSOMES; GENE REARRANGEMENT; MOUSE EMBRYOS; EXPRESSION; CELLS; DIFFERENTIATION; INACTIVATION	The development of mature B cells involves a series of molecular decisions which culminate in the expression of a single light-chain and heavy-chain antigen receptor on the cell surface(1,2). There are two alleles for each receptor locus, so the ultimate choice of one receptor type must involve a process of allelic exclusion. One way to do this is with a feedback mechanism that downregulates rearrangement after the generation of a productive receptor molecule(3), but recent work suggests that monoallelic epigenetic changes may also take place even before rearrangement(4). To better understand the basis for distinguishing between alleles, we have analysed DNA replication timing. Here we show that all of the B-cell-receptor loci (mu, kappa and lambda) and the TCR beta locus replicate asynchronously. This pattern, which is established randomly in each cell early in development and maintained by cloning, represents an epigenetic mark for allelic exclusion, because it is almost always the early-replicating allele which is initially selected to undergo rearrangement in B cells. These results indicate that allelic exclusion in the immune system may be very similar to the process of X chromosome inactivation.	Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Expt Med & Canc Res, IL-91120 Jerusalem, Israel; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Natl Inst Genet, Dept Evolutionary Genet, Mishima, Shizuoka 4118540, Japan; Hadassah Ein Kerem Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; Hadassah Ein Kerem Univ Hosp, Goldyn Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; MIT, Dept Biol, Cambridge, MA 02139 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); Whitehead Institute; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Massachusetts Institute of Technology (MIT)	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, POB 12272, IL-91120 Jerusalem, Israel.		Schlesinger, Sharon/A-5283-2016	Schlesinger, Sharon/0000-0001-9549-2383; Reubinoff, Benjamin/0000-0003-0353-1299				APEL TW, 1995, GENE, V156, P191, DOI 10.1016/0378-1119(94)00901-4; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; CEBRA JJ, 1966, J EXP MED, V123, P547, DOI 10.1084/jem.123.3.547; Cedar H, 1999, CURR OPIN IMMUNOL, V11, P64, DOI 10.1016/S0952-7915(99)80012-0; Chess A, 1998, SCIENCE, V279, P2067, DOI 10.1126/science.279.5359.2067; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Gorman JR, 1998, ADV IMMUNOL, V69, P113, DOI 10.1016/S0065-2776(08)60607-0; Hogan B., 2014, MANIPULATING MOUSE E; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; LUNINGPRAK E, 1995, J EXP MED, V182, P541; MCCARREY JR, 1987, J EXP ZOOL, V242, P107, DOI 10.1002/jez.1402420116; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; MULLINS LJ, 1987, MOL CELL BIOL, V7, P3916, DOI 10.1128/MCB.7.11.3916; NADON N, 1988, SOMAT CELL MOLEC GEN, V14, P541, DOI 10.1007/BF01535309; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; SIMON I, 1996, DNA REPLICATION EUKA, P387; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TAKAGI N, 1974, EXP CELL RES, V86, P127, DOI 10.1016/0014-4827(74)90657-0; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; Tenzen T, 1997, MOL CELL BIOL, V17, P4043, DOI 10.1128/MCB.17.7.4043	32	197	205	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					221	225		10.1038/35102606	http://dx.doi.org/10.1038/35102606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700561				2022-12-01	WOS:000172029100051
J	Niswender, KD; Morton, GJ; Stearns, WH; Rhodes, CJ; Myers, MG; Schwartz, MW				Niswender, KD; Morton, GJ; Stearns, WH; Rhodes, CJ; Myers, MG; Schwartz, MW			Intracellular signalling - Key enzyme in leptin-induced anorexia	NATURE			English	Article							ACTIVATION; 3-KINASE; OBESE; MICE		Univ Washington, Sch Med, Div Metab Endocrinol & Nutr, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Pacific NW Res Inst, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Niswender, KD (corresponding author), Univ Washington, Sch Med, Div Metab Endocrinol & Nutr, Seattle, WA 98104 USA.	mschwart@u.washington.edu	Schwartz, Michael W/H-9950-2012					Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	12	473	488	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					794	795		10.1038/35101657	http://dx.doi.org/10.1038/35101657			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677594				2022-12-01	WOS:000171750200033
J	Bates-Jensen, BM				Bates-Jensen, BM			Quality indicators for prevention and management of pressure ulcers in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							PREDICTIVE-VALIDITY; COST-EFFECTIVENESS; RANDOMIZED TRIAL; WOUND CLEANSERS; BRADEN-SCALE; SORE RISK; INTERVENTIONS; DEBRIDEMENT; MULTISITE; DRESSINGS		Univ Calif Los Angeles, Borun Ctr Gerontol Res, Reseda, CA 91335 USA	University of California System; University of California Los Angeles	Bates-Jensen, BM (corresponding author), Univ Calif Los Angeles, Borun Ctr Gerontol Res, 7150 Tampa Ave, Reseda, CA 91335 USA.		Bates-Jensen, Barbara/ABA-3726-2020					ALLMAN RM, 1987, ANN INTERN MED, V107, P641, DOI 10.7326/0003-4819-107-5-641; ALLMAN RM, 1986, ANN INTERN MED, V105, P337, DOI 10.7326/0003-4819-105-3-337; *AM MED DIR ASS, 1996, PRESS ULC CLIN PRACT; AMLUNG S, 2000, 14 ANN CLIN S WOUND, P234; Bale S, 1998, J Wound Care, V7, P65; Bates-Jensen B M, 1992, Decubitus, V5, P20; Bates-Jensen B M, 1997, Adv Wound Care, V10, P65; BATESJENSEN BM, 1999, WOUND CARE COLLABORA, P139; BATESJENSEN BM, 1999, THESIS LOS ANGELES U, V59; BATESJENSEN BM, 1998, WOUND CARE COLLABORA, P235; Bergstrom N, 1996, J AM GERIATR SOC, V44, P22, DOI 10.1111/j.1532-5415.1996.tb05633.x; Bergstrom N, 1998, NURS RES, V47, P261, DOI 10.1097/00006199-199809000-00005; BERGSTROM N, 1992, J AM GERIATR SOC, V40, P747, DOI 10.1111/j.1532-5415.1992.tb01845.x; BERLOWITZ DR, 1989, J AM GERIATR SOC, V37, P1043, DOI 10.1111/j.1532-5415.1989.tb06918.x; BERLOWITZ DR, 1990, J AM GERIATR SOC, V38, P748, DOI 10.1111/j.1532-5415.1990.tb01464.x; BRADEN BJ, 1994, RES NURS HEALTH, V17, P459, DOI 10.1002/nur.4770170609; BRANDEIS GH, 1990, JAMA-J AM MED ASSOC, V264, P2905, DOI 10.1001/jama.264.22.2905; BRENNAN SS, 1988, ANN EMERG MED, V17, P1274; Colin D, 1996, J Wound Care, V5, P444; *DESCR NPUAP, 1995, ADV WOUND CAR S, V8, P93; FERRELL BA, 1993, JAMA-J AM MED ASSOC, V269, P494, DOI 10.1001/jama.269.4.494; Flanagan M, 1995, J Wound Care, V4, P264; FORESMAN PA, 1993, WOUNDS, V5, P226; GORSE GJ, 1987, ARCH DERMATOL, V123, P766, DOI 10.1001/archderm.123.6.766; Hellewell TB, 1997, WOUNDS, V9, P15; LAZARUS GS, 1994, ARCH DERMATOL, V130, P489, DOI 10.1001/archderm.130.4.489; LEVINE NS, 1976, J TRAUMA, V16, P89, DOI 10.1097/00005373-197602000-00002; LINEAWEAVER W, 1985, ARCH SURG-CHICAGO, V120, P267; Martin S J, 1996, J Wound Care, V5, P310; MOOLTEN SE, 1972, ARCH PHYS MED REHAB, V53, P430; Mulder G D, 1995, Ostomy Wound Manage, V41, P62; MULDER GD, 1993, WOUNDS, V5, P112; *NAT PRESS ULC ADV, 2001, STAT PRESS ULC PREV; *NPUAP STAT REV ST, 1995, NPUAP REP NEWSL NAT, V4, P1; PINCHCOFSKYDEVIN GD, 1986, J AM GERIATR SOC, V34, P435, DOI 10.1111/j.1532-5415.1986.tb03411.x; *PRESS ULC AD PREV, 1992, AHCPR PUBL; ROBSON MC, 1988, ANN EMERG MED, V17, P1274, DOI 10.1016/S0196-0644(88)80352-4; ROBSON MC, 1990, CLIN PLAST SURG, V17, P485; ROUSSEAU P, 1989, WOUNDS, V1, P135; SAPICO FL, 1986, DIAGN MICR INFEC DIS, V5, P31, DOI 10.1016/0732-8893(86)90089-1; Saydak S J, 1990, J Enterostomal Ther, V17, P139; SEBERN MD, 1986, ARCH PHYS MED REHAB, V67, P726, DOI 10.1016/0003-9993(86)90004-3; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Steed DL, 1996, J AM COLL SURGEONS, V183, P61; Stotts N A, 1995, Adv Wound Care, V8, P46; Thomas D R, 1997, Adv Wound Care, V10, P96; Thomas DR, 1997, CLIN GERIATR MED, V13, P497; THOMAS DR, 1997, GERIATRIC MED, P767; *TREATM PRESS ULC, 1994, AHCPR PUBL; *US DEP HHS, 2000, HLTH PEOP 2010; van Rijswijk L, 1993, Decubitus, V6, P16; van Rijswijk L, 1994, Ostomy Wound Manage, V40, P40; van Rijswijk L, 1999, Ostomy Wound Manage, V45, p56S; VANRIJSWIJK L, 1997, CHRONIC WOUND CARE C; Whittington K, 2000, J Wound Ostomy Continence Nurs, V27, P209, DOI 10.1067/mjw.2000.107879; XAKELLIS GC, 1992, J AM GERIATR SOC, V40, P1250, DOI 10.1111/j.1532-5415.1992.tb03651.x; XAKELLIS GC, 1992, ARCH PHYS MED REHAB, V73, P463	57	40	42	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				744	751		10.7326/0003-4819-135-8_Part_2-200110161-00014	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00014			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601958				2022-12-01	WOS:000171542400014
J	MacLean, CH				MacLean, CH			Quality indicators for the management of osteoarthritis in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ARTHRITIS SELF-MANAGEMENT; SERIOUS GASTROINTESTINAL COMPLICATIONS; TOTAL HIP-ARTHROPLASTY; RHEUMATOID-ARTHRITIS; PATIENT EDUCATION; DOUBLE-BLIND; KNEE OSTEOARTHRITIS; MEDICAL-MANAGEMENT; FUNCTIONAL STATUS		RAND Corp, RAND Hlth, Santa Monica, CA 90407 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA	RAND Corporation; University of California System; University of California Los Angeles	MacLean, CH (corresponding author), RAND Corp, RAND Hlth, 1700 Main St,M-23C, Santa Monica, CA 90407 USA.							*AM AC ORTH SURG, 1991, OST HIP CLIN POL; [Anonymous], 1994, NIH Consens Statement, V12, P1; Bautch JC, 1997, ARTHRIT CARE RES, V10, P48, DOI 10.1002/art.1790100108; BECKENBAUGH RD, 1978, J BONE JOINT SURG AM, V60, P306, DOI 10.2106/00004623-197860030-00005; Bensen WG, 1999, MAYO CLIN PROC, V74, P1095, DOI 10.4065/74.11.1095; BOLLINI P, 1992, ARCH INTERN MED, V152, P1289, DOI 10.1001/archinte.152.6.1289; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Borjesson M, 1996, Physiother Res Int, V1, P89; BRADLEY JD, 1991, NEW ENGL J MED, V325, P87, DOI 10.1056/NEJM199107113250203; *CADM J SERV, 1998, 18 AM BOARD FAM PRAC; CALLAGHAN MJ, 1995, CLIN REHABIL, V9, P213, DOI DOI 10.1177/026921559500900306; CALLAHAN CM, 1994, JAMA-J AM MED ASSOC, V271, P1349, DOI 10.1001/jama.271.17.1349; Chamberlain M A, 1982, Int Rehabil Med, V4, P101; COVENTRY MB, 1974, J BONE JOINT SURG AM, VA 56, P273, DOI 10.2106/00004623-197456020-00005; DALTROY LH, 1993, HEALTH EDUC QUART, V20, P3, DOI 10.1177/109019819302000103; Deyle GD, 2000, ANN INTERN MED, V132, P173, DOI 10.7326/0003-4819-132-3-200002010-00002; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; FELSON DT, 1990, SEMIN ARTHRITIS RHEU, V20, P42, DOI 10.1016/0049-0172(90)90046-I; FREUND D, 1995, ASSESSING IMPROVING; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; GOEPPINGER J, 1989, ARTHRITIS RHEUM, V32, P706, DOI 10.1002/anr.1780320608; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; HIRANO PC, 1994, PATIENT EDUC COUNS, V24, P9, DOI 10.1016/0738-3991(94)90024-8; Hochberg M C, 1996, Arthritis Care Res, V9, P170, DOI 10.1002/1529-0131(199606)9:3<170::AID-ANR1790090304>3.0.CO;2-K; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1535, DOI 10.1002/art.1780381103; Holman HR, 1997, WESTERN J MED, V167, P265; Hughes SL, 1995, ARTHRIT CARE RES, V8, P257, DOI 10.1002/art.1790080409; HUGHES SL, 1991, ARTHRITIS RHEUM-US, V34, P856, DOI 10.1002/art.1780340711; Jan M H, 1991, J Formos Med Assoc, V90, P1008; Katz BP, 1996, HEALTH SERV RES, V31, P125; KAVANAGH BF, 1989, J BONE JOINT SURG AM, V71A, P1496, DOI 10.2106/00004623-198971100-00007; KEEFE FJ, 1990, BEHAV THER, V21, P435, DOI 10.1016/S0005-7894(05)80357-0; KJAERSGAARDANDERSEN P, 1990, PAIN, V43, P309, DOI 10.1016/0304-3959(90)90028-C; KNETTNER KE, 1995, OSTEOARTHRITIC DISOR, pR21; Koch M, 1996, ARCH INTERN MED, V156, P2321, DOI 10.1001/archinte.156.20.2321; KOVAR PA, 1992, ANN INTERN MED, V116, P529, DOI 10.7326/0003-4819-116-7-529; LABORDE JM, 1989, MULTIPLE LINEAR REGR, V12, P12; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; Lanza FL, 1998, AM J GASTROENTEROL, V93, P2037; LORIG K, 1992, HEALTH EDUC QUART, V19, P355, DOI 10.1177/109019819201900307; LORIG K, 1989, ARTHRITIS RHEUM, V32, P91, DOI 10.1002/anr.1780320116; LORIG K, 1986, J RHEUMATOL, V13, P763; LORIG K, 1989, SOC SCI MED, V29, P221, DOI 10.1016/0277-9536(89)90170-6; LORIG K, 1987, PATIENT EDUC COUNS, V10, P207, DOI 10.1016/0738-3991(87)90126-1; LORIG K, 1993, HEALTH EDUC QUART, V20, P17, DOI 10.1177/109019819302000104; LORIG K, 1985, ARTHRITIS RHEUM, V28, P680, DOI 10.1002/art.1780280612; MCCUNE WJ, 1997, TXB RHEUMATOLOGY, P378; MINOR MA, 1989, ARTHRITIS RHEUM, V32, P1396, DOI 10.1002/anr.1780321108; MULLEN PD, 1987, J RHEUMATOL, V14, P33; *OST ARTHR KNEE DE, 1996, CLIN POL AM AC ORTH; Pincus T, 2001, ARTHRITIS RHEUM-US, V44, P1587, DOI 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X; Schilke JM, 1996, NURS RES, V45, P68, DOI 10.1097/00006199-199603000-00002; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Shmerling RH, 1996, ARTHRITIS RHEUM, V39, P1; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simon LS, 1999, JAMA-J AM MED ASSOC, V282, P1921, DOI 10.1001/jama.282.20.1921; SuperioCabuslay E, 1996, ARTHRIT CARE RES, V9, P292, DOI 10.1002/1529-0131(199608)9:4<292::AID-ANR1790090414>3.0.CO;2-4; Taal E, 1997, SEMIN ARTHRITIS RHEU, V26, P805, DOI 10.1016/S0049-0172(97)80024-8; Taal E, 1996, ARTHRIT CARE RES, V9, P229, DOI 10.1002/1529-0131(199606)9:3<229::AID-ANR1790090312>3.0.CO;2-U; TOWHEED T, 2001, OSTEOARTHRITIS SYSTE, P2; Towheed TE, 1996, SEMIN ARTHRITIS RHEU, V26, P483, DOI 10.1016/S0049-0172(96)80029-1; Van Baar ME, 1998, J RHEUMATOL, V25, P2432; Van Baar ME, 1999, ARTHRITIS RHEUM-US, V42, P1361, DOI 10.1002/1529-0131(199907)42:7<1361::AID-ANR9>3.0.CO;2-9; VERBRUGGE LM, 1991, J GERONTOL, V46, pS71, DOI 10.1093/geronj/46.2.S71; WATSON MC, 2001, OSTEOARTHRITIS COMP, P2; WEINBERGER M, 1989, ARTHRITIS RHEUM, V32, P1577, DOI 10.1002/anr.1780321212; WHITE RH, 1990, J GEN INTERN MED, V5, P304, DOI 10.1007/BF02600396; WILLIAMS HJ, 1993, ARTHRITIS RHEUM-US, V36, P1196, DOI 10.1002/art.1780360904; YELIN EH, 1990, ARTHRITIS RHEUM, V33, P1205; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104; Zicat B, 1993, J Arthroplasty, V8, P395, DOI 10.1016/S0883-5403(06)80038-0	74	49	51	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				711	721		10.7326/0003-4819-135-8_Part_2-200110161-00010	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601954				2022-12-01	WOS:000171542400010
J	Schnelle, JF; Smith, RL				Schnelle, JF; Smith, RL			Quality indicators for the management of urinary incontinence in vulnerable community-dwelling elders	ANNALS OF INTERNAL MEDICINE			English	Article							INTRINSIC SPHINCTERIC DEFICIENCY; GENUINE STRESS-INCONTINENCE; RANDOMIZED CONTROLLED TRIAL; MUSCLE EXERCISE TREATMENT; DETRUSOR INSTABILITY; OLDER WOMEN; OXYBUTYNIN CHLORIDE; SURGICAL-TREATMENT; FOLLOW-UP; FEMALE		Anna & Harry Borun Ctr Gerontol Res, Reseda, CA 91335 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; Los Angeles Jewish Home Aging, Los Angeles, CA USA; Ctr Geriatr Res Educ & Clin, Sepulveda, CA USA; Vet Affairs Greater Los Angeles Healthcare Syst, Sepulveda, CA USA	University of California System; University of California Los Angeles; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Schnelle, JF (corresponding author), Anna & Harry Borun Ctr Gerontol Res, 7150 Tampa Ave, Reseda, CA 91335 USA.	lcarmona@ucla.edu						BENT AE, 1983, AM J OBSTET GYNECOL, V145, P218, DOI 10.1016/0002-9378(83)90495-7; Berghmans LCM, 1996, NEUROUROL URODYNAM, V15, P37, DOI 10.1002/(SICI)1520-6777(1996)15:1<37::AID-NAU4>3.0.CO;2-G; Blowman C, 1991, PHYSIOTHERAPY, V77, P661; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Burgio KL, 2000, J AM GERIATR SOC, V48, P370, DOI 10.1111/j.1532-5415.2000.tb04692.x; BURGIO KL, 1986, AM J OBSTET GYNECOL, V154, P58; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; BURNS PA, 1993, J GERONTOL, V48, pM167; Chang PL, 1998, J UROLOGY, V160, P402, DOI 10.1016/S0022-5347(01)62908-2; Cohen SJ, 1999, J GERONTOL A-BIOL, V54, pM34, DOI 10.1093/gerona/54.1.M34; COUILLARD DR, 1994, UROLOGY, V43, P203, DOI 10.1016/0090-4295(94)90045-0; Demarco Eileen, 1994, Journal of Urology, V151, p420A; DIOKNO A, 1995, J UROLOGY, V154, P1727, DOI 10.1016/S0022-5347(01)66768-5; DIOKNO AC, 1988, J UROLOGY, V140, P567, DOI 10.1016/S0022-5347(17)41720-4; Dugan E, 2000, J AM GERIATR SOC, V48, P413, DOI 10.1111/j.1532-5415.2000.tb04699.x; EASTWOOD HDH, 1984, AGE AGEING, V13, P230, DOI 10.1093/ageing/13.4.230; FANTL JA, 1991, JAMA-J AM MED ASSOC, V265, P609, DOI 10.1001/jama.265.5.609; Galloway NTM, 1997, AM J MED SCI, V314, P268, DOI 10.1097/00000441-199710000-00011; Haab F, 1997, J UROLOGY, V158, P1738, DOI 10.1016/S0022-5347(01)64114-4; HILTON P, 1981, BRIT MED J, V282, P940, DOI 10.1136/bmj.282.6268.940; HOLMES DM, 1989, BRIT J OBSTET GYNAEC, V96, P607, DOI 10.1111/j.1471-0528.1989.tb03263.x; JENSEN JK, 1994, OBSTET GYNECOL, V83, P904; Johnson TM, 1997, AM J MED SCI, V314, P250, DOI 10.1097/00000441-199710000-00008; JUMA S, 1992, UROLOGY, V39, P424, DOI 10.1016/0090-4295(92)90238-R; Kaplan SA, 1996, UROLOGY, V47, P885, DOI 10.1016/S0090-4295(96)00062-3; Kinn AC, 1995, SCAND J UROL NEPHROL, V29, P449, DOI 10.3109/00365599509180026; Kondo A, 1998, J UROLOGY, V160, P756, DOI 10.1016/S0022-5347(01)62778-2; KOONINGS PP, 1990, UROLOGY, V36, P245, DOI 10.1016/0090-4295(90)80265-O; Leach GE, 1997, J UROLOGY, V158, P875, DOI 10.1016/S0022-5347(01)64346-5; Litwiller SE, 1997, J UROLOGY, V157, P1279, DOI 10.1016/S0022-5347(01)64950-4; Mason RC, 1996, J UROLOGY, V156, P1991, DOI 10.1016/S0022-5347(01)65412-0; MCGUIRE EJ, 1995, UROL CLIN N AM, V22, P657; Miller JM, 1998, J AM GERIATR SOC, V46, P870, DOI 10.1111/j.1532-5415.1998.tb02721.x; Mostwin JL, 1996, J ENDOUROL, V10, P207, DOI 10.1089/end.1996.10.207; NORTON PA, 1994, OBSTET GYNECOL, V84, P770; OUSLANDER J, 1988, J UROLOGY, V140, P1482, DOI 10.1016/S0022-5347(17)42080-5; OUSLANDER J, 1989, J AM GERIATR SOC, V37, P715, DOI 10.1111/j.1532-5415.1989.tb02232.x; OUSLANDER JG, 1986, J AM GERIATR SOC, V34, P507, DOI 10.1111/j.1532-5415.1986.tb04242.x; PANNILL FC, 1988, J AM GERIATR SOC, V36, P902, DOI 10.1111/j.1532-5415.1988.tb05783.x; Pfister S M, 1994, J Community Health Nurs, V11, P155, DOI 10.1207/s15327655jchn1103_4; RESNICK NM, 1987, JAMA-J AM MED ASSOC, V257, P3076, DOI 10.1001/jama.257.22.3076; RESNICK NM, 1995, LANCET, V346, P94, DOI 10.1016/S0140-6736(95)92117-6; RESNICK NM, 1989, NEW ENGL J MED, V320, P1, DOI 10.1056/NEJM198901053200101; Resnick NM, 1995, NEUROUROL URODYNAM, V14, P577; SAND PK, 1995, AM J OBSTET GYNECOL, V173, P72, DOI 10.1016/0002-9378(95)90172-8; SAND PK, 1987, OBSTET GYNECOL, V69, P399; SCHNELLE JF, 1990, J AM GERIATR SOC, V38, P356, DOI 10.1111/j.1532-5415.1990.tb03521.x; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Smith JJ, 1996, J UROLOGY, V155, P127, DOI 10.1016/S0022-5347(01)66567-4; SUMMITT RL, 1990, J REPROD MED, V35, P877; Swierzewski Stanley J. Iii, 1994, Journal of Urology, V151, p419A; SWIFT SE, 1996, UROGYNECOLOGY URODYN; SZONYI G, 1995, AGE AGEING, V24, P287, DOI 10.1093/ageing/24.4.287; TAPP AJS, 1990, BRIT J OBSTET GYNAEC, V97, P521, DOI 10.1111/j.1471-0528.1990.tb02523.x; *UR INC AD AC CHRO, 1996, 2 CLIN PRACT GUID UR; WELLS TJ, 1991, J AM GERIATR SOC, V39, P785, DOI 10.1111/j.1532-5415.1991.tb02701.x; WISKIND AK, 1994, OBSTET GYNECOL, V83, P108; Wright EJ, 1998, J UROLOGY, V160, P759, DOI 10.1016/S0022-5347(01)62779-4; Wyman JF, 1998, AM J OBSTET GYNECOL, V179, P999, DOI 10.1016/S0002-9378(98)70206-6; Yamada T, 1998, J UROLOGY, V160, P746, DOI 10.1016/S0022-5347(01)62774-5; ZORZITTO ML, 1989, AGE AGEING, V18, P195, DOI 10.1093/ageing/18.3.195	61	26	26	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				752	758		10.7326/0003-4819-135-8_Part_2-200110161-00015	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601959				2022-12-01	WOS:000171542400015
J	Chisholm, SW; Falkowski, PG; Cullen, JJ				Chisholm, SW; Falkowski, PG; Cullen, JJ			Oceans - Dis-crediting ocean fertilization	SCIENCE			English	Editorial Material							PHYTOPLANKTON BLOOM; CARBON-CYCLE; CO2		MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Rutgers State Univ, Dept Geol, New Brunswick, NJ 08901 USA; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada	Massachusetts Institute of Technology (MIT); Rutgers State University New Brunswick; Dalhousie University	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chisholm@mit.edu	Cuillen, John/AAE-1371-2019; Cullen, John J/B-6105-2008	Cuillen, John/0000-0002-7740-0999; Cullen, John J/0000-0002-7740-0999; Chisholm, Sallie/0000-0003-1480-2445				BERNER RA, 1990, SCIENCE, V249, P1382, DOI 10.1126/science.249.4975.1382; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Carson Rachel, 1951, SEA US; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; FUHRMAN JA, 1991, LIMNOL OCEANOGR, V36, P1951, DOI 10.4319/lo.1991.36.8.1951; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Jones RR, 1997, ADV ATOM MOL OPT PHY, V38, P1; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; MARTIN JH, 1992, ENVIR SCI R, V43, P123; Ney RA, 2000, ENVIRON SCI TECHNOL, V34, p176A, DOI 10.1021/es003230m; PEARCE F, 2000, NEW SCI         0408, P18; RAWLS R, 2000, CHEM ENG NEWS   0918, P66; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; Seibel BA, 2001, SCIENCE, V294, P319, DOI 10.1126/science.1065301; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smetacek V., 2001, US JGOFS NEWS, V11, P11; 5965117; 5992089; 5535701; 6200530; 20010002983; 5967087; 55433173; 6056919	28	121	124	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					309	310		10.1126/science.1065349	http://dx.doi.org/10.1126/science.1065349			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598285				2022-12-01	WOS:000171601400023
J	Stevens, DR; Seifert, R; Bufe, B; Muller, F; Kremmer, E; Gauss, R; Meyerhof, W; Kaupp, UB; Lindemann, B				Stevens, DR; Seifert, R; Bufe, B; Muller, F; Kremmer, E; Gauss, R; Meyerhof, W; Kaupp, UB; Lindemann, B			Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli	NATURE			English	Article							TASTE CELLS; PACEMAKER CHANNELS; INTRACELLULAR PH; CHORDA TYMPANI; CATION CURRENT; TRANSDUCTION; RAT; HAMSTER; NEURONS; FAMILY	Sour taste is initiated by protons acting at receptor proteins or channels. In vertebrates, transduction of this taste quality involves several parallel pathways(1-5). Here we examine the effects of sour stimuli on taste cells in slices of vallate papilla from rat. From a subset of cells, we identified a hyperpolarization-activated current that was enhanced by sour stimulation at the taste pore. This current resembled Ih found in neurons and cardio-myocytes(6,7), a current carried by members of the family of hyperpolarization-activated and cyclic-nucleotide-gated (HCN) channels(8-13). We show by in situ hybridization and immunohistochemistry that HCN1 and HCN4 are expressed in a subset of taste cells. By contrast, gustducin, the G-protein involved in bitter and sweet taste(14), is not expressed in these cells. Lowering extracellular pH causes a dose-dependent flattening of the activation curve of HCN channels and a shift in the voltage of half-maximal activation to more positive voltages. Our results indicate that HCN channels are gated by extracellular protons and may act as receptors for sour taste.	Univ Saarland, Dept Physiol, D-66421 Homburg, Germany; Forschungszentrum Julich, Inst Biol Informat Proc, D-52425 Julich, Germany; Deutsch Inst Ernahrungsforsch, Dept Mol Genet, D-14558 Potsdam, Germany; GSF, Inst Mol Immunol, D-81377 Munich, Germany	Saarland University; Helmholtz Association; Research Center Julich; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lindemann, B (corresponding author), Univ Saarland, Dept Physiol, D-66421 Homburg, Germany.	phblin@uniklinik-saarland.de	Mueller, Frank/I-7196-2013; Bufe, Bernd/N-6685-2018	Mueller, Frank/0000-0001-7264-1227; Bufe, Bernd/0000-0003-1610-0658; Stevens, David/0000-0003-4651-1706				Boughter JD, 1997, J NEUROSCI, V17, P2852; DESIMONE JA, 1995, AM J PHYSIOL-CELL PH, V268, pC1295, DOI 10.1152/ajpcell.1995.268.5.C1295; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GILBERTSON TA, 1992, J GEN PHYSIOL, V100, P803, DOI 10.1085/jgp.100.5.803; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Miyamoto T, 1998, J NEUROPHYSIOL, V80, P1852, DOI 10.1152/jn.1998.80.4.1852; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Muller F, 2001, J PHYSIOL-LONDON, V532, P399, DOI 10.1111/j.1469-7793.2001.0399f.x; Munsch T, 1999, J PHYSIOL-LONDON, V519, P493, DOI 10.1111/j.1469-7793.1999.0493m.x; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; Pittman DW, 1998, BRAIN RES, V790, P224, DOI 10.1016/S0006-8993(98)00059-6; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Stewart RE, 1998, AM J PHYSIOL-CELL PH, V275, pC227, DOI 10.1152/ajpcell.1998.275.1.C227; STRIEM B J, 1991, Cellular Physiology and Biochemistry, V1, P46, DOI 10.1159/000154592; Trotier D, 1996, J PHYSIOL-LONDON, V490, P611, DOI 10.1113/jphysiol.1996.sp021171; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zong XG, 2001, J BIOL CHEM, V276, P6313, DOI 10.1074/jbc.M010326200	23	166	178	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					631	635		10.1038/35098087	http://dx.doi.org/10.1038/35098087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675786				2022-12-01	WOS:000171485700049
J	Epstein, ACR; Gleadle, JM; McNeill, LA; Hewitson, KS; O'Rourke, J; Mole, DR; Mukherji, M; Metzen, E; Wilson, MI; Dhanda, A; Tian, YM; Masson, N; Hamilton, DL; Jaakkola, P; Barstead, R; Hodgkin, J; Maxwell, PH; Pugh, CW; Schofield, CJ; Ratcliffe, PJ				Epstein, ACR; Gleadle, JM; McNeill, LA; Hewitson, KS; O'Rourke, J; Mole, DR; Mukherji, M; Metzen, E; Wilson, MI; Dhanda, A; Tian, YM; Masson, N; Hamilton, DL; Jaakkola, P; Barstead, R; Hodgkin, J; Maxwell, PH; Pugh, CW; Schofield, CJ; Ratcliffe, PJ			C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation	CELL			English	Article							INDUCIBLE FACTOR 1-ALPHA; CAENORHABDITIS-ELEGANS; FACTOR-I; ALPHA; PROTEIN; GENE; UBIQUITINATION; EXPRESSION; MECHANISM; BINDING	HIF is a transcriptional complex that plays a central role in mammalian oxygen homeostasis. Recent studies have defined posttranslational modification by prolyl hydroxylation as a key regulatory event that targets HIF-alpha. subunits for proteasomal destruction via the von Hippel-Lindau ubiquitylation complex. Here, we define a conserved HIF-VHL-prolyl hydroxylase pathway in C. elegans, and use a genetic approach to identify EGL-9 as a dioxygenase that regulates HIF by prolyl hydroxylation. In mammalian cells, we show that the HIF-prolyl hydroxylases are represented by a series of isoforms bearing a conserved 2-histidine-1-carboxylate iron coordination motif at the catalytic site. Direct modulation of recombinant enzyme activity by graded hypoxia, iron chelation, and cobaltous ions mirrors the characteristics of HIF induction in vivo, fulfilling requirements for these enzymes being oxygen sensors that regulate HIF.	Oxford Ctr Mol Sci, Oxford OX1 3QY, England; Dyson Perrins Lab, Oxford OX1 3QY, England; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	University of Oxford; University of Oxford; Oklahoma Medical Research Foundation; University of Oxford	Ratcliffe, PJ (corresponding author), Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	peter.ratcliffe@imm.ox.ac.uk	Gleadle, Jonathan M/K-4188-2012; Jaakkola, Panu M/B-4355-2012; Knowles, Helen/F-3857-2018; Maxwell, Patrick H/C-5557-2008	Gleadle, Jonathan M/0000-0002-5215-7208; Knowles, Helen/0000-0002-9575-6067; Maxwell, Patrick H/0000-0002-0338-2679; Schofield, Christopher/0000-0002-0290-6565; Pugh, Chris/0000-0002-5170-1662; Mole, David/0000-0002-0984-300X; Ratcliffe, Peter/0000-0002-2853-806X; Jaakkola, Panu/0000-0002-2365-4985				BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Berra E, 2001, FEBS LETT, V491, P85, DOI 10.1016/S0014-5793(01)02159-7; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Dupuy D, 2000, GENOMICS, V69, P348, DOI 10.1006/geno.2000.6343; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Lipscomb EA, 2001, J BIOL CHEM, V276, P5085, DOI 10.1074/jbc.M008407200; Lloyd MD, 1999, J MOL BIOL, V287, P943, DOI 10.1006/jmbi.1999.2594; Madden SL, 1996, CANCER RES, V56, P5384; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mukherji M, 2001, CHEM COMMUN, P972, DOI 10.1039/b101039p; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; TRENT C, 1983, GENETICS, V104, P619; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WAX SD, 1994, J BIOL CHEM, V269, P13041; Wenger RH, 2000, J EXP BIOL, V203, P1253; Woodward ER, 2000, GENOMICS, V65, P253, DOI 10.1006/geno.2000.6144; Wu M, 1999, J AM CHEM SOC, V121, P587, DOI 10.1021/ja981193h; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127; Zhou J, 1998, J AM CHEM SOC, V120, P13539, DOI 10.1021/ja983534x; Zhu H, 2001, SCIENCE, V292, P449, DOI 10.1126/science.1060849	40	2608	2727	3	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2001	107	1					43	54		10.1016/S0092-8674(01)00507-4	http://dx.doi.org/10.1016/S0092-8674(01)00507-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595184	Bronze			2022-12-01	WOS:000171453100008
J	Emery, J				Emery, J			Silent suffering	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 16	1995	311	7020					1647	1647		10.1136/bmj.311.7020.1647	http://dx.doi.org/10.1136/bmj.311.7020.1647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TL422	11644742	Green Published			2022-12-01	WOS:A1995TL42200080
J	Feinberg, H; Mitchell, DA; Drickamer, K; Weis, WI				Feinberg, H; Mitchell, DA; Drickamer, K; Weis, WI			Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR	SCIENCE			English	Article							MANNOSE-BINDING PROTEIN; CELLS	Dendritic cell specific intracellular adhesion molecule-3 (ICAM-3) grabbing nonintegrin (DC-SIGN), a C-type lectin present on the surface of dendritic cells, mediates the initial interaction of dendritic cells with T cells by binding to ICAM-3. DC-SIGN and DC-SIGNR, a related receptor found on the endothelium of Liver sinusoids, placental capillaries, and Lymph nodes, bind to oligosaccharides that are present on the envelope of human immunodeficiency virus (HIV), an interaction that strongly promotes viral infection of T cells. Crystal structures of carbohydrate-recognition domains of DC-SIGN and of DC-SIGNR bound to oligosaccharide, in combination with binding studies, reveal that these receptors selectively recognize endogenous high-mannose oligosaccharides and may represent a new avenue for developing HIV prophylactics.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England	Stanford University; Stanford University; University of Oxford	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.		Weis, William I/G-1437-2011; Mitchell, Daniel A/A-6580-2009	Weis, William I/0000-0002-5583-6150; Mitchell, Daniel A/0000-0003-0936-6212	NIGMS NIH HHS [GM50565] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; MIZUOCHI T, 1990, J BIOL CHEM, V265, P8519; Nicholls A., 1992, GRASP GRAPHICAL REPR; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Woods RJ, 1998, EUR J BIOCHEM, V258, P372, DOI 10.1046/j.1432-1327.1998.2580372.x	19	538	578	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2163	2166		10.1126/science.1066371	http://dx.doi.org/10.1126/science.1066371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739956				2022-12-01	WOS:000172647700050
J	Seisenberger, G; Ried, MU; Endress, T; Buning, H; Hallek, M; Brauchle, C				Seisenberger, G; Ried, MU; Endress, T; Buning, H; Hallek, M; Brauchle, C			Real-time single-molecule imaging of the infection pathway of an adeno-associated virus	SCIENCE			English	Article							ADENOASSOCIATED VIRUS; GENE-THERAPY; MEMBRANE; DIFFUSION; DYNAMICS; TRACKING; TYPE-2; CORECEPTOR; MICROSCOPY; CYTOPLASM	We describe a method, based on single-molecule imaging, that allows the real-time visualization of the infection pathway of single viruses in living cells, each labeled with only one fluorescent dye molecule. The tracking of single viruses removes ensemble averaging. Diffusion trajectories with high spatial and time resolution show various modes of motion of adeno-associated viruses (AAV) during their infection pathway into living HeLa cells: (i) consecutive virus touching at the cell surface and fast endocytosis; (il) free and anomalous diffusion of the endosome and the virus in the cytoplasm and the nucleus; and (iii) directed motion by motor proteins in the cytoplasm and in nuclear tubular structures. The real-time visualization of the infection pathway of single AAVs shows a much faster infection than was generally observed so far.	Univ Munich, Dept Chem, D-81377 Munich, Germany; Univ Munich, Klinikum Grosshadern, Med Klin 3, Lab Mol Biol,Genzentrum, D-81377 Munich, Germany; GSF, Natl Ctr Res & Environm, KKG Gentherapie, D-81377 Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Brauchle, C (corresponding author), Univ Munich, Dept Chem, Butenandtstr 11, D-81377 Munich, Germany.		Buening, Hildegard/AAJ-2352-2020; Buening, Hildegard/AAV-9928-2021; Hallek, Michael/Y-3191-2019	Buening, Hildegard/0000-0002-3365-6933; Hallek, Michael/0000-0002-7425-4455				Bartlett JS, 1998, NAT MED, V4, P635, DOI 10.1038/nm0598-635; Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000; Berg, 2018, RANDOM WALKS BIOL; Broers JLV, 1999, J CELL SCI, V112, P3463; Dickson RM, 1996, SCIENCE, V274, P966, DOI 10.1126/science.274.5289.966; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Goulian M, 2000, BIOPHYS J, V79, P2188, DOI 10.1016/S0006-3495(00)76467-8; Ishii Y., 2000, Single Molecules, V1, P5, DOI 10.1002/(SICI)1438-5171(200004)1:1<5::AID-SIMO5>3.0.CO;2-A; KOTIN RM, 1994, HUM GENE THER, V5, P793, DOI 10.1089/hum.1994.5.7-793; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sanlioglu S, 2000, J VIROL, V74, P9184, DOI 10.1128/JVI.74.19.9184-9196.2000; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SCHMIDT T, 1995, J PHYS CHEM-US, V99, P17662, DOI 10.1021/j100049a030; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; Xu XH, 1997, SCIENCE, V275, P1106, DOI 10.1126/science.275.5303.1106	31	645	677	4	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1929	1932		10.1126/science.1064103	http://dx.doi.org/10.1126/science.1064103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729319				2022-12-01	WOS:000172465000060
J	Moret, Y; Schmid-Hempel, P				Moret, Y; Schmid-Hempel, P			Entomology - Immune defence in bumble-bee offspring	NATURE			English	Article							IMMUNIZATION; HEMOLYMPH; SYSTEM; INSECT		ETH Zurich, ETH Zentrum NW, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Moret, Y (corresponding author), ETH Zurich, ETH Zentrum NW, CH-8092 Zurich, Switzerland.		Moret, Yannick/I-9282-2012					Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Coste A, 2000, J VIROL, V74, P8966, DOI 10.1128/JVI.74.19.8966-8971.2000; Hanson LA, 1998, ANN ALLERG ASTHMA IM, V81, P523, DOI 10.1016/S1081-1206(10)62704-4; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; KATO Y, 1994, INSECT BIOCHEM MOLEC, V24, P539, DOI 10.1016/0965-1748(94)90089-2; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Nigam Y, 1997, J INVERTEBR PATHOL, V69, P279, DOI 10.1006/jipa.1996.4652; Rollier C, 2000, VACCINE, V18, P3091, DOI 10.1016/S0264-410X(00)00130-4; SCHIMDHEMPEL P, 1998, PARASITES SOCIAL INS; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; TORNQVIST PO, 1996, DIS ASIAN AQUACULTUR, V3, P203	13	172	176	2	92	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					506	506		10.1038/35107138	http://dx.doi.org/10.1038/35107138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734840				2022-12-01	WOS:000172405900033
J	Kang-Decker, N; Mantchev, GT; Juneja, SC; McNiven, MA; van Deursen, JMA				Kang-Decker, N; Mantchev, GT; Juneja, SC; McNiven, MA; van Deursen, JMA			Lack of acrosome formation in Hrb-deficient mice	SCIENCE			English	Article							PROTEIN	The sperm acrosome is essential for sperm-egg fusion and is often defective in men with nonobstructive infertility. Here we report that mate mice with a null mutation in Hrb are infertile and display round-headed spermatozoa that Lack an acrosome. In wild-type spermatids, Hrb is associated with the cytosolic surface of proacrosomic transport vesicles that fuse to create a single Large acrosomic vesicle at step 3 of spermiogenesis. Although proacrosomic vesicles form in spermatids that lack Hrb, the vesicles are unable to fuse, blocking acrosome development at step 2. We conclude that Hrb is required for docking and/or fusion of proacrosomic vesicles during acrosome biogenesis.	Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	van Deursen, JMA (corresponding author), Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, 200 1st St SW, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu		Juneja, Subhash/0000-0002-8536-5724				Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; Clermont Y., 1993, FRONT ENDOCRINOL, P332; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Hogan B., 2014, MANIPULATING MOUSE E; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; SCHILL WB, 1991, HUM REPROD, V6, P969, DOI 10.1093/oxfordjournals.humrep.a137471; SINGH G, 1992, INT J FERTIL, V37, P99; TESARIK JN, 1995, NEW ENGL J MED, V333, P525, DOI 10.1056/NEJM199508243330819; Venables JP, 2000, J ENDOCRINOL INVEST, V23, P584, DOI 10.1007/BF03343780	11	191	205	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1531	1533		10.1126/science.1063665	http://dx.doi.org/10.1126/science.1063665			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711676				2022-12-01	WOS:000172240500050
J	Modiano, D; Luoni, G; Sirima, BS; Simpore, J; Verra, F; Konate, A; Rastrelli, E; Olivieri, A; Calissano, C; Paganotti, GM; D'Urbano, L; Sanou, I; Sawadogo, A; Modiano, G; Coluzzi, M				Modiano, D; Luoni, G; Sirima, BS; Simpore, J; Verra, F; Konate, A; Rastrelli, E; Olivieri, A; Calissano, C; Paganotti, GM; D'Urbano, L; Sanou, I; Sawadogo, A; Modiano, G; Coluzzi, M			Haemoglobin C protects against clinical Plasmodium falciparum malaria	NATURE			English	Article							NATURAL-SELECTION; HEMOGLOBIN-C; P-FALCIPARUM; GLOBIN GENE; RESISTANCE; MECHANISM; MUTATION; ORIGIN; AFRICA; CHILDREN	Haemoglobin C (HbC; beta 6Glu --> Lys) is common in malarious areas of West Africa, especially in Burkina Faso(1,2). Conclusive evidence exists on the protective role against severe malaria of haemoglobin S (HbS; beta 6Glu --> Val) heterozygosity(3), whereas conflicting results for the HbC trait have been reported(4-10) and no epidemiological data exist on the possible role of the HbCC genotype. In vitro studies suggested that HbCC erythrocytes fail to support the growth of P. falciparum(11,12) but HbC homozygotes with high P. falciparum parasitaemias have been observed(10). Here we show, in a large case-control study performed in Burkina Faso on 4,348 Mossi subjects, that HbC is associated with a 29% reduction in risk of clinical malaria in HbAC heterozygotes (P = 0.0008) and of 93% in HbCC homozygotes (P = 0.0011). These findings, together with the limited pathology of HbAC and HbCC(13) compared to the severely disadvantaged HbSS and HbSC genotypes and the low beta (S) gene frequency in the geographic epicentre of beta (C1,2,14), support the hypothesis that, in the long term and in the absence of malaria control, HbC would replace HbS in central West Africa.	Univ Roma La Sapienza, WHO Collaborating Ctr Malaria Epidemiol & Control, Sez Parassitol, Dipartimento Sci Sanita Pubbl, I-00185 Rome, Italy; Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; Ctr Hosp Natl Yalgado Ouedraogo, Serv Pediat, Ouagadougou, Burkina Faso; Ctr Med St Camille, Ouagadougou, Burkina Faso; Minist Sante, Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Rome Tor Vergata	Modiano, D (corresponding author), Univ Roma La Sapienza, WHO Collaborating Ctr Malaria Epidemiol & Control, Sez Parassitol, Dipartimento Sci Sanita Pubbl, I-00185 Rome, Italy.	david.modiano@uniroma1.it	OLIVIERI, ANNA/C-2952-2016; SIMPORE, Jacques/ABA-4873-2020	OLIVIERI, ANNA/0000-0003-3882-8017; SIMPORE, Jacques/0000-0002-0415-9161; Paganotti, Giacomo/0000-0002-0751-0682				Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P6608, DOI 10.1073/pnas.79.21.6608; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; FRIEDMAN MJ, 1979, AM J TROP MED HYG, V28, P777, DOI 10.4269/ajtmh.1979.28.777; GILLES HM, 1967, LANCET, V1, P138; Guinet F, 1997, ACTA TROP, V68, P175, DOI 10.1016/S0001-706X(97)00089-2; Haldane JBS., 1949, HEREDITAS S, V35, P267, DOI DOI 10.1111/J.1601-5223.1949.TB03339.X; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hutagalung R, 1999, J INFECT DIS, V179, P283, DOI 10.1086/314561; KULOZIK AE, 1986, AM J HUM GENET, V39, P239; LABIE D, 1984, HUM GENET, V65, P300, DOI 10.1007/BF00286522; LIVINGSTON FB, 1967, ABNORMAL HEMOGLOBINS; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; MODIANO G, 1981, P NATL ACAD SCI-BIOL, V78, P1110, DOI 10.1073/pnas.78.2.1110; Molineaux L., 1980, GARKI PROJECT RES EP; OLSON JA, 1986, BLOOD, V67, P997; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; RINGELHANN B, 1976, AM J HUM GENET, V28, P270; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sanchaisuriya K, 2001, AM J HEMATOL, V67, P189, DOI 10.1002/ajh.1105; SFORZA C, 1971, GENETICS HUMAN POPUL; SMITH EW, 1959, B JOHNS HOPKINS HOSP, V104, P17; THOMPSON GR, 1963, BMJ-BRIT MED J, P976, DOI 10.1136/bmj.2.5363.976; THOMPSON GR, 1962, BMJ-BRIT MED J, P682, DOI 10.1136/bmj.1.5279.682; TRABUCHET G, 1991, HUM GENET, V87, P597	30	240	251	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2001	414	6861					305	308		10.1038/35104556	http://dx.doi.org/10.1038/35104556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713529				2022-12-01	WOS:000172150700043
J	Yarrow, K; Haggard, P; Heal, R; Brown, P; Rothwell, JC				Yarrow, K; Haggard, P; Heal, R; Brown, P; Rothwell, JC			Illusory perceptions of space and time preserve cross-saccadic perceptual continuity	NATURE			English	Article							EYE-MOVEMENTS; INFORMATION; INTEGRATION; OBJECT	When voluntary saccadic eye movements are made to a silently ticking clock, observers sometimes think that the second hand takes longer than normal to move to its next position(1). For a short period, the clock appears to have stopped (chronostasis). Here we show that the illusion occurs because the brain extends the percept of the saccadic target backwards in time to just before the onset of the saccade. This occurs every time we move the eyes but it is only perceived when an external time reference alerts us to the phenomenon. The illusion does not seem to depend on the shift of spatial attention that accompanies the saccade. However, if the target is moved unpredictably during the saccade, breaking perception of the target's spatial continuity, then the illusion disappears. We suggest that temporal extension of the target's percept is one of the mechanisms that 'fill in' the perceptual 'gap' during saccadic suppression. The effect is critically linked to perceptual mechanisms that identify a target's spatial stability.	Inst Neurol, Sobell Dept Neurophysiol, London WC1N 3BG, England; UCL, Dept Psychol, Inst Cognit Neurosci, London WC1N 3AR, England; Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England	University of London; University College London; University of London; University College London; University of Oxford	Yarrow, K (corresponding author), Inst Neurol, Sobell Dept Neurophysiol, 8-11 Queen Sq, London WC1N 3BG, England.		Brown, Peter/J-4307-2016; Haggard, Patrick/A-5081-2010	Brown, Peter/0000-0002-5201-3044; Rothwell, John/0000-0003-1367-6467; Yarrow, Kielan/0000-0003-0666-2163; Haggard, Patrick/0000-0001-7798-793X				BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; Brown EA, 1997, J ART MANAG LAW SOC, V27, P23, DOI 10.1080/10632929709597265; Currie CB, 2000, PERCEPT PSYCHOPHYS, V62, P673, DOI 10.3758/BF03206914; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Deubel H, 1999, CURRENT OCULOMOTOR RESEARCH, P65; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; GELDARD FA, 1986, SCI AM, V255, P84; HAGGARD P, IN PRESS ATTENTION P, P19; HOMMEL B, IN PRESS BEHAV BRAIN; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; KOLERS PA, 1976, VISION RES, V16, P329, DOI 10.1016/0042-6989(76)90192-9; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; LIBET B, 1979, BRAIN, V102, P193, DOI 10.1093/brain/102.1.193; MACK A, 1970, PERCEPT PSYCHOPHYS, V8, P291, DOI 10.3758/BF03212596; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P232; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; TYRELL RA, 1988, BEHAV RES METH INSTR, V20, P137; VOLKMANN FC, 1978, VISUAL PSYCHOPHYSICS, P353	24	171	173	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					302	305		10.1038/35104551	http://dx.doi.org/10.1038/35104551			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713528	Green Accepted			2022-12-01	WOS:000172150700042
J	Pannifer, AD; Wong, TY; Schwarzenbacher, R; Renatus, M; Petosa, C; Bienkowska, J; Lacy, DB; Collier, RJ; Park, S; Leppla, SH; Hanna, P; Liddington, RC				Pannifer, AD; Wong, TY; Schwarzenbacher, R; Renatus, M; Petosa, C; Bienkowska, J; Lacy, DB; Collier, RJ; Park, S; Leppla, SH; Hanna, P; Liddington, RC			Crystal structure of the anthrax lethal factor	NATURE			English	Article							PROTECTIVE ANTIGEN; BACILLUS-ANTHRACIS; FACTOR CLEAVES; TOXIN; MACROPHAGES; PROTEIN; IDENTIFICATION; PROGRAM	Lethal factor (LF) is a protein (relative molecular mass 90,000) that is critical in the pathogenesis of anthrax(1-3). It is a highly specific protease that cleaves members of the mitogen-activated protein kinase kinase (MAPKK) family near to their amino termini, leading to the inhibition of one or more signalling pathways(4-6). Here we describe the crystal structure of LF and its complex with the N terminus of MAPKK-2. LF comprises four domains: domain I binds the membrane-translocating component of anthrax toxin, the protective antigen (PA); domains II, III and IV together create a long deep groove that holds the 16-residue N-terminal tail of MAPKK-2 before cleavage. Domain II resembles the ADP-ribosylating toxin from Bacillus cereus, but the active site has been mutated and recruited to augment substrate recognition. Domain III is inserted into domain II, and seems to have arisen from a repeated duplication of a structural element of domain II. Domain IV is distantly related to the zinc metalloprotease family, and contains the catalytic centre; it also resembles domain I. The structure thus reveals a protein that has evolved through a process of gene duplication, mutation and fusion, into an enzyme with high and unusual specificity.	Burnham Inst, La Jolla, CA 92037 USA; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Leicester; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Michigan System; University of Michigan	Liddington, RC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Wong, Tien Yin/AAC-9724-2020; Lacy, D. Borden/AFQ-2203-2022	Wong, Tien Yin/0000-0002-8448-1264; Lacy, Borden/0000-0003-2273-8121; Collier, R John/0000-0002-2427-4239; Petosa, Carlo/0000-0002-9975-1167	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000677] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Ballard JD, 1996, P NATL ACAD SCI USA, V93, P12531, DOI 10.1073/pnas.93.22.12531; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARROLL SF, 1984, P NATL ACAD SCI-BIOL, V81, P3307, DOI 10.1073/pnas.81.11.3307; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Goletz TJ, 1997, P NATL ACAD SCI USA, V94, P12059, DOI 10.1073/pnas.94.22.12059; Gupta P, 2001, BIOCHEM BIOPH RES CO, V280, P158, DOI 10.1006/bbrc.2000.4099; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEPPLA SH, 1999, COMPREHENSIVE SOURCE, P243; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mock WL, 1996, BIOCHEMISTRY-US, V35, P7369, DOI 10.1021/bi952827p; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; QUINN CP, 1991, J BIOL CHEM, V266, P20124; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wang XM, 1996, BIOCHEMISTRY-US, V35, P14939, DOI 10.1021/bi961518b; [No title captured]	31	323	372	0	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					229	233		10.1038/n35101998	http://dx.doi.org/10.1038/n35101998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700563	Green Published			2022-12-01	WOS:000172029100053
J	Schaumberg, DA; Buring, JE; Sullivan, DA; Dana, MR				Schaumberg, DA; Buring, JE; Sullivan, DA; Dana, MR			Hormone replacement therapy and dry eye syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; POSTMENOPAUSAL WOMEN; SJOGRENS-SYNDROME; STEROID-HORMONES; EPIDEMIOLOGY; GLANDS; PREVENTION; HEALTH; TRIAL	Context Postmenopausal hormone replacement therapy (HRT) use is common in the United States. Some research suggests that estrogen may have detrimental effects on the tear film and could influence the development of dry eye syndrome, but few data are available on this relationship. Objective To determine the relationship of HRT and dry eye syndrome. Design, Setting, and Participants The Women's Health Study, a large cohort study in which 25665 postmenopausal women provided information about use of HRT at baseline (1992), 12, and 36 months and dry eye syndrome at 48 months. Main Outcome Measures (1) Clinically diagnosed dry eye syndrome, as reported by participants; (2) severe symptoms (both ocular dryness and irritation either constantly or often); and (3) either clinically diagnosed dry eye syndrome or severe symptoms, compared between women who used HRT vs those who did not. Results For the combined end point of either clinically diagnosed dry eye syndrome or severe symptoms, the multivariable-adjusted odds ratios were 1.69 (95% confidence interval [CI], 1.49-1.91) for estrogen use alone and 1.29 (95% Cl, 1.13-1.48) for estrogen plus progesterone/progestin use compared with no HRT use, Each 3-year increase in the duration of HRT use was associated with a significant 15% (95% CI, 11%-19%) elevation in risk of clinically diagnosed dry eye syndrome or severe symptoms. Results were similar for the combined end point of clinically diagnosed dry eye syndrome and severe symptoms. Conclusions These data suggest that women who use HRT, particularly estrogen alone, are at increased risk of dry eye syndrome. Physicians caring for women who are taking or considering HRT should be apprised of this potential complication.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02215 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Ophthalmol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard T.H. Chan School of Public Health	Schaumberg, DA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.			Sullivan, David A/0000-0002-3424-3778	NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY000365] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER; NCI NIH HHS [CA47988] Funding Source: Medline; NEI NIH HHS [K23 EY000365-05, K23 EY000365-04, EY00365] Funding Source: Medline; NHLBI NIH HHS [HL43851] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELCHETZ PE, 1994, NEW ENGL J MED, V330, P1062; BRENNAN NA, 1989, OPTOMETRY VISION SCI, V66, P834, DOI 10.1097/00006324-198912000-00006; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; Caffery BE, 1998, ADV EXP MED BIOL, V438, P805; Davis S, 2001, J REPROD MED, V46, P291; Esmaeli B, 2000, OPHTHALMOLOGY, V107, P180, DOI 10.1016/S0161-6420(99)00040-8; Frieling UM, 2000, ARCH DERMATOL, V136, P179, DOI 10.1001/archderm.136.2.179; GILBARD JP, 1994, PRINCIPLES PRACTICE, P257; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; GURWOOD AS, 1995, OPTOMETRY VISION SCI, V72, P29, DOI 10.1097/00006324-199501000-00006; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunter David J., 1990, Annals of Epidemiology, V1, P13; Keating NL, 1999, ANN INTERN MED, V130, P545, DOI 10.7326/0003-4819-130-7-199904060-00002; Korb DR, 2000, CORNEA, V19, P483, DOI 10.1097/00003226-200007000-00016; Lemp MA, 1998, ADV EXP MED BIOL, V438, P791; McCarty CA, 1998, OPHTHALMOLOGY, V105, P1114, DOI 10.1016/S0161-6420(98)96016-X; McMonnies C W, 1987, J Am Optom Assoc, V58, P296; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Nagler RM, 2000, SEMIN ARTHRITIS RHEU, V30, P209, DOI 10.1053/sarh.2000.18234; Nelson JD, 2000, ADV THER, V17, P84, DOI 10.1007/BF02854841; Nichols KK, 2000, CORNEA, V19, P477, DOI 10.1097/00003226-200007000-00015; Oden NL, 1998, ADV EXP MED BIOL, V438, P807; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; SATO EH, 1994, INVEST OPHTH VIS SCI, V35, P2632; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; Sullivan DA, 1999, ANN NY ACAD SCI, V876, P312, DOI 10.1111/j.1749-6632.1999.tb07656.x; Sullivan DA, 1998, ADV EXP MED BIOL, V438, P11; Sullivan DA, 1998, ADV EXP MED BIOL, V438, P327; SULLIVAN DA, 1997, RES PREVENT BLINDNES, P57; Taskinen MR, 1998, ANN MED, V30, P443, DOI 10.3109/07853899809002485; Tavani A, 1999, DRUG AGING, V14, P347, DOI 10.2165/00002512-199914050-00003; TAYLOR HR, 1980, ANN OPHTHALMOL, V12, P531; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; *WRIT GROUP PEPI T, 1995, JAMA-J AM MED ASSOC, V274, P1676	35	250	269	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2114	2119		10.1001/jama.286.17.2114	http://dx.doi.org/10.1001/jama.286.17.2114			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694152	Bronze, Green Published			2022-12-01	WOS:000172032100030
J	Schwetz, BA				Schwetz, BA			Grant applications for clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2085	2085		10.1001/jama.286.17.2085	http://dx.doi.org/10.1001/jama.286.17.2085			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694130				2022-12-01	WOS:000172032100009
J	Hypponen, E; Laara, E; Reunanene, A; Jarvelin, MR; Virtanen, SM				Hypponen, E; Laara, E; Reunanene, A; Jarvelin, MR; Virtanen, SM			Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study	LANCET			English	Article							FINNISH CHILDREN; NOD MICE; MELLITUS; ONSET	Background Dietary vitamin D supplementation is associated with reduced risk of type 1 diabetes in animals. Our aim was to ascertain whether or not vitamin D supplementation or deficiency in infancy could affect development of type 1 diabetes. Methods A birth-cohort study was done, in which all pregnant women (n=12055) in Oulu and Lapland, northern Finland, who were due to give birth in 1966 were enrolled. Data was collected in the first year of life about frequency and dose of vitamin D supplementation and presence of suspected rickets. Our primary outcome measure was diagnosis of type 1 diabetes by end of December, 1997. Findings 12058 of 12231 represented live births, and 10821 (91% of those alive) children were followed-up at age 1 year. Of the 10366 children included in analyses, 81 were diagnosed with diabetes during the study. Vitamin D supplementation was associated with a decreased frequency of type 1 diabetes when adjusted for neonatal, anthropometric, and social characteristics (rate ratio [RR] for regular vs no supplementation 0.12, 95% CI 0.03-0.51, and irregular vs no supplementation 0.16, 0.04-0.74. Children who regularly took the recommended dose of vitamin D (2000 IU daily) had a RR of 0.22 (0.05-0.89) compared with those who regularly received less than the recommended amount. Children suspected of having rickets during the first year of life had a RR of 3.0 (1.0-9.0) compared with those without such a suspicion. Interpretation Dietary vitamin D supplementation is associated with reduced risk of type 1 diabetes. Ensuring adequate vitamin D supplementation for infants could help to reverse the increasing trend in the incidence of type 1 diabetes.	Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England; Imperial Coll Sch Med, Dept Epidemiol & Publ Hlth, London, England; Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Paediat, Tampere, Finland; Univ Oulu, Dept Math Sci, Oulu, Finland; Univ Oulu, Dept Publ Hlth Sci, Oulu, Finland; Univ Oulu, Dept Gen Practice, Oulu, Finland; Natl Publ Hlth Inst, Helsinki, Finland	University of London; University College London; Imperial College London; Tampere University; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare	Hypponen, E (corresponding author), Inst Child Hlth, Dept Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	e.hypponen@ich.ucl.ac.uk	Hypponen, Elina/B-2596-2014; Virtanen, Suvi/AAP-1922-2021	Hypponen, Elina/0000-0003-3670-9399; Virtanen, Suvi/0000-0001-8928-0878; Jarvelin, Marjo-Riitta/0000-0002-2149-0630				Ala-Houhala M, 1995, Duodecim, V111, P337; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; BAUMGARTI HJ, 1991, DIABETES RES CLIN EX, V16, P145; BLOM L, 1989, DIABETOLOGIA, V32, P7; Casteels K, 1998, CLIN EXP IMMUNOL, V112, P181; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; FISHER KD, 1985, AM J CLIN NUTR, V42, P1318; HALLMAN N, 1964, Duodecim, V80, P185; Karvonen M, 1999, DIABETES CARE, V22, P1066, DOI 10.2337/diacare.22.7.1066; LAITINEN S, 1995, SCAND J SOC MED, V23, P88, DOI 10.1177/140349489502300203; Lemire J, 2000, Z RHEUMATOL, V59, P24; MATHIEU C, 1994, DIABETOLOGIA, V37, P552, DOI 10.1007/BF00403372; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; RANTAKALLIO P, 1983, GROWTH, V47, P122; RANTAKALLIO P, 1985, EARLY HUM DEV, V11, P141, DOI 10.1016/0378-3782(85)90101-X; REUNANEN A, 1982, ACTA PAEDIATR SCAND, V71, P893, DOI 10.1111/j.1651-2227.1982.tb09545.x; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; SAGGESE G, 1989, J ENDOCRINOL INVEST, V12, P329, DOI 10.1007/BF03349999; Stene LC, 2000, DIABETOLOGIA, V43, P1093, DOI 10.1007/s001250051499; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Virtanen SM, 1998, DIABETIC MED, V15, P730, DOI 10.1002/(SICI)1096-9136(199809)15:9&lt;730::AID-DIA646&gt;3.0.CO;2-C; VIRTANEN SM, 1993, DIABETES, V42, P1786, DOI 10.2337/diabetes.42.12.1786	24	1334	1404	2	131	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2001	358	9292					1500	1503		10.1016/S0140-6736(01)06580-1	http://dx.doi.org/10.1016/S0140-6736(01)06580-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MN	11705562				2022-12-01	WOS:000172055800012
J	Beckmann, R; Spahn, CMT; Eswar, N; Helmers, J; Penczek, PA; Sali, A; Frank, J; Blobel, G				Beckmann, R; Spahn, CMT; Eswar, N; Helmers, J; Penczek, PA; Sali, A; Frank, J; Blobel, G			Architecture of the protein-conducting channel associated with the translating 80S ribosome	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; COLI 70S RIBOSOME; ESCHERICHIA-COLI; ER MEMBRANE; CRYOELECTRON MICROSCOPY; ANGSTROM RESOLUTION; SECRETORY PROTEINS; SEC61P COMPLEX; TRANSLOCATION CHANNEL	In vitro assembled yeast ribosome-nascent chain complexes (RNCs) containing a signal sequence in the nascent chain were immunopurified and reconstituted with the purified protein-conducting channel (PCC) of yeast endoplasmic reticulum, the Sec61 complex. A cryo-EM reconstruction of the RNC-Sec61 complex at 15.4 Angstrom resolution shows a tRNA in the P site. Distinct rRNA elements and proteins of the large ribosomal subunit form four connections with the PCC across a gap of about 10-20 Angstrom. Binding of the PCC influences the position of the highly dynamic rRNA expansion segment 27. The RNC-bound Sec61 complex has a compact appearance and was estimated to be a trimer. We propose a binary model of cotranslational translocation entailing only two basic functional states of the translating ribosome-channel complex.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA; Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Albany, NY 12201 USA; Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Lab Mol Biophys, New York, NY 10021 USA; Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Humboldt Univ, Charite, Inst Biochem, D-10117 Berlin, Germany	Howard Hughes Medical Institute; Rockefeller University; Health Research Inc; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center; Rockefeller University; University of Texas System; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Beckmann, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM060635] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM29169, R01 GM60635] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BERNABEU C, 1983, J CELL BIOL, V96, P1471, DOI 10.1083/jcb.96.5.1471; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; CARSON M, 1991, APPL CRYSTALLOGR, V24, P103; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Matlack KES, 1997, SCIENCE, V277, P938, DOI 10.1126/science.277.5328.938; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Meyer TH, 1999, J MOL BIOL, V285, P1789, DOI 10.1006/jmbi.1998.2413; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2000, STRUCTURE, V8, P937, DOI 10.1016/S0969-2126(00)00185-4; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; SWEENEY R, 1994, MOL CELL BIOL, V14, P4203, DOI 10.1128/MCB.14.6.4203; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wang L, 1999, FEBS LETT, V457, P316, DOI 10.1016/S0014-5793(99)01075-3; WATERS MG, 1986, J CELL BIOL, V102, P1543, DOI 10.1083/jcb.102.5.1543; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590	54	313	318	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					361	372		10.1016/S0092-8674(01)00541-4	http://dx.doi.org/10.1016/S0092-8674(01)00541-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701126	Bronze			2022-12-01	WOS:000172022800007
J	Ellervik, C; Mandrup-Poulsen, T; Nordestgaard, BG; Larsen, LE; Appleyard, M; Frandsen, M; Petersen, P; Schlichting, P; Saermark, T; Tybjaerg-Hansen, A; Birgens, H				Ellervik, C; Mandrup-Poulsen, T; Nordestgaard, BG; Larsen, LE; Appleyard, M; Frandsen, M; Petersen, P; Schlichting, P; Saermark, T; Tybjaerg-Hansen, A; Birgens, H			Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study	LANCET			English	Article							HEMOCHROMATOSIS GENE-MUTATIONS; C282Y MUTATION; EXPRESSION; POPULATION; HFE	Background Although genotyping studies suggest that hereditary haemochromatosis is one of the most common genetic disorders in white people, it is still thought of as an uncommon disease. Our aim was to test the hypothesis that hereditary haemochromatosis is a disease often overlooked in patients with late-onset type 1 diabetes mellitus, a late manifestation of untreated iron overload. Methods We did a retrospective study in which we genotyped for the C282Y and H63D mutations in the haemochromatosis gene in 716 unselected Danish patients who developed type I diabetes mellitus after age 30 years and 9174 controls from the general Danish population. We also screened for hereditary haemochromatosis by assessment of transferrin saturation. Findings More patients with diabetes (n=9, relative frequency 1.26%, 95% CI 0.58-2.37) than controls (23, 0.25%, 0.16-0.38) were homozygous for C282Y (odds ratio 4.6, 2.0-10.1, p=0.0001). These patients had unrecognised signs of haemochromatosis. Transferrin saturation and ferritin concentrations ranged from 57% to 102% and 17 mug/L to 8125 mug/L, respectively. Frequency of compound heterozygosity (C282Y/H63D) did not differ between patients with diabetes (eight) and controls (131) (odds ratio 0.8, 95% CI 0.4-1.7). Positive and negative predictive values of transferrin saturation greater than 50%, in identification of C282Y homozygosity, were 0.26 and 1.00, respectively. A saturation of less than 50% therefore excluded C282Y homozygosity, whereas a saturation of more than 50% suggested C282Y homozygosity. Interpretation Measurement of transferrin saturation followed by genetic testing could prevent liver and heart problems and improve life expectancy in patients with diabetes. Population screening before the onset of diabetes might improve the outlook of patients even further, but will be less cost effective.	Univ Copenhagen, Herlev Hosp, Dept Haematol, DK-2730 Herlev, Denmark; Univ Copenhagen, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Herlev Hosp, Dept Gastroenterol C, DK-2730 Herlev, Denmark; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Bispebjerg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; Univ Copenhagen, Univ Copenhagen Hosp, Dept Clin Biochem, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Steno Diabetes Center; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Birgens, H (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Haematol, DK-2730 Herlev, Denmark.		Nordestgaard, Borge Gronne/ABF-1310-2020; Ellervik, Christina/H-2977-2019	Ellervik, Christina/0000-0002-3088-4375; Mandrup-Poulsen, Thomas/0000-0002-3215-9273				Adams PC, 1999, HEPATOLOGY, V29, P1324, DOI 10.1002/hep.510290425; APPLEYARD M, 1989, SCAND J SOC MED S, V41, P1; Baty D, 1998, J CLIN PATHOL, V51, P73, DOI 10.1136/jcp.51.1.73; BOMFORD A, 1976, Q J MED, V45, P611; Brissot Pierre, 1998, Journal of Hepatology, V28, P14, DOI 10.1016/S0168-8278(98)80369-3; Burt MJ, 1998, GUT, V43, P830, DOI 10.1136/gut.43.6.830; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; Crawford DHG, 1998, GASTROENTEROLOGY, V114, P1003, DOI 10.1016/S0016-5085(98)70320-8; Cullen LM, 1997, BLOOD, V90, P4236, DOI 10.1182/blood.V90.10.4236; DAVIS WD, 1952, J LAB CLIN MED, V39, P526; Dubois-Laforgue D, 2000, DIABETES METAB, V26, P65; EDWARDS CQ, 1982, CLIN HAEMATOL, V11, P411; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Hickman P, 1998, HEPATOLOGY, V28, p422A; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Olynyk J, 1998, HEPATOLOGY, V28, p528A; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; PHATAK PD, 1994, BLOOD REV, V8, P193, DOI 10.1016/0268-960X(94)90107-4; PICKUP J, 1997, TXB DIABETES, P7; POWELL LW, 1990, GASTROENTEROLOGY, V98, P1625, DOI 10.1016/0016-5085(90)91100-K; Robson KJH, 2000, BRIT J HAEMATOL, V108, P31; RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, P809; Ryan E, 1998, HEPATOLOGY, V28, p527A; Salonen JT, 2000, BRIT MED J, V320, P1706, DOI 10.1136/bmj.320.7251.1706; Sampson MJ, 2000, J LAB CLIN MED, V135, P170, DOI 10.1067/mlc.2000.104464; SCHEUER PJ, 1962, J PATHOL BACTERIOL, V84, P53, DOI 10.1002/path.1700840107; *WHO EXP COMM DIAB, 1980, WHO TECHN SER, V646	29	94	97	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1405	1409		10.1016/S0140-6736(01)06526-6	http://dx.doi.org/10.1016/S0140-6736(01)06526-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705485				2022-12-01	WOS:000171940100010
J	Lagos-Quintana, M; Rauhut, R; Lendeckel, W; Tuschl, T				Lagos-Quintana, M; Rauhut, R; Lendeckel, W; Tuschl, T			Identification of novel genes coding for small expressed RNAs	SCIENCE			English	Article							INTERFERENCE; SEQUENCE; RDE-1	In Caenorhabditis elegans, lin-4 and let-7 encode 22- and 21-nucleotide (nt) RNAs, respectively, which function as key regulators of developmental timing. Because the appearance of these short RNAs is regulated during development, they are also referred to as small temporal RNAs (stRNAs). We show that many 21- and 22-nt expressed RNAs, termed microRNAs, exist in invertebrates and vertebrates and that some of these novel RNAs, similar to let-7 stRNA, are highly conserved. This suggests that sequence-specific, posttranscriptional regulatory mechanisms mediated by small RNAs are more general than previously appreciated.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Max Planck Society	Tuschl, T (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.	ttuschl@mpibpc.gwdg.de	Quintana, Mariana Lagos/A-7919-2010					Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Moss EG, 2000, CURR BIOL, V10, pR436, DOI 10.1016/S0960-9822(00)00528-5; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Slack F, 1997, ANNU REV GENET, V31, P611, DOI 10.1146/annurev.genet.31.1.611; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	29	3661	4287	10	401	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					853	858		10.1126/science.1064921	http://dx.doi.org/10.1126/science.1064921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679670	Green Submitted			2022-12-01	WOS:000171851800047
J	Klaassen, M; Lindstrom, A; Meltofte, H; Piersma, T				Klaassen, M; Lindstrom, A; Meltofte, H; Piersma, T			Ornithology - Arctic waders are not capital breeders	NATURE			English	Article							STABLE ISOTOPES		Netherlands Inst Ecol, Ctr Limnol, NL-3600 BG Maarssen, Netherlands; Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9750 AA Haren, Netherlands; Natl Environm Res Inst, Dept Arctic Environm, DK-4000 Roskilde, Denmark	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Lund University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; Aarhus University	Klaassen, M (corresponding author), Netherlands Inst Ecol, Ctr Limnol, POB 1299, NL-3600 BG Maarssen, Netherlands.		Piersma, Theunis/D-1871-2012; Klaassen, Marcel/B-4325-2008; Bond, Alexander L/A-3786-2010	Klaassen, Marcel/0000-0003-3907-9599; 				Cramp S., 1980, BIRDS W PALEARCTIC, V2; Davidson N.C., 1988, P342; DRENT RH, 1980, ARDEA, V68, P225; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Newton I., 1977, P113; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Stettenheim P., 1972, AVIAN BIOL, V2, P1; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050	8	169	178	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					794	794		10.1038/35101654	http://dx.doi.org/10.1038/35101654			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677593	Green Published			2022-12-01	WOS:000171750200032
J	Barnett, RN; Cleveland, CL; Joy, A; Landman, U; Schuster, GB				Barnett, RN; Cleveland, CL; Joy, A; Landman, U; Schuster, GB			Charge migration in DNA: Ion-gated transport	SCIENCE			English	Article							HOLE TRANSPORT; POTENTIALS; DYNAMICS; BASES	Electron hole (radical cation) migration in DNA, where the quantum transport of an injected charge is gated in a correlated manner by the thermal motions of the hydrated counterions, is described here. Classical molecular dynamics simulations in conjunction with large-scale first-principles electronic structure calculations reveal that different counterion configurations Lead to formation of states characterized by varying spatial distributions and degrees of charge localization. Stochastic dynamic fluctuations between such ionic configurations can induce correlated changes in the spatial distribution of the hole, with concomitant transport along the DNA double helix. Comparative ultraviolet tight-induced cleavage experiments on native B DNA oligomers and on ones modified to contain counterion (Na+)-starved bridges between damage-susceptible hole-trapping sites called GG steps show in the Latter a reduction in damage at the distal step. This reduction indicates a reduced mobility of the hole across the modified bridge as predicted theoretically.	Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Landman, U (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	gary.schuster@cos.gatech.edu						ARNOTT S, 1977, HDB BIOCH MOL BIOL, P411; BARNETT RN, 1993, PHYS REV B, V48, P2081, DOI 10.1103/PhysRevB.48.2081; Berlin YA, 2001, J AM CHEM SOC, V123, P260, DOI 10.1021/ja001496n; Beveridge DL, 2000, CURR OPIN STRUC BIOL, V10, P182, DOI 10.1016/S0959-440X(00)00076-2; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Fink HW, 2001, CELL MOL LIFE SCI, V58, P1, DOI 10.1007/PL00000770; Giese B, 2000, ACCOUNTS CHEM RES, V33, P631, DOI 10.1021/ar990040b; Grozema FC, 2000, J AM CHEM SOC, V122, P10903, DOI 10.1021/ja001497f; Heller A, 2000, FARADAY DISCUSS, V116, P1, DOI 10.1039/b006196o; Henderson PT, 1999, P NATL ACAD SCI USA, V96, P8353, DOI 10.1073/pnas.96.15.8353; Hud NV, 2001, CURR OPIN STRUC BIOL, V11, P293, DOI 10.1016/S0959-440X(00)00205-0; HUSH NS, 1975, CHEM PHYS LETT, V34, P11, DOI 10.1016/0009-2614(75)80190-4; Jackson NM, 2001, CURR OPIN CHEM BIOL, V5, P209, DOI 10.1016/S1367-5931(00)00192-7; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Lewis FD, 2001, ACCOUNTS CHEM RES, V34, P159, DOI 10.1021/ar0000197; LIAS SG, 1988, J PHYS CHEM REF DATA, V17, P1; Marcus RA, 1998, J PHYS CHEM B, V102, P10071, DOI 10.1021/jp9834457; McFail-Isom L, 1999, CURR OPIN STRUC BIOL, V9, P298, DOI 10.1016/S0959-440X(99)80040-2; Meggers E, 1998, J AM CHEM SOC, V120, P12950, DOI 10.1021/ja983092p; ORLOV VM, 1976, TETRAHEDRON LETT, P4377; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Ratner MA, 2001, P NATL ACAD SCI USA, V98, P387, DOI 10.1073/pnas.98.2.387; Schuster GB, 2000, ACCOUNTS CHEM RES, V33, P253, DOI 10.1021/ar980059z; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Wan CZ, 2000, P NATL ACAD SCI USA, V97, P14052, DOI 10.1073/pnas.250483297; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; [No title captured]	29	338	347	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					567	571		10.1126/science.1062864	http://dx.doi.org/10.1126/science.1062864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641491				2022-12-01	WOS:000171695600039
J	Murphy, DJ; Liebling, RE; Verity, L; Swingler, R; Patel, R				Murphy, DJ; Liebling, RE; Verity, L; Swingler, R; Patel, R			Early maternal and neonatal morbidity associated with operative delivery in second stage of labour: a cohort study	LANCET			English	Article							CESAREAN-SECTION; VAGINAL DELIVERY; TRIAL; MIDFORCEPS; FORCEPS	Background A frequent dilemma for obstetricians is how to keep morbidity to a minimum when faced with arrested progress at full dilatation of the cervix. Our aim was to examine maternal and neonatal morbidity associated with vaginal instrumental delivery in theatre and caesarean section, at full dilatation. Methods We did a prospective cohort study of 393 women, who had term, singleton, liveborn, cephalic pregnancies requiring operative delivery in theatre at full dilatation for 1 year. Findings Factors increasing the likelihood of caesarean section included maternal body-mass index greater than 30 (adjusted odds ratio 2.4, 95% CI 1.2-4.9), neonatal birthweight greater than 4.0 kg (2.3, 1.3-3.8), and occipitoposterior position (2.5, 1.6-3.9). Women undergoing caesarean section were more likely to have a major haemorrhage (>1 L; 2.8, 1.1-7.6) and extended hospital stay (greater than or equal to6 days; 3.5, 1.6-7.6) than those with vaginal delivery. Babies delivered by caesarean section were more likely to require admission for intensive care (2.6, 1.2-6.0) but less likely to have trauma (0.4, 0.2-0.7) than babies delivered by forceps. Overall neonatal morbidity was low, but a few babies in each group had serious complications (serious trauma, eight vs three; sepsis, six vs 13; and jaundice, ten vs 12 after vaginal delivery and caesarean section, respectively). Major haemorrhage was less likely after delivery by a skilled obstetrician (0.5, 0.3-0.9). Interpretation The data lend support to an aim to deliver women vaginally, unless there are clear signs of cephalopelvic disproportion, and underline the importance of skilled obstetricians supervising complex operative deliveries.	Univ Bristol, St Michaels Hosp, Div Obstet & Gynecol, Bristol BS2 8EG, Avon, England; Southmead Gen Hosp, N Bristol NHS Trust, Bristol, Avon, England	University of Bristol; North Bristol NHS Trust; Southmead Hospital	Murphy, DJ (corresponding author), Univ Bristol, St Michaels Hosp, Div Obstet & Gynecol, Southwell St, Bristol BS2 8EG, Avon, England.			Murphy, Deirdre/0000-0001-6074-6718; Patel, Roshni/0000-0002-1399-3131				AlMufti R, 1996, LANCET, V347, P544, DOI 10.1016/S0140-6736(96)91176-9; *ASS IMPR MAT SERV, 1997, CHART ETH RES MAT CA; BASHORE RA, 1990, AM J OBSTET GYNECOL, V162, P1428, DOI 10.1016/0002-9378(90)90902-J; CHISWICK ML, 1979, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6155.7; CIBILS LA, 1990, J PERINAT MED, V18, P5, DOI 10.1515/jpme.1990.18.1.5; CLARK SL, 1984, OBSTET GYNECOL, V64, P376; DIERKER LJ, 1985, AM J OBSTET GYNECOL, V152, P176, DOI 10.1016/S0002-9378(85)80019-3; *EXP MAT GROUP, 1993, CHANG CHILDB 1; Fynes M, 1999, LANCET, V354, P983, DOI 10.1016/S0140-6736(98)11205-9; Fynes M, 1998, OBSTET GYNECOL, V92, P496, DOI 10.1016/S0029-7844(98)00256-7; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Johanson RB, 1999, BRIT J OBSTET GYNAEC, V106, P544, DOI 10.1111/j.1471-0528.1999.tb08322.x; LOMAS J, 1989, EFFECTIVE CARE PREGN, P1189; LOWE B, 1987, BRIT J OBSTET GYNAEC, V94, P60, DOI 10.1111/j.1471-0528.1987.tb02254.x; Penn ZJ, 1996, BRIT J OBSTET GYNAEC, V103, P684, DOI 10.1111/j.1471-0528.1996.tb09838.x; REPKE JT, 1984, SURG GYNECOL OBSTET, V158, P112; Revah A, 1997, AM J OBSTET GYNECOL, V176, P200, DOI 10.1016/S0002-9378(97)80036-1; ROBERTSON PA, 1990, AM J OBSTET GYNECOL, V162, P1436, DOI 10.1016/0002-9378(90)90903-K; RODRIGUEZ AI, 1994, AM J OBSTET GYNECOL, V171, P1022, DOI 10.1016/0002-9378(94)90026-4; Sachs BP, 1999, NEW ENGL J MED, V340, P54, DOI 10.1056/NEJM199901073400112; Wagner M, 2000, LANCET, V356, P1677, DOI 10.1016/S0140-6736(00)03169-X	21	214	222	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1203	1207		10.1016/S0140-6736(01)06341-3	http://dx.doi.org/10.1016/S0140-6736(01)06341-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675055				2022-12-01	WOS:000171527000007
J	Titan, SMO; Bingham, S; Welch, A; Luben, R; Oakes, S; Day, N; Khaw, KT				Titan, SMO; Bingham, S; Welch, A; Luben, R; Oakes, S; Day, N; Khaw, KT			Frequency of eating and concentrations of serum cholesterol in the Norfolk population of the European prospective investigation into cancer (EPIC-Norfolk): cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							INCREASED MEAL FREQUENCY; HEART-DISEASE; PLASMA; LIPIDS	Objectives To examine the relation between self reported eating frequency and serum lipid concentrations in a free living population. Design Cross sectional population based study. Setting Norfolk, England. Participants 14 666 men and women aged 45-75 years from the Norfolk cohort of the European prospective investigation into cancer (EPIC-Norfolk). Main outcome measures Concentrations of blood lipids. Results Mean concentrations of total cholesterol and low density lipoprotein cholesterol decreased in a continuous relation with increasing daily frequency of eating in men and women. No consistent relation was observed for high density lipoprotein cholesterol, body mass index, waist to hip ratio, or blood pressure. Mean cholesterol concentrations differed by about 0.25 mmol/l between people eating more than six times a day and those eating once or twice daily; this difference was reduced to 0.15 mmol/l after adjustment for possible confounding variables, including age, obesity, cigarette smoking, physical activity, and intake of energy, and nutrients (alcohol, fat, fatty acids, protein, and carbohydrate). Conclusions Concentrations of total cholesterol and low density lipoprotein cholesterol are negatively and consistently associated with frequency of eating in a general population. The effects of eating frequency on lipid concentrations induced in short term trials in animals and human volunteers under controlled laboratory conditions can be observed in a free living general population. We need to consider not just what we eat but how often we eat.	Univ Cambridge, Inst Publ Hlth, Cambridge CB2 2SR, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Khaw, KT (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Gerontol Unit, Box 251, Cambridge CB2 2QQ, England.		Welch, Ailsa Ann/A-4850-2008; Luben, Robert N/H-5519-2015; Khaw, Kay-Tee/AAZ-3209-2021	Welch, Ailsa Ann/0000-0002-6702-3704; Luben, Robert N/0000-0002-5088-6343; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARNOLD LM, 1993, AM J CLIN NUTR, V57, P446, DOI 10.1093/ajcn/57.3.446; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; COHN C, 1960, METABOLISM, V9, P492; COHN C, 1959, AM J PHYSIOL, V196, P965, DOI 10.1152/ajplegacy.1959.196.5.965; Colhoun H, 1996, SERIES HS; Day N, 1999, BRIT J CANCER, V80, P95; EDELSTEIN SL, 1992, AM J CLIN NUTR, V55, P664, DOI 10.1093/ajcn/55.3.664; FABRY P, 1968, LANCET, V2, P190; FABRY P, 1970, AM J CLIN NUTR, V23, P1059; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GWINUP G, 1963, AM J CLIN NUTR, V13, P209, DOI 10.1093/ajcn/13.4.209; JENKINS DJA, 1989, NEW ENGL J MED, V321, P929, DOI 10.1056/NEJM198910053211403; MCGRATH SA, 1994, EUR J CLIN NUTR, V48, P402; Murphy MC, 1996, EUR J CLIN NUTR, V50, P491; Powell JT, 1999, J CARDIOVASC RISK, V6, P19; Wald NJ, 1995, ATHEROSCLEROSIS, V118, pS1, DOI 10.1016/0021-9150(95)90067-5; WOLEVER TMS, 1990, METABOLISM, V39, P947, DOI 10.1016/0026-0495(90)90306-W	19	63	64	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2001	323	7324					1286	1288A		10.1136/bmj.323.7324.1286	http://dx.doi.org/10.1136/bmj.323.7324.1286			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YG	11731392	Green Published, Bronze			2022-12-01	WOS:000172655800019
J	Tang, GL; Minemoto, Y; Dibling, B; Purcell, NH; Li, ZW; Karin, M; Lin, A				Tang, GL; Minemoto, Y; Dibling, B; Purcell, NH; Li, ZW; Karin, M; Lin, A			Inhibition of JNK activation through NF-kappa B target genes	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE; TNF RECEPTOR-1; JUN KINASES; CELL-DEATH; IAP GENE; APOPTOSIS; IDENTIFICATION; DOMAIN; INDUCTION	The proinflammatory cytokine tumour necrosis factor-alpha (TNF-alpha) regulates immune responses, inflammation and programmed cell death (apoptosis)(1-4). The ultimate fate of a cell exposed to TNF-alpha is determined by signal integration between its different effectors, including I kappaB kinase (IKK), c-Jun N-terminal protein kinase (JNK) and caspases(1). Activation of caspases is required for apoptotic cell death(5), whereas IKK activation inhibits apoptosis through the transcription factor NF-kappaB, whose target genes include caspase inhibitors(1,6-10). JNK activates the transcription factor c-Jun/AP-1, as well as other targets(11-16). However, the role of JNK activation in apoptosis induced by TNF-alpha is less clear(17,18). It is unknown whether any crosstalk occurs between IKK and JNK, and, if so, how it affects TNF-alpha -induced apoptosis. We investigated this using murine embryonic fibroblasts that are deficient in either the IKK beta catalytic subunit of the IKK complex or the RelA/p65 subunit of NF-kappaB. Here we show that in addition to inhibiting caspases, the IKK/NF-kappaB pathway negatively modulates TNF-alpha -mediated JNK activation, partly through NF-kappaB-induced X-chromosome-linked inhibitor of apoptosis (XIAP)(7,9). This negative crosstalk, which is specific to TNF-alpha signalling and does not affect JNK activation by interleukin-1 (IL-1), contributes to inhibition of apoptosis.	Univ Chicago, Ben May Inst Canc Res, Comm Canc Biol, Chicago, IL 60637 USA; Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of Chicago; University of California System; University of California San Diego	Lin, A (corresponding author), Univ Chicago, Ben May Inst Canc Res, Comm Canc Biol, 5841 S Maryland Ave,MC 6027, Chicago, IL 60637 USA.							Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; ROTHWARF DM, 1999, SCIENCE STKE; Sanna MG, 1998, P NATL ACAD SCI USA, V95, P6015, DOI 10.1073/pnas.95.11.6015; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TRACEY KJ, 1993, CRITICAL CARE MED, V21, P415; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	30	631	646	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					313	317		10.1038/35104568	http://dx.doi.org/10.1038/35104568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713531				2022-12-01	WOS:000172150700045
J	Barbour, V				Barbour, V			Imatinib for chronic myeloid leukaemia: a NICE mess	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Barbour, V (corresponding author), Lancet, London WC1X 8RR, England.			Barbour, Virginia/0000-0002-2358-2440				Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Goldman JM, 2000, LANCET, V355, P1031, DOI 10.1016/S0140-6736(00)02029-8; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538	4	7	9	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 3	2001	358	9292					1478	1478		10.1016/S0140-6736(01)06571-0	http://dx.doi.org/10.1016/S0140-6736(01)06571-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MN	11705557				2022-12-01	WOS:000172055800007
J	Tounian, P; Aggoun, Y; Dubern, B; Varille, V; Guy-Grand, B; Sidi, D; Girardet, JP; Bonnet, D				Tounian, P; Aggoun, Y; Dubern, B; Varille, V; Guy-Grand, B; Sidi, D; Girardet, JP; Bonnet, D			Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study	LANCET			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-FAT DISTRIBUTION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; BLOOD-FLOW; FOLLOW-UP; ADOLESCENTS; ATHEROSCLEROSIS; ASSOCIATION	Background Epidemiological studies suggest that obesity-induced atherosclerosis may start in childhood, but this process has never been demonstrated. We looked for arterial changes and investigated their relation to cardiovascular risk factors in obese children. Methods Non-invasive ultrasonographic measurements were made in 48 severely obese children and 27 controls to investigate arterial mechanics and endothelial function. Plasma lipid concentrations, indices of insulin resistance, and body composition were assessed in the obese children. Findings The obese children had significantly lower arterial compliance than the healthy controls (median 0.132 [0.022-0.273], vs 0.143 [0.112-0.237] mm(2).mm Hg; p=0.02) and lower distensibility (0.60 [0.10-1.00] vs 0.70 [0.50-1.10] mm Hg-1.10(-2); p=0.0001). Conversely, the obese children had higher values than the controls for wall stress (3.36 [2.00-5.01] vs 2.65 [2.13-3.54] mm Hg.10(2); p=0.0001) and incremental elastic modulus (1.68 [0.72-10.8] vs 0.96 [0.64-1.47]; p=0.0001). Endothelium-dependent and independent function were also lower in the obese than in the control children. An android fat distribution was positively correlated with indices of insulin resistance and plasma triglyceride concentrations and was negatively correlated with plasma HDL-cholesterol concentration and arterial compliance. Endothelial dysfunction was correlated with low plasma apolipoprotein A-1 and with insulin resistance indices. Interpretation Severe obesity in children is associated with arterial wall stiffness and endothelial dysfunction. Low plasma apolipoprotein A-1, insulin resistance, and android fat distribution may be the main risk factors for these arterial changes, which are of considerable concern as possible early events in the genesis of atheroma.	Necker Enfants Malad Teaching Hosp, Dept Paediat Cardiol, F-75015 Paris, France; Armand Trousseau Teaching Hosp, Dept Paediat Gastroenterol & Nutr, Paris, France; Hotel Dieu Teaching Hosp, Dept Nutr, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Bonnet, D (corresponding author), Necker Enfants Malad Teaching Hosp, Dept Paediat Cardiol, 149 Rue Sevres, F-75015 Paris, France.		AGGOUN, Yacine/ABC-7903-2020; Tounian, Patrick/AAF-6226-2021					Aggoun Y, 2000, HEART, V84, P290, DOI 10.1136/heart.84.3.290; Aggoun Y, 2000, ARTERIOSCL THROM VAS, V20, P2070; Arcaro G, 1999, INT J OBESITY, V23, P936, DOI 10.1038/sj.ijo.0801022; Bachorik PS, 1997, CLIN CHEM, V43, P2364; BARON AD, 1995, J CLIN INVEST, V96, P786, DOI 10.1172/JCI118124; Bonadonna RC, 1998, CIRCULATION, V98, P234, DOI 10.1161/01.CIR.98.3.234; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Clarkson P, 1996, J CLIN INVEST, V97, P1989, DOI 10.1172/JCI118632; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; GIRARDET JP, 1993, ANN PEDIATR-PARIS, V40, P297; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HARRIS M, 1979, DIABETES, V28, P1039; KANNEL WB, 1987, AM HEART J, V114, P413, DOI 10.1016/0002-8703(87)90511-4; KWITEROVICH PO, 1990, PEDIATR CLIN N AM, V37, P1489; Laine M, 1998, J CLIN INVEST, V101, P1156, DOI 10.1172/JCI1065; Lebuffe G, 1997, BIOCHEM BIOPH RES CO, V241, P205, DOI 10.1006/bbrc.1997.7790; Markus RA, 1997, AM J CLIN NUTR, V65, P1000, DOI 10.1093/ajcn/65.4.1000; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mietus-Snyder M, 1998, J PEDIATR-US, V133, P35, DOI 10.1016/S0022-3476(98)70174-X; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Owens S, 1998, J PEDIATR-US, V133, P41, DOI 10.1016/S0022-3476(98)70175-1; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Shinozaki K, 1999, DIABETES, V48, P2437, DOI 10.2337/diabetes.48.12.2437; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Toikka JO, 1999, ATHEROSCLEROSIS, V147, P133, DOI 10.1016/S0021-9150(99)00186-0; Tounian P, 1999, INT J OBESITY, V23, P830, DOI 10.1038/sj.ijo.0800959; Wascher TC, 2000, DIABETES, V49, P803, DOI 10.2337/diabetes.49.5.803; Yamamoto M, 1997, INT J OBESITY, V21, P948, DOI 10.1038/sj.ijo.0800501	30	592	623	2	28	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1400	1404		10.1016/S0140-6736(01)06525-4	http://dx.doi.org/10.1016/S0140-6736(01)06525-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705484				2022-12-01	WOS:000171940100009
J	Tilman, D; Reich, PB; Knops, J; Wedin, D; Mielke, T; Lehman, C				Tilman, D; Reich, PB; Knops, J; Wedin, D; Mielke, T; Lehman, C			Diversity and productivity in a long-term grassland experiment	SCIENCE			English	Article							ECOSYSTEM FUNCTION; SPECIES-DIVERSITY; PLANT COMPOSITION; BIODIVERSITY; PERFORMANCE; ALTER	Plant diversity and niche complementarity had progressively stronger effects on ecosystem functioning during a 7-year experiment, with 16-species plots attaining 2.7 times greater biomass than monocultures. Diversity effects were neither transients nor explained solely by a few productive or unviable species. Rather, many higher-diversity plots outperformed the best monoculture. These results help resolve debate over biodiversity and ecosystem functioning, show effects at higher than expected diversity levels, and demonstrate, for these ecosystems, that even the best-chosen monocultures cannot achieve greater productivity or carbon stores than higher-diversity sites.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Nebraska, Sch Nat Resource Sci, Lincoln, NE 68583 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Tilman, David/ABD-5309-2021; Knops, Johannes/AAA-8546-2020; Wedin, David A/K-4093-2012	Reich, Peter/0000-0003-4424-662X				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Garnier E, 1997, ACTA OECOL, V18, P657, DOI 10.1016/S1146-609X(97)80049-5; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Guterman L, 2000, CHRON HIGHER EDUC, pA24; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hodgson JG, 1998, FUNCT ECOL, V12, P843, DOI 10.1046/j.1365-2435.1998.00253.x; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Kaiser J, 2000, SCIENCE, V289, P1282, DOI 10.1126/science.289.5483.1282; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; SWIFT MJ, 1993, ECOL STU AN, V99, P15; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	22	1499	1684	39	1028	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					843	845		10.1126/science.1060391	http://dx.doi.org/10.1126/science.1060391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679667	Green Published, Green Submitted			2022-12-01	WOS:000171851800044
J	Capewell, S; MacIntyre, K; Stewart, S; Chalmers, JWT; Boyd, J; Finlayson, A; Redpath, A; Pell, JP; McMurray, JJV				Capewell, S; MacIntyre, K; Stewart, S; Chalmers, JWT; Boyd, J; Finlayson, A; Redpath, A; Pell, JP; McMurray, JJV			Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY HEART-DISEASE; MONICA PROJECT POPULATIONS; CASE-FATALITY; RISK-FACTORS; MORTALITY-RATES; EVENT RATES; REGISTER; SURVIVAL; CARDIOLOGY	Background Most deaths from coronary heart disease occur out of hospital. Hospital patients face social, age, and sex inequalities. Our aim was to examine inequalities and trends in out-of-hospital cardiac deaths. Methods We used the Scottish record linked database to identify all deaths from acute myocardial infarction that occurred in Scotland (population 5.1 million), in 1986-95. We have compared population-based death rates for men and women across age and social groups. Findings Between 1986 and 1995, 83 365 people died from acute myocardial infarction, out of hospital and without previous hospital admission (44 655 men, 38 710 women); and 117 749 were admitted with a first acute myocardial infarction, of whom 37 020 died within 1 year. Thus, out-of-hospital deaths accounted for 69.2% (95% CI 69.0-69.5) of all 120 385 deaths. Out-of-hospital deaths, measured as a proportion of all acute myocardial infarction events (deaths plus first hospital admissions), increased with age, from 20.1% (19.2-21.0) in people younger than 55 years, to 62.1% (61.3-62.9) in those older than 85 years. Population-based out-of-hospital mortality rates fell by a third in men and by a quarter in women. Mean yearly falls were larger in people aged 55-64 years (5.6% per year in men, 3.7% in women), than in those older than 85 years (2.5% in men and women), Mortality rates were substantially higher in deprived socioeconomic groups than in affluent groups, especially in people younger than 65 years. Interpretation These inequalities in age, sex, and socioeconomic class should be actively addressed by prevention strategies for coronary heart disease.	Univ Glasgow, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy NHS Scotland, Informat & Stat Div, Edinburgh, Midlothian, Scotland; Greater Glasgow Hlth Board, Glasgow, Lanark, Scotland; Glasgow Western Infirm, Dept Cardiol, Glasgow, Lanark, Scotland	University of Glasgow	Capewell, S (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.		Macintyre, Kate/J-7174-2014; mcmurray, John/B-2467-2013; Stewart, Simon/M-3316-2016	Macintyre, Kate/0000-0003-2741-0467; mcmurray, John/0000-0002-6317-3975; Boyd, James/0000-0002-8925-8811; Stewart, Simon/0000-0001-9032-8998; Pell, Jill/0000-0002-8898-7035				Blane D, 1998, BRIT MED J, V317, P255, DOI 10.1136/bmj.317.7153.255; Bowling A, 1999, BRIT MED J, V319, P1353, DOI 10.1136/bmj.319.7221.1353; Brophy JM, 1997, CAN J CARDIOL, V13, P474; Brown N, 1997, BMJ-BRIT MED J, V315, P159, DOI 10.1136/bmj.315.7101.159; Capewell S, 1999, BRIT MED J, V318, P1072, DOI 10.1136/bmj.318.7190.1072; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 1996, HEART, V76, P70, DOI 10.1136/hrt.76.1.70; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Carstairs V., 1991, DEPRIVATION HLTH SCO; CRITCHLEY JA, 2000, J EPIDEMIOL COMMUNIT, V54, P774; Dobson AJ, 1999, J CLIN EPIDEMIOL, V52, P761, DOI 10.1016/S0895-4356(99)00052-9; Hallqvist J, 1998, INT J EPIDEMIOL, V27, P410, DOI 10.1093/ije/27.3.410; Harley K, 1996, Health Bull (Edinb), V54, P410; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Macintyre K, 2001, BRIT MED J, V322, P1152, DOI 10.1136/bmj.322.7295.1152; MARMOT M, 1999, INEQUALITIES CORONAR; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; MCMURRAY J, 1994, BMJ-BRIT MED J, V309, P1343, DOI 10.1136/bmj.309.6965.1343; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; *NAT SERV, 2000, NAT SERV FRAM COR HE; NAYHA S, 1992, INT J EPIDEMIOL, V21, P30, DOI 10.1093/ije/21.1.30; NAYLOR CD, 1994, J AM COLL CARDIOL, V24, P1431, DOI 10.1016/0735-1097(94)90136-8; Rathore SS, 2000, CIRCULATION, V102, P642, DOI 10.1161/01.CIR.102.6.642; *REG GEN SCOTL, 1998, ANN REP; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Rosen M, 2000, J INTERN MED, V248, P159, DOI 10.1046/j.1365-2796.2000.00716.x; Salomaa V, 2000, CIRCULATION, V101, P1913, DOI 10.1161/01.CIR.101.16.1913; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Volmink JA, 1998, HEART, V80, P40, DOI 10.1136/hrt.80.1.40; Woodward M, 1996, J EPIDEMIOL COMMUN H, V50, P570, DOI 10.1136/jech.50.5.570	33	79	80	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1213	1217		10.1016/S0140-6736(01)06343-7	http://dx.doi.org/10.1016/S0140-6736(01)06343-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675057				2022-12-01	WOS:000171527000009
J	Mahal, LK; Charter, NW; Angata, K; Fukuda, M; Koshland, DE; Bertozzi, CR				Mahal, LK; Charter, NW; Angata, K; Fukuda, M; Koshland, DE; Bertozzi, CR			A small-molecule modulator of poly-alpha 2,8-sialic acid expression on cultured neurons and tumor cells	SCIENCE			English	Article							ADHESION MOLECULE; POLYSIALIC ACID; 2 POLYSIALYLTRANSFERASES; SIALIC ACIDS; STX; SURFACE; PST; POLYSIALYLATION; PLASTICITY; PATTERN	Poly-alpha2,8-sialic acid (PSA) has been implicated in numerous normal and pathological processes, including development, neuronal plasticity, and tumor metastasis. We report that cell surface PSA expression can be reversibly inhibited by a small molecule, N-butanoylmannosamine (ManBut). Inhibition occurs through a metabolic mechanism in which ManBut is converted to unnatural sialic acid derivatives that effectively act as chain terminators during cellular PSA biosynthesis. N-Propanoylmannosamine (ManProp), which differs from ManBut by a single methylene group, did not inhibit PSA biosynthesis. Modulation of PSA expression by chemical means has a rote complementary to genetic and biochemical approaches in the study of complex PSA-mediated events.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Burnham Inst, Ctr Canc Res, Glycobiol Program, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Sanford Burnham Prebys Medical Discovery Institute	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Mahal, Lara/GRY-7287-2022; Angata, Kiyohiko/M-2749-2018	Angata, Kiyohiko/0000-0001-5561-1368; Mahal, Lara/0000-0003-4791-8524	NATIONAL CANCER INSTITUTE [R01CA033895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009765, R37DK009765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058867, R37GM058867] Funding Source: NIH RePORTER; NCI NIH HHS [CA33895] Funding Source: Medline; NIDDK NIH HHS [DK09765] Funding Source: Medline; NIGMS NIH HHS [GM58867-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; BERTOZZI CR, 1995, CHEM BIOL, V2, P703, DOI 10.1016/1074-5521(95)90096-9; Chappell MD, 1997, TETRAHEDRON, V53, P11109, DOI 10.1016/S0040-4020(97)00370-0; Charter NW, 2000, GLYCOBIOLOGY, V10, P1049, DOI 10.1093/glycob/10.10.1049; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Fukuda M, 1996, CANCER RES, V56, P2237; Hildebrandt H, 1998, CANCER RES, V58, P779; JORGENSEN OS, 1995, NEUROCHEM RES, V20, P533, DOI 10.1007/BF01694535; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Liu TM, 2000, J BIOL CHEM, V275, P32832, DOI 10.1074/jbc.C000573200; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PROBSTMEIER R, 1994, J NEUROSCI RES, V37, P324, DOI 10.1002/jnr.490370305; Rutishauser U, 1998, J CELL BIOCHEM, V70, P304, DOI 10.1002/(SICI)1097-4644(19980901)70:3<304::AID-JCB3>3.0.CO;2-R; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Schumacher U, 1996, HISTOCHEM CELL BIOL, V106, P599; SZELE FG, 1994, NEUROSCIENCE, V60, P133, DOI 10.1016/0306-4522(94)90209-7; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Yarema KJ, 1998, J BIOL CHEM, V273, P31168, DOI 10.1074/jbc.273.47.31168	26	90	91	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					380	382		10.1126/science.1062192	http://dx.doi.org/10.1126/science.1062192			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598302				2022-12-01	WOS:000171601400045
J	Schumacher, MA; Miller, MC; Grkovic, S; Brown, MH; Skurray, RA; Brennan, RG				Schumacher, MA; Miller, MC; Grkovic, S; Brown, MH; Skurray, RA; Brennan, RG			Structural mechanisms of QacR induction and multidrug recognition	SCIENCE			English	Article							P-GLYCOPROTEIN; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; BINDING; PROTEIN; GENE; TRANSPORTER; REGULATOR; IDENTIFICATION; EXPRESSION	The Staphylococcus aureus multidrug binding protein QacR represses transcription of the qacA multidrug transporter gene and is induced by structurally diverse cationic lipophilic drugs. Here, we report the crystal structures of six QacR-drug complexes. Compared to the DNA bound structure, drug binding elicits a coil-to-helix transition that causes induction and creates an expansive multidrug-binding pocket, containing four glutamates and multiple aromatic and polar residues. These structures indicate the presence of separate but linked drug-binding sites within a single protein. This muttisite drug-binding mechanism is consonant with studies on multidrug resistance transporters.	Oregon Hlth Sci & Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Oregon Health & Science University; University of Sydney	Brennan, RG (corresponding author), Oregon Hlth Sci & Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	brennanr@ohsu.edu	; Brown, Melissa/V-2296-2017	Brennan, Richard/0000-0001-7647-485X; Brown, Melissa/0000-0001-6461-7550	NIAID NIH HHS [AI 48593] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED M, 1994, J BIOL CHEM, V269, P28506; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Aramaki H, 1995, PROTEIN ENG, V8, P1259, DOI 10.1093/protein/8.12.1259; BEHR H, 1994, PATHOL BIOL, V42, P438; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Brooun A, 1999, J BACTERIOL, V181, P5131, DOI 10.1128/JB.181.16.5131-5133.1999; Brown MH, 2001, J MOL MICROB BIOTECH, V3, P163; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; DOUBLIE S, 1999, METHOD ENZYMOL, V276, P523; GOLDSTEIN LJ, 1992, CRIT REV ONCOL HEMAT, V12, P243, DOI 10.1016/1040-8428(92)90057-W; Gottesman MM, 1996, CURR OPIN GENET DEV, V6, P610, DOI 10.1016/S0959-437X(96)80091-8; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; GRKOVIC S, UNPUB; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVY SB, 1992, ANTIMICROB AGENTS CH, V36, P695, DOI 10.1128/AAC.36.4.695; Lewis K, 2001, J MOL MICROB BIOTECH, V3, P247; Licht T, 1996, ANN HEMATOL, V72, P184, DOI 10.1007/s002770050159; Lovell S, 1999, J CHEM SOC PERK T 2, P2241, DOI 10.1039/a904367e; Mayer S, 2001, J ANTIMICROB CHEMOTH, V47, P896, DOI 10.1093/jac/47.6.896; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Paulsen IT, 1996, P NATL ACAD SCI USA, V93, P3630, DOI 10.1073/pnas.93.8.3630; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; RAYMENT I, 1999, METHOD ENZYMOL, V276, P176; SCHUMACHER MA, UNPUB; TAMAI I, 1991, J BIOL CHEM, V266, P16796; TENNENT JM, 1989, J GEN MICROBIOL, V135, P1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762	41	319	329	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2158	2163		10.1126/science.1066020	http://dx.doi.org/10.1126/science.1066020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739955				2022-12-01	WOS:000172647700049
J	Wright, CM; Parker, L; Lamont, D; Craft, AW				Wright, CM; Parker, L; Lamont, D; Craft, AW			Implications of childhood obesity for adult health: findings from thousand families cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; FOLLOW-UP; BRITISH CHILDREN; BIRTH; GROWTH; AGE; OVERWEIGHT; MORTALITY	Objective To determine whether being overweight in childhood increases adult obesity and risk of disease. Design Prospective cohort study. Setting City of Newcastle upon Tyne. Participants 932 members of thousand families 1947 birth cohort, of whom 412 attended for clinical examination age 50. Main outcome measures Blood pressure; carotid artery intima-media thickness; fibrinogen concentration; total, low density lipoprotein, and high density lipoprotein cholesterol concentrations; triglyceride concentration; fasting insulin and 2 hour glucose concentrations; body mass index; and percentage body fat. Results Body mass index at age 9 years was significantly correlated with body mass index age 50 (r = 0.24, P < 0.001) but not with percentage body fat age 50 (r = 0.10, P = 0.07). After adult body mass index had been adjusted for, body mass index at age 9 showed a significant inverse association with measures of lipid and glucose metabolism in both sexes and with blood pressure in women. However, after adjustment for adult percentage fat instead of body mass index, only the inverse associations with triglycerides (regression coefficient = -0.21, P < 0.01) and total cholesterol (-0.17, P < 0.05) in women remained significant. Conclusions Little tracking from childhood overweight to adulthood obesity was found when using a measure of fatness that was independent of build. Only children who were obese at 13 showed in increased risk of obesity as adults. No excess adult health risk from childhood or teenage overweight was found. Being thin in childhood offered no protection against adult fatness, and the thinnest children tended to have the highest adult risk at every level of adult obesity.	Newcastle Univ, Gateshead NE8 1EB, Tyne & Wear, England; Newcastle Univ, Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Wright, CM (corresponding author), Newcastle Univ, Donald Court House, Gateshead NE8 1EB, Tyne & Wear, England.	C.M.Wright@Newcastle.ac.uk		PARKER, LOUISE/0000-0002-5188-8113	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABRAHAM S, 1971, HEALTH SERV REP, V86, P273, DOI 10.2307/4594149; ALBERMAN E, 1991, ARCH DIS CHILD, V66, P1304, DOI 10.1136/adc.66.11.1304; ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; ALTMAN DG, 1991, PRACTICAL STAT MED R, P443; *AUD COMM, 1993, 7 NHS AUD COMM; Blair M, 2001, ARCH DIS CHILD, V84, P1, DOI 10.1136/adc.84.1.1; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; *CLIN STAND ADV GR, 1993, NEON INT CAR; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; CUMBERLEDGE J, 1993, CHANGING CHILDBIRT 1; Dawson C, 1997, ARCH DIS CHILD-FETAL, V77, pF206, DOI 10.1136/fn.77.3.F206; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; FOMON SJ, 1982, AM J CLIN NUTR, V35, P1169, DOI 10.1093/ajcn/35.5.1169; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Garrow JS, 2000, HUMAN NUTR DIETETICS, P13; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HALL DMB, 1996, HLTH ALL CHILDREN RE; HALL DMB, 1991, HLTH ALL CHILDREN RE; HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8; HOFFMANS MDAF, 1989, J CLIN EPIDEMIOL, V42, P513, DOI 10.1016/0895-4356(89)90147-9; *HOUS COMM HLTH CO, 1992, SESS 1991 2 MAT SERV; JOHNSON A, 1993, BRIT MED J, V306, P1715, DOI 10.1136/bmj.306.6894.1715; Kerry SM, 1998, BMJ-BRIT MED J, V316, P54, DOI 10.1136/bmj.316.7124.54; Lamont D, 2000, BMJ-BRIT MED J, V320, P273, DOI 10.1136/bmj.320.7230.273; Lamont DW, 1998, PUBLIC HEALTH, V112, P85, DOI 10.1016/S0033-3506(98)00591-5; LAUER RM, 1988, PEDIATRICS, V82, P309; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; *NAT PER EP UN OXF, 1994, DIS PER CAR MEAS HLT, P2; Netten A, 1999, UNIT COSTS HLTH SOCI; NIETO FJ, 1992, AM J EPIDEMIOL, V136, P201, DOI 10.1093/oxfordjournals.aje.a116486; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454; SPENCE JC, 1954, 1000 FAMILIES NEWCAS; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; TANNER JM, 1966, ARCH DIS CHILD, V41, P454, DOI 10.1136/adc.41.219.454; Turnbull D, 1998, LANCET, V352, P1875, DOI 10.1016/S0140-6736(05)60392-3; Vanhala M, 1998, BRIT MED J, V317, P319, DOI 10.1136/bmj.317.7154.319; WARIYAR UK, 1989, LANCET, V1, P387; *WHITL COUNC HLTH, 1999, ADM CLER STAFFS COUN	44	240	251	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2001	323	7324					1280	1284		10.1136/bmj.323.7324.1280	http://dx.doi.org/10.1136/bmj.323.7324.1280			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YG	11731390	Bronze, Green Published			2022-12-01	WOS:000172655800017
J	Watson, R; Pauly, D				Watson, R; Pauly, D			Systematic distortions in world fisheries catch trends	NATURE			English	Article							FISH	Over 75% of the world marine fisheries catch (over 80 million tonnes per year) is sold on international markets, in contrast to other food commodities (such as rice)(1,2). At present, only one institution, the Food and Agriculture Organization of the United Nations (FAO) maintains global fisheries statistics. As an intergovernmental organization, however, FAO must generally rely on the statistics provided by member countries, even if it is doubtful that these correspond to reality. Here we show that misreporting by countries with large fisheries, combined with the large and widely fluctuating catch of species such as the Peruvian anchoveta, can cause globally spurious trends. Such trends influence unwise investment decisions by firms in the fishing sector and by banks, and prevent the effective management of international fisheries.	Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Watson, R (corresponding author), Univ British Columbia, Fisheries Ctr, 2204 Main Mall, Vancouver, BC V6T 1Z4, Canada.		Watson, Reg A/F-4850-2012; Pauly, Daniel Marc/AAY-2316-2021	Watson, Reg A/0000-0001-7201-8865; Pauly, Daniel/0000-0003-3756-4793				ALVERSONS DL, 1994, 339 FAO, P1; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; CHEN W, 1999, 950 FAO, P1; *DAT AN PROD DIV M, 2000, S PLUS GUID STAT, V1; *FOOD AGR ORG, 2000, 961 FAO DAT STAT UN, P1; *FOOD AGR ORG, 2000, FISHSTAT PLUS U SOFT; Froese R., 2000, FISHBASE 2000 CONCEP; *GLOB MAR BOUND DA, 2000, VER INF SOL 2000; Huang B., 1983, North American Journal of Fisheries Management, V3, P295, DOI 10.1577/1548-8659(1983)3<295:CAAPDO>2.0.CO;2; KWONG L, 1997, POLITICAL EC CORRUPT, P1; LONGHURST A, 1998, ECOLOGICAL GEOGRAPHY, P77; MACLEAN J, 1997, RICE ALMANAC, P31; Muck Peter, 1989, P386; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; PANG L, 2000, 9 U BRIT COL FISH, P1; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 1996, FISH RES, V25, P25, DOI 10.1016/0165-7836(95)00436-X; Tang Q., 1989, AAAS (American Association for the Advancement of Science) Selected Symposium, V111, P7; WATSON R, IN PRESS FISHERIES I	19	418	445	1	107	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					534	536		10.1038/35107050	http://dx.doi.org/10.1038/35107050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734851				2022-12-01	WOS:000172405900044
J	Hartgerink, JD; Beniash, E; Stupp, SI				Hartgerink, JD; Beniash, E; Stupp, SI			Self-assembly and mineralization of peptide-amphiphile nanofibers	SCIENCE			English	Article							IN-VITRO; BONE; NUCLEATION; COLLAGEN; MICROSTRUCTURES; SPECTROSCOPY; SEQUENCES; CRYSTALS	We have used the pH-induced self-assembly of a peptide-amphiphile to make a nanostructured fibrous scaffold reminiscent of extracellular matrix. The design of this peptide-amphiphile allows the nanofibers to be reversibly crosslinked to enhance or decrease their structural integrity. After cross-linking, the fibers are able to direct mineralization of hydroxyapatite to form a composite material in which the crystallographic c axes of hydroxyapatite are aligned with the tong axes of the fibers. This alignment is the same as that observed between Collagen fibrils and hydroxyapatite crystals in bone.	Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Sch Med, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Stupp, SI (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, 2225 N Campus Dr, Evanston, IL 60208 USA.	s-stupp@northwestern.edu	Stupp, Samuel/B-6737-2009; Stupp, Samuel/AGV-1942-2022; Hartgerink, Jeffrey D/G-4275-2016	Hartgerink, Jeffrey D/0000-0002-3186-5395				ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Archer EA, 2000, J AM CHEM SOC, V122, P5006, DOI 10.1021/ja000777s; ARCHIBALD DD, 1993, NATURE, V364, P430, DOI 10.1038/364430a0; Beniash E, 2000, J STRUCT BIOL, V132, P212, DOI 10.1006/jsbi.2000.4320; Bigi A, 2000, BIOMACROMOLECULES, V1, P752, DOI 10.1021/bm0055854; BOND GM, 1995, J MATER ENG PERFORM, V4, P334, DOI 10.1007/BF02649071; Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p; Burkett SL, 1996, CHEM COMMUN, P321, DOI 10.1039/cc9960000321; Cardullo F, 2000, CHEM COMMUN, P367, DOI 10.1039/a909459h; Clark TD, 1999, CHEM-EUR J, V5, P782, DOI 10.1002/(SICI)1521-3765(19990201)5:2<782::AID-CHEM782>3.0.CO;2-A; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Harris J. R., 1991, ELECT MICROSCOPY BIO, P32; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8; Israelachvili J., 1992, INTERMOLECULAR SURFA; JACKSON DY, 1991, J AM CHEM SOC, V113, P9391, DOI 10.1021/ja00024a067; Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; Lee KC, 1999, LANGMUIR, V15, P5500, DOI 10.1021/la9900775; Mann S, 1997, J CHEM SOC DALTON, P3953, DOI 10.1039/a704004k; MANN S, 1986, NATURE, V324, P565, DOI 10.1038/324565a0; Martinez JS, 2000, SCIENCE, V287, P1245, DOI 10.1126/science.287.5456.1245; Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; Varma HK, 1999, J MATER SCI-MATER M, V10, P395, DOI 10.1023/A:1008970913107; Veis A., 1989, P189; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; YAMADA K, 1984, CHEM LETT, P1713, DOI 10.1246/cl.1984.1713; Yu YC, 1997, METHOD ENZYMOL, V289, P571; Zubarev ER, 1999, SCIENCE, V283, P523, DOI 10.1126/science.283.5401.523	42	3057	3221	34	2018	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1684	1688		10.1126/science.1063187	http://dx.doi.org/10.1126/science.1063187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721046				2022-12-01	WOS:000172307400034
J	Ricklefs, RE; Bermingham, E				Ricklefs, RE; Bermingham, E			Nonequilibrium diversity dynamics of the Lesser Antillean avifauna	SCIENCE			English	Article							ISLAND BIOGEOGRAPHY; EVOLUTION; IMPACT; RATES; SCALE	MacArthur and Wilson's model of island diversity predicts an increase in the number of species until colonization and extinction are balanced at a long-term steady state. We appraise this model on an evolutionary time scale by molecular phylogenetic analysis of the colonization of the Lesser Antilles by small land birds. The pattern of accumulation of species with time, estimated by genetic divergence between island and source lineages, rejects a homogeneous model of colonization and extinction. Rather, our results suggest an abrupt, roughly 10-fold increase in colonization rate or a 90% mass extinction event 0.55 to 0.75 million years ago.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Smithsonian Trop Res Inst, Balboa, Panama; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Missouri System; University of Missouri Saint Louis; Smithsonian Institution; Smithsonian Tropical Research Institute; McGill University	Ricklefs, RE (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.							Arendt WJ, 1999, BIRD CONSERV INT, V9, P351, DOI 10.1017/S095927090000352X; BONATTI E, 1973, NATURE, V244, P563, DOI 10.1038/244563a0; BOND J, 1956, CHECKLIST BIRDS W IN; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Gersonde R, 1997, NATURE, V390, P357, DOI 10.1038/37044; Grant PR, 2001, OIKOS, V92, P385, DOI 10.1034/j.1600-0706.2001.920301.x; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Johnson KP, 2000, EVOLUTION, V54, P387; Krajewski C, 1996, MOL BIOL EVOL, V13, P21, DOI 10.1093/oxfordjournals.molbev.a025558; Lack D., 1976, ISLAND BIOL ILLUSTRA; Losos Jonathan B., 1996, P308; MAC ARTHUR ROBERT H., 1967; Pregill Gregory K., 1994, Bulletin of Carnegie Museum of Natural History, V30, P1; RICKLEFS RE, 1972, AM NAT, V106, P195, DOI 10.1086/282762; RICKLEFS RE, 1977, OIKOS, V29, P60, DOI 10.2307/3543293; RUSSELL GJ, 1995, J ANIM ECOL, V64, P628, DOI 10.2307/5805; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Tsikalas F, 1998, J GEOPHYS RES-SOL EA, V103, P30469, DOI 10.1029/97JB03389; Whittaker RJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P75, DOI 10.1046/j.1365-2699.2000.00200.x; WILCOX BA, 1978, SCIENCE, V199, P996, DOI 10.1126/science.199.4332.996; Wiley James W., 1993, Bird Conservation International, V3, P319; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174	23	95	99	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1522	1524		10.1126/science.1065005	http://dx.doi.org/10.1126/science.1065005			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711673	Green Submitted			2022-12-01	WOS:000172240500047
J	Sakai, H; Honma, T; Aoyama, T; Sato, S; Kato, T; Tabata, S; Oka, A				Sakai, H; Honma, T; Aoyama, T; Sato, S; Kato, T; Tabata, S; Oka, A			ARR1, a transcription factor for genes immediately responsive to cytokinins	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; REGULATORS; EXPRESSION; PLANTS; TARGET	Cytokinins are a class of phytohormones involved in various physiological events of plants. The Arabidopsis sensor histidine kinase CRE1 was recently reported to be a cytokinin receptor. We used asteroid-inducible system to show that the transcription factor-type response regulator ARR1 directs transcriptional activation of the ARR6 gene, which responds to cytokinins without de novo protein synthesis. This fact, together with characteristics of ARR1-over-expressing plants and arr1 mutant plants, indicates that the phosphorelay to ARR1, probably from CRE1, constitutes an intracellular signal transduction occurring immediately after cytokinin perception.	Kyoto Univ, Chem Res Inst, Mol Biol Lab, Kyoto 6110011, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan	Kyoto University; Kazusa DNA Research Institute	Oka, A (corresponding author), Kyoto Univ, Chem Res Inst, Mol Biol Lab, Kyoto 6110011, Japan.		Sato, Shusei/A-3616-2015	Sato, Shusei/0000-0002-0293-5366				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; Imamura A, 1998, P NATL ACAD SCI USA, V95, P2691, DOI 10.1073/pnas.95.5.2691; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; Lohrmann J, 1999, PLANT BIOLOGY, V1, P495, DOI 10.1111/j.1438-8677.1999.tb00775.x; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; Mok MC., 1994, CYTOKININS CHEM ACTI, P155, DOI DOI 10.1201/9781351071284; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P493, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Sakai H, 1998, PLANT CELL PHYSIOL, V39, P1232, DOI 10.1093/oxfordjournals.pcp.a029325; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; SAKAI H, UNPUB; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Taniguchi M, 1998, FEBS LETT, V429, P259, DOI 10.1016/S0014-5793(98)00611-5; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582	25	353	373	7	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1519	1521		10.1126/science.1065201	http://dx.doi.org/10.1126/science.1065201			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11691951				2022-12-01	WOS:000172240500046
J	Schoener, TW; Spiller, DA; Losos, JB				Schoener, TW; Spiller, DA; Losos, JB			Natural restoration of the species-area relation for a lizard after a hurricane	SCIENCE			English	Article							EXTINCTION; TURNOVER; ISLANDS; RATES	We document the decimation and recovery of the commonest lizard species, Anolis sagrei, on 66 islands in the Bahamas that were directly hit by Hurricane Floyd in September 1999. Before the hurricane, an island's area was a better predictor of the occurrence of A. sagrei than was its altitude. Immediately after, altitude was a better predictor: Apparently all Lizards on islands Lower than about 3 meters maximum elevation perished in the storm surge. After about 1 year, area again became the better predictor. By 19 months after the hurricane, A. sagrei populations occurred on 88% of the islands they formerly occupied. Recovery occurred via overwater colonization and propagation from eggs that survived inundation, mechanisms that were enhanced by larger island area. Thus, natural processes first destroyed and then quickly restored a highly regular species-area distribution.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	Washington University (WUSTL); University of California System; University of California Davis	Schoener, TW (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.							Brown J.H., 1998, BIOGEOGRAPHY; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; DIAMOND JM, 1977, SCIENCE, V197, P266, DOI 10.1126/science.197.4300.266; DIAMOND JM, 1976, P NATL ACAD SCI USA, V73, P262, DOI 10.1073/pnas.73.1.262; HAMILTON TH, 1963, SCIENCE, V142, P1575, DOI 10.1126/science.142.3599.1575; Hanski I. A., 1999, METAPOPULATION ECOLO; Licht P, 1970, U CALIF PUBL ZOOL, V95, P1; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; LOSOS JB, 1986, OECOLOGIA, V68, P338, DOI 10.1007/BF01036735; MAC ARTHUR ROBERT H., 1967; Picket S.T., 1985, ECOLOGY NATURAL DIST; Pimm S.L., 1991, BALANCE NATURE; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Schoener T.W., 1976, P 16 INT ORNITHOLOGI, V1, P629, DOI DOI 10.1111/J.1474-919X.1905.TB07792.X; Schoener T.W., 1986, COMMUNITY ECOLOGY, P556; SCHOENER TW, 1983, NATURE, V302, P332, DOI 10.1038/302332a0; Schoener TW, 1999, AM NAT, V153, P347, DOI 10.1086/303177; SCHOENER TW, 1983, J ANIM ECOL, V52, P209, DOI 10.2307/4597; SCHOENER TW, 1987, NATURE, V330, P474, DOI 10.1038/330474a0; SCHOENER TW, 1988, AM NAT, V131, P847, DOI 10.1086/284826; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; THORNTON I, 1996, KRAKATOA; TOWNES DR, 1990, ECOLOGICAL RESTORATI; VANDERVLIET PC, 1990, EUKARYOTIC NUCLEUS, V1, P1; Williamson M. H., 1981, ISLAND POPULATIONS	28	71	78	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1525	1528		10.1126/science.1064396	http://dx.doi.org/10.1126/science.1064396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711674				2022-12-01	WOS:000172240500048
J	Schnupp, JWH; Mrsic-Flogel, TD; King, AJ				Schnupp, JWH; Mrsic-Flogel, TD; King, AJ			Linear processing of spatial cues in primary auditory cortex	NATURE			English	Article							SOUND-LOCALIZATION BEHAVIOR; FERRET MUSTELA-PUTORIUS; BINAURAL STIMULATION; CORTICAL-NEURONS; CAT; RESPONSES; SENSITIVITY; PATHWAYS; LESIONS; CELLS	To determine the direction of a sound source in space, animals must process a variety of auditory spatial cues, including interaural level and time differences, as well as changes in the sound spectrum caused by the direction-dependent filtering of sound by the outer ear(1). Behavioural deficits observed when primary auditory cortex (A1) is damaged have led to the widespread view that A1 may have an essential role in this complex computational task(2-5). Here we show, however, that the spatial selectivity exhibited by the large majority of A1 neurons is well predicted by a simple linear model, which assumes that neurons additively integrate sound levels in each frequency band and ear. The success of this linear model is surprising, given that computing sound source direction is a necessarily nonlinear operation(6-9). However, because linear operations preserve information, our results are consistent with the hypothesis that A1 may also form a gateway to higher, more specialized cortical areas(10,11).	Univ Oxford, Univ Lab Physiol, Oxford OX1 3PT, England	University of Oxford	Schnupp, JWH (corresponding author), Univ Oxford, Univ Lab Physiol, S Parks Rd, Oxford OX1 3PT, England.	jan.schnupp@physiol.ox.ac.uk	schnupp, jan/A-3006-2012; King, Andrew J/M-6708-2013	King, Andrew J/0000-0001-5180-7179; schnupp, jan w h/0000-0002-2604-0057; Mrsic-Flogel, Tom/0000-0002-8947-408X				BRUGGE JF, 1994, HEARING RES, V73, P67, DOI 10.1016/0378-5955(94)90284-4; CARLILE S, 1990, J ACOUST SOC AM, V88, P2196, DOI 10.1121/1.400116; Clarey JC, 1992, MAMMALIAN AUDITORY P, P232, DOI [10.1007/978-1-4612-2838-7_5, DOI 10.1007/978-1-4612-2838-7_5]; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; KITZES LM, 1980, J COMP NEUROL, V192, P455, DOI 10.1002/cne.901920306; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Masterton RB, 1997, ACOUSTICAL SIGNAL PROCESSING IN THE CENTRAL AUDITORY SYSTEM, P1, DOI 10.1007/978-1-4419-8712-9_1; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Mrsic-Flogel TD, 2001, J NEUROPHYSIOL, V86, P1043, DOI 10.1152/jn.2001.86.2.1043; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; PHILLIPS DP, 1988, BRAIN RES, V443, P281, DOI 10.1016/0006-8993(88)91622-8; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Ruggero M. A., 1992, MAMMALIAN AUDITORY P, DOI [10.1007/978-1-4612-2838-7_2, DOI 10.1007/978-1-4612-2838-7_2]; SAMSON FK, 1994, J NEUROPHYSIOL, V71, P2194, DOI 10.1152/jn.1994.71.6.2194; Schreiner CE, 1998, AUDIOL NEURO-OTOL, V3, P104, DOI 10.1159/000013785; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; Wightman FL, 1997, J ACOUST SOC AM, V101, P1050, DOI 10.1121/1.418029; WIGHTMAN FL, 1993, HUMAN PSYCHOPHYSICS, P155; Yu JJ, 2000, P NATL ACAD SCI USA, V97, P11780, DOI 10.1073/pnas.97.22.11780	30	104	106	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2001	414	6860					200	204		10.1038/35102568	http://dx.doi.org/10.1038/35102568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700557				2022-12-01	WOS:000172029100046
J	Preminger, B				Preminger, B			The "Jewish nose" and plastic surgery: Origins and implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Cornell University	Preminger, B (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10021 USA.							Blair Vilray P., 1936, J AM DENT ASSOC, V23, P236; BLOODGOOD JC, 1927, DELINEATOR       OCT, P60; BLOODGOOD JC, 1927, DELINEATOR       OCT, P20; CARTER WW, 1930, LARYNGOSCOPE, V40, P504; Efron J. M., 1994, DEFENDERS RACE; Gilman Sander L., 1991, JEWS BODY; Haiken E., 1997, VENUS ENVY HIST COSM; MATORY E, 1998, ETHNIC CONSIDERATION; MILALRD RD, 1996, RHINOPLASTY TETRALOG; Nicolle F.V., 1996, AESTHETIC RHINOPLAST	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2161	2161		10.1001/jama.286.17.2161	http://dx.doi.org/10.1001/jama.286.17.2161			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694162	hybrid			2022-12-01	WOS:000172032100040
J	Peters, AHFM; O'Carroll, D; Scherthan, H; Mechtler, K; Sauer, S; Schofer, C; Weipoltshammer, K; Pagani, M; Lachner, M; Kohlmaier, A; Opravil, S; Doyle, M; Sibilia, M; Jenuwein, T				Peters, AHFM; O'Carroll, D; Scherthan, H; Mechtler, K; Sauer, S; Schofer, C; Weipoltshammer, K; Pagani, M; Lachner, M; Kohlmaier, A; Opravil, S; Doyle, M; Sibilia, M; Jenuwein, T			Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability	CELL			English	Article							POSITION-EFFECT VARIEGATION; CHROMOSOME SEGREGATION; FISSION YEAST; MITOTIC PHOSPHORYLATION; CENTRIC HETEROCHROMATIN; FEMALE MEIOSIS; DROSOPHILA; PROTEIN; H3; CENTROMERES	Histone H3 lysine 9 methylation has been proposed to provide a major "switch" for the functional organization of chromosomal subdomains. Here, we show that the murine Suv39h histone methyltransferases (HMTases) govern H3-K9 methylation at pericentric heterochromatin and induce a specialized histone methylation pattern that differs from the broad H3-K9 methylation present at other chromosomal regions. Suv39h-deficient mice display severely impaired viability and chromosomal instabilities that are associated with an increased tumor risk and perturbed chromosome interactions during male meiosis. These in vivo data assign a crucial role for pericentric H3-K9 methylation in protecting genome stability, and define the: Suv39h HMTases as important epigenetic regulators for mammalian development.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Kaiserslautern, Dept Human Biol, D-67663 Kaiserslautern, Germany; Univ Vienna, Inst Histol & Embryol, A-1090 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Kaiserslautern; University of Vienna	Jenuwein, T (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.		jia, xu/A-8386-2016; Mechtler, Karl/AAF-2717-2019	Mechtler, Karl/0000-0002-3392-9946; Schofer, Christian/0000-0001-9570-5692; Sibilia, Maria/0000-0001-6129-5613; O'Carroll, Donal/0000-0002-8626-2217; Peters, Antoine/0000-0002-0311-1887				Aagaard L, 2000, J CELL SCI, V113, P817; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Cobb J, 1999, CHROMOSOMA, V108, P412, DOI 10.1007/s004120050393; Csink AK, 1998, TRENDS GENET, V14, P200, DOI 10.1016/S0168-9525(98)01444-9; Czvitkovich S, 2001, MECH DEVELOP, V107, P141, DOI 10.1016/S0925-4773(01)00464-6; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; EISSENBERG JC, 1992, GENETICS, V131, P345; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; FOON KA, 1995, BLOOD PRINCIPLES PRA, P783; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; KELLUM R, 1995, J CELL SCI, V108, P1419; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kirschmann DA, 2000, CANCER RES, V60, P3359; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAMMERS JHM, 1995, CHROMOSOMA, V104, P154, DOI 10.1007/s004120050103; Lyko F, 2001, TRENDS GENET, V17, P169, DOI 10.1016/S0168-9525(01)02234-X; McKee BD, 2000, GENETICA, V109, P77, DOI 10.1023/A:1026536200594; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Murphy TD, 1998, CELL, V93, P317, DOI 10.1016/S0092-8674(00)81158-7; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; PARDUE ML, 1970, SCIENCE, V168, P1356, DOI 10.1126/science.168.3937.1356; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Taplick J, 1998, FEBS LETT, V436, P349, DOI 10.1016/S0014-5793(98)01164-8; THON G, 1994, GENETICS, V138, P29; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; TURNER JM, 2001, IN PRESS J CELL SCI; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; YOSHIDA N, 1998, REC RES DEV FERMEN 1, V1, P1; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	58	1287	1333	3	44	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					323	337		10.1016/S0092-8674(01)00542-6	http://dx.doi.org/10.1016/S0092-8674(01)00542-6			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701123	Bronze			2022-12-01	WOS:000172022800004
J	Cheah, J				Cheah, J			Chronic disease management: a Singapore perspective	BRITISH MEDICAL JOURNAL			English	Article							CHRONIC ILLNESS; CARE		Natl Univ Singapore, Dept Community Occupat & Family Med, Singapore 119074, Singapore	National University of Singapore	Cheah, J (corresponding author), Natl Univ Singapore, Dept Community Occupat & Family Med, Singapore 119074, Singapore.							COUCH JB, 1997, PHYSICIANS GUIDE DIS; ELLRODT G, 1997, JAMA-J AM MED ASSOC, V278, P687; FRIEDMAN N, 1999, DIS MANAGEMENT HLTH, V6, P355; FULLER MG, 1999, DIS MANAG HEALTH OUT, V6, P29; Ketner L, 1999, Healthc Financ Manage, V53, P36; KONGSTVEDT PR, 1998, BEST PRACTICES MED M; Leider H.L, 1999, DIS MANAG HEALTH OUT, V6, P327, DOI [10.2165/00115677-199906060-00003, DOI 10.2165/00115677-199906060-00003]; *MIN COMM DEV MIN, 1999, REP INT COMM AG POP; *MIN HLTH, 2001, ANN REP 2000; STONE RE, 1999, DIS MANAGEMENT HLTH, V5, P145; TODD W, 1997, DIS MANAGEMENT SYSTE; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569	14	36	38	5	18	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					990	993		10.1136/bmj.323.7319.990	http://dx.doi.org/10.1136/bmj.323.7319.990			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679392	Green Published			2022-12-01	WOS:000171918500023
J	Chaudhuri, TK; Farr, GW; Fenton, WA; Rospert, S; Horwich, AL				Chaudhuri, TK; Farr, GW; Fenton, WA; Rospert, S; Horwich, AL			GroEL/GroES-mediated folding of a protein too large to be encapsulated	CELL			English	Article							THERMODYNAMIC COUPLING MECHANISM; CHAPERONIN GROEL; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; BINDING; SUBSTRATE; POLYPEPTIDE; ATP; INTERMEDIATE; ACONITASE	The chaperonin GroEL binds nonnative proteins too large to fit inside the productive GroEL-GroES cis cavity, but whether and how it assists their folding has remained unanswered. We have examined yeast mitochondrial aconitase, an 82 kDa monomeric Fe4S4 cluster-containing enzyme, observed to aggregate in chaperonin-deficient mitochondria. We observed that aconitase folding both in vivo and in vitro requires both GroEL and GroES, and proceeds via multiple rounds of binding and release. Unlike the folding of smaller substrates, however, this mechanism does not involve cis encapsulation but, rather, requires GroES binding to the trans ring to release nonnative substrate, which likely folds in solution. Following the phase of ATP/ GroES-dependent refolding, GroEL stably bound apoaconitase, releasing active holoenzyme upon Fe4S4 co-factor formation, independent of ATP and GroES.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; MPI Enxymol Prot Folding, D-06120 Halle Saale, Germany	Howard Hughes Medical Institute; Yale University; Yale University	Horwich, AL (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06510 USA.			Rospert, Sabine/0000-0002-3089-9614				Bhutani N, 2000, J MOL BIOL, V297, P1037, DOI 10.1006/jmbi.2000.3648; BRUNSCHIER R, 1993, J BIOL CHEM, V268, P2767; Burston SG, 1996, NATURE, V383, P96, DOI 10.1038/383096a0; Chuang JL, 1999, J BIOL CHEM, V274, P10395, DOI 10.1074/jbc.274.15.10395; Clark AC, 1999, J MOL BIOL, V285, P1777, DOI 10.1006/jmbi.1998.2403; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Dubaquie Y, 1998, EMBO J, V17, P5868, DOI 10.1093/emboj/17.20.5868; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GORDON CL, 1994, J BIOL CHEM, V269, P27941; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Huang YS, 1999, J BIOL CHEM, V274, P10405, DOI 10.1074/jbc.274.15.10405; Iametti S, 2001, EUR J BIOCHEM, V268, P2421, DOI 10.1046/j.1432-1327.2001.02130.x; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; KENT TA, 1985, J BIOL CHEM, V260, P6871; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MORRISON JF, 1954, BIOCHEM J, V58, P685, DOI 10.1042/bj0580685; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Ribbe MW, 2001, P NATL ACAD SCI USA, V98, P5521, DOI 10.1073/pnas.101119498; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Song JL, 2000, J BIOL CHEM, V275, P22305, DOI 10.1074/jbc.M002038200; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; Walter S, 1996, P NATL ACAD SCI USA, V93, P9425, DOI 10.1073/pnas.93.18.9425; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 1996, J MOL BIOL, V255, P356, DOI 10.1006/jmbi.1996.0028; Zahn R, 1996, SCIENCE, V271, P642, DOI 10.1126/science.271.5249.642; ZAHN R, 1994, J MOL BIOL, V242, P165, DOI 10.1006/jmbi.1994.1567	38	138	141	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					235	246		10.1016/S0092-8674(01)00523-2	http://dx.doi.org/10.1016/S0092-8674(01)00523-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672530	Bronze			2022-12-01	WOS:000171694800012
J	Wild, K; Sinning, I; Cusack, S				Wild, K; Sinning, I; Cusack, S			Crystal structure of an early protein-RNA assembly complex of the signal recognition particle	SCIENCE			English	Article							SITE-DIRECTED MUTAGENESIS; RIBOSOMAL-RNA; BINDING; DOMAIN; SRP19; IDENTIFICATION; TRANSLOCATION; TETRALOOPS; SEQUENCE; LOOP	The signal recognition particle (SRP) is a universally conserved ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to cellular membranes. A crucial early step in SRP assembly in archaea and eukarya is the binding of protein SRP19 to specific sites on SRP RNA. Here we report the 1.8 angstrom resolution crystal structure of human SRP19 in complex with its primary binding site on helix 6 of SRP RNA, which consists of a stem-loop structure closed by an unusual GGAG tetraloop. Protein-RNA interactions are mediated by the specific recognition of a widened major groove and the tetraloop without any direct protein-base contacts and include a complex network of highly ordered water molecules. A model of the assembly of the SRP core comprising SRP19, SRP54, and SRP RNA based on crystallographic and biochemical data is proposed.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Wild, K (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	klemens.wild@bzh.uni-heidelberg.de	Sinning, Irmgard/A-2982-2010	Cusack, Stephen/0000-0002-9324-0796				Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Birse DEA, 1997, EMBO J, V16, P3757, DOI 10.1093/emboj/16.13.3757; Black SD, 1997, EUR J BIOCHEM, V245, P564, DOI 10.1111/j.1432-1033.1997.00564.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHITTENDEN K, 1994, J BIOL CHEM, V269, P20497; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Diener JL, 2000, BIOCHEMISTRY-US, V39, P12862, DOI 10.1021/bi001180s; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; GLUCK A, 1992, J MOL BIOL, V226, P411, DOI 10.1016/0022-2836(92)90956-K; Gowda K, 1997, NUCLEIC ACIDS RES, V25, P2835, DOI 10.1093/nar/25.14.2835; HAUSER S, 1995, EMBO J, V14, P5485, DOI 10.1002/j.1460-2075.1995.tb00235.x; Jagath JR, 2001, RNA, V7, P293, DOI 10.1017/S1355838201002205; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jucker FM, 1996, J MOL BIOL, V264, P968, DOI 10.1006/jmbi.1996.0690; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Canadillas JM, 2001, CURR OPIN STRUC BIOL, V11, P53, DOI 10.1016/S0959-440X(00)00164-0; PLEY HW, 1994, NATURE, V372, P111, DOI 10.1038/372111a0; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; Rose MA, 2001, NAT STRUCT BIOL, V8, P515, DOI 10.1038/88577; UHLENBECK OC, 1990, NATURE, V346, P613, DOI 10.1038/346613a0; WALTER P, 1983, CELL, V34, P525, DOI 10.1016/0092-8674(83)90385-9; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cellbio.10.1.87; Wild K, 1999, STRUCTURE, V7, P1345, DOI 10.1016/S0969-2126(00)80024-6; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; ZWIEB C, 1992, J BIOL CHEM, V267, P15650; Zwieb C, 1997, NUCLEIC ACIDS RES, V25, P107, DOI 10.1093/nar/25.1.107	34	65	68	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					598	601		10.1126/science.1063839	http://dx.doi.org/10.1126/science.1063839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641499				2022-12-01	WOS:000171695600048
J	Knight, EL; Avorn, J				Knight, EL; Avorn, J			Quality indicators for appropriate medication use in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING ENZYME-INHIBITOR; OVERACTIVE BLADDER; HEART-FAILURE; RISK-FACTORS; HYPOGLYCEMIA; HYPERTENSION; INTERVENTION; OUTPATIENTS; THERAPY; DRUGS		Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Avorn, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, 221 Londwood Ave, Boston, MA 02115 USA.							Abrams P, 1998, BRIT J UROL, V81, P801; *ABT ASS, 1998, EV DRUG US REV DEM P; Appell RA, 1997, UROLOGY, V50, P90, DOI 10.1016/S0090-4295(97)00599-2; ASPLUND K, 1983, DIABETOLOGIA, V24, P412; AVORN J, 2001, GERIATRIC MED; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; BEERS MH, 1992, ANN INTERN MED, V117, P684, DOI 10.7326/0003-4819-117-8-684; Black HR, 1997, ARCH INTERN MED, V157, P2413; Chiquette E, 1998, ARCH INTERN MED, V158, P1641, DOI 10.1001/archinte.158.15.1641; CHRISCHILLES EA, 1992, J GERONTOL, V47, pM137, DOI 10.1093/geronj/47.5.M137; EISENDRATH SJ, 1987, AM J PSYCHIAT, V144, P1062; FERNER RE, 1988, BRIT MED J, V296, P949, DOI 10.1136/bmj.296.6627.949; GOETZ DW, 1989, J ALLERGY CLIN IMMUN, V84, P316, DOI 10.1016/0091-6749(89)90414-4; GONZALEZFERNANDEZ RA, 1990, AM J CARDIOL, V65, P1384, DOI 10.1016/0002-9149(90)91332-Z; GOODYER LI, 1995, BRIT J CLIN PRACT, V49, P173; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; HIRSH J, 1995, AM J CARDIOL, V75, pB39, DOI 10.1016/0002-9149(95)80009-H; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Kalra PA, 1999, BMJ-BRIT MED J, V318, P234; Knight EL, 1999, AM HEART J, V138, P849, DOI 10.1016/S0002-8703(99)70009-8; Koenig K L, 1994, Acad Emerg Med, V1, P544; LOWE CJ, 1995, BRIT MED J, V310, P1229, DOI 10.1136/bmj.310.6989.1229; MACDONALD JB, 1977, BRIT MED J, V2, P483, DOI 10.1136/bmj.2.6085.483; MacDowall P, 1998, LANCET, V352, P13, DOI 10.1016/S0140-6736(97)11060-1; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; MONANE M, 1993, ARCH INTERN MED, V153, P633, DOI 10.1001/archinte.153.5.633; Monane M, 1998, JAMA-J AM MED ASSOC, V280, P1249, DOI 10.1001/jama.280.14.1249; PAICE BJ, 1985, ADVERSE DRUG REACT T, V4, P23; POTAMIANOS G, 1982, BRIT J PSYCHIAT, V140, P470, DOI 10.1192/bjp.140.5.470; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; Rich MW, 1996, AM J MED, V101, P270, DOI 10.1016/S0002-9343(96)00172-6; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Sands L, 1997, AM J GERIAT PSYCHIAT, V5, P156; SELTZER HS, 1972, DIABETES, V21, P955, DOI 10.2337/diab.21.9.955; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V267, P1083, DOI 10.1001/jama.267.8.1083; SIMONS FER, 1994, NEW ENGL J MED, V330, P1663; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; 1991, JAMA, V165, P3255	45	93	94	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				703	710		10.7326/0003-4819-135-8_Part_2-200110161-00009	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481WA	11601953				2022-12-01	WOS:000171542400009
J	Bibby, TS; Nield, J; Partensky, F; Barber, J				Bibby, TS; Nield, J; Partensky, F; Barber, J			Oxyphotobacteria - Antenna ring around photosystem I	NATURE			English	Article							MARINE PROKARYOTE; PROCHLOROCOCCUS; LIGHT; PROCHLOROPHYTE		Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England; CNRS, Observ Oceanol Roscoff, F-29682 Roscoff, France; Univ Paris 06, Biol Stn, F-29682 Roscoff, France	Imperial College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Bibby, TS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England.	j.barber@ic.ac.uk	Partensky, Frédéric/AAH-1170-2021; Bibby, Thomas/C-9159-2014; Partensky, Frédéric/B-9194-2018; Nield, Jon/C-5892-2013	Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Nield, Jon/0000-0001-9983-0239; Bibby, Thomas/0000-0003-1743-473X				Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; CHISHOLM SW, 1992, ARCH MICROBIOL, V157, P297, DOI 10.1007/BF00245165; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; LEWIN RA, 1976, NATURE, V261, P697, DOI 10.1038/261697b0; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	10	81	92	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					590	590		10.1038/35098153	http://dx.doi.org/10.1038/35098153			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11595938	Bronze			2022-12-01	WOS:000171485700038
J	Ooi, SL; Shoemaker, DD; Boeke, JD				Ooi, SL; Shoemaker, DD; Boeke, JD			A DNA microarray-based genetic screen for nonhomologous end-joining mutants in Saccharomyces cerevisiae	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; REPAIR; YEAST; MAINTENANCE; DELETION; PROTEIN; GENOME; XRCC4	We describe a microarray-based screen performed by imposing different genetic selections on thousands of yeast mutants in parallel, representing most genes in the yeast genome. The presence or absence of mutants was detected by oligonucleotide arrays that hybridize to 20-nucleotide "barcodes." We used this method to screen for components of the nonhomologous end-joining (NHEJ) pathway. Known components of the pathway were identified, as well as a gene not previously known to be involved in NHEJ, NEJ1. Nej1 protein interacts with the amino terminus of LIF1/XRCC4, a recently recognized "guardian of the genome" against cancer.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Rosetta Inpharmat Inc, Kirkland, WA 98034 USA	Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 617 Hunterian Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.			Boeke, Jef/0000-0001-5322-4946	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036481] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01627] Funding Source: Medline; NIGMS NIH HHS [GM36481] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; de la Torre-Ruiz MA, 2000, FEBS LETT, V467, P311, DOI 10.1016/S0014-5793(00)01180-7; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; GLAEVER G, 1999, NAT GENET, V21, P278; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hegde V, 2000, NUCLEIC ACIDS RES, V28, P2779, DOI 10.1093/nar/28.14.2779; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Roth DB, 2000, NATURE, V404, P823, DOI 10.1038/35009180; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Tsukamoto Y, 1997, MOL GEN GENET, V255, P543, DOI 10.1007/s004380050527; VALENCIA M, IN PRESS NATURE; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	22	117	121	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2552	2556		10.1126/science.1065672	http://dx.doi.org/10.1126/science.1065672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11701889				2022-12-01	WOS:000172927700060
J	Parsons, TJ; Power, C; Manor, O				Parsons, TJ; Power, C; Manor, O			Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							CATCH-UP GROWTH; CORONARY HEART-DISEASE; WEIGHT-FOR-HEIGHT; CARDIOVASCULAR RISK; BLOOD-PRESSURE; IN-UTERO; CHILDHOOD; OBESITY; ADOLESCENCE; WOMEN	Objectives To determine the influence of birth weight on body mass index at different stages of later life; whether this relation persists after accounting for potential confounding factors; and the role of indicators of fetal growth (birth weight relative to parental size) and childhood growth. Design Longitudinal study of the 1958 British birth cohort. Setting England, Scotland, and Wales. Participants All singletons born 3-9 March 1958 (10 683 participants with data available at age 33). Main outcome measures Body mass index at ages 7, 11, 16, 23, and 33 years. Results The relation between birth weight and body mass index was positive and weak, becoming more J shaped with increasing age. When adjustments were made for maternal weight, there was no relation between birth weight and boyd mass index at age 33. Indicators of poor fetal growth based on the mother's body size were not predictive, but the risk of adult obesity was higher among participants who had grown to a greater proportion of their eventual adult height by age 7. In men only, the effect of childhood growth was strongest in those with lower birth weights and, to a lesser extend, those born to lighter mothers. Conclusions Maternal weight (or body mass index) largely explains the association between birth weight and adult body mass index, and it may be a more important risk factor for obesity in the child than birth weight. Birth weight and maternal weight seem to modify the effect of childhood linear growth on adult obesity in men. Intergenerational associations between the mother's and her offspring's body mass index seem to underlie the well documented association between birth weight and body mass index. Other measures of fetal growth are needed for a fuller understanding of the role of the intrauterine environment in the development of obesity.	Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England; Hebrew Univ Jerusalem, Sch Publ Hlth & Community Med, IL-91120 Jerusalem, Israel	University of London; University College London; Hebrew University of Jerusalem	Parsons, TJ (corresponding author), Inst Child Hlth, Dept Paediat Epidemiol & Biostat, London WC1N 1EH, England.							BEUNEN G, 1994, INT J OBESITY, V18, P670; Butler N.R., 1963, PERINATAL MORTALITY; *CTR LONG STUD I E, 1994, NAT CHILD DEV STUD C; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; FERRI E, 1993, LIFE 33 5 FOLLOW UP; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; FREEMAN JV, 1995, INT J EPIDEMIOL, V24, P970, DOI 10.1093/ije/24.5.970; *GREAT BRIT GEN RE, 1956, CENS 1951 CLASS OCC; Hulman S, 1998, J PEDIATR-US, V132, P90, DOI 10.1016/S0022-3476(98)70491-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; LAKE JK, 1998, THESIS U COLL LONDON; Leon DA, 1996, BRIT MED J, V312, P401, DOI 10.1136/bmj.312.7028.401; Ong KKL, 2000, BRIT MED J, V320, P1244; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; POWER C, 1988, INT J OBESITY, V12, P445; SEIDMAN DS, 1991, AM J DIS CHILD, V145, P782; vanLenthe FJ, 1996, AM J CLIN NUTR, V64, P18, DOI 10.1093/ajcn/64.1.18; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6	24	363	373	0	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 8	2001	323	7325					1331	1335		10.1136/bmj.323.7325.1331	http://dx.doi.org/10.1136/bmj.323.7325.1331			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501ZC	11739217	Green Published, Bronze			2022-12-01	WOS:000172716900014
J	Goodlad, RA; Englyst, HN				Goodlad, RA; Englyst, HN			Redefining dietary fibre: potentially a recipe for disaster	LANCET			English	Editorial Material							RECURRENCE		Imperial Canc Res Fund, Histopathol Unit, London WC2A 3PX, England	Cancer Research UK	Goodlad, RA (corresponding author), Imperial Canc Res Fund, Histopathol Unit, 35-43 Lincolns Inn Fields, London WC2A 3PX, England.	goodlad@icrf.icnet.uk		Goodlad, Robert/0000-0002-7660-4287				Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; [Anonymous], 1998, FAO Food Nutr Pap, V66, P1; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; Englyst HN, 1996, FOOD CHEM, V57, P15, DOI 10.1016/0308-8146(96)00056-8; Goodlad RA, 2001, GUT, V48, P587, DOI 10.1136/gut.48.5.587; McCullough JS, 1998, GUT, V42, P799, DOI 10.1136/gut.42.6.799; Michels KB, 2000, JNCI-J NATL CANCER I, V92, P1740, DOI 10.1093/jnci/92.21.1740; *PAN DEF DIET FIB, 2001, PROP DEF DIET FIB; PELL JD, 1995, GASTROENTEROLOGY, V108, P1745, DOI 10.1016/0016-5085(95)90136-1; SOUTHGATE DAT, 1985, DIETARY FIBRE FIBRE, P31; TROWELL H, 1985, DIETARY FIBRE FIBRE, P1; Wasan HS, 1996, LANCET, V348, P319, DOI 10.1016/S0140-6736(96)01401-8; Wasan HS, 1998, J PATHOL, V185, P246; Williamson SLH, 1999, CARCINOGENESIS, V20, P805, DOI 10.1093/carcin/20.5.805	14	24	27	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2001	358	9296					1833	1834		10.1016/S0140-6736(01)06882-9	http://dx.doi.org/10.1016/S0140-6736(01)06882-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741620				2022-12-01	WOS:000172463000006
J	Gallouzi, IE; Steitz, JA				Gallouzi, IE; Steitz, JA			Delineation of mRNA export pathways by the use of cell-permeable peptides	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLEAR-PROTEIN EXPORT; REV ACTIVATION DOMAIN; RNA-BINDING-PROTEINS; AU-RICH ELEMENTS; MESSENGER-RNA; HNRNP A1; IN-VIVO; NUCLEOCYTOPLASMIC TRANSPORT; ANTENNAPEDIA HOMEODOMAIN	The transport of messenger RNAs (mRNAs) from the nucleus to the cytoplasm involves adapter proteins that bind the mRNA as well as receptor proteins that interact with the nuclear pore complex. We demonstrate the utility of cell-permeable peptides designed to interfere with interactions between potential adapter and receptor proteins to define the pathways accessed by particular mRNAs. We show that HuR, a protein implicated in the stabilization of short-lived mRNAs containing AU-rich elements (AREs), serves as an adapter for c-fos mRNA export through two pathways. One involves the HuR shuttling domain, HNS, which exhibits a heat shock-sensitive interaction with transportin 2 (Trn2); the other involves two protein ligands of HuR-pp32 and APRIL-which contain leucine-rich nuclear export signals (NES) recognized by the export receptor CRM1. Heterokaryon and in situ hybridization experiments reveal that the peptides selectively block the nucleocytoplasmic shuttling of their respective adapter proteins without perturbing the overall cellular distribution of polyadenylated mRNAs.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu			NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NCI NIH HHS [CA16038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Cullen BR, 2000, MOL CELL BIOL, V20, P4181, DOI 10.1128/MCB.20.12.4181-4187.2000; Dahlberg JE, 1998, CURR OPIN CELL BIOL, V10, P400, DOI 10.1016/S0955-0674(98)80017-3; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; HOPE TJ, 1990, P NATL ACAD SCI USA, V87, P7787, DOI 10.1073/pnas.87.19.7787; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; LAZO PA, 1987, EUR J BIOCHEM, V165, P393, DOI 10.1111/j.1432-1033.1987.tb11452.x; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mencinger M, 1998, BBA-GENE STRUCT EXPR, V1395, P176, DOI 10.1016/S0167-4781(97)00165-6; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MICHAEL WM, 1995, CELL, V83, P415; MOORE MS, 1994, TRENDS BIOCHEM SCI, V19, P211, DOI 10.1016/0968-0004(94)90024-8; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pasquinelli AE, 1997, P NATL ACAD SCI USA, V94, P14394, DOI 10.1073/pnas.94.26.14394; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; PINOLROMA S, 1989, METHOD ENZYMOL, V180, P410; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; SCHIAVI SC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P95, DOI 10.1016/0304-419X(92)90009-N; SCHNEIDERGADICKE A, 1988, CANCER RES, V48, P2969; Siomi MC, 1998, MOL CELL BIOL, V18, P4141, DOI 10.1128/MCB.18.7.4141; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Stutz F, 1998, GENE DEV, V12, P3303, DOI 10.1101/gad.12.21.3303; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; VAKALOPOULOU E, 1991, MOL CELL BIOL, V11, P3355, DOI 10.1128/MCB.11.6.3355; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Veyrune J L, 1997, Prog Mol Subcell Biol, V18, P35; Visa N, 1996, CELL, V84, P253, DOI 10.1016/S0092-8674(00)80980-0; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	72	239	246	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1895	1901		10.1126/science.1064693	http://dx.doi.org/10.1126/science.1064693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729309				2022-12-01	WOS:000172465000050
J	Harms, J; Schluenzen, F; Zarivach, R; Bashan, A; Gat, S; Agmon, I; Bartels, H; Franceschi, F; Yonath, A				Harms, J; Schluenzen, F; Zarivach, R; Bashan, A; Gat, S; Agmon, I; Bartels, H; Franceschi, F; Yonath, A			High resolution structure of the large ribosomal subunit from a mesophilic Eubacterium	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; ESCHERICHIA-COLI; ANGSTROM-RESOLUTION; CRYSTAL-STRUCTURE; THERMUS-THERMOPHILUS; PROTEIN L1; RNA; LOCATION; 23-S; CRYSTALLOGRAPHY	We describe the high resolution structure of the large ribosomal subunit from Deinococcus radiodurans (D50S), a gram-positive mesophile suitable for binding of antibiotics and functionally relevant ligands. The overall structure of D50S is similar to that from the archae bacterium Haloarcula marismortui (H50S); however, a detailed comparison revealed significant differences, for example, in the orientation of nucleotides in peptidyl transferase center and in the structures of many ribosomal proteins. Analysis of ribosomal features involved in dynamic aspects of protein biosynthesis that are partially or fully disordered in H50S revealed the conformations of intersubunit bridges in unbound subunits, suggesting how they may change upon subunit association and how movements of the L1-stalk may, facilitate the exit of tRNA.	Max Planck Res Unit Ribosomal Struct, D-22603 Hamburg, Germany; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Max Planck Society; Weizmann Institute of Science; Max Planck Society	Yonath, A (corresponding author), Max Planck Res Unit Ribosomal Struct, Notkestr 85, D-22603 Hamburg, Germany.		Harms, Joerg/K-8786-2012; Schluenzen, Frank/H-6274-2014; Franceschi, Francois/AAF-5860-2021; ZARIVACH, RAZ/F-1671-2012; Schluenzen, Frank/P-9177-2019	Harms, Joerg/0000-0002-9442-8264; Schluenzen, Frank/0000-0003-2849-0542; ZARIVACH, RAZ/0000-0001-6543-0296; Schluenzen, Frank/0000-0003-2849-0542; Franceschi, Francois/0000-0002-1554-7944				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Baranov PV, 1999, NUCLEIC ACIDS RES, V27, P184, DOI 10.1093/nar/27.1.184; Berg J M, 2001, Science, V291, P203; Bayfield MA, 2001, P NATL ACAD SCI USA, V98, P10096, DOI 10.1073/pnas.171319598; BISCHOF O, 1995, J BIOL CHEM, V270, P23060, DOI 10.1074/jbc.270.39.23060; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; CUNDLIFFE E, 1979, J MOL BIOL, V132, P235, DOI 10.1016/0022-2836(79)90393-0; Davies C, 1996, STRUCTURE, V4, P55, DOI 10.1016/S0969-2126(96)00009-3; DELAFORTELLE E, 1997, METHODS ENZYMOLOGY; Fedorov R, 1999, ACTA CRYSTALLOGR D, V55, P1827, DOI 10.1107/S0907444999010227; Fedorov R, 2001, ACTA CRYSTALLOGR D, V57, P968, DOI 10.1107/S0907444901006291; GINZBURG M, 1970, J GEN PHYSIOL, V55, P178; GOLDEN BL, 1993, EMBO J, V12, P4901, DOI 10.1002/j.1460-2075.1993.tb06184.x; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GuhaThakurta D, 2000, J MOL BIOL, V295, P569, DOI 10.1006/jmbi.1999.3372; GUTELL RR, 1996, RIBOSOMAL RNA STRUCT, P111; HALL CC, 1988, BIOCHEMISTRY-US, V27, P3983, DOI 10.1021/bi00411a014; Hard T, 2000, J MOL BIOL, V296, P169, DOI 10.1006/jmbi.1999.3433; HINCK AP, 1997, J MOL BIOL, V234, P1013; Hoffman DW, 1996, J MOL BIOL, V264, P1058, DOI 10.1006/jmbi.1996.0696; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lu M, 2000, P NATL ACAD SCI USA, V97, P2023, DOI 10.1073/pnas.97.5.2023; MALKIN LI, 1967, J MOL BIOL, V26, P329, DOI 10.1016/0022-2836(67)90301-4; MANKIN AS, 1991, J BACTERIOL, V173, P3559, DOI 10.1128/jb.173.11.3559-3563.1991; MILLIGAN RA, 1986, NATURE, V319, P693, DOI 10.1038/319693a0; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; Nakashima T, 2001, RNA, V7, P692, DOI 10.1017/S1355838201002345; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P57; Nikonov S, 1996, EMBO J, V15, P1350, DOI 10.1002/j.1460-2075.1996.tb00477.x; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLL M, 1973, J MOL BIOL, V75, P281, DOI 10.1016/0022-2836(73)90021-1; Ostergaard P, 1998, J MOL BIOL, V284, P227, DOI 10.1006/jmbi.1998.2185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penczek P, 1999, J STRUCT BIOL, V128, P44, DOI 10.1006/jsbi.1999.4157; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; PORSE BT, 1995, J MOL BIOL, V249, P1, DOI 10.1006/jmbi.1995.0276; RYAN PC, 1991, J MOL BIOL, V221, P1257, DOI 10.1016/0022-2836(91)90932-V; SABATINI DD, 1970, J CELL BIOL, V45, P146, DOI 10.1083/jcb.45.1.146; Sanyal SC, 2000, CURR OPIN STRUC BIOL, V10, P633, DOI 10.1016/S0959-440X(00)00143-3; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; SONENBERG N, 1973, P NATL ACAD SCI USA, V70, P1423, DOI 10.1073/pnas.70.5.1423; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; Unge J, 1998, STRUCTURE, V6, P1577, DOI 10.1016/S0969-2126(98)00155-5; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; WALLECZEK J, 1989, BIOCHEMISTRY-US, V28, P4099, DOI 10.1021/bi00435a071; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WITTMANN HG, 1983, ANNU REV BIOCHEM, V52, P35, DOI 10.1146/annurev.bi.52.070183.000343; Worbs M, 2000, EMBO J, V19, P807, DOI 10.1093/emboj/19.5.807; Wower IK, 1998, J BIOL CHEM, V273, P19847, DOI 10.1074/jbc.273.31.19847; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	62	733	792	2	55	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					679	688		10.1016/S0092-8674(01)00546-3	http://dx.doi.org/10.1016/S0092-8674(01)00546-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733066	Bronze			2022-12-01	WOS:000172575300014
J	McDonald, MJ; Rosbach, M				McDonald, MJ; Rosbach, M			Microarray analysis and organization of circadian gene expression Drosophila	CELL			English	Article							CLOCK MUTANTS; COMPLEMENT ACTIVATION; TRANSCRIPTION; RHYTHMS; MELANOGASTER; PROTEIN; PERIOD; COMPONENT; PACEMAKER; FEEDBACK	We have used high-density oligonucleotide arrays to study global circadian gene expression in Drosophila melanogaster. Coupled with an analysis of clock mutant (Clk) flies, a cell line designed to identify direct targets of the CLOCK (CLK) transcription factor and differential display, we uncovered several striking features of circadian gene networks. These include the identification of 134 cycling genes, which contribute to a wide range of diverse processes. Many of these clock or clock-regulated genes are located in gene clusters, which appear subject to transcriptional coregulation. All oscillating gene expression is under clk control, indicating that Drosophila has no clk-independent circadian systems. An even larger number of genes is affected in Clk flies, suggesting that clk affects other genetic networks. As we identified a small number of direct target genes, the data suggest that most of the circadian gene network is indirectly regulated by clk.	Natl Sci Fdn, Ctr Biol Timing, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA	National Science Foundation (NSF); NSF - Center for Biological Timing; Brandeis University; Howard Hughes Medical Institute	Rosbach, M (corresponding author), Natl Sci Fdn, Ctr Biol Timing, Dept Biol, Waltham, MA 02454 USA.	rosbash@brandeis.edu			NIGMS NIH HHS [GM33205] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS JM, 1992, P NATL ACAD SCI USA, V89, P10375, DOI 10.1073/pnas.89.21.10375; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRIERLEY CH, 1993, BIOESSAYS, V15, P749, DOI 10.1002/bies.950151108; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DEAR TN, 1991, EMBO J, V10, P2813, DOI 10.1002/j.1460-2075.1991.tb07830.x; Doi M, 2001, P NATL ACAD SCI USA, V98, P8089, DOI 10.1073/pnas.141090998; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hedlund E, 2001, CURR DRUG METAB, V2, P245, DOI 10.2174/1389200013338513; Hovemann BT, 1997, GENE, V189, P213, DOI 10.1016/S0378-1119(96)00851-7; Isaac RE, 2000, BIOCHEM SOC T, V28, P460, DOI 10.1042/0300-5127:0280460; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KOMMANN B, 2001, NUCLEIC ACIDS RES, V29, pE51; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LAZARD D, 1990, BIOCHEMISTRY-US, V29, P7433, DOI 10.1021/bi00484a012; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; Lee C, 1999, MOL CELL BIOL, V19, P5316; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; MCCLUNG CR, 1989, NATURE, V339, P558, DOI 10.1038/339558a0; McDonald MJ, 2001, MOL CELL BIOL, V21, P1207, DOI 10.1128/MCB.21.4.1207-1217.2001; Meyer UA, 1996, J PHARMACOKINET BIOP, V24, P449, DOI 10.1007/BF02353473; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Naylor E, 2000, J NEUROSCI, V20, P8138; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Petersen SV, 2001, MOL IMMUNOL, V38, P133; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ripperger JA, 2000, GENE DEV, V14, P679; RIZKI TM, 1978, GENETICS BIOL DROS B, V2, P398; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SAUNDERS DS, 1990, J BIOL RHYTHM, V5, P315, DOI 10.1177/074873049000500404; Saunders DS, 1982, INSECT CLOCKS; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Scully AL, 2000, CELL, V100, P297, DOI 10.1016/S0092-8674(00)80665-0; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Stover C, 2001, GENES IMMUN, V2, P119, DOI 10.1038/sj.gene.6363745; Taylor CAM, 1996, GENE, V181, P191, DOI 10.1016/S0378-1119(96)00503-3; Theopold U, 1999, BIOCHEM BIOPH RES CO, V261, P923, DOI 10.1006/bbrc.1999.1121; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; Zimmer S, 2000, J BIOL CHEM, V275, P25672, DOI 10.1074/jbc.M000851200	76	483	507	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					567	578		10.1016/S0092-8674(01)00545-1	http://dx.doi.org/10.1016/S0092-8674(01)00545-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733057	Green Submitted, Bronze			2022-12-01	WOS:000172575300005
J	Zhang, YQ; Bailey, AM; Matthies, HJG; Renden, RB; Smith, MA; Speese, SD; Rubin, GM; Broadie, K				Zhang, YQ; Bailey, AM; Matthies, HJG; Renden, RB; Smith, MA; Speese, SD; Rubin, GM; Broadie, K			Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function	CELL			English	Article							MENTAL-RETARDATION PROTEIN; DENDRITIC SPINES; RNA-BINDING; FMR-1; LOCALIZATION; MELANOGASTER; EXPRESSION; PRODUCT	Fragile X mental retardation gene (FMR1) encodes an RNA binding protein that acts as a negative translational regulator. We have developed a Drosophila fragile X syndrome model using loss-of-function mutants and overexpression of the FMR1 homolog (dfxr). dfxr nulls display enlarged synaptic terminals, whereas neuronal overexpression results in fewer and larger synaptic boutons. Synaptic structural defects are accompanied by altered neurotransmission, with synapse type-specific regulation in central and peripheral synapses. These phenotypes mimic those observed in mutants of microtubule-associated Futsch. Immunoprecipitation of dFXR shows association with futsch mRNA, and Western analyses demonstrate that dFXR inversely regulates Futsch expression. dfxr futsch double mutants restore normal synaptic structure and function. We propose that dFXR acts as a translational repressor of Futsch to regulate microtubule-dependent synaptic growth and function.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Broadie, K (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	broadie@biology.utah.edu	Renden, Robert/AAC-8294-2020; Matthies, Heinrich/AAD-2375-2019; Matthies, Heinrich/B-7284-2017	Renden, Robert/0000-0001-7905-4789; Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571; Zhang, Yong Q./0000-0003-0581-4882; Rubin, Gerald/0000-0001-8762-8703; Speese, Sean/0000-0002-3965-9828	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040654] Funding Source: NIH RePORTER; NICHD NIH HHS [HD40654] Funding Source: Medline; OHS HRSA HHS [ST32 HD07491] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OHS HRSA HHS		ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 2000, DROSOPHILA PROTOCOLS, P297; BROADIE KS, 1993, J NEUROSCI, V13, P144; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; ILIUS M, 1994, J NEUROGENET, V9, P189, DOI 10.3109/01677069409167279; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Lindsley D.L., 1992, GENOME DROSOPHILA ME; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Rodesch CK, 2000, NEUROREPORT, V11, pR45, DOI 10.1097/00001756-200012180-00002; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Rorth P, 1998, DEVELOPMENT, V125, P1049; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Tamanini F, 1996, HUM MOL GENET, V5, P809, DOI 10.1093/hmg/5.6.809; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395	37	506	521	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2001	107	5					591	603		10.1016/S0092-8674(01)00589-X	http://dx.doi.org/10.1016/S0092-8674(01)00589-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733059	Bronze			2022-12-01	WOS:000172575300007
J	Nizet, V; Ohtake, T; Lauth, X; Trowbridge, J; Rudisill, J; Dorschner, RA; Pestonjamasp, V; Piraino, J; Huttner, K; Gallo, RL				Nizet, V; Ohtake, T; Lauth, X; Trowbridge, J; Rudisill, J; Dorschner, RA; Pestonjamasp, V; Piraino, J; Huttner, K; Gallo, RL			Innate antimicrobial peptide protects the skin from invasive bacterial infection	NATURE			English	Article							ANTIBACTERIAL PEPTIDE; CYSTIC-FIBROSIS; STREPTOLYSIN-S; IDENTIFICATION; RESISTANCE; VIRULENCE; IMMUNITY; NEUTROPHILS; DEFENSINS; PRECURSOR	In mammals, several gene families encode peptides with antibacterial activity, such as the beta -defensins and cathelicidins(1-3). These peptides are expressed on epithelial surfaces and in neutrophils, and have been proposed to provide a first line of defence against infection by acting as 'natural antibiotics'(4,5). The protective effect of antimicrobial peptides is brought into question by observations that several of these peptides are easily inactivated(6-8) and have diverse cellular effects that are distinct from antimicrobial activity demonstrated in vitro(9-13). To investigate the function of a specific antimicrobial peptide in a mouse model of cutaneous infection, we applied a combined mammalian and bacterial genetic approach to the cathelicidin antimicrobial gene family(14). The mature human (LL-37)(15) and mouse (CRAMP)(16) peptides are encoded by similar genes (CAMP and Cnlp, respectively), and have similar alpha -helical structures, spectra of antimicrobial activity and tissue distribution. Here we show that cathelicidins are an important native component of innate host defence in mice and provide protection against necrotic skin infection caused by Group A Streptococcus (GAS).	Univ Calif San Diego, Dept Pediat, San Diego, CA 92161 USA; Univ Calif San Diego, Div Dermatol, San Diego, CA 92161 USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; Massachusetts Gen Hosp, Div Neonatol, Boston, MA 02114 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Harvard University; Massachusetts General Hospital	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92161 USA.	rgallo@vapop.ucsd.edu	Gallo, Richard L/A-8931-2009; Nizet, Victor/AAF-3190-2019	Gallo, Richard L/0000-0002-1401-7861; Nizet, Victor/0000-0003-3847-0422; Dorschner, Robert/0000-0002-4773-4461				Bals R, 1999, J CLIN INVEST, V103, P1113, DOI 10.1172/JCI6570; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Cole AM, 2001, BLOOD, V97, P297, DOI 10.1182/blood.V97.1.297; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 1999, MOL MED TODAY, V5, P292, DOI 10.1016/S1357-4310(99)01490-2; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; GROISMAN EA, 1992, P NATL ACAD SCI USA, V89, P11939, DOI 10.1073/pnas.89.24.11939; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Karlyshev AV, 2000, BIOTECHNIQUES, V28, P1078, DOI 10.2144/00286bm05; Lencer WI, 1997, P NATL ACAD SCI USA, V94, P8585, DOI 10.1073/pnas.94.16.8585; MILLER SI, 1990, INFECT IMMUN, V58, P3706, DOI 10.1128/IAI.58.11.3706-3710.1990; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; Peekhaus N, 1998, J BACTERIOL, V180, P1777, DOI 10.1128/JB.180.7.1777-1785.1998; Risso A, 1998, CELL IMMUNOL, V189, P107, DOI 10.1006/cimm.1998.1358; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	30	948	995	6	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					454	457		10.1038/35106587	http://dx.doi.org/10.1038/35106587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719807				2022-12-01	WOS:000172304500045
J	Sanders, GD; Hlatky, MA; Every, NR; McDonald, KM; Heidenreich, PA; Parsons, LS; Owens, DK				Sanders, GD; Hlatky, MA; Every, NR; McDonald, KM; Heidenreich, PA; Parsons, LS; Owens, DK			Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; SUDDEN CARDIAC DEATH; LOW-DOSE AMIODARONE; CONGESTIVE-HEART-FAILURE; PLACEBO-CONTROLLED TRIAL; CORONARY-ARTERY-DISEASE; BYPASS GRAFT-SURGERY; RANDOMIZED-TRIAL; HIGH-RISK; PREMATURE DEPOLARIZATIONS	Background. Clinical trials have shown; that implantable cardioverter defibrillators (ICDs) improve survival in patients with sustained ventricular arrhythmias. Objective: To determine the efficacy necessary to make prophylactic ICD or amiodarone therapy cost-effective in patients with myocardial infarction. Design: Markov model-based cost utility analysis. Data Sources: survival, cardiac death, and inpatient costs were estimated on the basis of the Myocardial Infarction Triage and intervention registry. Other data were derived; from the literature. Target Population: Patients with: past myocardial infarction who did not have sustained ventricular arrhythmia. Time Horizon: Lifetime. Perspective: societal. Interventions, ICD or amiodarone compared with no treatment. Outcome Measures- Life-years, quality-adjusted life-years (QALYs), costs, number needed to treat, and! incremental cost-effectiveness. Results of Base-Case Analysis: Compared with no treatment, ICD use led to the greatest QALYs and the highest expenditures. Amiodarone use resulted in intermediate QALYs and costs. To obtain acceptable cost-effectiveness thresholds (less than or equal to $75 000/ QALY), ICDs had to reduce arrhythmic death by 50% and amiodarone had to reduce total death by 7% in patients with depressed election fraction. Results of Sensitivity Analysis: For moderate efficacies, in patients with ejection fractions less than or equal to 0.3, 0.31 to 0.4, and greater than 0.4, the cost-effectiveness of amiodarone compared with no therapy was $43 100/QALY, $66 500/QALY, and $132 500/QALY, respectively, and the cost-effectiveness of ICD compared with amiodarone was $71 800/QALY, $195 700/QALY, and $557 900/QALY, respectively. Conclusions: Use of ICD or amiodarone in patients with past myocardial infarction and severely depressed left ventricular function may provide substantial clinical benefit at an acceptable cost. These results highlight the importance of clinical trials of ICDs in patients with low ejection fractions who have had myocardial infarction.	Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Seattle Vet Affairs Med Ctr, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Washington; University of Washington Seattle	Sanders, GD (corresponding author), Stanford Univ, Ctr Primary Care & Outcomes Res, 179 Encina Commons, Stanford, CA 94305 USA.	sanders@stanford.edu	Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490; Hlatky, Mark/0000-0003-4686-9441	AHRQ HHS [HS 08362] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008362] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AHERN TS, 1994, J AM COLL CARDIOL, V23, P1521; BAKKER PFA, 1992, PACE, V15, P654, DOI 10.1111/j.1540-8159.1992.tb05158.x; BARDY GH, 1999, AM J CARDIOL, V83, pD91; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; Bigger JT, 1999, CIRCULATION, V99, P1416, DOI 10.1161/01.CIR.99.11.1416; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; *BUR LAB STAT, 1998, CONS PRIC IND ALL UR; BURKART F, 1990, J AM COLL CARDIOL, V16, P1711, DOI 10.1016/0735-1097(90)90324-I; Buxton AE, 2000, NEW ENGL J MED, V342, P1937, DOI 10.1056/NEJM200006293422602; BUXTON AE, 1993, PROG CARDIOVASC DIS, V36, P215, DOI 10.1016/0033-0620(93)90015-6; BUXTON AE, 1984, AM J CARDIOL, V53, P1275, DOI 10.1016/0002-9149(84)90078-X; Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; CAIRNS JA, 1991, CIRCULATION, V84, P550, DOI 10.1161/01.CIR.84.2.550; CAMM AJ, 1993, AM J CARDIOL, V72, pF95, DOI 10.1016/0002-9149(93)90970-N; CEREMUZYNSKI L, 1992, J AM COLL CARDIOL, V20, P1056, DOI 10.1016/0735-1097(92)90357-S; COBB LA, 1992, CIRCULATION, V85, P98; Connolly SJ, 1997, LANCET, V350, P1417; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Domanski MJ, 1999, J AM COLL CARDIOL, V34, P1090, DOI 10.1016/S0735-1097(99)00327-7; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DOVAL HC, 1994, LANCET, V344, P493, DOI 10.1016/S0140-6736(94)91895-3; EPSTEIN AE, 1991, J AM COLL CARDIOL, V18, P14, DOI 10.1016/S0735-1097(10)80210-4; Every NR, 1997, AM HEART J, V134, P1129, DOI 10.1016/S0002-8703(97)70035-8; Every NR, 1997, CIRCULATION, V96, P1770, DOI 10.1161/01.CIR.96.6.1770; EVERY NR, IN PRESS AM HEART J; Farre J, 1999, AM J CARDIOL, V83, p55D; GABRY MD, 1987, J AM COLL CARDIOL, V9, P1349, DOI 10.1016/S0735-1097(87)80477-1; GREENE HL, 1993, AM J CARDIOL, V72, P280; Grimm W, 1999, PACE, V22, P206, DOI 10.1111/j.1540-8159.1999.tb00334.x; HAMER AWF, 1989, J AM COLL CARDIOL, V14, P1768, DOI 10.1016/0735-1097(89)90030-2; HLATKY MA, 1987, IN PRESS AM HEART J; HOCKINGS BEF, 1987, AM J CARDIOL, V60, P967, DOI 10.1016/0002-9149(87)90334-1; Jafri SM, 1998, PROG CARDIOVASC DIS, V41, P65, DOI 10.1016/S0033-0620(98)80023-6; Julian DG, 1997, LANCET, V349, P667, DOI 10.1016/S0140-6736(96)09145-3; KLEMAN JM, 1994, CIRCULATION, V90, P2833, DOI 10.1161/01.CIR.90.6.2833; KUPERSMITH J, 1995, AM HEART J, V130, P507, DOI 10.1016/0002-8703(95)90359-3; KUPPERMANN M, 1990, CIRCULATION, V81, P91, DOI 10.1161/01.CIR.81.1.91; LARSEN GC, 1992, J AM COLL CARDIOL, V19, P1323, DOI 10.1016/0735-1097(92)90341-J; Lipscomb J, 1996, COST EFFECTIVENESS H, P214; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; MCDONALD KM, 2000, MED DECIS MAKING, V20, P501; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; MOYE LA, 1991, AM J CARDIOL, V68, pD70; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; Mushlin AI, 1998, CIRCULATION, V97, P2129, DOI 10.1161/01.CIR.97.21.2129; NAVARROLOPEZ F, 1993, AM J CARDIOL, V72, P1243, DOI 10.1016/0002-9149(93)90291-J; NICKLAS JM, 1991, AM HEART J, V122, P1016, DOI 10.1016/0002-8703(91)90466-U; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; NUNAIN SO, 1995, CIRCULATION, V91, P2204, DOI 10.1161/01.CIR.91.8.2204; Owens DK, 1998, J GEN INTERN MED, V13, P716, DOI 10.1046/j.1525-1497.1998.00211.x; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; RITCHIE JL, 1985, AM J CARDIOL, V55, P645, DOI 10.1016/0002-9149(85)90129-8; Rosenqvist M, 1998, CIRCULATION, V98, P663, DOI 10.1161/01.CIR.98.7.663; Roy D, 1998, CIRCULATION, V98, P495; RUBERMAN W, 1981, CIRCULATION, V64, P297, DOI 10.1161/01.CIR.64.2.297; SAKSENA S, 1992, J AM COLL CARDIOL, V19, P490, DOI 10.1016/S0735-1097(10)80260-8; Sanders G D, 1995, Proc Annu Symp Comput Appl Med Care, P258; SIEBELS J, 1994, AM HEART J, V127, P1139, DOI 10.1016/0002-8703(94)90101-5; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Sim I, 1997, CIRCULATION, V96, P2823, DOI 10.1161/01.CIR.96.9.2823; SINGH SN, 1993, AM J CARDIOL, V72, pF99, DOI 10.1016/0002-9149(93)90971-E; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Stevenson WG, 1997, JPN CIRC J, V61, P727, DOI 10.1253/jcj.61.727; TANNENBAUM TN, 1990, CAN MED ASSOC J, V143, P875; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; WEINBERG BA, 1993, AM HEART J, V125, P109, DOI 10.1016/0002-8703(93)90063-F; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wever EFD, 1996, CIRCULATION, V93, P489, DOI 10.1161/01.CIR.93.3.489; ZIPES DP, 1995, CIRCULATION, V92, P59, DOI 10.1161/01.CIR.92.1.59; 1999, DRUG TOPICS RED BOOK; 1998, VITAL STAT US, V2; 1998, 1999 HEART STROKE ST	75	61	61	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2001	135	10					870	883		10.7326/0003-4819-135-10-200111200-00007	http://dx.doi.org/10.7326/0003-4819-135-10-200111200-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DY	11712877				2022-12-01	WOS:000172267500003
J	Gray, WM; Kepinski, S; Rouse, D; Leyser, O; Estelle, M				Gray, WM; Kepinski, S; Rouse, D; Leyser, O; Estelle, M			Auxin regulates SCFTIR1-dependent degradation of AUX/IAA proteins	NATURE			English	Article							SCF UBIQUITIN-LIGASE; ARABIDOPSIS-THALIANA; RESPONSE ELEMENTS; GENE; YEAST; TRANSCRIPTION; PATHWAY; FAMILY; NEDD8; RUB1	The plant hormone auxin is central in many aspects of plant development. Previous studies have implicated the ubiquitin-ligase SCFTIR1 and the AUX/IAA proteins in auxin response. Dominant mutations in several AUX/IAA genes confer pleiotropic auxin-related phenotypes, whereas recessive mutations affecting the function of SCFTIR1 decrease auxin response. Here we show that SCFTIR1 is required for AUX/IAA degradation. We demonstrate that SCFTIR1 interacts with AXR2/IAA7 and AXR3/IAA17, and that domain II of these proteins is necessary and sufficient for this interaction. Further, auxin stimulates binding of SCFTIR1 to the AUX/IAA proteins, and their degradation. Because domain II is conserved in nearly all AUX/IAA proteins in Arabidopsis, we propose that auxin promotes the degradation of this large family of transcriptional regulators, leading to diverse downstream effects.	Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of Texas System; University of Texas Austin; University of York - UK	Estelle, M (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	mestelle@mail.utexas.edu	Leyser, Ottoline/AAC-5577-2019; Estelle, Mark/ABD-6742-2021; Rouse, Dean/B-3636-2009; Gray, William M/F-9402-2010	Gray, William M/0000-0002-1320-290X; Leyser, Ottoline/0000-0003-2161-3829				ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; BERLETH T, 1993, DEVELOPMENT, V118, P575; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Gray WM, 2000, TRENDS BIOCHEM SCI, V25, P133, DOI 10.1016/S0968-0004(00)01544-9; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; SMART CM, 1991, PLANT CELL, V3, P647, DOI 10.1105/tpc.3.7.647; STOMP AM, 1991, GUS PROTOCOLS, P103; Tian Q, 1999, DEVELOPMENT, V126, P711; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x	30	978	1065	10	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2001	414	6861					271	276		10.1038/35104500	http://dx.doi.org/10.1038/35104500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713520	Green Accepted			2022-12-01	WOS:000172150700034
J	Shine, R; Phillips, B; Waye, H; LeMaster, M; Mason, RT				Shine, R; Phillips, B; Waye, H; LeMaster, M; Mason, RT			Benefits of female mimicry in snakes	NATURE			English	Article							THAMNOPHIS-SIRTALIS-PARIETALIS; GARTER SNAKES; SIZE		Univ Sydney, Dept Biol Sci, Sydney, NSW 2006, Australia; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	University of Sydney; Oregon State University	Shine, R (corresponding author), Univ Sydney, Dept Biol Sci, Sydney, NSW 2006, Australia.	rics@bio.usyd.edu.au	Phillips, Ben/C-7957-2009; Shine, Richard/B-8711-2008	Phillips, Ben/0000-0003-2580-2336; 				Andersson Malte, 1994; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HECKROTTE C, 1967, COPEIA, P759; MASON RT, 1985, NATURE, V316, P59, DOI 10.1038/316059a0; OLSON DH, 1989, COPEIA, P391, DOI 10.2307/1445435; Shine R, 2000, PHYSIOL BIOCHEM ZOOL, V73, P508, DOI 10.1086/317734; Shine R, 2000, CAN J ZOOL, V78, P1391, DOI 10.1139/cjz-78-8-1391; Shine R, 2000, ANIM BEHAV, V59, P349, DOI 10.1006/anbe.1999.1321; Shine R, 2001, EVOLUTION, V55, P598, DOI 10.1554/0014-3820(2001)055[0598:BITSDE]2.0.CO;2; TRIVERS RL, 1976, EVOLUTION, V30, P253, DOI 10.1111/j.1558-5646.1976.tb00908.x; WHITTIER JM, 1985, BEHAV ECOL SOCIOBIOL, V16, P257, DOI 10.1007/BF00310989	11	48	49	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2001	414	6861					267	267		10.1038/35104687	http://dx.doi.org/10.1038/35104687			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713516				2022-12-01	WOS:000172150700030
J	Mason, J; Freemantle, N; Browning, G				Mason, J; Freemantle, N; Browning, G			Impact of Effective Health Care bulletin on treatment of persistent glue ear in children: time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Newcastle Univ, Ctr Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England	Newcastle University - UK	Mason, J (corresponding author), Newcastle Univ, Ctr Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.		Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; Freemantle, Nick/0000-0001-5807-5740				BLACK N, 1984, LANCET, V1, P835; Department of Health, 1996, HLTH PERS SOC SERV S; Mason J, 1998, HLTH TRENDS, V30, P120; SHELDON TA, 1992, LANCET, V340, P1324; 1992, EFFECTIVE HLTH CARE	5	30	30	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2001	323	7321					1096	1097		10.1136/bmj.323.7321.1096	http://dx.doi.org/10.1136/bmj.323.7321.1096			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701573	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000172188400012
J	Sanders, DS; Carter, MJ; Hurlstone, DP; Pearce, A; Ward, AM; McAlindon, ME; Lobo, AJ				Sanders, DS; Carter, MJ; Hurlstone, DP; Pearce, A; Ward, AM; McAlindon, ME; Lobo, AJ			Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care	LANCET			English	Article							CELIAC-DISEASE; CLINICAL-FEATURES; SYMPTOMS; PREVALENCE; DIAGNOSIS; ANTIENDOMYSIUM; SENSITIVITY; DEFICIENCY; ANTIBODIES; COMMUNITY	Background Irritable bowel syndrome has a high prevalence. Consensus diagnostic criteria (ROME II) based on symptoms have been established to aid diagnosis. Although coeliac disease can be misdiagnosed as irritable bowel syndrome, no prospective study has been published in which patients with this disorder are investigated for coeliac disease. We aimed to assess the association of coeliac disease with irritable bowel syndrome in patients fulfilling ROME II criteria. Methods We undertook a case-control study at a university hospital. 300 consecutive new patients who fulfilled Rome II criteria for irritable bowel syndrome, and 300 healthy controls (age and sex matched) were investigated for coeliac disease by analysis of serum IgA antigliadin, IgG antigliadin, and endomysial antibodies (EMA). Patients and controls with positive antibody results were offered duodenal biopsy to confirm the possibility of coeliac disease. Findings 66 patients with irritable bowel syndrome had positive antibody results, of whom 14 had coeliac disease (11 EMA positive, three EMA negative). Nine patients with positive antibody results were lost to follow-up or refused biopsy (only one EMA-positive patient refused biopsy), and 43 had normal duodenal mucosa. Two controls, both of whom were EMA positive, had coeliac disease. Compared with matched controls, irritable bowel syndrome was significantly associated with coeliac disease (p=0.004, odds ratio=7.0 [95% CI 1.7-28.0]). Interpretation Patients with irritable bowel syndrome referred to secondary care should be investigated routinely for coeliac disease. With only EMA, three of 14 cases would have been missed.	Royal Hallamshire Hosp, Gastroenterol & Liver Unit, Sheffield S10 2JF, S Yorkshire, England; Univ Sheffield, Sch Med, Sheffield, S Yorkshire, England; No Gen Hosp, Suprareg Prot Reference Unit, Sheffield S5 7AU, S Yorkshire, England	University of Sheffield; University of Sheffield; Northern General Hospital	Sanders, DS (corresponding author), Royal Hallamshire Hosp, Gastroenterol & Liver Unit, Room P14,Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	d.s.sanders28@btopenworld.com						*AM GASTR ASS, 1997, GASTROENTEROLOGY, V112, P2118; Cataldo F, 1998, GUT, V42, P362, DOI 10.1136/gut.42.3.362; Cataldo F, 2000, GUT, V47, P366, DOI 10.1136/gut.47.3.366; CATASSI C, 1994, LANCET, V343, P200, DOI 10.1016/S0140-6736(94)90989-X; Collin P, 1999, DIGEST DIS, V17, P100, DOI 10.1159/000016911; Collin P, 1996, GUT, V39, P382, DOI 10.1136/gut.39.3.382; Dahele A., 2000, P R COLL PHYSICIANS, V30, P100; Drossman D., 1990, GASTR INT, V3, P159; Feighery C, 1999, BMJ-BRIT MED J, V319, P236, DOI 10.1136/bmj.319.7204.236; FERGUSON A, 1993, GUT, V34, P150, DOI 10.1136/gut.34.2.150; Hadjivassiliou M, 1996, LANCET, V347, P369, DOI 10.1016/S0140-6736(96)90540-1; Hamm LR, 1999, AM J GASTROENTEROL, V94, P1279, DOI 10.1016/S0002-9270(99)00133-1; HARVEY RF, 1987, LANCET, V1, P963; HEATON KW, 1992, GASTROENTEROLOGY, V102, P1962, DOI 10.1016/0016-5085(92)90320-X; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; ISGAR B, 1983, GUT, V24, P190, DOI 10.1136/gut.24.3.190; Johnston SD, 1997, LANCET, V350, P1370, DOI 10.1016/S0140-6736(05)65142-2; Jones J, 2000, GUT, V47, pII1, DOI 10.1136/gut.47.suppl_2.ii1; Longstreth GF, 1997, DIGEST DIS SCI, V42, P1105, DOI 10.1023/A:1018864915375; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; MCFARLANE XA, 1995, GUT, V36, P710, DOI 10.1136/gut.36.5.710; Rostami K, 1999, AM J GASTROENTEROL, V94, P888; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; TALLEY NJ, 1991, GASTROENTEROLOGY, V101, P927, DOI 10.1016/0016-5085(91)90717-Y; Taub E, 1995, DIGEST DIS SCI, V40, P2647, DOI 10.1007/BF02220455; Thompson WG, 1999, GUT, V45, P43; THOMPSON WG, 1984, GUT, V25, P1089, DOI 10.1136/gut.25.10.1089; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Thompson WG, 1997, EUR J GASTROEN HEPAT, V9, P299; TOLLIVER BA, 1994, AM J GASTROENTEROL, V89, P176; Troncone R, 1996, ACTA PAEDIATR, V85, P10, DOI 10.1111/j.1651-2227.1996.tb14240.x; Volta U, 1998, LANCET, V352, P26, DOI 10.1016/S0140-6736(97)11222-3; West J, 2001, GUT, V48, pA63; WHITEHEAD WE, 1990, GASTROENTEROLOGY, V98, P336, DOI 10.1016/0016-5085(90)90822-I	35	290	304	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2001	358	9292					1504	1508		10.1016/S0140-6736(01)06581-3	http://dx.doi.org/10.1016/S0140-6736(01)06581-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MN	11705563				2022-12-01	WOS:000172055800013
J	Bynum, WF				Bynum, WF			Nature's helping hand	NATURE			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London NW1 1AD, England	University of London; University College London	Bynum, WF (corresponding author), UCL, Wellcome Trust Ctr Hist Med, 24 Eversholt St, London NW1 1AD, England.							NESSE RM, 1995, EVOLUTION HEALING; Neuburger Max, 1932, DOCTRINE HEALING POW; Warner J. H., 1986, THERAPEUTIC PERSPECT	3	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					21	21		10.1038/35102123	http://dx.doi.org/10.1038/35102123			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689921	Bronze			2022-12-01	WOS:000171898900022
J	Zhou, YF; Morais-Cabral, JH; Kaufman, A; MacKinnon, R				Zhou, YF; Morais-Cabral, JH; Kaufman, A; MacKinnon, R			Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 angstrom resolution	NATURE			English	Article							POTASSIUM CHANNEL; CONDUCTION; PORE	Ion transport proteins must remove an ion's hydration shell to coordinate the ion selectively on the basis of its size and charge. To discover how the K+ channel solves this fundamental aspect of ion conduction, we solved the structure of the KcsA K+ channel in complex with a monoclonal Fab antibody fragment at 2.0 Angstrom resolution. Here we show how the K+ channel displaces water molecules around an ion at its extracellular entryway, and how it holds a K+ ion in a square antiprism of water molecules in a cavity near its intracellular entryway. Carbonyl oxygen atoms within the selectivity filter form a very similar square antiprism around each K+ binding site, as if to mimic the waters of hydration. The selectivity filter changes its ion coordination structure in low K+ solutions. This structural change is crucial to the operation of the selectivity filter in the cellular context, where the K+ ion concentration near the selectivity filter varies in response to channel gating.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716				ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADEN BC, 1994, J MOL BIOL, V243, P767, DOI 10.1016/0022-2836(94)90046-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clare Speakman J., 1972, STRUCTURE BONDING, P141; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; DOBLER M, 1969, HELV CHIM ACTA, V52, P2573, DOI 10.1002/hlca.19690520840; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNITZ JD, 1977, BIOL ASPECTS INORGAN, P113; Harlow E., 1989, ANTIBODIES LAB MANUA; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Jencks W.P., 1987, CATALYSIS CHEM ENZYM; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; MILLER C, 1987, J GEN PHYSIOL, V90, P427, DOI 10.1085/jgp.90.3.427; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEUPERTLAVES K, 1975, HELV CHIM ACTA, V58, P432, DOI 10.1002/hlca.19750580212; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457	30	1620	1656	8	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					43	48		10.1038/35102009	http://dx.doi.org/10.1038/35102009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689936				2022-12-01	WOS:000171898900035
J	Padkin, A; Rowan, K; Black, N				Padkin, A; Rowan, K; Black, N			Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C	BRITISH MEDICAL JOURNAL			English	Article							CARE		Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England; Intens Care Natl Audit & Res Ctr, London WC1H 9HR, England	University of London; London School of Hygiene & Tropical Medicine; Intensive Care National Audit & Research Centre	Padkin, A (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England.							APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Black N, 2001, BRIT MED J, V323, P275, DOI 10.1136/bmj.323.7307.275; Black N, 1996, BRIT MED J, V312, P1215; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; *BRIT MED ASS, 1992, 33 BMA RPS; Britton A, 1999, J Health Serv Res Policy, V4, P112; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; MATHER CMP, 1995, ANAESTHESIA, V50, P189, DOI 10.1111/j.1365-2044.1995.tb04552.x; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; ROWAN K, 2001, PROGRAMME INTENSIVE, P51; ROWAN K, 2000, HLTH CARE UK     SPR, P42; Turner S, 1998, BRIT MED J, V316, P343, DOI 10.1136/bmj.316.7128.343	15	43	43	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					923	926		10.1136/bmj.323.7318.923	http://dx.doi.org/10.1136/bmj.323.7318.923			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668142	Green Accepted, Green Published			2022-12-01	WOS:000171798200028
J	Piccirillo, JF; Mager, DE; Frisse, ME; Brophy, RH; Goggin, A				Piccirillo, JF; Mager, DE; Frisse, ME; Brophy, RH; Goggin, A			Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; ANTIMICROBIAL TREATMENT; AMOXICILLIN; ADULTS; RHINOSINUSITIS; THERAPY; INFECTIONS; PRINCIPLES; CURE	Context Studies suggest little benefit in relief of acute sinusitis symptoms from the use of newer and more expensive (second-line) antibiotics instead of older and less expensive (first-line) antibiotics. However, researchers have failed to include development of complications and cost of care in their analyses. Objective To compare the effectiveness and cost of first-line with second-line antibiotics for the treatment of acute uncomplicated sinusitis in adults. Design, Setting, and Patients Retrospective cohort study using a pharmaceutical database containing demographic, clinical (International Classification of Diseases, Ninth Revision), treatment, and charge information for 29102 adults with a diagnosis of acute sinusitis receiving initial antibiotic treatment between July 1, 1996, and June 30, 1997. Main Outcome Measures Absence of additional claim for an antibiotic in the 28 days after the initial antibiotic, presence of a claim for a second antibiotic, serious complications of sinusitis, and direct charges and use for the acute sinusitis treatment. Results There were 17 different antibiotics prescribed in this study. The majority (59.5%) of patients received 1 of the first-line antibiotics. The overall success rate was 90.4% (95% confidence interval [CI], 90.0%-90.8%). The success rate for the 17 329 patients who received a first-line antibiotic was 90.1% and for the 11773 patients who received a second-line antibiotic was 90.8%, a difference of 0.7% (95% CI, 0.01%-1.40%; P<.05). There were 2 cases of periorbital cellulitis, one in each treatment group. The average total direct charge for patients receiving a first-line antibiotic was $68.98 and a second-line antibiotic was $135.17, a difference of $66.19 (95% Cl, $64.95-$67.43; P<.001). This difference was due entirely to the difference in charge of antibiotics and not other charges, such as professional fees, laboratory tests, or emergency department visits. Conclusions Patients treated with a first-line antibiotic for acute uncomplicated sinusitis did not have clinically significant differences in outcomes vs those treated with a second-line antibiotic. However, cost of care was significantly higher for patients treated with a second-line antibiotic.	Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Clin Outcomes Res, St Louis, MO 63110 USA; Express Scripts Inc, Maryland Hts, MO USA	Washington University (WUSTL); Express Scripts Holding Company	Piccirillo, JF (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Clin Outcomes Res, Campus Box 8115,660 S Euclid Ave, St Louis, MO 63110 USA.	piccirij@msnotes.wustl.edu	Frisse, Mark E/B-3824-2016; Brophy, Robert H/AAX-8562-2021	Frisse, Mark E/0000-0003-0382-6222; Brophy, Robert H/0000-0002-2912-8265				Adelglass J, 1999, OTOLARYNG HEAD NECK, V120, P320, DOI 10.1016/S0194-5998(99)70269-X; Adelglass J, 1998, CLIN THER, V20, P1115, DOI 10.1016/S0149-2918(98)80108-2; *AG HLTH CAR POL R, 1999, 999E015 AG HLTH CAR; Benninger MS, 1997, ARCH OTOLARYNGOL, V123, P1175; BERG O, 1986, Rhinology (Utrecht), V24, P223; Bro F, 1988, Scand J Prim Health Care, V6, P175, DOI 10.3109/02813438809009312; Burke T, 1999, CLIN THER, V21, P1664, DOI 10.1016/S0149-2918(99)80046-0; De Bock Geertruida H., 1994, Scandinavian Journal of Primary Health Care, V12, P9, DOI 10.3109/02813439408997050; de Bock GH, 2001, SCAND J PRIM HEALTH, V19, P58, DOI 10.1080/028134301300034729; de Ferranti SD, 1998, BMJ-BRIT MED J, V317, P632, DOI 10.1136/bmj.317.7159.632; deBock GH, 1997, J CLIN EPIDEMIOL, V50, P881, DOI 10.1016/S0895-4356(97)00117-0; DINGLE JH, 1964, ILLNESS HOME STUDY 2, P347; Dowell SF, 1999, PEDIATR INFECT DIS J, V18, P1, DOI 10.1097/00006454-199901000-00002; EDELSTEIN DR, 1993, LARYNGOSCOPE, V103, P33; Garbutt JM, 2001, PEDIATRICS, V107, P619, DOI 10.1542/peds.107.4.619; GEHANNO P, 1990, J ANTIMICROB CHEMOTH, V26, P87, DOI 10.1093/jac/26.suppl_E.87; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Halpern M, 2000, AM J HEALTH-SYST PH, V57, P875, DOI 10.1093/ajhp/57.9.875; Hickner JM, 2001, ANN INTERN MED, V134, P498, DOI 10.7326/0003-4819-134-6-200103200-00017; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; KENNEDY DW, 1990, OTOLARYNG HEAD NECK, V103, P887, DOI 10.1177/01945998901030S510; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Lindbaek M, 1996, BMJ-BRIT MED J, V313, P325, DOI 10.1136/bmj.313.7053.325; MANN W, 1981, HNO, V29, P92; Mansfield E L, 1994, J La State Med Soc, V146, P287; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; MCCOMBS JS, 1995, PHARMACOECONOMICS, V7, P543, DOI 10.2165/00019053-199507060-00008; Piccirillo JF, 1995, AM J RHINOL, V9, P297, DOI 10.2500/105065895781808711; POOLE MD, 1999, AM J MED, V106, P385; *RHIN TASK FORC CO, 1997, OTOLARYNGOL HEAD NEC, V117, pS1; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schrag SJ, 2001, JAMA-J AM MED ASSOC, V286, P49, DOI 10.1001/jama.286.1.49; *SIN ALL HLTH PART, 2000, OTOLARYNGOL HEAD NEC, V123, pS1; Snow V, 2001, ANN INTERN MED, V134, P495, DOI 10.7326/0003-4819-134-6-200103200-00016; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; WAGENMANN M, 1992, J ALLERGY CLIN IMMUN, V90, P552, DOI 10.1016/0091-6749(92)90184-4; WILLIAMS JW, 1993, JAMA-J AM MED ASSOC, V270, P1242, DOI 10.1001/jama.270.10.1242; WILLIAMS JW, 1995, JAMA-J AM MED ASSOC, V273, P1015, DOI 10.1001/jama.273.13.1015; WILLIAMS JW, 2001, ANTIBIOTICS ACUTE MA	41	72	73	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1849	1856		10.1001/jama.286.15.1849	http://dx.doi.org/10.1001/jama.286.15.1849			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482UH	11597286	Bronze			2022-12-01	WOS:000171595300025
J	Strasser, K; Hurt, E				Strasser, K; Hurt, E			Splicing factor Sub2p is required for nuclear mRNA export through its interaction with Yra1p	NATURE			English	Article							YEAST HOMOLOG; MEX67P; IDENTIFICATION; BINDING; PROTEIN	The yeast nuclear protein Yra1p is an essential export factor for mRNA. Yra1p interacts directly with the mRNA transport factor Mex67p/Mtr2p, which is associated with the nuclear pore(1,2). Here, we report a genetic interaction between YRA1 and SUB2, the gene for a DEAD box helicase involved in splicing(3-5). Mutation of SUB2 as well as its overexpression leads to a defect in mRNA export. Moreover, Yra1p and Sub2p bind directly to each other both in vivo and in vitro. Significantly, Sub2p and Mex67p/Mtr2p bind to the same domains of Yra1p, and the proteins compete for binding to Yra1p. Together, these data indicate that the spliceosomal component Sub2p is also important in mRNA export and may function to recruit Yra1p to the mRNA. Sub2p may then be displaced from Yra1p by the binding of Mex67p/Mtr2p, which participates in the export of mRNA through the nuclear pores.	BZH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hurt, E (corresponding author), BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	eg5@ix.urz.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Strasser, Katja/0000-0003-3533-5516				Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Hurt E, 2000, J BIOL CHEM, V275, P8361, DOI 10.1074/jbc.275.12.8361; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Portenoy RK, 1997, J PALLIATIVE CARE, V13, P56; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Virbasius CMA, 1999, MOL CELL, V4, P219, DOI 10.1016/S1097-2765(00)80369-X; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	17	242	246	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					648	652		10.1038/35098113	http://dx.doi.org/10.1038/35098113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675790				2022-12-01	WOS:000171485700053
J	Duchek, P; Somogyi, K; Jekely, G; Beccari, S; Rorth, P				Duchek, P; Somogyi, K; Jekely, G; Beccari, S; Rorth, P			Guidance of cell migration by the Drosophila PDGF/VEGF receptor	CELL			English	Article							SH2/SH3 ADAPTER PROTEIN; TYROSINE KINASE; MYOBLAST CITY; EGF RECEPTOR; ACTIVATION; OOGENESIS; MORPHOGENESIS; PHAGOCYTOSIS; CHEMOTAXIS; MEMBRANE	Directed cell migrations are important for development, but the signaling pathways and mechanisms responsible for guiding cell migration in vivo are poorly understood. Migration of border cells during Drosophila oogenesis is a simple and attractive model system in which to address these questions. We demonstrate that PVR, a receptor tyrosine kinase related to mammalian PDGF and VEGF receptors, acts in border cells to guide them to the oocyte. The oocyte is the source of a ligand for PVR, PDGF/VEGF factor 1 (PVF1). Intriguingly, the guidance function of PVR is largely redundant with that of EGFR. We present evidence implicating Rac and the Rac activator Mbc/DOCK180/CED-5 as mediators of the guidance signal.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Rorth, P (corresponding author), European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany.		Rørth, Pernille/H-3020-2011; Jékely, Gáspár/I-8708-2012	Jékely, Gáspár/0000-0001-8496-9836				Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Edwards KA, 1996, DEVELOPMENT, V122, P1499; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Galletta BJ, 1999, GENE, V228, P243, DOI 10.1016/S0378-1119(99)00010-4; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Holder N, 1999, DEVELOPMENT, V126, P2033; KING RC, 1970, OVARIAN DEV DROSOPHL; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Liu YR, 2001, DEVELOPMENT, V128, P321; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; NOBES CD, 1995, J CELL SCI, V108, P225; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Queenan AM, 1997, DEVELOPMENT, V124, P3871; RAABE T, 1995, EMBO J, V14, P2509, DOI 10.1002/j.1460-2075.1995.tb07248.x; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Reich A, 1999, DEVELOPMENT, V126, P4139; RIDELY AJ, 1992, CELL, V70, P401; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Tallquist MD, 2000, GENE DEV, V14, P3179, DOI 10.1101/gad.844700; WENNSTROM S, 1994, ONCOGENE, V9, P651; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; XU T, 1993, DEVELOPMENT, V117, P1223	54	343	347	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					17	26		10.1016/S0092-8674(01)00502-5	http://dx.doi.org/10.1016/S0092-8674(01)00502-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595182	Bronze			2022-12-01	WOS:000171453100006
J	Davis, JS; Hassanzadeh, S; Winitsky, S; Lin, H; Satorius, C; Vemuri, R; Aletras, AH; Wen, H; Epstein, ND				Davis, JS; Hassanzadeh, S; Winitsky, S; Lin, H; Satorius, C; Vemuri, R; Aletras, AH; Wen, H; Epstein, ND			The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation	CELL			English	Article							HYPERTROPHIC CARDIOMYOPATHY; SKELETAL-MUSCLE; STRETCH-ACTIVATION; LEFT-VENTRICLE; BETA-MYOSIN; MUTATIONS; DEFORMATION; EXPRESSION; FILAMENTS; KINASE	Evolution of the human heart has incorporated a variety of successful strategies for motion used throughout the animal kingdom. One such strategy is to add the efficiency of torsion to compression so that blood is wrung, as well as pumped, out of the heart. Models of cardiac torsion have assumed uniform contractile properties of muscle fibers throughout the heart. Here, we show how a spatial gradient of myosin light chain phosphorylation across the heart facilitates torsion by inversely altering tension production and the stretch activation response. To demonstrate the importance of cardiac light chain phosphorylation, we, cloned a myosin light chain kinase from a human heart and have identified a gain-in-function mutation in two individuals with cardiac hypertrophy.	NHLBI, Mol Physiol Sect, Cardiol Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Cardiac Energet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Epstein, ND (corresponding author), NHLBI, Mol Physiol Sect, Cardiol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.		Wen, Han/G-3081-2010; Aletras, Anthony/ABE-9967-2020	Wen, Han/0000-0001-6844-2997; Aletras, Anthony/0000-0002-3786-3817	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004996, Z01HL004996] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aletras AH, 2001, MAGNET RESON MED, V46, P523, DOI 10.1002/mrm.1223; ARTS T, 1984, CARDIOVASC RES, V18, P183, DOI 10.1093/cvr/18.3.183; BEYAR R, 1986, ANN BIOMED ENG, V14, P547, DOI 10.1007/BF02484472; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; BUCHALTER MB, 1990, CIRCULATION, V81, P1236, DOI 10.1161/01.CIR.81.4.1236; Callaghan P. T., 1991, PRINCIPLES NUCL MAGN; CRAIG R, 1987, J CELL BIOL, V105, P1319, DOI 10.1083/jcb.105.3.1319; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; Davis JS, 2000, METHOD ENZYMOL, V321, P23; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; HERRING BP, 1990, J BIOL CHEM, V265, P1724; Herring BP, 2000, AM J PHYSIOL-CELL PH, V279, pC1656, DOI 10.1152/ajpcell.2000.279.5.C1656; LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795; Levine RJC, 1998, J STRUCT BIOL, V122, P149, DOI 10.1006/jsbi.1998.3980; LILLEHEI CW, 1964, J THORAC CARDIOV SUR, V47, P532, DOI 10.1016/S0022-5223(19)33587-1; MAIER SE, 1992, CIRCULATION, V86, P1919, DOI 10.1161/01.CIR.86.6.1919; Moon MR, 1996, CIRCULATION, V94, P143; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; PERRIE WT, 1972, BIOCHEM J, V128, pP105, DOI 10.1042/bj1280105P; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; PRINGLE JWS, 1978, PROC R SOC SER B-BIO, V201, P107, DOI 10.1098/rspb.1978.0035; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; RUSHMER RF, 1956, AM J PHYSIOL, V184, P188, DOI 10.1152/ajplegacy.1955.184.1.188; Steiger G.J., 1977, P221; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Vemuri R, 1999, P NATL ACAD SCI USA, V96, P1048, DOI 10.1073/pnas.96.3.1048; YOUNG AA, 1994, CIRCULATION, V90, P854, DOI 10.1161/01.CIR.90.2.854; ZUR Y, 1990, MAGNET RESON MED, V16, P444, DOI 10.1002/mrm.1910160311	30	210	227	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					631	641		10.1016/S0092-8674(01)00586-4	http://dx.doi.org/10.1016/S0092-8674(01)00586-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733062	Bronze			2022-12-01	WOS:000172575300010
J	Lehmann, FA				Lehmann, FA			Matching spiracle opening to metabolic need during flight in Drosophila	SCIENCE			English	Article							MELANOGASTER; PERFORMANCE; INSECT	The respiratory exchange system of insects must maximize the flux of respiratory gases through the spiracles of the tracheal system white minimizing water loss. This trade-off between gas exchange and water Loss becomes crucial when locomotor activity is increased during flight and metabolic needs are greatest. Insects that keep their spiracles mostly closed during flight reduce water Loss but limit the flux of oxygen and carbon dioxide into and out of the tracheal system and thus attenuate locomotor performance. Insects that keep their spiracles completely open allow maximum gas exchange but face desiccation stress more quickly. Experiments in which water vapor was used as a tracer gas to track changes in the conductance of the respiratory system indicated that flying fruit flies minimize potential water Loss by matching the area of the open spiracles to their gas exchange required for metabolic needs. This behavior maintained approximately constant pressure for carbon dioxide (1.35 kilopascals) and oxygen (19.9 kilopascals) within the tracheal. system while reducing respirometric water loss by up to 23% compared with a strategy in which the spiracles are held wide open during flight. The adaptive spiracle-closing behavior in fruit flies has general implications for the ecology of flying insects because it shows how these animals may cope with environmental challenges during high locomotor performance.	Univ Wurzburg, Theodor Boveri Inst, Dept Behav Physiol & Sociobiol, D-97074 Wurzburg, Germany	University of Wurzburg	Lehmann, FA (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Dept Behav Physiol & Sociobiol, D-97074 Wurzburg, Germany.							BEAMENT J. W. L., 1964, ADVANCES INSECT PHYSIOL, V2, P67, DOI 10.1016/S0065-2806(08)60072-7; Chan WP, 1996, J EXP BIOL, V199, P2767; DENNY MW, 1993, AIR WATER BIOL PHYSI, P70; EDNEY EB, 1977, WATER BALANCE LAND A; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P115, DOI 10.1098/rstb.1984.0053; GERTHSEN C, 1993, PHYSIK, P238; Kestler P., 1985, P137; Komai Y, 1998, J EXP BIOL, V201, P2359; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Lehmann FO, 1999, J COMP PHYSIOL B, V169, P165, DOI 10.1007/s003600050207; LEHMANN FO, 1994, THESIS U TUBINGEN GE; LIGHTON JRB, 1993, J EXP BIOL, V179, P233; Manning Gerards, 1993, P609; MARDEN JH, 1987, J EXP BIOL, V130, P235; MILLER PL, 1966, J EXP BIOL, V45, P285; Nikam T.B., 1989, INSECT SPIRACULAR SY, Vfirst; WEISFOGH T, 1964, J EXP BIOL, V41, P229; Wigglesworth V.B., 1983, Advances in Insect Physiology, V17, P85, DOI 10.1016/S0065-2806(08)60217-9; Ziegler R., 1985, P95	20	75	77	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1926	1929		10.1126/science.1064821	http://dx.doi.org/10.1126/science.1064821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729318				2022-12-01	WOS:000172465000059
J	Rape, M; Hoppe, T; Gorr, I; Kalocay, M; Richly, H; Jentsch, S				Rape, M; Hoppe, T; Gorr, I; Kalocay, M; Richly, H; Jentsch, S			Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; PROTEIN; FUSION; CDC48P; PROTEOLYSIS; DEGRADATION; PATHWAY; ATPASE; GENES	The OLE pathway of yeast regulates the level of the ER-bound enzyme Delta9-fatty acid desaturase OLE1, thereby, controlling membrane fluidity. A central component of this regulon is the transcription factor SPT23, a homolog of mammalian NF-kappaB. SPT23 is synthesized as an inactive, ER membrane-anchored precursor that is activated by regulated ubiquitin/proteasome-dependent processing (RUP). We now show that SPT23 dimerizes prior to processing and that the processed molecule, p90, retains its ubiquitin modification and initially remains tethered to its unprocessed, membrane-bound SPT23 partner. Subsequently, p90 is liberated from its partner for nuclear targeting by the: activity of the chaperone-like CDC48(UFD1/NPL4) complex. Remarkably, this enzyme binds preferentially ubiquitinated substrates, suggesting that CDC48(UFD1/NPL4) is qualified to selectively remove ubiquitin conjugates from protein complexes.	Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hoppe, Thorsten/AAC-7880-2020; Kalocsay, Marian/ABH-5959-2020	Kalocsay, Marian/0000-0002-4187-5829; Rape, Michael/0000-0003-4849-6343; Hoppe, Thorsten/0000-0002-4734-9352				Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DeHoratius C, 1996, MOL BIOL CELL, V7, P1835, DOI 10.1091/mbc.7.11.1835; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; FROHLICH KU, 1995, BBA-PROTEIN STRUCT M, V1253, P25, DOI 10.1016/0167-4838(95)00136-I; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Golbik R, 1999, BIOL CHEM, V380, P1049, DOI 10.1515/BC.1999.131; Guthrie C., 1991, METHODS ENZYMOLOGY G; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lin L, 1996, MOL CELL BIOL, V16, P2248; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; NELSON MK, 1993, GENETICS, V134, P159; Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Zhang SR, 1999, GENETICS, V151, P473; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	34	361	372	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					667	677		10.1016/S0092-8674(01)00595-5	http://dx.doi.org/10.1016/S0092-8674(01)00595-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733065	hybrid			2022-12-01	WOS:000172575300013
J	Feduccia, A				Feduccia, A			Palaeoecology - Fossils and avian evolution	NATURE			English	Article							EARLY TERTIARY ORIGIN; ORDERS; BIRDS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Feduccia, A (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.							Bleiweiss R, 1998, GEOLOGY, V26, P323, DOI 10.1130/0091-7613(1998)026<0323:FGASET>2.3.CO;2; Dyke GJ, 1999, NATURE, V399, P317, DOI 10.1038/20583; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2nd; Hou LH, 1996, SCIENCE, V274, P1164, DOI 10.1126/science.274.5290.1164; KAROCHKIN EN, 2000, CRETACEOUS STRATIGRA, P533; Marshall CR, 1999, GEOLOGY, V27, P95, DOI 10.1130/0091-7613(1999)027<0095:FGASET>2.3.CO;2; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; SHUVALOV VF, 2000, CREATACEOUS STRATIGR, P256	9	2	2	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					507	508		10.1038/35107144	http://dx.doi.org/10.1038/35107144			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734842				2022-12-01	WOS:000172405900035
J	Hogg, RS; Yip, B; Chan, KJ; Wood, E; Craib, KJP; O'Shaughnessy, MV; Montaner, JSG				Hogg, RS; Yip, B; Chan, KJ; Wood, E; Craib, KJP; O'Shaughnessy, MV; Montaner, JSG			Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; UPDATED RECOMMENDATIONS; IMPROVED SURVIVAL; CONTROLLED-TRIAL; AIDS DIAGNOSIS; VIRUS; ZIDOVUDINE; ADULTS; RNA	Context Current recommendations for initiation of antiretroviral therapy in patients infected with human immunodeficiency virus type 1 (HIV) are based on CD4 T-lymphocyte cell counts and plasma HIV RNA levels. The relative prognostic value of each marker following initiation of therapy has not been fully characterized. Objective To describe rates of disease progression to death and AIDS or death among patients starting triple-drug antiretroviral therapy, stratified by baseline CD4 cell count and HIV RNA levels. Design, Setting, and Participants Population-based analysis of 1219 antiretroviral therapy-naive HIV-positive men and women aged 18 years or older in British Columbia who initiated triple-drug therapy between August 1, 1996, and September 30, 1999. Main Outcome Measure Cumulative mortality rates from the initiation of triple-drug antiretroviral therapy to September 30, 2000, determined using various CD4 cell and plasma HIV RNA thresholds. Results As of September 30, 2000, 82 patients had died of AIDS-related causes, for a crude AIDS-related mortality rate of 6.7%. The product limit estimate (SE) of the cumulative mortality rate at 12 months was 2.9% (0.5%), In univariate analyses, a prior diagnosis of acquired immunodeficiency syndrome (AIDS), CD4 cell count, use of protease inhibitors, and HIV RNA level were associated with mortality. There was no difference in mortality by age or sex, Only CD4 cell count remained statistically significant in the multivariate analysis. After controlling for AIDS, protease inhibitor use, and plasma HIV RNA level at baseline, patients with CD4 cell counts of less than 50/muL were 6.67 (95% confidence interval [CI], 3.61-12.34) times and those with counts of 50/muL to 199/muL were 3.41 (95% CI, 1.93-6.03) times more likely to die than those with counts of at least 200/muL. Conclusion Our data demonstrate uniformly low rates of disease progression to death and AIDS or death among patients starting antiretroviral therapy with CD4 cell counts of at least 200/muL. In our study, disease progression to death and AIDS or death was clustered among patients starting therapy with CD4 cell counts less than 200/muL.	Univ British Columbia, Fac Med, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada; Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada; Univ British Columbia, Fac Med, Dept Hlth Care & Epidemiol, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Montaner, JSG (corresponding author), Univ British Columbia, St Pauls Hosp, AIDS Res Programme, 667-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@hivnet.ubc.ca	Hogg, Robert S/B-2783-2012; Montaner, Julio/K-7621-2012	Hogg, Robert S/0000-0003-3463-5488; 				BINDELS PJE, 1995, J INFECT DIS, V172, P97, DOI 10.1093/infdis/172.1.97; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; CHEN R, 2001, 8 C RETR OPP INF FEB; COX DR, 1972, J R STAT SOC B, V34, P187; Craib KJP, 1997, J INFECT DIS, V176, P798, DOI 10.1086/517305; *CTR EXC HIV AIDS, 1999, THER GUID TREATM HIV; Galli M, 2000, AIDS, V14, pS55; Gazzard B, 1998, LANCET, V352, P314, DOI 10.1016/S0140-6736(98)04084-7; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; HOGG RS, 2000, 7 C RETR OPP INF JAN; KAPLAN J, 2001, 8 C RETR OPP INF FEB; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; LEMP GF, 1990, JAMA-J AM MED ASSOC, V263, P402, DOI 10.1001/jama.263.3.402; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; *PAN CLIN PRACT TR, 2000, GUID US ANT AG HIV I; PEDERSEN C, 1990, AIDS, V4, P1111, DOI 10.1097/00002030-199011000-00009; Phillips AN, 2000, AIDS, V14, pS3; SAAH AJ, 1994, J ACQ IMMUN DEF SYND, V7, P287; STERLING TR, 2001, 8 C RETR OPP INF FEB; VOLBERDING PA, 1995, NEW ENGL J MED, V333, P401, DOI 10.1056/NEJM199508173330701; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221	31	563	577	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2001	286	20					2568	2577		10.1001/jama.286.20.2568	http://dx.doi.org/10.1001/jama.286.20.2568			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FH	11722271				2022-12-01	WOS:000172385200031
J	Grantcharov, TP; Bardram, L; Funch-Jensen, P; Rosenberg, J				Grantcharov, TP; Bardram, L; Funch-Jensen, P; Rosenberg, J			Laparoscopic performance after one night on call in a surgical department: prospective study	BRITISH MEDICAL JOURNAL			English	Article							SLEEP-DEPRIVATION; MIST VR; SIMULATOR		Aarhus Univ, Aarhus Kommune Hosp, Dept Surg Gastroenterol L, DK-8000 Aarhus, Denmark; Univ Copenhagen, Hvidovre Hosp, Dept Surg Gastroenterol 435, DK-2650 Hvidovre, Denmark	Aarhus University; University of Copenhagen	Grantcharov, TP (corresponding author), Aarhus Univ, Aarhus Kommune Hosp, Dept Surg Gastroenterol L, DK-8000 Aarhus, Denmark.							Chaudhry A, 1999, ANN ROY COLL SURG, V81, P281; Grantcharov TP, 2001, SURG ENDOSC-ULTRAS, V15, P242, DOI 10.1007/s004640090008; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Wilson MS, 1997, ANN ROY COLL SURG, V79, P403	5	220	221	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 24	2001	323	7323					1222	1223		10.1136/bmj.323.7323.1222	http://dx.doi.org/10.1136/bmj.323.7323.1222			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497HZ	11719413	Green Published, Bronze			2022-12-01	WOS:000172450500019
J	Keely, PJ				Keely, PJ			Rho GTPases as early markers for tumour progression	LANCET			English	Editorial Material							CELL MOTILITY; FAMILY; INVASION; RAC1		Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53706 USA; Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Keely, PJ (corresponding author), Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53706 USA.							Abraham MT, 2001, LARYNGOSCOPE, V111, P1285, DOI 10.1097/00005537-200107000-00027; BEARER EL, 1993, AM J RESP CELL MOL, V8, P582, DOI 10.1165/ajrcmb/8.6.582; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; MOSCOW JA, 1994, ONCOGENE, V9, P189; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	18	14	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2001	358	9295					1744	1745		10.1016/S0140-6736(01)06840-4	http://dx.doi.org/10.1016/S0140-6736(01)06840-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FG	11734226				2022-12-01	WOS:000172385100004
J	Molino, JF; Sabatier, D				Molino, JF; Sabatier, D			Tree diversity in tropical rain forests: A validation of the intermediate disturbance hypothesis	SCIENCE			English	Article							SPECIES-DIVERSITY; NEOTROPICAL FOREST; GAPS	The "intermediate disturbance hypothesis," which postulates maximum diversity at intermediate regimes of disturbance, has never been clearly proved to apply to species-rich tropical forest tree communities and to local-scale canopy disturbances that modify light environments. This hypothesis was tested on a sample of 17,000 trees in a Guianan forest, 10 years after a silvicultural, experiment that added to natural treefall gaps a wide range of disturbance intensities. Species richness, standardized to eliminate density effects, peaked at intermediate disturbance levels, particularly when disturbance intensity was estimated through the percentage of stems of strongly light-dependent species.	Cirad Foret, Inst Rech Dev, F-34398 Montpellier 5, France	CIRAD; Institut de Recherche pour le Developpement (IRD)	Molino, JF (corresponding author), Cirad Foret, Inst Rech Dev, Campus Int Baillarguet,TA 10-D, F-34398 Montpellier 5, France.		Molino, Jean-François/C-5011-2009; Sabatier, Daniel/D-9117-2011	Molino, Jean-François/0000-0001-8853-7133; Sabatier, Daniel/0000-0003-0883-1530				Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; CANHAM CD, 1989, ECOLOGY, V70, P548, DOI 10.2307/1940200; CHAZDON RL, 1999, SCIENCE, V285, pA1459; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; Condit R, 1996, J TROP ECOL, V12, P231, DOI 10.1017/S0266467400009433; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DENSLOW JS, 1980, OECOLOGIA, V46, P18, DOI 10.1007/BF00346960; DENSLOW JS, 1984, BIOTROPICA, V16, P240, DOI 10.2307/2388059; Gentry A.H., 1990, 4 NEOTROPICAL FOREST; Gourlet-Fleury S, 2000, FOREST ECOL MANAG, V131, P269, DOI 10.1016/S0378-1127(99)00212-1; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; LIEBERMAN M, 1989, ECOLOGY, V70, P550, DOI 10.2307/1940201; SCHMITT L, 1990, BOIS FOR TROP, V220, P3; Ter Steege H, 2000, J TROP ECOL, V16, P801, DOI 10.1017/S0266467400001735; VANDERMAAREL E, 1993, J VEG SCI, V4, P733, DOI 10.2307/3235608; WHITMORE TC, 1984, BIOTROPICA, V16, P239, DOI 10.2307/2388058	18	269	289	21	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1702	1704		10.1126/science.1060284	http://dx.doi.org/10.1126/science.1060284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721052	Green Submitted			2022-12-01	WOS:000172307400040
J	Parry, J; Stevens, A				Parry, J; Stevens, A			Prospective health impact assessment: pitfalls, problems, and possible ways forward	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Dept Epidemiol & Publ Hlth, Hlth Impact Assessment Res Unit, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Parry, J (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Hlth Impact Assessment Res Unit, Birmingham B15 2TT, W Midlands, England.	J.M.Parry.1@bham.ac.uk		Stevens, Andrew/0000-0003-2079-3397				[Anonymous], 1998, INDEPENDENT INQUIRY; BENTHAM G, 1988, SOC SCI MED, V26, P49, DOI 10.1016/0277-9536(88)90044-5; BORUCH R, 2001, CAMPBELL COLLABORATI; BULUSU L, 1991, 39 OFF POP CENS SURV; Calman KC, 1997, BMJ-BRIT MED J, V315, P939; Campbell D. T., 1966, EXPT QUASIEXPERIMENT; *DEP HLTH, 1999, HLTH IMP ASS REP MET; *DEP HLTH, 1998, SAV LIV OUR HLTH NAT; *EC SOC RES COUNC, 2001, EV BAS POL PRACT IN; European Centre for Health Policy W, 1999, HLTH IMP ASS MAIN CO; European Parliament, 1957, TREAT AMST AM TREAT; Fotheringham, 1998, DETERMINANTS MIGRATI; ISSON E, 2000, RESOURCE HLTH IMPACT; KEMM J, 1999, DEV HLTH IMPACT ASSE; Khan KS, 2001, UNDERTAKING SYSTEMAT; Lilford RJ, 1996, BRIT MED J, V313, P603; Macintyre S, 2000, J EPIDEMIOL COMMUN H, V54, P802, DOI 10.1136/jech.54.11.802; Mcintyre L., 1999, METHODS HLTH IMPACT; RHODES J, 1999, HLTH IMP ASS REP MET; Saunders P, 2001, J PUBLIC HEALTH MED, V23, P103, DOI 10.1093/pubmed/23.2.103; *SCOTT NEEDS ASS P, 2000, HLTH IMPA ASS POL PR; SCOTTSAMUEL A, 1996, MERSEYSIDE GUIDELINE; Weiss C, 1995, NEW APPROACHES EVALU, V1; WHO, 1999, HLTH 21 HLTH ALL 21, V68, P146; *WHO REG OFF EUR, 2001, METH IMPL EQ FOC HLT; World Health Organization, 2000, Environ Health Perspect, V108, P997, DOI 10.2307/3435062	26	94	96	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2001	323	7322					1177	1182		10.1136/bmj.323.7322.1177	http://dx.doi.org/10.1136/bmj.323.7322.1177			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495NG	11711414	Green Published			2022-12-01	WOS:000172346800023
J	Vasan, RS; Larson, MG; Leip, EP; Kannel, WB; Levy, D				Vasan, RS; Larson, MG; Leip, EP; Kannel, WB; Levy, D			Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study	LANCET			English	Article							NUTRITION EXAMINATION SURVEY; NORMAL BLOOD-PRESSURE; NATIONAL-HEALTH; UNITED-STATES; POPULATION; PREVALENCE; DISEASE; MEN	Background Patients with optimum (<120/80 mm Hg), normal (120-129/80-84 mm Hg), and high normal (130-139/85-89 mm Hg) blood pressure (BP) may progress to hypertension (<greater than or equal to>140/90 mm Hg) over time. We aimed to establish the best frequency of BP screening by assessing the rates and determinants of progression to hypertension. Methods We assessed repeated BP measurements in individuals without hypertension (BP<140/90 mm Hg) from the Framingham Study (4200 men, 5645 women; mean age 52 years) who attended clinic examinations during 1978-94. The incidence of hypertension (or use of anti hypertensive treatment) and its determinants were studied. Findings A stepwise, increase in hypertension incidence occurred across the three non-hypertensive BP categories; 5.3% (95% CI 4.4-6.3%) of participants with optimum BP, 17.6% (15.2-20.3%) with normal, and 37.3% (33.3-41.5%) with high normal BP aged below age 65 years progressed to hypertension over 4 years. Corresponding 4-year rates of progression for patients 65 years and older were 16.0% (12.0-20.9), 25.5% (20.4-31.4), and 49.5% (42.6-56.4), respectively. Obesity and weight gain also contributed to progression; a 5% weight gain on follow-up was associated with 20-30% increased odds of hypertension. Interpretation High normal BP and normal BP frequently progress to hypertension over a period of 4 years, especially in older adults. These findings support recommendations for monitoring individuals with high normal BP once a year, and monitoring those with normal BP every 2 years, and they emphasise the importance of weight control as a measure for primary prevention of hypertension.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA; Harvard Univ, Sch Med, Beth Israel Hosp, Div Cardiol, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Hosp, Div Clin Epidemiol, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 5 Thurber St, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL04334, N01-HC-38038] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bakx JC, 1999, J CLIN EPIDEMIOL, V52, P531, DOI 10.1016/S0895-4356(99)00023-2; Black HR, 1997, ARCH INTERN MED, V157, P2413; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chalmers J, 1999, J HYPERTENS, V17, P151; CORNONIHUNTLEY J, 1989, ARCH INTERN MED, V149, P780, DOI 10.1001/archinte.149.4.780; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dyer AR, 1999, J HUM HYPERTENS, V13, P13, DOI 10.1038/sj.jhh.1000740; ECHEVERRIA RF, 1992, MEDICINA-BUENOS AIRE, V52, P145; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; GORDON T, 1976, INT J EPIDEMIOL, V5, P327, DOI 10.1093/ije/5.4.327; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; LEITSCHUH M, 1991, HYPERTENSION, V17, P22, DOI 10.1161/01.HYP.17.1.22; PERRY HM, 1992, J HYPERTENS, V10, P887; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; RODRIGUEZ BL, 1994, HYPERTENSION, V24, P779, DOI 10.1161/01.HYP.24.6.779; ROSNER B, 1983, AM J EPIDEMIOL, V117, P429, DOI 10.1093/oxfordjournals.aje.a113561; ROSNER B, 1977, J CHRON DIS, V30, P7, DOI 10.1016/0021-9681(77)90047-9; SCHECHTER CB, 1988, MED DECIS MAKING, V8, P182, DOI 10.1177/0272989X8800800306; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stamler J, 1991, Ann Epidemiol, V1, P347, DOI 10.1016/1047-2797(91)90045-E; THOMAS J, 1985, AM HEART J, V110, P637, DOI 10.1016/0002-8703(85)90087-0; WEISSFELD JL, 1985, J CHRON DIS, V38, P915, DOI 10.1016/0021-9681(85)90127-4; WHELTON PK, 1993, ARCH INTERN MED, V153, P186, DOI 10.1001/archinte.153.2.186; Wood D, 1998, J HYPERTENS, V16, P1407, DOI 10.1097/00004872-199816100-00003; WU M, 1980, J CHRON DIS, V33, P637, DOI 10.1016/0021-9681(80)90006-5	25	714	773	0	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2001	358	9294					1682	1686		10.1016/S0140-6736(01)06710-1	http://dx.doi.org/10.1016/S0140-6736(01)06710-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495MC	11728544				2022-12-01	WOS:000172344100012
J	Sereno, MI; Pitzalis, S; Martinez, A				Sereno, MI; Pitzalis, S; Martinez, A			Mapping of contralateral space in retinotopic coordinates by a parietal cortical area in humans	SCIENCE			English	Article							HUMAN VISUAL-CORTEX; LATERAL INTRAPARIETAL AREA; SPATIAL WORKING-MEMORY; SURFACE-BASED ANALYSIS; SUPERIOR COLLICULUS; EYE-MOVEMENTS; NEURONS; ATTENTION; FMRI; ORGANIZATION	The internal organization of a higher level visual area in the human parietal cortex was mapped. Functional magnetic resonance images were acquired while the polar angle of a peripheral target for a delayed saccade was gradually changed. A region in the superior parietal cortex showed robust retinotopic mapping of the remembered target angle. The map reversed when the direction of rotation of the remembered targets was reversed and persisted unchanged when study participants detected rare target reappearances while maintaining fixation, or when the eccentricity of successive remembered targets was unpredictable. This region may correspond to the lateral intraparietal area in macaque monkeys.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Sereno, MI (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.		Martinez, Antigona/X-2317-2019; Pitzalis, Sabrina/AAA-9406-2019; Sereno, Martin I/F-7657-2012	Sereno, Martin I/0000-0002-7598-7829; Martinez, Antigona/0000-0003-4806-5199; pitzalis, sabrina/0000-0002-4445-0391	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD022614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH025594, R37MH025594] Funding Source: NIH RePORTER; NICHD NIH HHS [NICHD22614] Funding Source: Medline; NIMH NIH HHS [MH25594] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLMAN JM, 1975, BRAIN RES, V100, P473, DOI 10.1016/0006-8993(75)90153-5; Andersen RA, 1998, NOVART FDN SYMP, V218, P109; Awh E, 1999, PSYCHOL SCI, V10, P433, DOI 10.1111/1467-9280.00182; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Critchley M., 1953, PARIETAL LOBES; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; INGLE D, 1975, SCIENCE, V188, P1033, DOI 10.1126/science.1170636; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; KLEIST K, 1916, ERGEB NEUROL PSYCHIA, V1, P342; KRUBITZER L, 1995, TRENDS NEUROSCI, V18, P408, DOI 10.1016/0166-2236(95)93938-T; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Press WA, 2001, VISION RES, V41, P1321, DOI 10.1016/S0042-6989(01)00074-8; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno Martin I., 1991, P160; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SERENO MI, 1994, CEREB CORTEX, V4, P601, DOI 10.1093/cercor/4.6.601; Sereno MI, 1998, CURR OPIN NEUROBIOL, V8, P188, DOI 10.1016/S0959-4388(98)80139-6; Smith AT, 1998, J NEUROSCI, V18, P3816; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; VanEssen DC, 1997, J NEUROSCI, V17, P7079; Wang G, 1998, NEUROSCI RES, V32, P33, DOI 10.1016/S0168-0102(98)00062-5; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7	44	518	521	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1350	1354		10.1126/science.1063695	http://dx.doi.org/10.1126/science.1063695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701930	Green Submitted			2022-12-01	WOS:000172130200052
J	de Fonseca, FR; Navarro, M; Gomez, R; Escuredo, L; Nava, F; Fu, J; Murillo-Rodriguez, E; Giuffrida, A; LoVerme, J; Gaetani, S; Kathuria, S; Gall, C; Piomelli, D				de Fonseca, FR; Navarro, M; Gomez, R; Escuredo, L; Nava, F; Fu, J; Murillo-Rodriguez, E; Giuffrida, A; LoVerme, J; Gaetani, S; Kathuria, S; Gall, C; Piomelli, D			An anorexic lipid mediator regulated by feeding	NATURE			English	Article							ENDOGENOUS CANNABINOID PRECURSOR; FOOD-INTAKE; RAT-BRAIN; MESSENGER-RNA; ANANDAMIDE; RECEPTOR; CHOLECYSTOKININ; AMIDOHYDROLASE; BIOSYNTHESIS; NEURONS	Oleylethanolamide (OEA) is a natural analogue of the endogenous cannabinoid anandamide. Like anandamide, OEA is produced in cells in a stimulus-dependent manner and is rapidly eliminated by enzymatic hydrolysis, suggesting a function in cellular signalling(1). However, OEA does not activate cannabinoid receptors and its biological functions are still unknown(2). Here we show that, in rats, food deprivation markedly reduces OEA biosynthesis in the small intestine. Administration of OEA causes a potent and persistent decrease in food intake and gain in body mass. This anorexic effect is behaviourally selective and is associated with the discrete activation of brain regions (the paraventricular hypothalamic nucleus and the nucleus of the solitary tract) involved in the control of satiety. OEA does not affect food intake when injected into the brain ventricles, and its anorexic actions are prevented when peripheral sensory fibres are removed by treatment with capsaicin. These results indicate that OEA is a lipid mediator involved in the peripheral regulation of feeding.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Complutense, Dept Psychobiol, Madrid 28233, Spain; Fdn Hosp Carlos Haya, Malaga 29010, Spain; Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine; Complutense University of Madrid; University of California System; University of California Irvine	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.		Nava, Felice Alfonso/K-3920-2016; Nava, Felice Alfonso/AGM-7177-2022; Fu, Jin/A-3510-2012; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Giuffrida, Andrea/H-3770-2013; Gaetani, Silvana/D-3455-2009; de Heras, Raquel Gomez/F-3484-2016	Nava, Felice Alfonso/0000-0002-3103-0355; Giuffrida, Andrea/0000-0002-3773-0694; de Heras, Raquel Gomez/0000-0002-5846-1059				BACHUR NR, 1965, J BIOL CHEM, V240, P1019; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berdyshev EV, 2000, BIOCHEM J, V346, P369, DOI 10.1042/0264-6021:3460369; Cadas H, 1996, J NEUROSCI, V16, P3934; Cadas H, 1997, J NEUROSCI, V17, P1226; Chapman KD, 2000, CHEM PHYS LIPIDS, V108, P221, DOI 10.1016/S0009-3084(00)00198-5; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; CURRAN T, 1987, ONCOGENE, V2, P79; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; GIUFFRIDA A, 1998, LIPID 2 MESSENGERS, P113; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; Kaneko H, 1998, AM J PHYSIOL-GASTR L, V275, pG1056, DOI 10.1152/ajpgi.1998.275.5.G1056; Khanolkar AD, 1999, LIFE SCI, V65, P607, DOI 10.1016/S0024-3205(99)00283-0; LAUTERBORN JC, 1993, MOL BRAIN RES, V17, P59, DOI 10.1016/0169-328X(93)90073-X; Lee MD, 1998, PSYCHOPHARMACOLOGY, V136, P304, DOI 10.1007/s002130050570; MACLEAN DB, 1985, REGUL PEPTIDES, V11, P321, DOI 10.1016/0167-0115(85)90204-6; Navarro M, 1996, J NEUROCHEM, V67, P1982; Navarro M, 1997, NEUROREPORT, V8, P491, DOI 10.1097/00001756-199701200-00023; Pertwee RG, 2000, EXPERT OPIN INV DRUG, V9, P1553, DOI 10.1517/13543784.9.7.1553; Piomelli D, 1998, NEUROBIOL DIS, V5, P462, DOI 10.1006/nbdi.1998.0221; Ritter RC, 1999, NEUROPEPTIDES, V33, P387, DOI 10.1054/npep.1999.0051; Schmid HHO, 1996, CHEM PHYS LIPIDS, V80, P133, DOI 10.1016/0009-3084(96)02554-6; SCHMID PC, 1985, J BIOL CHEM, V260, P4145; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; WILLIAMS SK, 1999, TIS ENGN INTELL UNIT, V1, P143	29	481	506	1	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					209	212		10.1038/35102582	http://dx.doi.org/10.1038/35102582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700558	Green Published			2022-12-01	WOS:000172029100048
J	Bushby, K; Raybould, S; O'Donnell, S; Steele, JG				Bushby, K; Raybould, S; O'Donnell, S; Steele, JG			Social deprivation in Duchenne muscular dystrophy: population based study	BRITISH MEDICAL JOURNAL			English	Article									Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Newcastle Upon Tyne, Ctr Urban & Reg Dev Studies, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Restorat Dent, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Bushby, K (corresponding author), Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.							Acheson D., 1998, INDEPENDENT ENQUIRY; Benzeval M, 1996, J PUBLIC HEALTH MED, V18, P33, DOI 10.1093/oxfordjournals.pubmed.a024459; Bushby KMD, 1999, LANCET, V353, P557, DOI 10.1016/S0140-6736(98)05279-9; Gorospe Jose Rafael M., 1992, Current Opinion in Rheumatology, V4, P794; Townsend P, 1988, HLTH DEPRIVATION INE	5	9	9	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1035	1036		10.1136/bmj.323.7320.1035	http://dx.doi.org/10.1136/bmj.323.7320.1035			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691762	Green Published, Bronze			2022-12-01	WOS:000172055900018
J	Schoch, S; Deak, F; Konigstorfer, A; Mozhayeva, M; Sara, Y; Sudhof, TC; Kavalali, ET				Schoch, S; Deak, F; Konigstorfer, A; Mozhayeva, M; Sara, Y; Sudhof, TC; Kavalali, ET			SNARE function analyzed in synaptobrevin/VAMP knockout mice	SCIENCE			English	Article							MEMBRANE-FUSION; SYNAPTIC-TRANSMISSION; COMPLEX-FORMATION; VESICLES; NEUROTRANSMITTER; SPECIFICITY; EXOCYTOSIS; DISTINCT; CA2+; NSF	SNAREs (soluble NSF-attachment protein receptors) are generally acknowledged as central components of membrane fusion reactions, but their precise function has remained enigmatic. Competing hypotheses suggest roles for SNARES in mediating the specificity of fusion, catalyzing fusion, or actually executing fusion. We generated knockout mice lacking synaptobrevin/VAMP 2, the vesicular SNARE protein responsible for synaptic vesicle fusion in forebrain synapses, to make use of the exquisite temporal resolution of electrophysiology in measuring fusion. in the absence of synaptobrevin 2, spontaneous synaptic vesicle fusion and fusion induced by hypertonic sucrose were decreased similar to 10-fold, but fast Ca2+-triggered fusion was decreased more than 100-fold. Thus, synaptobrevin 2 may function in catalyzing fusion reactions and stabilizing fusion intermediates but is not absolutely required for synaptic fusion.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Howard Hughes Med Inst, Dallas, TX 75390 USA; Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.	Thomas.Sudhof@UTSouthwestern.edu; Ege.Kavalali@UTSouthwestern.edu	Schoch, Susanne/F-7741-2012; Deak, Ferenc/AAE-4324-2019	Sara, Yildirim/0000-0003-1079-0782				Ashton AC, 2000, J NEUROCHEM, V74, P1979, DOI 10.1046/j.1471-4159.2000.0741979.x; Baines RA, 1999, CURR BIOL, V9, P1267, DOI 10.1016/S0960-9822(99)80510-7; BAUMERT M, 1990, J CELL BIOL, V110, P1285, DOI 10.1083/jcb.110.4.1285; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; Capogna M, 1997, J NEUROSCI, V17, P7190; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Foran PGP, 1999, J BIOL CHEM, V274, P28087, DOI 10.1074/jbc.274.40.28087; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; Mayer A, 1999, CURR OPIN CELL BIOL, V11, P447, DOI 10.1016/S0955-0674(99)80064-7; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Muller JMM, 1999, NAT CELL BIOL, V1, P335, DOI 10.1038/14025; Nonet ML, 1998, J NEUROSCI, V18, P70; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	42	484	495	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1117	1122		10.1126/science.1064335	http://dx.doi.org/10.1126/science.1064335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691998				2022-12-01	WOS:000172013800055
J	Weiss, JB; Suyama, KL; Lee, HH; Scott, MP				Weiss, JB; Suyama, KL; Lee, HH; Scott, MP			Jelly belly: A Drosophila LDL receptor repeat-containing, signal required for mesoderm migration and differentiation	CELL			English	Article							PROGRAMMED CELL-DEATH; TRANSCRIPTION FACTORS; GENETIC SELECTION; EXPRESSION; PROTEIN; IDENTIFICATION; SPECIFICATION; TINMAN; FATES; EMBRYOGENESIS	Inductive interactions subdivide the Drosophila mesoderm into visceral, somatic, and heart muscle precursors. The muscle precursors form organs by executing tissue-specific migrations and cell fusions. We identified a novel gene, jelly belly (jeb), which is required for visceral mesoderm development. jeb encodes a secreted protein that contains an LDL receptor repeat. In jeb mutants, visceral mesoderm precursors form, but they fail to migrate or differentiate normally; no visceral muscles develop. Jeb protein is produced in somatic muscle precursors and taken up by visceral muscle precursors. jeb reveals a signaling process in which somatic muscle precursors support the proper migration and differentiation of visceral muscle cells. Later in embryogenesis, jeb is transcribed in neurons and Jeb protein is found in axons.	Stanford Univ, Sch Med, Beckman Ctr B300, Howard Hughes Med Inst,Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Howard Hughes Med Inst,Dept Genet, Stanford, CA 94305 USA; CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Weiss, JB (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,NRC3, Portland, OR 97201 USA.			LEE, HSIU-HSIANG/0000-0001-7707-8461	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [KO8 HL03627-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003627] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183; BODMER R, 1993, DEVELOPMENT, V118, P719; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CHEN WS, 1995, ONCOL REP, V2, P5; Cooper JA, 1999, CELL, V97, P671, DOI 10.1016/S0092-8674(00)80778-3; Evans SM, 1999, SEMIN CELL DEV BIOL, V10, P73, DOI 10.1006/scdb.1999.0282; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Gobron S, 1996, J CELL SCI, V109, P1053; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Griffin KJP, 2000, DEV BIOL, V218, P235, DOI 10.1006/dbio.1999.9571; HAMILTON BA, 1994, DROSOPHILA MELANOGAS, P81; Harlow, 1999, USING ANTIBODIES LAB; HONG CC, 1995, CELL, V82, P785, DOI 10.1016/0092-8674(95)90475-1; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; KIM YS, 1989, P NATL ACAD SCI USA, V86, P7716, DOI 10.1073/pnas.86.20.7716; Knirr S, 1999, DEVELOPMENT, V126, P4525; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Li L, 2000, J EXP MED, V191, P1077, DOI 10.1084/jem.191.6.1077; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; LIU J, 1993, COMPANION METHODS EN, V5, P127; LORD PCW, 1995, DEV BIOL, V171, P627, DOI 10.1006/dbio.1995.1310; MASTICK GS, 1995, GENETICS, V139, P349; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Nguyen HT, 1998, DEV BIOL, V204, P550, DOI 10.1006/dbio.1998.9081; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; REUTER R, 1993, DEVELOPMENT, V119, P1135; Riechmann V, 1997, DEVELOPMENT, V124, P2915; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541	42	66	67	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					387	398		10.1016/S0092-8674(01)00540-2	http://dx.doi.org/10.1016/S0092-8674(01)00540-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701128	Bronze			2022-12-01	WOS:000172022800009
J	Kaplan, EL; Wotton, JT; Johnson, DR				Kaplan, EL; Wotton, JT; Johnson, DR			Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis	LANCET			English	Article							GROUP-A STREPTOCOCCI; RHEUMATIC-FEVER; INFECTIONS; PYOGENES; DISEASE; FAILURE	Background Despite the past 15 years of heightened awareness of the disease-causing potential of group A streptococci, the possible epidemiological influence of rapid changes in prevalent serotypes has not been fully appreciated. Methods We analysed throat cultures collected as part of routine medical care in a semi-closed community of nearly 500 children and adults between January, 1999, and April, 2000. beta -haemolytic streptococci from all positive cultures were characterised by serological grouping, T-agglutination pattern, and serotyping for M protein or opacity factor. Findings We saw an increase in the number of symptomatic individuals with pharyngitis beginning in mid-1999. Between July 1 and Dec 31, 1999, 111 (29%) of 378 throat cultures yielded group A streptococci, 102 (92%) of which were serotype M1. Between Jan 1 and Mar 31, 2000, 126 (45%) of 277 throat cultures yielded group A streptococci. Unexpectedly, 106 (84%) of these throat isolates were serotype M6, and only 16 (13%) were M1. 20 ((28%.) of the 71 individuals with M1 infection subsequently acquired infection with M6. Interpretation This rapid and almost complete shift in predominance of group A streptococcal serotype in this community draws attention to the dynamic epidemiology of these organisms. This change has important implications for further understanding the epidemiology of group A streptococcal infections, and for the development and use of a vaccine.	Univ Minnesota, Sch Med, Dept Pediat,WHO, Collaborating Ctr Reference & Res Streptococci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; World Health Organization	Kaplan, EL (corresponding author), Univ Minnesota, Sch Med, Dept Pediat,WHO, Collaborating Ctr Reference & Res Streptococci, MMC 296,420 Delaware St SE, Minneapolis, MN 55455 USA.							ANTHONY BF, 1976, AM J EPIDEMIOL, V104, P652, DOI 10.1093/oxfordjournals.aje.a112344; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; CLEARY PP, 2000, STREPTOCOCCI STREPTO, P437; CORNFELD D, 1961, NEW ENGL J MED, V264, P211, DOI 10.1056/NEJM196102022640502; DALE JB, 2000, STREPTOCOCCI STREPTO, P473; Facklam R, 1999, EMERG INFECT DIS, V5, P247, DOI 10.3201/eid0502.990209; FISCHETTI VA, 2000, STREPTOCOCCI STREPTO, P433; GASTANADUY AS, 1980, LANCET, V2, P498; GAWORZEWSKA E, 1988, EPIDEMIOL INFECT, V100, P257, DOI 10.1017/S095026880006739X; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; Johnson DR., 1996, LAB DIAGNOSIS GROUP; JONES KF, 1988, P NATL ACAD SCI USA, V85, P8271, DOI 10.1073/pnas.85.21.8271; KAPLAN EL, 1979, PEDIATRICS, V64, P904; KAPLAN EL, 1981, J LAB CLIN MED, V98, P326; KAPLAN EL, 1993, CIRCULATION, V88, P1964, DOI 10.1161/01.CIR.88.4.1964; MARTIN PR, 1990, SCAND J INFECT DIS, V22, P421, DOI 10.3109/00365549009027073; SCHWARTZ B, 1990, LANCET, V336, P1167, DOI 10.1016/0140-6736(90)92777-F; Stevens DL., 2000, STREPTOCOCCAL INFECT; WANNAMAKER LW, 1954, STREPTOCOCCAL INFECT	20	81	81	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1334	1337		10.1016/S0140-6736(01)06415-7	http://dx.doi.org/10.1016/S0140-6736(01)06415-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684215				2022-12-01	WOS:000171702500014
J	Alvarez, B; Martinez, C; Burgering, BMT; Carrera, AC				Alvarez, B; Martinez, C; Burgering, BMT; Carrera, AC			Forkhead transcription factors contribute to execution of the mitotic programme in mammals	NATURE			English	Article							CELL-CYCLE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; REGULATORY SUBUNIT; FACTOR FKHR; KINASE; MITOSIS; PROGRESSION; PROTEIN; GROWTH	Cell cycle progression is a process that is tightly controlled by internal and external signals. Environmental cues, such as those provided by growth factors, activate early signals that promote cell cycle entry(1-3). Cells that have progressed past the restriction point become independent of growth factors, and cell cycle progression is then controlled endogenously. The phosphatidylinositol 3OH kinase (PI(3)K)/protein kinase B (PKB) pathway must be activated in G1 to inactivate forkhead transcription factors (FKH-TFs)(4,5) and allow cell cycle entry(2,3). Here we show that subsequent attenuation of the PI(3)K/PKB pathway is required to allow transcriptional activation of FKH-TF in G2. FKH-TF activity in G2 controls mammalian cell cycle termination, as interference with FKH transcriptional activation by disrupting PI(3)K/PKB downregulation, or by expressing a transcriptionally inactive FKH mutant, induces cell accumulation in G2/M, defective cytokinesis, and delayed transition from M to G1 of the cell cycle. We demonstrate that FKH-TFs regulate expression of mitotic genes such as cyclin B and polo-like kinase (Plk). Our results support the important role of forkhead in the control of mammalian cell cycle completion, and suggest that efficient execution of the mitotic programme depends on downregulation of PI(3)K/PKB and consequent induction of FKH transcriptional activity.	Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain; Univ Med Ctr, Dept Hematol, NL-3584 CG Utrecht, Netherlands	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utrecht University; Utrecht University Medical Center	Carrera, AC (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain.	acarrera@cnb.uam.es		Carrera, Ana/0000-0002-3999-5434				Borlado LR, 2000, FASEB J, V14, P895; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; BRAUNINGER A, 1995, ONCOGENE, V11, P1793; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; del Peso L, 1999, ONCOGENE, V18, P7328, DOI 10.1038/sj.onc.1203159; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Jones SM, 1999, CURR BIOL, V9, P512, DOI 10.1016/S0960-9822(99)80235-8; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Zachariae W, 1999, CURR OPIN CELL BIOL, V11, P708, DOI 10.1016/S0955-0674(99)00041-1; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	29	232	235	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					744	747		10.1038/35099574	http://dx.doi.org/10.1038/35099574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607034				2022-12-01	WOS:000171608000046
J	White, DG; Zhao, S; Sudler, R; Ayers, S; Friedman, S; Chen, S; McDermott, PF; McDermott, S; Wagner, DD; Meng, JH				White, DG; Zhao, S; Sudler, R; Ayers, S; Friedman, S; Chen, S; McDermott, PF; McDermott, S; Wagner, DD; Meng, JH			The isolation of antibiotic-resistant Salmonella from retail ground meats.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYPHIMURIUM DT104 INFECTIONS; FIELD GEL-ELECTROPHORESIS; PHAGE TYPE DT104; RAW-MILK CHEESE; MULTIDRUG-RESISTANT; UNITED-STATES; ANTIMICROBIAL RESISTANCE; INTEGRONS; GENES; CONSEQUENCES	Background: Salmonella is a leading cause of food-borne illness. The emergence of antimicrobial-resistant salmonella is associated with the use of antibiotics in animals raised for food; resistant bacteria can be transmitted to humans through foods, particularly those of animal origin. We identified and characterized strains of salmonella isolated from ground meats purchased in the Washington, D.C., area. Methods: Salmonella was isolated from samples of ground chicken, beef, turkey, and pork purchased at three supermarkets. The isolates were characterized by serotyping, antimicrobial-susceptibility testing, phage typing, and pulsed-field gel electrophoresis. The polymerase chain reaction and DNA sequencing were used to identify resistance integrons and extended spectrum beta -lactamase genes. Results: Of 200 meat samples, 41 (20 percent) contained salmonella, with a total of 13 serotypes. Eighty-four percent of the isolates were resistant to at least one antibiotic, and 53 percent were resistant to at least three antibiotics. Sixteen percent of the isolates were resistant to ceftriaxone, the drug of choice for treating salmonellosis in children. Bacteriophage typing identified four isolates of Salmonella enterica serotype typhimurium definitive type 104 (DT104), one of DT104b, and two of DT208. Five isolates of S. enterica serotype agona had resistance to 9 antibiotics, and the two isolates of serotype typhimurium DT208 were resistant to 12 antibiotics. Electrophoretic patterns of DNA that were indistinguishable from one another were repeatedly found in isolates from different meat samples and different stores. Eighteen isolates, representing four serotypes, had integrons with genes conferring resistance to aminoglycosides, sulfonamides, trimethoprim, and beta -lactams. Conclusions: Resistant strains of salmonella are common in retail ground meats. These findings provide support for the adoption of guidelines for the prudent use of antibiotics in food animals and for a reduction in the number of pathogens present on farms and in slaughterhouses. National surveillance for antimicrobial-resistant salmonella should be extended to include retail meats. (N Engl J Med 2001;345:1147-54.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; US FDA, Ctr Vet Med, Div Anim & Food Microbiol Off Res, Laurel, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA)	Meng, JH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	jm332@umail.umd.edu	McDermott, Patrick F./ABE-4374-2021	McDermott, Patrick F./0000-0003-1868-8096; Chen, Sheng/0000-0003-3526-7808				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; *AOAC INT, 1998, BACT AN MAN; Baggesen DL, 2000, J CLIN MICROBIOL, V38, P1581, DOI 10.1128/JCM.38.4.1581-1586.2000; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Calvert N, 1998, VET REC, V143, P351, DOI 10.1136/vr.143.13.351; *CDCP, 1998, STAND MOL SUBT FOODB; Cloeckaert A, 2000, ANTIMICROB AGENTS CH, V44, P1359, DOI 10.1128/AAC.44.5.1359-1361.2000; Cody SH, 1999, JAMA-J AM MED ASSOC, V281, P1805, DOI 10.1001/jama.281.19.1805; Davies A, 1996, Commun Dis Rep CDR Rev, V6, pR159; Davis MA, 1999, EMERG INFECT DIS, V5, P802, DOI 10.3201/eid0506.990610; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901; Gomez Thomas M., 1997, World Health Statistics Quarterly, V50, P81; Grein T, 1999, IRISH MED J, V92, P238; Guerra B, 2000, ANTIMICROB AGENTS CH, V44, P2166, DOI 10.1128/AAC.44.8.2166-2169.2000; Hall RM, 1997, CIBA F SYMP, V207, P192; HALL RM, 1993, GENETICA, V90, P115, DOI 10.1007/BF01435034; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Izumiya H, 1999, JPN J INFECT DIS, V52, P133; Markogiannakis A, 2000, J CLIN MICROBIOL, V38, P1269, DOI 10.1128/JCM.38.3.1269-1271.2000; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; *NAT COMM CLIN LAB, 1999, M31A NCCLS; National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS; Ridley A, 1998, MICROB DRUG RESIST, V4, P113, DOI 10.1089/mdr.1998.4.113; Sandvang D, 1998, FEMS MICROBIOL LETT, V160, P37, DOI [10.1111/j.1574-6968.1998.tb12887.x, 10.1016/S0378-1097(98)00006-8]; Synnott M B, 1998, Commun Dis Public Health, V1, P176; Taylor JP, 1998, J CLIN MICROBIOL, V36, P2861, DOI 10.1128/JCM.36.10.2861-2864.1998; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tollefson L, 1997, REV SCI TECH OIE, V16, P709, DOI 10.20506/rst.16.2.1054; Tollefson L, 1998, VET CLIN N AM-FOOD A, V14, P141, DOI 10.1016/S0749-0720(15)30285-1; Villar RG, 1999, JAMA-J AM MED ASSOC, V281, P1811, DOI 10.1001/jama.281.19.1811; WHO, 2000, OV ANT RES; Winokur PL, 2000, ANTIMICROB AGENTS CH, V44, P2777, DOI 10.1128/AAC.44.10.2777-2783.2000; Witte W, 1998, SCIENCE, V279, P996, DOI 10.1126/science.279.5353.996; 1999, WKLY EPIDEMIOL REC, V74, P345; 1998, MMWR MORB MORTAL WKL, V47, P462	38	363	385	2	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1147	1154		10.1056/NEJMoa010315	http://dx.doi.org/10.1056/NEJMoa010315			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642230	Bronze			2022-12-01	WOS:000171605800001
J	Riedler, J; Braun-Fahrlander, C; Eder, W; Schreuer, M; Waser, M; Maisch, S; Carr, D; Schierl, R; Nowak, D; von Mutius, E				Riedler, J; Braun-Fahrlander, C; Eder, W; Schreuer, M; Waser, M; Maisch, S; Carr, D; Schierl, R; Nowak, D; von Mutius, E		ALEX Study Team	Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey	LANCET			English	Article							HAY-FEVER; AUSTRIAN CHILDREN; IGE PRODUCTION; CHILDHOOD; SENSITIZATION; PREVALENCE; ATOPY; RISK; STIMULATION; CHALLENGE	Background A farming environment protects against development of asthma, hay fever, and atopic sensitisation in children. We aimed to establish whether increased exposure to microbial compounds has to occur early in life to affect maturation of the immune system and thereby reduces risk for development of allergic diseases. Methods We did a cross-sectional survey in rural areas of Austria, Germany, and Switzerland. 2618 (75%) of 3504 parents of 6-13-year-old children completed a standardised questionnaire on asthma, hay fever, and atopic eczema. Children from farming families, and a random sample of non-farmers' children, who gave consent for blood samples to be obtained for measurements of specific serum IgE antibodies to common allergens were invited to participate (n = 901). Findings Exposure of children younger than 1 year, compared with those aged 1-5 years, to stables and consumption of farm milk was associated with lower frequencies of asthma (1% [3/218] vs 11% [15/138]), hay fever (3% [7] vs 13% [18]), and atopic sensitisation (12% [27] vs 29% [40]). Protection against development of asthma was independent from effect on atopic sensitisation. Continual long-term exposure to stables until age 5 years was associated with the lowest frequencies of asthma (0.8% [1/122]), hay fever (0.8% [1]), and atopic sensitisation (8.2% [10]). Interpretation Long-term and early-life exposure to stables and farm milk induces a strong protective effect against development of asthma, hay fever, and atopic sensitisation.	Childrens Hosp, A-5020 Salzburg, Austria; Univ Basel, Inst Social & Prevent Med, Basel, Switzerland; Salzburg Univ, Dept Sociol, A-5020 Salzburg, Austria; Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; Univ Munich, Inst Occupat & Environm Med, Munich, Germany	University of Basel; Salzburg University; University of Munich; University of Munich	Riedler, J (corresponding author), Childrens Hosp, Muellner Hauptstr 48, A-5020 Salzburg, Austria.		riedler, josef/AAQ-4666-2020					Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Ernst P, 2000, AM J RESP CRIT CARE, V161, P1563, DOI 10.1164/ajrccm.161.5.9908119; Holt PG, 1996, J EXP MED, V183, P1297, DOI 10.1084/jem.183.4.1297; Kilewein G, 1994, LEITFADEN MILCHKUNDE, P83; Kilpelainen M, 2000, CLIN EXP ALLERGY, V30, P201, DOI 10.1046/j.1365-2222.2000.00800.x; Klinman DM, 1999, VACCINE, V17, P19, DOI 10.1016/S0264-410X(98)00151-0; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Lewis SA, 2000, CLIN EXP ALLERGY, V30, P153; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Murosaki S, 1998, J ALLERGY CLIN IMMUN, V102, P57, DOI 10.1016/S0091-6749(98)70055-7; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; RIEDLER J, 1994, AM J RESP CRIT CARE, V150, P1632, DOI 10.1164/ajrccm.150.6.7952626; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Riedler J, 1998, EUR RESPIR J, V11, P355, DOI 10.1183/09031936.98.11020355; Sudo N, 1997, J IMMUNOL, V159, P1739; SUHREN G, 1986, MILCHWISSENSCHAFT, V41, P156; Tariq SM, 1998, J ALLERGY CLIN IMMUN, V101, P587, DOI 10.1016/S0091-6749(98)70164-2; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230	24	1063	1093	0	148	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1129	1133		10.1016/S0140-6736(01)06252-3	http://dx.doi.org/10.1016/S0140-6736(01)06252-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597666				2022-12-01	WOS:000171399000009
J	Zavialov, AV; Buckingham, RH; Ehrenberg, M				Zavialov, AV; Buckingham, RH; Ehrenberg, M			A posttermination ribosomal complex is the guanine nucleotide exchange factor for peptide release factor RF3	CELL			English	Article							ELONGATION-FACTOR TU; ESCHERICHIA-COLI; TRANSLATION TERMINATION; POLYPEPTIDE-SYNTHESIS; MESSENGER-RNA; FACTOR RF-3; BINDING; ERF3; INITIATION; MECHANISM	The mechanism by which peptide release factor RF3 recycles RF1 and RF2 has been clarified and incorporated in a complete scheme for translation termination. Free RF3 is in vivo stably bound to GDP, and ribosomes in complex with RF1 or RF2 act as guanine nucleotide exchange factors (GEF). Hydrolysis of peptldyl-tRNA by RF1 or RF2 allows GTP binding to RF3 on the ribosome. This induces an RF3 conformation with high affinity for ribosomes and leads to rapid dissociation of RF1 or RF2. Dissociation of RF3 from the ribosome requires GTP hydrolysis. Our data suggest that RF3 and its eukaryotic counterpart, eRF3, have mechanistic principles in common.	Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Inst Biol Physicochim, CNRS, UPR 9073, F-75005 Paris, France	Uppsala University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Zavialov, AV (corresponding author), Uppsala Univ, BMC, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.		Zavialov, Anton V./C-7664-2015	Zavialov, Anton V./0000-0001-6191-5931; Buckingham, Richard/0000-0002-8567-4500; Zavialov, Andrey/0000-0001-6420-0368				ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CM, 1994, J BIOL CHEM, V269, P33164; BRUNEL C, 1993, BIOCHIMIE, V75, P1167, DOI 10.1016/0300-9084(93)90016-L; Ehrenberg M, 1990, RIBOSOMES PROTEIN SY, P101; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; GOLDSTEIN JL, 1970, P NATL ACAD SCI USA, V67, P537, DOI 10.1073/pnas.67.2.537; GOODY RS, 1991, TRENDS BIOCHEM SCI, V16, P327, DOI 10.1016/0968-0004(91)90134-H; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; Grentzmann G, 1998, RNA, V4, P973, DOI 10.1017/S1355838298971576; Holst-Hansen P, 1997, BIOCHIMIE, V79, P725, DOI 10.1016/S0300-9084(97)86930-1; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, RNA, V4, P958, DOI 10.1017/S1355838298971874; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Merkulova TI, 1999, FEBS LETT, V443, P41, DOI 10.1016/S0014-5793(98)01669-X; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; MILMAN G, 1969, P NATL ACAD SCI USA, V63, P183, DOI 10.1073/pnas.63.1.183; Mortensen KK, 1995, EUR J BIOCHEM, V234, P732, DOI 10.1111/j.1432-1033.1995.732_a.x; Nakamura Y, 2000, CELL, V101, P349, DOI 10.1016/S0092-8674(00)80845-4; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pavlov MY, 1997, EMBO J, V16, P4134, DOI 10.1093/emboj/16.13.4134; Pel HJ, 1998, RNA, V4, P47; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; RUUSALA T, 1982, EMBO J, V1, P75, DOI 10.1002/j.1460-2075.1982.tb01127.x; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SOFFIENTINI A, 1994, PROTEIN EXPRES PURIF, V5, P118, DOI 10.1006/prep.1994.1018; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	39	161	170	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					115	124		10.1016/S0092-8674(01)00508-6	http://dx.doi.org/10.1016/S0092-8674(01)00508-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595190	Bronze			2022-12-01	WOS:000171453100014
J	Bradley, J; Reuter, D; Frings, S				Bradley, J; Reuter, D; Frings, S			Facilitation of calmodulin-mediated odor adaptation by cAMP-gated channel subunits	SCIENCE			English	Article							CGMP; SENSITIVITY; MODULATION; ACTIVATION; NEURONS; TRANSDUCTION; MECHANISM; RODS	Calcium (Ca(2+)) influx through Ca(2+)-permeable ion channels plays a pivotal role in a variety of neuronal signaling processes, and negative-feed back control of this influx by Ca(2+) itself is often equally important for modulation of such signaling. Negative modulation by Ca(2+) through calmodulin (CaM) on cyclic nucleotide-gated (CNG) channels underlies the adaptation of olfactory receptor neurons to odorants. We show that this feedback requires two additional subunits of the native olfactory channel, CNGA4 and CNGB1b, even though the machinery for CaM binding and modulation is present in the principal subunit CNGA2. This provides a rationale for the presence of three distinct subunits in the native olfactory channel and underscores the subtle link between the molecular make-up of an ion channel and the physiological function it subserves.	Forschungszentrum Julich, Inst Biol Informat Verarbeitung, D-52425 Julich, Germany; Ecole Normale Super, Neurobiol Lab, F-75230 Paris, France	Helmholtz Association; Research Center Julich; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Frings, S (corresponding author), Forschungszentrum Julich, Inst Biol Informat Verarbeitung, Postfach 1913, D-52425 Julich, Germany.	s.frings@fz-juelich.de		Bradley, Jonathan/0000-0002-6933-1153				Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Dzeja C, 1999, EMBO J, V18, P131, DOI 10.1093/emboj/18.1.131; Frings S, 2001, CELL MOL LIFE SCI, V58, P510, DOI 10.1007/PL00000876; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Gordon SE, 2000, METHOD ENZYMOL, V315, P772; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Hagen V, 1996, BIOCHEMISTRY-US, V35, P7762, DOI 10.1021/bi952895b; Hagen V, 2001, ANGEW CHEM INT EDIT, V40, P1046; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Muller F, 1998, J NEUROSCI, V18, P164; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	20	81	83	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2176	2178		10.1126/science.1063415	http://dx.doi.org/10.1126/science.1063415			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739960				2022-12-01	WOS:000172647700054
J	Munger, SD; Lane, AP; Zhong, HN; Leinders-Zufall, T; Yau, KW; Zufall, F; Reed, RR				Munger, SD; Lane, AP; Zhong, HN; Leinders-Zufall, T; Yau, KW; Zufall, F; Reed, RR			Central role of the CNGA4 channel subunit in Ca2+-calmodulin-dependent odor adaptation	SCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; OLFACTORY RECEPTOR CELL; CALCIUM-CALMODULIN; ACTIVATED CHANNEL; CATION CHANNEL; BETA-SUBUNIT; NEURONS; SENSITIVITY; RAT; TRANSDUCTION	Heteromultimeric cyclic nucleotide-gated (CNG) channels play a central role in the transduction of odorant signals and subsequent adaptation. The contributions of individual subunits to native channel function in olfactory receptor neurons remain unclear. Here, we show that the targeted deletion of the mouse CNGA4 gene, which encodes a modulatory CNG subunit, results in a defect in odorant-dependent adaptation. Channels in excised membrane patches from the CNGA4 null mouse exhibited slower Ca2+-calmodulin-mediated channel desensitization. Thus, the CNGA4 subunit accelerates the Ca2+-mediated negative feedback in olfactory signaling and allows rapid adaptation in this sensory system.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Reed, RR (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.		Leinders-Zufall, Trese/B-4103-2009; Zufall, Frank/AAE-5290-2021; Leinders-Zufall, Trese/S-3664-2019	Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Leinders-Zufall, Trese/0000-0002-0678-362X	NATIONAL EYE INSTITUTE [R37EY006837] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837-14, R37 EY006837, R37 EY006837-13] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baker H, 1999, J NEUROSCI, V19, P9313; BAKER H, 1983, J NEUROSCI, V3, P69; Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Dzeja C, 1999, EMBO J, V18, P131, DOI 10.1093/emboj/18.1.131; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Menini A, 1999, CURR OPIN NEUROBIOL, V9, P419, DOI 10.1016/S0959-4388(99)80063-4; MUNGER SD, UNPUB; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	23	94	99	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2172	2175		10.1126/science.1063224	http://dx.doi.org/10.1126/science.1063224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739959	Green Accepted			2022-12-01	WOS:000172647700053
J	Siegert, MJ; Ellis-Evans, JC; Tranter, M; Mayer, C; Petit, JR; Salamatin, A; Priscu, JC				Siegert, MJ; Ellis-Evans, JC; Tranter, M; Mayer, C; Petit, JR; Salamatin, A; Priscu, JC			Physical, chemical and biological processes in Lake Vostok and other Antarctic subglacial lakes	NATURE			English	Review							WATER EXCHANGE; ICE-CORE; BENEATH; CONSTRAINTS; STATION; MODEL	Over 70 lakes have now been identified beneath the Antarctic ice sheet. Although water from none of the lakes has been sampled directly, analysis of lake ice frozen (accreted) to the underside of the ice sheet above Lake Vostok, the largest of these lakes, has allowed inferences to be made on lake water chemistry and has revealed small quantities of microbes. These findings suggest that Lake Vostok is an extreme, yet viable, environment for life. All subglacial lakes are subject to high pressure (similar to 350 atmospheres), low temperatures (about -3 degreesC) and permanent darkness. Any microbes present must therefore use chemical sources to power biological processes. Importantly, dissolved oxygen is available at least at the lake surface, from equilibration with air hydrates released from melting basal glacier ice. Microbes found in Lake Vostok's accreted ice are relatively modern, but the probability of ancient lake-floor sediments leads to a possibility of a very old biota at the base of subglacial lakes.	Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England; British Antarctic Survey, Biosci Div, Freshwater Ecol Grp, Cambridge CB3 0ET, England; Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Kazan VI Lenin State Univ, Dept Appl Math, Kazan 420008, Russia; Montana State Univ, Bozeman, MT 59717 USA	University of Bristol; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Innsbruck; Centre National de la Recherche Scientifique (CNRS); Kazan Federal University; Montana State University System; Montana State University Bozeman	Siegert, MJ (corresponding author), Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England.	m.j.siegert@bristol.ac.uk	Tranter, Martyn/E-3722-2010; Siegert, Martin J/A-3826-2008; Salamatin, Andrey/A-9831-2016; Siegert, Martin/M-9939-2019	Tranter, Martyn/0000-0003-2071-3094; Siegert, Martin J/0000-0002-0090-4806; Salamatin, Andrey/0000-0002-5988-6024; Siegert, Martin/0000-0002-0090-4806				Abyzov SS, 1998, MICROBIOLOGY+, V67, P451; BARKOV NI, 2001, IN PRESS ARKTIKA ANT; Barrett P.J, 1996, TERRA ANTARCTICA, V3, P103; BELL RE, UNPUB NATURE; BOTTRELL SH, IN PRESS HYDROL PROC; CHRISTNER BC, IN PRESS APPL ENV MI; Dowdeswell JA, 1999, GEOL SOC AM BULL, V111, P254, DOI 10.1130/0016-7606(1999)111<0254:TDATSO>2.3.CO;2; EllisEvans JC, 1996, BIODIVERS CONSERV, V5, P1395, DOI 10.1007/BF00051985; Fang JS, 2000, DEEP-SEA RES PT I, V47, P1173, DOI 10.1016/S0967-0637(99)00080-1; Gaidos EJ, 1999, SCIENCE, V284, P1631, DOI 10.1126/science.284.5420.1631; Gorman MR, 1999, J GEOPHYS RES-SOL EA, V104, P29311, DOI 10.1029/1999JB900271; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Jean-Baptiste P, 2001, NATURE, V411, P460, DOI 10.1038/35078045; Jouzel J, 1999, SCIENCE, V286, P2138, DOI 10.1126/science.286.5447.2138; Kapitsa AP, 1996, NATURE, V381, P684, DOI 10.1038/381684a0; Karl DM, 1999, SCIENCE, V286, P2144, DOI 10.1126/science.286.5447.2144; KENNICUTT MC, 2001, SUBGLACIAL LAKE EXPL; Killawee JA, 1998, GEOCHIM COSMOCHIM AC, V62, P3637, DOI 10.1016/S0016-7037(98)00268-3; Kuhs W.F., 2000, PHYSICS ICE CORE REC, P373; Kwok R, 2000, J GLACIOL, V46, P689, DOI 10.3189/172756500781832710; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lee SY, 2000, ANN NY ACAD SCI, V912, P614; Lipenkov V., 2000, PHYS ICE CORE RECORD, P327; LIPENKOV VY, 2001, IN PRESS MAT ISSLED, V91; Lipenkov VYa, 2000, PROBL ARKT ANTARKT, V72, P197; Lukin V V, 2000, PROBLEMY ARKTIKI ANT, V72, P237; Mayer C, 2000, J GLACIOL, V46, P197, DOI 10.3189/172756500781832981; MAYER C, UNPUB EARTH PLANET S; OSWALD GKA, 1973, NATURE, V245, P251, DOI 10.1038/245251a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Prentice AP, 1998, GSA TODAY, V8, P1; Priscu JC, 1999, BIOSCIENCE, V49, P997, DOI 10.2307/1313733; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; ROCHSCHILD LJ, 2001, NATURE, V409, P1092; Salamatin A. N., 1998, MAT GLYATSIOL ISSLED, V85, P233; Salamatin A. N., 2000, PHYS ICE CORE RECORD, P243; Siegert MJ, 2000, EARTH PLANET SC LETT, V179, P227, DOI 10.1016/S0012-821X(00)00121-7; Siegert MJ, 2000, EARTH-SCI REV, V50, P29, DOI 10.1016/S0012-8252(99)00068-9; Siegert MJ, 2000, NATURE, V403, P643, DOI 10.1038/35001049; Siegert MJ, 1998, J GEOPHYS RES-SOL EA, V103, P10195, DOI 10.1029/98JB00390; Siegert MJ, 1996, ANTARCT SCI, V8, P281, DOI 10.1017/S0954102096000405; Souchez R, 2000, EARTH PLANET SC LETT, V181, P529, DOI 10.1016/S0012-821X(00)00228-4; TABACCO IE, UNPUB J GLACIOL; TRANTER M, IN PRESS HYDROL PROC; UCHIDA T, 1994, J GLACIOL, V40, P79, DOI 10.3189/S0022143000003828; Williams MJM, 2001, GEOPHYS RES LETT, V28, P531, DOI 10.1029/2000GL012107; Wuest A, 2000, OCEAN MODEL, V2, P29, DOI 10.1016/S1463-5003(00)00007-X	47	146	156	6	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					603	609		10.1038/414603a	http://dx.doi.org/10.1038/414603a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740551				2022-12-01	WOS:000172535600039
J	Terborgh, J; Lopez, L; Nunez, P; Rao, M; Shahabuddin, G; Orihuela, G; Riveros, M; Ascanio, R; Adler, GH; Lambert, TD; Balbas, L				Terborgh, J; Lopez, L; Nunez, P; Rao, M; Shahabuddin, G; Orihuela, G; Riveros, M; Ascanio, R; Adler, GH; Lambert, TD; Balbas, L			Ecological meltdown in predator-free forest fragments	SCIENCE			English	Article							TROPHIC CASCADES; COMMUNITY STRUCTURE; HYPOTHESIS; VEGETATION; FOOD	The manner in which terrestrial ecosystems are regulated is controversial. The "top-down" school holds that predators Limit herbivores and thereby prevent them from overexploiting vegetation. "Bottom-up" proponents stress the role of plant chemical defenses in limiting plant depredation by herbivores. A set of predator-free islands created by a hydroelectric impoundment in Venezuela allows a test of these competing world views. Limited area restricts the fauna of small (0.25 to 0.9 hectare) islands to predators of invertebrates (birds, lizards, anurans, and spiders), seed predators (rodents), and herbivores (howler monkeys, iguanas, and leaf-cutter ants). Predators of vertebrates are absent, and densities of rodents, howler monkeys, iguanas, and leaf-cutter ants are 10 to 100 times greater than on the nearby mainland, suggesting that predators normally Limit their populations. The densities of seedlings and saplings of canopy trees are severely reduced on herbivore-affected islands, providing evidence of a trophic cascade unleashed in the absence of top-down regulation.	Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA; Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; Univ Nacl San Antonio de Abad, Herbario Vargas, Cuzco, Peru; Wildlife Conservat Soc, Bronx, NY 10464 USA; Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England; Chintan Environm Res & Act Grp, New Delhi 110014, India; Univ Ricardo Palma, Fac Ciencias Biol, Lima 18, Peru; Fdn Museo Ciencias, Ctr Adolfo Ernst, Caracas 1010, Venezuela; Univ Complutense Madrid, Fac Ciencias Biol, Dept Ecol, E-28040 Madrid, Spain; Univ Toronto, Fac Forestry, Toronto, ON M5S 3B2, Canada; Univ Wisconsin, Dept Biol & Microbiol, Oshkosh, WI 54901 USA; EDELCA, Puerto Ordaz, Estado Bolivar, Venezuela	Duke University; State University System of Florida; Florida International University; Wildlife Conservation Society; University of Cambridge; Universidad Ricardo Palma; Complutense University of Madrid; University of Toronto; University of Wisconsin System	Terborgh, J (corresponding author), Duke Univ, Ctr Trop Conservat, Box 90381, Durham, NC 27708 USA.	manu@duke.edu	Fahimifar, Sepideh/M-5303-2019; Langerhans, R. Brian/A-7205-2009	Rao, Madhu/0000-0002-5360-4073				ALVAREZ E, 1986, INTERCIENCIA, V11, P325; ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; BRAMWELL D, 1979, PLANTS ISLANDS; BREMAN H, 1992, BIOTROPICA, V24, P328, DOI 10.2307/2388526; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; ELLIS J, 1994, BIOSCIENCE, V44, P340, DOI 10.2307/1312384; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hubbell SP, 1998, MAN BIOSPH, V20, P17; HUBER O, 1986, INTERCIENCIA, V11, P301; Ickes K, 2001, J TROP ECOL, V17, P191, DOI 10.1017/S0266467401001134; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; LAMBERT TD, UNPUB POPULATIONS FR; LEIGH EG, 1993, EVOL ECOL, V7, P76, DOI 10.1007/BF01237735; Martin P. S., 1984, QUATERNARY EXTINCTIO; MCLAREN BE, 1994, SCIENCE, V266, P1555, DOI 10.1126/science.266.5190.1555; McShea WJ, 1997, SCI OVERABUNDANCE DE; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Persson L, 1999, OIKOS, V85, P385, DOI 10.2307/3546688; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Rao M, 2000, J TROP ECOL, V16, P209, DOI 10.1017/S026646740000136X; Rao M, 2001, CONSERV BIOL, V15, P624, DOI 10.1046/j.1523-1739.2001.015003624.x; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Terborgh J, 1997, ECOLOGY, V78, P1494, DOI 10.1890/0012-9658(1997)078[1494:BCITTL]2.0.CO;2; Terborgh John, 1999, P39; Terborgh John, 1997, P256; White T.C., 1993, INADEQUATE ENV NITRO	29	993	1065	14	635	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1923	1926		10.1126/science.1064397	http://dx.doi.org/10.1126/science.1064397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729317				2022-12-01	WOS:000172465000058
J	Estevez, R; Bottger, T; Stein, V; Birkenhager, R; Otto, E; Hildebrandt, F; Jentsch, TJ				Estevez, R; Bottger, T; Stein, V; Birkenhager, R; Otto, E; Hildebrandt, F; Jentsch, TJ			Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion	NATURE			English	Article							CHLORIDE CHANNEL; RAT-KIDNEY; MUTATIONS; GENE; COTRANSPORTER; DEAFNESS; DISEASE; JERVELL; CIC-K1; FAMILY	Renal salt loss in Bartter's syndrome is caused by impaired transepithelial transport in the loop of Henle. Sodium chloride is taken up apically by the combined activity of NKCC2 (Na+-K--2Cl(-) cotransporters) and ROMK potassium channels. Chloride ions exit from the cell through basolateral ClC-Kb chloride channels. Mutations in the three corresponding genes have been identired(1-3) that correspond to Bartter's syndrome types(1-3). The gene(4) encoding the integral membrane protein barttin is mutated in a form of Bartter's syndrome that is associated with congenital deafness and renal failure. Here we show that barttin acts as an essential beta -subunit for ClC-Ka and ClC-Kb chloride channels, with which it colocalizes in basolateral membranes of renal tubules and of potassium-secreting epithelia of the inner ear. Disease-causing mutations in either ClC-Kb or barttin compromise currents through heteromeric channels. Currents can be stimulated further by mutating a proline-tyrosine (PY) motif on barttin. This work describes the first known beta -subunit for CLC chloride channels and reveals that heteromers formed by ClC-K and barttin are crucial for renal salt reabsorption and potassium recycling in the inner ear(5).	Univ Hamburg, Zentrum Mol Neurobiol ZMNH, D-20246 Hamburg, Germany; Univ Freiburg, Kinderklin, D-79106 Freiburg, Germany	University of Hamburg; University of Freiburg	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol ZMNH, Falkenried 94, D-20246 Hamburg, Germany.		Estevez, Raul/D-8610-2015; Boettger, Thomas/E-3406-2012	Estevez, Raul/0000-0003-1579-650X; Boettger, Thomas/0000-0003-4280-8449; Stein, Valentin/0000-0003-1222-4928; Otto, Edgar/0000-0002-2387-9973; Jentsch, Thomas/0000-0002-3509-2553				ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Ando M, 2000, NEUROSCI LETT, V284, P171, DOI 10.1016/S0304-3940(00)01021-1; Baloh RW, 1998, LANCET, V352, P1841, DOI 10.1016/S0140-6736(98)05430-0; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dixon MJ, 1999, HUM MOL GENET, V8, P1579, DOI 10.1093/hmg/8.8.1579; Jeck N, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e5; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; Vandewalle A, 1997, AM J PHYSIOL-RENAL, V272, pF678, DOI 10.1152/ajprenal.1997.272.5.F678; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	29	420	445	1	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					558	561		10.1038/35107099	http://dx.doi.org/10.1038/35107099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734858				2022-12-01	WOS:000172405900051
J	Burdet, E; Osu, R; Franklin, DW; Milner, TE; Kawato, M				Burdet, E; Osu, R; Franklin, DW; Milner, TE; Kawato, M			The central nervous system stabilizes unstable dynamics by learning optimal impedance	NATURE			English	Article							INTERNAL MODELS; MULTIJOINT ARM; STIFFNESS; MOVEMENT; POSTURE; MUSCLE; TASK	To manipulate objects or to use tools we must compensate for any forces arising from interaction with the physical environment. Recent studies indicate that this compensation is achieved by learning an internal model of the dynamics(1-6), that is, a neural representation of the relation between motor command and movement(5,7). In these studies interaction with the physical environment was stable, but many common tasks are intrinsically unstable(8,9). For example, keeping a screwdriver in the slot of a screw is unstable because excessive force parallel to the slot can cause the screwdriver to slip and because misdirected force can cause loss of contact between the screwdriver and the screw. Stability may be dependent on the control of mechanical impedance in the human arm because mechanical impedance can generate forces which resist destabilizing motion. Here we examined arm movements in an unstable dynamic environment created by a robotic interface. Our results show that humans learn to stabilize unstable dynamics using the skilful and energy-efficient strategy of selective control of impedance geometry.	JST, ERATO, Kawato Dynam Brain Project, Seika, Kyoto 6190288, Japan; Natl Univ Singapore, Dept Mech Engn, Singapore 119260, Singapore; ATR Human Informat Sci Labs, Seika, Kyoto 6190288, Japan; Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada	Japan Science & Technology Agency (JST); National University of Singapore; Simon Fraser University	Kawato, M (corresponding author), JST, ERATO, Kawato Dynam Brain Project, Seika, Kyoto 6190288, Japan.		Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Milner, Theodore/0000-0002-8111-6843				AKAZAWA K, 1983, J NEUROPHYSIOL, V49, P16, DOI 10.1152/jn.1983.49.1.16; Burdet E, 2000, J BIOMECH, V33, P1705, DOI 10.1016/S0021-9290(00)00142-1; Burdet E., 1999, P 1999 ASME ANN S HA, P421; COLGATE JE, 1988, INT J CONTROL, V48, P65, DOI 10.1080/00207178808906161; DESERRES SJ, 1991, EXP BRAIN RES, V86, P451, DOI 10.1007/BF00228972; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; GOMI H, 1995, ISRL954 NTT BAS RES; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; HUNTER IW, 1982, J BIOMECH, V15, P747, DOI 10.1016/0021-9290(82)90089-6; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; McIntyre J, 1996, EXP BRAIN RES, V110, P248; MILNER TE, 1993, EXP BRAIN RES, V94, P522; Milner TE, 1995, EXP BRAIN RES, V107, P293; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Rack P.M., 2011, COMPR PHYSIOL, P229, DOI [10.1002/cphy.cp010207, DOI 10.1002/CPHY.CP010207]; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; WON J, 1995, EXP BRAIN RES, V107, P125	26	745	754	6	101	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					446	449		10.1038/35106566	http://dx.doi.org/10.1038/35106566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719805				2022-12-01	WOS:000172304500043
J	Saha, S; Bardelli, A; Buckhaults, P; Velculescu, VE; Rago, C; St Croix, B; Romans, KE; Choti, MA; Lengauer, C; Kinzler, KW; Vogelstein, B				Saha, S; Bardelli, A; Buckhaults, P; Velculescu, VE; Rago, C; St Croix, B; Romans, KE; Choti, MA; Lengauer, C; Kinzler, KW; Vogelstein, B			A phosphatase associated with metastasis of colorectal cancer	SCIENCE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PROTEIN-TYROSINE PHOSPHATASES; TUMOR-SUPPRESSOR GENES; PROSTATE-CANCER; AMPLIFICATION; TRANSCRIPTOMES; PRENYLATION; EXPRESSION; BREAST	To gain insights into the molecular basis for metastasis, we compared the global gene expression profile of metastatic colorectal cancer with that of primary cancers, benign colorectal tumors, and normal colorectal epithelium. Among the genes identified, the PRL-3 protein tyrosine phosphatase gene was of particular interest. It was expressed at high levels in each of 18 cancer metastases studied but at lower levels in nonmetastatic tumors and normal colorectal epithelium. In 3 of 12 metastases examined, multiple copies of the PRL-3 gene were found within a small amplicon located at chromosome 8q24.3. These data suggest that the PRL-3 gene is important for colorectal cancer metastasis and provide a new therapeutic target for these intractable lesions.	Johns Hopkins Med Inst, Howard Hughes Med Inst, Ctr Oncol, Dept Surg, Baltimore, MD 21231 USA; Johns Hopkins Med Inst, Program Cellular & Mol Med, Baltimore, MD 21231 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Kinzler, KW (corresponding author), Johns Hopkins Med Inst, Howard Hughes Med Inst, Ctr Oncol, Dept Surg, Baltimore, MD 21231 USA.	kinzlke@jhmi.edu; vogelbe@welch.jhu.edu	Velculescu, Victor/ABF-4846-2020; BARDELLI, Alberto/J-9721-2018	Velculescu, Victor/0000-0003-1195-438X; BARDELLI, Alberto/0000-0003-1647-5070	NCI NIH HHS [CA 62924, CA43460, CA57345] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043460, R37CA043460, P50CA062924, R37CA057345, R01CA057345] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alers JC, 1997, LAB INVEST, V77, P437; BRODEUR GM, 1998, GENETIC BASIS HUMAN, V1, P161; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; El Gedaily A, 2001, PROSTATE, V46, P184; Fidler I J, 2001, Surg Oncol Clin N Am, V10, P257; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; Heiskanen MA, 2000, CANCER RES, V60, P799; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Nupponen NN, 2000, GENE CHROMOSOME CANC, V28, P203; Paredes-Zaglul A, 1998, CLIN CANCER RES, V4, P879; Pegram M D, 2000, Cancer Treat Res, V103, P57; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ridley A, 2000, NATURE, V406, P466, DOI 10.1038/35020170; Velculescu VE, 2000, TRENDS GENET, V16, P423, DOI 10.1016/S0168-9525(00)02114-4; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weiss L, 2000, CANCER METAST REV, V19, P193, DOI 10.1023/A:1010646304844; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	24	548	618	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545					1343	1346		10.1126/science.1065817	http://dx.doi.org/10.1126/science.1065817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11598267				2022-12-01	WOS:000172130200050
J	Kawakita, H; Watanabe, J; Ando, H; Aoki, W; Fuse, T; Honda, S; Izumiura, H; Kajino, T; Kambe, E; Kawanomoto, S; Noguchi, K; Okita, K; Sadakane, K; Sato, B; Takada-Hidai, M; Takeda, Y; Usuda, T; Watanabe, E; Yoshida, M				Kawakita, H; Watanabe, J; Ando, H; Aoki, W; Fuse, T; Honda, S; Izumiura, H; Kajino, T; Kambe, E; Kawanomoto, S; Noguchi, K; Okita, K; Sadakane, K; Sato, B; Takada-Hidai, M; Takeda, Y; Usuda, T; Watanabe, E; Yoshida, M			The spin temperature of NH3 in Comet C/1999S4 (LINEAR)	SCIENCE			English	Article							O1 HALE-BOPP; DISPERSION SPECTRA; AMMONIA; DEUTERIUM; CATALOG; RATIO; C2	A high-dispersion spectrum of Comet C/1999S4 (LINEAR) was obtained in the optical region with the high-dispersion spectrograph on the Subaru telescope when the comet was 0.863 astronomical units from the Sun before its disintegration. We obtained high signal-to-noise ratio emission tines of the cometary NH2 bands from which an ortho-to-para ratio (OPR) of 3.33 +/- 0.07 was derived on the basis of a fluorescence excitation model. Assuming that cometary NH2 mainly originates from ammonia through photodissociation, the derived OPR of NH2, molecules should reflect that of ammonia, which provides information on the environment of molecular formation or condensation and of the thermal history of cometary ices. Assuming that the OPR of ammonia in comets was unchanged in the nucleus, the derived spin temperature of ammonia (28 +/- 2 kelvin) suggests that a formation region of the cometary ammonia ice was between the orbit of Saturn and that of Uranus in the solar nebula.	Gunma Astron Observ, Gunma 3770702, Japan; Natl Astron Observ Japan, Tokyo 1818588, Japan; Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; Natl Astron Observ Japan, Okayama Astrophys Observ, Okayama 7190232, Japan; Natl Def Acad, Dept Earth & Ocean Sci, Kanagawa 2398686, Japan; Osaka Kyoiku Univ, Astron Inst, Kashiwara, Osaka 5828582, Japan; Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; Tokai Univ, Liberal Arts Educ Ctr, Hiratsuka, Kanagawa 2591292, Japan; Komazawa Univ, Setagaya Ku, Tokyo 1548525, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Defence Academy - Japan; Osaka University of Education; University of Tokyo; Tokai University	Kawakita, H (corresponding author), Gunma Astron Observ, 6860-86 Nakayama, Gunma 3770702, Japan.	kawakita@astron.pref.gunma.jp						AHEARN MF, 1978, ASTROPHYS J, V219, P768, DOI 10.1086/155837; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Aikawa Y, 1999, ASTROPHYS J, V519, P705, DOI 10.1086/307400; Bachir IH, 1999, J MOL SPECTROSC, V193, P326, DOI 10.1006/jmsp.1998.7752; Bird MK, 1997, ASTRON ASTROPHYS, V325, pL5; Bird MK, 1997, EARTH MOON PLANETS, V78, P21, DOI 10.1023/A:1006246606131; BIRSS FW, 1985, COMPUT PHYS COMMUN, V38, P83, DOI 10.1016/0010-4655(85)90048-7; Blake GA, 1999, NATURE, V398, P213, DOI 10.1038/18372; Bockelee-Morvan D, 2000, ASTRON ASTROPHYS, V353, P1101; Bockelee-Morvan D, 2001, SCIENCE, V292, P1339, DOI 10.1126/science.1058512; Brown ME, 1996, ASTRON J, V112, P1197, DOI 10.1086/118090; BUENKER RJ, 1981, MOL PHYS, V43, P987, DOI 10.1080/00268978100101821; Crovisier J, 1999, NATO ADV SCI I C-MAT, V523, P389; FINK U, 1991, ASTROPHYS J, V383, P356, DOI 10.1086/170794; FUJII M, UNPUB; HIRAOKA K, 1995, ASTROPHYS J, V443, P363, DOI 10.1086/175531; Irvine W. M., 2000, Protostars and planets 4, P1159; Kawakita H, 2000, PUBL ASTRON SOC JPN, V52, P925, DOI 10.1093/pasj/52.5.925; Kawakita H, 1998, ASTROPHYS J, V495, P946, DOI 10.1086/305318; Kawakita H, 2001, PUBL ASTRON SOC JPN, V53, pL5, DOI 10.1093/pasj/53.1.L5; KURUCZ RL, 1984, 1 HARV U NAT SOL OBS; KURUCZ RL, 1984, 1 NAT SOL OBS; Meier R, 1998, SCIENCE, V279, P842, DOI 10.1126/science.279.5352.842; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; Mumma MJ, 2001, SCIENCE, V292, P1334, DOI 10.1126/science.1058929; MUMMA MJ, 1987, ASTRON ASTROPHYS, V187, P419; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1177; NOGUCHI K, 1999, SPIE, V3355, P354; QUACK M, 1977, MOL PHYS, V34, P477, DOI 10.1080/00268977700101861; Stern SA, 2000, ASTROPHYS J, V544, pL169, DOI 10.1086/317312; Takano S, 2000, PUBL ASTRON SOC JPN, V52, pL67, DOI 10.1093/pasj/52.6.L67; TEGLER S, 1989, ASTROPHYS J, V343, P445, DOI 10.1086/167717; TEGLER SC, 1992, ASTROPHYS J, V384, P292, DOI 10.1086/170872; THEKAEKARA MP, 1974, APPL OPTICS, V13, P518, DOI 10.1364/AO.13.000518; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606; Willacy K, 1998, ASTRON ASTROPHYS, V338, P995; WOMACK M, 1997, 7474 IAU; Zhang HW, 2001, ASTRON ASTROPHYS, V367, P1049, DOI 10.1051/0004-6361:20010008	39	55	56	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1089	1091		10.1126/science.1064339	http://dx.doi.org/10.1126/science.1064339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691989				2022-12-01	WOS:000172013800046
J	Spahn, CMT; Beckmann, R; Eswar, N; Penczek, PA; Sali, A; Blobel, G; Frank, J				Spahn, CMT; Beckmann, R; Eswar, N; Penczek, PA; Sali, A; Blobel, G; Frank, J			Structure of the 80S ribosome from Saccharomyces cerevisiae - tRNA-ribosome and subunit-subunit interactions	CELL			English	Article							COLI 70S RIBOSOME; ANGSTROM RESOLUTION; CRYOELECTRON MICROSCOPY; TRANSFER-RNA; EXPANSION SEGMENTS; DENSITY MAPS; PSI-BLAST; A-SITE; P-SITE; 30 S	A cryo-EM reconstruction of the translating yeast 80S ribosome was analyzed. Computationally separated rRNA and protein densities were used for docking of appropriately modified rRNA models and homology models of yeast ribosomal proteins. The core of the ribosome shows a remarkable degree of conservation. However, some significant differences in functionally important regions and dramatic changes in the periphery due to expansion segments and additional ribosomal proteins are evident. As in the bacterial ribosome, bridges between the subunits are mainly formed by RNA contacts. Four new bridges are present at the periphery. The position of the P site tRNA coincides precisely with its prokaryotic counterpart, with mainly rRNA contributing to its molecular environment. This analysis presents an exhaustive inventory of an eukaryotic ribosome at the molecular level.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA; Humboldt Univ, Charite, Inst Biochem, D-10117 Berlin, Germany; Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Lab Mol Biophys, New York, NY 10021 USA; Univ Texas, Sch Med, Houston, TX 77030 USA	Health Research Inc; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Howard Hughes Medical Institute; Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; University of Texas System	Frank, J (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.				NCRR NIH HHS [P41 RR01219] Funding Source: Medline; NIGMS NIH HHS [R01 GM60635, R37 GM29169, GM 54762] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635, R29GM054762, R01GM054762, R37GM029169] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1999, CURR OPIN STRUC BIOL, V9, P215, DOI 10.1016/S0959-440X(99)80031-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BRIMACOMBE R, 1995, EUR J BIOCHEM, V230, P365; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P103; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; DABROWSKI M, 1995, EMBO J, V14, P4872, DOI 10.1002/j.1460-2075.1995.tb00168.x; Diedrich G, 2000, EMBO J, V19, P5241, DOI 10.1093/emboj/19.19.5241; Dube P, 1998, J MOL BIOL, V279, P403, DOI 10.1006/jmbi.1998.1804; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUTELL RR, 2001, COMP SEQUENCE ANAL P; Hardesty B, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P287; HINGERTY B, 1978, J MOL BIOL, V124, P523, DOI 10.1016/0022-2836(78)90185-7; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Merryman C, 1999, J MOL BIOL, V285, P97, DOI 10.1006/jmbi.1998.2242; Merryman C, 1999, J MOL BIOL, V285, P107, DOI 10.1006/jmbi.1998.2243; MITCHELL P, 1992, BIOCHEMISTRY-US, V31, P3004, DOI 10.1021/bi00126a023; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Nierhaus KH, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P319; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.3.CO;2-L; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Sanchez R, 2000, NUCLEIC ACIDS RES, V28, P250, DOI 10.1093/nar/28.1.250; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Spahn CMT, 1999, STRUCT FOLD DES, V7, P1567, DOI 10.1016/S0969-2126(00)88347-1; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/BF00217518; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Spahn CMT, 2000, STRUCTURE, V8, P937, DOI 10.1016/S0969-2126(00)00185-4; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Uchiumi T, 1999, J BIOL CHEM, V274, P27578, DOI 10.1074/jbc.274.39.27578; Verschoor A, 1998, NUCLEIC ACIDS RES, V26, P655, DOI 10.1093/nar/26.2.655; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Wittmann-Liebold Brigitte, 1986, STRUCTURE FUNCTION G, P326; WOOL IG, 1990, RIBOSOME, P203; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	62	393	448	0	51	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 2	2001	107	3					373	386		10.1016/S0092-8674(01)00539-6	http://dx.doi.org/10.1016/S0092-8674(01)00539-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701127	Bronze			2022-12-01	WOS:000172022800008
J	Farooqi, IS; Keogh, JM; Kamath, S; Jones, S; Gibson, WT; Trussell, R; Jebb, SA; Lip, GYH; O'Rahilly, S				Farooqi, IS; Keogh, JM; Kamath, S; Jones, S; Gibson, WT; Trussell, R; Jebb, SA; Lip, GYH; O'Rahilly, S			Metabolism - Partial leptin deficiency and human adiposity	NATURE			English	Article							RECOMBINANT LEPTIN; OBESE		Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; City Hosp, Univ Dept Med, Birmingham B18 7QH, W Midlands, England; MRC Human Nutr Res, Cambridge CB1 9NL, England; Alberta Childrens Prov Gen Hosp, Dept Med Genet, Calgary, AB T2T 5C7, Canada; Alberta Childrens Prov Gen Hosp, Dept Paediat Endocrinol, Calgary, AB T2T 5C7, Canada	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Birmingham; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary	Farooqi, IS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 2QQ, England.	sorahill@hgmp.mrc.ac.uk	Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Gibson, William/0000-0002-6552-402X; Farooqi, Sadaf/0000-0001-7609-3504; Jebb, Susan/0000-0001-9190-2920				Chung WK, 1998, AM J PHYSIOL-REG I, V274, pR985, DOI 10.1152/ajpregu.1998.274.4.R985; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; Havel PJ, 2000, P NUTR SOC, V59, P359, DOI 10.1017/S0029665100000410; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Ravussin E, 1997, NAT MED, V3, P238, DOI 10.1038/nm0297-238; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	9	282	288	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					34	35		10.1038/35102112	http://dx.doi.org/10.1038/35102112			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689931				2022-12-01	WOS:000171898900030
J	Vrijhoef, HJM; Spreeuwenberg, C; Eijkelberg, IMJG; Wolffenbuttel, BHR; van Merode, GG				Vrijhoef, HJM; Spreeuwenberg, C; Eijkelberg, IMJG; Wolffenbuttel, BHR; van Merode, GG			Adoption of disease management model for diabetes in region of Maastricht	BRITISH MEDICAL JOURNAL			English	Article							CARE; TECHNOLOGY; QUALITY		Univ Maastricht, Fac Hlth Sci, Dept Hlth Care Studies, NL-6200 MD Maastricht, Netherlands; Univ Maastricht, Fac Hlth Sci, Dept Hlth Org Policy & Econ, NL-6200 MD Maastricht, Netherlands; Univ Hosp Maastricht, Dept Endocrinol, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Vrijhoef, HJM (corresponding author), Univ Maastricht, Fac Hlth Sci, Dept Hlth Care Studies, POB 616, NL-6200 MD Maastricht, Netherlands.		Wolffenbuttel, Bruce/A-8419-2011; Vrijhoef, Hubertus/AAR-2387-2020	Wolffenbuttel, Bruce/0000-0001-9262-6921; Vrijhoef, Hubertus/0000-0002-5539-4671				Davis RM, 1999, BRIT MED J, V318, P1090, DOI 10.1136/bmj.318.7191.1090; Drummond M, 2000, INT J TECHNOL ASSESS, V16, P1, DOI 10.1017/S0266462300016111; EIJKELBERG I, 2000, HDB TRANSMURALE ZORG, P37; EIJKELBERG IMJ, 2001, INT J INTEGRATED CAR, V1; Eisenberg JM, 1999, JAMA-J AM MED ASSOC, V282, P1865, DOI 10.1001/jama.282.19.1865; Ellrodt G, 1997, JAMA-J AM MED ASSOC, V278, P1687, DOI 10.1001/jama.278.20.1687; Epstein RS, 1996, ANN INTERN MED, V124, P832, DOI 10.7326/0003-4819-124-9-199605010-00008; Grol R, 2000, INT J QUAL HEALTH C, V12, P297, DOI 10.1093/intqhc/12.4.297; Hampson JP, 1996, FAM PRACT, V13, P264, DOI 10.1093/fampra/13.3.264; Hunter DJ, 1997, BRIT MED J, V315, P50, DOI 10.1136/bmj.315.7099.50; Hunter DJ, 2000, BRIT MED J, V320, P530, DOI 10.1136/bmj.320.7234.530; Kesteloot K, 1999, INT J TECHNOL ASSESS, V15, P506, DOI 10.1017/S0266462399015366; Richards T, 1998, BRIT MED J, V317, P426; Vrijhoef HJM, 2000, PATIENT EDUC COUNS, V41, P243, DOI 10.1016/S0738-3991(99)00104-4; VRIJHOEF HJM, IN PRESS J ADV NURS; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Yin R, 1994, CASE STUDY RES DESIG	17	35	36	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					983	985		10.1136/bmj.323.7319.983	http://dx.doi.org/10.1136/bmj.323.7319.983			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	488CU	11679390	Green Published			2022-12-01	WOS:000171918500021
J	Brinker, A; Pfeifer, G; Kerner, MJ; Naylor, DJ; Hartl, FU; Hayer-Hartl, M				Brinker, A; Pfeifer, G; Kerner, MJ; Naylor, DJ; Hartl, FU; Hayer-Hartl, M			Dual function of protein confinement in chaperonin-assisted protein folding	CELL			English	Article							RIBULOSEBISPHOSPHATE CARBOXYLASE; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATPASE CYCLE; IN-VIVO; RHODOSPIRILLUM-RUBRUM; NONNATIVE FORMS; CENTRAL CAVITY; GROEL	The GroEL/GroES chaperonin system mediates the folding of a range of newly synthesized polypeptides in the bacterial cytosol. Using a rapid biotin-streptavidin-based inhibition of chaperonin function, we show that the cage formed by GroEL and its cofactor GroES can have a dual role in promoting folding. First, enclosure of nonnative protein in the GroEL:GroES complex is essential for folding to proceed unimpaired by aggregation. Second, folding inside the cage can be significantly faster than folding in free solution, independently of ATP-driven cycles of GroES binding and release. This suggests that confinement of unfolded protein in the narrow hydrophilic space of the chaperonin cage smoothes the energy landscape for the folding of some proteins, increasing the flux of folding intermediates toward the native state.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742				AGARD DA, 1993, SCIENCE, V260, P1903, DOI 10.1126/science.8100365; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; CORRALES FJ, 1995, P NATL ACAD SCI USA, V92, P5326, DOI 10.1073/pnas.92.12.5326; Corrales FJ, 1996, P NATL ACAD SCI USA, V93, P4509, DOI 10.1073/pnas.93.9.4509; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; COYLE JE, 1997, FOLD DES, V2, P93; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542; ELLIS RJ, 1994, CURR BIOL, V4, P633; ENGEL A, 1995, SCIENCE, V269, P832, DOI 10.1126/science.7638600; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Luo S, 2001, J BIOL CHEM, V276, P7023, DOI 10.1074/jbc.M006838200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MINTON AP, 1992, BIOPHYS J, V63, P1090, DOI 10.1016/S0006-3495(92)81663-6; MURAL RJ, 1990, J BIOL CHEM, V265, P6501; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Richardson A, 1998, TRENDS BIOCHEM SCI, V23, P138, DOI 10.1016/S0968-0004(98)01193-1; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; SCHLOSS JV, 1979, J BACTERIOL, V137, P490, DOI 10.1128/JB.137.1.490-501.1979; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; SOMERVILLE CR, 1984, MOL GEN GENET, V193, P214, DOI 10.1007/BF00330670; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; VANDERVIES SM, 1992, BIOCHEMISTRY-US, V31, P3635, DOI 10.1021/bi00129a012; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Wang JD, 1999, NAT STRUCT BIOL, V6, P597; Weber F, 1998, NAT STRUCT BIOL, V5, P977, DOI 10.1038/2952; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	58	238	241	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					223	233		10.1016/S0092-8674(01)00517-7	http://dx.doi.org/10.1016/S0092-8674(01)00517-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672529	Bronze			2022-12-01	WOS:000171694800011
J	Richter, C; Wunsch, M; Rasheed, M; Kotter, I; Badran, MI				Richter, C; Wunsch, M; Rasheed, M; Kotter, I; Badran, MI			Endoscopic exploration of Red Sea coral reefs reveals dense populations of cavity-dwelling sponges	NATURE			English	Article							PHYTOPLANKTON; ABUNDANCE; DEPLETION; PLANKTON	Framework cavities are the largest but least explored coral reef habitat(1). Previous dive studies of caverns, spaces below plate corals, rubble and artificial cavities(1-3) suggest that cavity-dwelling (coelobite) filter-feeders are important in the trophodynamics of reefs(2,4,5). Quantitative community data are lacking, however, as the bulk of the narrow crevices interlacing the reef framework are inaccessible to conventional analysis methods(6). Here we have developed endoscopic techniques to explore Red Sea framework crevices up to 4 m into the carbonate rock, revealing a large internal surface (2.5-7.4 m(2) per projected m(2) reef) dominated by encrusting filter-feeders. Sponges alone provided up to 60% of coelobite cover, outweighing epi-reefal filter-feeder biomass by two orders of magnitude. Coelobite community filtration removed more than 60% of the phytoplankton in the course of its less than 5-minute passage through the crevices, corresponding to an uptake of roughly 0.9 g carbon m(-2) d(-1). Mineralization of the largely allochthonous organic material is a principal source of nutrients supporting coral and algal growth. The supply of new material by coelobites may provide a key to understanding the 'coral reef paradox'-a rich ecosystem thriving in nutrient-poor water.	Zentrum Marine Trop Okol, D-28359 Bremen, Germany; Univ Jordan, Marine Sci Stn, Aqaba, Jordan; Yarmouk Univ, Aqaba, Jordan; Max Planck Inst Marien Mikrobiol, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; University of Jordan; Yarmouk University; Max Planck Society	Richter, C (corresponding author), Zentrum Marine Trop Okol, Fahrenheitstr 6, D-28359 Bremen, Germany.	crichter@uni-bremen.de	Koetter, Ina/O-3121-2019; Richter, Claudio/AAT-1212-2020	Koetter, Ina/0000-0002-9262-005X; Richter, Claudio/0000-0002-8182-6896; Rasheed, Mohammed/0000-0002-6131-368X				ANDREWS JC, 1983, LIMNOL OCEANOGR, V28, P215, DOI 10.4319/lo.1983.28.2.0215; ATKINSON MJ, 1983, LIMNOL OCEANOGR, V28, P568, DOI 10.4319/lo.1983.28.3.0568; AYUKAI T, 1995, CORAL REEFS, V14, P141, DOI 10.1007/BF00367231; BUSS LW, 1981, J EXP MAR BIOL ECOL, V49, P151, DOI 10.1016/0022-0981(81)90067-8; D'Elia CF, 1988, CONCEPTS ECOSYSTEM E, P195; Darwin C., 1842, STRUCTURE DISTRIBUTI; Ferrier-Pages C, 1998, MICROBIAL ECOL, V35, P46, DOI 10.1007/s002489900059; Gast GJ, 1998, MAR ECOL PROG SER, V167, P37, DOI 10.3354/meps167037; Ginsburg RN, 1983, PERSPECTIVES CORAL R, P148; GLYNN PW, 1973, MAR BIOL, V22, P1, DOI 10.1007/BF00388905; JACKSON JBC, 1971, SCIENCE, V173, P623, DOI 10.1126/science.173.3997.623; JOKIEL PL, 1993, MAR ECOL PROG SER, V93, P175, DOI 10.3354/meps093175; KOBLUK D R, 1988, Palaios, V3, P379, DOI 10.2307/3514784; Mergner H., 1985, P 5 INT COR REEF C, V6, P243; MERGNER H, 1980, P S COAST MAR ENV RE, P39; MEYER JL, 1983, SCIENCE, V220, P1047, DOI 10.1126/science.220.4601.1047; Parsons TR, 1984, MANUAL CHEM BIOL MET; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Richter C, 1999, MAR ECOL PROG SER, V188, P105, DOI 10.3354/meps188105; ROUGERIE F, 1995, OCEANOL ACTA, V18, P61; SHASHAR N, 1994, CORAL REEFS, V13, P171, DOI 10.1007/BF00301195; Sorokin Y. I., 1995, CORAL REEF ECOLOGY; Tribble G.W., 1988, P 6 INT CORAL REEF S, P577; Wulff JL, 1997, MAR BIOL, V129, P41, DOI 10.1007/s002270050144; Wunsch M, 1998, MAR ECOL PROG SER, V169, P277, DOI 10.3354/meps169277; Yahel G, 1998, LIMNOL OCEANOGR, V43, P551, DOI 10.4319/lo.1998.43.4.0551; [No title captured]; [No title captured]	30	159	163	0	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					726	730		10.1038/35099547	http://dx.doi.org/10.1038/35099547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607030				2022-12-01	WOS:000171608000042
J	Singleton, MR; Scaife, S; Wigley, DB				Singleton, MR; Scaife, S; Wigley, DB			Structural analysis of DNA replication fork reversal by RecG	CELL			English	Article							SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; HOLLIDAY JUNCTION; BRANCH MIGRATION; PCRA HELICASE; PROTEIN; RECOMBINATION; MECHANISM; RUVA; TRANSLOCATION	The stalling of DNA replication forks that occurs as a consequence of encountering DNA damage is a critical problem for cells. RecG protein is involved in the processing of stalled replication forks, and acts by reversing the fork past the damage to create a four-way junction that allows template switching and lesion bypass. We have determined the crystal structure of RecG bound to a DNA substrate that mimics a stalled replication fork. The structure not only reveals the elegant mechanism used by the protein to recognize junctions but has also trapped the protein in the initial stage of fork reversal. We propose a mechanism for how forks are processed by RecG to facilitate replication fork restart. In addition, this structure suggests that the mechanism and function of the two largest helicase superfamilies are distinct.	Imperial Canc Res Fund, Clare Hall Labs, Potters Bar EN6 3LD, Herts, England		Wigley, DB (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Blanche Lane, Potters Bar EN6 3LD, Herts, England.	d.wigley@icrf.icnet.uk		Singleton, Martin/0000-0001-5716-7715				Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; ASAI T, 1993, EMBO J, V12, P3287, DOI 10.1002/j.1460-2075.1993.tb05998.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAIRNS J, 1963, J MOL BIOL, V6, P208, DOI 10.1016/S0022-2836(63)80070-4; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DELTITO BJD, 1995, J BACTERIOL, V177, P7086, DOI 10.1128/jb.177.24.7086-7091.1995; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; DUCKETT DR, 1990, EMBO J, V9, P583, DOI 10.1002/j.1460-2075.1990.tb08146.x; Dudas KC, 2001, MOL CELL BIOL, V21, P2706, DOI 10.1128/MCB.21.8.2706-2715.2001; Frei C, 2000, J CELL SCI, V113, P2641; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HONG XK, 1995, EMBO J, V14, P2385, DOI 10.1002/j.1460-2075.1995.tb07233.x; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kornberg A., 1992, DNA REPLICATION; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; Machius M, 1999, P NATL ACAD SCI USA, V96, P11717, DOI 10.1073/pnas.96.21.11717; Mahdi AA, 1997, NUCLEIC ACIDS RES, V25, P3875, DOI 10.1093/nar/25.19.3875; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; MOSIG G, 1987, ANNU REV GENET, V21, P347, DOI 10.1146/annurev.ge.21.120187.002023; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skalka A., 1974, MECH RECOMBINATION, P421, DOI [10.1007/978-1-4684-2133-0_37, DOI 10.1007/978-1-4684-2133-0_37]; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Vincent SD, 1996, J MOL BIOL, V264, P713, DOI 10.1006/jmbi.1996.0671; West SC, 1996, J BACTERIOL, V178, P1237, DOI 10.1128/jb.178.5.1237-1241.1996; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; Yamada K, 2001, P NATL ACAD SCI USA, V98, P1442, DOI 10.1073/pnas.031470598; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658	61	233	246	3	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2001	107	1					79	89		10.1016/S0092-8674(01)00501-3	http://dx.doi.org/10.1016/S0092-8674(01)00501-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595187	Bronze			2022-12-01	WOS:000171453100011
J	Kinghorn, W				Kinghorn, W			Indecision	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University	Kinghorn, W (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	1998	280	17					1538	1538		10.1001/jama.280.17.1538	http://dx.doi.org/10.1001/jama.280.17.1538			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134RR	11645112	hybrid			2022-12-01	WOS:000076757200034
J	BRAHAMS, D				BRAHAMS, D			FRAUD IN DRUG RESEARCH	LANCET			English	Editorial Material																			0	0	0	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 22	1992	340	8817					477	478		10.1016/0140-6736(92)91788-A	http://dx.doi.org/10.1016/0140-6736(92)91788-A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ877	11643085				2022-12-01	WOS:A1992JJ87700018
J	[Anonymous]				[Anonymous]			EUTHANASIA - CONCLUSIONS OF A BMA WORKING PARTY SET UP TO REVIEW THE ASSOCIATIONS GUIDANCE ON EUTHANASIA	BRITISH MEDICAL JOURNAL			English	Editorial Material																		1988, EUTHANASIA REPORT	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1988	296	6633					1376	1377						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	N4544	11652526				2022-12-01	WOS:A1988N454400020
J	Costard, F; Forget, F; Mangold, N; Peulvast, JP				Costard, F; Forget, F; Mangold, N; Peulvast, JP			Formation of recent Martian debris flows by melting of near-surface ground ice at high obliquity	SCIENCE			English	Article							MARS; ATMOSPHERE; BEHAVIOR	The observation of small gullies associated with recent surface runoff on Mars has renewed the question of liquid water stability at the surface of Mars. The gullies could be formed by groundwater seepage from underground aquifers; however, observations of gullies originating from isolated peaks and dune crests question this scenario. We show that these Landforms may result from the melting of water ice in the top few meters of the martian subsurface at high obliquity. Our conclusions are based on the analogy between the martian gullies and terrestrial debris flows observed in Greenland and numerical simulations that show that above-freezing temperatures can occur at high obliquities in the near surface of Mars, and that such temperatures are only predicted at latitudes and for slope orientations corresponding to where the gullies have been observed on Mars.	Univ Paris 06, CNRS, Meteorol Dynam Lab, F-75252 Paris 05, France; Univ Paris 11, CNRS, UMR8616, Equipe Geomorphol Planetaire, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Forget, F (corresponding author), Univ Paris 06, CNRS, Meteorol Dynam Lab, Boite Postal 99, F-75252 Paris 05, France.	forget@lmd.jussieu.fr						ALLEN PA, 1997, EARTH SURFACE PROCES; Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; CARR MH, 1983, ICARUS, V56, P476, DOI 10.1016/0019-1035(83)90168-9; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; Gaidos EJ, 2001, ICARUS, V153, P218, DOI 10.1006/icar.2001.6649; HARRIS SA, 1993, Z GEOMORPHOL, V37, P41; Hartmann WK, 2001, SPACE SCI REV, V96, P405, DOI 10.1023/A:1011969927462; INNES JL, 1983, PROG PHYS GEOG, V7, P469, DOI 10.1177/030913338300700401; Kieffer H., 1992, MARS; Knauth LP, 2000, SCIENCE, V290, P711; Lewis SR, 1999, J GEOPHYS RES-PLANET, V104, P24177, DOI 10.1029/1999JE001024; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MARTIN TZ, 1979, J GEOPHYS RES, V84, P2830, DOI 10.1029/JB084iB06p02830; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; Peulvast J.P., 1988, GEOGR ANN SER B, V70, P351, DOI 10.2307/521268; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; [No title captured]; [No title captured]; [No title captured]; [No title captured]	22	314	320	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					110	113		10.1126/science.1066698	http://dx.doi.org/10.1126/science.1066698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11729267				2022-12-01	WOS:000173143100044
J	McCarter, J; Boge, G; Darlow, G				McCarter, J; Boge, G; Darlow, G			Safeguarding the world's natural treasures	SCIENCE			English	Editorial Material									Field Museum, 1400 Lake Shore Dr, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago)	McCarter, J (corresponding author), Field Museum, 1400 Lake Shore Dr, Chicago, IL 60605 USA.							MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; RAVEN PH, 1992, SCIENCE, V258, P1099, DOI 10.1126/science.258.5085.1099; WILSON E O, 1992	3	10	10	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2001	294	5549					2099	2101		10.1126/science.1067223	http://dx.doi.org/10.1126/science.1067223			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739937				2022-12-01	WOS:000172647700026
J	Koehl, MAR; Koseff, JR; Crimaldi, JP; McCay, MG; Cooper, T; Wiley, MB; Moore, PA				Koehl, MAR; Koseff, JR; Crimaldi, JP; McCay, MG; Cooper, T; Wiley, MB; Moore, PA			Lobster sniffing: Antennule design and hydrodynamic filtering of information in an odor plume	SCIENCE			English	Article							PANULIRUS-ARGUS; FLUID-DYNAMICS; SPINY LOBSTER; APPENDAGES; OLFACTION; INSECTS; FLOW	The first step in processing olfactory information, before neural filtering, is the physical capture of odor molecules from the surrounding fluid. Many animals capture odors from turbulent water currents or wind using antennae that bear chemosensory hairs. We used planar laser-induced fluorescence to reveal how lobster olfactory antennules hydrodynamically alter the spatiotemporal patterns of concentration in turbulent odor plumes. As antennules flick, water penetrates their chemosensory hair array during the fast downstroke, carrying fine-scale patterns of concentration into the receptor area. This spatial pattern, blurred by flow along the antennule during the downstroke, is retained during the slower return stroke and is not shed until the next flick.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Stanford Univ, Dept Civil & Environm Engn, Environm Fluid Mech Lab, Stanford, CA 94305 USA; Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; Bowling Green State Univ, JP Scott Ctr Neurosci Mind & Behav, Bowling Green, OH 43403 USA	University of California System; University of California Berkeley; Stanford University; University System of Ohio; Bowling Green State University; University System of Ohio; Bowling Green State University	Koehl, MAR (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	cnidaria@socrates.berkeley.edu		Koseff, Jeffrey/0000-0003-2121-4844				Atema J, 1996, BIOL BULL, V191, P129, DOI 10.2307/1543074; ATEMA J, 1991, MAR ECOL PROG SER, V74, P303, DOI 10.3354/meps074303; BOSSERT WH, 1963, J THEOR BIOL, V5, P443, DOI 10.1016/0022-5193(63)90089-4; CARDE RT, 1984, CHEM ECOLOGY INSECTS, P109; CHEER AYL, 1987, IMA J MATH APPL MED, V4, P185; CHEER AYL, 1987, J THEOR BIOL, V129, P17, DOI 10.1016/S0022-5193(87)80201-1; Crimaldi JP, 2001, EXP FLUIDS, V31, P90, DOI 10.1007/s003480000263; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GLEESON RA, 1993, CHEM SENSES, V18, P67, DOI 10.1093/chemse/18.1.67; Goldman JA, 2001, CHEM SENSES, V26, P385, DOI 10.1093/chemse/26.4.385; Gomez G, 1996, J EXP BIOL, V199, P1771; GRUNERT U, 1988, CELL TISSUE RES, V251, P95, DOI 10.1007/BF00215452; Koehl M.A.R., 1995, Symposia of the Society for Experimental Biology, V49, P157; Koehl MAR, 1996, MAR FRESHW BEHAV PHY, V27, P127, DOI 10.1080/10236249609378959; Koehl MAR, 2001, IMA V MATH, V124, P97; Loudon C, 2000, J EXP BIOL, V203, P2977; Mead KS, 2000, J EXP BIOL, V203, P3795; MOORE PA, 1991, BIOL BULL, V181, P408, DOI 10.2307/1542361; MOORE PA, 1994, J CHEM ECOL, V20, P255, DOI 10.1007/BF02064435; MOORE PA, 1991, CHEM SENSES, V16, P663, DOI 10.1093/chemse/16.6.663; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Murlis J., 1986, MECH INSECT OLFACTIO, P27; MURRAY JD, 1976, LECT NONLINEAR DIFFE, P83; ORIORDAN CA, 1993, LIMNOL OCEANOGR, V38, P1712, DOI 10.4319/lo.1993.38.8.1712; SCHMITT BC, 1979, SCIENCE, V205, P204, DOI 10.1126/science.205.4402.204; STACEY M, IN PRESS J MATH BIOL; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Weissburg MJ, 2000, BIOL BULL-US, V198, P188, DOI 10.2307/1542523; WESTERBERG J, 1991, P 10 INT S OLF TAST, P45; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, V6, P1; ZIMMERFAUST RK, 1995, BIOL BULL-US, V188, P111, DOI 10.2307/1542075	31	129	133	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2001	294	5548					1948	1951		10.1126/science.1063724	http://dx.doi.org/10.1126/science.1063724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729325				2022-12-01	WOS:000172465000066
J	Leishman, AJ; Naidenko, OV; Attinger, A; Koning, F; Lena, CJ; Xiong, Y; Chang, HC; Reinherz, E; Kronenberg, M; Cheroutre, H				Leishman, AJ; Naidenko, OV; Attinger, A; Koning, F; Lena, CJ; Xiong, Y; Chang, HC; Reinherz, E; Kronenberg, M; Cheroutre, H			T cell responses modulated through interaction between CD8 alpha alpha and the nonclassical MHC class I molecule, TL	SCIENCE			English	Article							THYMUS LEUKEMIA ANTIGEN; LYMPHOCYTES; EXPRESSION; CD8; MOUSE; SELECTION; RECEPTORS; MICE; VIVO	The thymus leukemia antigen (TL) is a nonclassical class I molecule, expressed abundantly on intestinal epithelial cells. We show that, in contrast to other major histocompatibility complex (MHC) class I molecules that bind CD8 alpha beta, TL preferentially binds the homotypic form of CD8 alpha (CD8 alpha alpha). Thus, TL tetramers react specifically to CD8 alpha alpha -expressing cells, including most intestinal intraepithelial lymphocytes. Compared with CD8 alpha beta, which recognizes the same MHC as the T cell, receptor (TCR) and thus acts as a TCR coreceptor, high-affinity binding of CD8 alpha alpha to TL modifies responses mediated by TCR recognition of antigen presented by distinct MHC molecules. These findings define a novel mechanism of lymphocyte regulation through CD8 alpha alpha and MHC class I.	La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA; Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA	La Jolla Institute for Immunology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Dana-Farber Cancer Institute	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.			Koning, Frits/0000-0002-4007-5715	NCI NIH HHS [CA52511] Funding Source: Medline; NIAID NIH HHS [AI 19807, AI50263] Funding Source: Medline; NIDDK NIH HHS [DK54451] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019807, R37AI019807, R56AI019807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK054451, R01DK054451] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; CHEROUTRE H, UNPUB; Chidgey A, 1997, INT IMMUNOL, V9, P1527, DOI 10.1093/intimm/9.10.1527; Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.3.CO;2-O; Cruz D, 1998, J EXP MED, V188, P255, DOI 10.1084/jem.188.2.255; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; FISHER DA, 1985, J EXP MED, V162, P528, DOI 10.1084/jem.162.2.528; Gao GF, 2000, IMMUNOL TODAY, V21, P630, DOI 10.1016/S0167-5699(00)01750-3; HERSHBERG R, 1990, P NATL ACAD SCI USA, V87, P9727, DOI 10.1073/pnas.87.24.9727; HOLCOMBE HR, 1995, J EXP MED, V181, P1433, DOI 10.1084/jem.181.4.1433; HORI T, 1991, INT IMMUNOL, V3, P737, DOI 10.1093/intimm/3.7.737; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; LEISHMAN A, UNPUB; Levelt CN, 1999, P NATL ACAD SCI USA, V96, P5628, DOI 10.1073/pnas.96.10.5628; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; MICELI MC, 1991, P NATL ACAD SCI USA, V88, P2623, DOI 10.1073/pnas.88.7.2623; Mingari MC, 1996, P NATL ACAD SCI USA, V93, P12433, DOI 10.1073/pnas.93.22.12433; MORRISSEY PJ, 1995, J IMMUNOL, V154, P2678; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; TEITELL M, 1994, CRIT REV IMMUNOL, V14, P1; TEITELL M, 1991, J EXP MED, V174, P1131, DOI 10.1084/jem.174.5.1131	23	206	209	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1936	1939		10.1126/science.1063564	http://dx.doi.org/10.1126/science.1063564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729321				2022-12-01	WOS:000172465000062
J	Barford, CC; Wofsy, SC; Goulden, ML; Munger, JW; Pyle, EH; Urbanski, SP; Hutyra, L; Saleska, SR; Fitzjarrald, D; Moore, K				Barford, CC; Wofsy, SC; Goulden, ML; Munger, JW; Pyle, EH; Urbanski, SP; Hutyra, L; Saleska, SR; Fitzjarrald, D; Moore, K			Factors controlling long- and short-term sequestration of atmospheric CO2 in a mid-latitude forest	SCIENCE			English	Article							CARBON BUDGET; TEMPERATE FOREST; DECIDUOUS FOREST; EXCHANGE; BIOMASS; ECOSYSTEMS; SINKS; DEPOSITION; CLIMATE; STORAGE	Net uptake of carbon dioxide (CO2) measured by eddy covariance in a 60- to 80-year-old forest averaged 2.0 +/- 0.4 megagrams of carbon per hectare per year during 1993 to 2000, with interannual variations exceeding 50%. Biometry indicated storage of 1.6 +/- 0.4 megagrams of carbon per hectare per year over 8 years, 60% in Live biomass and the balance in coarse woody debris and soils, confirming eddy-covariance results. Weather and seasonal climate (e.g., variations in growing-season length or cloudiness) regulated seasonal and interannual fluctuations of carbon uptake. Legacies of prior disturbance and management, especially stand age and composition, controlled carbon uptake on the decadal time scale, implying that eastern forests could be managed for Sequestration of carbon.	Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; SUNY Albany, Atmospher Sci Res Ctr, Albany, NY 12203 USA	Harvard University; Harvard University; University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Wofsy, SC (corresponding author), Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.	steven_wofsy@harvard.edu	Saleska, Scott R/K-1733-2016; Munger, J William/H-4502-2013; Fitzjarrald, David/AAV-2289-2020; Noojipady, Praveen/B-2511-2010; Goulden, Michael L/B-9934-2008	Saleska, Scott R/0000-0002-4974-3628; Munger, J William/0000-0002-1042-8452; Goulden, Michael/0000-0002-9379-3948				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; [Anonymous], 2001, CLIMATE CHANGE 2001; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; BIRDSEY RA, 1993, FOREST ECOL MANAG, V58, P33, DOI 10.1016/0378-1127(93)90129-B; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; Foster DR, 1997, BIOSCIENCE, V47, P437, DOI 10.2307/1313059; Gaudinski JB, 2000, BIOGEOCHEMISTRY, V51, P33, DOI 10.1023/A:1006301010014; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Harmon ME, 1996, PUBLICATION US LTER, V20; Holland EA, 1997, J GEOPHYS RES-ATMOS, V102, P15849, DOI 10.1029/96JD03164; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Jenkins JC, 2001, ECOL APPL, V11, P1174, DOI 10.1890/1051-0761(2001)011[1174:BANEFT]2.0.CO;2; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Lee X, 1999, AGR FOREST METEOROL, V97, P65, DOI 10.1016/S0168-1923(99)00048-9; Lee XH, 1999, J GEOPHYS RES-ATMOS, V104, P15975, DOI 10.1029/1999JD900227; McGee GG, 1999, ECOL APPL, V9, P1316, DOI 10.1890/1051-0761(1999)009[1316:SCOOGM]2.0.CO;2; Munger JW, 1998, J GEOPHYS RES-ATMOS, V103, P8355, DOI 10.1029/98JD00168; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Randerson JT, 1999, GEOPHYS RES LETT, V26, P2765, DOI 10.1029/1999GL900500; SAMPSON RN, 1996, FORESTS GLOBAL CHANG, V2; Sander I.L., 1990, AGR HDB, V654; Savage KE, 2001, GLOBAL BIOGEOCHEM CY, V15, P337, DOI 10.1029/1999GB001248; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Schmid HP, 2000, AGR FOREST METEOROL, V103, P357, DOI 10.1016/S0168-1923(00)00140-4; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; TRITTON LM, 1982, NE69 USDA FOR SERV; TURNER DP, 1995, ECOL APPL, V5, P421, DOI 10.2307/1942033; WHITTAKER RH, 1974, ECOL MONOGR, V44, P233, DOI 10.2307/1942313; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314	36	433	473	7	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1688	1691		10.1126/science.1062962	http://dx.doi.org/10.1126/science.1062962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721047	Green Published			2022-12-01	WOS:000172307400035
J	Berman-Frank, I; Lundgren, P; Chen, YB; Kupper, H; Kolber, Z; Bergman, B; Falkowski, P				Berman-Frank, I; Lundgren, P; Chen, YB; Kupper, H; Kolber, Z; Bergman, B; Falkowski, P			Segregation of nitrogen fixation and oxygenic photosynthesis in the marine cyanobacterium Trichodesmium	SCIENCE			English	Article							NONHETEROCYSTOUS CYANOBACTERIUM; CHLOROPHYLL FLUORESCENCE; FIXING MICROORGANISMS; N-2 FIXATION; THIEBAUTII; EXPRESSION; OCEANS; RHYTHM; GENES; CELLS	In the modern ocean, a significant amount of nitrogen fixation is attributed to filamentous, nonheterocystous cyanobacteria of the genus Trichodesmium. In these organisms, nitrogen fixation is confined to the photoperiod and occurs simultaneously with oxygenic photosynthesis. Nitrogenase, the enzyme responsible for biological N-2 fixation, is irreversibly inhibited by oxygen in vitro. How nitrogenase is protected from damage by photosynthetically produced O-2 was once an enigma. Using fast repetition rate fluorometry and fluorescence kinetic microscopy, we show that there is both temporal and spatial segregation of N-2 fixation and photosynthesis within the photoperiod. Linear photosynthetic electron transport protects nitrogenase by reducing photosynthetically evolved O-2 in photosystem I (PSI). We postulate that in the early evolutionary phase of oxygenic photosynthesis, nitrogenase served as an electron acceptor for anaerobic heterotrophic metabolism and that PSI was favored by selection because it provided a micro-anaerobic environment for N-2 fixation in cyanobacteria.	Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Stockholm Univ, Dept Bot, SE-10691 Stockholm, Sweden; Inst Microbiol, Photosynth Res Ctr, CZ-37981 Trebon, Czech Republic; Univ S Bohemia, Lab Biomembranes, CZ-37005 Ceske Budejovice, Czech Republic; Univ Konstanz, Fac Sci, Dept Biol, D-78457 Constance, Germany	Rutgers State University New Brunswick; Stockholm University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Konstanz	Berman-Frank, I (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	irfrank@imcs.rutgers.edu	Küpper, Hendrik/J-5152-2012	Küpper, Hendrik/0000-0003-0712-7023; Berman-Frank, Ilana/0000-0003-3497-1844				Bergman B, 1997, FEMS MICROBIOL REV, V19, P139, DOI 10.1016/S0168-6445(96)00028-9; BERGMAN B, 1993, APPL ENVIRON MICROB, V59, P3239, DOI 10.1128/AEM.59.10.3239-3244.1993; BERGMAN B, 1999, MARINE NITROGEN FIXI, P158; BERMANFRANK L, UNPUB; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARPENTER EJ, 1976, SCIENCE, V191, P1278, DOI 10.1126/science.1257749; CARPENTER EJ, 1995, MAR ECOL PROG SER, V118, P267, DOI 10.3354/meps118267; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; Chen YB, 1999, PLANT MOL BIOL, V41, P89, DOI 10.1023/A:1006231805030; DUGDALE RC, 1961, DEEP-SEA RES, V7, P297, DOI 10.1016/0146-6313(61)90051-X; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; FREDRIKSSON C, 1995, MICROBIOL-UK, V141, P2471, DOI 10.1099/13500872-141-10-2471; Fredriksson C, 1997, PROTOPLASMA, V197, P76, DOI 10.1007/BF01279886; HIRANO M, 1980, Photosynthesis Research, V1, P149, DOI 10.1007/BF00020594; JANSON S, 1994, FEMS MICROBIOL LETT, V118, P9, DOI 10.1111/j.1574-6968.1994.tb06796.x; KANA TM, 1992, NATO ADV SCI I C-MAT, V362, P29; KANA TM, 1993, LIMNOL OCEANOGR, V38, P18, DOI 10.4319/lo.1993.38.1.0018; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kupper H, 2000, PHOTOSYNTHETICA, V38, P553, DOI 10.1023/A:1012461407557; Letelier RM, 1998, AQUAT MICROB ECOL, V15, P265, DOI 10.3354/ame015265; Lin SJ, 1998, APPL ENVIRON MICROB, V64, P3052; Ludden P. W., 1995, Anoxygenic photosynthetic bacteria., P929; LUNDGREN P, UNPUB; MATTHIJS JCP, 1988, BIOCH ALGAE CYANOBAC, P131; PAERL HW, 1994, J PHYCOL, V30, P790, DOI 10.1111/j.0022-3646.1994.00790.x; ROENNEBERG T, 1993, MAR BIOL, V117, P693, DOI 10.1007/BF00349782; SAINO T, 1978, DEEP-SEA RES, V25, P1259, DOI 10.1016/0146-6291(78)90019-X; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI [DOI 10.1007/978-94-011-0227-8_27, 10.1007/0-306-48205-3_27]; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4	35	273	284	8	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1534	1537		10.1126/science.1064082	http://dx.doi.org/10.1126/science.1064082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711677	Green Submitted			2022-12-01	WOS:000172240500051
J	Silphaduang, U; Noga, EJ				Silphaduang, U; Noga, EJ			Antimicrobials - Peptide antibiotics in mast cells of fish	NATURE			English	Article							INNATE		N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27606 USA	University of North Carolina; North Carolina State University	Silphaduang, U (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Clin Sci, 4700 Hillsborough St, Raleigh, NC 27606 USA.							BACCARI GC, 2000, MAST CELLS BASOPHILS, P117; Ganz T, 1997, Curr Opin Hematol, V4, P53; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; HARWIG SSL, 1993, ANAL BIOCHEM, V208, P382, DOI 10.1006/abio.1993.1065; Jia X, 2000, APPL ENVIRON MICROB, V66, P1928, DOI 10.1128/AEM.66.5.1928-1932.2000; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; Malaviya R, 2000, J LEUKOCYTE BIOL, V67, P841, DOI 10.1002/jlb.67.6.841; MCNEIL HP, 1995, SAMTERS IMMUNOLOGIC, V1, P185; Reite OB, 1998, FISH SHELLFISH IMMUN, V8, P489, DOI 10.1006/fsim.1998.0162; Robinette D, 1998, CELL MOL LIFE SCI, V54, P467, DOI 10.1007/s000180050175; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0	13	285	308	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					268	269		10.1038/35104690	http://dx.doi.org/10.1038/35104690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713517				2022-12-01	WOS:000172150700031
J	Tamaru, H; Selker, EU				Tamaru, H; Selker, EU			A histone H3 methyltransferase controls DNA methylation in Neurospora crassa	NATURE			English	Article							POSITION-EFFECT VARIEGATION; INDUCED POINT MUTATION; FISSION YEAST CENTROMERES; DROSOPHILA-MELANOGASTER; CHROMOSOME SEGREGATION; GENE; PROTEIN; DOMAINS; CELLS; HETEROCHROMATIN	DNA methylation is involved in epigenetic processes such as X-chromosome inactivation, imprinting and silencing of transposons. We have demonstrated previously that dim-2 encodes a DNA methyltransferase that is responsible for all known cytosine methylation in Neurospora crassa. Here we report that another Neurospora gene, dim-5, is required for DNA methylation, as well as for normal growth and full fertility. We mapped dim-5 and identified it by transformation with a candidate gene. The mutant has a nonsense mutation in a SET domain of a gene related to histone methyltransferases that are involved in heterochromatin formation in other organisms. Transformation of a wild-type strain with a segment of dim-5 reactivated a silenced hph gene, apparently by 'quelling' of dim-5. We demonstrate that recombinant DIM-5 protein specifically methylates histone H3 and that replacement of lysine 9 in histone H3 with either a leucine or an arginine phenocopies the dim-5 mutation. We conclude that DNA methylation depends on histone methylation.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Selker, EU (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.		Hu, Ruogu/B-2203-2008					ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; Cambareri EB, 1996, GENETICS, V143, P137; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Colot V, 1999, BIOESSAYS, V21, P402, DOI 10.1002/(SICI)1521-1878(199905)21:5<402::AID-BIES7>3.0.CO;2-B; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; FOSS HM, 1993, SCIENCE, V262, P1737, DOI 10.1126/science.7505062; Foss HM, 1998, MOL GEN GENET, V259, P60, DOI 10.1007/s004380050789; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Hennig W, 1999, CHROMOSOMA, V108, P1, DOI 10.1007/s004120050346; Irelan JT, 1997, GENETICS, V146, P509; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Larsson J, 1996, GENETICS, V143, P887; LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Margolin BS, 1998, GENETICS, V149, P1787; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Miao VPW, 2000, J MOL BIOL, V300, P249, DOI 10.1006/jmbi.2000.3864; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; ORBACH MJ, 1986, MOL CELL BIOL, V6, P2452, DOI 10.1128/MCB.6.7.2452; PERKINS DD, 2001, NEUROSPORA COMPENDIU; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Scheid OM, 2000, PLANT MOL BIOL, V43, P235, DOI 10.1023/A:1006487529698; SELKER EU, 1993, SCIENCE, V262, P1724, DOI 10.1126/science.8259516; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; WOUDT LP, 1983, NUCLEIC ACIDS RES, V11, P5347, DOI 10.1093/nar/11.16.5347; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125	50	796	837	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					277	283		10.1038/35104508	http://dx.doi.org/10.1038/35104508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713521				2022-12-01	WOS:000172150700035
J	Kondo, T; Wakayama, T; Naiki, T; Matsumoto, K; Sugimoto, K				Kondo, T; Wakayama, T; Naiki, T; Matsumoto, K; Sugimoto, K			Recruitment of Mec1 and Dcd1 checkpoint proteins to double-strand breaks through distinct mechanisms	SCIENCE			English	Article							DNA-DAMAGE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; BUDDING YEAST; SLIDING CLAMP; COMPLEX; RAD24; RECOMBINATION; ADAPTATION; ARREST	In response to DNA damage, eukaryotic cells activate checkpoint pathways that arrest cell cycle progression and induce the expression of genes required for DNA repair. In budding yeast, the homothallic switching (HO) endonuclease creates a site-specific double-strand break at the mating type (MAT) Locus. Continuous HO expression results in the phosphorylation of Rad53, which is dependent on products of the ataxia telangiectasia mutated-related MEC1 gene and other checkpoint genes, including DDC1, RAD9, and RAD24. Chromatin immunoprecipitation experiments revealed that the Ddc1 protein associates with a region near the MAT locus after HO expression. Ddc1 association required Rad24 but not Mec1 or Rad9. Mec1 also associated with a region near the cleavage site after HO expression, but this association is independent of Ddc1, Rad9, and Rad24. Thus, Mec1 and Ddc1 are recruited independently to sites of DNA damage, suggesting the existence of two separate mechanisms involved in recognition of DNA damage.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4640814, Japan; Japan Sci & Technol Corp, CREST, Nagoya, Aichi 4640814, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Kondo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4640814, Japan.	j46036a@nucc.cc.nagoya-u.ac.jp						Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; Demeter J, 2000, MOL CELL, V6, P487, DOI 10.1016/S1097-2765(00)00047-2; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; Haber JE, 2000, MUTAT RES-FUND MOL M, V451, P53, DOI 10.1016/S0027-5107(00)00040-3; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Kondo T, 1999, MOL CELL BIOL, V19, P1136; KONDO T, UNPUB; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 1998, MOL CELL BIOL, V18, P1891, DOI 10.1128/MCB.18.4.1891; Longhese MP, 1998, EMBO J, V17, P5525, DOI 10.1093/emboj/17.19.5525; Naiki T, 2000, MOL CELL BIOL, V20, P5888, DOI 10.1128/MCB.20.16.5888-5896.2000; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Shimomura T, 1998, MOL CELL BIOL, V18, P5485, DOI 10.1128/MCB.18.9.5485; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	26	219	223	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					867	870		10.1126/science.1063827	http://dx.doi.org/10.1126/science.1063827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679674				2022-12-01	WOS:000171851800051
J	McClelland, M; Sanderson, KE; Spieth, J; Clifton, SW; Latreille, P; Courtney, L; Porwollik, S; Ali, J; Dante, M; Du, FY; Hou, SF; Layman, D; Leonard, S; Nguyen, C; Scott, K; Holmes, A; Grewal, N; Mulvaney, E; Ryan, E; Sun, H; Florea, L; Miller, W; Stoneking, T; Nhan, M; Waterston, R; Wilson, RK				McClelland, M; Sanderson, KE; Spieth, J; Clifton, SW; Latreille, P; Courtney, L; Porwollik, S; Ali, J; Dante, M; Du, FY; Hou, SF; Layman, D; Leonard, S; Nguyen, C; Scott, K; Holmes, A; Grewal, N; Mulvaney, E; Ryan, E; Sun, H; Florea, L; Miller, W; Stoneking, T; Nhan, M; Waterston, R; Wilson, RK			Complete genome sequence of Salmonella enterica serovar typhimurium LT2	NATURE			English	Article							ESCHERICHIA-COLI; FOODBORNE ILLNESS; GENE-TRANSFER; IDENTIFICATION; EPIDEMIOLOGY; MALTOSE; SYSTEM	Salmonella enterica subspecies I, serovar Typhimurium (S. typhimurium), is a leading cause of human gastroenteritis, and is used as a mouse model of human typhoid fever(1). The incidence of non-typhoid salmonellosis is increasing worldwide(2-4), causing millions of infections and many deaths in the human population each year. Here we sequenced the 4,857-kilobase (kb) chromosome and 94-kb virulence plasmid of S. typhimurium strain LT2. The distribution of close homologues of S. typhimurium LT2 genes in eight related enterobacteria was determined using previously completed genomes of three related bacteria, sample sequencing of both S. enterica serovar Paratyphi A (S. paratyphi A) and Klebsiella pneumoniae, and hybridization of three unsequenced genomes to a microarray of S. typhimurium LT2 genes. Lateral transfer of genes is frequent, with 11% of the S. typhimurium LT2 genes missing from S. enterica serovar Typhi (S. typhi), and 29% missing from Escherichia coli K12. The 352 gene homologues of S. typhimurium LT2 confined to subspecies I of S. enterica- containing most mammalian and bird pathogens(5)- are useful for studies of epidemiology, host specificity and pathogenesis. Most of these homologues were previously unknown, and 50 may be exported to the periplasm or outer membrane, rendering them accessible as therapeutic or vaccine targets.	Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA	University of Calgary; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	McClelland, M (corresponding author), Sidney Kimmel Canc Ctr, 10835 Altman Row, San Diego, CA 92121 USA.		Wilson, Richard K./AAF-4139-2019; McClelland, Michael/A-8583-2011	Wilson, Richard K./0000-0002-1992-1358; McClelland, Michael/0000-0003-1788-9347				Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Bermudes D, 2000, ADV EXP MED BIOL, V465, P57; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bumann D, 2000, FEMS IMMUNOL MED MIC, V27, P357, DOI 10.1111/j.1574-695X.2000.tb01450.x; CHALKER RB, 1988, REV INFECT DIS, V10, P111; COOKE EM, 1990, LANCET, V336, P790, DOI 10.1016/0140-6736(90)93251-J; Decker K, 1999, MOL MICROBIOL, V32, P777, DOI 10.1046/j.1365-2958.1999.01395.x; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Florea L, 2000, NUCLEIC ACIDS RES, V28, P3486, DOI 10.1093/nar/28.18.3486; GUPTA SD, 1995, J BACTERIOL, V177, P4207, DOI 10.1128/jb.177.15.4207-4215.1995; Lan RT, 1996, MOL BIOL EVOL, V13, P47, DOI 10.1093/oxfordjournals.molbev.a025569; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; McClelland M, 2000, NUCLEIC ACIDS RES, V28, P4974, DOI 10.1093/nar/28.24.4974; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEIDHARDT FC, 1996, CELLULAR MOL BIOL; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Popoff MY, 2000, RES MICROBIOL, V151, P893, DOI 10.1016/S0923-2508(00)01157-8; Porwollik S, 2001, MUTAT RES-FUND MOL M, V483, P1, DOI 10.1016/S0027-5107(01)00239-1; REIDL J, 1991, J BACTERIOL, V173, P4862, DOI 10.1128/jb.173.15.4862-4876.1991; SELANDER RK, 1996, CELLULAR MOL BIOL, P2691; Stanley TL, 2000, J BACTERIOL, V182, P4406, DOI 10.1128/JB.182.16.4406-4413.2000; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TODD E, 1990, LANCET, V336, P788, DOI 10.1016/0140-6736(90)93250-S; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001	30	1449	3344	7	171	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					852	856		10.1038/35101614	http://dx.doi.org/10.1038/35101614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677609	Bronze			2022-12-01	WOS:000171750200048
J	Parkhill, J; Dougan, G; James, KD; Thomson, NR; Pickard, D; Wain, J; Churcher, C; Mungall, KL; Bentley, SD; Holden, MTG; Sebaihia, M; Baker, S; Basham, D; Brooks, K; Chillingworth, T; Connerton, P; Cronin, A; Davis, P; Davies, RM; Dowd, L; White, N; Farrar, J; Feltwell, T; Hamlin, N; Haque, A; Hien, TT; Holroyd, S; Jagels, K; Krogh, A; Larsen, TS; Leather, S; Moule, S; O'Gaora, P; Parry, C; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG				Parkhill, J; Dougan, G; James, KD; Thomson, NR; Pickard, D; Wain, J; Churcher, C; Mungall, KL; Bentley, SD; Holden, MTG; Sebaihia, M; Baker, S; Basham, D; Brooks, K; Chillingworth, T; Connerton, P; Cronin, A; Davis, P; Davies, RM; Dowd, L; White, N; Farrar, J; Feltwell, T; Hamlin, N; Haque, A; Hien, TT; Holroyd, S; Jagels, K; Krogh, A; Larsen, TS; Leather, S; Moule, S; O'Gaora, P; Parry, C; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG			Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18	NATURE			English	Article							COMPLETE DNA-SEQUENCE; YERSINIA-PESTIS; EPITHELIAL-CELLS; TYPHIMURIUM; IDENTIFICATION; PROTEIN; VIRULENCE; BACTERIA; PLASMID; STRAIN	Salmonella enterica serovar Typhi (S. typhi) is the aetiological agent of typhoid fever, a serious invasive bacterial disease of humans with an annual global burden of approximately 16 million cases, leading to 600,000 fatalities(1). Many S. enterica serovars actively invade the mucosal surface of the intestine but are normally contained in healthy individuals by the local immune defence mechanisms. However, S. typhi has evolved the ability to spread to the deeper tissues of humans, including liver, spleen and bone marrow. Here we have sequenced the 4,809,037-base pair (bp) genome of a S. typhi (CT18) that is resistant to multiple drugs, revealing the presence of hundreds of insertions and deletions compared with the Escherichia coli genome, ranging in size from single genes to large islands. Notably, the genome sequence identifies over two hundred pseudogenes, several corresponding to genes that are known to contribute to virulence in Salmonella typhimurium. This genetic degradation may contribute to the human-restricted host range for S. typhi. CT18 harbours a 218,150-bp multiple-drug-resistance incH1 plasmid (pHCM1), and a 106,516-bp cryptic plasmid (pHCM2), which shows recent common ancestry with a virulence plasmid of Yersinia pestis.	Sanger Ctr, Cambridge CB10 1SA, England; Univ London Imperial Coll Sci Technol & Med, Dept Sci Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; Univ Oxford, Ctr Trop Med, Oxford OX3 9DU, England; Univ Oxford, Wellcome Trust Clin Res Unit, Ctr Trop Dis, Ho Chi Minh City, Vietnam; Tech Univ Denmark, Biocentrum DTU, CTr Biol Sequence Anal, DK-2800 Lyngby, Denmark	Wellcome Trust Sanger Institute; Imperial College London; University of Oxford; University of Oxford; Technical University of Denmark	Parkhill, J (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk; g.dougan@ic.ac.uk	Quail, michael/ABE-6131-2020; O'Gaora, Peadar/F-9400-2011; Haque, Ashraful/H-8697-2014; White, Nicholas J/I-4629-2012; Rutherford, Kim/Y-7995-2018; Wain, John/B-3446-2013; Sebaihia, Mohammed/AAF-6589-2019; White, Nick/AAC-6527-2019; Connerton, Phillippa/K-2479-2019; Parkhill, Julian/G-4703-2011; Farrar, Jeremy J./HGA-7610-2022; Holden, Matthew TG/K-6449-2014; Thomson, Nicholas/P-5988-2014; Krogh, Anders/M-1541-2014	O'Gaora, Peadar/0000-0002-6417-7054; Haque, Ashraful/0000-0003-2260-0026; Rutherford, Kim/0000-0001-6277-726X; Wain, John/0000-0002-1257-1148; Sebaihia, Mohammed/0000-0002-3324-3346; White, Nick/0000-0002-1897-1978; Parkhill, Julian/0000-0002-7069-5958; Holden, Matthew TG/0000-0002-4958-2166; Davies, Robert/0000-0002-9983-1378; Thomson, Nicholas/0000-0002-4432-8505; Davis, Paul/0000-0001-5545-0824; Baker, Stephen/0000-0003-1308-5755; Krogh, Anders/0000-0002-5147-6282; Farrar, Jeremy/0000-0002-2700-623X; Connerton, Phillippa/0000-0002-7686-5700				Bakshi CS, 2000, J BACTERIOL, V182, P2341, DOI 10.1128/JB.182.8.2341-2344.2000; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; HASHIMOTO Y, 1993, J BACTERIOL, V175, P4456, DOI 10.1128/JB.175.14.4456-4465.1993; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; IVANOV V, 1995, ELEMENTA, V2, P1; Jing DH, 1999, J BIOL CHEM, V274, P27287, DOI 10.1074/jbc.274.38.27287; Kingsley RA, 2000, MOL MICROBIOL, V36, P1006, DOI 10.1046/j.1365-2958.2000.01907.x; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Parry C, 1998, LANCET, V351, P1289, DOI 10.1016/S0140-6736(05)79356-9; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sanderson KE, 1998, ELECTROPHORESIS, V19, P569, DOI 10.1002/elps.1150190417; Sherburne CK, 2000, NUCLEIC ACIDS RES, V28, P2177, DOI 10.1093/nar/28.10.2177; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Wong KK, 1998, INFECT IMMUN, V66, P3365, DOI 10.1128/IAI.66.7.3365-3371.1998; Zhang XL, 2000, INFECT IMMUN, V68, P3067, DOI 10.1128/IAI.68.6.3067-3073.2000	30	932	2322	6	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					848	852		10.1038/35101607	http://dx.doi.org/10.1038/35101607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677608	Bronze			2022-12-01	WOS:000171750200047
J	Henson, SM; Costantino, RF; Cushing, JM; Desharnais, RA; Dennis, B; King, AA				Henson, SM; Costantino, RF; Cushing, JM; Desharnais, RA; Dennis, B; King, AA			Lattice effects observed in chaotic dynamics of experimental populations	SCIENCE			English	Article							INSECT POPULATION; CYCLES; MODELS; TRANSITIONS; COMPLEXITY; HABITATS	Animals and many plants are counted in discrete units. The collection of possible values (state space) of population numbers is thus a nonnegative integer lattice. Despite this fact, many mathematical population models assume a continuum of system states. The complex dynamics, such as chaos, often displayed by such continuous-state models have stimulated much ecological research; yet discrete-state models with bounded population size can display only cyclic behavior. Motivated by data from a population experiment, we compared the predictions of discrete-state and continuous-state population models. Neither the discrete- nor continuous-state models completely account for the data. Rather, the observed dynamics are explained by a stochastic blending of the chaotic dynamics predicted by the continuous-state model and the cyclic dynamics predicted by the discrete-state models. We suggest that such lattice effects could be an important component of natural population fluctuations.	Andrews Univ, Dept Math, Berrien Springs, MI 49104 USA; Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; Univ Arizona, Dept Math, Interdisciplinary Program Appl Math, Tucson, AZ 85721 USA; Calif State Univ Los Angeles, Dept Biol & Microbiol, Los Angeles, CA 90032 USA; Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID 83844 USA; Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	Andrews University; University of Rhode Island; University of Arizona; California State University System; California State University Los Angeles; Idaho; University of Idaho; University of California System; University of California Davis	Henson, SM (corresponding author), Andrews Univ, Dept Math, Berrien Springs, MI 49104 USA.	henson@andrews.edu	King, Aaron A/B-8092-2012	King, Aaron A/0000-0001-6159-3207; Cushing, Jim/0000-0003-1844-661X; Desharnais, Robert/0000-0003-2874-6835				BEDDINGTON JR, 1975, NATURE, V255, P58, DOI 10.1038/255058a0; Briggs CJ, 2000, J ANIM ECOL, V69, P352, DOI 10.1046/j.1365-2656.2000.00398.x; Chapman RN, 1928, ECOLOGY, V9, P111, DOI 10.2307/1929348; Costantino R. F., 1991, POPULATION DYNAMICS; COSTANTINO RF, 1995, NATURE, V375, P227, DOI 10.1038/375227a0; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Costantino RF, 1998, B MATH BIOL, V60, P247, DOI 10.1006/bulm.1997.0017; CROMBIE AC, 1946, PROC R SOC SER B-BIO, V133, P76, DOI 10.1098/rspb.1946.0004; Cushing JM, 2001, CHAOS SOLITON FRACT, V12, P219, DOI 10.1016/S0960-0779(00)00109-0; Cushing JM, 1996, ECOL MODEL, V92, P111, DOI 10.1016/0304-3800(95)00170-0; Cushing JM, 1998, J ANIM ECOL, V67, P298, DOI 10.1046/j.1365-2656.1998.00194.x; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Dennis B, 1997, J ANIM ECOL, V66, P704, DOI 10.2307/5923; DENNIS B, 1995, ECOL MONOGR, V65, P261, DOI 10.2307/2937060; Desharnais RA, 1997, SCIENCE, V276, P1881; Desharnais RA, 2001, ECOL LETT, V4, P229, DOI 10.1046/j.1461-0248.2001.00223.x; Hassell MP, 2000, J ANIM ECOL, V69, P543, DOI 10.1046/j.1365-2656.2000.00445.x; HASTINGS A, 1993, ANN REV ECOL SYST, V24; Henson SM, 1998, P ROY SOC B-BIOL SCI, V265, P2229, DOI 10.1098/rspb.1998.0564; Henson SM, 1999, B MATH BIOL, V61, P1121, DOI 10.1006/bulm.1999.0136; JACKSON EA, 1989, PERSPECTIVES NONLINE, V1, P216; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; May RM, 1974, SYST MAN CYBERN, DOI 10.2307/j.ctvs32rq4; MORAN PAP, 1950, BIOMETRICS, V6, P250, DOI 10.2307/3001822; Nicholson AJ, 1933, J ANIM ECOL, V2, P132, DOI 10.2307/954; NICHOLSON AJ, 1935, P ZOOL SOC LOND, V3, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Wilson HB, 1997, P ROY SOC B-BIOL SCI, V264, P1189, DOI 10.1098/rspb.1997.0164	29	67	70	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					602	605		10.1126/science.1063358	http://dx.doi.org/10.1126/science.1063358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641500	Green Submitted			2022-12-01	WOS:000171695600049
J	Chow, TW; MacLean, CH				Chow, TW; MacLean, CH			Quality indicators for dementia in vulnerable community-dwelling and hospitalized elders	ANNALS OF INTERNAL MEDICINE			English	Article							NURSING-HOME PLACEMENT; MENTAL-STATE-EXAMINATION; ALZHEIMERS-DISEASE; CONTROLLED TRIAL; DOUBLE-BLIND; PHYSICAL RESTRAINTS; REVERSIBLE DEMENTIA; COGNITIVE DECLINE; AMERICAN-ACADEMY; SENILE DEMENTIA		Univ So Calif, Rancho Los Amigos Natl Rehabil Ctr, Alzheimers Dis Ctr, Downey, CA 90242 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; RAND Corp, Hlth, Santa Monica, CA 90406 USA	University of Southern California; University of California System; University of California Los Angeles; RAND Corporation	Chow, TW (corresponding author), Univ So Calif, Rancho Los Amigos Natl Rehabil Ctr, Alzheimers Dis Ctr, 7601 E Imperial Highway,800,W Annex, Downey, CA 90242 USA.	tchow@usc.edu						Aevarsson O, 1998, ARCH NEUROL-CHICAGO, V55, P1226, DOI 10.1001/archneur.55.9.1226; ALEXANDER EM, 1995, J AM GERIATR SOC, V43, P138, DOI 10.1111/j.1532-5415.1995.tb06378.x; *AM MED DIR ASS, 1998, CLIN PRACT GIUD 1998; American Psychiatric Association, 1997, PRACT GUID TREATM PA; Bellini M, 1998, ARCH GERONTOL GERIAT, P33; Bowen JD, 1996, NEUROLOGY, V47, P433, DOI 10.1212/WNL.47.2.433; BRADSHAW JR, 1983, BRIT MED J, V286, P277, DOI 10.1136/bmj.286.6361.277; Brodaty H, 1991, Int Psychogeriatr, V3, P11, DOI 10.1017/S1041610291000479; BURDZ MP, 1988, PSYCHOL AGING, V3, P38; BURTON LC, 1992, J AM GERIATR SOC, V40, P811, DOI 10.1111/j.1532-5415.1992.tb01854.x; CAIN ED, 2000, KAPLAN SADOCKS COMPR, P892; CAINE E, 1996, AM J GERIAT PSYCHI S, V4, pS56; Castle NG, 1998, MED CARE RES REV, V55, P139, DOI 10.1177/107755879805500201; CHIVERTON P, 1989, J AM GERIATR SOC, V37, P593, DOI 10.1111/j.1532-5415.1989.tb01248.x; Chow TW, 2000, INT J GERIATR PSYCH, V15, P838, DOI 10.1002/1099-1166(200009)15:9<838::AID-GPS209>3.0.CO;2-U; Chui H, 1997, NEUROLOGY, V49, P925, DOI 10.1212/WNL.49.4.925; CLARFIELD AM, 1988, ANN INTERN MED, V109, P476, DOI 10.7326/0003-4819-109-6-476; COREYBLOOM J, 1995, NEUROLOGY, V45, P211, DOI 10.1212/WNL.45.2.211; COSTA PT, 1996, AHCPR PUBL; COYNE AC, 1995, AM J ALZHEIMER DIS, P27; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; CUMMINGS J, 1983, DEMENTIA CLIN APPROA; DIETCH JT, 1983, WESTERN J MED, V138, P835; DRACHMAN DA, 1993, NEUROLOGY, V43, P2448, DOI 10.1212/WNL.43.12.2448; Draper B, 1998, AGE AGEING, V27, P503, DOI 10.1093/ageing/27.4.503; Dubinsky RM, 2000, NEUROLOGY, V54, P2205, DOI 10.1212/WNL.54.12.2205; Eccles M, 1998, BMJ-BRIT MED J, V317, P802, DOI 10.1136/bmj.317.7161.802; Fillenbaum GG, 1996, AGING-CLIN EXP RES, V8, P379, DOI 10.1007/BF03339599; FRIEDLAND RP, 1988, ANN NEUROL, V24, P782, DOI 10.1002/ana.410240613; GAUTHIER S, 1990, NEW ENGL J MED, V322, P1272, DOI 10.1056/NEJM199005033221804; GRAFSTROM M, 1993, SCAND J SOC MED, V21, P247, DOI 10.1177/140349489302100404; Grasel E, 1997, Int Psychogeriatr, V9, P437; Gurian B, 1997, J GERIATR PSYCHIAT, V30, P211; HALL GR, 1996, RES BASES PROTOCOL A; Hendrie HC, 1998, AM J GERIAT PSYCHIAT, V6, pS3, DOI 10.1097/00019442-199821001-00002; HUNT L, 1993, J AM GERIATR SOC, V41, P747, DOI 10.1111/j.1532-5415.1993.tb07465.x; Innes E M, 1983, QRB Qual Rev Bull, V9, P30; JARVIK LF, 1991, GERIATRICS, V46, P31; Johansson K, 1996, J AM GERIATR SOC, V44, P1198, DOI 10.1111/j.1532-5415.1996.tb01369.x; Kapust L R, 1992, J Geriatr Psychiatry Neurol, V5, P210; Kaufer DI, 1996, J GERIATR PSYCH NEUR, V9, P1, DOI 10.1177/089198879600900101; Keady J, 1995, J Psychiatr Ment Health Nurs, V2, P33, DOI 10.1111/j.1365-2850.1995.tb00163.x; KENT DL, 1994, ANN INTERN MED, V120, P872; KITANO H, 1969, CROSS CULTURAL COUNS, P228; KNIGHT BG, 1993, GERONTOLOGIST, V33, P240, DOI 10.1093/geront/33.2.240; Knopman D, 1996, NEUROLOGY, V47, P166, DOI 10.1212/WNL.47.1.166; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; KOENIG HG, 1989, J AM GERIATR SOC, V37, P599, DOI 10.1111/j.1532-5415.1989.tb01249.x; Kunik ME, 1998, J NERV MENT DIS, V186, P299, DOI 10.1097/00005053-199805000-00006; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; LEDFORD L, 1996, RES BASES PROTOCOL; LIN KM, 1997, DSM IV 4 SOURCE BOOK, V3, P885; MAHLER ME, 1987, WESTERN J MED, V146, P705; MARAE TD, 1999, REICHELS CARE ELDERL, P200; MARTIN DC, 1987, ARCH INTERN MED, V147, P77, DOI 10.1001/archinte.147.1.77; McCurry SM, 1999, INT J GERIATR PSYCH, V14, P882, DOI 10.1002/(SICI)1099-1166(199910)14:10<882::AID-GPS42>3.0.CO;2-D; McHutchion E, 1989, J Gerontol Nurs, V15, P16; MILES SH, 1992, GERONTOLOGIST, V32, P762, DOI 10.1093/geront/32.6.762; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; MOHIDE EA, 1990, J AM GERIATR SOC, V38, P446, DOI 10.1111/j.1532-5415.1990.tb03544.x; MOSCA LJ, 1992, CLIN RES, V40, pA561; Mungas D, 1996, NEUROLOGY, V46, P700, DOI 10.1212/WNL.46.3.700; *OFF GER EXT CAR D, 1989, DEM GUID DIAGN TREAT; OKAGAKI JF, 1994, NEUROLOGY, V44, P2203; Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720; Perryman KM, 1996, J GERIATR PSYCH NEUR, V9, P136, DOI 10.1177/089198879600900306; Rao R, 1997, INT J GERIATR PSYCH, V12, P337, DOI 10.1002/(SICI)1099-1166(199703)12:3<337::AID-GPS498>3.0.CO;2-T; ROCCA WA, 1986, ANN NEUROL, V19, P415, DOI 10.1002/ana.410190502; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Ross GW, 1997, JAMA-J AM MED ASSOC, V277, P800, DOI 10.1001/jama.277.10.800; SCHNELLE JF, 1992, GERONTOLOGIST, V32, P767, DOI 10.1093/geront/32.6.767; SCHULZ B M, 1991, Clinical Gerontologist, V11, P80; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; SMALL G, 1995, COMPREHENSIVE TXB PS, V2, P2562; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.1997.03550160083043; Small GW, 1998, CLIN THER, V20, P838, DOI 10.1016/S0149-2918(98)80145-8; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.1997.03540340047031; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Teunisse S, 1996, J NEUROL, V243, P522, DOI 10.1007/BF00886874; Thal LJ, 1997, NEUROLOGY, V49, P897, DOI 10.1212/WNL.49.3.897-b; THOMPSON P, 1987, BRIT J PSYCHIAT, V151, P206, DOI 10.1192/bjp.151.2.206; *UCLA MED CTR STAN, 1998, INV PHYS RESTR POL 0; *US BUR CENS, 1996, US BUR CENS PUBL; *VET HLTH ADM US D, 1997, DEM ID ASS GUID PRIM, P1; Walstra GJM, 1997, J NEUROL, V244, P17; WEYTINGH MD, 1995, J NEUROL, V242, P466, DOI 10.1007/BF00873551; 1986, JAMA, V256, P2234	88	23	23	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				668	676		10.7326/0003-4819-135-8_Part_2-200110161-00005	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601949				2022-12-01	WOS:000171542400005
J	Pattison, S				Pattison, S			Dealing with uncertainty	BRITISH MEDICAL JOURNAL			English	Editorial Material									Cardiff Univ, Dept Reigious & Theol Studies, Cardiff CF10 3EU, S Glam, Wales	Cardiff University	Pattison, S (corresponding author), Cardiff Univ, Dept Reigious & Theol Studies, Cardiff CF10 3EU, S Glam, Wales.							Oakley Justin, 1992, MORALITY EMOTIONS; Smith M., 1991, COMPANION ETHICS	2	4	4	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2001	323	7317					840	840						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11683153				2022-12-01	WOS:000171650500028
J	Kampe, KKW; Frith, CD; Dolan, RJ; Frith, U				Kampe, KKW; Frith, CD; Dolan, RJ; Frith, U			Reward value of attractiveness and gaze - Making eye contact enhances the appeal of a pleasing face, irrespective of gender.	NATURE			English	Article									UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Kampe, KKW (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	k.kampe@ucl.ac.uk	Frith, Uta/C-1757-2008; Frith, Chris D/A-2171-2009	Frith, Uta/0000-0002-9063-4466; Frith, Chris D/0000-0002-8665-0690; Dolan, Ray/0000-0001-9356-761X				Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1	6	329	335	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					589	589		10.1038/35098149	http://dx.doi.org/10.1038/35098149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480WE	11595937	Green Published, Bronze			2022-12-01	WOS:000171485700037
J	Heldin, CH; Ericsson, J				Heldin, CH; Ericsson, J			Signal transduction - RIPping tyrosine kinase receptors apart	SCIENCE			English	Editorial Material							INTRAMEMBRANE PROTEOLYSIS		Ludwig Inst Canc Res, Ctr Biomed, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research	Heldin, CH (corresponding author), Ludwig Inst Canc Res, Ctr Biomed, Box 595, SE-75124 Uppsala, Sweden.		Ericsson, Johan/AAA-6664-2020	Ericsson, Johan/0000-0003-1186-6574				Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065	8	30	31	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2111	+		10.1126/science.1067628	http://dx.doi.org/10.1126/science.1067628			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11739942				2022-12-01	WOS:000172647700034
J	Zheng, B; Ma, YC; Ostrom, RS; Lavoie, C; Gill, GN; Insel, PA; Huang, XY; Farquhar, MG				Zheng, B; Ma, YC; Ostrom, RS; Lavoie, C; Gill, GN; Insel, PA; Huang, XY; Farquhar, MG			RGS-PX1, a GAP for G alpha(s) and sorting nexin in vesicular trafficking	SCIENCE			English	Article							GTPASE-ACTIVATING PROTEINS; ALPHA-SUBUNITS; RECEPTOR; IDENTIFICATION; HYDROLYSIS; KINASE; FAMILY; RGS4; BETA	Heterotrimeric GTP-binding proteins (G proteins) control cellular functions by transducing signals from the outside to the inside of cells. Regulator of G protein signaling (RGS) proteins are key modulators of the amplitude and duration of G protein-mediated signaling through their ability to serve as guanosine triphosphatase-activating proteins (GAPS). We have identified RGS-PX1, a G alpha (s)-specific GAP. The RGS domain of RGS-PX1 specifically interacted with G alpha (s) accelerated its GTP hydrolysis, and attenuated G alpha (s)-mediated signaling. RGS-PX1 also contains a Phox (PX) domain that resembles those in sorting nexin (SNX) proteins. Expression of RGS-PX1 delayed Lysosomal degradation of the EGF receptor. Because of its bifunctional role as both a GAP and a SNX, RGS-PX1 may link heterotrimeric G protein signaling and vesicular trafficking.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University	Farquhar, MG (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.			Ma, Yongchao/0000-0002-2469-4356; Ostrom, Rennolds/0000-0002-7204-0357; Zheng, Bin/0000-0002-0998-7177	NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063885, P50HL053773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017780, R37DK017780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014563] Funding Source: NIH RePORTER; NCI NIH HHS [CA58689] Funding Source: Medline; NHLBI NIH HHS [HL63885, HL53773] Funding Source: Medline; NIA NIH HHS [AG14563] Funding Source: Medline; NIDDK NIH HHS [DK17780] Funding Source: Medline; NIGMS NIH HHS [GM56904] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.biochem.56.1.615; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; HELMS JB, 1995, FEBS LETT, V369, P84, DOI 10.1016/0014-5793(95)00620-O; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; OSTROM RS, 2001, J BIOL CHEM; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999; Zheng B, 2000, P NATL ACAD SCI USA, V97, P3999, DOI 10.1073/pnas.97.8.3999	19	186	190	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1939	1942		10.1126/science.1064757	http://dx.doi.org/10.1126/science.1064757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729322				2022-12-01	WOS:000172465000063
J	Pearson, H				Pearson, H			China caught out as model shows net fall in fish	NATURE			English	News Item																			0	1	1	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					477	477		10.1038/35107216	http://dx.doi.org/10.1038/35107216			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734811	Bronze			2022-12-01	WOS:000172405900008
J	Wildermuth, MC; Dewdney, J; Wu, G; Ausubel, FM				Wildermuth, MC; Dewdney, J; Wu, G; Ausubel, FM			Isochorismate synthase is required to synthesize salicylic acid for plant defence	NATURE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; GENE-EXPRESSION; TRANSCRIPTION FACTORS; DISEASE RESISTANCE; ARABIDOPSIS; TOBACCO; BIOSYNTHESIS; INDUCTION; MUTANT; PROTEIN	Salicylic acid (SA) mediates plant defences against pathogens, accumulating in both infected and distal leaves in response to pathogen attack(1-5). Pathogenesis-related gene expression and the synthesis of defensive compounds associated with both local and systemic acquired resistance (LAR and SAR) in plants require SA. In Arabidopsis, exogenous application of SA suffices to establish SAR, resulting in enhanced resistance to a variety of pathogens. However, despite its importance in plant defence against pathogens, SA biosynthesis is not well defined. Previous work has suggested that plants synthesize SA from phenylalanine(6-10); however, SA could still be produced when this pathway was inhibited(6,8), and the specirc activity of radiolabelled SA in feeding experiments was often lower than expected(7,8). Some bacteria such as Pseudomonas aeruginosa synthesize SA using isochorismate synthase (ICS) and pyruvate lyase(11). Here we show, by cloning and characterizing an Arabidopsis defence-related gene (SID2) defined by mutation, that SA is synthesized from chorismate by means of ICS, and that SA made by this pathway is required for LAR and SAR responses.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Brandeis Univ, Michtom Sch Comp Sci, Waltham, MA 02254 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Brandeis University; Harvard University; Harvard Medical School	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.							Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Coquoz JL, 1998, PLANT PHYSIOL, V117, P1095, DOI 10.1104/pp.117.3.1095; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; Dorey S, 1997, MOL PLANT MICROBE IN, V10, P646, DOI 10.1094/MPMI.1997.10.5.646; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; LEON J, 1995, P NATL ACAD SCI USA, V92, P10413, DOI 10.1073/pnas.92.22.10413; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; Reuber TL, 1998, PLANT J, V16, P473, DOI 10.1046/j.1365-313x.1998.00319.x; Ribnicky DM, 1998, PLANT PHYSIOL, V118, P565, DOI 10.1104/pp.118.2.565; Ryals J, 1997, PLANT CELL, V9, P425, DOI 10.1105/tpc.9.3.425; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; UKNES S, 1993, MOL PLANT MICROBE IN, V6, P692, DOI 10.1094/MPMI-6-692; van Tegelen LJP, 1999, PLANT PHYSIOL, V119, P705, DOI 10.1104/pp.119.2.705; YALPANI N, 1993, PLANT PHYSIOL, V103, P315, DOI 10.1104/pp.103.2.315; Yang YO, 1996, P NATL ACAD SCI USA, V93, P14972, DOI 10.1073/pnas.93.25.14972	30	1506	1584	7	253	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					562	565		10.1038/35107108	http://dx.doi.org/10.1038/35107108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734859				2022-12-01	WOS:000172405900052
J	Satcher, D				Satcher, D			Global HIV/AIDS revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2001	286	20					2535	2535		10.1001/jama.286.20.2535	http://dx.doi.org/10.1001/jama.286.20.2535			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FH	11722254				2022-12-01	WOS:000172385200009
J	Dervyn, E; Suski, C; Daniel, R; Bruand, C; Chapuis, J; Errington, J; Janniere, L; Ehrlich, SD				Dervyn, E; Suski, C; Daniel, R; Bruand, C; Chapuis, J; Errington, J; Janniere, L; Ehrlich, SD			Two essential DNA polymerases at the bacterial replication fork	SCIENCE			English	Article							BACILLUS-SUBTILIS; SACCHAROMYCES-CEREVISIAE; EPSILON; PAM-BETA-1; INITIATION; GENE	DNA replication in bacteria is carried out by a multiprotein complex, which is thought to contain only one essential DNA polymerase, specified by the dhaE gene in Escherichia coli and the polC gene in Bacillus subtilis. Bacillus subtilis genome analysis has revealed another DNA polymerase gene, dnaE(BS), which is homologous to dnaE. We show that, in B. subtilis, dnaE(BS) is essential for cell viability and for the elongation step of DNA replication, as is polC, and we conclude that there are two different essential DNA polymerases at the replication fork of B. subtilis, as was previously observed in eukaryotes. dnaE(BS) appears to be involved in the synthesis of the tagging DNA strand and to be associated with the replication factory, which suggests that two different polymerases carry out synthesis of the two DNA strands in B. subtilis and in many other bacteria that contain both polC and dnaE genes.	INRA, F-78352 Jouy En Josas, France; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Ehrlich, SD (corresponding author), INRA, F-78352 Jouy En Josas, France.	ehrlich@jouy.mra.fr	Bruand, Claude/AAF-7695-2020; Errington, Jeff/G-1832-2011; Ehrlich, S./Y-2423-2019	Errington, Jeff/0000-0002-6977-9388; Ehrlich, S./0000-0002-7563-4046; Bruand, Claude/0000-0002-2367-0782; Janniere, Laurent/0000-0003-2353-3160; Suski Grabowski, Catherine/0000-0002-4892-6633				ARAKI H, 1992, EMBO J, V11, P733, DOI 10.1002/j.1460-2075.1992.tb05106.x; BAZILL GW, 1973, NATURE-NEW BIOL, V243, P241, DOI 10.1038/newbio243241a0; Bidnenko V, 1998, MOL MICROBIOL, V28, P1005, DOI 10.1046/j.1365-2958.1998.00862.x; BOE L, 1989, J BACTERIOL, V171, P3366, DOI 10.1128/jb.171.6.3366-3372.1989; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; BRUAND C, 1991, EMBO J, V10, P2171, DOI 10.1002/j.1460-2075.1991.tb07752.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; BRUAND C, UNPUB; Bruck I, 2000, J BIOL CHEM, V275, P28971, DOI 10.1074/jbc.M003565200; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; DALENCON E, UNPUB; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; GANESAN AT, 1988, GENETICS BIOTECHNOLO, V2, P317; Goodman MF, 2000, TRENDS BIOCHEM SCI, V25, P189, DOI 10.1016/S0968-0004(00)01564-4; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; Karthikeyan R, 2000, J MOL BIOL, V299, P405, DOI 10.1006/jmbi.2000.3744; Kornberg A., 1992, DNA REPLICATION; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LeChatelier E, 1996, MOL MICROBIOL, V20, P1099; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Moriya S, 1999, PLASMID, V41, P17, DOI 10.1006/plas.1998.1381; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; YASBIN RE, 1980, GENE, V12, P155, DOI 10.1016/0378-1119(80)90026-8; Yasbin Ronald E., 1993, P529; YOSHIKAWA H, 1963, P NATL ACAD SCI USA, V49, P559, DOI 10.1073/pnas.49.4.559	29	117	122	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1716	1719		10.1126/science.1066351	http://dx.doi.org/10.1126/science.1066351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721055				2022-12-01	WOS:000172307400044
J	Valleron, AJ; Boelle, PY; Will, R; Cesbron, JY				Valleron, AJ; Boelle, PY; Will, R; Cesbron, JY			Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; GREAT-BRITAIN; BSE; VARIANT; CJD	The size of the variant Creutzfeldt-Jakob Disease (vCJD) epidemic in the United Kingdom is a major public health concern and a subject of speculation. The cases are young (mean age = 28). Assuming that the risk of developing the disease in susceptible exposed subjects decreases exponentially with age after age 15, that all infections occurred between 1980 and 1989, and that the distribution of the incubation period is lognormal, we estimate that the mean duration of the incubation period is 16.7 years [95% confidence interval (CI): 12.4 to 23.2] and that the total number of cases will be 205 (upper limit of the 95% CI: 403).	Univ Paris 06, CHU St Antoine, INSERM, U444, 27 Rue Chaligny, F-75012 Paris, France; Assistance Publ Hop Paris, F-75012 Paris, France; Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Grenoble 1, UFR Med Grenoble, Immun Antiinfect JE 2236, F-38706 La Tronche, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Edinburgh; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Valleron, AJ (corresponding author), Univ Paris 06, CHU St Antoine, INSERM, U444, 27 Rue Chaligny, F-75012 Paris, France.							ANDERSON R M, 1991; BRILLINGER DR, 1986, BIOMETRICS, V42, P693, DOI 10.2307/2530689; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CHEVRET S, 1992, J EPIDEMIOL COMMUN H, V46, P582, DOI 10.1136/jech.46.6.582; Cohen CH, 1999, INT J EPIDEMIOL, V28, P526, DOI 10.1093/ije/28.3.526; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; d'Aignaux JH, 1999, NEUROLOGY, V53, P1197, DOI 10.1212/WNL.53.6.1197; *EUR UN SCI STEER, 1999, OP SCI STEER COMM HU; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; KLITZMAN R, 1984, NEUROEPIDEMIOLOGY, V3, P20; SARTWELL PE, 1950, AM J HYG, V51, P310, DOI 10.1093/oxfordjournals.aje.a119397	12	157	162	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1726	1728		10.1126/science.1066838	http://dx.doi.org/10.1126/science.1066838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721058				2022-12-01	WOS:000172307400047
J	Cicero, S; Curcio, P; Papageorghiou, A; Sonek, J; Nicolaides, K				Cicero, S; Curcio, P; Papageorghiou, A; Sonek, J; Nicolaides, K			Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study	LANCET			English	Article							FETAL NUCHAL TRANSLUCENCY; DOWNS-SYNDROME; PREGNANCY; SKIN	Background Prenatal diagnosis of trisomy 21 requires an invasive test in women regarded as being at high risk after screening. At present there are four screening tests, and for a 5% false-positive rate, the sensitivities are about 30% for maternal age alone, 60-70% for maternal age and second-trimester maternal serum biochemical testing, 75% for maternal age and first-trimester fetal nuchal translucency scanning, and 85% for maternal age with fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks. In this study, we examined the possible improvement in screening for trisomy 21 by examining the fetal nasal bone with ultrasound at 11-14 weeks of gestation. Methods We did an ultrasound examination of the fetal profile in 701 fetuses at 11-14 weeks' gestation immediately before karyotyping for a possible chromosomal abnormality detected by maternal age and fetal nuchal translucency screening. The presence or absence of a nasal bone was noted. Findings The fetal profile was successfully examined In all cases. The nasal bone was absent in 43 of 59 (73%) trisomy 21 fetuses and in three of 603 (0.5%) chromosomally normal fetuses. The likelihood ratio for trisomy 21 was 146 (95% CI 50-434) for absent nasal bone and 0.27 (0.18-0.40) for present nasal bone. In screening for trisomy 21, by a combination of maternal age and fetal nuchal translucency, we estimated that inclusion of examination of the fetal profile for the presence or absence of nasal bone could increase the sensitivity to 85% and decrease the false-positive rate to about 1%. Interpretation In screening for trisomy 21, examination of the fetal nasal bone could result In major reduction in the need for invasive testing and a substantial increase in sensitivity.	Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr Fetal Med, London SE5 8RX, England; Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University System of Ohio; Ohio State University	Nicolaides, K (corresponding author), Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr Fetal Med, Denmark Hill, London SE5 8RX, England.	fmf@fetalmedicine.com		Nicolaides, Kypros/0000-0003-1266-0711; Papageorghiou, Aris T./0000-0001-8143-2232				Bohlandt S, 2000, HUM REPROD, V15, P1155, DOI 10.1093/humrep/15.5.1155; CUCKLE H, 1991, PRENATAL DIAG, V11, P29, DOI 10.1002/pd.1970110106; Cuckle H, 2001, CURR OPIN OBSTET GYN, V13, P175, DOI 10.1097/00001703-200104000-00013; de Graaf IM, 1999, PRENATAL DIAG, V19, P458, DOI 10.1002/(SICI)1097-0223(199905)19:5<458::AID-PD569>3.0.CO;2-A; Dick PT, 1996, CAN MED ASSOC J, V154, P465; Down John Langdon, 1866, CLIN LECT REPORTS LO, V3, P259; Moss M.L., 1962, VISTAS ORTHODONTICS; NICOLAIDES KH, 1992, BRIT MED J, V304, P867, DOI 10.1136/bmj.304.6831.867; Nicolaides KH, 1998, PRENATAL DIAG, V18, P519, DOI 10.1002/(SICI)1097-0223(199805)18:5<519::AID-PD398>3.0.CO;2-U; SANDIKCIOGLU M, 1994, J CRAN GENET DEV BIO, V14, P124; SNIDJERS RMJ, 1998, LANCET, V351, P343; Spencer K, 1999, ULTRASOUND OBST GYN, V13, P231, DOI 10.1046/j.1469-0705.1999.13040231.x; von Kaisenberg CS, 1998, ANAT EMBRYOL, V197, P105, DOI 10.1007/s004290050123; Von Kaisenberg CS, 1998, OBSTET GYNECOL, V91, P319, DOI 10.1016/S0029-7844(97)00697-2; WALD NJ, 1992, BMJ-BRIT MED J, V305, P391, DOI 10.1136/bmj.305.6850.391	15	339	367	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2001	358	9294					1665	1667		10.1016/S0140-6736(01)06709-5	http://dx.doi.org/10.1016/S0140-6736(01)06709-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495MC	11728540				2022-12-01	WOS:000172344100008
J	Yang, ZY; Zhu, QW; Luo, KX; Zhou, Q				Yang, ZY; Zhu, QW; Luo, KX; Zhou, Q			The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; P-TEFB; TERMINAL DOMAIN; POLYMERASE-II; HIV-1 TAT; ELONGATION; ACTIVATION; PROMOTER; PHOSPHORYLATION; MECHANISM	The human positive transcription elongation factor P-TEFb, consisting of a CDK9/cyclin T1 heterodimer, functions as both a general and an HIV-1 Tat-specific transcription factor(1,2). P-TEFb activates transcription by phosphorylating RNA polymerase (Pol) II, leading to the formation of processive elongation complexes. As a Tat cofactor, P-TEFb stimulates HIV-1 transcription by interacting with Tat and the transactivating responsive (TAR) RNA structure located at the 5' end of the nascent viral transcript(3). Here we identified 7SK, an abundant and evolutionarily conserved small nuclear RNA (snRNA) of unknown function(4,5), as a specific P-TEFb-associated factor. 7SK inhibits general and HIV-1 Tat-specific transcriptional activities of P-TEFb in vivo and in vitro by inhibiting the kinase activity of CDK9 and preventing recruitment of P-TEFb to the HIV-1 promoter. 7SK is efficiently dissociated from P-TEFb by treatment of cells with ultraviolet irradiation and actinomycin D. As these two agents have been shown to significantly enhance HIV-1 transcription and phosphorylation of Pol II (refs 6-8), our data provide a mechanistic explanation for their stimulatory effects. The 7SK/P-TEFb interaction may serve as a principal control point for the induction of cellular and HIV-1 viral gene expression during stress-related responses. Our studies demonstrate the involvement of an snRNA in controlling the activity of a Cdk-cyclin kinase.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhou, Q (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		Yang, Zhiyuan/C-9543-2012	Yang, Zhiyuan/0000-0002-1175-4188				BLACK CC, 1985, WEEK PHYSL, V2, P1; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Kretz-Remy C, 1994, FEBS Lett, V353, P339; Kumar S, 1996, J BIOL CHEM, V271, P30864, DOI 10.1074/jbc.271.48.30451; Lis JT, 2000, GENE DEV, V14, P792; Luo Y, 1997, J CELL BIOCHEM, V64, P313, DOI 10.1002/(SICI)1097-4644(199702)64:2<313::AID-JCB13>3.0.CO;2-J; MURPHY S, 1984, J MOL BIOL, V177, P575, DOI 10.1016/0022-2836(84)90038-X; Peter M, 1997, Prog Cell Cycle Res, V3, P99; Ping YH, 1999, J BIOL CHEM, V274, P7399, DOI 10.1074/jbc.274.11.7399; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; VALERIE K, 1988, NATURE, V333, P78, DOI 10.1038/333078a0; VLACH J, 1995, VIROLOGY, V208, P753, DOI 10.1006/viro.1995.1207; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x; ZIEVE G, 1977, BIOCHEMISTRY-US, V16, P4520, DOI 10.1021/bi00639a029; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1	24	527	549	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2001	414	6861					317	322		10.1038/35104575	http://dx.doi.org/10.1038/35104575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492CM	11713532				2022-12-01	WOS:000172150700046
J	Weggen, S; Eriksen, JL; Das, P; Sagi, SA; Wang, R; Pietrzik, CU; Findlay, KA; Smith, TE; Murphy, MP; Butler, T; Kang, DE; Marquez-Sterling, N; Golde, TE; Koo, EH				Weggen, S; Eriksen, JL; Das, P; Sagi, SA; Wang, R; Pietrzik, CU; Findlay, KA; Smith, TE; Murphy, MP; Butler, T; Kang, DE; Marquez-Sterling, N; Golde, TE; Koo, EH			A subset of NSAIDs lower amyloidogenic A beta 42 independently of cyclooxygenase activity	NATURE			English	Article							ALZHEIMERS-DISEASE; BETA-PROTEIN; PRECURSOR PROTEIN; INFLAMMATION; PRESENILIN-1; INHIBITION; PATHWAY; DOMAIN; BRAIN	Epidemiological studies have documented a reduced prevalence of Alzheimer's disease among users of nonsteroidal anti-inflammatory drugs (NSAIDs)(1-5). It has been proposed that NSAIDs exert their beneficial effects in part by reducing neurotoxic inflammatory responses in the brain, although this mechanism has not been proved. Here we report that the NSAIDs ibuprofen, indomethacin and sulindac sulphide preferentially decrease the highly amyloidogenic A beta 42 peptide (the 42-residue isoform of the amyloid-beta peptide) produced from a variety of cultured cells by as much as 80%. This effect was not seen in all NSAIDs and seems not to be mediated by inhibition of cyclooxygenase (COX) activity, the principal pharmacological target of NSAIDs(6). Furthermore, short-term administration of ibuprofen to mice that produce mutant beta -amyloid precursor protein (APP) lowered their brain levels of A beta 42. In cultured cells, the decrease in A beta 42 secretion was accompanied by an increase in the A beta (1-38) isoform, indicating that NSAIDs subtly alter gamma -secretase activity without significantly perturbing other APP processing pathways or Notch cleavage. Our findings suggest that NSAIDs directly affect amyloid pathology in the brain by reducing A beta 42 peptide levels independently of COX activity and that this A beta 42-lowering activity could be optimized to selectively target the pathogenic A beta 42 species.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Mayo Clin Jacksonville, Dept Neurosci & Pharmacol, Jacksonville, FL 32224 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA	University of California System; University of California San Diego; Mayo Clinic; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; California Institute of Technology; Northwestern University	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.		Kang, David E./E-5234-2012; Wang, Rong/A-8721-2009; Eriksen, Jason/A-8054-2008	Eriksen, Jason/0000-0003-1549-4165; Bulter, Thomas/0000-0002-7968-5844; Kang, David E./0000-0002-7132-821X				ABDELHALIM MS, 1978, ACTA PHARMACOL TOX, V43, P266; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Hadland BK, 2001, P NATL ACAD SCI USA, V98, P7487, DOI 10.1073/pnas.131202798; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; MCEVOY GK, 1998, AHFS DRUG INFORMATIO; McGeer PL, 2000, DRUG AGING, V17, P1, DOI 10.2165/00002512-200017010-00001; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Piazza GA, 1997, CANCER RES, V57, P2452; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1; Yuan H, 1999, J NEUROSCI METH, V88, P45, DOI 10.1016/S0165-0270(99)00011-4; Zhang XP, 1999, J EXP MED, V190, P451, DOI 10.1084/jem.190.4.451	30	1177	1298	1	62	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					212	216		10.1038/35102591	http://dx.doi.org/10.1038/35102591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700559				2022-12-01	WOS:000172029100049
J	Schwetz, BA				Schwetz, BA			Pacemaker for congestive heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2085	2085		10.1001/jama.286.17.2085	http://dx.doi.org/10.1001/jama.286.17.2085			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694130				2022-12-01	WOS:000172032100008
J	Zhang, ZL; Brennan, ML; Fu, XM; Aviles, RJ; Pearce, GL; Penn, MS; Topol, EJ; Sprecher, DL; Hazen, SL				Zhang, ZL; Brennan, ML; Fu, XM; Aviles, RJ; Pearce, GL; Penn, MS; Topol, EJ; Sprecher, DL; Hazen, SL			Association between myeloperoxidase levels and risk of coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DENSITY-LIPOPROTEIN; HUMAN ATHEROSCLEROTIC INTIMA; MASS-SPECTROMETRIC QUANTIFICATION; SCAVENGER RECEPTOR CD36; NITRIC-OXIDE; P-HYDROXYPHENYLACETALDEHYDE; LIPID-PEROXIDATION; IN-VITRO; OXIDATION; LDL	Context Myeloperoxidase (MPO), a leukocyte enzyme that promotes oxidation of lipoproteins in atheroma, has been proposed as a possible mediator of atherosclerosis. Objective To determine the association between MPO levels and prevalence of coronary artery disease (CAD). Design, Setting, and Patients Case-control study conducted from July to September 2000 in a US tertiary care referral center, including 158 patients with established CAD (cases) and 175 patients without angiographically significant CAD (controls). Main Outcome Measures Association of MPO levels per milligram of neutrophil protein (leukocyte-MPO) and MPO levels per milliliter of blood (blood-MPO) with CAD risk. Results Leukocyte- and blood-MPO levels were both significantly greater in patients with CAD than in controls (P<.001). In multivariable models adjusting for traditional cardiovascular risk factors, Framingham risk score, and white blood cell counts, MPO levels were significantly associated with presence of CAD, with an OR of 11.9 (95% CI, 5.5-25.5) for the highest vs lowest quartiles of leukocyte-MPO and an OR of 20.4 (95% CI, 8.9-47.2) for the highest vs lowest quartiles of blood-MPO. Conclusions Elevated levels of leukocyte- and blood-MPO are associated with the presence of CAD. These findings support a potential role for MPO as an inflammatory marker in CAD and may have implications for atherosclerosis diagnosis and risk assessment.	Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Sect Prevent Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin Fdn, Dept Cell Biol, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.		Hazen, Stanley L/ABD-5845-2021	Topol, Eric/0000-0002-1478-4729	NHLBI NIH HHS [HL62526, HL61878] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062526, R01HL061878] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Abu-Soud Husam M., 2000, Nitric Oxide, V4, P179; AKIYAMA Y, 1983, J CLIN INVEST, V72, P1093, DOI 10.1172/JCI111034; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Biasucci LM, 1996, J AM COLL CARDIOL, V27, P611, DOI 10.1016/0735-1097(95)00524-2; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Capeillere-Blandin C, 1998, BIOCHEM J, V336, P395, DOI 10.1042/bj3360395; Carr AC, 2000, FEBS LETT, V487, P176, DOI 10.1016/S0014-5793(00)02227-4; Chisolm GM, 2000, FREE RADICAL BIO MED, V28, P1815, DOI 10.1016/S0891-5849(00)00344-0; Chisolm GM, 1999, J BIOL CHEM, V274, P25959, DOI 10.1074/jbc.274.37.25959; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; ERNST E, 1987, JAMA-J AM MED ASSOC, V257, P2318, DOI 10.1001/jama.257.17.2318; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; Hazen SL, 1999, CIRC RES, V85, P950; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hazen SL, 1996, J BIOL CHEM, V271, P1861, DOI 10.1074/jbc.271.4.1861; Hazen SL, 2000, BIOCHEM J, V352, P693, DOI 10.1042/0264-6021:3520693; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Heinecke JW, 1999, FASEB J, V13, P1113, DOI 10.1096/fasebj.13.10.1113; Heller JI, 2000, J BIOL CHEM, V275, P9957, DOI 10.1074/jbc.275.14.9957; KLEBANOFF SJ, 1984, METHOD ENZYMOL, V105, P399; Kullo IJ, 2000, MAYO CLIN PROC, V75, P369, DOI 10.4065/75.4.369; Kutter D, 2000, ACTA HAEMATOL-BASEL, V104, P10, DOI 10.1159/000041062; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520; Malech HL, 1997, SEMIN HEMATOL, V34, P279; MALLE E, 1995, ARTERIOSCL THROM VAS, V15, P982, DOI 10.1161/01.ATV.15.7.982; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; NAUSEEF WM, 1988, HEMATOL ONCOL CLIN N, V2, P135; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; OWEN CA, 1994, AM J PHYSIOL-LUNG C, V267, pL775, DOI 10.1152/ajplung.1994.267.6.L775; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; PEPPIN GJ, 1986, P NATL ACAD SCI USA, V83, P4322, DOI 10.1073/pnas.83.12.4322; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; SAVENKOVA MI, 1994, J BIOL CHEM, V269, P20394; Schmitt D, 1999, BIOCHEMISTRY-US, V38, P16904, DOI 10.1021/bi991623w; Shabani F, 1998, FREE RADICAL RES, V28, P115, DOI 10.3109/10715769809065797; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Taylor AJ, 2000, CIRCULATION, V101, P1243, DOI 10.1161/01.CIR.101.11.1243; Yang CY, 1999, J LIPID RES, V40, P686	50	698	761	1	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2136	2142		10.1001/jama.286.17.2136	http://dx.doi.org/10.1001/jama.286.17.2136			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694155	Bronze			2022-12-01	WOS:000172032100033
J	Brock, J; Sauaia, T; Ahnen, D; Marine, W; Schluter, W; Stevens, BR; Scinto, JD; Karp, H; Bratzler, D				Brock, J; Sauaia, T; Ahnen, D; Marine, W; Schluter, W; Stevens, BR; Scinto, JD; Karp, H; Bratzler, D			Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease - Results from a quality improvement project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERIOUS GASTROINTESTINAL COMPLICATIONS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HELICOBACTER-PYLORI; DUODENAL-ULCER; DOUBLE-BLIND; ERADICATION; RANITIDINE; RECURRENCE; ARTHRITIS; RISK	Context Since publication in 1994 of guidelines for management of peptic ulcer disease (PUD), trends in physician practice and outcomes related to guideline application have not been evaluated. Objectives To describe changes in process of care that occurred in a quality improvement program for patients hospitalized with PUD and to evaluate associations between in-hospital treatment of PUD and 1-year rehospitalization for PUD and mortality in a subset of these patients. Design, Setting, and Patients Cohort study of 4292 sequential Medicare beneficiaries hospitalized at acute care hospitals with a principal diagnosis of PUD in 5 states (Colorado, Georgia, Connecticut, Oklahoma, and Virginia) in 1995 (baseline) and 1997 (remeasurement); outcomes were evaluated for 752 patients in Colorado. Main Outcome Measures Changes in rates of screening for Helicobacter pylori infection, treatment for H pylori infection, screening for nonsteroidal anti-inflammatory drug (NSAID) use, counseling about NSAID use; outcomes included rehospitalization for PUD and all-cause mortality within 1 year of discharge in Colorado. Results Screening for H pylori infection increased significantly (12%-19% increase; P<.001) in each of the 5 states. Treatment of H pylori infection increased in each state and was significantly increased for the entire group of hospitalizations examined (8% increase overalls P=.001). Despite increased screening, detection of H pylori infection was less frequent than expected in every state, (13%-24%) and did not increase in any state. Screening for and counseling about NSAIDs did not significantly increase overall or in any state. In the Colorado cohort, the proportion of patients rehospitalized was unchanged in 1995 (8.9%) and 1997 (6.8%), and 124 patients (16%) in the combined 1995 and 1997 cohorts died within 1 year, Treatment for H pylori was not associated with a reduction in rehospitalization within 1 year (adjusted odds ratio [OR], 1.24; 95% confidence interval [CI], 0.65-2.36) or with a reduction in mortality (adjusted OR, 1.08; 95% Cl, 0.68-1.71). Counseling about NSAID use was associated with a decrease in risk of 1-year rehospitalization for PUD (adjusted OR, 0.47; 95% CI, 0.22-0.99) and risk of all-cause mortality (adjusted OR, 0.44; 95% CI, 0.26-0.75). Conclusions This quality improvement program for elderly patients with PUD resulted in increased screening for H pylori and increased treatment of H pylori Infection but no change in counseling about NSAID use. However, with the low prevalence of H pylori detected, treatment of H pylori infection was not associated with a reduction in repeat hospitalization for PUD or subsequent mortality, whereas counseling about the risks of using NSAIDs was associated with a reduction in the risk of both outcomes.	Colorado Fdn Med Care, Aurora, CO 80014 USA; Univ Colorado, Sch Med, Dept Prevent Med, Denver, CO USA; Denver Vet Adm Hosp, Dept Gastroenterol, Denver, CO USA; Qualidigm, Middletown, CT USA; Univ Connecticut, Ctr Hlth, Sch Med, Farmington, CT USA; Georgia Med Care Fdn, Atlanta, GA USA; Oklahoma Fdn Med Qual, Oklahoma City, OK USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Connecticut	Brock, J (corresponding author), Colorado Fdn Med Care, 2851 S Parker Rd,Suite 1000, Aurora, CO 80014 USA.	jbrockp@yahoo.com			PHS HHS [5D33HP10030-03] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; BROWN DM, 1994, PUBLICATION NIH, P55; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COGHLAN JG, 1987, LANCET, V2, P1109; DAVIES J, 1986, BRIT J RHEUMATOL, V25, P54; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DICKER RC, 1998, QUALITY CARE SURVEIL; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1653, DOI 10.1016/0016-5085(91)90665-8; GRAHAM DY, 1992, ANN INTERN MED, V116, P705, DOI 10.7326/0003-4819-116-9-705; GRAHAM DY, 1993, SCAND J GASTROENTERO, V28, P939, DOI 10.3109/00365529309098288; GREENE JM, 1992, ARCH INTERN MED, V152, P1995, DOI 10.1001/archinte.152.10.1995; Haddix A, 1996, PREVENTION EFFECTIVE; HENTSCHEL E, 1993, NEW ENGL J MED, V328, P308, DOI 10.1056/NEJM199302043280503; HOSKING SW, 1992, GASTROENTEROLOGY, V102, P85; HOSMER DW, 1989, APPL LOGISTIC REGRES, P86; JASPERSEN D, 1995, GASTROINTEST ENDOSC, V41, P5, DOI 10.1016/S0016-5107(95)70267-9; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; JENSEN D M, 1992, Gastroenterology, V102, pA90; LABENZ J, 1994, DIGESTION, V55, P19, DOI 10.1159/000201117; LAINE L, 1998, SLEISENGER FORDTRANS, P205; LANAS AI, 1995, GASTROENTEROLOGY, V109, P1124, DOI 10.1016/0016-5085(95)90570-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LOEB DS, 1992, GASTROENTEROLOGY, V102, P1899, DOI 10.1016/0016-5085(92)90311-L; Malfertheiner P, 1997, GUT, V41, P8; MARSHALL BJ, 1988, LANCET, V2, P1437; Ofman JJ, 2000, AM J GASTROENTEROL, V95, P106; PAULUS HE, 1998, ARTHRITIS RHEUM, V31, P1450; *PEER REV ORG QUAL, 2001, PILL QUAL; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; ROKKAS T, 1995, GASTROINTEST ENDOSC, V41, P1, DOI 10.1016/S0016-5107(95)70266-0; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Smith WR, 2000, CHEST, V118, p8S, DOI 10.1378/chest.118.2_suppl.8S; Soll AH, 1996, JAMA-J AM MED ASSOC, V275, P622; Sonnenberg A, 1996, AM J PUBLIC HEALTH, V86, P200, DOI 10.2105/AJPH.86.2.200; SONNENBERG A, 1994, PUBLICATION NIH, P359; *US DEP HHS, 1988, INT CLASS DIS 9 REV; WILSON MC, 1995, JAMA-J AM MED ASSOC, V274, P1630, DOI 10.1001/jama.274.20.1630; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104; 2000, MEDICARE PROVIDER AN	42	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					1985	+		10.1001/jama.286.16.1985	http://dx.doi.org/10.1001/jama.286.16.1985			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667935				2022-12-01	WOS:000171750500022
J	Norman, RJ				Norman, RJ			Reproductive consequences of COX-2 inhibition	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INFERTILITY		Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia	University of Adelaide	Norman, RJ (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia.		Norman, Robert J/A-1155-2007	Norman, Robert J/0000-0002-3118-3896				Akil M, 1996, BRIT J RHEUMATOL, V35, P76; BRANNSTROM M, 1993, HUM REPROD, V8, P1762; DeWitt DL, 1999, MOL PHARMACOL, V55, P625; Duffy DM, 2001, MOL HUM REPROD, V7, P731, DOI 10.1093/molehr/7.8.731; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; JANSSENCASPERS HAB, 1986, FERTIL STERIL, V46, P823; Joyce IM, 2001, ENDOCRINOLOGY, V142, P3187, DOI 10.1210/en.142.7.3187; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Matsumoto H, 2001, BIOL REPROD, V64, P1557, DOI 10.1095/biolreprod64.5.1557; Mendonca LLF, 2000, RHEUMATOLOGY, V39, P880, DOI 10.1093/rheumatology/39.8.880; Pall M, 2001, HUM REPROD, V16, P1323, DOI 10.1093/humrep/16.7.1323; Reese J, 2000, P NATL ACAD SCI USA, V97, P9759, DOI 10.1073/pnas.97.17.9759; Smith G, 1996, BRIT J RHEUMATOL, V35, P458; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97	15	20	23	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 20	2001	358	9290					1287	1288		10.1016/S0140-6736(01)06455-8	http://dx.doi.org/10.1016/S0140-6736(01)06455-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684206				2022-12-01	WOS:000171702500005
J	Alexopoulou, L; Holt, AC; Medzhitov, R; Flavell, RA				Alexopoulou, L; Holt, AC; Medzhitov, R; Flavell, RA			Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; SIGNALING PATHWAYS; ADAPTER PROTEIN; CPG-DNA; MICE; PKR; FAMILY; CELLS; TLR4; ENDOTOXIN	Toll-like receptors (TLRs) are a family of innate immune-recognition receptors that recognize molecular patterns associated with microbial pathogens, and induce antimicrobial immune responses(1,2). Double-stranded RNA (dsRNA) is a molecular pattern associated with viral infection, because it is produced by most viruses at some point during their replication(3). Here we show that mammalian TLR3 recognizes dsRNA, and that activation of the receptor induces the activation of NF-kappaB and the production of type I interferons (IFNs). TLR3-deficient (TLR3(-/-)) mice showed reduced responses to polyinosine-polycytidylic acid (poly(I:C)), resistance to the lethal effect of poly(I:C) when sensitized with D-galactosamine (D-GalN), and reduced production of inflammatory cytokines. MyD88 is an adaptor protein that is shared by all the known TLRs(1). When activated by poly(I:C), TLR3 induces cytokine production through a signalling pathway dependent on MyD88. Moreover, poly(I:C) can induce activation of NF-kappaB and mitogen-activated protein (MAP) kinases independently of MyD88, and cause dendritic cells to mature.	Immunobiol Sect, New Haven, CT 06520 USA; Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Immunobiol Sect, New Haven, CT 06520 USA.		Alexopoulou, Lena/A-5041-2017	Alexopoulou, Lena/0000-0003-4619-697X				Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KIMURA M, 1994, AM J PHYSIOL-REG I, V267, pR1596, DOI 10.1152/ajpregu.1994.267.6.R1596; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	29	4612	4959	10	447	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					732	738		10.1038/35099560	http://dx.doi.org/10.1038/35099560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607032				2022-12-01	WOS:000171608000044
J	Kleijn, D; Berendse, F; Smit, R; Gilissen, N				Kleijn, D; Berendse, F; Smit, R; Gilissen, N			Agri-environment schemes do not effectively protect biodiversity in Dutch agricultural landscapes	NATURE			English	Article							CONSERVATION; GRASSLAND; DIVERSITY; ABUNDANCE; FARMLAND; EUROPE; POLICY; AREAS	Roughly 20% of the European Union's farmland is under some form of agri-environment scheme to counteract the negative impacts of modern agriculture on the environment 1. The associated costs represent about 4% (1.7 billion euros) of the European Union's total expenditure on the Common Agricultural Policy and are expected to rise to 10% in the near future(2). Although agri-environment schemes have been implemented in various countries for well over a decade, to date no reliable, sufficiently replicated studies have been performed to test whether such measures have the presumed positive effects on biodiversity(1,3,4). Here we present the results of a study evaluating the contribution of agri-environment schemes to the protection of biodiversity in intensively used Dutch agricultural landscapes. We surveyed plants, birds, hover flies and bees on 78 paired fields that either had agri-environment schemes in the form of management agreements or were managed conventionally. Management agreements were not effective in protecting the species richness of the investigated species groups: no positive effects on plant and bird species diversity were found. The four most common wader species were observed even less frequently on fields with management agreements. By contrast, hover flies and bees showed modest increases in species richness on fields with management agreements. Our results indicate that there is a pressing need for a scientifically sound evaluation of agri-environment schemes.	Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, NL-6708 PD Wageningen, Netherlands	Wageningen University & Research	Kleijn, D (corresponding author), Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, Bornsesteeg 69, NL-6708 PD Wageningen, Netherlands.	David.Kleijn@staf.ton.wau.nl	Kleijn, David/HCH-3477-2022	Kleijn, David/0000-0003-2500-7164				Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; BANASZAK J, 1983, Polish Ecological Studies, V9, P421; BEINTEMA AJ, 1987, J APPL ECOL, V24, P743, DOI 10.2307/2403978; Beintema Albert J., 1997, P269; Berendse F., 1993, LANDSCAPE ECOLOGY ST, P104, DOI [10. 1007/978-94-011-2318-1, DOI 10.1007/978-94-011-2318-1]; Bignal EM, 1998, J APPL ECOL, V35, P949, DOI 10.1111/j.1365-2664.1998.tb00013.x; Branquart E, 2000, ECOGRAPHY, V23, P732, DOI 10.1034/j.1600-0587.2000.230610.x; Chamberlain DE, 1999, J APPL ECOL, V36, P856, DOI 10.1046/j.1365-2664.1999.00453.x; *COMM STAT DEP, 1993, GENST 5 REL 3 REF MA; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; European Commission, 1997, AG 2000, VI; Evans Andy, 1997, P331; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Henderson IG, 2000, ECOGRAPHY, V23, P50, DOI 10.1034/j.1600-0587.2000.230106.x; Kokko H, 2001, EVOL ECOL RES, V3, P537; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Milsom TP, 1998, BIOL CONSERV, V84, P119, DOI 10.1016/S0006-3207(97)00111-0; Ovenden GN, 1998, J APPL ECOL, V35, P955, DOI 10.1111/j.1365-2664.1998.tb00014.x; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Schekkerman Hans, 2000, Limosa, V73, P121; STANDEN V, 1984, J APPL ECOL, V21, P293, DOI 10.2307/2403055; VANDIJK AJ, 1996, SURVEYING BREEDING B	23	467	493	3	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					723	725		10.1038/35099540	http://dx.doi.org/10.1038/35099540			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607029				2022-12-01	WOS:000171608000041
J	Ramsey, SD; Clarke, L; Etzioni, R; Higashi, M; Berry, K; Urban, N				Ramsey, SD; Clarke, L; Etzioni, R; Higashi, M; Berry, K; Urban, N			Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Article							INSTITUTE WORKSHOP; FAMILIES; COLON; PREDISPOSITION; RISK; SUSCEPTIBILITY; SURVEILLANCE; COLONOSCOPY; MANAGEMENT; CARCINOMA	Background: The National Cancer Institute has published consensus guidelines for universal screening for hereditary nonpolyposis colorectal cancer (HNPCC) in patients with newly diagnosed colorectal cancer. Objective: To determine the cost-effectiveness of screening compared with standard care in eligible patients with colorectal cancer and their siblings and children. Design: Cost-effectiveness analysis. Data Sources: National colorectal cancer registry data, the Creighton International Hereditary Colorectal Cancer Registry, Medicare claims records, and published literature. Target Population: Patients with newly diagnosed colorectal cancer and their siblings and children. Time Horizon: Lifetime (varies depending on age at screening). Perspective: societal. Interventions: initial office-based screening to determine eligibility (based on personal and family cancer history), followed by tumor testing for microsatellite instability, Those with microsatellite instability were offered genetic testing for HNPCC. Siblings and children of patients with cancer and the HNPCC mutation were offered genetic testing, and those who were found to carry the mutation received lifelong colorectal cancer screening. Measurements: Life-years gained. Results of Base-Case Analysis: When only the patients with cancer were considered, cost-effectiveness of screening was $42 210 per life-year gained. When patients with cancer and their siblings and children were considered together, cost-effectiveness increased to $7556 per life-year gained. Results of Sensitivity Analysis: The model was most sensitive to the estimated survival gain from screening siblings and children, to the prevalence of HNPCC mutations among patients with newly diagnosed cancer, and to the discount rate. In probabilistic analysis, the 90% CI for the cost-effectiveness of screening patients with cancer plus their relatives was $4874 to $21 576 per life-year gained. Conclusion: Screening patients with newly diagnosed colorectal cancer for HNPCC is cost-effective, especially if the benefits to their immediate relatives are considered.				sramsey@fhcrc.org			NATIONAL CANCER INSTITUTE [U01CA074794] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA074794] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1994, CANCER DETECT PREV, V18, P57; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; American Cancer Society, 1999, CANC FACTS FIG 1999; Benson AB, 2000, J CLIN ONCOL, V18, P3586, DOI 10.1200/JCO.2000.18.20.3586; Bernhardt B A, 1998, J Genet Couns, V7, P317, DOI 10.1023/A:1022067916528; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; Boland CR, 1998, CANCER RES, V58, P5248; BOLAND CR, 1998, GENETIC BASIS HUMAN; BROWN ML, 1995, J NATL CANCER I, V87, P1131, DOI 10.1093/jnci/87.15.1131; Bubb VJ, 1996, ONCOGENE, V12, P2641; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; CORAN AG, 1990, ANN SURG, V212, P242, DOI 10.1097/00000658-199009000-00002; CROYLE RT, 1993, PREV MED, V22, P284, DOI 10.1006/pmed.1993.1023; Deftos L J, 1998, Spec Law Dig Health Care Law, P9; deLeon MP, 1996, TUMORI, V82, P102, DOI 10.1177/030089169608200202; Etzioni R, 1996, J CLIN EPIDEMIOL, V49, P95, DOI 10.1016/0895-4356(96)89259-6; Freyer G, 1999, ANN ONCOL, V10, P87, DOI 10.1023/A:1008349318728; GOLD MR, 1996, COST EFFECTIVENESS H, P214; Gonzalez-Garcia I, 2000, JNCI-J NATL CANCER I, V92, P544, DOI 10.1093/jnci/92.7.544; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; *HLTH CAR FIN ADM, 2001, MED PROV AN REV MEDP; HOULSTON RS, 1992, ANN HUM GENET, V56, P99, DOI 10.1111/j.1469-1809.1992.tb01136.x; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; JENTSCHURA D, 1994, SURG ENDOSC, V8, P472; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Kinney AY, 2000, AM J PREV MED, V18, P249, DOI 10.1016/S0749-3797(99)00162-2; KOLATA G, 1998, NY TIMES        0327; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; Lerman C, 1999, JAMA-J AM MED ASSOC, V281, P1618, DOI 10.1001/jama.281.17.1618; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LO AY, 1994, J AM COLL SURGEONS, V179, P333; LOTHE RA, 1993, CANCER RES, V53, P5849; Lynch HT, 1999, CANCER, V86, P2449, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2449::AID-CNCR1>3.0.CO;2-M; Lynch HT, 1999, SEMIN ONCOL, V26, P478; MACRAE FA, 1983, GUT, V24, P376, DOI 10.1136/gut.24.5.376; Marta M R, 1999, J Healthc Risk Manag, V19, P26; Myrhoj T, 1997, SCAND J GASTROENTERO, V32, P572, DOI 10.3109/00365529709025102; Nakahara M, 1997, CANCER EPIDEM BIOMAR, V6, P1057; *NAT CANC I DIV CA, 2000, SURV EP END RES SEER; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Olick R S, 2000, N J Med, V97, P43; PEDERSEN T, 1990, ACTA ANAESTH SCAND, V34, P176, DOI 10.1111/j.1399-6576.1990.tb03066.x; Peltomaki P, 1999, ADV EXP MED BIOL, V470, P95; Percesepe A, 1997, INT J CANCER, V71, P373, DOI 10.1002/(SICI)1097-0215(19970502)71:3<373::AID-IJC12>3.0.CO;2-H; POTOSKY AL, 1993, MED CARE, V31, P732; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; ROUFFET F, 1994, DIS COLON RECTUM, V37, P651, DOI 10.1007/BF02054407; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; STELZNER M, 1989, SURG GYNECOL OBSTET, V169, P187; STEVENSON G, 1989, COLON CANC DIAGNOSIS; SUTER SM, 1993, MICH LAW REV, V91, P1854, DOI 10.2307/1289655; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; *US C OFF TECHN AS, 1992, GEN TESTS HLTH INS R; *US CENS BUR, 2000, STAT ABSTR US 1999; *US CENS BUR, 2000, STAT ABSTR US; VASEN HF, 1993, DIS COLON RECTUM, V36, P1, DOI 10.1007/BF02050292; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; 2000, FERTILITY AM WOMEN	60	99	100	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	1				577	588		10.7326/0003-4819-135-8_Part_1-200110160-00008	http://dx.doi.org/10.7326/0003-4819-135-8_Part_1-200110160-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481VY	11601929				2022-12-01	WOS:000171542200003
J	Wiechert, U; Halliday, AN; Lee, DC; Snyder, GA; Taylor, LA; Rumble, D				Wiechert, U; Halliday, AN; Lee, DC; Snyder, GA; Taylor, LA; Rumble, D			Oxygen isotopes and the moon-forming giant impact	SCIENCE			English	Article							ORIGIN; RATIOS; EARTH; GAS	We have determined the abundances of O-16, O-17, and O-18 in 31 lunar samples from Apollo missions 11, 12, 15, 16, and 17 using a high-precision laser fluorination technique. All oxygen isotope compositions plot within +/-0.016 per mit (2 standard deviations) on a single mass-dependent fractionation line that is identical to the terrestrial fractionation tine within uncertainties. This observation is consistent with the Giant Impact model, provided that the proto-Earth and the smaller impactor planet (named Theia) formed from an identical mix of components. The similarity between the proto-Earth and Theia is consistent with formation at about the same heliocentric distance. The three oxygen isotopes (Delta O-17) provide no evidence that isotopic heterogeneity on the Moon was created by lunar impacts.	ETH Zentrum, Dept Earth Sci, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland; Univ Tennessee, Dept Geol Sci, Planetary Geosci Inst, Knoxville, TN 37996 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Tennessee System; University of Tennessee Knoxville; Carnegie Institution for Science	Wiechert, U (corresponding author), ETH Zentrum, Dept Earth Sci, Inst Isotope Geol & Mineral Resources, Sonneggstr 5, CH-8092 Zurich, Switzerland.	wiechert@erdw.ethz.ch	Rumble, Douglas/AAU-3930-2020; Lee, Der-Chuen/N-9225-2013	Rumble, Douglas/0000-0002-7440-9189; Lee, Der-Chuen/0000-0001-8855-9594				BENZ W, COMMUNICATION; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; Cameron AGW, 2001, METEORIT PLANET SCI, V36, P9, DOI 10.1111/j.1945-5100.2001.tb01806.x; CAMERON AGW, 1998, LUNAR PLANET SCI, V29, P1062; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CLAYTON RN, 1977, EARTH PLANET SC LETT, V34, P209, DOI 10.1016/0012-821X(77)90005-X; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.ea.21.050193.000555; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; CLAYTON RN, 1984, P LUNAR PLANET SCI C, V15, pC245; CLAYTON RN, 1975, P LUNAR PLANET SCI C, V11, P1761; Eiler JM, 2000, NATURE, V403, P530, DOI 10.1038/35000553; Franchi IA, 1999, METEORIT PLANET SCI, V34, P657, DOI 10.1111/j.1945-5100.1999.tb01371.x; Halliday AN, 2000, EARTH PLANET SC LETT, V176, P17, DOI 10.1016/S0012-821X(99)00317-9; HALLIDAY AN, IN PRESS EARTH PLANE; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; Newton J, 2000, METEORIT PLANET SCI, V35, P689, DOI 10.1111/j.1945-5100.2000.tb01452.x; Rumble D, 1997, GEOCHIM COSMOCHIM AC, V61, P4229, DOI 10.1016/S0016-7037(97)00232-9; SHARP ZD, 1990, GEOCHIM COSMOCHIM AC, V54, P1353, DOI 10.1016/0016-7037(90)90160-M; Valley JW, 1995, GEOCHIM COSMOCHIM AC, V59, P5223, DOI 10.1016/0016-7037(95)00386-X; WETHERILL GW, 1994, GEOCHIM COSMOCHIM AC, V58, P4513, DOI 10.1016/0016-7037(94)90352-2; Yi W, 2000, J GEOPHYS RES-SOL EA, V105, P18927, DOI 10.1029/2000JB900152; Young ED, 1999, SCIENCE, V286, P1331, DOI 10.1126/science.286.5443.1331	23	265	268	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					345	348		10.1126/science.1063037	http://dx.doi.org/10.1126/science.1063037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598294				2022-12-01	WOS:000171601400035
J	Gumienny, TL; Brugnera, E; Tosello-Trampont, AC; Kinchen, JM; Haney, LB; Nishiwaki, K; Walk, SF; Nemergut, ME; Macara, IG; Francis, R; Schedl, T; Qin, Y; Van Aelst, L; Hengartner, MO; Ravichandran, KS				Gumienny, TL; Brugnera, E; Tosello-Trampont, AC; Kinchen, JM; Haney, LB; Nishiwaki, K; Walk, SF; Nemergut, ME; Macara, IG; Francis, R; Schedl, T; Qin, Y; Van Aelst, L; Hengartner, MO; Ravichandran, KS			CED-12/ELMO, a novel member of the crkII/dock180/rac pathway, is required for phagocytosis and cell migration	CELL			English	Article							CORPSE ENGULFMENT; BINDING PROTEIN; MYOBLAST CITY; RHO GTPASES; NEMATODE; ENCODES; GENES; DEATH; MECHANISMS; EXPRESSION	The C. elegans genes ced-2, ced-5, and ced-10, and their mammalian homologs crkII, dock180, and rac1, mediate cytoskeletal rearrangements during phagocytosis of apoptotic cells and cell motility. Here, we describe an additional member of this signaling pathway, ced-12, and its mammalian homologs, elmo1 and elmo2. In C. elegans, CED-12 is required for engulfment of dying cells and for cell migrations. In mammalian cells, ELMO1 functionally cooperates with CrkII and Dock180 to promote phagocytosis and cell shape changes. CED-12/ELMO-1 binds directly to CED-5/ Dock180; this evolutionarily conserved complex stimulates a Rac-GEF, leading to Rac1 activation and cytoskeletal rearrangements. These studies identify CED-12/ELMO as an upstream regulator of Rac1 that affects engulfment and cell migration from C. elegans to mammals.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11743 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Japan Sci & Technol Corp, PRESTO, Tsukuba, Ibaraki 3058501, Japan; NEC Corp Ltd, Fundamental Res Labs, Tsukuba, Ibaraki 3058501, Japan; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Virginia; University of Virginia; Japan Science & Technology Agency (JST); NEC Corporation; University of Virginia; Washington University (WUSTL)	Hengartner, MO (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11743 USA.	michael.hengartner@molbio.unizh.ch; ravi@virginia.edu	Gumienny, Tina/AAJ-5273-2020; Hengartner, Michael O/A-7058-2008; Hengartner, Michael O/E-6235-2011; Kinchen, Jason/ABC-5663-2021	Gumienny, Tina/0000-0002-3932-7815; Kinchen, Jason/0000-0001-8430-2265; Nemergut, Michael/0000-0002-6803-1765; Hengartner, Michael/0000-0002-7584-596X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052540, R01GM063310] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63310, R01 GM063310, GM52540] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; ELLIS RE, 1991, GENETICS, V129, P79; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Hengartner MO, 1999, RECENT PROG HORM RES, V54, P213; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; HODGKIN J, 1988, NEMATODE CAENORHABDI, P502; Hubbard EJA, 2000, DEV DYNAM, V218, P2, DOI 10.1002/(SICI)1097-0177(200005)218:1<2::AID-DVDY2>3.0.CO;2-W; Kiyokawa E, 1997, CRIT REV ONCOGENESIS, V8, P329, DOI 10.1615/CritRevOncog.v8.i4.30; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; KLASS M, 1976, DEV BIOL, V52, P1, DOI 10.1016/0012-1606(76)90002-6; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Montell DJ, 1999, DEVELOPMENT, V126, P3035; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nishiwaki K, 1999, GENETICS, V152, P985; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; TOSELLOTRAMPONT A, 2001, IN PRESS J BIOL CHEM; VAN AL, 1997, GENE DEV, V11, P2295; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	46	427	455	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2001	107	1					27	41		10.1016/S0092-8674(01)00520-7	http://dx.doi.org/10.1016/S0092-8674(01)00520-7			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595183	Green Accepted, Bronze			2022-12-01	WOS:000171453100007
J	Chertow, GM; Lee, J; Kuperman, GJ; Burdick, E; Horsky, J; Seger, DL; Lee, R; Mekala, A; Song, J; Komaroff, AL; Bates, DW				Chertow, GM; Lee, J; Kuperman, GJ; Burdick, E; Horsky, J; Seger, DL; Lee, R; Mekala, A; Song, J; Komaroff, AL; Bates, DW			Guided medication dosing for inpatients with renal insufficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	31st Congress of the American-Society-of-Nephrology	OCT 24-28, 1998	PHILADELPHIA, PENNSYLVANIA	Amer Soc Nephrol			ADVERSE DRUG EVENTS; FAILURE; INTERVENTION; PREVENTION; MORTALITY	Context Usual drug-prescribing practices may not consider the effects of renal insufficiency on the disposition of certain drugs. Decision aids may help optimize prescribing behavior and reduce medical error. Objective To determine if a system application for adjusting drug close and frequency in patients with renal insufficiency, when merged with a computerized order entry system, improves drug prescribing and patient outcomes. Design, Setting, and Patients Four consecutive 2-month intervals consisting of control (usual computerized order entry) alternating with intervention (computerized order entry plus decision support system), conducted in September 1997-April 1998 with outcomes assessed among a consecutive sample of 17 828 adults admitted to an urban tertiary care teaching hospital. Intervention Real-time computerized decision support system for prescribing drugs in patients with renal insufficiency. During intervention periods, the adjusted dose list, default dose amount, and default frequency were displayed to the order-entry user and a notation was provided that adjustments had been made based on renal insufficiency. During control periods, these recommended adjustments were not revealed to the order-entry user, and the unadjusted parameters were displayed. Main Outcome Measures Rates of appropriate prescription by dose and frequency, length of stay, hospital and pharmacy costs, and changes in renal function, compared among patients with renal insufficiency who were hospitalized during the intervention vs control periods. Results A total of 7490 patients were found to have some degree of renal insufficiency. In this group, 97 151 orders were written on renally cleared or nephrotoxic medications, of which 14440 (15%) had at least 1 dosing parameter modified Ely the computer based on renal function. The fraction of prescriptions deemed appropriate during the intervention vs control periods by dose was 67% vs 54% (P<.001) and by frequency was 59% vs 35% (P<.001). Mean (SD) length of stay was 4.3 (4.5) days vs 4.5 (4.8) days in the intervention vs control periods, respectively (P=.009). There were no significant differences in estimated hospital and pharmacy costs or in the proportion of patients who experienced a decline in renal function during hospitalization. Conclusions Guided medication dosing for inpatients with renal insufficiency appears to result in improved dose and frequency choices. This intervention demonstrates a way in which computer-based decision support systems can improve care.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gen Internal Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Renal Div, Boston, MA 02115 USA; Partners Healthcare Syst, Dept Informat Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System	Chertow, GM (corresponding author), UCSF Laurel Hts, Dept Med Res, 3333 Calif St,Suite 430, San Francisco, CA 94118 USA.			Horsky, Jan/0000-0001-6326-9427; Chertow, Glenn/0000-0002-7599-0534; Kuperman, Gilad/0000-0002-4130-1577				Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; EDWARDS N, 1994, HEALTH CARE FINANC R, V16, P45; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Jha AK, 1998, J AM MED INFORM ASSN, V5, P305, DOI 10.1136/jamia.1998.0050305; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Nightingale PG, 2000, BMJ-BRIT MED J, V320, P750, DOI 10.1136/bmj.320.7237.750; Nolan CR, 1998, J AM SOC NEPHROL, V9, P710; Obialo CI, 2000, ARCH INTERN MED, V160, P1309, DOI 10.1001/archinte.160.9.1309; RIND DM, 1994, ARCH INTERN MED, V154, P1511, DOI 10.1001/archinte.154.13.1511; Wang R, 1998, ARCH INTERN MED, V158, P2464, DOI 10.1001/archinte.158.22.2464	15	304	311	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2839	2844		10.1001/jama.286.22.2839	http://dx.doi.org/10.1001/jama.286.22.2839			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735759	Bronze			2022-12-01	WOS:000172655400032
J	Strauss, RS; Pollack, HA				Strauss, RS; Pollack, HA			Epidemic increase in childhood overweight, 1986-1998	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; NATIONAL-HEALTH; OBESITY; ADOLESCENTS; INTERVENTION; PREVALENCE; CHILDREN; GROWTH	Context Overweight is the most common health problem facing US children. Data for adults suggest that overweight prevalence has increased by more than 50% in the last 10 years. Data for children also suggest that the prevalence of overweight continues to increase rapidly. Objective To investigate recent changes in the prevalence of overweight within a nationally representative sample of children, Design, Setting, and Participants The National Longitudinal Survey cf Youth, a prospective cohort study conducted from 1986 to 1998 among 8270 children aged 4 to 12 years (24 174 growth points were analyzed). Main Outcome Measures Prevalence of overweight children, defined as body mass index (BMI) greater than the 95th percentile for age and sex, and prevalence of overweight and at-risk children, defined as BMI greater than the 85th percentile for age and sex. The roles of race/ethnicity, sex, income, and region of residence were also examined. Results Between 1986 and 1998, overweight increased significantly and steadily among African American (P<.001), Hispanic (P<.001), and white (P=.03) children. By 1998, overweight prevalence increased to 21.5% among African Americans, 21.8% among Hispanics, and 12.3% among non-Hispanic whites. In addition, overweight children were heavier in 1998 compared with 1986 (P<.001). After adjusting for confounding variables, overweight increased fastest among minorities and Southerners, creating large demographic differences in the prevalence of childhood overweight by 1998. The number of children with BMI greater than the 85th percentile increased significantly from 1986 to 1998 among African American and Hispanic children (P<.001 for both) and nonsignificantly among white children (P=.77). Conclusions Childhood overweight continues to increase rapidly in the Un ted States, particularly among African Americans and Hispanics. Culturally competent treatment strategies as well as other policy interventions are required to increase physical activity and encourage healthy eating patterns among children.	UMDNJ, Robert Wood Johnson Med Sch, Div Pediat Gastroenterol & Nutr,Dept Pediat, Childhood Weight Control Program, New Brunswick, NJ 08903 USA; Univ Michigan, Sch Publ Hlth, Dept Hlth Policy & Management, Ann Arbor, MI 48109 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Michigan System; University of Michigan	Strauss, RS (corresponding author), UMDNJ, Robert Wood Johnson Med Sch, Div Pediat Gastroenterol & Nutr,Dept Pediat, Childhood Weight Control Program, 1 Robert Wood Johnson Pl,CN-19, New Brunswick, NJ 08903 USA.		Pollack, Harold A/A-1166-2007		PHS HHS [U48/CCU51577] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], [No title captured]; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; *CTR HUM RES RES, 2000, 1998 CHILD YOUNG AD, P1; *CTR HUM RES RES, 1993, NLSY CHILD HDB, P85; Erlinger TP, 2000, J AM GERIATR SOC, V48, P1486, DOI 10.1111/jgs.2000.48.11.1486; Gauthier BM, 2000, ARCH PEDIAT ADOL MED, V154, P625, DOI 10.1001/archpedi.154.6.625; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; GORTMAKER SL, 1987, AM J DIS CHILD, V141, P535, DOI 10.1001/archpedi.1987.04460050077035; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Levine JA, 2001, J MARRIAGE FAM, V63, P355, DOI 10.1111/j.1741-3737.2001.00355.x; MELNICK TA, 1998, MMWR-MORBID MORTAL W, V47, P980; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; MUST A, 1991, AM J CLIN NUTR, V53, P839, DOI 10.1093/ajcn/53.4.839; National Center for Health Statistics, 2001, PREV OV CHILDR AD US; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; WHITAKER RC, 1994, J PEDIATR-US, V125, P535, DOI 10.1016/S0022-3476(94)70004-4; 1997, MMWR MORB MORTAL WKL, V46, P199	21	788	804	0	35	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2845	2848		10.1001/jama.286.22.2845	http://dx.doi.org/10.1001/jama.286.22.2845			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735760	Bronze			2022-12-01	WOS:000172655400033
J	Bachmann, A; Schneider, M; Theilenberg, E; Grawe, F; Knust, E				Bachmann, A; Schneider, M; Theilenberg, E; Grawe, F; Knust, E			Drosophila Stardust is a partner of Crumbs in the control of epithelial cell polarity	NATURE			English	Article							ZONULA ADHERENS FORMATION; GUANYLATE KINASE DOMAINS; INTRAMOLECULAR INTERACTION; PLASMA-MEMBRANE; BAZOOKA; PROTEIN; LOCALIZATION; ORGANIZATION; EXPRESSION; ARMADILLO	The polarized architecture of epithelial cells depends on the highly stereotypic distribution of cellular junctions and other membrane-associated protein complexes. In epithelial cells of the Drosophila embryo, three distinct domains subdivide the lateral plasma membrane. The most apical one comprises the subapical complex (SAC). It is followed by the zonula adherens (ZA) and, further basally, by the septate junction(1). A core component of the SAC is the transmembrane protein Crumbs, the cytoplasmic domain of which recruits the PDZ-protein Discs Lost into the complex(2,3). Cells lacking crumbs or the functionally related gene stardust fail to organize a continuous ZA and to maintain cell polarity(4-6). Here we show that stardust provides an essential component of the SAC. Stardust proteins colocalize with Crumbs and bind to the carboxy-terminal amino acids of its cytoplasmic tail. We introduce two different Stardust proteins here: one MAGUK protein, characterized by a PDZ domain, an SH3 domain and a guanylate kinase domain; and a second isoform comprising only the guanylate kinase domain. The Stardust proteins represent versatile candidates as structural and possibly regulatory constituents of the SAC, a crucial element in the control of epithelial cell polarity.	Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Knust, E (corresponding author), Univ Dusseldorf, Inst Genet, Univ Str 1, D-40225 Dusseldorf, Germany.	knust@uni-duesseldorf.de	Knust, Elisabeth/B-4338-2017	Grawe, Ferdi/0000-0001-6448-4989				Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Dimitratos SD, 1997, MECH DEVELOP, V63, P127, DOI 10.1016/S0925-4773(97)00668-0; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Grawe F, 1996, DEVELOPMENT, V122, P951; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HOVEMANN BT, 1991, NUCLEIC ACIDS RES, V19, P4909, DOI 10.1093/nar/19.18.4909; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Lammel U, 2000, DEV GENES EVOL, V210, P525, DOI 10.1007/s004270000096; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Muller HAJ, 2000, DEV DYNAM, V218, P52; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; TOWER J, 1993, GENETICS, V133, P347; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740	30	227	231	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					638	643		10.1038/414638a	http://dx.doi.org/10.1038/414638a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740560				2022-12-01	WOS:000172535600048
J	Hong, Y; Stronach, B; Perrimon, N; Jan, LY; Jan, YN				Hong, Y; Stronach, B; Perrimon, N; Jan, LY; Jan, YN			Drosophila Stardust interacts with Crumbs to control polarity of epithelia but not neuroblasts	NATURE			English	Article							ZONULA ADHERENS FORMATION; LARVAL CUTICLE; ZYGOTIC LOCI; PLASMA-MEMBRANE; CELL POLARITY; LOCALIZATION; MUTATIONS; PROTEIN; MELANOGASTER; BAZOOKA	Establishing cellular polarity is critical for tissue organization and function. Initially discovered in the landmark genetic screen for Drosophila developmental mutants(1-4), bazooka, crumbs, shotgun and stardust mutants exhibit severe disruption in apicobasal polarity in embryonic epithelia, resulting in multilayered epithelia, tissue disintegration, and defects in cuticle formation(5). Here we report that stardust encodes single PDZ domain MAGUK (membrane-associated guanylate kinase) proteins that are expressed in all primary embryonic epithelia from the onset of gastrulation. Stardust colocalizes with Crumbs(6) at the apicolateral boundary, although their expression patterns in sensory organs differ. Stardust binds to the carboxy terminus of Crumbs in vitro, and Stardust and Crumbs are mutually dependent in their stability, localization and function in controlling the apicobasal polarity of epithelial cells. However, for the subset of ectodermal cells that delaminate and form neuroblasts, their polarity requires the function of Bazooka(7,8), but not of Stardust or Crumbs.	Univ Calif San Francisco, Dept Physiol & Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol & Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299; Perrimon, Norbert/0000-0001-7542-472X; Stronach, Beth/0000-0002-1699-8683; Jan, Lily/0000-0003-3938-8498				Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Brenman JE, 1998, J NEUROSCI, V18, P8805; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Grawe F, 1996, DEVELOPMENT, V122, P951; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Muller HAJ, 2000, DEV DYNAM, V218, P52; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Rashbass P, 2000, CURR BIOL, V10, pR234, DOI 10.1016/S0960-9822(00)00372-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1997, BIOESSAYS, V19, P673, DOI 10.1002/bies.950190807; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	29	197	199	1	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					634	638		10.1038/414634a	http://dx.doi.org/10.1038/414634a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740559				2022-12-01	WOS:000172535600047
J	Hurst, JL; Payne, CE; Nevison, CM; Marie, AD; Humphries, RE; Robertson, DHL; Cavaggioni, A; Beynon, RJ				Hurst, JL; Payne, CE; Nevison, CM; Marie, AD; Humphries, RE; Robertson, DHL; Cavaggioni, A; Beynon, RJ			Individual recognition in mice mediated by major urinary proteins	NATURE			English	Article							HOUSE MOUSE; FEMALE MICE; SYNTHETIC ANALOGS; BINDING; STIMULATION; CHEMISTRY; PHEROMONE; MARKING	The ability to recognize individuals is essential to many aspects of social behaviour, such as the maintenance of stable social groups, parent-offspring or mate recognition, inbreeding avoidance and the modulation of competitive relationships. Odours are a primary mediator of individuality signals among many mammals(1). One source of odour complexity in rodents, and possibly in humans, resides in the highly polymorphic major histocompatibility complex (MHC)(2). The olfactory acuity of mice(3) and rats(4) allows them to distinguish between the urinary odours of congenic strains differing only in single genes within the MHC, although the chemical mediators or odorants are unknown. However, rodent urine also contains a class of proteins, termed major urinary proteins (MUPs)(5), that bind and release small volatile pheromones(6,7). We have shown that the combinatorial diversity of expression of MUPs among wild mice might be as great as for MHC, and at protein concentrations a million times higher(8). Here we show in wild house mice (Mus domesticus) that urinary MUPs play an important role in the individual recognition mechanism.	Univ Liverpool, Dept Vet Clin Sci & Anim Husb, Neston CH64 7TE, England; Univ Liverpool, Dept Preclin Vet Sci, Liverpool L69 3BX, Merseyside, England; Univ Padua, Dipartimento Anat & Fisiol Umana, I-35100 Padua, Italy	University of Liverpool; University of Liverpool; University of Padua	Hurst, JL (corresponding author), Univ Liverpool, Dept Vet Clin Sci & Anim Husb, Neston CH64 7TE, England.	jane.hurst@liverpool.ac.uk	Mariee, Amr/AAA-4370-2022; Hurst, Jane L/G-8793-2015; Beynon, Robert J/K-1408-2014	Hurst, Jane L/0000-0002-3728-9624; Beynon, Robert J/0000-0003-0857-495X; Mariee, Amr/0000-0001-5786-2072				BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; Beynon RJ, 2001, CHEM SIGNAL, V9, P149; BEYNON RJ, 1999, ADV CHEM COMMUNICATI, P137; BISHOP JO, 1982, EMBO J, V1, P615, DOI 10.1002/j.1460-2075.1982.tb01217.x; Brennan PA, 1999, NEUROSCIENCE, V90, P1463, DOI 10.1016/S0306-4522(98)00556-9; Brown R. E., 1985, SOCIAL ODOURS MAMMAL, V1-2; Humphries RE, 1999, ANIM BEHAV, V58, P1177, DOI 10.1006/anbe.1999.1252; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Hurst JL, 2001, CHEM SIGNAL, V9, P43; HURST JL, 1990, ANIM BEHAV, V40, P209, DOI 10.1016/S0003-3472(05)80916-9; JEMIOLO B, 1986, P NATL ACAD SCI USA, V83, P4576, DOI 10.1073/pnas.83.12.4576; JEMIOLO B, 1985, ANIM BEHAV, V33, P1114, DOI 10.1016/S0003-3472(85)80170-6; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Lucke C, 1999, EUR J BIOCHEM, V266, P1210, DOI 10.1046/j.1432-1327.1999.00984.x; Marchlewska-Koj A, 2000, J CHEM ECOL, V26, P2355, DOI 10.1023/A:1005578911652; Marie AD, 2001, PROTEIN SCI, V10, P411, DOI 10.1110/ps.31701; Mucignat-Caretta C, 1999, ANIM BEHAV, V57, P765, DOI 10.1006/anbe.1998.1023; Nevison CM, 2000, P ROY SOC B-BIOL SCI, V267, P687, DOI 10.1098/rspb.2000.1057; NOVOTNY M, 1990, EXPERIENTIA, V46, P109, DOI 10.1007/BF01955433; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; PAYNE CE, 2000, CHEM SIGNALS VERTEBR, P233; Pearse-Pratt R, 1998, GENETICA, V104, P223, DOI 10.1023/A:1026489524199; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; ROBERTSON DHL, 1993, J CHEM ECOL, V19, P1405, DOI 10.1007/BF00984885; Singer AG, 1997, P NATL ACAD SCI USA, V94, P2210, DOI 10.1073/pnas.94.6.2210; SINGER AG, 1993, J CHEM ECOL, V19, P569, DOI 10.1007/BF00994326; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; YAMAZAKI K, 1983, P NATL ACAD SCI-BIOL, V80, P5685, DOI 10.1073/pnas.80.18.5685; Yamazaki K, 1998, GENETICA, V104, P235, DOI 10.1023/A:1026433925744	30	466	484	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2001	414	6864					631	634		10.1038/414631a	http://dx.doi.org/10.1038/414631a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740558				2022-12-01	WOS:000172535600046
J	Schwetz, BA				Schwetz, BA			New drug for HIV-1 infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	10	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2660	2660		10.1001/jama.286.21.2660-b	http://dx.doi.org/10.1001/jama.286.21.2660-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730423				2022-12-01	WOS:000172488300004
J	Opie, LH				Opie, LH			Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension	LANCET			English	Editorial Material							CONVERTING ENZYME-INHIBITION; CALCIUM-CHANNEL BLOCKERS; BLOOD-PRESSURE CONTROL; RENAL-DISEASE; NEPHROPATHY; PROGRESSION; PROTEINURIA; DIET		Univ Cape Town, Dept Med, Cape Heart Ctr, ZA-7925 Cape Town, South Africa	University of Cape Town	Opie, LH (corresponding author), Univ Cape Town, Dept Med, Cape Heart Ctr, ZA-7925 Cape Town, South Africa.							Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Bakris GL, 1997, HYPERTENSION, V29, P744, DOI 10.1161/01.HYP.29.3.744; Bakris GL, 1996, KIDNEY INT, V50, P1641, DOI 10.1038/ki.1996.480; Black HR, 1997, ARCH INTERN MED, V157, P2413; BP TRIAL, 2000, LANCET, V355, P1955; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chrysostomou A, 2001, NEW ENGL J MED, V345, P925, DOI 10.1056/NEJM200109203451215; DiBona GF, 2000, HYPERTENSION, V36, P1083, DOI 10.1161/01.HYP.36.6.1083; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Lacourciere Y, 2000, KIDNEY INT, V58, P762, DOI 10.1046/j.1523-1755.2000.00224.x; Lazarus JM, 1997, HYPERTENSION, V29, P641, DOI 10.1161/01.HYP.29.2.641; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; Ruggenenti P, 1998, J AM SOC NEPHROL, V9, P2096; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X	19	27	27	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2001	358	9296					1829	1831		10.1016/S0140-6736(01)06879-9	http://dx.doi.org/10.1016/S0140-6736(01)06879-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497NU	11741617				2022-12-01	WOS:000172463000003
J	Hirama, M; Oishi, T; Uehara, H; Inoue, M; Maruyama, M; Guri, H; Satake, M				Hirama, M; Oishi, T; Uehara, H; Inoue, M; Maruyama, M; Guri, H; Satake, M			Total synthesis of ciguatoxin CTX3C	SCIENCE			English	Article							RING-CLOSING METATHESIS; GAMBIERDISCUS-TOXICUS; CONVERGENT SYNTHESIS; SODIUM-CHANNELS; BREVETOXIN-A; PTYCHODISCUS-BREVIS; CIGUATERA; DINOFLAGELLATE; SYSTEM; CONFIGURATION	More than 20,000 people suffer annually from ciguatera seafood poisoning in subtropical and tropical regions. The extremely Low content of the causative neurotoxins, designated as ciguatoxins, in fish has hampered the isolation, detailed biological studies, and preparation of anti-ciguatoxin antibodies for detecting these toxins. The large (3 nanometers long) and complicated molecular structure of ciguatoxins has impeded chemists from completing their total synthesis. Our highly convergent strategic approach featuring the chemoselective ring-closing metathesis reaction as a key tactic has enabled the total synthesis of ciguatoxin CTX3C, which will provide a practical supply for further studies.	Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; Japan Sci & Technol Corp, CREST, Sendai, Miyagi 9808578, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Appl Bioorgan Chem, Sendai, Miyagi 9808555, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University	Hirama, M (corresponding author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.		Oguri, Hiroki/B-7366-2014; Oguri, Hiroki/F-9541-2015	Oguri, Hiroki/0000-0001-8007-1631				Anger T, 2001, J MED CHEM, V44, P115, DOI 10.1021/jm000155h; BAGNIS R, 1980, TOXICON, V18, P199, DOI 10.1016/0041-0101(80)90074-4; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Dechraoui MY, 1999, TOXICON, V37, P125, DOI 10.1016/S0041-0101(98)00169-X; FU GC, 1993, J AM CHEM SOC, V115, P9856, DOI 10.1021/ja00074a085; Fujiwara K, 2001, SYNLETT, P691; FUKUZAWA S, 1995, SYNLETT, P1077; GAWLEY RE, 1995, CHEM BIOL, V2, P533, DOI 10.1016/1074-5521(95)90187-6; Grubbs RH, 1998, TETRAHEDRON, V54, P4413, DOI 10.1016/S0040-4020(97)10427-6; Hokama Y, 1998, J AOAC INT, V81, P727; Imai H, 2001, TETRAHEDRON LETT, V42, P6219, DOI 10.1016/S0040-4039(01)01219-9; Inoue M, 1999, TETRAHEDRON, V55, P10949, DOI 10.1016/S0040-4020(99)00620-1; Inoue M, 1999, J ORG CHEM, V64, P9416, DOI 10.1021/jo990989b; Ishihara K, 1996, SYNLETT, P839; KIM DS, 1994, NEURAL PROCESS LETT, V1, P17, DOI 10.1007/BF02312396; Kira K, 2001, TETRAHEDRON LETT, V42, P2821, DOI 10.1016/S0040-4039(01)00286-6; LEE E, 1993, TETRAHEDRON LETT, V34, P4831, DOI 10.1016/S0040-4039(00)74101-3; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; Maruyama M, 2001, HETEROCYCLES, V54, P93; MURATA M, 1989, J AM CHEM SOC, V111, P8929, DOI 10.1021/ja00206a032; MURATA M, 1990, J AM CHEM SOC, V112, P4380, DOI 10.1021/ja00167a040; Nagumo Y, 2001, BIOORG MED CHEM LETT, V11, P2037, DOI 10.1016/S0960-894X(01)00358-4; Nicolaou KC, 1998, NATURE, V392, P264, DOI 10.1038/32623; NICOLAOU KC, 1995, J AM CHEM SOC, V117, P10252, DOI 10.1021/ja00146a010; Nicolaou KC, 1999, CHEM-EUR J, V5, P646, DOI 10.1002/(SICI)1521-3765(19990201)5:2<646::AID-CHEM646>3.0.CO;2-E; Oguri H, 1999, SYNTHESIS-STUTTGART, P1431; Oishi T, 1998, CHEM COMMUN, P1041, DOI 10.1039/a801678j; Oishi T, 2001, CHEM COMMUN, P381, DOI 10.1039/b009506k; Pauillac S, 2000, TOXICON, V38, P669, DOI 10.1016/S0041-0101(99)00183-X; Rahim MA, 2000, TETRAHEDRON, V56, P763, DOI 10.1016/S0040-4020(99)01091-1; Sabes SF, 1998, J AM CHEM SOC, V120, P2534, DOI 10.1021/ja973286p; Sasaki M, 1998, TETRAHEDRON LETT, V39, P2783, DOI 10.1016/S0040-4039(98)00338-4; Sasaki M, 1999, TETRAHEDRON LETT, V40, P1337, DOI 10.1016/S0040-4039(98)02606-9; SATAKE M, 1993, TETRAHEDRON LETT, V34, P1975, DOI 10.1016/S0040-4039(00)91978-6; Satake M, 1997, J AM CHEM SOC, V119, P11325, DOI 10.1021/ja972482t; SCHEUER PJ, 1994, TETRAHEDRON, V50, P3, DOI 10.1016/S0040-4020(01)80733-X; SHIMIZU Y, 1986, J AM CHEM SOC, V108, P514, DOI 10.1021/ja00263a031; Takakura H, 2001, ANGEW CHEM INT EDIT, V40, P1090, DOI 10.1002/1521-3773(20010316)40:6<1090::AID-ANIE10900>3.0.CO;2-W; YASUMOTO T, 1993, CHEM REV, V93, P1897, DOI 10.1021/cr00021a011; Yasumoto T, 2000, J AM CHEM SOC, V122, P4988, DOI 10.1021/ja9944204	42	221	224	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1904	1907		10.1126/science.1065757	http://dx.doi.org/10.1126/science.1065757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729311				2022-12-01	WOS:000172465000052
J	Streets, DG; Jiang, KJ; Hu, XL; Sinton, JE; Zhang, XQ; Xu, DY; Jacobson, MZ; Hansen, JE				Streets, DG; Jiang, KJ; Hu, XL; Sinton, JE; Zhang, XQ; Xu, DY; Jacobson, MZ; Hansen, JE			Climate change - Recent reductions in China's greenhouse gas emissions	SCIENCE			English	Editorial Material									Argonne Natl Lab, Decis & Informat Sci Div, Argonne, IL 60439 USA; Energy Res Inst, Ctr Energy Environm & Climate Change, Beijing 100038, Peoples R China; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Energy Anal, Berkeley, CA 94720 USA; Chinese Acad Forestry, Forest Ecol & Environm Inst, Beijing 100091, Peoples R China; Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Streets, DG (corresponding author), Argonne Natl Lab, Decis & Informat Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.			Jacobson, Mark/0000-0002-4315-4128; Streets, David/0000-0002-0223-1350				[Anonymous], 1999, CHINA CLIMATE CHANGE; China Statistical Press, 2001, CHINA STAT YB 2001; *DEP EN, 2001, DOEEIA021999; DOU Q, 2000, TECHNOLOGY ASSESSMEN; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Houghton J.T., 1997, CH4 EMISSIONS COAL M; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Nakicenovic N., 2000, SPECIAL REPORT EMISS, V1, P595; *NAT BUR STAT, 2001, ZHONGG TONGJ ZHAIYAO; OLIVIER GJ, 1996, 771060002 NAT I PUBL; Rawski T.G., 2001, CHINA PERSPECTIVES, P25; Sinton JE, 2000, ENERG POLICY, V28, P671, DOI 10.1016/S0301-4215(00)00053-7; SINTON JE, 2001, SINOSPHERE, V4, P3; Streets DG, 2000, ATMOS ENVIRON, V34, P4413, DOI 10.1016/S1352-2310(00)00187-4; Streets DG, 2001, ATMOS ENVIRON, V35, P4281, DOI 10.1016/S1352-2310(01)00179-0; WANG QY, 2001, NENGYUAN ZHENGCE YAN, V1, P57; ZHANG XQ, 2001, POTENTIAL CARBON SEQ; 2001, WASHINGTON POST 0814; 2001, NY TIMES        0615	19	122	151	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1835	+		10.1126/science.1065226	http://dx.doi.org/10.1126/science.1065226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729288	Green Submitted			2022-12-01	WOS:000172465000028
J	Poldrack, RA; Clark, J; Pare-Blagoev, EJ; Shohamy, D; Moyano, JC; Myers, C; Gluck, MA				Poldrack, RA; Clark, J; Pare-Blagoev, EJ; Shohamy, D; Moyano, JC; Myers, C; Gluck, MA			Interactive memory systems in the human brain	NATURE			English	Article							EVENT-RELATED FMRI; CAUDATE-NUCLEUS; HIPPOCAMPUS; ACQUISITION; AMNESIA; LESIONS; PLACE; RATS	Learning and memory in humans rely upon several memory systems, which appear to have dissociable brain substrates(1,2). A fundamental question concerns whether, and how, these memory systems interact. Here we show using functional magnetic resonance imaging (FMRI) that these memory systems may compete with each other during classification learning in humans. The medial temporal lobe and basal ganglia were differently engaged across subjects during classification learning depending upon whether the task emphasized declarative or nondeclarative memory, even when the to-be-learned material and the level of performance did not differ. Consistent with competition between memory systems suggested by animal studies(3,4) and neuroimaging(5), activity in these regions was negatively correlated across individuals. Further examination of classification learning using event-related FMRI showed rapid modulation of activity in these regions at the beginning of learning, suggesting that subjects relied upon the medial temporal lobe early in learning. However, this dependence rapidly declined with training, as predicted by previous computational models of associative learning(6-8).	Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02131 USA; Harvard Univ, Sch Med, Charlestown, MA 02131 USA; Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA; Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick	Poldrack, RA (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02131 USA.		Myers, Catherine E./AAU-5804-2020	Myers, Catherine E./0000-0002-2776-4823; Shohamy, Daphna/0000-0003-4239-4960				Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; EICHENBAUM H, 1988, BEHAV NEUROSCI, V102, P331, DOI 10.1037/0735-7044.102.3.331; Eichenbaum H, 2004, CONDITIONING CONSCIO; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Gluck M.A., 2001, GATEWAY MEMORY INTRO; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; GLUCK MA, 1988, J EXP PSYCHOL GEN, V117, P227, DOI 10.1037/0096-3445.117.3.227; Gluck MA, 1996, LEARN MEMORY, V3, P326, DOI 10.1101/lm.3.4.326; HOPKINS R, 2001, SOC NEUR ABSTR, V27; HORWITZ B, 1995, BEHAV BRAIN RES, V66, P187, DOI 10.1016/0166-4328(94)00139-7; Kim JJ, 2001, TRENDS NEUROSCI, V24, P324, DOI 10.1016/S0166-2236(00)01818-X; Knowlton B J, 1994, Learn Mem, V1, P106; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Knowlton BJ, 1996, NEUROPSYCHOLOGY, V10, P538; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Packard MG, 1999, P NATL ACAD SCI USA, V96, P12881, DOI 10.1073/pnas.96.22.12881; Petri HL, 1984, NEUROPSYCHOLOGY MEMO, P287; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Reber PJ, 1996, BEHAV NEUROSCI, V110, P861, DOI 10.1037/0735-7044.110.5.861; SEARS LL, 1990, BEHAV NEUROSCI, V104, P681, DOI 10.1037/0735-7044.104.5.681; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tagamets MA, 2001, BRAIN RES BULL, V54, P267, DOI 10.1016/S0361-9230(00)00435-4; Waldvogel D, 2000, NATURE, V406, P995, DOI 10.1038/35023171; WARRINGTON EK, 1982, NEUROPSYCHOLOGIA, V20, P233, DOI 10.1016/0028-3932(82)90099-9; WINOCUR G, 1976, NEUROPSYCHOLOGIA, V14, P97, DOI 10.1016/0028-3932(76)90011-7	29	783	790	1	76	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					546	550		10.1038/35107080	http://dx.doi.org/10.1038/35107080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	496PV	11734855				2022-12-01	WOS:000172405900048
J	Lauvau, G; Vijh, S; Kong, P; Horng, T; Kerksiek, K; Serbina, N; Tuma, RA; Pamer, EG				Lauvau, G; Vijh, S; Kong, P; Horng, T; Kerksiek, K; Serbina, N; Tuma, RA; Pamer, EG			Priming of memory but not effector CD8 T cells by a killed bacterial vaccine	SCIENCE			English	Article							LISTERIA-MONOCYTOGENES; CLONAL EXPANSION; DIFFERENTIATION; IMMUNITY; ANTIGEN; STIMULATION; RESISTANCE	Killed or inactivated vaccines targeting intracellular bacterial and protozoal pathogens are notoriously ineffective at generating protective immunity. For example, vaccination with heat-killed Listeria monocytogenes (HKLM) is not protective, although infection with live L. monocytogenes induces long-lived, CD8 T cell-mediated immunity. We demonstrate that HKLM immunization primes memory CD8 T lymphocyte populations that, although substantial in size, are ineffective at providing protection from subsequent L. monocytogenes infection. In contrast to live infection, which elicits large numbers of effector CD8 T cells, HKLM immunization primes T lymphocytes that do not acquire effector functions. Our studies show that it is possible to dissociate T cell-dependent protective immunity from memory T cell expansion, and that generation of effector T cells may be necessary for long-term protective immunity.	Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Immunol Program,Sloan Kettering Inst, New York, NY 10021 USA; Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06511 USA	Memorial Sloan Kettering Cancer Center; Yale University	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Immunol Program,Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	pamere@mskcc.org			NIAID NIH HHS [F32 AI09629-02, AI 39031, AI42135] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039031, R01AI039031, R01AI042135, F32AI009629] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; DUNN PL, 1991, J INFECT DIS, V164, P878, DOI 10.1093/infdis/164.5.878; Edelson BT, 1999, J IMMUNOL, V163, P4087; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; HARTY JT, 1992, P NATL ACAD SCI USA, V89, P11612, DOI 10.1073/pnas.89.23.11612; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KAUFMANN SHE, 1986, J EXP MED, V164, P363, DOI 10.1084/jem.164.1.363; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MITCHELL T, 2001, NATURE IMMUNOL, V2, P377; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; PAMER EG, 1994, J IMMUNOL, V152, P686; Pape KA, 1997, J IMMUNOL, V159, P591; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rolph MS, 2001, J IMMUNOL, V166, P5115, DOI 10.4049/jimmunol.166.8.5115; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SERBINA N, UNPUB; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vijh S, 1999, INFECT IMMUN, V67, P1303, DOI 10.1128/IAI.67.3.1303-1309.1999; VONKOENIG CHW, 1982, NATURE, V297, P233, DOI 10.1038/297233a0	27	237	252	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1735	1739		10.1126/science.1064571	http://dx.doi.org/10.1126/science.1064571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11721060				2022-12-01	WOS:000172307400050
J	Shu, DG; Morris, SC; Han, J; Chen, L; Zhang, XL; Zhang, ZF; Liu, HQ; Li, Y; Liu, JN				Shu, DG; Morris, SC; Han, J; Chen, L; Zhang, XL; Zhang, ZF; Liu, HQ; Li, Y; Liu, JN			Primitive deuterostomes from the Chengjiang Lagerstatte (Lower Cambrian, China)	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; PTYCHODERA-FLAVA; TORNARIA LARVAE; GENE-EXPRESSION; SOUTH CHINA; HEMICHORDATE; CHORDATE; ENTEROPNEUST; EVOLUTION; MOLECULES	Cambrian fossil-Lagerstatten (sites of exceptional fossil preservation), such as those from Chengjiang (Lower Cambrian) and the Burgess Shale (Middle Cambrian), provide our best window into the Cambrian 'explosion'. Such faunas are known from about 40 localities, and have yielded a widely disparate series of taxa ranging from ctenophores to agnathan fish. Recent excavations of the Chengjiang fossil-Lagerstatte, known from a series of sites near Kunming in Yunnan, south China, have resulted in the discovery of several new forms. In conjunction with material described earlier, these provide evidence for a new group of metazoans, the vetulicolians. Several features, notably a series of gill slits, suggest that this group can throw light on an early stage of deuterostome diversification.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	Northwest University Xi'an; Northwest University Xi'an; University of Cambridge	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.	dgshu@sein.sxgb.com.cn	Zhang, Zhifei/F-2532-2011	Zhang, Zhifei/0000-0003-0325-5116				Bromham LD, 1999, EVOL DEV, V1, P166, DOI 10.1046/j.1525-142x.1999.99026.x; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Chen J-Y, 1996, CHENGJIANG BIOTA UNI; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Dzik Jerzy, 1995, Acta Palaeontologica Polonica, V40, P341; FIORONI P, 1980, REV SUISSE ZOOL, V87, P261, DOI 10.5962/bhl.part.85517; Gee H, 2001, SYST ASSOC SPEC VOL, V61, P1; Gee H., 1996, BACKBONE VIEWS ORIGI; GILMOUR THJ, 1979, CAN J ZOOL, V57, P1136, DOI 10.1139/z79-143; GILMOUR THJ, 1982, CAN J ZOOL, V60, P3010, DOI 10.1139/z82-384; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Hou X.-g., 1987, Acta Palaeontologica Sinica, V26, P286; Hou X. -G., 1999, CHENGJIANG FAUNA EXC; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Jefferies R.P.S., 1986, ANCESTRY VERTEBRATES; Lacalli TC, 1997, INVERTEBR BIOL, V116, P363, DOI 10.2307/3226869; LACALLI TC, 1994, AM ZOOL, V34, P533; LUO H., 1999, EARLY CAMBRIAN CHENG; Morris SC, 2000, CELL, V100, P1, DOI 10.1016/S0092-8674(00)81679-7; Nielsen C, 1999, DEV GENES EVOL, V209, P198, DOI 10.1007/s004270050244; Ogasawara M, 1999, ZOOL SCI, V16, P559, DOI 10.2108/zsj.16.559; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; Okai N, 2000, DEV DYNAM, V217, P309, DOI 10.1002/(SICI)1097-0177(200003)217:3<309::AID-DVDY9>3.0.CO;2-2; Peterson KJ, 1999, DEVELOPMENT, V126, P85; Romer AS, 1972, EVOLUTIONARY BIOL, P121, DOI DOI 10.1007/978-1-4684-9063-3_5; Romer AS, 1964, VERTEBRATE BODY; Ruppert EE, 1999, INVERTEBR BIOL, V118, P202, DOI 10.2307/3227061; SCHAEFFER B, 1987, EVOL BIOL, V21, P179; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu D, 1999, NATURE, V400, P746, DOI 10.1038/23445; Shu D. G., 2001, ZOOL SCI, V18, P447; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; SHU DG, 1996, PROGR GEOLOGY CHINA, P42; Tagawa K, 1998, MECH DEVELOP, V75, P139, DOI 10.1016/S0925-4773(98)00078-1; Tagawa K, 2000, J EXP ZOOL, V288, P23, DOI 10.1002/(SICI)1097-010X(20000415)288:1<23::AID-JEZ3>3.0.CO;2-H; Taguchi S, 2000, DEV GENES EVOL, V210, P11, DOI 10.1007/PL00008181; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Valentine JW, 1999, DEVELOPMENT, V126, P851; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Walcott C.D., 1911, SMITHSONIAN MISCELLA, V57, P109, DOI DOI 10.1126/SCIENCE.1091376; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	44	136	153	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					419	424		10.1038/35106514	http://dx.doi.org/10.1038/35106514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719797				2022-12-01	WOS:000172304500035
J	Gusarov, I; Nudler, E				Gusarov, I; Nudler, E			Control of intrinsic transcription termination by N and NusA: The basic mechanisms	CELL			English	Article							COLI RNA-POLYMERASE; ELONGATION-FACTOR NUSA; ARGININE-RICH MOTIF; ESCHERICHIA-COLI; BACTERIOPHAGE-LAMBDA; PHAGE-LAMBDA; ANTITERMINATION PROTEIN; ALPHA-SUBUNIT; PROCESSIVE ANTITERMINATION; GENE-EXPRESSION	Intrinsic transcription termination plays a crucial role in regulating gene expression in prokaryotes. After a short pause, the termination signal appears in RNA as a hairpin that destabilizes the elongation complex (EC). We demonstrate that negative and positive-termination factors control the efficiency of termination primarily through a direct modulation of hairpin folding and, to a much lesser extent, by changing pausing at the point of termination. The mechanism controlling hairpin formation at the termination point relies on weak protein interactions with single-stranded RNA, which corresponds to the upstream portion of the hairpin. Escherichia coli NusA protein destabilizes these interactions and thus promotes hairpin folding and termination. Stabilization of these contacts by phage lambda N protein leads to antitermination.	NYU Med Ctr, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU Med Ctr, Dept Biochem, New York, NY 10016 USA.		Gusarov, Ivan/AAJ-6282-2020	Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRENDEL V, 1986, J BIOMOL STRUCT DYN, V3, P705, DOI 10.1080/07391102.1986.10508457; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; CHATTOPADHYAY S, 1995, P NATL ACAD SCI USA, V92, P4061, DOI 10.1073/pnas.92.9.4061; CLERGET M, 1995, J MOL BIOL, V248, P768, DOI 10.1006/jmbi.1995.0259; DAS A, 1993, ANNU REV BIOCHEM, V62, P893; DEVITO J, 1994, P NATL ACAD SCI USA, V91, P8660, DOI 10.1073/pnas.91.18.8660; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; FRANKLIN NC, 1993, J MOL BIOL, V231, P343, DOI 10.1006/jmbi.1993.1287; FRIEDMAN DI, 1983, CELL, V34, P143, DOI 10.1016/0092-8674(83)90144-7; FRIEDMAN DI, 1995, MOL MICROBIOL, V18, P191, DOI 10.1111/j.1365-2958.1995.mmi_18020191.x; FRIEDMAN DI, 1987, ANNU REV GENET, V21, P453; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Henkin TM, 2000, CURR OPIN MICROBIOL, V3, P149, DOI 10.1016/S1369-5274(00)00067-9; HOARD DE, 1965, J AM CHEM SOC, V87, P1785, DOI 10.1021/ja01086a031; HORWITZ RJ, 1987, CELL, V51, P631, DOI 10.1016/0092-8674(87)90132-2; KASHLEV M, 1990, SCIENCE, V248, P1006, DOI 10.1126/science.1693014; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; Landick R, 1996, METHOD ENZYMOL, V274, P334; Landick R, 1996, ESCHERICHIA COLI SAL, P1263; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Liu KB, 1996, EMBO J, V15, P150, DOI 10.1002/j.1460-2075.1996.tb00343.x; LIU KB, 1995, P NATL ACAD SCI USA, V92, P5012, DOI 10.1073/pnas.92.11.5012; Mah TF, 1999, MOL MICROBIOL, V34, P523, DOI 10.1046/j.1365-2958.1999.01618.x; Mah TF, 2000, GENE DEV, V14, P2664, DOI 10.1101/gad.822900; MASON SW, 1992, J BIOL CHEM, V267, P19418; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; MOGRIDGE J, 1995, GENE DEV, V9, P2831, DOI 10.1101/gad.9.22.2831; Mogridge J, 1998, MOL CELL, V1, P265, DOI 10.1016/S1097-2765(00)80027-1; Neely MN, 2000, MOL MICROBIOL, V38, P1074, DOI 10.1046/j.1365-2958.2000.02217.x; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; Rees WA, 1996, P NATL ACAD SCI USA, V93, P342, DOI 10.1073/pnas.93.1.342; Rees WA, 1997, J MOL BIOL, V273, P797, DOI 10.1006/jmbi.1997.1327; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; ROBERTS JW, 1993, CELL, V72, P653, DOI 10.1016/0092-8674(93)90394-6; Sambrook J., 1989, MOL CLONING; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Su LL, 1997, BIOCHEMISTRY-US, V36, P12722, DOI 10.1021/bi971408k; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; VanGilst MR, 1997, BIOCHEMISTRY-US, V36, P1514, DOI 10.1021/bi961920q; VOGEL U, 1994, J BIOL CHEM, V269, P16236; VONHIPPEL PH, 1992, SCIENCE, V255, P809, DOI 10.1126/science.1536005; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; WHALEN W, 1988, P NATL ACAD SCI USA, V85, P2494, DOI 10.1073/pnas.85.8.2494; WHALEN W, 1990, NEW BIOL, P975; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	56	123	126	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 16	2001	107	4					437	449		10.1016/S0092-8674(01)00582-7	http://dx.doi.org/10.1016/S0092-8674(01)00582-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	494GG	11719185	Bronze			2022-12-01	WOS:000172272900005
J	Rawson, H; Crampin, A; Noah, N				Rawson, H; Crampin, A; Noah, N			Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data	BRITISH MEDICAL JOURNAL			English	Article							AGE	Objective To evaluate the epidemiology and impact of mortality from chickenpox in England and Wales. Design Review of death certificates from the Office for National Statistics on which codes for "chickenpox" or "varicella" were mentioned. Further information ascertained from certifying physician. Participants Those certified as having died from chickenpox in England and Wales, 1995-7. Main outcome measures Diagnosis and age and sex distributions of deaths from chickenpox. Results On average, 25 people a year die from chickenpox. Overall case fatality was 9.22 per 100 000 consultations for chickenpox. Adults accounted for 81% of deaths and 19% of consultations. Deaths were twice as common in men as in women. More of those who died were born outside United Kingdom than expected (12% v 4%). Conclusions Chickenpox is not a mild disease. Deaths in adults are increasing, both in number and proportion.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Guys Kings Coll, London SE1 8AW, England; St Thomas Hosp Sch Med & Dent, London SE1 8AW, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of London; King's College London	Noah, N (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.			Crampin, Amelia/0000-0002-1513-4330				*CDCP, 1998, MMWR-MORBID MORTAL W, V47, P365; *DEP HLTH, 1991, REP CONF ENQ MAT DEA; FAIRLEY CK, 1996, J INFECT DIS S3, V174, P314; GARNETT GP, 1993, EPIDEMIOL INFECT, V110, P361, DOI 10.1017/S0950268800068308; JOSEPH CA, 1988, BMJ-BRIT MED J, V296, P673, DOI 10.1136/bmj.296.6623.673; Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463; MILLER E, 1993, LANCET, V341, P308, DOI 10.1016/0140-6736(93)92663-E	7	90	96	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2001	323	7321					1091	1093		10.1136/bmj.323.7321.1091	http://dx.doi.org/10.1136/bmj.323.7321.1091			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701571	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000172188400010
J	Blackburn, TM; Duncan, RP				Blackburn, TM; Duncan, RP			Determinants of establishment success in introduced birds	NATURE			English	Article							GLOBAL PATTERNS; INVASIONS; CONSEQUENCES; MODELS; RANGE	A major component of human-induced global change is the deliberate or accidental translocation of species from their native ranges to alien environments(1,2), where they may cause substantial environmental and economic damage(3,4). Thus we need to understand why some introductions succeed while others fail. Successful introductions tend to be concentrated in certain regions(2), especially islands and the temperate zone, suggesting that species-rich mainland and tropical locations are harder to invade because of greater biotic resistance(1,5-9). However, this pattern could also reflect variation in the suitability of the abiotic environment at introduction locations for the species introduced(3,9-11), coupled with known confounding effects of non-random selection of species and locations for introduction(8,12-14). Here, we test these alternative hypotheses using a global data set of historical bird introductions, employing a statistical framework that accounts for differences among species and regions in terms of introduction success. By removing these confounding effects, we show that the pattern of avian introduction success is not consistent with the biotic resistance hypothesis. Instead, success depends on the suitability of the abiotic environment for the exotic species at the introduction site.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Lincoln Univ, Soil Plant & Ecol Sci Div, Ecol & Entomol Grp, Canterbury, New Zealand	University of Birmingham; Lincoln University - New Zealand	Blackburn, TM (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	t.blackburn@bham.ac.uk	Duncan, Richard/ABD-4099-2020; Blackburn, Tim M/A-7685-2011; Blackburn, Tim/AAC-3144-2019; Duncan, Richard P/E-7899-2013	Duncan, Richard/0000-0003-2295-449X; Blackburn, Tim/0000-0003-0152-2663; Duncan, Richard P/0000-0003-2295-449X				BLACKBURN TM, IN PRESS J BIOGEOGR; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1989, BIOL INVASIONS GLOBA, P85; Case TJ, 1996, BIOL CONSERV, V78, P69, DOI 10.1016/0006-3207(96)00019-5; CASE TJ, 1991, BIOL J LINN SOC, V42, P239, DOI 10.1111/j.1095-8312.1991.tb00562.x; Crawley M. J., 1997, P36; CRAWLEY MJ, 1986, PHILOS T ROY SOC B, V314, P711, DOI 10.1098/rstb.1986.0082; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Duncan RP, 2001, J ANIM ECOL, V70, P621, DOI 10.1046/j.1365-2656.2001.00517.x; Ehrlich P.R., 1989, BIOL INVASIONS GLOBA, P315; Elton C. S., 1958, ECOLOGY INVASIONS; GASTON KJ, 1994, RARITY, P117; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th, DOI DOI 10.1002/9780470973394; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hodkinson ID, 1999, J ANIM ECOL, V68, P1259, DOI 10.1046/j.1365-2656.1999.00372.x; HOLDGATE MW, 1986, PHILOS T ROY SOC B, V314, P733, DOI 10.1098/rstb.1986.0083; LAWTON JH, 1986, PHILOS T ROY SOC B, V314, P606; Littell R.C., 2006, SAS SYSTEM MIXED MOD, DOI 10.1017/CBO9781107415324.004; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Newsome A.E., 1986, P1; Pimm SL, 1989, BIOL INVASIONS GLOBA, P351; Rejmanek M, 1996, ECOL STU AN, V122, P153; SIMBERLOFF D, 1989, BIOL INVASIONS, P00061; Smith C.S., 1999, Biological Invasions, V1, P89, DOI 10.1023/A:1010091918466; Sol D, 2000, ECOGRAPHY, V23, P687, DOI 10.1034/j.1600-0587.2000.230606.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Williamson M, 1996, BIOL INVASIONS; WILLIAMSON MH, 1986, PHILOS T R SOC B, V314, P505, DOI 10.1098/rstb.1986.0070; [No title captured]	30	248	256	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					195	197		10.1038/35102557	http://dx.doi.org/10.1038/35102557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11700555				2022-12-01	WOS:000172029100044
J	Singer, S; Bergthold, L				Singer, S; Bergthold, L			Cosmetic vs reconstructive surgery for cleft palate: A window into the medical necessity debate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA	Stanford University	Singer, S (corresponding author), Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA.		Singer, Lynn/Q-2045-2019	Singer, Lynn/0000-0003-2950-9460				Cockell A, 2000, PRENATAL DIAG, V20, P149, DOI 10.1002/(SICI)1097-0223(200002)20:2<149::AID-PD764>3.0.CO;2-U; FREUDENHEIM M, 1999, NY TIMES        1109, pA1; LAUDICINA SS, 1999, LEGISLATIVE HLTH CAR; 2001, AETNA US HEALTHCARE	4	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2162	2162		10.1001/jama.286.17.2162	http://dx.doi.org/10.1001/jama.286.17.2162			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694163				2022-12-01	WOS:000172032100041
J	Barnes, PM; Price, L; Maddocks, A; Lyons, RA; Nash, P; McCabe, M				Barnes, PM; Price, L; Maddocks, A; Lyons, RA; Nash, P; McCabe, M			Unnecessary school absence after minor injury: case-control study	BRITISH MEDICAL JOURNAL			English	Article									Swansea NHS Trust, Cent Clin, Dept Community Child Hlth, Swansea SA1 1LT, W Glam, Wales; Iechyd Morgannwg Hlth Author, Dept Publ Hlth, Swansea SA1 1LT, W Glam, Wales; Neath Gen Hosp, Local Accid Ctr, Neath SA11 2LQ, Wales; Morriston Hosp, Swansea NHS Trust, Dept Accid & Emergency, Swansea SA6 6NL, W Glam, Wales	Morriston Hospital	Maddocks, A (corresponding author), Swansea NHS Trust, Cent Clin, Dept Community Child Hlth, Swansea SA1 1LT, W Glam, Wales.		Lyons, Ronan/G-7741-2012	Lyons, Ronan/0000-0001-5225-000X				KLERMAN LV, 1988, PEDIATR CLIN N AM, V35, P1253; Lyons R A, 1995, Inj Prev, V1, P173, DOI 10.1136/ip.1.3.173; TOWNSEND P, 1998, HLTH DEPRIVATION INE	3	21	21	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 3	2001	323	7320					1034	1035		10.1136/bmj.323.7320.1034	http://dx.doi.org/10.1136/bmj.323.7320.1034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691761	Bronze, Green Published			2022-12-01	WOS:000172055900017
J	Liu, ZH; Luyten, I; Bottomley, MJ; Messias, AC; Houngninou-Molango, S; Sprangers, R; Zanier, K; Kramer, A; Sattler, M				Liu, ZH; Luyten, I; Bottomley, MJ; Messias, AC; Houngninou-Molango, S; Sprangers, R; Zanier, K; Kramer, A; Sattler, M			Structural basis for recognition of the intron branch site RNA by splicing factor 1	SCIENCE			English	Article							PRE-MESSENGER-RNA; FRAGILE-X-SYNDROME; KH DOMAIN; BINDING-PROTEIN; SEQUENCE; HOMOLOGY; NMR; SPECIFICITY; ACTIVATION; ASSIGNMENT	During spliceosome assembly, splicing factor 1 (SF1) specifically recognizes the intron branch point sequence (BPS) UACUAAC in the pre-mRNA transcripts. We show that the KH-QUA2 region of SF1 defines an enlarged KH (hn RNP K) fold which is necessary and sufficient for BPS binding. The 3' part of the BPS (UAAC), including the conserved branch point adenosine (underlined), is specifically recognized in a hydrophobic cleft formed by the Gly-Pro-Arg-Gly motif and the variable loop of the KH domain. The QUA2 region recognizes the 5' nucleotides of the BPS (ACU). The branch point adenosine acting as the nucleophile in the first biochemical step of splicing is deeply buried. BPS RNA recognition suggests how SF1 may facilitate subsequent formation of the prespliceosomal complex A.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland	European Molecular Biology Laboratory (EMBL); University of Geneva	Sattler, M (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Sattler, Michael/A-2407-2012; Sattler, Michael/C-1169-2010	Sattler, Michael/0000-0002-1594-0527; Messias, Ana/0000-0002-5449-9922				Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Berglund JA, 1998, RNA, V4, P998, DOI 10.1017/S1355838298980499; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Berglund JA, 2001, RNA, V7, P682, DOI 10.1017/S1355838201002187; Billeter M, 1995, J BIOMOL NMR, V5, P1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Klein A, 1998, HUM MOL GENET, V7, P393, DOI 10.1093/hmg/7.3.393; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Folmer RHA, 1997, J BIOMOL NMR, V9, P245, DOI 10.1023/A:1018670623695; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Guth S, 2000, J BIOL CHEM, V275, P38059, DOI 10.1074/jbc.M001483200; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; Kuivenhoven JA, 1996, J CLIN INVEST, V98, P358, DOI 10.1172/JCI118800; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Musco G, 1997, NAT STRUCT BIOL, V4, P712, DOI 10.1038/nsb0997-712; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NICHOLLS A, 1991, PROTEIN-STRUCT FUNCT, V11, P282; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; Rutz B, 1999, RNA, V5, P819, DOI 10.1017/S1355838299982286; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Varani G, 1996, PROG NUCL MAG RES SP, V29, P51, DOI 10.1016/0079-6565(96)01028-X; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752	36	185	190	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1098	1102		10.1126/science.1064719	http://dx.doi.org/10.1126/science.1064719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691992				2022-12-01	WOS:000172013800049
J	Keeling, MJ; Woolhouse, MEJ; Shaw, DJ; Matthews, L; Chase-Topping, M; Haydon, DT; Cornell, SJ; Kappey, J; Wilesmith, J; Grenfell, BT				Keeling, MJ; Woolhouse, MEJ; Shaw, DJ; Matthews, L; Chase-Topping, M; Haydon, DT; Cornell, SJ; Kappey, J; Wilesmith, J; Grenfell, BT			Dynamics of the 2001 UK foot and mouth epidemic: Stochastic dispersal in a heterogeneous landscape	SCIENCE			English	Article							DISEASE EPIDEMIC; GREAT-BRITAIN; SPREAD; VACCINATION; STRATEGIES; MODELS; RATES; SHEEP; RISK; FMD	Foot-and-mouth is one of the world's most economically important livestock diseases. We developed an individual farm-based stochastic model of the current UK epidemic. The fine grain of the epidemiological data reveals the infection dynamics at an unusually high spatiotemporal resolution. We show that the spatial distribution, size, and species composition of farms all influence the observed pattern and regional variability of outbreaks. The other key dynamical component is long-tailed stochastic dispersal of infection, combining frequent local movements with occasional long jumps. We assess the history and possible duration of the epidemic, the performance of control strategies, and general implications for disease dynamics in space and time.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England	University of Cambridge; University of Edinburgh; University of Guelph; Veterinary Laboratories Agency	Keeling, MJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	matt@zoo.cam.ac.uk	Cornell, Stephen J/D-3955-2009; Matthews, Louise/E-2913-2013; Keeling, Matt J/J-9280-2012	Matthews, Louise/0000-0003-4420-8367; Keeling, Matt J/0000-0003-4639-4765; Shaw, Darren/0000-0003-2016-1541; Haydon, Daniel/0000-0002-1240-1886				ANDERSON R M, 1991; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Bates TW, 2001, AM J VET RES, V62, P1121, DOI 10.2460/ajvr.2001.62.1121; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Brownlie J, 2001, VET REC, V148, P358; Cannon RM, 1999, ENVIRON INT, V25, P713, DOI 10.1016/S0160-4120(99)00049-5; Cox SJ, 1999, VACCINE, V17, P1858, DOI 10.1016/S0264-410X(98)00486-1; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; DURRETT R, 1994, PHILOS T ROY SOC B, V343, P329, DOI 10.1098/rstb.1994.0028; Enserink M, 2001, SCIENCE, V292, P410, DOI 10.1126/science.292.5516.410; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Giles J, 2001, NATURE, V410, P727, DOI 10.1038/35071239; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; HUGHJONES ME, 1972, RES VET SCI, V13, P411, DOI 10.1016/S0034-5288(18)33984-5; HUGHJONES ME, 1970, J HYG-CAMB, V68, P253, DOI 10.1017/S0022172400028722; Hutber AM, 2000, TROP ANIM HEALTH PRO, V32, P285, DOI 10.1023/A:1005212922884; Kao RR, 2001, VET REC, V148, P746, DOI 10.1136/vr.148.24.746; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kitching R. P., 1994, State Veterinary Journal, V4, P7; Mason PW, 2001, AUST VET J, V79, P342, DOI 10.1111/j.1751-0813.2001.tb12009.x; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Morris RS, 2001, VET REC, V149, P137, DOI 10.1136/vr.149.5.137; Nielen M, 1996, PREV VET MED, V28, P143, DOI 10.1016/0167-5877(96)01042-2; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; Salt J. S., 1997, VET VACCINOLOGY, P641; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Woolhouse MEJ, 1996, EPIDEMIOL INFECT, V116, P363, DOI 10.1017/S0950268800052699	30	648	660	6	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					813	817		10.1126/science.1065973	http://dx.doi.org/10.1126/science.1065973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679661				2022-12-01	WOS:000171851800036
J	Glynn, I				Glynn, I			An intriguing door	NATURE			English	Editorial Material									Univ Cambridge, Trinity Coll, Cambridge CB2 1QT, England	University of Cambridge	Glynn, I (corresponding author), Univ Cambridge, Trinity Coll, Cambridge CB2 1QT, England.							Glynn I., 1999, ANATOMY THOUGHT ORIG; Holifield Robert J., 1987, DARWIN EMERGENCE EVO, P418; LOGOTHETIS NK, 1999, SCI AM           NOV, P44; ORICK F, 1994, ASTONISHING HYPOTHES	4	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					683	683		10.1038/35099639	http://dx.doi.org/10.1038/35099639			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607008	Bronze			2022-12-01	WOS:000171608000022
J	Steffan, JS; Bodai, L; Pallos, J; Poelman, M; McCampbell, A; Apostol, BL; Kazantsev, A; Schmidt, E; Zhu, YZ; Greenwald, M; Kurokawa, R; Housman, DE; Jackson, GR; Marsh, JL; Thompson, LM				Steffan, JS; Bodai, L; Pallos, J; Poelman, M; McCampbell, A; Apostol, BL; Kazantsev, A; Schmidt, E; Zhu, YZ; Greenwald, M; Kurokawa, R; Housman, DE; Jackson, GR; Marsh, JL; Thompson, LM			Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila	NATURE			English	Article							CREB-BINDING PROTEIN; HUNTINGTONS-DISEASE; EXPANDED POLYGLUTAMINE; MAMMALIAN-CELLS; TRANSGENIC MICE; LOCALIZATION; AGGREGATION; EXPRESSION; APOPTOSIS; GROWTH	Proteins with expanded polyglutamine repeats cause Huntington's disease and other neurodegenerative diseases. Transcriptional dysregulation and loss of function of transcriptional coactivator proteins have been implicated in the pathogenesis of these diseases(1). Huntington's disease is caused by expansion of a repeated sequence of the amino acid glutamine in the abnormal protein huntingtin (Htt). Here we show that the polyglutamine-containing domain of Htt, Htt exon 1 protein (Httex1p), directly binds the acetyltransferase domains of two distinct proteins: CREB-binding protein (CBP) and p300/CBP-associated factor (P/CAF). In cell-free assays, Httex1p also inhibits the acetyltransferase activity of at least three enzymes: p300, P/CAF and CBP. Expression of Httex1p in cultured cells reduces the level of the acetylated histones H3 and H4, and this reduction can be reversed by administering inhibitors of histone deacetylase (HDAC). In vivo, HDAC inhibitors arrest ongoing progressive neuronal degeneration induced by polyglutamine repeat expansion, and they reduce lethality in two Drosophila models of polyglutamine disease. These findings raise the possibility that therapy with HDAC inhibitors may slow or prevent the progressive neurodegeneration seen in Huntington's disease and other polyglutamine-repeat diseases, even after the onset of symptoms.	Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; NINCDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; University of California System; University of California Los Angeles	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Gillespie 2121, Irvine, CA 92697 USA.		Bodai, Laszlo/A-9764-2012; Pallos, Judit/AAE-6833-2020	Bodai, Laszlo/0000-0001-8411-626X; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002974, ZIANS002974] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AILSIALI S, 1998, NUCLEIC ACIDS RES, V26, P3869; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Franceschini N., 1972, INFORMATION PROCESSI, P75; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goodman RH, 2000, GENE DEV, V14, P1553; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Neufeld TP, 1998, GENETICS, V148, P277; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; REUTER G, 1982, MOL GEN GENET, V188, P480, DOI 10.1007/BF00330052; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Suhr ST, 1998, P NATL ACAD SCI USA, V95, P7999, DOI 10.1073/pnas.95.14.7999; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	27	942	1000	1	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					739	743		10.1038/35099568	http://dx.doi.org/10.1038/35099568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607033	Green Published			2022-12-01	WOS:000171608000045
J	Moss, J; DeCastro, R; Patronas, NJ; Taveira-DeSilva, A				Moss, J; DeCastro, R; Patronas, NJ; Taveira-DeSilva, A			Meningiomas in lymphangioleiomyomatosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; PROGESTERONE-RECEPTORS; TSC2; MUTATIONS; WOMEN; LYMPHANGIOMYOMATOSIS; EPIDEMIOLOGY; GROWTH; GENES	Context Lymphangioleiomyomatosis (LAM), a cystic lung disease associated with progressive respiratory failure, is found predominantly in women of childbearing age and therefore has been treated with progesterone and other hormonal agents. However, meningiomas have progesterone receptors, and progesterone is believed to be a mitogen for meningioma cells in culture. Since 30% to 40% of patients with tuberous sclerosis complex (TSC) have LAM, we routinely screen patients with LAM for brain lesions found in TSC. Objective To determine the prevalence of meningiomas in women with LAM. Design and Setting Analysis of results from ongoing routine screening protocols initiated in December 1995 at the National Heart, Lung, and Blood Institute. Patients Two hundred fifty women with sporadic LAM who were referred for screening by magnetic resonance imaging (MRI) and/or computed tomography (CT) of the brain. Main Outcome Measures Presence of meningiomas on MRI and/or CT scans. Results Eight women with LAM (3 with and 5 without a diagnosis of TSC) had lesions on MRI scans compatible with meningiomas. Five of the patients had been treated with progesterone. Multiple meningiomas were observed in 2 patients. Conclusions Women with LAM appear to have a high prevalence of meningiomas. We recommend that patients with LAM be screened for meningiomas regardless of diagnosis of TSC. In view of the lack of a documented effect of progesterone on progression of lung disease in LAM and the reported mitogenic response of meningiomas to progesterone, we recommend that the drug not be given to LAM patients with an MRI result consistent with diagnosis of meningioma.	NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA; NIH, Dept Diagnost Radiol, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Moss, J (corresponding author), NHLBI, Pulm Crit Care Med Branch, NIH, Room 6D05,Bldg 10,MSC 1590, Bethesda, MD 20892 USA.	mossj@nhlbi.nih.gov						Avila NA, 2000, RADIOLOGY, V214, P441, DOI 10.1148/radiology.214.2.r00fe41441; Blankenstein MA, 2000, STEROIDS, V65, P795, DOI 10.1016/S0039-128X(00)00193-8; Boehler A, 1996, NEW ENGL J MED, V335, P1275, DOI 10.1056/NEJM199610243351704; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; BONETTI F, 1993, AM J SURG PATHOL, V17, P1092, DOI 10.1097/00000478-199311000-00002; CARROLL RS, 1993, CANCER RES, V53, P1312; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chu SC, 1999, CHEST, V115, P1041, DOI 10.1378/chest.115.4.1041; Cordier JF, 1999, LUNG BIOL HEALTH DIS, V131, P9; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Gomez MR, 1988, TUBEROUS SCLEROSIS, P9; GRUNBERG SM, 1994, HUM REPROD, V9, P202, DOI 10.1093/humrep/9.suppl_1.202; Hewitt S, 1999, AM J RESP CRIT CARE, V159, pA531; Izumi T, 1999, LUNG BIOL HEALTH DIS, V131, P1; JAY JR, 1985, J NEUROSURG, V62, P757, DOI 10.3171/jns.1985.62.5.0757; KALASSIAN GK, 1999, LAM OTHER DIS CHARAC, P45; Kalassian KG, 1997, AM J RESP CRIT CARE, V155, P1183, DOI 10.1164/ajrccm.155.4.9105053; Lie J. T., 1999, TUBEROUS SCLEROSIS C, P207; MAXWELL M, 1990, INT J CANCER, V46, P16, DOI 10.1002/ijc.2910460106; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; NELLIST M, 1993, CELL, V75, P1305; Roach ES, 1999, J CHILD NEUROL, V14, P401, DOI 10.1177/088307389901400610; Short MP, 1999, LUNG BIOL HEALTH DIS, V131, P387; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Strizheva GD, 2001, AM J RESP CRIT CARE, V163, P253, DOI 10.1164/ajrccm.163.1.2005004; SUTHERLAND GR, 1987, CAN J NEUROL SCI, V14, P586; TAYLOR JR, 1990, NEW ENGL J MED, V323, P1254, DOI 10.1056/NEJM199011013231807; TONN JC, 1994, ANTICANCER RES, V14, P2453; Trulock EP, 1999, LUNG BIOL HEALTH DIS, V131, P65; VALENCIA JC, 2000, AM J RESP CRIT CARE, V161, pA15; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Weiner DM, 1998, J AM COLL SURGEONS, V187, P548, DOI 10.1016/S1072-7515(98)00239-7; Zhang H, 1999, J HUM GENET, V44, P391, DOI 10.1007/s100380050185	33	35	36	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1879	1881		10.1001/jama.286.15.1879	http://dx.doi.org/10.1001/jama.286.15.1879			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482UH	11597290	Bronze			2022-12-01	WOS:000171595300029
J	Fagarasan, S; Kinoshita, K; Muramatsu, M; Ikuta, K; Honjo, T				Fagarasan, S; Kinoshita, K; Muramatsu, M; Ikuta, K; Honjo, T			In situ class switching and differentiation to IgA-producing cells in the gut lamina propria	NATURE			English	Article							CYTIDINE DEAMINASE AID; B-CELLS; SURFACE-RECEPTORS; MARGINAL ZONE; PLASMA-CELLS; CD40 LIGAND; FC RECEPTOR; MICE; ACTIVATION; EXPRESSION	One of the front lines of the immune defence is the gut mucosa, where immunoglobulin-alpha (IgA) is continuously produced to react with commensal bacteria and dietary antigens. It is generally accepted that, after antigenic stimulation in the Peyer's patches, IgA(+) lymphoblasts (B220(+)IgA(+)) migrate through the lymph and blood circulation, and eventually home to the lamina propria of the intestine(1,2). Mice that lack activation-induced cytidine deaminase (AID) are defective in class switch recombination (CSR) and somatic hypermutation(3). CSR changes the immunoglobulin heavy chain constant region (CH) gene being expressed from C mu to other CH genes, resulting in a switch of the immunoglobulin isotype from IgM to IgG, IgE or IgA. AID(-/-) mice also secrete large amounts of immunoglobulin-m (IgM) into faeces, and accumulate B220(-)IgM(+) plasma cells as well as B220(+)IgM(+) cells in the gut. Here we show that lamina propria B220(+)IgA(+) cells have just completed CSR, as they still express both AID and transcripts from circular DNA that has been 'looped-out' during CSR. Lamina propria IgM(+) B cells seem to be pre-committed to switching to IgA(+) in vitro as well as in vivo. Culturing lamina propria IgM(+) B cells together with lamina propria stromal cells enhances preferential switching and differentiation of B cells to IgA(+) plasma cells. We conclude that IgA(+) cells in the gut lamina propria are generated in situ from B220(+)IgM(+) lymphocytes.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Muramatsu, Masamichi/C-4339-2015; Fagarasan, Sidonia/A-5258-2016; Honjo, Tasuku/N-4470-2016	Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan, Sidonia/0000-0003-2086-6402; Ikuta, Koichi/0000-0003-1319-1021				COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fagarasan S, 2000, IMMUNOL REV, V176, P205; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; KINOSHITA K, IN PRESS P NATL ACAD; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; LEBMAN DA, 1987, J EXP MED, V166, P1405, DOI 10.1084/jem.166.5.1405; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martin F, 1999, CURR TOP MICROBIOL, V246, P45; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Shparago N, 1996, INT IMMUNOL, V8, P781, DOI 10.1093/intimm/8.5.781; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; TSENG J, 1981, J IMMUNOL, V127, P2039; WALDSCHMIDT TJ, 1988, J IMMUNOL, V140, P2148; WALDSCHMIDT TJ, 1991, INT IMMUNOL, V3, P305, DOI 10.1093/intimm/3.4.305; Watanabe N, 2000, J EXP MED, V192, P1577, DOI 10.1084/jem.192.11.1577; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5	31	325	338	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					639	643		10.1038/35098100	http://dx.doi.org/10.1038/35098100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675788				2022-12-01	WOS:000171485700051
J	Hemann, MT; Strong, MA; Hao, LY; Greider, CW				Hemann, MT; Strong, MA; Hao, LY; Greider, CW			The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability	CELL			English	Article							MINOR SATELLITE DNA; REPLICATIVE SENESCENCE; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; HUMAN FIBROBLASTS; PROTEIN; REPAIR; RNA; IDENTIFICATION; RECOMBINATION	Loss of telomere function can induce cell cycle arrest and apoptosis. To investigate the processes that trigger cellular responses to telomere dysfunction, we crossed mTR-/- G6 mice that have short telomeres with mice heterozygous for telomerase (mTR+/-) that have long telomeres. The phenotype of the telomerase null offspring was similar to that of the late generation parent, although only half of the chromosomes were short. Strikingly, spectra[ karyotyping (SKY) analysis revealed that loss of telomere function occurred preferentially on chromosomes with critically short telomeres. Our data indicate that, while average telomere length is measured in most studies, it is not the average but rather the shortest telomeres that constitute telomere dysfunction and limit cellular survival in the absence of telomerase.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Grad Training Program Human Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Greider, CW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.			Greider, Carol/0000-0002-5494-8126; Strong, Margaret/0000-0002-0055-6573	NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA16519] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Blackburn E, 1999, MT SINAI J MED, V66, P292; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Chiu CP, 1997, P SOC EXP BIOL MED, V214, P99; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; GARAGNA S, 1995, CHROMOSOMA, V103, P685, DOI 10.1007/BF00344229; Garagna S, 2001, P NATL ACAD SCI USA, V98, P171, DOI 10.1073/pnas.98.1.171; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guiducci C, 2001, ONCOGENE, V20, P714, DOI 10.1038/sj.onc.1204145; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; HEMANN MT, 2001, COLD SPRING HARB S Q; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim MM, 2001, P NATL ACAD SCI USA, V98, P7982, DOI 10.1073/pnas.131211098; KIPLING D, 1991, GENOMICS, V11, P235, DOI 10.1016/0888-7543(91)90128-2; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633; Lansdorp PM, 2000, MECH AGEING DEV, V118, P23, DOI 10.1016/S0047-6374(00)00151-2; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Marusic L, 1997, MOL CELL BIOL, V17, P6394, DOI 10.1128/MCB.17.11.6394; McClintock B, 1942, P NATL ACAD SCI USA, V28, P458, DOI 10.1073/pnas.28.11.458; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; McClintock B, 1941, GENETICS, V26, P234; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; Muller HJ., 1938, COLLECT NET, V13, P181; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; PIETRAS DF, 1983, NUCLEIC ACIDS RES, V11, P6965, DOI 10.1093/nar/11.20.6965; SHAMPAY J, 1988, P NATL ACAD SCI USA, V85, P534, DOI 10.1073/pnas.85.2.534; Slijepcevic P, 1998, CHROMOSOMA, V107, P136, DOI 10.1007/s004120050289; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	50	859	887	3	53	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					67	77		10.1016/S0092-8674(01)00504-9	http://dx.doi.org/10.1016/S0092-8674(01)00504-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595186	Bronze			2022-12-01	WOS:000171453100010
J	Ling, H; Boudsocq, F; Woodgate, R; Yang, W				Ling, H; Boudsocq, F; Woodgate, R; Yang, W			Crystal structure of a Y-family DNA polymerase in action: A mechanism for error-prone and lesion-bypass replication	CELL			English	Article							REPAIR PROTEIN MUTS; ESCHERICHIA-COLI; MISMATCH REPAIR; GENE ENCODES; LARGE FRAGMENT; THYMINE DIMER; FIDELITY; COMPLEX; IOTA; ETA	Sulfolobus solfataricus P2 DNA polymerase IV [Dpo4) is a DinB homolog that belongs to the recently described Y-family of DNA polymerases, which are best characterized by their low-fidelity synthesis on undamaged DNA templates and propensity to traverse normally replication-blocking lesions. Crystal structures of Dpo4 in ternary complexes with DNA and an incoming nucleotide, either correct or incorrect, have been solved at 1.7 Angstrom and 2.1 Angstrom resolution, respectively. Despite a conserved active site and a hand-like configuration similar to all known polymerases, Dpo4 makes limited and nonspecific contacts with the replicating base pair, thus relaxing base selection. Dpo4 is also captured in the crystal translocating two template bases to the active site at once, suggesting a possible mechanism for bypassing thymine dimers.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		Yang, Wei/ABB-4785-2020; Yang, Wei/D-4926-2011; Ling, Hong/E-3729-2010	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Woodgate, Roger/0000-0001-5581-4616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036119, ZIADK036119] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOUDSOCQ F, 2001, IN PRESS NUCL ACIDS; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Friedberg EC, 1999, CELL, V98, P413, DOI 10.1016/S0092-8674(00)81970-4; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ishikawa T, 2001, J BIOL CHEM, V276, P15155, DOI 10.1074/jbc.M009822200; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2000, P NATL ACAD SCI USA, V97, P3838, DOI 10.1073/pnas.97.8.3838; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kondratick CM, 2001, MOL CELL BIOL, V21, P2018, DOI 10.1128/MCB.21.6.2018-2025.2001; Kulaeva OI, 1996, MUTAT RES-FUND MOL M, V357, P245, DOI 10.1016/0027-5107(96)00164-9; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ohashi E, 2000, GENE DEV, V14, P1589; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Strauss BS, 2000, J BACTERIOL, V182, P6742, DOI 10.1128/JB.182.23.6742-6750.2000; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tissier A, 2000, GENE DEV, V14, P1642; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Vaisman A, 2001, J BIOL CHEM, V276, P30615, DOI 10.1074/jbc.M102694200; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	56	532	540	2	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					91	102		10.1016/S0092-8674(01)00515-3	http://dx.doi.org/10.1016/S0092-8674(01)00515-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595188	Bronze			2022-12-01	WOS:000171453100012
J	Beecham, L; Dorozynski, A; Sheldon, T; Turone, F; Mach, A; Bosch, X; Charatan, FB; Mahkorn, DT; Siegel-Itzkovich, J				Beecham, L; Dorozynski, A; Sheldon, T; Turone, F; Mach, A; Bosch, X; Charatan, FB; Mahkorn, DT; Siegel-Itzkovich, J			Viagra falls: the debate over rationing continues	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 26	1998	317	7162					836	838						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125DN	11645103				2022-12-01	WOS:000076222300013
J	Kao, RR; Gravenor, MB; Baylis, M; Bostock, CJ; Chihota, CM; Evans, JC; Goldmann, W; Smith, AJA; McLean, AR				Kao, RR; Gravenor, MB; Baylis, M; Bostock, CJ; Chihota, CM; Evans, JC; Goldmann, W; Smith, AJA; McLean, AR			The potential size and duration of an epidemic of bovine spongiform encephalopathy in British sheep	SCIENCE			English	Article							GREAT-BRITAIN; PRP GENOTYPE; SCRAPIE; TRANSMISSION; INFECTIVITY; MODEL	Because there is a theoretical possibility that the British national sheep flock is infected with bovine spongiform encephalopathy (BSE), we examined the extent of a putative epidemic. An age cohort analysis based on numbers of infected cattle, dose responses of cattle and sheep to BSE, levels of exposure to infected feed, and number of BSE-susceptible sheep in the United Kingdom showed that at the putative epidemic peak in 1990, the number of cases of BSE-infected sheep would have ranged from fewer than 10 to about 1500. The model predicts that fewer than 20 clinical cases of BSE in sheep would be expected in 2001 if maternal transmission occurred at a rate of 10%. Although there are large uncertainties in the parameter estimates, all indications are that current prevalence is low; however, a simple model of flock-to-flock BSE transmission shows that horizontal transmission, if it has occurred, could eventually cause a large epidemic.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Inst Anim Hlth, Compton Lab, Compton RG20 7NN, Berks, England; Inst Anim Hlth, Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Edinburgh	Kao, RR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Baylis, Matthew/S-7694-2019	Baylis, Matthew/0000-0003-0335-187X; Kao, Rowland/0000-0003-0919-6401				ALMOND J, 1999, RES SURVEILLANCE TSE; Balter M, 2000, SCIENCE, V287, P1906, DOI 10.1126/science.287.5460.1906; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; BAYLIS M, UNPUB; *DEP ENV FOOD RUR, 2001, PB5796 DEP ENV FOOD; DICKINSON AG, 1975, NATURE, V253, P556, DOI 10.1038/253556a0; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Gravenor MB, 2000, NATURE, V406, P584, DOI 10.1038/35020692; Gravenor MB, 2001, P ROY SOC B-BIOL SCI, V268, P587, DOI 10.1098/rspb.2000.1462; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hoinville L, 1999, VET REC, V145, P405, DOI 10.1136/vr.145.14.405; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Horn G., 2001, REV ORIGIN BSE, P4; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Kao RR, 2001, MATH BIOSCI, V174, P61, DOI 10.1016/S0025-5564(01)00082-7; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1994, ANN NY ACAD SCI, V724, P210, DOI 10.1111/j.1749-6632.1994.tb38911.x; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; PHILLIPS N, 1999, REPORT INQUIRY BSE V; Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669; Stevenson MA, 2000, VET REC, V147, P349, DOI 10.1136/vr.147.13.349; Stringer SM, 1998, MATH BIOSCI, V153, P79, DOI 10.1016/S0025-5564(98)10036-6; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0; 1998, C782506 MEAT LIV COM; 2001, VET REC, V149, P164; 1998, 5211 SEAC	29	80	82	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					332	335		10.1126/science.1067475	http://dx.doi.org/10.1126/science.1067475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11719694				2022-12-01	WOS:000173278600051
J	Schwetz, BA				Schwetz, BA			Remote data pacemaker	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	10	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2001	286	21					2660	2660		10.1001/jama.286.21.2660-b	http://dx.doi.org/10.1001/jama.286.21.2660-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498AU	11730423				2022-12-01	WOS:000172488300006
J	Moore, MJ; Rosbash, M				Moore, MJ; Rosbash, M			Cell biology - TAPping into mRNA export	SCIENCE			English	Editorial Material							DELIVERY; PEPTIDES; PROTEINS		Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute	Moore, MJ (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.							Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Gariepy J, 2001, TRENDS BIOTECHNOL, V19, P21, DOI 10.1016/S0167-7799(00)01520-1; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hawiger J, 1999, CURR OPIN CHEM BIOL, V3, P89, DOI 10.1016/S1367-5931(99)80016-7; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Morris MC, 2000, CURR OPIN BIOTECH, V11, P461, DOI 10.1016/S0958-1669(00)00128-2; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Zenklusen D, 2001, FEBS LETT, V498, P150, DOI 10.1016/S0014-5793(01)02482-6	15	14	14	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1841	1842		10.1126/science.1067676	http://dx.doi.org/10.1126/science.1067676			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729289				2022-12-01	WOS:000172465000031
J	Polis, MA; Sidorov, IA; Yoder, C; Jankelevich, S; Metcalf, J; Mueller, BU; Dimitrov, MA; Pizzo, P; Yarchoan, R; Dimitrov, DS				Polis, MA; Sidorov, IA; Yoder, C; Jankelevich, S; Metcalf, J; Mueller, BU; Dimitrov, MA; Pizzo, P; Yarchoan, R; Dimitrov, DS			Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy	LANCET			English	Article							LYMPHOCYTE COUNTS; PHASE I/II; THERAPY; INFECTION; SUPPRESSION; DURATION; CHILDREN; VIRUS	Background Early assessment of antiretroviral drug efficacy is important for prevention of the emergence of drug-resistant virus and unnecessary exposure to ineffective drug regimens. Current US guidelines for changing therapy are based on measurements of plasma HIV-1 RNA concentrations 4 or 8 weeks after the start of treatment with cut-off points of 0.75 or 1.00 log, respectively. We investigated the possibility of assessing drug efficacy from measurements of plasma HIV-1 concentrations made during the first week on therapy. Methods The kinetics of virus decay in plasma during the first 12 weeks of treatment was analysed for 124 HIV-1-infected patients being treated for the first time with a protease inhibitor. Patients with a continuous decline of HIV-1 concentrations and in whom HIV-1 was either undetectable or declined by more than 1.5 log at 12 weeks were defined as good responders; the rest were poor responders. Findings The individual virus decay rate constants (k) at day 6 correlated significantly (r>0.66, p<0.0001) with changes in HIV-1 concentrations at 4, 8, and 12 weeks, and correctly predicted 84% of the responses with a cut-off value of k=0.21 per day (in log scale). Reduction in plasma HIV-1 of less than 0.72 log by day 6 after initiation of therapy predicted poor long-term responses in more than 99% of patients. Interpretation These results suggest that changes in HIV-1 concentration at day 6 after treatment initiation are major correlates of longer-term virological responses. They offer a very early measure of individual long-term responses, suggesting that treatment could be optimised after only a few days of therapy.	NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; NCI, Lab Expt & Computat Biol, NIH, Frederick, MD 21701 USA; NIH, Warren Grant Magnuson Clin Ctr, Dept Crit Care Med, Bethesda, MD 20892 USA; Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; Baylor Coll Med, Hematol Serv, Houston, TX 77030 USA; NIH, Ctr Sci Review, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; NCI, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Polis, MA (corresponding author), NIAID, Immunoregulat Lab, NIH, Bldg 10,Room 11C103, Bethesda, MD 20892 USA.			Polis, Michael/0000-0002-9151-2268; Sidorov, Igor/0000-0001-6519-4983	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000390, Z01AI000390] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Grossman Z, 1998, IMMUNOL TODAY, V19, P528, DOI 10.1016/S0167-5699(98)01353-X; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Hoetelmans RMW, 1998, AIDS, V12, pF111, DOI 10.1097/00002030-199811000-00002; Huang W, 2001, J INFECT DIS, V183, P1455, DOI 10.1086/320192; Hughes MD, 1997, ANN INTERN MED, V126, P929, DOI 10.7326/0003-4819-126-12-199706150-00001; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Lepri AC, 2001, AIDS, V15, P47, DOI 10.1097/00002030-200101050-00008; Maggiolo F, 2000, J ACQ IMMUN DEF SYND, V25, P36, DOI 10.1097/00126334-200009010-00005; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MILLER RG, 1974, BIOMETRIKA, V61, P1; Mittler J, 2001, ANTIMICROB AGENTS CH, V45, P1438, DOI 10.1128/AAC.45.5.1438-1443.2001; Mueller BU, 1998, PEDIATRICS, V102, P101, DOI 10.1542/peds.102.1.101; Mueller BU, 1998, AIDS, V12, pF191, DOI 10.1097/00002030-199815000-00004; Mueller BU, 1998, PEDIATRICS, V101, P335, DOI 10.1542/peds.101.3.335; Nelson PW, 2000, MATH BIOSCI, V163, P201, DOI 10.1016/S0025-5564(99)00055-3; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; OBrien WA, 1997, ANN INTERN MED, V126, P939, DOI 10.7326/0003-4819-126-12-199706150-00002; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Rizzardi GP, 2000, J CLIN INVEST, V105, P777, DOI 10.1172/JCI9079; *US HLTH HUM SERV, 2001, GUID US ANT AG HIV I; Wein LM, 1998, J THEOR BIOL, V192, P81, DOI 10.1006/jtbi.1997.0622; Weverling GJ, 1998, AIDS, V12, pF117, DOI 10.1097/00002030-199811000-00003; Wu H, 1999, AIDS, V13, P429, DOI 10.1097/00002030-199902250-00022; Wu HL, 1999, J INFECT DIS, V179, P799, DOI 10.1086/314670	25	85	86	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 24	2001	358	9295					1760	1765		10.1016/S0140-6736(01)06802-7	http://dx.doi.org/10.1016/S0140-6736(01)06802-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496FG	11734232				2022-12-01	WOS:000172385100010
J	Emery, NJ; Clayton, NS				Emery, NJ; Clayton, NS			Effects of experience and social context on prospective caching strategies by scrub jays	NATURE			English	Article							BLACK-CAPPED CHICKADEES; APHELOCOMA-COERULESCENS; MEMORY; BEHAVIOR; PRIMATES; CACHES; SITES; TIME; MIND	Social life has costs associated with competition for resources such as food(1). Food storing may reduce this competition as the food can be collected quickly and hidden elsewhere(2-4); however, it is a risky strategy because caches can be pilfered by others(5-9). Scrub jays (Aphelocoma coerulescens) remember 'what', 'where' and 'when' they cached(10-13). Like other corvids(6-9,14), they remember where conspecifics have cached, pilfering them when given the opportunity, but may also adjust their own caching strategies to minimize potential pilfering. To test this, jays were allowed to cache either in private (when the other bird's view was obscured) or while a conspecific was watching, and then recover their caches in private. Here we show that jays with prior experience of pilfering another bird's caches subsequently re-cached food in new cache sites during recovery trials, but only when they had been observed caching. Jays without pilfering experience did not, even though they had observed other jays caching. Our results suggest that jays relate information about their previous experience as a pilferer to the possibility of future stealing by another bird, and modify their caching strategy accordingly.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England	University of Cambridge; University of Cambridge	Clayton, NS (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.		Clayton, Nicola s/A-2891-2010	Clayton, Nicola/0000-0003-1835-423X				BAKER MC, 1995, ANIM BEHAV, V49, P1599, DOI 10.1016/0003-3472(95)90081-0; Bednekoff PA, 1996, ANIM BEHAV, V52, P833, DOI 10.1006/anbe.1996.0228; BUGNYAR T, 2001, ADV ETHOL, V36, P106; CLARKSON K, 1986, J ANIM ECOL, V55, P111, DOI 10.2307/4696; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 1999, J COMP PSYCHOL, V113, P403, DOI 10.1037/0735-7036.113.4.403; Clayton NS, 2001, PHILOS T R SOC B, V356, P1483, DOI 10.1098/rstb.2001.0947; Clayton NS, 1999, ANIM BEHAV, V57, P435, DOI 10.1006/anbe.1998.0989; Clayton NS, 2001, J EXP PSYCHOL-ANIM B, V27, P17, DOI 10.1037//0097-7403.27.1.17; Clayton NS, 1999, J EXP PSYCHOL ANIM B, V25, P82, DOI 10.1037/0097-7403.25.1.82; GIBB JOHN A., 1960, IBIS, V102, P163, DOI 10.1111/j.1474-919X.1960.tb07112.x; Goodwin D., 1956, Ibis, V98, P186, DOI 10.1111/j.1474-919X.1956.tb03040.x; HAMPTON RR, 1994, BEHAV ECOL, V5, P44, DOI 10.1093/beheco/5.1.44; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Heinrich B, 1998, ANIM BEHAV, V56, P1083, DOI 10.1006/anbe.1998.0906; Heinrich B., 1999, MIND RAVEN; Heyes CM, 1998, BEHAV BRAIN SCI, V21, P101, DOI 10.1017/S0140525X98000703; SHETTLEWORTH SJ, 1995, BEHAV BRAIN RES NATU, P158; STEVENS TA, 1986, IBIS, V128, P513, DOI 10.1111/j.1474-919X.1986.tb02703.x; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Vander Wall S.B., 1990, FOOD HOARDING ANIMAL; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682; ZENTALL TR, 1998, SOCIAL LEARNING PSYC	24	333	348	3	120	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					443	446		10.1038/35106560	http://dx.doi.org/10.1038/35106560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	494UP	11719804				2022-12-01	WOS:000172304500042
J	Katinka, MD; Duprat, S; Cornillot, E; Metenier, G; Thomarat, F; Prensier, G; Barbe, V; Peyretaillade, E; Brottier, P; Wincker, P; Delbac, F; El Alaoui, H; Peyret, P; Saurin, W; Gouy, M; Weissenbach, J; Vivares, CP				Katinka, MD; Duprat, S; Cornillot, E; Metenier, G; Thomarat, F; Prensier, G; Barbe, V; Peyretaillade, E; Brottier, P; Wincker, P; Delbac, F; El Alaoui, H; Peyret, P; Saurin, W; Gouy, M; Weissenbach, J; Vivares, CP			Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi	NATURE			English	Article							MOLECULAR EVIDENCE; MICROSPORIDIA; PROTEIN; AMITOCHONDRIATE; MITOCHONDRIA; PHYLOGENY; ORIGIN; HSP70	Microsporidia are obligate intracellular parasites infesting many animal groups(1). Lacking mitochondria and peroxysomes, these unicellular eukaryotes were first considered a deeply branching protist lineage(2) that diverged before the endosymbiotic event that led to mitochondria. The discovery of a gene for a mitochondrial-type chaperone(3-5) combined with molecular phylogenetic data(6-9) later implied that microsporidia are atypical fungi that lost mitochondria during evolution. Here we report the DNA sequences of the 11 chromosomes of the similar to2.9-megabase (Mb) genome of Encephalitozoon cuniculi (1,997 potential protein-coding genes). Genome compaction is reflected by reduced intergenic spacers and by the shortness of most putative proteins relative to their eukaryote orthologues. The strong host dependence is illustrated by the lack of genes for some biosynthetic pathways and for the tricarboxylic acid cycle. Phylogenetic analysis lends substantial credit to the fungal affiliation of microsporidia. Because the E. cuniculi genome contains genes related to some mitochondrial functions (for example, Fe-S cluster assembly), we hypothesize that microsporidia have retained a mitochondrion-derived organelle.	Univ Clermont Ferrand, Lab Biol Protistes, CNRS, UMR 6023, F-63177 Clermont Ferrand, France; Genoscope, CNRS, UMR 8030, F-91057 Evry, France; Univ Lyon 1, Lab Biometrie & Biol Evolut, CNRS, UMR 5558, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Vivares, CP (corresponding author), Univ Clermont Ferrand, Lab Biol Protistes, CNRS, UMR 6023, F-63177 Clermont Ferrand, France.	christian.vivares@lbp.univ-bpclermont.fr	Cornillot, Emmanuel/P-9656-2017	Cornillot, Emmanuel/0000-0002-1202-1162; El Alaoui, Hicham/0000-0003-1926-0905; PEYRET, Pierre/0000-0003-3114-0586				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Artiguenave F, 2000, FEBS LETT, V487, P13, DOI 10.1016/S0014-5793(00)02273-0; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Biderre C, 1995, MOL BIOCHEM PARASIT, V74, P229, DOI 10.1016/0166-6851(95)02495-6; Bohne W, 2000, INFECT IMMUN, V68, P2268, DOI 10.1128/IAI.68.4.2268-2275.2000; Brugere JF, 2000, NUCLEIC ACIDS RES, V28, P2026, DOI 10.1093/nar/28.10.2026; Delbac F, 2001, INFECT IMMUN, V69, P1016, DOI 10.1128/IAI.69.2.1016-1024.2001; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0; El Alaoui H, 2001, J PARASITOL, V87, P554; Germot A, 1997, MOL BIOCHEM PARASIT, V87, P159, DOI 10.1016/S0166-6851(97)00064-9; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Hirt RP, 1997, CURR BIOL, V7, P995, DOI 10.1016/S0960-9822(06)00420-9; Karlberg O, 2000, YEAST, V17, P170, DOI 10.1002/1097-0061(20000930)17:3<170::AID-YEA25>3.0.CO;2-V; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Mai ZM, 1999, MOL CELL BIOL, V19, P2198; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Peyret P, 2001, GENOME RES, V11, P198, DOI 10.1101/gr.164301; Peyretaillade E, 1998, MOL BIOL EVOL, V15, P683, DOI 10.1093/oxfordjournals.molbev.a025971; Rodriguez MA, 1998, MICROB PATHOGENESIS, V25, P1, DOI 10.1006/mpat.1998.0202; Shirakura T, 2001, MOL BIOCHEM PARASIT, V112, P153, DOI 10.1016/S0166-6851(00)00356-X; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Van de Peer Y, 2000, GENE, V246, P1, DOI 10.1016/S0378-1119(00)00063-9; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; Weidner Earl, 1999, P172; Wittner M., 1999, MICROSPORIDIA MICROS, DOI 10.1128/9781555818227; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	30	766	1265	1	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 22	2001	414	6862					450	453		10.1038/35106579	http://dx.doi.org/10.1038/35106579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719806	hybrid			2022-12-01	WOS:000172304500044
J	Gesensway, D				Gesensway, D			Reasons for sex-specific and gender-specific study of health topics	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2001	135	10					935	938		10.7326/0003-4819-135-10-200111200-00032	http://dx.doi.org/10.7326/0003-4819-135-10-200111200-00032			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DY	11712902				2022-12-01	WOS:000172267500026
J	Loucks, CJ; Lu, Z; Dinerstein, E; Wang, H; Olson, DM; Zhu, CQ; Wang, DJ				Loucks, CJ; Lu, Z; Dinerstein, E; Wang, H; Olson, DM; Zhu, CQ; Wang, DJ			Ecology - Giant pandas in a changing landscape	SCIENCE			English	Editorial Material									World Wildlife Fund US, Washington, DC 20037 USA; World Wildlife Fund Nat China, Beijing 100020, Peoples R China; Peking Univ, Giant Panda Conservat & Res Ctr, Beijing 100871, Peoples R China	Peking University	Loucks, CJ (corresponding author), World Wildlife Fund US, Washington, DC 20037 USA.	colby.loucks@wwfus.org						Baragona K, 2001, SCIENCE, V293, P603; Brooks T, 2001, SCIENCE, V293, P603; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; *CHIN MIN FOR WWF, 1989, NAT CONS MAN PLAN GI; Liu JG, 2001, SCIENCE, V293, P603; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; LOUCKS CJ, UNPUB; Lu Zhi, 2000, Conservation Biology Series (Cambridge), V3, P325; OBRIEN SJ, 1994, NATURE, V369, P179, DOI 10.1038/369179a0; Pan W., 2001, OPPORTUNITY GIANT PA; Pan W., 1988, GIANT PANDAS NATURAL; Peyton B., 1999, BEARS STATUS SURVEY; *WWF TRAFF, 2001, REP EC SOC ENV IMP C; YAN X, 2000, GIANT PAND CONS ASS; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135; ZHU C, IN PRESS CASE STUDY	16	102	118	2	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1465	1465		10.1126/science.1064710	http://dx.doi.org/10.1126/science.1064710			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711657				2022-12-01	WOS:000172240500026
J	Cheng, E; Myers, L; Wolf, S; Shatin, D; Cui, XP; Ellison, G; Belin, T; Vickrey, B				Cheng, E; Myers, L; Wolf, S; Shatin, D; Cui, XP; Ellison, G; Belin, T; Vickrey, B			Mobility impairments and use of preventive services in women with multiple sclerosis: observational study	BRITISH MEDICAL JOURNAL			English	Article									Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Ctr Hlth Care Policy & Evaluat, Minnetonka, MN USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cheng, E (corresponding author), Univ Calif Los Angeles, Dept Neurol, 650 Charles Young Dr S, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS081764] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Becker H, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90218-5; FRAME PS, 1992, AM FAM PHYSICIAN, V45, P1192; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; US Department of Health and Human Services, 1995, HLTH PEOPL 2000 NAT; Vickrey BG, 2000, NEUROLOGY, V55, P1341, DOI 10.1212/WNL.55.9.1341	5	36	37	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					968	969		10.1136/bmj.323.7319.968	http://dx.doi.org/10.1136/bmj.323.7319.968			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679386	Green Published, Bronze			2022-12-01	WOS:000171918500017
J	Griffiths, C; Kaur, G; Gantley, M; Feder, G; Hillier, S; Goddard, J; Packe, G				Griffiths, C; Kaur, G; Gantley, M; Feder, G; Hillier, S; Goddard, J; Packe, G			Influences on hospital admission for asthma in south Asian and white adults: qualitative interview study	BRITISH MEDICAL JOURNAL			English	Article							SOCIOECONOMICALLY DEPRIVED AREAS; SUBCONTINENT ETHNIC-GROUPS; OUTCOMES; RATES; POPULATION; BIRMINGHAM; EDUCATION; IMPACT; CITY; UK	Objective To explore reasons for increased risk of hospital admission among south Asian patients with asthma. Design Qualitative interview study using modified critical incident technique and framework analysis. Setting Newham, east London, a deprived area with a large mixed south Asian population. Participants 58 south Asian and white adults With asthma (49 admitted to hospital with asthma, 9 not admitted); 17 general practitioners; 5 accident and emergency doctors; 2 out of hours general practitioners; 1 asthma specialist nurse. Main outcome measures Patients' and health professionals' views on influences on admission, events leading to admission, general practices' organisation and asthma strategies, doctor-patient relationship, and cultural attitudes to asthma. Results South Asian and white patients admitted to hospital coped differently with asthma. South Asians described less confidence in controlling their asthma, were unfamiliar with the concept of preventive medication, and often expressed less confidence in their general practitioner. South Asians managed asthma exacerbations with family advocacy, without systematic changes in prophylaxis, and without systemic corticosteroids. Patients describing difficulty accessing primary care during asthma exacerbations were registered with practices with weak strategies for asthma care and were often south Asian. Patients with easy access described care suggesting partnerships with their general practitioner, had better confidence to control asthma, and were registered with practices with Well developed asthma strategies that included policies low avoiding hospital admission. Conclusions The different ways of coping with asd)ina exacerbations and accessing care may partly explain the increased risk of hospital admission in south Asian patients. Interventions that increase confidence to control asthma, confidence in the general practitioner, understanding of preventive treatment, and use of systemic corticosteroids in exacerbations may reduce hospital admissions. Development of more sophisticated asthma strategies by practices with better access and partnerships with patients tray also achieve this.	Queen Marys Sch Med & Dent, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England; Royal London Hosp, Dept Human Sci & Med Eth, London E1 2AD, England; Newham Dist Gen Hosp, London, England	University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital	Griffiths, C (corresponding author), Queen Marys Sch Med & Dent, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England.			Feder, Gene/0000-0002-7890-3926				[Anonymous], 1997, SELF EFFICACY; AYRES JG, 1986, BRIT J DIS CHEST, V80, P242, DOI 10.1016/0007-0971(86)90059-8; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; BRADLEY CP, 1992, FAM PRACT, V9, P98, DOI 10.1093/fampra/9.1.98; Clark NM, 1998, PEDIATRICS, V101, P831, DOI 10.1542/peds.101.5.831; *COMM HLTH SCI RES, 2000, SYST REV ACC TREATM; Conner P., 2006, PREDICT HEAL BEHAV, P172; DEPALO VA, 1994, CHEST, V106, P447, DOI 10.1378/chest.106.2.447; *E LOND CIT HLTH A, 2000, HLTH E END ANN PUBL; GIBSON PG, 2000, COCHRANE DATABASE SY; Gilthorpe MS, 1998, RESP MED, V92, P642, DOI 10.1016/S0954-6111(98)90511-X; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; KELSO TM, 1995, AM J EMERG MED, V13, P632, DOI 10.1016/0735-6757(95)90046-2; Moudgil H, 1998, THORAX, V53, P490, DOI 10.1136/thx.53.6.490; Moudgil H, 2000, THORAX, V55, P177, DOI 10.1136/thorax.55.3.177; MYERS P, 1992, RESP MED, V86, P297, DOI 10.1016/S0954-6111(06)80027-2; ORMEROD LP, 1995, RESP MED, V89, P415, DOI 10.1016/0954-6111(95)90209-0; ORMEROD LP, 1995, RESP MED, V89, P115; Partridge MR, 2000, THORAX, V55, P175, DOI 10.1136/thorax.55.3.175; PATTEN MQ, 1990, QUALITATIVE EVALUATI; Ritchie J., 2002, ANAL QUALITATIVE DAT, V1, P187; Rona RJ, 2000, THORAX, V55, P239, DOI 10.1136/thorax.55.3.239; ROWE BH, 1992, AM J EMERG MED, V10, P301, DOI 10.1016/0735-6757(92)90007-K; SPERBER K, 1995, J ASTHMA, V32, P335, DOI 10.3109/02770909509082758; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	26	55	55	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					962	966A		10.1136/bmj.323.7319.962	http://dx.doi.org/10.1136/bmj.323.7319.962			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679384	Green Published, Bronze			2022-12-01	WOS:000171918500015
J	Ueda, M; Sako, Y; Tanaka, T; Devreotes, P; Yanagida, T				Ueda, M; Sako, Y; Tanaka, T; Devreotes, P; Yanagida, T			Single-molecule analysis of chemotactic signaling in Dictyostelium cells	SCIENCE			English	Article							SURFACE CAMP RECEPTOR; LIVING CELLS; TRANSDUCTION; DISCOIDEUM; LOCALIZATION; DESENSITIZATION; ACTIVATION; AFFINITY; CYCLASE; BINDING	Single-molecule imaging techniques were used to reveal the binding of individual cyclic adenosine 3',5'-monophosphate molecules to heterotrimeric guanine nucleotide-binding protein coupled receptors on the surface of living Dictyostelium discoideum cells, The binding sites were uniformly distributed and diffused rapidly in the plane of the membrane. The probabilities of individual association and dissociation events were greater for receptors at the anterior end of the cell. Agonist-induced receptor phosphorylation had little effect on any of the monitored properties, whereas G protein coupling influenced the binding kinetics. These observations illustrate the dynamic properties of receptors involved in gradient sensing and suggest that these may be polarized in chemotactic cells.	Japan Sci & Technol Corp, Recognit & Format, Tokyo, Japan; Japan Sci & Technol Corp, PRESTO, Times Arrow & Biosignaling, Kawaguchi, Japan; JST, ICORP, Single Mol Proc Project, Osaka 5620035, Japan; Biomol Engn Res Inst, Osaka 5650874, Japan; Johns Hopkins Med Inst, Dept Cell Biol, Baltimore, MD 21205 USA; Osaka Univ, Grad Sch Med, Dept Physiol & Biosignalling, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Johns Hopkins University; Johns Hopkins Medicine; Osaka University	Ueda, M (corresponding author), Japan Sci & Technol Corp, Recognit & Format, Tokyo, Japan.		Sako, Yasushi/B-3253-2015	Sako, Yasushi/0000-0002-5707-5455				CLAVIEZ M, 1982, EMBO J, V1, P1017, DOI 10.1002/j.1460-2075.1982.tb01287.x; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; HALL AL, 1988, J CELL BIOCHEM, V37, P285, DOI 10.1002/jcb.240370304; Ishijima A, 2001, TRENDS BIOCHEM SCI, V26, P438, DOI 10.1016/S0968-0004(01)01860-6; JANS DA, 1992, BIOCHIM BIOPHYS ACTA, V1113, P271, DOI 10.1016/0304-4157(92)90001-Q; JANSSENS PMW, 1987, MICROBIOL REV, V51, P396, DOI 10.1128/MMBR.51.4.396-418.1987; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; KONIJN TM, 1987, METHOD CELL BIOL, V28, P283; LEVITZKI A, 1993, LIFE SCI, V52, P2093, DOI 10.1016/0024-3205(93)90724-H; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P3321; VANHAASTERT PJM, 1986, J BIOL CHEM, V261, P6904; VANHAASTERT PJM, 1983, J BIOL CHEM, V258, P9636; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiao Z, 1999, J BIOL CHEM, V274, P1440, DOI 10.1074/jbc.274.3.1440; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894	22	266	287	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2001	294	5543					864	867		10.1126/science.1063951	http://dx.doi.org/10.1126/science.1063951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11679673				2022-12-01	WOS:000171851800050
J	Schiermeier, Q				Schiermeier, Q			Bid to end EU's transgenic impasse	NATURE			English	News Item																		2001, NATURE, V409, P967	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					661	661		10.1038/35099712	http://dx.doi.org/10.1038/35099712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11606987	Bronze			2022-12-01	WOS:000171608000012
J	Raedle, J; Trojan, J; Brieger, A; Weber, N; Schafer, D; Plotz, G; Staib-Sebler, E; Kriener, S; Lorenz, M; Zeuzem, S				Raedle, J; Trojan, J; Brieger, A; Weber, N; Schafer, D; Plotz, G; Staib-Sebler, E; Kriener, S; Lorenz, M; Zeuzem, S			Bethesda guidelines: Relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Article							MISMATCH REPAIR GENES; REPLICATION ERRORS; GERMLINE MUTATIONS; DNA METHYLATION; HMLH1 PROMOTER; COLON-CANCER; HYPERMETHYLATION; TUMORS; HMSH2; EPIGENETICS	Background: Microsatellite instability is a hallmark of mismatch repair deficiency in hereditary nonpolyposis colorectal cancer and results from mutations in the mismatch repair genes MLH1 or MSH2 or from gene inactivation associated with DNA methylation. The Bethesda guidelines were established to identify patients with colorectal cancer who should be tested for microsatellite instability. Objective: To assess the Bethesda guidelines for detection, of microsatellite instability and to determine the role of MLH1 promoter methylation in colorectal cancer. Design: Prospective cohort study. Setting: Tertiary care referral center in Frankfurt, Germany. Patients: 125 consecutive patients with colorectal cancer. Measurements, Patients were assessed according to the Bethesda guidelines, and tumor specimens were analyzed for micro-satellite instability. Patients with microsatellite Instability were tested for MLH1 promoter methylation and MLH1 and MSH2 germline mutations. Results: Microsatellite instability was detected in 17 of 58 patients who fulfilled and 5 of 67 patients who did not fulfill criteria of the Bethesda guidelines. In I I of 17 patients with microsatellite instability who fulfilled Bethesda guidelines, an MLH1 (n = 3), MSH2 (n = 7), or combined MLH1 and MSH2 (n = 1) mutation was found. Among the patients with microsatellite instability who did not fulfill Bethesda guidelines, no mutations were observed; MLH1 promoter methylation was observed in 6 of 11 patients with an MLH1 or MSH2 mutation and 5 of 11 patients without an MLH1 or MSH2 mutation. Conclusions: The Bethesda guidelines are useful for selecting patients for microsatellite instability testing. MLH1 and MSH2 testing should be recommended in all patients with colorectal cancer and microsatellite instability who fulfill at least one Bethesda criterion. MLH1 promoter methylation may accompany rather than initiate carcinogenesis in patients with colorectal cancer who have mismatch repair gene defects.	Goethe Univ Frankfurt, Dept Internal Med 2, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Inst Human Genet, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Gen & Vasc Surg, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Pathol, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Raedle, J (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Raedle@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019					AALTONEN LA, 1994, CANCER RES, V54, P1645; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Basik M, 1997, GENE CHROMOSOME CANC, V18, P19, DOI 10.1002/(SICI)1098-2264(199701)18:1<19::AID-GCC3>3.0.CO;2-4; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bocker T, 1997, CANCER RES, V57, P4739; Boland CR, 1998, CANCER RES, V58, P5248; Brieger A, 1999, CLIN CHEM, V45, P1564; Canzian F, 1996, CANCER RES, V56, P3331; CAWKWELL L, 1995, GASTROENTEROLOGY, V109, P465, DOI 10.1016/0016-5085(95)90334-8; Cravo ML, 1999, CANCER, V85, P779, DOI 10.1002/(SICI)1097-0142(19990215)85:4<779::AID-CNCR4>3.0.CO;2-C; Cunningham JM, 1998, CANCER RES, V58, P3455; Dietmaier W, 1997, CANCER RES, V57, P4749; Farrington SM, 1998, AM J HUM GENET, V63, P749, DOI 10.1086/301996; Fleisher AS, 1999, CANCER RES, V59, P1090; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; *INT COLL GROUP HE, 2001, MUT DAT PATH MUT MSH; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kane MF, 1997, CANCER RES, V57, P808; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KOLODNER RD, 1995, CANCER RES, V55, P242; Kuismanen SA, 2000, AM J PATHOL, V156, P1773, DOI 10.1016/S0002-9440(10)65048-1; Lamberti C, 1999, GUT, V44, P839, DOI 10.1136/gut.44.6.839; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LIU B, 1994, CANCER RES, V54, P4590; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; Lynch HT, 1996, CANCER, V78, P1149, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5; Lynch HT, 1998, NEW ENGL J MED, V338, P1537, DOI 10.1056/NEJM199805213382109; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Oda S, 1997, NUCLEIC ACIDS RES, V25, P3415, DOI 10.1093/nar/25.17.3415; Peltomaki P, 1997, ADV CANCER RES, V71, P93, DOI 10.1016/S0065-230X(08)60097-4; Raedle J, 1999, MODERN PATHOL, V12, P485; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; Syngal S, 2000, J MED GENET, V37, P641, DOI 10.1136/jmg.37.9.641; Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874; Trojan J, 2000, GUT, V47, P272, DOI 10.1136/gut.47.2.272; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wang Q, 1999, HUM GENET, V105, P79, DOI 10.1007/s004390051067; Wheeler JMD, 2000, GUT, V47, P148, DOI 10.1136/gut.47.1.148; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804	48	58	59	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	1				566	576		10.7326/0003-4819-135-8_Part_1-200110160-00007	http://dx.doi.org/10.7326/0003-4819-135-8_Part_1-200110160-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481VY	11601928				2022-12-01	WOS:000171542200002
J	Dowey, JA				Dowey, JA			Child B: A personal view	BRITISH MEDICAL JOURNAL			English	Article																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 18	1997	314	7075					200	200						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WD911	11644899				2022-12-01	WOS:A1997WD91100034
J	DOROZYNSKI, A				DOROZYNSKI, A			FRENCH DOCTORS PUZZLE OVER GENE OWNERSHIP	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	APR 2	1994	308	6933					873	874		10.1136/bmj.308.6933.873a	http://dx.doi.org/10.1136/bmj.308.6933.873a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE600	11644527	Green Published			2022-12-01	WOS:A1994NE60000008
J	WARD, E				WARD, E			A TRAGIC AND WICKED WASTE OF LIFE	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 5	1991	302	6767					57	57		10.1136/bmj.302.6767.57	http://dx.doi.org/10.1136/bmj.302.6767.57			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER372	11642869	Green Published, Bronze			2022-12-01	WOS:A1991ER37200061
J	Siris, ES; Miller, PD; Barrett-Connor, E; Faulkner, KG; Wehren, LE; Abbott, TA; Berger, ML; Santora, AC; Sherwood, LM				Siris, ES; Miller, PD; Barrett-Connor, E; Faulkner, KG; Wehren, LE; Abbott, TA; Berger, ML; Santora, AC; Sherwood, LM			Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women - Results from the National Osteoporosis Risk Assessment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIP FRACTURE; ELDERLY WOMEN; PERIMENOPAUSAL WOMEN; GENETIC-DIFFERENCES; SELF-REPORTS; OLDER WOMEN; MASS; POPULATION; VALIDITY; HOSPITALIZATION	Context Large segments of the population at risk for osteoporosis and fracture have not been evaluated, and the usefulness of peripheral measurements for short-term prediction of fracture risk is uncertain. Objectives To describe the occurrence of low bone mineral density (BMD) in postmenopausal women, its risk factors, and fracture incidence during short-term follow-up. Design The National Osteoporosis Risk Assessment, a longitudinal observational study initiated September 1997 to March 1999, with approximately 12 months of subsequent follow-up. Setting and Participants A total of 200160 ambulatory postmenopausal women aged 50 years or older with no previous osteoporosis diagnosis, derived from 4236 primary care practices in 34 states. Main Outcome Measures Baseline BMD T scores, obtained from peripheral bone densitometry performed at the heel, finger, or forearm; risk factors for low BMD, derived from questionnaire responses; and clinical fracture rates at 12-month follow-up. Results Using World Health Organization criteria, 39.6% had osteopenia (T score of -1 to -2.49) and 7.2% had osteoporosis (T score less than or equal to -2.5). Age, personal or family history of fracture, Asian or Hispanic heritage, smoking, and cortisone use were associated with significantly increased likelihood of osteoporosis; higher body mass index, African American heritage, estrogen or diuretic use, exercise, and alcohol consumption significantly decreased the likelihood. Among the 163 979 participants with follow-up information, osteoporosis was associated with a fracture rate approximately 4 times that of normal BMD (rate ratio, 4.03; 95% confidence interval [CII, 3.59-4.53) and osteopenia was associated with a 1.8-fold higher rate (95% Cl, 1.49-2.18). Conclusions Almost half of this population had previously undetected low BMD, including 7% with osteoporosis. Peripheral BMD results were highly predictive of fracture risk. Given the economic and social costs of osteoporotic fractures, strategies to identify and manage osteoporosis in the primary care setting need to be established and implemented.	Columbia Univ, Coll Phys & Surg, New York, NY USA; Colorado Ctr Bone Res, Lakewood, CO USA; Univ Calif San Diego, La Jolla, CA 92093 USA; Synarc, Portland, OR USA; Univ Maryland, Baltimore, MD 21201 USA; Merck & Co Inc, W Point, PA USA	Columbia University; Colorado Center For Bone Research; University of California System; University of California San Diego; Synarc; University System of Maryland; University of Maryland Baltimore; Merck & Company	Siris, ES (corresponding author), Columbia Presbyterian Med Ctr, Toni Stabile Osteoporosis Ctr, 180 Ft Washington Ave, New York, NY 10032 USA.							ANDERSON JJB, 1994, ADV NUTR RES, V9, P129; BAUER RL, 1988, AM J EPIDEMIOL, V127, P145, DOI 10.1093/oxfordjournals.aje.a114774; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; BLACK DM, 1992, J BONE MINER RES, V7, P633; Burger H, 1998, AM J EPIDEMIOL, V147, P871, DOI 10.1093/oxfordjournals.aje.a009541; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; DAVIS JW, 1994, J BONE MINER RES, V9, P305; DAVIS JW, 1994, CALCIFIED TISSUE INT, V55, P249, DOI 10.1007/BF00310400; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241, DOI 10.1111/j.1532-5415.2000.tb02641.x; FASANO G, 1998, BONE, V23, pS590; Freedman KB, 2000, J BONE JOINT SURG AM, V82A, P1063, DOI 10.2106/00004623-200008000-00001; Garnero P, 1998, OSTEOPOROSIS INT, V8, P563, DOI 10.1007/s001980050100; Grampp S, 1997, J BONE MINER RES, V12, P697, DOI 10.1359/jbmr.1997.12.5.697; GREENDALE GA, 1995, J AM GERIATR SOC, V43, P955, DOI 10.1111/j.1532-5415.1995.tb05557.x; Hajcsar EE, 2000, CAN MED ASSOC J, V163, P819; HOLBROOK TL, 1993, BMJ-BRIT MED J, V306, P1506, DOI 10.1136/bmj.306.6891.1506; Honkanen K, 1999, AM J EPIDEMIOL, V150, P511; Ismail AA, 2000, OSTEOPOROSIS INT, V11, P248, DOI 10.1007/s001980050288; Johnell O, 1997, Am J Med, V103, p20S, DOI 10.1016/S0002-9343(97)90023-1; Kamel HK, 2000, AM J MED, V109, P326, DOI 10.1016/S0002-9343(00)00457-5; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; KROGER H, 1994, CALCIFIED TISSUE INT, V55, P1, DOI 10.1007/BF00310160; Lips Paul, 1997, American Journal of Medicine, V103, p3S, DOI 10.1016/S0002-9343(97)90021-8; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Miller P, 2001, J BONE MINER RES, V16, pS193; MILLER P, 2001, INT SOC CLIN DENS AN; Miller PD, 1998, J CLIN DENSITOM, V1, P211, DOI 10.1385/JCD:1:3:211; *NAT OST FDN, 1998, OSTEOPOROS INT S4, V8, pS1; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; NGUYEN TV, 1994, J BONE MINER RES, V9, P1339; POLLITZER WS, 1989, AM J CLIN NUTR, V50, P1244, DOI 10.1093/ajcn/50.6.1244; Pothuaud L, 1998, OSTEOPOROSIS INT, V8, P618, DOI 10.1007/s001980050108; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Ross PD, 1996, CALCIFIED TISSUE INT, V59, P339, DOI 10.1007/s002239900137; ROSS PD, 1991, AM J EPIDEMIOL, V133, P801, DOI 10.1093/oxfordjournals.aje.a115959; SCHOTT AM, 1995, J BONE MINER RES, V10, P243; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; SILVERMAN SL, 1988, AM J PUBLIC HEALTH, V78, P1482, DOI 10.2105/AJPH.78.11.1482; Siris E, 1998, OSTEOPOROSIS INT, V8, pS62; TURNER CH, 1995, OSTEOPOROSIS INT, V5, P130, DOI 10.1007/BF01623314; World Health Organization, 1994, ASS FRACT RISK APPL	43	893	931	2	49	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2001	286	22					2815	2822		10.1001/jama.286.22.2815	http://dx.doi.org/10.1001/jama.286.22.2815			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YC	11735756	Bronze			2022-12-01	WOS:000172655400029
J	Kinoshita, T; Doi, M; Suetsugu, N; Kagawa, T; Wada, M; Shimazaki, K				Kinoshita, T; Doi, M; Suetsugu, N; Kagawa, T; Wada, M; Shimazaki, K			phot1 and phot2 mediate blue light regulation of stomatal opening	NATURE			English	Article							GUARD-CELL PROTOPLASTS; VICIA-FABA; SIGNAL-TRANSDUCTION; ACTION SPECTRUM; PHOSPHORYLATION; PHOTORECEPTOR; PROTEIN; BINDING; MUTANTS; PLANTS	The stomatal pores of higher plants allow for gaseous exchange into and out of leaves. Situated in the epidermis, they are surrounded by a pair of guard cells which control their opening in response to many environmental stimuli, including blue light(1,2). Opening of the pores is mediated by K+ accumulation in guard cells through a K+ channel and driven by an inside-negative electrical potential(3). Blue light causes phosphorylation and activation of the plasma membrane H+-ATPase that creates this potential(1,2,4-6). Thus far, no blue light receptor mediating stomatal opening has been identified(7), although the carotenoid, zeaxanthin, has been proposed(2,8). Arabidopsis mutants deficient in specific blue-light-mediated responses have identified(7,9-14) four blue light receptors, cryptochrome 1 (cry1), cryptochrome 2 (cry2), phot1 and phot2. Here we show that in a double mutant of phot1 and phot2 stomata do not respond to blue light although single mutants are phenotypically normal. These results demonstrate that phot1 and phot2 act redundantly as blue light receptors mediating stomatal opening.	Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan; Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Japan Sci & Technol Corp, PRESTO, Unit Proc & Combined Circuit, Kawaguchi, Saitama 3320012, Japan	Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Metropolitan University; Japan Science & Technology Agency (JST)	Shimazaki, K (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan.		Kinoshita, Toshinori/C-2891-2012; Suetsugu, Noriyuki/AAB-5274-2019	Kinoshita, Toshinori/0000-0001-7621-1259; Suetsugu, Noriyuki/0000-0002-3328-3313				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; ASSMANN SM, 1993, ANNU REV CELL BIOL, V9, P345, DOI 10.1146/annurev.cb.09.110193.002021; ASSMANN SM, 1985, NATURE, V318, P285, DOI 10.1038/318285a0; BALLIO A, 1964, NATURE, V203, P297, DOI 10.1038/203297a0; Baum G, 1999, P NATL ACAD SCI USA, V96, P13554, DOI 10.1073/pnas.96.23.13554; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs WR, 2001, PLANT CELL, V13, P993, DOI 10.1105/tpc.13.5.993; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Eckert M, 2000, J EXP BOT, V51, P1435, DOI 10.1093/jexbot/51.349.1435; Eisinger W, 2000, PLANT PHYSIOL, V122, P99, DOI 10.1104/pp.122.1.99; HUALA E, 1997, SCIENCE, V278, P2121; IINO M, 1985, P NATL ACAD SCI USA, V82, P8019, DOI 10.1073/pnas.82.23.8019; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; KARLSSON PE, 1986, PHYSIOL PLANTARUM, V66, P207, DOI 10.1111/j.1399-3054.1986.tb02410.x; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; KONDO N, 1978, PLANT CELL PHYSIOL, V19, P365, DOI 10.1093/oxfordjournals.pcp.a075604; Lasceve G, 1999, PLANT PHYSIOL, V120, P605, DOI 10.1104/pp.120.2.605; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; SCHROEDER JI, 1987, P NATL ACAD SCI USA, V84, P4108, DOI 10.1073/pnas.84.12.4108; SCHWARTZ A, 1984, PLANTA, V161, P129, DOI 10.1007/BF00395472; SHIMAZAKI K, 1986, NATURE, V319, P324, DOI 10.1038/319324a0; Shimazaki K, 1999, PHYSIOL PLANTARUM, V105, P554, DOI 10.1034/j.1399-3054.1999.105322.x; Willmer C., 1996, STOMATA, DOI DOI 10.1007/978-94-011-0579-8; Zeiger E, 1998, J EXP BOT, V49, P433, DOI 10.1093/jexbot/49.suppl_1.433	30	663	695	6	188	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2001	414	6864					656	660		10.1038/414656a	http://dx.doi.org/10.1038/414656a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498WB	11740564				2022-12-01	WOS:000172535600052
J	Roberts, CM; Bohnsack, JA; Gell, F; Hawkins, JP; Goodridge, R				Roberts, CM; Bohnsack, JA; Gell, F; Hawkins, JP; Goodridge, R			Effects of marine reserves on adjacent fisheries	SCIENCE			English	Article							SPOTTED SEA-TROUT; FLORIDA WATERS; MANAGEMENT; PHILIPPINES; MORTALITY; GROWTH; PARK; DRUM; FISH	Marine reserves have been widely promoted as conservation and fishery management tools. There are robust demonstrations of conservation benefits, but fishery benefits remain controversial. We show that marine reserves in Florida (United States) and St. Lucia have enhanced adjacent fisheries. Within 5 years of creation, a network of five small reserves in St. Lucia increased adjacent catches of artisanal fishers by between 46 and 90%, depending on the type of gear the fishers used. In Florida, reserve zones in the Merritt island National Wildlife Refuge have supplied increasing numbers of world record-sized fish to adjacent recreational fisheries since the 1970s. Our study confirms theoretical predictions that marine reserves can play a key role in supporting fisheries.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; Natl Ocean & Atmospher Adm Fisheries, SE Fisheries Sci Ctr, Miami, FL 33149 USA; Univ W Indies, Fac Nat Sci, Dept Marine Resource & Environm Management, Cave Hill, Barbados	Harvard University; University of York - UK; National Oceanic Atmospheric Admin (NOAA) - USA; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Roberts, CM (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.		Ruimy, Raymond/P-6068-2016					Alcala A. C., 1990, J CONS INT EXPLOR ME, V46, P40; ANDERSON WW, 1965, US FISH WILDLIFE SER, V514; [Anonymous], 1988, NMFSSEFC215 NOAA; Bohnsack JA, 1998, AUST J ECOL, V23, P298, DOI 10.1111/j.1442-9993.1998.tb00734.x; BOHNSACK JA, 1986, 41 NOAA NAT MAR FISH; GOODRIDGE R, 1997, P GULF CARIBBEAN FIS, V49, P316; GOODRIDGE R, 1996, THESIS U W INDIES BA; HALPERN B, IN PRESS ECOL APPL; *INT GAM FISH ASS, 2000, IGFA RUL BOOK FRESHW; Johnson Darlene R., 1999, North American Journal of Fisheries Management, V19, P436, DOI 10.1577/1548-8675(1999)019<0436:EOAEEN>2.0.CO;2; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Murawski SA, 2000, B MAR SCI, V66, P775; MURPHY MD, 1994, T AM FISH SOC, V123, P482, DOI 10.1577/1548-8659(1994)123<0482:AGAMOS>2.3.CO;2; MURPHY MD, 1990, FISH B-NOAA, V88, P531; Murphy MD, 1998, FISH B-NOAA, V96, P382; National Research Council, 1999, SUST MAR FISH; National Research Council, 2001, MAR PROT AR TOOLS SU; Nowlis JS, 1999, FISH B-NOAA, V97, P604; PALSSON WA, 1995, RESPONSE ROCKY REEF, V1; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; POLOVINA JJ, 1995, CRUSTACEANA, V68, P203, DOI 10.1163/156854095X00106; Roberts C., 2000, WWF ENDANGERED SEAS; ROBERTS CJ, UNPUB; Roberts CM, 1997, TRENDS ECOL EVOL, V12, P35, DOI 10.1016/S0169-5347(96)20109-0; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Russ GR, 1999, CORAL REEFS, V18, P307, DOI 10.1007/s003380050203; SCHIRRIPA MJ, 1994, B MAR SCI, V54, P1019; [No title captured]	30	693	718	1	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1920	1923		10.1126/science.294.5548.1920	http://dx.doi.org/10.1126/science.294.5548.1920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729316				2022-12-01	WOS:000172465000057
J	Wu, LZ; Timmers, C; Maiti, B; Saavedra, HI; Sang, L; Chong, GT; Nuckolls, F; Giangrande, P; Wright, FA; Field, SJ; Greenberg, ME; Orkin, S; Nevins, JR; Robinson, ML; Leone, G				Wu, LZ; Timmers, C; Maiti, B; Saavedra, HI; Sang, L; Chong, GT; Nuckolls, F; Giangrande, P; Wright, FA; Field, SJ; Greenberg, ME; Orkin, S; Nevins, JR; Robinson, ML; Leone, G			The E2F1-3 transcription factors are essential for cellular proliferation	NATURE			English	Article							RETINOBLASTOMA PROTEIN; HISTONE DEACETYLASE; S-PHASE; REPRESS TRANSCRIPTION; E2F-1; APOPTOSIS; INDUCTION; MECHANISM; COMPLEX; EXTENDS	The retinoblastoma tumour suppressor (Rb) pathway is believed to have a critical role in the control of cellular proliferation by regulating E2F activities(1,2). E2F1, E2F2 and E2F3 belong to a subclass of E2F factors thought to act as transcriptional activators important for progression through the G1/S transition(3). Here we show, by taking a conditional gene targeting approach, that the combined loss of these three E2F factors severely affects E2F target expression and completely abolishes the ability of mouse embryonic fibroblasts to enter S phase, progress through mitosis and proliferate. Loss of E2F function results in an elevation of p21(Cip1) protein, leading to a decrease in cyclin-dependent kinase activity and Rb phosphorylation. These findings suggest a function for this subclass of E2F transcriptional activators in a positive feedback loop, through down-modulation of p21(Cip1), that leads to the inactivation of Rb-dependent repression and S phase entry. By targeting the entire subclass of E2F transcriptional activators we provide direct genetic evidence for their essential role in cell cycle progression, proliferation and development.	Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Ohio State Univ, Childrens Res Inst, Div Mol & Human Genet, Columbus, OH 43210 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Genet, Durham, NC 27710 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurosci, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Duke University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Leone, G (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA.			Field, Seth/0000-0002-8893-4806				Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; Humbert PO, 2000, GENE DEV, V14, P690; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; NEVINS JR, 1997, METHOD ENZYMOL, P678; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	30	477	490	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2001	414	6862					457	462		10.1038/35106593	http://dx.doi.org/10.1038/35106593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494UP	11719808				2022-12-01	WOS:000172304500046
J	Ackerman, MJ; Siu, BL; Sturner, WQ; Tester, DJ; Valdivia, CR; Makielski, JC; Towbin, JA				Ackerman, MJ; Siu, BL; Sturner, WQ; Tester, DJ; Valdivia, CR; Makielski, JC; Towbin, JA			Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-QT SYNDROME; SLEEP POSITION; PROLONGATION; INTERVAL; MECHANISMS; KVLQT1	Context Fatal arrhythmias from occult long QT syndrome may be responsible for some cases of sudden infant death syndrome (SIDS). Because patients who have long QT syndrome with sodium channel gene (SCN5A) defects have an increased frequency of cardiac events during sleep, and a recent case is reported of a sporadic SCN5A mutation in an infant with near SIDS, SCN5A has emerged as the leading candidate ion channel gene for SIDS. Objective To determine the prevalence and functional properties of SCN5A mutations in SIDS. Design, Setting, and Subjects Postmortem molecular analysis of 93 cases of SIDS or undetermined infant death identified by the Medical Examiner's Office of the Arkansas State Crime Laboratory between September 1997 and August 1999. Genomic DNA was extracted from frozen myocardium and subjected to SCN5A mutational analyses. Missense mutations were incorporated into the human heart sodium channel a subunit by mutagenesis, transiently transfected into human embryonic kidney cells, and characterized electrophysiologically. Main Outcome Measures Molecular and functional characterization of SCN5A defects. Results Two of the 93 cases of SIDS possessed SCN5A mutations: a 6-week-old white male with an A997S missense mutation in exon 17 and a 1-month old white male with an R1826H mutation in exon 28. These 2 distinct mutations occurred in highly conserved regions of the sodium channel and were absent in 400 control patients (800 alleles). Functionally, the A997S and R1826H mutant channels expressed a sodium current characterized by slower decay and a 2- to 3-fold increase in late sodium current. Conclusion Approximately 2% of this prospective, population-based cohort of SIDS cases had an identifiable SCN5A channel defect, suggesting that mutations in cardiac ion channels may provide a lethal arrhythmogenic substrate in some infants at risk for SIDS.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Cardiovasc Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Mayo Clin, Mayo Eugenio Litta Childrens Hosp, Div Cardiovasc Dis, Rochester, MN USA; Mayo Clin, Mayo Eugenio Litta Childrens Hosp, Div Pediat Cardiol, Rochester, MN USA; Mayo Clin, Dept Internal Med, Rochester, MN USA; Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; Arkansas State Crime Lab, Med Examiners Off, Little Rock, AR USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Sect Cardiovasc Med, Madison, WI 53706 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat, 1 Baylor Plaza,Room 333E, Houston, TX 77030 USA.	ackerman.michael@mayo.edu	Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; /0000-0003-1224-3088				*AAP TASK FORC INF, 1992, PEDIATRICS, V87, P1120; Ackerman MJ, 1998, PEDIATR RES, V44, P148, DOI 10.1203/00006450-199808000-00002; Ackerman MJ, 1997, NEW ENGL J MED, V336, P1575, DOI 10.1056/NEJM199705293362207; Ackerman MJ, 1998, MAYO CLIN PROC, V73, P250, DOI 10.4065/73.3.250; Ali RHH, 2000, AM J CARDIOL, V85, P457, DOI 10.1016/S0002-9149(99)90772-5; Boles RG, 1998, J PEDIATR-US, V132, P924, DOI 10.1016/S0022-3476(98)70385-3; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Dumaine R, 1996, CIRC RES, V78, P916, DOI 10.1161/01.RES.78.5.916; DWYER T, 1995, JAMA-J AM MED ASSOC, V273, P783, DOI 10.1001/jama.273.10.783; GIBSON E, 1995, PEDIATRICS, V96, P69; GUNTHEROTH WG, 1989, J AM COLL CARDIOL, V14, P443, DOI 10.1016/0735-1097(89)90200-3; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; Harper RM, 2000, RESP PHYSIOL, V119, P123, DOI 10.1016/S0034-5687(99)00107-3; HUNT CE, 1992, CLIN PERINATOL, V19, P757, DOI 10.1016/S0095-5108(18)30429-9; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Lucey JF, 1999, PEDIATRICS, V103, P812, DOI 10.1542/peds.103.4.812; MARON BJ, 1986, AM J CARDIOL, V58, P1104, DOI 10.1016/0002-9149(86)90122-0; MARON BJ, 1976, CIRCULATION, V54, P423, DOI 10.1161/01.CIR.54.3.423; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; Nagatomo T, 1998, AM J PHYSIOL-HEART C, V275, pH2016, DOI 10.1152/ajpheart.1998.275.6.H2016; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; PERTICONE F, 1991, CLIN CARDIOL, V14, P417, DOI 10.1002/clc.4960140510; Priori SG, 2000, LANCET, V355, P808, DOI 10.1016/S0140-6736(99)05277-0; SADEH D, 1987, NEW ENGL J MED, V317, P1501, DOI 10.1056/NEJM198712103172404; Schwartz PJ, 2000, NEW ENGL J MED, V343, P262, DOI 10.1056/NEJM200007273430405; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; STEINSCHNEIDER A, 1978, AM J DIS CHILD, V132, P688, DOI 10.1001/archpedi.1978.02120320048011; STRAMBABADIALE M, 1992, AM J PHYSIOL, V263, pH1514, DOI 10.1152/ajpheart.1992.263.5.H1514; Towbin JA, 1998, NEW ENGL J MED, V338, P1760, DOI 10.1056/NEJM199806113382409; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; VALDESDA.MA, 1973, NEW ENGL J MED, V289, P1195, DOI 10.1056/NEJM197311292892213; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; WILLINGER M, 1994, PEDIATRICS, V93, P814; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404	35	317	330	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2264	2269		10.1001/jama.286.18.2264	http://dx.doi.org/10.1001/jama.286.18.2264			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710892	Bronze			2022-12-01	WOS:000172129700021
J	Liotta, LA; Kohn, EC; Petricoin, EF				Liotta, LA; Kohn, EC; Petricoin, EF			Clinical proteomics - Personalized molecular medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							2-DIMENSIONAL ELECTROPHORESIS; QUANTITATIVE-ANALYSIS; PROTEIN; CANCER; COMPLEXES		NCI, CCR, NIH, Bethesda, MD 20892 USA; US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA)	Liotta, LA (corresponding author), 10 Ctr Dr,MSC 1500, Bethesda, MD 20892 USA.	lance@helix.nih.gov						Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Figeys D, 2001, ELECTROPHORESIS, V22, P208, DOI 10.1002/1522-2683(200101)22:2<208::AID-ELPS208>3.0.CO;2-O; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gygi SP, 2000, CURR OPIN CHEM BIOL, V4, P489, DOI 10.1016/S1367-5931(00)00121-6; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hanash SM, 2000, ELECTROPHORESIS, V21, P1202, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1202::AID-ELPS1202>3.0.CO;2-I; Humphery-Smith I, 1998, J PROTEIN CHEM, V17, P524; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ji JY, 2000, J CHROMATOGR B, V745, P197, DOI 10.1016/S0378-4347(00)00192-4; Legrain P, 2000, CURR OPIN BIOTECH, V11, P402, DOI 10.1016/S0958-1669(00)00117-8; Li JJ, 2000, ELECTROPHORESIS, V21, P198, DOI 10.1002/(SICI)1522-2683(20000101)21:1<198::AID-ELPS198>3.3.CO;2-M; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Oda Y, 2001, NAT BIOTECHNOL, V19, P379, DOI 10.1038/86783; Ornstein DK, 2000, ELECTROPHORESIS, V21, P2235, DOI 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.3.CO;2-1; Paweletz CP, 2000, DRUG DEVELOP RES, V49, P34, DOI 10.1002/(SICI)1098-2299(200001)49:1<34::AID-DDR6>3.0.CO;2-W; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shen YF, 2001, ANAL CHEM, V73, P3011, DOI 10.1021/ac001393n; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	25	170	184	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2001	286	18					2211	2214		10.1001/jama.286.18.2211	http://dx.doi.org/10.1001/jama.286.18.2211			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491VA	11710876				2022-12-01	WOS:000172129700001
J	Conway, KA; Rochet, JC; Bieganski, RM; Lansbury, PT				Conway, KA; Rochet, JC; Bieganski, RM; Lansbury, PT			Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct	SCIENCE			English	Article							PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; LEWY BODIES; FIBRILLIZATION; TOXICITY; MICE; LEVODOPA; MUTATION; MODEL	The substantia nigra in Parkinson's disease (PD) is depleted of dopaminergic neurons and contains fibrillar Lewy bodies comprising primarily alpha -synuclein. We screened a library to identify drug-like molecules to probe the relation between neurodegeneration and alpha -synuctein fibrilization. All but one of 15 fibril inhibitors were catecholamines related to dopamine. The inhibitory activity of dopamine depended on its oxidative ligation to alpha -synuctein and was selective for the protofibril-to-fibril conversion, causing accumulation of the alpha -synuctein protofibril. Adduct formation provides an explanation for the dopaminergic selectivity of alpha -synuctein-associated neurotoxicity in PD and has implications for current and future PD therapeutic and diagnostic strategies.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital	Lansbury, PT (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, 65 Landsdowne St, Cambridge, MA 02139 USA.	plansbury@rics.bwh.harvard.edu		Rochet, Jean-Christophe/0000-0002-6484-1541	NINDS NIH HHS [NS38375] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agid Y, 1998, NEUROLOGY, V50, P858, DOI 10.1212/WNL.50.4.858; Baba M, 1998, AM J PATHOL, V152, P879; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dawson TM, 2000, CELL, V101, P115, DOI 10.1016/S0092-8674(00)80629-7; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Fahn S, 1999, ARCH NEUROL-CHICAGO, V56, P529, DOI 10.1001/archneur.56.5.529; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kato Y, 2000, BIOCHEM BIOPH RES CO, V275, P11, DOI 10.1006/bbrc.2000.3265; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuhn DM, 1998, J NEUROSCI, V18, P7111; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Tabrizi SJ, 2000, HUM MOL GENET, V9, P2683, DOI 10.1093/hmg/9.18.2683; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; TOMITA K, UNPUB DATA; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	31	896	933	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545					1346	1349		10.1126/science.1063522	http://dx.doi.org/10.1126/science.1063522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701929				2022-12-01	WOS:000172130200051
J	Kinoshita, K; Arnal, I; Desai, A; Drechsel, DN; Hyman, AA				Kinoshita, K; Arnal, I; Desai, A; Drechsel, DN; Hyman, AA			Reconstitution of physiological microtubule dynamics using purified components	SCIENCE			English	Article							KINESIN-RELATED PROTEIN; XENOPUS EGG EXTRACTS; SPINDLE POLE BODY; MITOTIC SPINDLE; INDIVIDUAL MICROTUBULES; CYTOPLASMIC EXTRACTS; PLUS-END; INSTABILITY; VISUALIZATION; IDENTIFICATION	Microtubules are dynamically unstable polymers that interconvert stochastically between polymerization and depolymerization. Compared with microtubules assembled from purified tubulin, microtubules in a physiological environment polymerize faster and transit more frequently between polymerization and depolymerization. These dynamic properties are essential for the functions of the microtubule cytoskeleton during diverse cellular processes. Here, we have reconstituted the essential features of physiological microtubule dynamics by mixing three purified components: tubulin; a microtubule-stabilizing protein, XMAP215; and a microtubule-destabitizing kinesin, XKCM1. This represents an essential first step in the reconstitution of complex microtubule dynamics-dependent processes, such as chromosome segregation, from purified components.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Kinoshita, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Arnal, Isabelle/X-6559-2019	Hyman, Anthony A/0000-0003-3664-154X; Kinoshita, Kazuhisa/0000-0002-0882-4296; Arnal, Isabelle/0000-0001-6149-8189				BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; Cha BJ, 1999, J CELL SCI, V112, P4337; Charrasse S, 1998, J CELL SCI, V111, P1371; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Graf R, 2000, J CELL SCI, V113, P1747; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Hunter AW, 2000, J CELL SCI, V113, P4379; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	27	173	175	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1340	1343		10.1126/science.1064629	http://dx.doi.org/10.1126/science.1064629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11701928				2022-12-01	WOS:000172130200049
J	Schwetz, BA				Schwetz, BA			New combination therapy for advanced breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2085	2085		10.1001/jama.286.17.2085	http://dx.doi.org/10.1001/jama.286.17.2085			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490CD	11694130				2022-12-01	WOS:000172032100006
J	Silverman, DHS; Small, GW; Chang, CY; Lu, CS; de Aburto, MAK; Chen, W; Czernin, J; Rapoport, SI; Pietrini, P; Alexander, GE; Schapiro, MB; Jagust, WJ; Hoffman, JM; Welsh-Bohmer, KA; Alavi, A; Clark, CM; Salmon, E; de Leon, MJ; Mielke, R; Cummings, JL; Kowell, AP; Gambhir, SS; Hoh, CK; Phelps, ME				Silverman, DHS; Small, GW; Chang, CY; Lu, CS; de Aburto, MAK; Chen, W; Czernin, J; Rapoport, SI; Pietrini, P; Alexander, GE; Schapiro, MB; Jagust, WJ; Hoffman, JM; Welsh-Bohmer, KA; Alavi, A; Clark, CM; Salmon, E; de Leon, MJ; Mielke, R; Cummings, JL; Kowell, AP; Gambhir, SS; Hoh, CK; Phelps, ME			Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; DIFFERENTIAL-DIAGNOSIS; COGNITIVE DECLINE; FDG PET	Context Deficits in cerebral glucose utilization have been identified in patients with cognitive dysfunction attributed to various disease processes, but their prognostic and diagnostic value remains to be defined. Objective To assess the sensitivity and specificity with which cerebral metabolic patterns at a single point in time forecast subsequent documentation of progressive dementia. Design, Setting, and Patients Positron emission tomography (PET) studies of [F-18]fluorodeoxyglucose in 146 patients undergoing evaluation for dementia with at least 2 years' follow-up for disease progression at the University of California, Los Angeles, from 1991 to 2000, and PET studies in 138 patients undergoing evaluation for dementia at an international consortium of facilities, with histopathological diagnoses an average of 2.9 years later, conducted from 1984 to 2000. Main Outcome Measures Regional distribution of [F-18]fluorodeoxyglucose in each patient, classified by criteria established a priori as positive or negative for presence of a progressive neurodegenerative disease in general and of Alzheimer disease (AD) specifically, compared with results of longitudinal or neuropathologic analyses. Results Progressive dementia was detected by PET with a sensitivity of 93% (191/206) and a specificity of 76% (59/78). Among patients with neu ro pathologically based diagnoses, PET identified patients with AD and patients with any neurodegenerative disease with a sensitivity of 94% and specificities of 73% and 78%, respectively. The negative likelihood ratio of experiencing a progressive vs nonprogressive course over the several years following a single negative brain PET scan was 0.10 (95% confidence interval, 0.06-0.16), and the initial pattern of cerebral metabolism was significantly associated with the subsequent course of progression overall (P<.001). Conclusion In patients presenting with cognitive symptoms of dementia, regional brain metabolism was a sensitive indicator of AD and of neurodegenerative disease in general. A negative PET scan indicated that pathologic progression of cognitive impairment during the mean 3-year follow-up was unlikely to occur.	Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Ahmanson Biol Imaging Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Kaiser Permanente, Dept Internal Med, Los Angeles, CA USA; NIA, NIH, Bethesda, MD 20892 USA; Univ Pisa, Dept Clin Biochem, Pisa, Italy; Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; Duke Univ, Dept Radiol, Durham, NC 27710 USA; Duke Univ, Dept Psychiat, Durham, NC 27710 USA; Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; Univ Liege, Cyclotron Res Ctr, Liege, Belgium; NYU, Sch Med, Dept Psychiat, New York, NY USA; Max Planck Inst Neurol Res, Dept Neurol, D-50931 Cologne, Germany; Univ Calif San Diego, Div Nucl Med, San Diego, CA 92103 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pisa; University of California System; University of California Davis; Duke University; Duke University; University of Pennsylvania; University of Liege; New York University; Max Planck Society; University of California System; University of California San Diego	Silverman, DHS (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Ahmanson Biol Imaging Ctr, CHS AR-144, Los Angeles, CA 90095 USA.		Salmon, Eric/AAE-4901-2020; de Leon, Mony/AAP-7890-2021; Welsh-Bohmer, Kathleen/AAA-3178-2020; Pietrini, Pietro/Z-4202-2019; Jagust, William/ABE-6426-2020	Salmon, Eric/0000-0003-2520-9241; de Leon, Mony/0000-0003-2245-4380; Pietrini, Pietro/0000-0002-6768-5556	NIA NIH HHS [P50 AG05128-07, AG16570, AG10129] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005128, Z01AG000148, P50AG016570, P30AG010129] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENSON DF, 1981, T AM NEUROL ASSOC, V106, P68; Carr D. B., 1997, American Journal of Medicine, V103, p3S, DOI 10.1016/S0002-9343(97)00262-3; Chui H, 1997, NEUROLOGY, V49, P925, DOI 10.1212/WNL.49.4.925; ERNST RL, 1994, AM J PUBLIC HEALTH, V84, P1261, DOI 10.2105/AJPH.84.8.1261; EVANS DA, 1990, MILBANK Q, V68, P267, DOI 10.2307/3350099; FERRIS SH, 1980, NEUROBIOL AGING, V1, P127, DOI 10.1016/0197-4580(80)90005-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOSTER NL, 1983, NEUROLOGY, V33, P961, DOI 10.1212/WNL.33.8.961; FRACKOWIAK RSJ, 1981, BRAIN, V104, P753, DOI 10.1093/brain/104.4.753; FRIEDLAND RP, 1990, POSITRON EMISSION TO, P161; HAXBY JV, 1990, POSITRON EMISSION TO, P93; HERHOLZ K, 1995, ALZ DIS ASSOC DIS, V9, P6, DOI 10.1097/00002093-199505000-00004; Herholz K, 1999, DEMENT GERIATR COGN, V10, P494, DOI 10.1159/000017196; Hoffman JM, 2000, J NUCL MED, V41, P1920; MAZZIOTTA JC, 1992, SEMIN NUCL MED, V22, P233, DOI 10.1016/S0001-2998(05)80118-7; Mielke R, 1996, ACTA NEUROPATHOL, V91, P174, DOI 10.1007/s004010050410; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; *NAT I AG, 1996, PROGR REP ALZH DIS; OKAGAKI JF, 1994, NEUROLOGY, V44, P2203; Pietrini P, 2000, INT J PSYCHOPHYSIOL, V37, P87, DOI 10.1016/S0167-8760(00)00097-0; SALMON E, 1994, J NUCL MED, V35, P391; Silverman Daniel H.S., 1999, Clin Positron Imaging, V2, P119, DOI 10.1016/S1095-0397(99)00020-5; Silverman DHS, 2000, J NUCL MED, V41, P1929; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SMITH GS, 1992, ARCH NEUROL-CHICAGO, V49, P1142, DOI 10.1001/archneur.1992.00530350056020	26	632	659	2	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2120	2127		10.1001/jama.286.17.2120	http://dx.doi.org/10.1001/jama.286.17.2120			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	490CD	11694153				2022-12-01	WOS:000172032100031
J	Ammash, NM; Warnes, CA				Ammash, NM; Warnes, CA			Ventricular septal defects in adults	ANNALS OF INTERNAL MEDICINE			English	Review							CONGENITAL HEART-DISEASE; TWO-DIMENSIONAL ECHOCARDIOGRAPHY; TERM FOLLOW-UP; PULMONARY VASCULAR-RESISTANCE; AORTIC REGURGITATION; SURGICAL CLOSURE; NATURAL-HISTORY; DOPPLER-ECHOCARDIOGRAPHY; INFECTIVE ENDOCARDITIS; BACTERIAL-ENDOCARDITIS	Because congenital ventricular septal defects are of different sizes and locations, their clinical presentation, natural history, and treatment vary greatly. This review discusses the different types of ventricular septal defects commonly seen in adults in the authors' experience and in published literature. Ventricular septal defects are either isolated small defects or larger defects associated with pulmonary stenosis, pulmonary hypertension, or aortic regurgitation. These associations play an important role in the pathophysiologic consequences of the defect, its long-term complications, and treatment options. Knowledge of the different clinical presentations in adulthood and the specific features pertinent to these defects will help in the assessment and the care of adult patients with one of the most common congenital cardiac malformations.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Ammash, NM (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1St St Sw, Rochester, MN 55905 USA.							ABBOTT ME, 1931, NELSONS LOOSELEAF ME, V4, P207; ALPERT BS, 1973, AM J DIS CHILD, V125, P194, DOI 10.1001/archpedi.1973.04160020028005; Ammash N, 1996, J AM COLL CARDIOL, V28, P768, DOI 10.1016/0735-1097(96)00196-9; Ammash NM, 1999, J AM COLL CARDIOL, V33, P222, DOI 10.1016/S0735-1097(98)00554-3; ANDERSON RH, 1983, AM J CARDIOL, V52, P341, DOI 10.1016/0002-9149(83)90135-2; ANDO M, 1986, Heart and Vessels, V2, P117, DOI 10.1007/BF02059966; ANDRADE JL, 1991, ECHOCARDIOGR-J CARD, V8, P501, DOI 10.1111/j.1540-8175.1991.tb01010.x; BACKER CL, 1991, J THORAC CARDIOV SUR, V102, P288; BAKER EJ, 1988, BRIT HEART J, V59, P339; Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; BECU LM, 1956, CIRCULATION, V14, P349, DOI 10.1161/01.CIR.14.3.349; BIRCKS W, 1971, BRIT HEART J       S, V33, P88; BLACKSTONE EH, 1976, J THORAC CARDIOV SUR, V72, P661; BLAKE RS, 1982, BRIT HEART J, V47, P305; BLOOMFIELD DK, 1964, CIRCULATION, V29, P914, DOI 10.1161/01.CIR.29.6.914; Breckenridge I M, 1972, Ann Thorac Surg, V13, P128; CAMPBELL M, 1971, BRIT HEART J, V33, P246; CAPELLI H, 1983, AM J CARDIOL, V51, P1474, DOI 10.1016/0002-9149(83)90660-4; CHANG CH, 1988, SCAND J THORAC CARD, V22, P221, DOI 10.3109/14017438809106066; CHUNG KJ, 1974, AM HEART J, V87, P435, DOI 10.1016/0002-8703(74)90167-7; CLARKSON MB, 1968, CIRCULATION, V38, P129, DOI 10.1161/01.CIR.38.1.129; DAJANI AS, 1990, JAMA-J AM MED ASSOC, V264, P2919, DOI 10.1001/jama.264.22.2919; DRISCOLL DJ, 1993, CIRCULATION, V87, P102; ELLIS FH, 1963, CIRCULATION, V27, P789, DOI 10.1161/01.CIR.27.4.789; ELLIS JH, 1987, AM HEART J, V114, P115, DOI 10.1016/0002-8703(87)90315-2; FRIEDLI B, 1974, AM J CARDIOL, V33, P403, DOI 10.1016/0002-9149(74)90323-3; FRIEDMAN WF, 1965, CIRCULATION, V32, P35, DOI 10.1161/01.CIR.32.1.35; FRYDA RJ, 1971, BRIT HEART J, V33, P456; GARG A, 1990, CLIN CARDIOL, V13, P717, DOI 10.1002/clc.4960131009; GERSONY WM, 1993, CIRCULATION, V87, P52; GERSONY WM, 1993, CIRCULATION, V87, P121; GERSONY WM, 1977, CIRCULATION, V56, P84; GOOR DA, 1970, CHEST, V58, P468, DOI 10.1378/chest.58.5.468; Graham T P Jr, 1974, Adv Cardiol, V11, P81; GRAHAM TP, 1994, J AM COLL CARDIOL, V24, P867, DOI 10.1016/0735-1097(94)90842-7; GRIFFIN MR, 1985, JAMA-J AM MED ASSOC, V254, P1199, DOI 10.1001/jama.254.9.1199; HAGLER DJ, 1985, MAYO CLIN PROC, V60, P741, DOI 10.1016/S0025-6196(12)60416-9; HISATOMI K, 1987, ANN THORAC SURG, V43, P363, DOI 10.1016/S0003-4975(10)62804-4; HOFFMAN IE, 1968, CIRCULATION, V37, P97, DOI 10.1161/01.CIR.37.1.97; HUDSPETH AS, 1962, J THORAC CARDIOV SUR, V43, P157; JABLONSKY G, 1983, AM J CARDIOL, V51, P293, DOI 10.1016/S0002-9149(83)80053-8; KAGAWA Y, 1987, TOHOKU J EXP MED, V151, P1, DOI 10.1620/tjem.151.1; KIDD L, 1993, CIRCULATION, V87, P38; KULBERTUS HE, 1969, AM HEART J, V77, P123, DOI 10.1016/0002-8703(69)90136-7; KUROKAWA S, 1988, AM HEART J, V116, P1033, DOI 10.1016/0002-8703(88)90156-1; LAUBRY C, 1933, SOUFFLES MALADIE ROG, V50, P439; LEUNG MP, 1987, AM J CARDIOL, V60, P890, DOI 10.1016/0002-9149(87)91042-3; LILLEHEI CW, 1968, J AMER MED ASSOC, V205, P822, DOI 10.1001/jama.205.12.822; LUDOMIRSKY A, 1986, CIRCULATION, V74, P1317, DOI 10.1161/01.CIR.74.6.1317; Mahoney Larry T., 1993, Cardiology Clinics, V11, P603; MARON BJ, 1973, CIRCULATION, V48, P864, DOI 10.1161/01.CIR.48.4.864; MARTIN GR, 1989, PEDIATRICS, V83, P200; MCNAMARA DG, 1982, AM J CARDIOL, V50, P560, DOI 10.1016/0002-9149(82)90325-3; MEIJBOOM F, 1994, J AM COLL CARDIOL, V24, P1358, DOI 10.1016/0735-1097(94)90120-1; MENAHEM S, 1986, BRIT HEART J, V56, P242; MOE DG, 1987, AM J CARDIOL, V60, P674, DOI 10.1016/0002-9149(87)90380-8; MOMMA K, 1984, AM HEART J, V108, P1312, DOI 10.1016/0002-8703(84)90759-2; MORENOCABRAL RJ, 1977, J THORAC CARDIOV SUR, V73, P358; NADAS AS, 1964, CIRCULATION, V29, P862, DOI 10.1161/01.CIR.29.6.862; NEUTZE JM, 1989, AM J CARDIOL, V63, P327, DOI 10.1016/0002-9149(89)90340-8; NORA JJ, 1987, AM J CARDIOL, V59, P459, DOI 10.1016/0002-9149(87)90956-8; OHKITA Y, 1986, ANN THORAC SURG, V41, P489, DOI 10.1016/S0003-4975(10)63024-X; OKOROMA EO, 1975, AM HEART J, V90, P14, DOI 10.1016/0002-8703(75)90251-3; OTTERSTAD JE, 1986, ACTA MED SCAND, P1; PERASALO O, 1961, Acta Chir Scand Suppl, VSuppl 283, P123; PERLOFF JK, 1988, ANN INTERN MED, V109, P406, DOI 10.7326/0003-4819-109-5-406; PERLOFF JK, 1991, CONGENITAL HEART DIS, P313; PERLOFF JK, 1991, CONGENITAL HEART DIS, P21; PERLOFF JK, 1991, CONGENITAL HEART DIS, P124; Perloff JK, 1994, CLIN RECOGNITION CON, P396; PIERONI DR, 1993, CIRCULATION, V87, P80; PITTS JA, 1977, AM HEART J, V93, P321, DOI 10.1016/S0002-8703(77)80251-2; PLAUTH WH, 1965, AM J MED, V39, P552, DOI 10.1016/0002-9343(65)90079-3; ROBINSON G, 1962, J THORAC CARDIOV SUR, V43, P785, DOI 10.1016/S0022-5223(19)33017-X; SANTAMARIA H, 1983, AM J ROENTGENOL, V141, P273, DOI 10.2214/ajr.141.2.273; SCHMIDT KG, 1988, J AM COLL CARDIOL, V12, P1538, DOI 10.1016/S0735-1097(88)80023-8; SHEPHERD RL, 1972, AM J MED, V53, P446, DOI 10.1016/0002-9343(72)90140-4; SOMERVILLE J, 1970, CIRCULATION, V41, P317, DOI 10.1161/01.CIR.41.2.317; SOMERVILLE J, 1979, BRIT HEART J, V41, P1; SOTO B, 1987, PAEDIAT CARDIOLOGY, P125; SPENCER FC, 1973, J THORAC CARDIOV SUR, V65, P15; STEVENSON JG, 1978, CIRCULATION, V58, P322, DOI 10.1161/01.CIR.58.2.322; SUTHERLAND GR, 1982, BRIT HEART J, V47, P316; SUTHERLAND GR, 1989, BRIT HEART J, V62, P43; TATSUNO K, 1973, CIRCULATION, V48, P1028, DOI 10.1161/01.CIR.48.5.1028; TAYLOR JFN, 1971, BRIT HEART J, V33, P285; TRUSLER GA, 1973, J THORAC CARDIOV SUR, V66, P394; VANHARE GF, 1987, AM HEART J, V114, P606, DOI 10.1016/0002-8703(87)90759-9; VANPRAAGH R, 1989, J AM COLL CARDIOL, V14, P1298, DOI 10.1016/0735-1097(89)90431-2; VANPRAAGH R, 1968, AM HEART J, V75, P604, DOI 10.1016/0002-8703(68)90321-9; VETTER VL, 1982, AM J CARDIOL, V50, P588, DOI 10.1016/0002-9149(82)90328-9; VICKERS CW, 1960, RADIOLOGY, V75, P69, DOI 10.1148/75.1.69; Vogel J H, 1974, Adv Cardiol, V11, P108; WARNES CA, 1984, AM J CARDIOL, V54, P460, DOI 10.1016/0002-9149(84)90226-1; WARNES CA, 1991, CARDIOLOGY FUNDAMENT, V2, P1639; WEIDMAN WH, 1977, CIRCULATION, V56, P56; WOLFE RR, 1993, CIRCULATION, V87, P89	97	36	41	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2001	135	9					812	824		10.7326/0003-4819-135-9-200111060-00011	http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00011			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VT	11694106				2022-12-01	WOS:000172013700006
J	Lipardi, C; Wei, Q; Paterson, BM				Lipardi, C; Wei, Q; Paterson, BM			RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs	CELL			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; C-ELEGANS; GENETIC INTERFERENCE; SYNTHASE GENE; NEUROSPORA; TRANSGENE; PLANTS; VIRUS; POLYMERASE	In posttranscriptional gene silencing (PTGS), "quelling," and RNA interference (RNAi), 21-25 nucleotide RNA fragments are produced from the initiating dsRNA. These short interfering RNAs (siRNAs) mediate RNAi by an unknown mechanism. Here, we show that GFP and Pp-Luc siRNAs, isolated from a protein complex in Drosophila embryo extract, target mRNA degradation in vitro. Most importantly, these siRNAs, as well as a synthetic 21-nucleotide duplex GFP siRNA, serve as primers to transform the target mRNA into dsRNA. The nascent dsRNA is degraded to eliminate the incorporated target mRNA while generating new siRNAs in a cycle of dsRNA synthesis and degradation. Evidence is presented that mRNA-dependent siRNA incorporation to form dsRNA is carried out by an RNA-dependent RNA polymerase activity (RdRP).	NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Paterson, BM (corresponding author), NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA.	patersob@mail.nih.gov						Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Baulcombe D, 1999, ARCH VIROL, P189; Baulcombe DC, 2000, SCIENCE, V290, P1108, DOI 10.1126/science.290.5494.1108; Baulcombe DC, 1999, CURR BIOL, V9, pR599, DOI 10.1016/S0960-9822(99)80383-2; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gura T, 2000, NATURE, V404, P804, DOI 10.1038/35009245; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hunter CP, 2000, CURR BIOL, V10, pR137, DOI 10.1016/S0960-9822(00)00325-0; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; KRUPP G, 1979, NUCLEIC ACIDS RES, V6, P3481, DOI 10.1093/nar/6.11.3481; MAINE EM, 2000, GENOME BIOL, V1, P1018; Marx J, 2000, SCIENCE, V288, P1370, DOI 10.1126/science.288.5470.1370; MEADOR J, 1990, EUR J BIOCHEM, V187, P549, DOI 10.1111/j.1432-1033.1990.tb15336.x; Meins F, 2000, PLANT MOL BIOL, V43, P261, DOI 10.1023/A:1006443731515; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; MOSSNER E, 1980, H-S Z PHYSIOL CHEM, V361, P543, DOI 10.1515/bchm2.1980.361.1.543; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Sonoda S, 2000, PLANT J, V21, P1, DOI 10.1046/j.1365-313x.2000.00645.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; WANG MJ, 1990, NUCLEIC ACIDS RES, V18, P6625, DOI 10.1093/nar/18.22.6625; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	52	294	450	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2001	107	3					297	307		10.1016/S0092-8674(01)00537-2	http://dx.doi.org/10.1016/S0092-8674(01)00537-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	489ZH	11701121	Bronze			2022-12-01	WOS:000172022800002
J	Stebbins, CE; Galan, JE				Stebbins, CE; Galan, JE			Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion	NATURE			English	Article							PROTEIN; MODULATION; PROGRAM; SYSTEM; MODEL; SPTP	Many bacterial pathogens use a type III protein secretion system to deliver virulence effector proteins directly into the host cell cytosol, where they modulate cellular processes(1,2). A requirement for the effective translocation of several such effector proteins is the binding of specific cytosolic chaperones, which typically interact with discrete domains in the virulence factors(3,4,5). We report here the crystal structure at 1.9 Angstrom resolution of the chaperone-binding domain of the Salmonella effector protein SptP with its cognate chaperone SicP. The structure reveals that this domain is maintained in an extended, unfolded conformation that is wound around three successive chaperone molecules. Short segments from two different SptP molecules are juxtaposed by the chaperones, where they dimerize across a hydrophobic interface. These results imply that the chaperones associated with the type III secretion system maintain their substrates in a secretion-competent state that is capable of engaging the secretion machinery to travel through the type III apparatus in an unfolded or partially folded manner.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Stebbins, Erec/N-2565-2018	Stebbins, Erec/0000-0001-6229-5308				Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Evdokimov AG, 2001, ACTA CRYSTALLOGR D, V57, P793, DOI 10.1107/S0907444901004875; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; SMITH CL, IN PRESS MOL MICROBI; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wattiau P, 1996, MOL MICROBIOL, V20, P255, DOI 10.1111/j.1365-2958.1996.tb02614.x	24	247	254	0	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 01	2001	414	6859					77	81		10.1038/35102073	http://dx.doi.org/10.1038/35102073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487VC	11689946				2022-12-01	WOS:000171898900045
J	Winklbauer, R; Medina, A; Swain, RK; Steinbeisser, H				Winklbauer, R; Medina, A; Swain, RK; Steinbeisser, H			Frizzled-7 signalling controls tissue separation during Xenopus gastrulation	NATURE			English	Article							CONVERGENT EXTENSION MOVEMENTS; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; SIGNALING PATHWAYS; WNT; MORPHOGENESIS; MESODERM; EMBRYOS; TARGET	Cell signalling through Frizzled receptors has evolved to considerable complexity within the metazoans. The Frizzled-dependent signalling cascade comprises several branches, whose differential activation depends on specific Wnt ligands, Frizzled receptor isoforms and the cellular context. In Xenopus laevis embryos, the canonical beta -catenin pathway contributes to the establishment of the dorsal-ventral axis(1). A different branch, referred to as the planar cell polarity pathway, is essential for cell polarization during elongation of the axial mesoderm by convergent extension(2). Here we demonstrate that a third branch of the cascade is independent of Dishevelled function and involves signalling through trimeric G proteins and protein kinase C (PKC). During gastrulation, Frizzled-7 (Fz7)-dependent PKC signalling controls cell-sorting behaviour in the mesoderm. Loss of zygotic Fz7 function results in the inability of involuted anterior mesoderm to separate from the ectoderm, which leads to severe gastrulation defects. This result provides a developmentally relevant in vivo function for the Fz/PKC pathway in vertebrates.	Max Planck Inst Dev Biol, Dept Cell Biol, D-72076 Tubingen, Germany	Max Planck Society	Steinbeisser, H (corresponding author), Max Planck Inst Dev Biol, Dept Cell Biol, Spemann Str 35, D-72076 Tubingen, Germany.			Swain, Rajeeb/0000-0003-4815-8221				Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Djiane A, 2000, DEVELOPMENT, V127, P3091; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Munchberg SR, 1999, MECH DEVELOP, V80, P53, DOI 10.1016/S0925-4773(98)00193-2; OTTE AP, 1992, CELL, V68, P1021, DOI 10.1016/0092-8674(92)90074-M; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shi DL, 1998, MECH DEVELOP, V70, P35, DOI 10.1016/S0925-4773(97)00166-4; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Tada M, 2000, DEVELOPMENT, V127, P2227; Wacker S, 2000, DEV BIOL, V224, P428, DOI 10.1006/dbio.2000.9794; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Winklbauer R, 1999, DEVELOPMENT, V126, P3703; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	21	215	223	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					856	860		10.1038/35101621	http://dx.doi.org/10.1038/35101621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677610				2022-12-01	WOS:000171750200049
J	Roose, SP; Glassman, AH; Seidman, SN				Roose, SP; Glassman, AH; Seidman, SN			Relationship between depression and other medical illnesses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ASSOCIATION; EVENTS; MEN		Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Roose, SP (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	spr2@columbia.edu						AROMAA A, 1994, ACTA PSYCHIAT SCAND, V89, P77, DOI 10.1111/j.1600-0447.1994.tb05807.x; Berkman LF, 2000, AM HEART J, V139, P1; CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009; Carney RM, 2001, PSYCHOSOM MED, V63, P102; CONNERNEY I, 2000, P AM PSYCH SOC MARCH; FORD DE, 1994, CIRCULATION, V90, P614; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; GLASSMAN A, 2001, POST PRES AM PSYCH A; GLASSMAN AH, 1993, JAMA-J AM MED ASSOC, V269, P2673, DOI 10.1001/jama.269.20.2673; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4; KEMPER JW, 1957, ANN INTERN MED, V46, P831, DOI 10.7326/0003-4819-46-5-831; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; LaghrissiThode F, 1997, BIOL PSYCHIAT, V42, P290, DOI 10.1016/S0006-3223(96)00345-9; Lesperance F, 1998, J AM COLL CARDIOL, V31, p208A, DOI 10.1016/S0735-1097(97)84610-4; MORRIS PLP, 1993, AM J PSYCHIAT, V150, P124; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; POLLOCK BG, 1995, 34 ANN M AM COLL NEU; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P555, DOI 10.1016/0010-440X(83)90024-X; Roose SP, 1998, JAMA-J AM MED ASSOC, V279, P287, DOI 10.1001/jama.279.4.287; Roose SP, 1998, AM J PSYCHIAT, V155, P660, DOI 10.1176/ajp.155.5.660; ROOSE SP, 1991, J CLIN PSYCHIAT, V52, P34; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; SEIDMAN SN, IN PRESS AM J PSYCHI; Seidman SN, 1999, PSYCHIAT CLIN N AM, P21; Shabsigh R, 1998, UROLOGY, V52, P848, DOI 10.1016/S0090-4295(98)00292-1; Shapiro PA, 1999, AM HEART J, V137, P1100, DOI 10.1016/S0002-8703(99)70369-8; SIMONSICK EM, 1995, PSYCHOSOM MED, V57, P427, DOI 10.1097/00006842-199509000-00003; TROXLER RG, 1977, ATHEROSCLEROSIS, V26, P151, DOI 10.1016/0021-9150(77)90098-3	30	56	56	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1687	1690		10.1001/jama.286.14.1687	http://dx.doi.org/10.1001/jama.286.14.1687			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	480NC	11594878				2022-12-01	WOS:000171466800001
J	Thornton, S				Thornton, S			Personal view - The child B case - Reflections of a chief executive	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 21	1997	314	7097					1838	1839		10.1136/bmj.314.7097.1838a	http://dx.doi.org/10.1136/bmj.314.7097.1838a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XG166	11644948	Green Published			2022-12-01	WOS:A1997XG16600064
J	BRAHAMS, D				BRAHAMS, D			CHLORAMBUCIL INFERTILITY AND SPERM BANKING	LANCET			English	Editorial Material																			0	4	4	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 15	1992	339	8790					420	420		10.1016/0140-6736(92)90098-N	http://dx.doi.org/10.1016/0140-6736(92)90098-N			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD659	11659388				2022-12-01	WOS:A1992HD65900016
J	[Anonymous]				[Anonymous]			PATIENTS RIGHT TO KNOW IN JAPAN	LANCET			English	Editorial Material																		BRAHAMS D, 1989, LANCET, V2, P173; JOSEPH J, 1990, TIMES           1102; KIMURA R, 1988, BIOETHICAL SOCIOLEGA	3	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	1990	336	8726					1309	1310						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	11642858				2022-12-01	WOS:A1990EJ94300021
J	Kawano, H; Motoyama, T; Ohgushi, M; Kugiyama, K; Ogawa, H; Yasue, H				Kawano, H; Motoyama, T; Ohgushi, M; Kugiyama, K; Ogawa, H; Yasue, H			Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina	ANNALS OF INTERNAL MEDICINE			English	Article							ENDOTHELIUM-DEPENDENT VASODILATION; CORONARY-ARTERY SPASM; BRACHIAL-ARTERY; SMOOTH-MUSCLE; NITRIC-OXIDE; ACETYLCHOLINE; PATHOGENESIS; ESTROGEN; DILATATION; RELAXATION	Background: An abundance of ovarian hormones is assumed to be a major contributor to the low incidence of ischemic heart disease in premenopausal women. However, the effects of ovarian hormones remain undetermined. Objective: To examine whether the variation in ovarian hormone levels throughout a menstrual cycle affects myocardial ischemia in women with variant angina. Design: Prospective, observational study. Setting: University medical center in Japan. Participants: 10 premenopausal women with variant angina. Measurements: Frequency of spontaneous ischemic episodes, flow-mediated dilation of brachial artery, and serum levels of estradiol and progesterone. Results: Frequency of ischemic episodes was highest from the end of the luteal phase to the beginning of the menstrual phase and was lowest in the follicular phase. Flow-mediated vasodilation and estradiol levels were lowest from the end of the luteal phase to the beginning of the menstrual phase and were highest in the follicular phase. Conclusions: in premenopausal women with variant angina, we documented a cyclic variation in endothelial function and the frequency of myocardial ischemia that was associated with the variation in estrogen levels.	Kumamoto Univ, Sch Med, Kumamoto Reg Med Ctr, Dept Cardiovasc Med, Kumamoto 8608556, Japan; Kumamoto Aging Res Inst, Kumamoto, Japan	Kumamoto University	Kawano, H (corresponding author), Kumamoto Univ, Sch Med, Kumamoto Reg Med Ctr, Dept Cardiovasc Med, 1-1-1 Honjo, Kumamoto 8608556, Japan.	koumei@gpo.kumamoto-u.ac.jp		Yasue, Hirofumi/0000-0002-9952-9638				ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; BAIM DS, 2000, BROSSMANS CARDIAC CA, P211; English JL, 1998, AM J CARDIOL, V82, P256; Freay AD, 1997, CIRC RES, V81, P242, DOI 10.1161/01.RES.81.2.242; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gerhard M, 1998, CIRCULATION, V98, P1158, DOI 10.1161/01.CIR.98.12.1158; HASHIMOTO M, 1995, CIRCULATION, V92, P3431, DOI 10.1161/01.CIR.92.12.3431; HILLIS LD, 1978, NEW ENGL J MED, V299, P695, DOI 10.1056/NEJM197809282991305; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Kawano H, 1996, P ASSOC AM PHYSICIAN, V108, P473; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Motoyama T, 1998, J AM COLL CARDIOL, V32, P1672, DOI 10.1016/S0735-1097(98)00447-1; WITTEMAN JCM, 1989, BRIT MED J, V298, P642, DOI 10.1136/bmj.298.6674.642; Yasue H, 1997, INTERNAL MED, V36, P760, DOI 10.2169/internalmedicine.36.760; YASUE H, 1983, CIRC RES, V52, P147; YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955	17	77	80	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2001	135	11					977	981		10.7326/0003-4819-135-11-200112040-00009	http://dx.doi.org/10.7326/0003-4819-135-11-200112040-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PN	11730398				2022-12-01	WOS:000172520000004
J	Apoola, A; tenHof, J; Allan, PS				Apoola, A; tenHof, J; Allan, PS			Access to infertility investigations and treatment in couples infected with HIV: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							NEGATIVE WOMEN; PARTNERS		Coventry & Warwickshire Hosp, Dept Genitourinary Med, Coventry CV1 4FH, W Midlands, England; Univ Utrecht, Med Centrum, NL-3584 Utrecht, Netherlands	Atrium Medical Center; Utrecht University	Apoola, A (corresponding author), Coventry & Warwickshire Hosp, Dept Genitourinary Med, Stoney Stanton Rd, Coventry CV1 4FH, W Midlands, England.		Apoola, Ade/AAT-2097-2021					CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Gilling-Smith C, 2001, BRIT MED J, V322, P566, DOI 10.1136/bmj.322.7286.566; Mandelbrot L, 1997, LANCET, V349, P850, DOI 10.1016/S0140-6736(05)61754-0; Minkoff H, 2000, NEW ENGL J MED, V342, P1748, DOI 10.1056/NEJM200006083422312; SEMPRINI AE, 1993, LANCET, V341, P1343, DOI 10.1016/0140-6736(93)90850-G	5	12	12	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2001	323	7324					1285	1285		10.1136/bmj.323.7324.1285	http://dx.doi.org/10.1136/bmj.323.7324.1285			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500YG	11731391	Green Published, Bronze			2022-12-01	WOS:000172655800018
J	Hu, FH; Wang, YC; Liu, D; Li, YM; Qin, J; Elledge, SJ				Hu, FH; Wang, YC; Liu, D; Li, YM; Qin, J; Elledge, SJ			Regulation of the Bub2/Bfal GAP complex by Cdc5 and cell cycle checkpoints	CELL			English	Article							DNA-DAMAGE CHECKPOINT; POLO-LIKE KINASES; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC CHECKPOINT; PHOSPHATASE CDC14; EXIT; PROTEIN; MITOSIS; PATHWAY	During mitosis, a ras-related GTPase (Tem1) binds GTP and activates a signal transduction pathway to allow mitotic exit. During most of the cell cycle, Tem1 function is antagonized by a GTPase-activating protein complex, Bfa1/Bub2. How the Bfa1/Bub2 complex is regulated is not well understood. We find that Polo/ Cdc5 kinase acts upstream of Bfa1/Bub2 in the mitotic exit network. Cdc5 phosphorylates Bfa1 and acts to antagonize Bfa1 function to promote mitotic exit. Bfa1 is regulated by multiple cell cycle checkpoints. The spindle assembly and spindle orientation checkpoints inhibit Bfa1 phosphorylation. DNA damage does not inhibit Bfa1 phosphorylation and instead causes: a Rad53- and Dun1-dependent modification of Bfa1. Regulation of Bfa1 may therefore be a key step controlled by multiple checkpoint pathways to ensure a mitotic arrest.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.			Wang, Yanchang/0000-0001-6782-0570	NIGMS NIH HHS [GM44664] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM044664] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adames NR, 2001, J CELL BIOL, V153, P159, DOI 10.1083/jcb.153.1.159; Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Fesquet D, 1999, EMBO J, V18, P2424, DOI 10.1093/emboj/18.9.2424; Fournier N, 2001, ARCH MICROBIOL, V175, P62, DOI 10.1007/s002030000238; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Furge KA, 1998, CURR BIOL, V8, P947, DOI 10.1016/S0960-9822(98)70394-X; Gardner R, 1999, EMBO J, V18, P3173, DOI 10.1093/emboj/18.11.3173; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee SE, 2001, J CELL SCI, V114, P2345; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Li R, 1999, P NATL ACAD SCI USA, V96, P4989, DOI 10.1073/pnas.96.9.4989; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; MUHUA L, 1994, CELL, V78, P669, DOI 10.1016/0092-8674(94)90531-2; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(00)00002-2; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Wang YC, 2000, CURR BIOL, V10, P1379, DOI 10.1016/S0960-9822(00)00779-X; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111	41	206	207	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 30	2001	107	5					655	665		10.1016/S0092-8674(01)00580-3	http://dx.doi.org/10.1016/S0092-8674(01)00580-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	499MQ	11733064	Bronze			2022-12-01	WOS:000172575300012
J	Theissen, G				Theissen, G			Genetics of identity	NATURE			English	Editorial Material									Univ Jena, Inst Genet, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Theissen, G (corresponding author), Univ Jena, Inst Genet, Philosophenweg 12, D-07743 Jena, Germany.							Goto K, 2001, CURR OPIN GENET DEV, V11, P449, DOI 10.1016/S0959-437X(00)00216-1; Gutierrez-Cortines ME, 2000, TRENDS PLANT SCI, V5, P471, DOI 10.1016/S1360-1385(00)01761-1; Jack T, 2001, TRENDS PLANT SCI, V6, P310, DOI 10.1016/S1360-1385(01)01987-2; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172	4	15	15	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					491	491		10.1038/35107163	http://dx.doi.org/10.1038/35107163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734829				2022-12-01	WOS:000172405900024
J	Gretch, D				Gretch, D			Mechanism of interferon resistance in hepatitis C	LANCET			English	Editorial Material							NONSTRUCTURAL 5A PROTEIN; ALPHA THERAPY; VIRUS; REGION; SUBSTITUTIONS; SENSITIVITY; KINASE		Univ Washington, Dept Virol, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	Gretch, D (corresponding author), Univ Washington, Dept Virol, Seattle, WA 98104 USA.							ALTER HJ, 1995, BLOOD, V85, P1681, DOI 10.1182/blood.V85.7.1681.bloodjournal8571681; Asahina Y, 2001, HEPATOLOGY, V34, P377, DOI 10.1053/jhep.2001.26086; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Herion D, 1997, HEPATOLOGY, V25, P769, DOI 10.1002/hep.510250346; Lam NP, 1997, HEPATOLOGY, V26, P226; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Podevin P, 2001, HEPATOLOGY, V33, P1503, DOI 10.1053/jhep.2001.24749; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Polyak SJ, 1999, HEPATOLOGY, V29, P1262, DOI 10.1002/hep.510290438; Rosen HR, 1999, MOL MED TODAY, V5, P393, DOI 10.1016/S1357-4310(99)01523-3; Song J, 1999, J GEN VIROL, V80, P879, DOI 10.1099/0022-1317-80-4-879; Witherell GW, 2001, J MED VIROL, V63, P8, DOI 10.1002/1096-9071(200101)63:1&lt;8::AID-JMV1001&gt;3.0.CO;2-K	18	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 17	2001	358	9294					1662	1664		10.1016/S0140-6736(01)06728-9	http://dx.doi.org/10.1016/S0140-6736(01)06728-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	495MC	11728538				2022-12-01	WOS:000172344100006
J	Darnell, JC; Jensen, KB; Jin, P; Brown, V; Warren, ST; Darnell, RB				Darnell, JC; Jensen, KB; Jin, P; Brown, V; Warren, ST; Darnell, RB			Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function	CELL			English	Article							BINDING-PROTEIN; TELOMERIC DNA; DENDRITIC SPINES; IN-VIVO; FMR1 PROTEIN; RAT-BRAIN; KH DOMAIN; NUCLEAR; MICE; RECOGNITION	Loss of fragile X mental retardation protein (FMRP) function causes the fragile X mental retardation syndrome. FMRP harbors three RNA binding domains, associates with polysomes, and is thought to regulate mRNA translation and/or localization, but the RNAs to which it binds are unknown. We have used RNA selection to demonstrate that the FMRP RGG box binds intramolecular G quartets. This data allowed us to identify mRNAs encoding proteins involved in synaptic or developmental neurobiology that harbor FMRP binding elements. The majority of these mRNAs have an altered polysome association in fragile X patient cells. These data demonstrate that G quartets serve as physiologically relevant targets for FMRP and identify mRNAs whose dysregulation may underlie human mental retardation.	Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	Rockefeller University; Emory University; Emory University; Emory University	Darnell, RB (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockvax.rockefeller.edu	Darnell, Robert B/B-9022-2008; Jensen, Kirk/AAL-5883-2020; Jensen, Kirk/B-4756-2008; Warren, Stephen T/A-2498-2012	Darnell, Robert B/0000-0002-5134-8088; Jensen, Kirk/0000-0002-2084-1734; Jensen, Kirk/0000-0002-2084-1734; 	NICHD NIH HHS [R37HD20521, P01HD35576, R01 HD40647, R01 HD040647] Funding Source: Medline; NINDS NIH HHS [R01 NS34389] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040647] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035576, R01HD020521, R37HD020521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; ABSHER D, 2001, IMPORTANCE KH DOMAIN; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; Barberis C, 1996, CRIT REV NEUROBIOL, V10, P119; BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; GAUTHERET D, 1990, COMPUT APPL BIOSCI, V6, P325; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Grabowski PJ, 2000, NEURON, V25, P254, DOI 10.1016/S0896-6273(00)80888-0; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Iino S, 1999, NEUROSCIENCE, V91, P1435, DOI 10.1016/S0306-4522(98)00701-5; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jain RG, 1997, MOL CELL BIOL, V17, P954, DOI 10.1128/MCB.17.2.954; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kota RS, 1999, CHROMOSOMA, V108, P278, DOI 10.1007/s004120050379; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lau D, 2000, J NEUROSCI, V20, P9071; LEE JS, 1990, NUCLEIC ACIDS RES, V18, P6057, DOI 10.1093/nar/18.20.6057; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Maekawa S, 1999, J BIOL CHEM, V274, P21369, DOI 10.1074/jbc.274.30.21369; Mandell JW, 1996, PERSPECT DEV NEUROBI, V4, P125; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Oliver AW, 2000, J MOL BIOL, V301, P575, DOI 10.1006/jmbi.2000.3991; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; TSAI DE, 1991, NUCLEIC ACIDS RES, V19, P4931, DOI 10.1093/nar/19.18.4931; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Urban IJA, 1998, PROG BRAIN RES, V119, P285; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; YAMAKAWA K, 1995, HUM MOL GENET, V4, P709, DOI 10.1093/hmg/4.4.709; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	85	750	765	0	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2001	107	4					489	499		10.1016/S0092-8674(01)00566-9	http://dx.doi.org/10.1016/S0092-8674(01)00566-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	494GG	11719189	Bronze			2022-12-01	WOS:000172272900009
J	Clark, P; Rennie, L; Rawlinson, S				Clark, P; Rennie, L; Rawlinson, S			Quality improvement report - Effect of a formal education transfusions	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem Failure of correct identification and insufficient monitoring of patients receiving transfusions continue to be appreciable and avoidable causes of morbidity and mortality. Design A study by a regional transfusion service and a transfusion nurse specialist of the effects of an education programme based on the current national guidelines on identification and monitoring of patients receiving transfusions. Setting A large United Kingdom teaching hospital which houses the headquarters of the regional transfusion service. Key measures for improvement Improvement in compliance with published national guidelines on the prescription and administration of blood transfusions. Strategy for change An audit of current compliance followed by dissemination. by a transfusion nurse specialist of a clinical skills package (based on the best practice for transfusion) to all staff involved in giving transfusions. This was supported by trained instructors and the display of standard operating procedures for transfusion in all clinical areas. Effect of change An improvement in compliance with. the national guidelines to over 95% in six out of seven of the recommendations on best practice was seen 18 months after the initial intervention. Lessons learnt The study shows that education of those who prescribe and administer transfusions, as recommended by bodies concerned with the hazards of transfusion, can improve the safety of transfusions.	Ninewells Hosp, E Scotland Blood Transfus Serv, Dept Transfus Med, Dundee DD1 9SY, Scotland	University of Dundee	Clark, P (corresponding author), Ninewells Hosp, E Scotland Blood Transfus Serv, Dept Transfus Med, Dundee DD1 9SY, Scotland.	peter.clark@snbts.csa.scot.nhs.uk						Dinc L, 2000, INT J NURS STUD, V37, P371, DOI 10.1016/S0020-7489(00)00016-X; Kelsey P, 1999, TRANSFUSION MED, V9, P227; LOVE EM, 2001, SERIOUS HAZARDS TRAN; MCCLELLAND B, 1996, HDB TRANSFUSION MED, P30; ROWNTREE D, 1996, PREPARING MAT OPEN D; van den Arend IJM, 2000, DIABETIC MED, V17, P190, DOI 10.1046/j.1464-5491.2000.00232.x	6	25	25	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2001	323	7321					1118	1120		10.1136/bmj.323.7321.1118	http://dx.doi.org/10.1136/bmj.323.7321.1118			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492VN	11701582	Green Published			2022-12-01	WOS:000172188400021
J	Jefferis, GSXE; Marin, EC; Stocker, RF; Luo, LQ				Jefferis, GSXE; Marin, EC; Stocker, RF; Luo, LQ			Target neuron prespecification in the olfactory map of Drosophila	NATURE			English	Article							ODORANT RECEPTORS; NERVOUS-SYSTEM; ANTENNAL LOBE; SENSORY MAP; MELANOGASTER; MECHANISMS; INTERNEURONS; CONNECTIVITY; ORGANIZATION; GENERATION	In Drosophila and mice, olfactory receptor neurons (ORNs) expressing the same receptors have convergent axonal projections to specific glomerular targets in the antennal lobe/olfactory bulb, creating an odour map in this first olfactory structure of the central nervous system(1-3). Projection neurons of the Drosophila antennal lobe send dendrites into glomeruli and axons to higher brain centres(4), thereby transferring this odour map further into the brain. Here we use the MARCM method(5) to perform a systematic clonal analysis of projection neurons, allowing us to correlate lineage and birth time of projection neurons with their glomerular choice. We demonstrate that projection neurons are prespecified by lineage and birth order to form a synapse with specific incoming ORN axons, and therefore to carry specific olfactory information. This prespecification could be used to hardwire the fly's olfactory system, enabling stereotyped behavioural responses to odorants. Developmental studies lead us to hypothesize that recognition molecules ensure reciprocally specific connections of ORNs and projection neurons. These studies also imply a previously unanticipated role for precise dendritic targeting by postsynaptic neurons in determining connection specificity.	Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; Univ Fribourg, Program Neurosci, CH-1700 Fribourg, Switzerland	Stanford University; Stanford University; University of Fribourg; University of Fribourg	Luo, LQ (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.		Jefferis, Gregory/C-6386-2012	Jefferis, Gregory/0000-0002-0587-9355; Luo, Liqun/0000-0001-5467-9264				AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8	25	317	321	1	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2001	414	6860					204	208		10.1038/35102574	http://dx.doi.org/10.1038/35102574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490AY	11719930	Green Submitted			2022-12-01	WOS:000172029100047
J	Priest, P; Yudkin, P; McNulty, C; Mant, D				Priest, P; Yudkin, P; McNulty, C; Mant, D			Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To quantify the relation between community based antibacterial prescribing and antibacterial resistance in community acquired disease. Design Cross sectional study of antibacterial prescribing and antibacterial resistance of routine isolates within individual practices and primary care groups. Setting 405 general practices (38 groups) in south west and north west England. Main outcome measures Correlation between antibacterial prescribing and resistance for urinary coliforms and Streptococcus pneumoniae. Results Antibacterial resistance in urinary coliform isolates is common but the Correlation with prescribing rates was relatively low for individual practices (ampicillin and amoxicillin r(s) = 0.20, P = 0.001; trimethoprim. r(e) = 0.24, P = 0.0001) and primary care groups (ampicillin and amoxicillin r(s) = 0.44, P = 0.05; trimethoprim r(s) = 0.31, P = 0.09). Regression coefficients were also low; a practice prescribing 20% less ampicillin and amoxicillin than average would have about 1% fewer resistant isolates (0.94/100; 95% confidence interval 0.02 to 1.85). Resistance of S pneumoniae to both penicillin and erythromycin remains uncommon, and no clear relation with prescribing was found. Conclusions Routine microbiological isolates should not be used for surveillance of antibacterial resistance in the community or for monitoring the outcome of any change in antibacterial prescribing by general practitioners. Trying to reduce the overall level of antibiotic prescribing in UK general practice may not be the most effective strategy for reducing resistance in the community.	Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; Gloucestershire Royal Hosp, Gloucester Publ Hlth Lab, Gloucester GL1 3NN, England	University of Oxford; Gloucestershire Royal Hospital	Priest, P (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	patricia.priest@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009					Arason VA, 1996, BMJ-BRIT MED J, V313, P387; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Carbon C, 1998, BRIT MED J, V317, P663, DOI 10.1136/bmj.317.7159.663; DARDAMISSIS E, ANTIBIOTIC PRESCRIBI; Department of Health and Social Care (DHSC), 2000, UK ANT RES STRAT ACT; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Huovinen P, 1998, BRIT MED J, V317, P613, DOI 10.1136/bmj.317.7159.613; Lindbaek M, 1998, BRIT MED J, V317, P1521; Magee JT, 1999, BMJ-BRIT MED J, V319, P1239, DOI 10.1136/bmj.319.7219.1239; Seppala H, 1995, CLIN INFECT DIS, V21, P1378, DOI 10.1093/clinids/21.6.1378; Steinke DT, 2001, J ANTIMICROB CHEMOTH, V47, P781, DOI 10.1093/jac/47.6.781; van Weel C, 1999, LANCET, V354, P1052, DOI 10.1016/S0140-6736(99)90107-1; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609	13	40	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2001	323	7320					1037	1041		10.1136/bmj.323.7320.1037	http://dx.doi.org/10.1136/bmj.323.7320.1037			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490MP	11691763	Green Published, Bronze			2022-12-01	WOS:000172055900019
J	Dennis, PB; Jaeschke, A; Saitoh, M; Fowler, B; Kozma, SC; Thomas, G				Dennis, PB; Jaeschke, A; Saitoh, M; Fowler, B; Kozma, SC; Thomas, G			Mammalian TOR: A homeostatic ATP sensor	SCIENCE			English	Article							TRANSCRIPTION; P70(S6K); TARGET	The bacterial macrolide rapamycin is an efficacious anticancer agent against solid tumors. In a hypoxic environment, the increase in mass of solid tumors is dependent on the recruitment of mitogens and nutrients. When nutrient concentrations change, particularly those of essential amino acids, the mammalian Target of Rapamycin (mTOR) functions in regulatory pathways that control ribosome biogenesis and cell growth. In bacteria, ribosome biogenesis is independently regulated by amino acids and adenosine triphosphate (ATP). Here we demonstrate that the mTOR pathway is influenced by the intracellular concentration of ATP, independent of the abundance of amino acids, and that mTOR itself is an ATP sensor.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Univ Childrens Hosp, CH-4005 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Thomas, G (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	gthomas@fmi.ch	Thomas, George/K-9235-2014	Thomas, George/0000-0003-3518-8149				Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Dennis P.B., UNPUB; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Derenzini M, 2000, J PATHOL, V191, P181, DOI 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.bi.56.070187.003031; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Roberts J, 1997, SCIENCE, V278, P2073, DOI 10.1126/science.278.5346.2073; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751	18	760	802	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2001	294	5544					1102	1105		10.1126/science.1063518	http://dx.doi.org/10.1126/science.1063518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691993				2022-12-01	WOS:000172013800050
J	Jahoda, CAB; Reynolds, AJ				Jahoda, CAB; Reynolds, AJ			Hair follicle dermal sheath cells: unsung participants in wound healing	LANCET			English	Article							SMOOTH MUSCLE ACTIN; EXPRESSION; PROTEIN; SKIN	The dermal sheath that surrounds the outside of the hair follicle contains progenitor cells that maintain and regenerate the dermal papilla, a key component for hair growth. Our contention is that dermal sheath cells have other roles. We believe that they can become wound healing fibroblasts and perform an important function in the repair of skin dermis after injury. The dermal sheath has close developmental and anatomical parallels with follicle outer root sheath, the epithelial component that contains the stem cells responsible for replacing skin epidermis. Dermal sheath cells also have a myofibroblast or wound healing phenotype, and in animals with high follicle densities differences in wound healing are observed in conjunction with changes in the hair growth cycle. Similarly, in human beings there are apparent differences in wound healing responses between hairy and non-hairy body sites. Moreover, clinical and experimental data suggest that the involvement of follicle-derived dermal cells results in qualitatively Improved dermal repair. Therefore, in a therapeutic context, hair follicle dermal cells provide an accessible option for the creation of dermal or full skin equivalents that could both improve wound healing and reduce scarring. Indeed, given the inductive properties of adult hair follicle dermal cells, it is reasonable to envisage a tissue engineering approach for the production of a skin equivalent that will grow hair follicles when grafted.	Univ Durham, Dept Biol Sci, Durham DH1 3HP, England	Durham University	Jahoda, CAB (corresponding author), Univ Durham, Dept Biol Sci, Durham DH1 3HP, England.			Jahoda, Colin/0000-0002-1762-1220				BILLINGHAM RE, 1955, J ANAT, V89, P114; BISHOP GH, 1945, AM J ANAT, V76, P153, DOI 10.1002/aja.1000760202; Desmouliere A, 1996, MOL CELLULAR BIOL WO; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Hasan W, 2000, CELL TISSUE RES, V300, P97, DOI 10.1007/s004410050051; JAHODA CAB, 1991, J CELL SCI, V99, P627; JAHODA CAB, 1984, J EMBRYOL EXP MORPH, V83, P95; Jahoda CAB, 1998, EXP DERMATOL, V7, P235; MARTINOT V, 1994, BURNS, V20, P146, DOI 10.1016/S0305-4179(06)80012-4; Mast B.A., 1999, SKIN WOUND HEALING B; Matsumura Hajime, 1997, Journal of Burn Care and Rehabilitation, V18, P306, DOI 10.1097/00004630-199707000-00005; OLIVER RF, 1966, J EMBRYOL EXP MORPH, V16, P231; ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P857; REYNOLDS AJ, 1993, J INVEST DERMATOL, V101, P577, DOI 10.1111/1523-1747.ep12366032; Reynolds AJ, 1999, NATURE, V402, P33, DOI 10.1038/46938; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Zawacki B E, 1967, Br J Plast Surg, V20, P347, DOI 10.1016/S0007-1226(67)80065-1	17	173	192	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 27	2001	358	9291					1445	1448		10.1016/S0140-6736(01)06532-1	http://dx.doi.org/10.1016/S0140-6736(01)06532-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488MK	11705511				2022-12-01	WOS:000171940100035
J	Sorensen, HT; Pedersen, L; Nogard, L; Fonager, K; Rothman, KJ				Sorensen, HT; Pedersen, L; Nogard, L; Fonager, K; Rothman, KJ			Does month of birth affect risk of Crohn's disease in childhood and adolescence?	BRITISH MEDICAL JOURNAL			English	Article							IN-UTERO; MEASLES; EXPOSURE		Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; Aalborg Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; Aarhus Univ, Inst Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Boston University	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Vennelyst Blvd 6, DK-8000 Aarhus C, Denmark.		Nørgård, Bente M/F-9563-2013; Sorensen, Henrik Toft/Z-6181-2019	Nørgård, Bente M/0000-0002-9514-3033; Sorensen, Henrik Toft/0000-0003-4299-7040; Rothman, Kenneth/0000-0003-2398-1705; Fonager, Kirsten/0000-0001-9641-992X				Ekbom A, 1996, LANCET, V348, P515, DOI 10.1016/S0140-6736(96)04429-7; Haslam N, 2000, GUT, V47, P801, DOI 10.1136/gut.47.6.801; Nielsen LLW, 1998, BRIT MED J, V316, P196, DOI 10.1136/bmj.316.7126.196	3	24	24	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					907	907		10.1136/bmj.323.7318.907	http://dx.doi.org/10.1136/bmj.323.7318.907			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668136	Green Published, Bronze			2022-12-01	WOS:000171798200022
J	Cui, XD; Primak, A; Zarate, X; Tomfohr, J; Sankey, OF; Moore, AL; Moore, TA; Gust, D; Harris, G; Lindsay, SM				Cui, XD; Primak, A; Zarate, X; Tomfohr, J; Sankey, OF; Moore, AL; Moore, TA; Gust, D; Harris, G; Lindsay, SM			Reproducible measurement of single-molecule conductivity	SCIENCE			English	Article							ASSEMBLED ALKANETHIOL MONOLAYERS; METAL JUNCTIONS; TRANSPORT	A reliable method has been developed for making through-bond electrical contacts to molecules. Current-voltage curves are quantized as integer multiples of one fundamental curve, an observation used to identify single-molecule contacts. The resistance of a single octanedithiol molecule was 900 +/- 50 megohms, based on measurements on more than 1000 single molecules. In contrast, nonbonded contacts to octanethiol monolayers were at least four orders of magnitude more resistive, less reproducible, and had a different voltage dependence, demonstrating that the measurement of intrinsic molecular properties requires chemically bonded contacts.	Arizona State Univ, Dept Phys & Astron, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Motorola Inc, Tempe, AZ 85284 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Cui, XD (corresponding author), Arizona State Univ, Dept Phys & Astron, Tempe, AZ 85287 USA.		Cui, Xiaodong/C-2023-2009; Zarate, Xristo/AAH-1463-2020	Cui, Xiaodong/0000-0002-2013-8336; Zarate, Xristo/0000-0002-9824-3961				Cygan MT, 1998, J AM CHEM SOC, V120, P2721, DOI 10.1021/ja973448h; Datta S, 1997, PHYS REV LETT, V79, P2530, DOI 10.1103/PhysRevLett.79.2530; DEMKOV AA, 1995, PHYS REV B, V52, P1618, DOI 10.1103/PhysRevB.52.1618; DEROSE JA, 1991, SURF SCI, V256, P102, DOI 10.1016/0039-6028(91)91204-B; Di Ventra M, 2000, PHYS REV LETT, V84, P979, DOI 10.1103/PhysRevLett.84.979; DOROGI M, 1995, PHYS REV B, V52, P9071, DOI 10.1103/PhysRevB.52.9071; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Gittins DI, 2000, NATURE, V408, P67, DOI 10.1038/35040518; Holmlin RE, 2001, J AM CHEM SOC, V123, P5075, DOI 10.1021/ja004055c; Leatherman G, 1999, J PHYS CHEM B, V103, P4006, DOI 10.1021/jp9831278; MUJICA V, 1994, J CHEM PHYS, V101, P6849, DOI 10.1063/1.468314; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Schlenoff JB, 1995, J AM CHEM SOC, V117, P12528, DOI 10.1021/ja00155a016; SIEPMANN JI, 1993, PHYS REV LETT, V70, P453, DOI 10.1103/PhysRevLett.70.453; Son KA, 2001, PHYS REV LETT, V86, P5357, DOI 10.1103/PhysRevLett.86.5357; Weare WW, 2000, J AM CHEM SOC, V122, P12890, DOI 10.1021/ja002673n; Wold DJ, 2001, J AM CHEM SOC, V123, P5549, DOI 10.1021/ja0101532; Yang JS, 2000, J ORG CHEM, V65, P871, DOI 10.1021/jo991339a	20	1194	1224	9	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					571	574		10.1126/science.1064354	http://dx.doi.org/10.1126/science.1064354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641492				2022-12-01	WOS:000171695600040
J	Valadkhan, S; Manley, JL				Valadkhan, S; Manley, JL			Splicing-related catalysis by protein-free snRNAs	NATURE			English	Article							SMALL NUCLEAR-RNA; METAL-ION CATALYSIS; U6 SNRNA; TERTIARY INTERACTION; IN-VITRO; SPLICEOSOME; SELECTION; STEP; DNA; SEQUENCE	Removal of intervening sequences from eukaryotic messenger RNA precursors is carried out by the spliceosome, a complex assembly of five small nuclear RNAs (snRNAs) and a large number of proteins. Although it has been suggested that the spliceosome might be an RNA enzyme, direct evidence for this has been lacking, and the identity of the catalytic domain of the spliceosome is unknown. Here we show that a protein-free complex of two snRNAs, U2 and U6, can bind and position a small RNA containing the sequence of the intron branch site, and activate the branch adenosine to attack a catalytically critical domain of U6 in a reaction that is related to the first step of splicing. Our data provide direct evidence for the catalytic potential of spliceosomal snRNAs.	Columbia Univ, Sherman Fairchild Ctr Life Sci, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Sherman Fairchild Ctr Life Sci, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu	Valadkhan, Saba/G-5561-2010; Valadkhan, Saba/G-7271-2012	Manley, James/0000-0002-8341-1459				Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; BURGE CB, 1998, RNA WORLD, V2, P525; BURN AJ, 1961, J CHEM SOC, P5532, DOI 10.1039/jr9610005532; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Collins CA, 1999, GENE DEV, V13, P1970, DOI 10.1101/gad.13.15.1970; DATTA B, 1993, MOL CELL BIOL, V13, P5377, DOI 10.1128/MCB.13.9.5377; FABRIZIO P, 1992, NUCLEIC ACIDS RES, V20, P3659, DOI 10.1093/nar/20.14.3659; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; GISH G, 1988, SCIENCE, V240, P1520, DOI 10.1126/science.2453926; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Hetzer M, 1997, NATURE, V386, P417, DOI 10.1038/386417a0; Huang Z, 1996, NUCLEIC ACIDS RES, V24, P4360, DOI 10.1093/nar/24.21.4360; KOOLE LH, 1991, TETRAHEDRON, V47, P3183, DOI 10.1016/S0040-4020(01)96043-0; LEHMAN IR, 1974, SCIENCE, V186, P790; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; MADHANI HD, 1990, GENE DEV, V4, P2264, DOI 10.1101/gad.4.12b.2264; Newman A, 1997, CURR BIOL, V7, pR418, DOI 10.1016/S0960-9822(06)00206-5; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; OKeefe RT, 1996, CELL, V86, P679, DOI 10.1016/S0092-8674(00)80140-3; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x; Saenger W., 1984, PRINCIPLES NUCL ACID, P116, DOI DOI 10.1007/978-1-4612-5190-3_6; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Segault V, 1999, MOL CELL BIOL, V19, P2782; Siatecka M, 1999, GENE DEV, V13, P1983, DOI 10.1101/gad.13.15.1983; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; TANI T, 1991, GENE DEV, V5, P1022, DOI 10.1101/gad.5.6.1022; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; Tuschl T, 2001, RNA, V7, P29, DOI 10.1017/S1355838201001510; Tuschl T, 1998, EMBO J, V17, P2637, DOI 10.1093/emboj/17.9.2637; Valadkhan S, 2000, RNA, V6, P206, DOI 10.1017/S1355838200992197; WOLFF T, 1994, P NATL ACAD SCI USA, V91, P903, DOI 10.1073/pnas.91.3.903; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; YU YT, 1995, RNA, V1, P46; YU YT, 1993, CELL, V75, P1049, DOI 10.1016/0092-8674(93)90315-H	37	170	185	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					701	707		10.1038/35099500	http://dx.doi.org/10.1038/35099500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607023				2022-12-01	WOS:000171608000035
J	Chodosh, J; Ferrell, BA; Shekelle, PG; Wenger, NS				Chodosh, J; Ferrell, BA; Shekelle, PG; Wenger, NS			Quality indicators for pain management in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC MUSCULOSKELETAL PAIN; PLACEBO-CONTROLLED TRIAL; GENERAL-POPULATION; NUTRITION EXAMINATION; DEPRESSIVE SYMPTOMS; DIABETIC NEUROPATHY; RANDOMIZED TRIAL; NATIONAL-HEALTH; PEPTIC-ULCER; DRUG-USE		Univ Calif Los Angeles, Div Geriatr, Dept Med, Los Angeles, CA 90095 USA; RAND Corp, Hlth, Santa Monica, CA 90406 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Chodosh, J (corresponding author), Univ Calif Los Angeles, Div Geriatr, Dept Med, Los Angeles, CA 90095 USA.	jchodosh@mednet.ucla.edu		Chodosh, Joshua/0000-0001-7784-4306				ANDERSEN S, 1987, PAIN S, V4, P332; Becker N, 1997, PAIN, V73, P393, DOI 10.1016/S0304-3959(97)00126-7; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Brochet B, 1998, AGE AGEING, V27, P279, DOI 10.1093/ageing/27.3.279; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; COONER E, 1997, 628200 NATL COUNC AG; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Davis M A, 1988, Clin Geriatr Med, V4, P241; DIETRICH AJ, 1982, J FAM PRACTICE, V15, P929; Ellison Neil M., 1993, P185; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Ferrell BA, 1997, AGING-CLIN EXP RES, V9, P99, DOI 10.1007/BF03340134; Ferrell BA, 1998, J AM GERIATR SOC, V46, P635, DOI 10.1111/j.1532-5415.1998.tb01084.x; FERRELL BA, 1990, J AM GERIATR SOC, V38, P409, DOI 10.1111/j.1532-5415.1990.tb03538.x; Foley K, 1994, PRINCIPLES GERIATRIC, P317; GLARE P, 1992, J PAIN SYMPTOM MANAG, V7, P369, DOI 10.1016/0885-3924(92)90092-V; GRIFFIN MR, 1988, ANN INTERN MED, V109, P359, DOI 10.7326/0003-4819-109-5-359; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; GURWITZ JH, 1990, JAMA-J AM MED ASSOC, V264, P471, DOI 10.1001/jama.264.4.471; HAMEROFF SR, 1984, J CLIN PSYCHIAT, V45, P47; LAVSKYSHULAN M, 1985, J AM GERIATR SOC, V33, P23, DOI 10.1111/j.1532-5415.1985.tb02855.x; MAGNI G, 1993, PAIN, V53, P163, DOI 10.1016/0304-3959(93)90076-2; MAGNI G, 1990, PAIN, V43, P299, DOI 10.1016/0304-3959(90)90027-B; MAX MB, 1991, PAIN, V45, P3, DOI 10.1016/0304-3959(91)90157-S; MAX MB, 1992, NEW ENGL J MED, V326, P1250, DOI 10.1056/NEJM199205073261904; Mobily P., 1994, J AGING HEALTH, V6, P139, DOI DOI 10.1177/089826439400600201; PANERAI AE, 1990, ACTA NEUROL SCAND, V82, P34; PARMELEE PA, 1991, J GERONTOL, V46, pP15, DOI 10.1093/geronj/46.1.P15; PFEIFER MA, 1993, DIABETES CARE, V16, P1103, DOI 10.2337/diacare.16.8.1103; POPP B, 1996, PAIN ELDERLY, P21; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; ROGERS M, 1989, J CLIN GASTROENTEROL, V11, P132; ROY R, 1986, CAN FAM PHYSICIAN, V32, P513; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; *US AG HLTH CAR PO, 1994, AHCPR PUBL; Wilson PR, 1997, ANESTHESIOLOGY, V86, P995; World Health Organization, 1986, CANC PAIN REL	38	26	26	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				731	735		10.7326/0003-4819-135-8_Part_2-200110161-00012	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601956				2022-12-01	WOS:000171542400012
J	Bay-Nielsen, M; Kehlet, H; Strand, L; Malmstrom, J; Andersen, FH; Wara, P; Juul, P; Callesen, T				Bay-Nielsen, M; Kehlet, H; Strand, L; Malmstrom, J; Andersen, FH; Wara, P; Juul, P; Callesen, T		Danish Hernia Database Collaborat	Quality assessment of 26,304 herniorrhaphies in Denmark: a prospective nationwide study	LANCET			English	Article							INGUINAL HERNIORRHAPHY; HERNIA SURGERY	Background Groin hernia repair is one of the most frequent operations, but there is no consensus about surgical or anaesthetic technique. Furthermore, no nationwide studies have been done. Our aim was to investigate outcome results of groin hernia surgery to improve quality of treatment. Methods We prospectively recorded 26 304 groin hernia repairs done in Denmark from Jan 1, 1998, to June 30, 2000, in a nationwide Danish hernia database. Findings 93% of all groin herniorrhaphies done in Denmark in the 30 months of the study were recorded in the database. Kaplan-Meier estimates of reoperation rates 30 months after anterior mesh repair and laparoscopic repair were significantly lower than after sutured posterior wall repairs in primary inguinal hernia (2.2% and 2.6% vs 4.4%; p < 0.0001). Reoperation rates were also lower with anterior mesh repair (6.1%; p < 0.0001) and laparoscopic repair (3.4%; p < 0.0001) than with sutured posterior wall repair (10.6%) after recurrent hernia. Use of Lichtenstein mesh repair increased from 33% in January, 1998, to 62% in June, 2000, whereas use of laparoscopic repair remained constant at about 5%. Kaplan-Meier estimates of reoperation rates were 2.8% in the first 15 months and 1.6% in the second (p = 0.03). For elective repairs, only 59% of patients were treated on an outpatient basis, and only 18% had local anaesthesia. Interpretation Mesh repairs have a lower reoperation rate than conventional open repairs. Systematic prospective recording of treatment and outcome variables in a national clinical database improved the overall quality of surgical care. However, there is a large potential for cost savings and more efficient patient care with extended use of mesh techniques, outpatient surgery, and local anaesthesia.	Hvidovre Univ Hosp, Dept Surg Gastroenterol 435, DK-2650 Hvidovre, Denmark	University of Copenhagen	Bay-Nielsen, M (corresponding author), Hvidovre Univ Hosp, Dept Surg Gastroenterol 435, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	morten.bay.nielsen@hh.hosp.dk						Amid PK, 1998, HERNIA, V22, P89, DOI [DOI 10.1007/BF01207492, 10.1007/BF01207492]; Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001; Bay-Nielsen M, 1999, HERNIA, V3, P81; Black N, 1999, LANCET, V353, P1205, DOI 10.1016/S0140-6736(99)00108-7; Callesen T, 1997, ANESTHESIOLOGY, V87, P1219, DOI 10.1097/00000542-199711000-00027; Callesen T, 1998, ANAESTHESIA, V53, P31, DOI 10.1111/j.1365-2044.1998.00244.x; Callesen T, 1999, EUR J SURG, V165, P236; DEYSINE M, 1991, ARCH SURG-CHICAGO, V126, P628; Grant A, 2000, BRIT J SURG, V87, P854, DOI 10.1046/j.1365-2168.2000.01539.x; Grant A, 2000, BRIT J SURG, V87, P860, DOI 10.1046/j.1365-2168.2000.01540.x; Greenwood M., 1926, REPORTS PUBLIC HLTH, V33, P1; Kald A, 1998, EUR J SURG, V164, P45; Kark AE, 1998, J AM COLL SURGEONS, V186, P447, DOI 10.1016/S1072-7515(98)00057-X; Kingsnorth AN, 2000, HERNIA, V4, P1; MAJEED AW, 1995, BRIT MED J, V311, P296, DOI 10.1136/bmj.311.7000.296; Nilsson E, 1998, SURG CLIN N AM, V78, P1141, DOI 10.1016/S0039-6109(05)70375-3; Nilsson E, 1997, EUR J SURG, V163, P823; O'Riordan DC, 1998, SURG CLIN N AM, V78, P1129, DOI 10.1016/S0039-6109(05)70374-1; WELSH DRJ, 1993, SURG CLIN N AM, V73, P451	19	310	326	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2001	358	9288					1124	1128		10.1016/S0140-6736(01)06251-1	http://dx.doi.org/10.1016/S0140-6736(01)06251-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597665				2022-12-01	WOS:000171399000008
J	Siani, G; Paterne, M; Michel, E; Sulpizio, R; Sbrana, A; Arnold, M; Haddad, G				Siani, G; Paterne, M; Michel, E; Sulpizio, R; Sbrana, A; Arnold, M; Haddad, G			Mediterranean Sea surface radiocarbon reservoir age changes since the last glacial maximum	SCIENCE			English	Article							NORTH-ATLANTIC OCEAN; DEGLACIATION; C-14; PERIOD; EVENT; VENTILATION; CALIBRATION; RECORDS; ISOTOPE; BP	Sea surface reservoir ages must be known to establish a common chronological framework for marine, continental, and cryospheric paleoproxies, and are crucial for understanding ocean-continent climatic relationships and the paleoventilation of the ocean. Radiocarbon dates of planktonic foraminifera and tephra contemporaneously deposited over Mediterranean marine and terrestrial regions reveal that the reservoir ages were similar to the modern one (similar to 400 years) during most of the past 18,000 carbon-14 years. However, reservoir ages increased by a factor of 2 at the beginning of the last deglaciation. This is attributed to changes of the North Atlantic thermohaline circulation during the massive ice discharge event Heinrich 1.	CNRS, Lab Sci Climat & Environm, F-91118 Gif Sur Yvette, France; CNRS, Unite Mixte Serv, F-91118 Gif Sur Yvette, France; CNR, Ctr Studio Geol Strutturale & Dinam Appennino, I-56126 Pisa, Italy; CNR, Dipartimento Sci Terra, I-56126 Pisa, Italy; TotalFina Elf, Ctr Sci Jean Feger, F-64018 Pau, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Total SA; Centre Scientifique et Technique Jean Feger (CSTJF)	Paterne, M (corresponding author), CNRS, Lab Sci Climat & Environm, Ave Terrasse, F-91118 Gif Sur Yvette, France.		Sulpizio, Roberto/S-2133-2019	Sulpizio, Roberto/0000-0002-3930-5421; SBRANA, ALESSANDRO/0000-0003-1373-0603; Siani, Giuseppe/0000-0002-2090-5320				Adkins JF, 1998, SCIENCE, V280, P725, DOI 10.1126/science.280.5364.725; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; Bard E., 1987, CLIM DYNAM, V1, P101, DOI 10.1007/BF01054479; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; Broecker WS, 1988, PALEOCEANOGRAPHY, V3, P659, DOI 10.1029/PA003i006p00659; Broecker WS, 1990, GLOBAL BIOGEOCHEM CY, V4, P103, DOI 10.1029/GB004i001p00103; BROECKER WS, 1969, LIMNOL OCEANOGR, V14, P883, DOI 10.4319/lo.1969.14.6.0883; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Combourieu-Nebout N, 1998, QUATERNARY SCI REV, V17, P303, DOI 10.1016/S0277-3791(97)00039-5; Facorellis Y, 1998, RADIOCARBON, V40, P963; Hughen KA, 1998, RADIOCARBON, V40, P483; Kallel N, 1997, PALAEOGEOGR PALAEOCL, V135, P97, DOI 10.1016/S0031-0182(97)00021-7; Mercone D, 2000, PALEOCEANOGRAPHY, V15, P336, DOI 10.1029/1999PA000397; MICHEL E, 1995, PALEOCEANOGRAPHY, V10, P927, DOI 10.1029/95PA00978; OSTLUND HG, 1987, GEOSECS ATLANTIC PAC, P7; RUDDIMAN WF, 1981, PALAEOGEOGR PALAEOCL, V35, P145; SAMTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209; Siani G, 2000, RADIOCARBON, V42, P271, DOI 10.1017/S0033822200059075; SIANI G, 1999, THESIS U PARIS SUD O; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Stocker TF, 1998, RADIOCARBON, V40, P359; STUIVER M, 1991, QUATERNARY RES, V35, P1, DOI 10.1016/0033-5894(91)90091-I; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Vidal L, 1999, CLIM DYNAM, V15, P909, DOI 10.1007/s003820050321; von Grafenstein U, 1999, SCIENCE, V284, P1654, DOI 10.1126/science.284.5420.1654; Zahn R, 1997, PALEOCEANOGRAPHY, V12, P696, DOI 10.1029/97PA00581; Zahn R, 1987, PALEOCEANOGRAPHY, V2, P543, DOI 10.1029/PA002i006p00543	29	244	248	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2001	294	5548					1917	1920		10.1126/science.1063649	http://dx.doi.org/10.1126/science.1063649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497PQ	11729315				2022-12-01	WOS:000172465000056
J	Makino, Y; Cao, RH; Svensson, K; Bertilsson, GR; Asman, M; Tanaka, H; Cao, YH; Berkenstam, A; Poellinger, L				Makino, Y; Cao, RH; Svensson, K; Bertilsson, GR; Asman, M; Tanaka, H; Cao, YH; Berkenstam, A; Poellinger, L			Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression	NATURE			English	Article							TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; FACTOR 1-ALPHA; ANGIOGENESIS; FACTOR-1; GROWTH; ALPHA; PROTEOLYSIS; INDUCTION	Alteration of gene expression is a crucial component of adaptive responses to hypoxia. These responses are mediated by hypoxia-inducible transcription factors (HIFs)(1,2). Here we describe an inhibitory PAS (Per/Arnt/Sim) domain protein, IPAS, which is a basic helix-loop-helix (bHLH)/PAS protein structurally related to HIFs. IPAS contains no endogenous transactivation function but demonstrates dominant negative regulation of HIF-mediated control of gene expression. Ectopic expression of IPAS in hepatoma cells selectively impairs induction of genes involved in adaptation to a hypoxic environment, notably the vascular endothelial growth factor (VEGF) gene, and results in retarded tumour growth and tumour vascular density in vivo. In mice, IPAS was predominantly expressed in Purkinje cells of the cerebellum and in corneal epithelium of the eye. Expression of IPAS in the cornea correlates with low levels of expression of the VEGF gene under hypoxic conditions. Application of an IPAS antisense oligonucleotide to the mouse cornea induced angiogenesis under normal oxygen conditions, and demonstrated hypoxia-dependent induction of VEGF gene expression in hypoxic corneal cells. These results indicate a previously unknown mechanism for negative regulation of angiogenesis and maintenance of an avascular phenotype.	Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, Tokyo 1088639, Japan; Pharmacia Corp, S-12287 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Tokyo; Pfizer; Pharmacia Corporation	Poellinger, L (corresponding author), Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	lorenz.poellinger@cmb.ki.se	Berkenstam, Anders/E-7136-2012					Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Cao RH, 1999, P NATL ACAD SCI USA, V96, P5728, DOI 10.1073/pnas.96.10.5728; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Li J, 2000, NAT MED, V6, P49, DOI 10.1038/71527; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Ravi R, 2000, GENE DEV, V14, P34; Sack RA, 1999, CURR EYE RES, V18, P186, DOI 10.1076/ceyr.18.3.186.5367; Semenza GL, 2000, GENE DEV, V14, P1983; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Thakur A, 1998, J CLIN IMMUNOL, V18, P61, DOI 10.1023/A:1023291921695; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger RH, 2000, J EXP BIOL, V203, P1253; WIESENDANGER R, 1992, SCANNING TUNNELING M, V1, P1; Zundel W, 2000, GENE DEV, V14, P391; [No title captured]	24	490	521	1	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2001	414	6863					550	554		10.1038/35107085	http://dx.doi.org/10.1038/35107085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	496PV	11734856				2022-12-01	WOS:000172405900049
J	Blanco, P; Palucka, AK; Gill, M; Pascual, V; Banchereau, J				Blanco, P; Palucka, AK; Gill, M; Pascual, V; Banchereau, J			Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus	SCIENCE			English	Article							SOLUBLE CD40 LIGAND; B-LYMPHOCYTES; INTERFERON; DISEASE; ENHANCE; SERUM	Dendritic cells (DCs) are important in regulating both immunity and tolerance. Hence, we hypothesized that systemic lupus erythematosus (SLE), an autoimmune disease characterized by autoreactive B and T cells, may be caused by alterations in the functions of DCs. Consistent with this, monocytes from SLE patients' blood were found to function as antigen-presenting cells, in vitro. Furthermore, serum from SLE patients induced normal monocytes to differentiate into DCs. These DCs could capture antigens from dying cells and present them to CD4-positive T cells. The capacity of SLE patients' serum to induce DC differentiation correlated with disease activity and depended on the actions of interferon-alpha (IFN-alpha). Thus, unabated induction of DCs by IFN-alpha may drive the autoimmune response in SLE.	Baylor Inst Immunol Res, Dallas, TX 75204 USA; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	Baylor Scott & White Health; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Banchereau, J (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.		Pascual, Virginia/ABD-3099-2020		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046589] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR46589] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amoura Z, 1997, ARTHRITIS RHEUM, V40, P2217, DOI 10.1002/art.1780401217; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BLANCO PT, UNPUB; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Fayette J, 1998, SCAND J IMMUNOL, V48, P563; Galibert L, 1996, J EXP MED, V183, P77, DOI 10.1084/jem.183.1.77; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Herrmann M, 2000, IMMUNOL TODAY, V21, P424, DOI 10.1016/S0167-5699(00)01675-3; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; LAHITA RG, 1999, SYSTEMIC LUPUD ERYTH; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Lu LJ, 1999, J CLIN INVEST, V104, P345, DOI 10.1172/JCI6801; MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Tsokos GC, 2000, CURR OPIN RHEUMATOL, V12, P355, DOI 10.1097/00002281-200009000-00001; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Vallin H, 1999, CLIN EXP IMMUNOL, V115, P196; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1	26	977	1066	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1540	1543		10.1126/science.1064890	http://dx.doi.org/10.1126/science.1064890			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11711679				2022-12-01	WOS:000172240500053
J	Cheskin, LJ; Donze, LF				Cheskin, LJ; Donze, LF			Appearance vs health as motivators for weight loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EXERCISE		Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Cheskin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.		Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030				Brink PJ, 1998, WESTERN J NURS RES, V20, P84, DOI 10.1177/019394599802000106; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P199; CRAWFORD S, 1994, J SPORT EXERCISE PSY, V16, P70, DOI 10.1123/jsep.16.1.70; GILLETT PA, 1988, NURS RES, V37, P25; Green KL, 1997, CAN MED ASSOC J, V157, pS17; LEVY AS, 1993, ANN INTERN MED, V119, P661, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00007; Ryan RM, 1997, INT J SPORT PSYCHOL, V28, P335; WILSON GT, 1994, ADV BEHAV RES THER, V16, P31, DOI 10.1016/0146-6402(94)90002-7; Zayat EN, 1999, OBES RES, V7, P223, DOI 10.1002/j.1550-8528.1999.tb00705.x	9	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2001	286	17					2160	2160		10.1001/jama.286.17.2160	http://dx.doi.org/10.1001/jama.286.17.2160			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	490CD	11694161				2022-12-01	WOS:000172032100039
J	de Noronha, CMC; Sherman, MP; Lin, HW; Cavrois, MV; Moir, RD; Goldman, RD; Greene, WC				de Noronha, CMC; Sherman, MP; Lin, HW; Cavrois, MV; Moir, RD; Goldman, RD; Greene, WC			Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; PORE COMPLEXES; PREINTEGRATION COMPLEXES; LOCALIZATION SIGNAL; MUTATIONAL ANALYSIS; NONDIVIDING CELLS; GOLGI-APPARATUS; MATRIX PROTEIN; IN-VIVO	Human immunodeficiency virus-1 (HIV-1) Vpr expression halts the proliferation of human cells at or near the G(2) cell-cycle checkpoint. The transition from G(2) to mitosis is normally controlled by changes in the state of phosphorylation and subcellular compartmentalization of key cell-cycle regulatory proteins. In studies of the intracellular trafficking of these regulators, we unexpectedly found that wild-type Vpr, but not Vpr mutants impaired for G(2) arrest, induced transient, localized herniations in the nuclear envelope (NE). These herniations were associated with defects in the nuclear lamina. Intermittently, these herniations ruptured, resulting in the mixing of nuclear and cytoplasmic components. These Vpr-induced NE changes probably contribute to the observed cell-cycle arrest.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94103 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94103 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94103 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Northwestern University	Greene, WC (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94103 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER; NIAID NIH HHS [KO8 AI01866, R01 AI145234] Funding Source: Medline; NIMH NIH HHS [P30 MH59037] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Cecilia D, 1998, J VIROL, V72, P6988, DOI 10.1128/JVI.72.9.6988-6996.1998; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DENORONHA CM, UNPUB; DWORETZKY SI, 1988, J CELL BIOL, V106, P575, DOI 10.1083/jcb.106.3.575; Fouchier RAM, 1998, J VIROL, V72, P6004, DOI 10.1128/JVI.72.7.6004-6013.1998; Gallay P, 1996, J VIROL, V70, P1027, DOI 10.1128/JVI.70.2.1027-1032.1996; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P333, DOI 10.1089/aid.1994.10.333; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Gragerov A, 1998, VIROLOGY, V245, P323, DOI 10.1006/viro.1998.9138; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hrimech M, 1999, J VIROL, V73, P4101, DOI 10.1128/JVI.73.5.4101-4109.1999; JACKMAN M, 1995, EMBO J, V14, P1646, DOI 10.1002/j.1460-2075.1995.tb07153.x; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Mahalingam S, 1998, P NATL ACAD SCI USA, V95, P3419, DOI 10.1073/pnas.95.7.3419; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; Paddy MR, 1996, J CELL SCI, V109, P591; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; REFAELI Y, 1995, P NATL ACAD SCI USA, V92, P3621, DOI 10.1073/pnas.92.8.3621; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sherman MP, 2001, J VIROL, V75, P1522, DOI 10.1128/JVI.75.3.1522-1532.2001; STAFSTROM JP, 1984, EUR J CELL BIOL, V34, P179; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; VONSCHWEDLER U, 1994, P NATL ACAD SCI USA, V91, P6992, DOI 10.1073/pnas.91.15.6992; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; WENTE SR, 1994, J CELL BIOL, V125, P955, DOI 10.1083/jcb.125.5.955; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	45	216	218	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1105	1108		10.1126/science.1063957	http://dx.doi.org/10.1126/science.1063957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11691994				2022-12-01	WOS:000172013800051
J	Rehm, J; Gschwend, P; Steffen, T; Gutzwiller, F; Dobler-Mikola, A; Uchtenhagen, A				Rehm, J; Gschwend, P; Steffen, T; Gutzwiller, F; Dobler-Mikola, A; Uchtenhagen, A			Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study	LANCET			English	Article							TRIAL	Background Heroin-assisted substitution treatment for severely opioid-dependent drug users has been available in Switzerland since 1994. Our aim was to ascertain the feasibility, safety, and efficacy of this treatment. Methods We did a cohort study in 21 community outpatient treatment centres. We assessed 1969 opioid-dependent drug users, who began heroin-assisted substitution treatment between January, 1994, and December, 2000, to ascertain admission and discharge patterns, and patient characteristics. We also followed up a subset of 237 patients who began treatment between Jan 1, 1994, and March 31, 1995, and who stayed with the programme for at least 18 months. We used questionnaires, interviews, and medical examinations done at entry and after 6, 12, and 18 months to assess somatic and mental health, social integration, and treatment outcomes. Findings More than 70% (1378) of patients remained in treatment for more than a year. Treatment showed positive effects with respect to health and social outcomes. A long stay in treatment was related to a higher chance of starting abstinence-oriented therapy than a short stay. Interpretation: Heroin-assisted substitution treatment might be an effective option for chronically addicted patients for whom other treatments have failed.	Res Inst Addict, CH-8031 Zurich, Switzerland; Ctr Addict & Mental Hlth, Toronto, ON, Canada; Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Zurich	Rehm, J (corresponding author), Res Inst Addict, CH-8031 Zurich, Switzerland.	jtrehm@aol.com	Rem, Jürgen/H-1309-2011; Rehm, Jürgen/K-2147-2012	Rehm, Jürgen/0000-0001-5665-0385				ALI R, 1999, SUCHT, V45, P160; Bammer G, 1999, SCIENCE, V284, P1277, DOI 10.1126/science.284.5418.1277; CATTANEO M, 1993, EVALUATION FEDERAL M; CURDIN C, 2000, MED RUNDSCHAU PRAXIS, V89, P1899; DOBLERMIKOLA A, 1998, METHADON HEROINUNTER; *FED OFF PUBL HLTH, 1999, SCHWEIZ DROG STRAT V; Fischer B, 1997, CAN J PUBLIC HEALTH, V88, P367, DOI 10.1007/BF03403907; Frei A, 1998, SOZ PRAVENTIV MED, V43, P185, DOI 10.1007/BF01349248; FREI A, 2000, MED PRESCRIPTION NAR, V2, P37; GSCHWEND P, 1998, PRESCRIPTION NARCOTI; Kilias M, 1998, STUD CRIME PREVENT, V7, P127; Kleber H., 1981, SUBSTANCE ABUSE CLIN, P317; Klingemann H., 1998, DRUG TREATMENT SYSTE; Klingemann HKH, 1996, ADDICTION, V91, P723, DOI 10.1046/j.1360-0443.1996.9157238.x; RASCHKE P, 1994, SUBSTITUTIONSTHERAPI; REHM J, 1994, ENZYKLOPADIE PSYCH 1, V1, P508; REHM J, 2000, SUCHTMEDIZIN DIALOG, P71; REHM J, 2000, SUCHTTHERAPIE, V1, P57; ROSENBAUM M, 1988, CONTEMP DRUG PROBL, V15, P491; *SCHWEIZ BUND, 1992, VER 812 121 5 FORD W; Steffen T, 2001, SUBST USE MISUSE, V36, P71, DOI 10.1081/JA-100000229; Steffen T, 1999, INTERNIST, V40, P651, DOI 10.1007/s001080050385; Steffen T., 2000, SUCHTTHERAPIE, V1, P27, DOI [10.1055/s-2000-13255, DOI 10.1055/S-2000-13255]; *SWISS FED OFF PUB, 1991, 341F FOPH; UCHTENHAGEN A, 1999, PRESCRIPTION NARCOTI; UCHTENHAGEN A, 1985, HEROINABHANGIGE IHRE; van den Brink W, 1999, J DRUG ISSUES, V29, P587, DOI 10.1177/002204269902900309; ZELTNER T, 1996, ARZTLICHE VERSCHREIB	28	161	161	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 27	2001	358	9291					1417	1420		10.1016/S0140-6736(01)06529-1	http://dx.doi.org/10.1016/S0140-6736(01)06529-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	488MK	11705488				2022-12-01	WOS:000171940100013
J	Lu, Z; Klem, AM; Ramu, Y				Lu, Z; Klem, AM; Ramu, Y			Ion conduction pore is conserved among potassium channels	NATURE			English	Article							RECTIFIER K+ CHANNEL; VOLTAGE-SENSING RESIDUES; INWARD-RECTIFIER; STREPTOMYCES-LIVIDANS; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; GATING CHARGE; C-TERMINUS; RECTIFICATION; INACTIVATION	Potassium channels, a group of specialized membrane proteins, enable K+ ions to flow selectively across cell membranes. Transmembrane K+ currents underlie electrical signalling in neurons and other excitable cells. The atomic structure of a bacterial K+ channel pore has been solved by means of X-ray crystallography. To the extent that the prokaryotic pore is representative of other K+ channels, this landmark achievement has profound implications for our general understanding of K+ channels. But serious doubts have been raised concerning whether the prokaryotic K+ channel pore does actually represent those of eukaryotes. Here we have addressed this fundamental issue by substituting the prokaryotic pore into eukaryotic voltage-gated and inward-rectifier K+ channels. The resulting chimaeras retain the respective functional hallmarks of the eukaryotic channels, which indicates that the ion conduction pore is indeed conserved among K+ channels.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.							Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; Caprini M, 2001, J BIOL CHEM, V276, P21070, DOI 10.1074/jbc.M100487200; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Guo DL, 2000, J GEN PHYSIOL, V116, P561, DOI 10.1085/jgp.116.4.561; Hackos DH, 2001, BIOPHYS J, V80, p182A; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4	50	266	273	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					809	813		10.1038/35101535	http://dx.doi.org/10.1038/35101535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677598				2022-12-01	WOS:000171750200037
J	Hayes, PC; Lee, A				Hayes, PC; Lee, A			What progress with artificial livers?	LANCET			English	Editorial Material							FULMINANT HEPATIC-FAILURE; BIOARTIFICIAL LIVER; CHARCOAL HEMOPERFUSION; TRIAL		Royal Infirm, Dept Med & Anaesthet, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Hayes, PC (corresponding author), Royal Infirm, Dept Med & Anaesthet, Edinburgh EH3 9YW, Midlothian, Scotland.	phayes@srv1.med.ed.ac.uk						Clemmensen JO, 1997, EUR J GASTROEN HEPAT, V9, P55, DOI 10.1097/00042737-199701000-00014; Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1002/hep.510240625; GAZZARD BG, 1974, LANCET, V1, P1301; GERLACH JC, 1994, TRANSPLANTATION, V58, P984, DOI 10.1097/00007890-199411150-00002; KOBAYASHI N, 2000, SCIENCE, V287, P1185; Mitzner SR, 2000, LIVER TRANSPLANT, V6, P277, DOI 10.1053/lv.2000.6355; NYBERG SL, 1993, CELL TRANSPLANT, V2, P441, DOI 10.1177/096368979300200602; OGRADY JG, 1988, GASTROENTEROLOGY, V94, P1186, DOI 10.1016/0016-5085(88)90011-X; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Patzer JF, 1999, ANN NY ACAD SCI, V875, P340, DOI 10.1111/j.1749-6632.1999.tb08516.x; ROZGA J, 1994, ANN SURG, V219, P538, DOI 10.1097/00000658-199405000-00012; Sorkine P, 2001, CRIT CARE MED, V29, P1332, DOI 10.1097/00003246-200107000-00006; Tisaoussis J, 2001, LIVER TRANSPLANT, V7, P2, DOI 10.1053/jlts.2001.20845	13	7	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2001	358	9290					1286	1287		10.1016/S0140-6736(01)06454-6	http://dx.doi.org/10.1016/S0140-6736(01)06454-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484RC	11684205				2022-12-01	WOS:000171702500004
J	Wong, K; Ren, XR; Huang, YZ; Xie, Y; Liu, GF; Saito, H; Tang, H; Wen, L; Brady-Kalnay, SM; Mei, L; Wu, JY; Xiong, WC; Rao, Y				Wong, K; Ren, XR; Huang, YZ; Xie, Y; Liu, GF; Saito, H; Tang, H; Wen, L; Brady-Kalnay, SM; Mei, L; Wu, JY; Xiong, WC; Rao, Y			Signal transduction in neuronal migration: Roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway	CELL			English	Article							ACTIN-DEPOLYMERIZING PROTEIN; PHOTORECEPTOR AXON GUIDANCE; ALDRICH-SYNDROME PROTEIN; GROWTH-CONE COLLAPSE; ARP2/3 COMPLEX; N-WASP; DROSOPHILA-MELANOGASTER; CELL-ADHESION; RHO GTPASES; REPELLENT	The Slit protein guides neuronal and leukocyte migration through the transmembrane receptor Roundabout (Robo). We report here that the intracellular domain of Robo interacts with a novel family of Rho GTPase activating proteins (GAPs). Two of the Slit-Robo GAPs (srGAPs) are expressed in regions responsive to Slit. Slit increased srGAP1-Robo1 interaction and inactivated Cdc42. A dominant negative srGAP1 blocked Slit inactivation of Cdc42 and Slit repulsion of migratory cells from the anterior subventricular zone (SVZa) of the forebrain. A constitutively active Cdc42 blocked the repulsive effect of Slit. These results have demonstrated important roles for GAPs and Cdc42 in neuronal migration. We propose a signal transduction pathway from the extracellular guidance cue to intracellular actin polymerization.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University	Rao, Y (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	wxiong@path.uab.edu; raoyi@thalamus.wustl.edu	Tang, Hao/G-9841-2011; Mei, Lin/G-8755-2012		NCI NIH HHS [R01 CA114197-01A2] Funding Source: Medline; NEI NIH HHS [R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Battye R, 1999, DEVELOPMENT, V126, P2475; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cellbio.4.1.649; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Erskine L, 2000, J NEUROSCI, V20, P4975; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jin Z, 1997, J NEUROSCI, V17, P6256; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kuhn TB, 1999, J NEUROSCI, V19, P1965; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1999, CURR BIOL, V9, P405, DOI 10.1016/S0960-9822(99)80187-0; Niclou SP, 2000, J NEUROSCI, V20, P4962; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Paulus W, 1996, J VIROL, V70, P62, DOI 10.1128/JVI.70.1.62-67.1996; Pear Warren S., 1997, P41; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; SWIFT S, 1999, CURRENT PROTOCOL S31, V28; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	61	429	459	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2001	107	2					209	221		10.1016/S0092-8674(01)00530-X	http://dx.doi.org/10.1016/S0092-8674(01)00530-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672528	Bronze			2022-12-01	WOS:000171694800010
J	Heine, A; DeSantis, G; Luz, JG; Mitchell, M; Wong, CH; Wilson, IA				Heine, A; DeSantis, G; Luz, JG; Mitchell, M; Wong, CH; Wilson, IA			Observation of covalent intermediates in an enzyme mechanism at atomic resolution	SCIENCE			English	Article							FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; CRYSTAL-STRUCTURE; MUSCLE ALDOLASE; DEOXYRIBOSE-5-PHOSPHATE ALDOLASE; BINDING; CONDENSATION; ANTIBODIES; CATALYST; CLEAVAGE; ANGSTROM	In classical enzymology, intermediates and transition states in a catalytic mechanism are usually inferred from a series of biochemical experiments. Here, we derive an enzyme mechanism from true atomic-resolution x-ray structures of reaction intermediates. Two ultra-high resolution structures of wild-type and mutant D-2-deoxyribose-5-phosphate (DRP) aldolase complexes with DRP at 1.05 and 1.10 angstroms unambiguously identify the postulated covalent carbinolamine and Schiff base intermediates in the aldolase mechanism. In combination with site-directed mutagenesis and H-1 nuclear magnetic resonance, we can now propose how the heretofore elusive C-2 proton abstraction step and the overall stereochemical course are accomplished. A proton relay system appears to activate a conserved active-site water that functions as the critical mediator for proton transfer.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wong, CH (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044154, R37GM044154] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44154] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allard J, 2001, P NATL ACAD SCI USA, V98, P3679, DOI 10.1073/pnas.071380898; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; BARBAS CF, 1990, J AM CHEM SOC, V112, P2013, DOI 10.1021/ja00161a064; BARBAS CF, 1989, THESIS TEXAS A M U C; Blom N, 1997, NAT STRUCT BIOL, V4, P36, DOI 10.1038/nsb0197-36; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN LR, 1992, J AM CHEM SOC, V114, P741, DOI 10.1021/ja00028a050; Choi KH, 1999, BIOCHEMISTRY-US, V38, P12655, DOI 10.1021/bi9828371; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P439; COPLEY RR, 1994, J MOL BIOL, V242, P321; Dalby A, 1999, PROTEIN SCI, V8, P291; DeSantis G, 1998, J AM CHEM SOC, V120, P8582, DOI 10.1021/ja980072e; Fong S, 2000, CHEM BIOL, V7, P873, DOI 10.1016/S1074-5521(00)00035-1; GREEN MM, 1974, J ORG CHEM, V39, P2166, DOI 10.1021/jo00929a006; HEINE A, UNPUB; HOFFEE P, 1974, ARCH BIOCHEM BIOPHYS, V164, P736, DOI 10.1016/0003-9861(74)90087-3; Jia J, 1997, PROTEIN SCI, V6, P119; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlstrom A, 2000, P NATL ACAD SCI USA, V97, P3878, DOI 10.1073/pnas.97.8.3878; Kim H, 1998, BIOCHEMISTRY-US, V37, P4388, DOI 10.1021/bi972233h; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRISHNAN G, 1991, EUR J BIOCHEM, V195, P343, DOI 10.1111/j.1432-1033.1991.tb15712.x; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LITTLECHILD JA, 1993, TRENDS BIOCHEM SCI, V18, P36, DOI 10.1016/0968-0004(93)90048-R; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; MELOCHE HP, 1973, SCIENCE, V181, P350, DOI 10.1126/science.181.4097.350; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MORRIS AJ, 1994, BIOCHEMISTRY-US, V33, P12291, DOI 10.1021/bi00206a036; Morris AJ, 1996, PROTEIN ENG, V9, P61, DOI 10.1093/protein/9.1.61; NICHOLAS PC, 1988, BIOCHEM SOC T, V16, P752, DOI 10.1042/bst0160752; NICHOLAS PC, 1988, BIOCHEM SOC T, V76, P752; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRICER WE, 1960, J BIOL CHEM, V5, P1292; ROSE IA, 1967, ARCH BIOCHEM BIOPHYS, V118, P758, DOI 10.1016/0003-9861(67)90414-6; SCHMIDT DE, 1971, BIOCHEMISTRY-US, V10, P1249; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHERIFF S, 1993, IMMUNOMETHODS, V3, P191; SILVESTRI M, IN PRESS TOPICS STER; SYGUSCH J, 1987, P NATL ACAD SCI USA, V84, P7846, DOI 10.1073/pnas.84.22.7846; VALENTINHANSEN P, 1982, EUR J BIOCHEM, V125, P561, DOI 10.1111/j.1432-1033.1982.tb06719.x; Verlinde CLMJ, 1999, J MOL MODEL, V5, P37, DOI 10.1007/s008940050103; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; WESTHEIMER FH, 1995, TETRAHEDRON, V51, P3, DOI 10.1016/0040-4020(94)00865-R; Wymer N, 2001, STRUCTURE, V9, P1, DOI 10.1016/S0969-2126(00)00555-4; Zhong GF, 1999, ANGEW CHEM INT EDIT, V38, P3738, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3738::AID-ANIE3738>3.0.CO;2-2; Zhong GF, 1998, ANGEW CHEM INT EDIT, V37, P2481, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2481::AID-ANIE2481>3.0.CO;2-T	47	252	258	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					369	374		10.1126/science.1063601	http://dx.doi.org/10.1126/science.1063601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598300				2022-12-01	WOS:000171601400043
J	Seibel, BA; Walsh, PJ				Seibel, BA; Walsh, PJ			Carbon cycle - Potential, impacts of CO2 injection on deep-sea biota	SCIENCE			English	Editorial Material							ANIMALS; METABOLISM; DEPTH; ADAPTATIONS; HABITAT; FISHES; LIFE		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, NIEHS,Marine & Freshwater Biomed Sci Ctr, Miami, FL 33149 USA	Monterey Bay Aquarium Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Miami	Seibel, BA (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.							ARP AJ, 1985, PHYSIOL ZOOL, V58, P38, DOI 10.1086/physzool.58.1.30161218; AUERBACH D, 1996, OCEAN STORAGE CARBON, P41; BARRY JJA, UNPUB; Brewer P. G., 2000, OCEANOGRAPHY, V13, P84, DOI [DOI 10.5670/OCEANOG.2000.38, 10.5670/oceanog.2000.38]; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; Childress JJ, 1998, J EXP BIOL, V201, P1223; Drange H, 2001, GEOPHYS RES LETT, V28, P2637, DOI 10.1029/2000GL012609; Gage J.D., 1991, DEEP SEA BIOL NATURA, DOI 10.1017/CBO9781139163637; GIBBS A, 1990, MAR BIOL, V106, P315, DOI 10.1007/BF01344307; Goffredi SK, 2001, MAR BIOL, V138, P259, DOI 10.1007/s002270000462; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Haedrich RL, 1996, J FISH BIOL, V49, P40, DOI 10.1111/j.1095-8649.1996.tb06066.x; HEISLER N, 1989, CAN J ZOOL, V67, P2923, DOI 10.1139/z89-415; HENRY RP, 1990, J CRUSTACEAN BIOL, V10, P413, DOI 10.2307/1548331; Hunt JC, 2000, MAR BIOL, V136, P543, DOI 10.1007/s002270050714; Kerr RA, 2001, SCIENCE, V292, P1978, DOI 10.1126/science.292.5524.1978; Kochevar RE, 1996, MAR BIOL, V125, P375, DOI 10.1007/BF00346318; MARCHETTI C, 1977, CLIMATIC CHANGE, V1, P59, DOI 10.1007/BF00162777; MICKEL TJ, 1978, BIOL BULL, V154, P138, DOI 10.2307/1540779; Morgan IJ, 2001, GLOBAL CHANGE BIOL, V7, P345, DOI 10.1046/j.1365-2486.2001.00424.x; NOBLE RW, 1986, BIOCHIM BIOPHYS ACTA, V870, P552, DOI 10.1016/0167-4838(86)90265-7; Reipschloger A., 1996, OCEAN STORAGE CARBON, P57; Seibel BA, 1997, BIOL BULL, V192, P262, DOI 10.2307/1542720; SMITH KL, 1982, MAR BIOL, V68, P287, DOI 10.1007/BF00409595; Somero G.N., 1985, P454; Tamburri MN, 2000, MAR CHEM, V72, P95, DOI 10.1016/S0304-4203(00)00075-X; WALSH PJ, 1989, CAN J ZOOL, V67, P2994, DOI 10.1139/z89-422; White D, 2012, PHYSL BIOCH PROKARYO	28	154	163	4	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					319	320		10.1126/science.1065301	http://dx.doi.org/10.1126/science.1065301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598290				2022-12-01	WOS:000171601400030
J	Yokoyama, T; Yokoyama, S; Kamikado, T; Okuno, Y; Mashiko, S				Yokoyama, T; Yokoyama, S; Kamikado, T; Okuno, Y; Mashiko, S			Selective assembly on a surface of supramolecular aggregates with controlled size and shape	NATURE			English	Article							MOLECULES; AU(111); NANOSTRUCTURES; MANIPULATION; DEVICES	The realization of molecule-based miniature devices with advanced functions requires the development of new and efficient approaches for combining molecular building blocks into desired functional structures, ideally with these structures supported on suitable substrates(1-4). Supramolecular aggregation occurs spontaneously and can lead to controlled structures if selective and directional non-covalent interactions are exploited. But such selective supramolecular assembly has yielded almost exclusively crystals or dissolved structures(5); the self-assembly of absorbed molecules into larger structures(6-8), in contrast, has not yet been directed by controlling selective intermolecular interactions. Here we report the formation of surface-supported supramolecular structures whose size and aggregation pattern are rationally controlled by tuning the non-covalent interactions between individual absorbed molecules. Using low-temperature scanning tunnelling microscopy, we show that substituted porphyrin molecules adsorbed on a gold surface form monomers, trimers, tetramers or extended wire-like structures. We rnd that each structure corresponds in a predictable fashion to the geometric and chemical nature of the porphyrin substituents that mediate the interactions between individual adsorbed molecules. Our findings suggest that careful placement of functional groups that are able to participate in directed noncovalent interactions will allow the rational design and construction of a wide range of supramolecular architectures absorbed to surfaces.	Natl Inst Mat Sci, Moriyama Ku, Nagoya, Aichi 4630003, Japan; Commun Res Labs, Nishi Ku, Kobe, Hyogo 6512401, Japan	National Institute for Materials Science; National Institute of Information & Communications Technology (NICT) - Japan	Yokoyama, T (corresponding author), Natl Inst Mat Sci, Moriyama Ku, 2268-1 Shimo Shidami, Nagoya, Aichi 4630003, Japan.	Yokoyama.takashi@nims.go.jp	Yokoyama, Takashi/B-9845-2011					BARTH JV, 1990, PHYS REV B, V42, P9307, DOI 10.1103/PhysRevB.42.9307; Barth JV, 2000, ANGEW CHEM INT EDIT, V39, P1230, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1230::AID-ANIE1230>3.0.CO;2-I; Bohringer M, 1999, PHYS REV LETT, V83, P324, DOI 10.1103/PhysRevLett.83.324; Cai LT, 2000, APPL PHYS LETT, V77, P3105, DOI 10.1063/1.1323546; CHAMBLISS DD, 1991, PHYS REV LETT, V66, P1721, DOI 10.1103/PhysRevLett.66.1721; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; DEREGE PJF, 1995, SCIENCE, V269, P1409, DOI 10.1126/science.7660123; FIND HW, 1999, NATURE, V398, P407; Furukawa M, 2000, SURF SCI, V445, pL58, DOI 10.1016/S0039-6028(99)01068-7; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Jung TA, 1996, SCIENCE, V271, P181, DOI 10.1126/science.271.5246.181; Jung TA, 1997, NATURE, V386, P696, DOI 10.1038/386696a0; Lopinski GP, 2000, NATURE, V406, P48, DOI 10.1038/35017519; Moresco F, 2001, PHYS REV LETT, V86, P672, DOI 10.1103/PhysRevLett.86.672; Moresco F, 2001, APPL PHYS LETT, V78, P306, DOI 10.1063/1.1339251; Sanders JK, 1995, SUPRAMOLECULAR CHEM, V107, P2617; Sugiura K, 1999, CHEM LETT, P841, DOI 10.1246/cl.1999.841; Wada Y, 2000, JPN J APPL PHYS 1, V39, P3835, DOI 10.1143/JJAP.39.3835; Yokoyama T, 2001, J CHEM PHYS, V115, P3814, DOI 10.1063/1.1389276; Yokoyama T, 1999, PHYS REV B, V59, P12232, DOI 10.1103/PhysRevB.59.12232	20	741	748	8	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					619	621		10.1038/35098059	http://dx.doi.org/10.1038/35098059			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675782				2022-12-01	WOS:000171485700045
J	Zwart, F				Zwart, F			A very special day	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 26	1997	315	7102					260	260		10.1136/bmj.315.7102.260	http://dx.doi.org/10.1136/bmj.315.7102.260			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN517	11644985	Green Published			2022-12-01	WOS:A1997XN51700077
J	Rabinowitz, B				Rabinowitz, B			The great hijack	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 28	1996	313	7060					826	826						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VK566	11644828				2022-12-01	WOS:A1996VK56600087
J	DUNEA, G				DUNEA, G			EDITORS IN DISTRESS	BRITISH MEDICAL JOURNAL			English	Editorial Material																		1988, BR MED J, V296, P307; 1988, JAMA            0108, P272	2	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 6	1988	297	6645					430	430		10.1136/bmj.297.6645.430	http://dx.doi.org/10.1136/bmj.297.6645.430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5450	11644468	Green Published, Bronze			2022-12-01	WOS:A1988P545000065
J	Boettcher, B				Boettcher, B			Fatal episodes in medical history	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 5	1998	317	7172					1603	1603						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146VC	9836691				2022-12-01	WOS:000077451700090
J	AOUN, H				AOUN, H			FROM THE EYE OF THE STORM, WITH THE EYES OF A PHYSICIAN	ANNALS OF INTERNAL MEDICINE			English	Note						ACQUIRED IMMUNODEFICIENCY SYNDROME; PHYSICIAN-PATIENT RELATIONS; EDUCATION, MEDICAL; SOCIAL SUPPORT; ETHICS, MEDICAL		A physician acquires a terrible disease and, as a patient, is confronted with aspects of medical care that contribute to the suffering rather than the healing. As a result of these experiences, his views on what constitutes a good physician become simpler. A good physician cares for his patients and works toward preserving their dignity and independence. The issue is raised of whether current medical education can be effective in producing that caring physician, for it is particularly in caring for patients with catastrophic or incurable illnesses that the role of the physician is more, not less, important.										AOUN H, 1989, NEW ENGL J MED, V321, P693, DOI 10.1056/NEJM198909073211020; AOUN H, 1991, NEW ENGL J MED, V324, P265, DOI 10.1056/NEJM199101243240412; Harrison TR, 1950, PRINCIPLES INTERNAL; NATELSON BH, 1990, TOMORROWS DOCTORS PA; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; RABIN D, 1982, NEW ENGL J MED, V307, P506, DOI 10.1056/NEJM198208193070827; RABIN R, 1985, 6 PARTS LOVE ONE FAM; TOSTESON DC, 1990, NEW ENGL J MED, V322, P234, DOI 10.1056/NEJM199001253220405	8	23	23	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1992	116	4					335	338		10.7326/0003-4819-116-4-335	http://dx.doi.org/10.7326/0003-4819-116-4-335			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD546	11651175				2022-12-01	WOS:A1992HD54600012
